Representing term id	Representing term name	Representing term size	Representing term rank	Represented term number	gwas_female_adolescent_terms_by_significance.txt term rank	gwas_female_adult_terms_by_significance.txt term rank	gwas_female_child_terms_by_significance.txt term rank	gwas_female_infant_terms_by_significance.txt term rank	gwas_female_middle_adult_terms_by_significance.txt term rank	gwas_female_old_adult_terms_by_significance.txt term rank	gwas_female_older_adult_terms_by_significance.txt term rank	gwas_female_young_adult_terms_by_significance.txt term rank	gwas_female_young_child_terms_by_significance.txt term rank	gwas_male_adolescent_terms_by_significance.txt term rank	gwas_male_adult_terms_by_significance.txt term rank	gwas_male_child_terms_by_significance.txt term rank	gwas_male_infant_terms_by_significance.txt term rank	gwas_male_middle_adult_terms_by_significance.txt term rank	gwas_male_old_adult_terms_by_significance.txt term rank	gwas_male_older_adult_terms_by_significance.txt term rank	gwas_male_young_adult_terms_by_significance.txt term rank	gwas_male_young_child_terms_by_significance.txt term rank
1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	1654_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for age and sex)	25	1	1	1	1395	2992	2604	612	1907	1503	1533	1757	4164	3214	143	3284	2251	2953	2156	1077	2761
3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	3699_Diagnoses - secondary ICD10: K57 Diverticular disease of intestine	25	1	1	462	1	740	4445	3831	1744	436	1554	1264	1981	1190	2019	1778	2892	735	3975	2432	325
3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	3663_Cancer register - Behaviour of cancer tumour: Malignant, primary site	25	1	1	135	932	1	77	3566	3242	4542	2836	584	316	24	250	28	915	1720	3375	96	288
2997_FGG - Fibrinogen gamma chain	2997_FGG - Fibrinogen gamma chain	25	1	1	1058	2558	553	1	3	1695	2821	3417	3924	54	2409	1260	1	2388	19	562	1	545
1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	1320_Adiponectin (FBAT, adjusted for age, sex and BMI)	25	1	1	3572	37	118	778	1	3700	1268	1969	2280	2579	3156	1306	2033	970	1189	474	3300	2989
2304_CXCL1 - Growth-regulated alpha protein	2304_CXCL1 - Growth-regulated alpha protein	25	1	1	3713	200	972	644	1003	1	2913	158	1302	198	3301	2677	2281	455	3441	1216	623	750
889_Total lipids in large HDL	889_Total lipids in large HDL	25	1	1	2156	3136	1767	2217	4581	999	1	434	4719	1158	155	784	2140	106	1987	311	171	1987
4051_Anterior cruciate ligament rupture (random effect model)	4051_Anterior cruciate ligament rupture (random effect model)	25	1	1	2	2463	2021	2323	148	2039	3286	1	646	1915	1776	1774	1449	325	2035	1300	94	694
1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	1652_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for multivariable)	25	1	1	1663	4185	306	1725	3247	1713	787	1885	1	814	185	2737	137	1425	3588	494	3015	27
3529_Never eat eggs, dairy, wheat, sugar: Wheat products	3529_Never eat eggs, dairy, wheat, sugar: Wheat products	25	1	1	235	1783	17	373	96	388	1755	1590	1149	1	21	210	91	283	3360	3753	215	2632
4026_Childhood idiopathic nephrotic syndrome	4026_Childhood idiopathic nephrotic syndrome	25	1	1	1625	315	45	87	819	4402	4279	797	1140	91	1	393	138	74	4584	3482	71	1513
3544_Mouth/teeth dental problems: Mouth ulcers	3544_Mouth/teeth dental problems: Mouth ulcers	25	1	1	3896	139	1192	2462	3934	1117	13	83	3283	2128	4009	1	175	342	2393	2	2491	257
567_Lipid::Sphingolipid::palmitoyl sphingomyelin	567_Lipid::Sphingolipid::palmitoyl sphingomyelin	25	1	1	329	799	564	37	731	4706	2102	1106	63	471	4311	2925	266	1	254	412	120	900
1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	1273_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI and usual sleep duration)	25	1	1	2031	4	2047	1675	3881	4173	4359	381	955	246	1743	3787	1370	3281	1	3108	4479	591
3408_Average weekly intake of other alcoholic drinks	3408_Average weekly intake of other alcoholic drinks	25	1	1	596	731	2385	217	607	16	1180	67	4	2700	146	2533	236	1702	3066	1	9	11
4496_Right posterior cingulate	4496_Right posterior cingulate	25	1	1	216	3612	172	902	3074	3153	259	4678	127	3087	203	719	556	65	2336	420	311	1
526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	526_Lipid::Long chain fatty acid::palmitoleate (16:1n7)	25	2	1	4551	2	3052	436	206	32	152	185	3016	3024	1839	851	178	4708	3158	24	192	153
2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	2771_ANP32B - Acidic leucine-rich nuclear phosphoprotein 32 family member B	25	2	1	2544	1712	2	980	43	3103	839	2172	4196	1404	273	58	633	81	3880	3326	1382	688
2214_FGA FGB FGG - Fibrinogen	2214_FGA FGB FGG - Fibrinogen	25	2	1	1666	935	4618	2	570	3876	620	2211	1879	430	2643	822	2	2357	118	140	39	10
32_Neuroticism (IRT)	32_Neuroticism (IRT)	25	2	1	4220	2725	4323	4641	2	4128	701	801	1584	2186	4724	3730	4238	3980	385	4593	3696	4575
2549_FGF1 - Fibroblast growth factor 1	2549_FGF1 - Fibroblast growth factor 1	25	2	1	3875	3718	67	126	2133	2	453	4090	4011	1920	64	1534	121	1183	3202	4071	108	1112
956_Free cholesterol in very large HDL	956_Free cholesterol in very large HDL	25	2	1	4366	2431	869	1495	4438	4032	2	85	1547	3145	186	93	4660	194	697	885	68	4579
4050_Anterior cruciate ligament rupture (fixed effect model)	4050_Anterior cruciate ligament rupture (fixed effect model)	25	2	1	9	4281	4198	976	213	4312	4211	2	1309	4199	2989	4175	319	2507	3705	671	23	3324
4450_Left inferior parietal	4450_Left inferior parietal	25	2	1	338	3859	1116	561	3865	3082	940	3019	2	958	2962	238	373	3607	2739	2613	355	3966
208_Rheumatoid Arthritis	208_Rheumatoid Arthritis	25	2	1	672	3362	37	530	97	3584	187	273	395	2	32	731	165	652	1290	3442	140	699
67_Inflammatory Bowel Disease	67_Inflammatory Bowel Disease	25	2	1	101	963	13	154	3872	3165	205	103	196	632	2	920	90	184	229	408	106	272
3327_Had major operations	3327_Had major operations	25	2	1	4651	2443	268	16	1746	3169	1034	4528	3626	3419	2333	2	38	3553	819	3690	318	3335
3943_HbA1c	3943_HbA1c	25	2	1	1008	4001	4155	1854	734	2659	1902	3308	1820	2676	2331	2009	591	2	3952	3352	314	2195
4631_Right lateral ventricle	4631_Right lateral ventricle	25	2	1	1231	408	2731	104	207	5	28	98	952	4262	1173	2109	257	2263	2	38	128	2723
819_::::X-13435	819_::::X-13435	25	2	1	2265	3524	1912	4613	1195	2230	760	448	1785	2898	207	2780	2990	18	1004	88	2	4495
1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	1853_Neck average buckling ratio (GEE, male, adjussted for multivariable)	25	2	1	2439	4394	4616	212	4162	322	4613	2287	25	201	2115	999	527	3529	2504	64	3988	2
2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	2381_NAAA - N-acylethanolamine-hydrolyzing acid amidase	25	3	1	3	1660	4641	3006	4199	852	4126	1758	660	685	2223	1841	1988	154	3513	1707	3375	2030
1269_Epworth Sleepiness Scale (GEE)	1269_Epworth Sleepiness Scale (GEE)	25	3	1	1808	3	1148	319	4396	1153	3506	201	2142	2653	3960	2721	584	2900	49	3652	4605	1153
690_::::X-11261	690_::::X-11261	25	3	1	4552	2799	3	870	4244	3434	1722	1614	1426	826	1310	1960	1289	29	333	1750	353	2438
4190_Type 2 Diabetes	4190_Type 2 Diabetes	25	3	1	2047	4114	1899	3	862	929	1572	3663	3750	321	3148	1263	4	826	17	1034	294	258
2121_TACSTD2 - Tumor-associated calcium signal transducer 2	2121_TACSTD2 - Tumor-associated calcium signal transducer 2	25	3	1	511	193	3867	1521	2590	3	652	192	90	1986	2610	1922	752	908	5	113	52	456
754_::::X-12093	754_::::X-12093	25	3	1	150	3290	1622	85	622	2373	3	28	16	1197	3940	47	946	3744	346	3532	1148	2697
2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	2016_Lithium response in Bipolar I patients - Alda Scale of 5 to 6	25	3	1	11	1659	2336	925	39	4663	458	3	3993	3471	4604	4429	1234	1720	1312	967	126	2402
2476_CD207 - C-type lectin domain family 4 member K	2476_CD207 - C-type lectin domain family 4 member K	25	3	1	824	3973	483	1876	1936	1273	85	145	3	1434	3013	2044	1292	2555	3337	3260	2671	1220
3601_Non-cancer illness code, self-reported: diabetes	3601_Non-cancer illness code, self-reported: diabetes	25	3	1	615	588	21	481	94	1229	3474	2895	2404	3	49	424	244	604	1501	2631	66	1138
4267_Asthma (adult-onset)	4267_Asthma (adult-onset)	25	3	1	2028	3380	22	915	2076	4656	3321	1926	3855	259	3	3798	109	438	2743	1934	366	1463
3952_Amyotrophic lateral sclerosis (logistic)	3952_Amyotrophic lateral sclerosis (logistic)	25	3	1	1186	946	2080	944	1081	4717	1237	1683	4365	4382	3798	3	215	1496	2327	1394	289	1970
2352_C9 - Complement component C9	2352_C9 - Complement component C9	25	3	1	1637	2569	687	7	627	1669	3664	406	944	60	1595	1195	3	3500	817	1205	19	1168
2856_ZAP70 - Tyrosine-protein kinase ZAP-70	2856_ZAP70 - Tyrosine-protein kinase ZAP-70	25	3	1	2564	2575	708	2816	2258	3934	927	965	2463	4365	4264	190	1716	3	2138	188	934	193
1984_Age at natural menopause (FBAT, adjusted for multivariable)	1984_Age at natural menopause (FBAT, adjusted for multivariable)	25	3	1	3487	2401	4314	3256	3297	1727	1359	3318	3970	1416	3167	2467	3785	2636	3	714	3833	3110
4091_Proxy and clinically diagnosed Alzheimer's disease	4091_Proxy and clinically diagnosed Alzheimer's disease	25	3	1	3056	4591	722	1515	978	1691	3498	91	1869	2644	3894	156	515	2661	1902	3	1909	33
2024_Alcohol dependence	2024_Alcohol dependence	25	3	1	69	4277	3269	4088	46	3105	265	5	743	2384	1133	795	4330	38	3718	96	3	428
3596_Mineral and other dietary supplements: Iron	3596_Mineral and other dietary supplements: Iron	25	3	1	845	877	1611	195	1674	4263	2793	731	102	749	109	657	120	3070	1201	101	1899	3
1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	1730_Chronic kidney disease (at exam 7, FBAT, adjusted for age and sex)	25	4	1	4	2614	3475	4330	2512	3460	2297	379	3702	846	4672	490	3556	868	1454	1384	973	2711
69_Ulcerative Colitis	69_Ulcerative Colitis	25	4	1	198	3663	4	254	728	2343	2694	571	2603	185	19	984	77	520	2040	3275	59	557
200_Microalbuminuria	200_Microalbuminuria	25	4	1	537	3186	3866	4	1028	2870	4189	3150	2705	1847	4575	4232	5	2635	63	986	226	1589
2125_Human-virus - Protein E7_HPV18	2125_Human-virus - Protein E7_HPV18	25	4	1	193	56	2052	467	4	337	145	157	497	2283	537	3381	1412	2077	2177	57	158	903
719_::::X-11537	719_::::X-11537	25	4	1	2066	3042	201	1546	2240	4	3518	2797	83	4429	415	1326	56	4566	416	583	4401	83
954_Total cholesterol in very large HDL	954_Total cholesterol in very large HDL	25	4	1	866	2369	817	1002	1849	2401	4	118	4132	2691	28	107	2940	44	1299	1783	11	3880
2027_Cryptorchidism (group 1)	2027_Cryptorchidism (group 1)	25	4	1	25	759	1340	935	768	4124	250	4	2661	3113	894	697	387	3041	1274	1244	49	84
83_Lumbar Spine BMD	83_Lumbar Spine BMD	25	4	1	2251	980	2496	4664	2111	4133	563	3412	3728	4	442	520	3542	4318	1354	2930	1765	1602
3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	3605_Non-cancer illness code, self-reported: hayfever/allergic rhinitis	25	4	1	4331	318	16	2143	138	2876	780	2888	4651	338	4	1238	42	31	267	3535	755	658
3054_GPNMB - Transmembrane glycoprotein NMB	3054_GPNMB - Transmembrane glycoprotein NMB	25	4	1	1959	4149	253	23	2011	1467	2490	895	1041	3257	2412	4	44	865	3737	2940	2842	3794
1163_Hemoglobin A1C	1163_Hemoglobin A1C	25	4	1	604	577	2734	2677	317	2578	1369	2430	3057	2406	2958	1297	71	4	2525	4336	201	2911
423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	423_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxovalerate	25	4	1	1928	2610	2012	2279	3647	2566	4013	4261	2060	2876	2127	2883	1549	818	4	3931	1112	2338
3646_Illnesses of mother: Alzheimer's disease/dementia	3646_Illnesses of mother: Alzheimer's disease/dementia	25	4	1	2465	2301	709	1980	552	1937	4035	216	2092	2626	1729	90	1026	2267	31	4	1694	52
2025_10 mg response to amphetamine	2025_10 mg response to amphetamine	25	4	1	22	1751	2297	4518	120	4025	431	21	903	428	175	2711	321	429	2322	45	4	380
4597_Right posterior cingulate	4597_Right posterior cingulate	25	4	1	29	4613	162	1073	3127	2160	258	1433	139	1770	839	3031	1052	215	2605	1040	390	4
276_CD4:%RTE	276_CD4:%RTE	25	5	1	5	959	1500	660	1137	133	2026	3149	447	668	3630	582	341	2983	893	1828	32	293
1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	1271_Epworth Sleepiness Scale (GEE, adjusted for age, sex and BMI)	25	5	1	4205	5	1470	1009	2749	4279	3542	320	1741	1093	3648	3238	1418	3157	7	4401	3321	653
3938_Bisecting GlcNAc	3938_Bisecting GlcNAc	25	5	1	2899	2577	5	590	955	1062	2590	369	3598	926	93	2520	409	3811	586	4009	45	2105
331_NKeff:%Act(314+)	331_NKeff:%Act(314+)	25	5	1	2151	4558	2165	5	1271	362	1792	3724	1439	3499	2703	2397	11	4250	618	691	490	504
4558_Left middle temporal	4558_Left middle temporal	25	5	1	552	885	1917	91	5	815	1181	551	4028	648	477	2329	688	3559	210	485	3249	3104
955_Cholesterol esters in very large HDL	955_Cholesterol esters in very large HDL	25	5	1	440	2135	4439	822	1656	3401	5	48	1862	912	62	503	2261	328	1397	921	27	2095
4582_Right inferior parietal	4582_Right inferior parietal	25	5	1	2086	4057	2299	1407	282	667	4193	1742	5	522	3263	519	1819	3778	2539	1153	348	1208
2030_Ulcerative colitis	2030_Ulcerative colitis	25	5	1	158	4222	27	265	573	4522	4466	911	1530	5	27	581	146	632	1878	1570	132	1450
4235_Adrenergics, inhalants	4235_Adrenergics, inhalants	25	5	1	2407	3958	36	932	908	2425	4457	2565	3563	354	5	1076	78	41	2298	3259	360	756
998_Monocyte chemotactic protein-1 (CCL2)	998_Monocyte chemotactic protein-1 (CCL2)	25	5	1	124	1568	2226	350	1959	3348	59	32	1004	254	1583	5	70	3303	85	508	1780	3169
528_Lipid::Long chain fatty acid::stearate (18:0)	528_Lipid::Long chain fatty acid::stearate (18:0)	25	5	1	4010	3987	1026	994	3846	2693	3971	503	4245	1957	620	2507	1472	5	3721	233	4663	2200
1004_Macrophage inflammatory protein-1 (CCL4)	1004_Macrophage inflammatory protein-1 (CCL4)	25	5	1	2004	1988	2277	2994	3877	1965	35	2190	466	3892	2686	101	1214	2613	1279	5	3307	3986
537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	537_Lipid::Lysolipid::1-linoleoylglycerophosphocholine	25	5	1	829	3473	1569	1782	1253	699	3283	3347	2798	4354	107	3278	2583	333	4735	688	5	3435
2576_SERPINA1 - Alpha-1-antitrypsin	2576_SERPINA1 - Alpha-1-antitrypsin	25	5	1	4549	1785	662	10	192	3076	3708	2134	1093	4115	4366	66	7	1727	71	663	1462	5
210_Insomnia	210_Insomnia	25	6	1	6	1220	1104	3573	1087	1011	171	1970	3034	297	91	370	1563	688	4181	4183	1121	4357
2334_IL1B - Interleukin-1 beta	2334_IL1B - Interleukin-1 beta	25	6	1	1331	6	1009	247	1517	2237	2647	4728	3782	1563	238	2788	2314	4388	689	2188	2060	3260
3813_CD4+ T cell level	3813_CD4+ T cell level	25	6	1	881	976	6	1624	215	1313	3804	269	4047	7	83	30	3086	2848	2407	1417	1327	2790
267_CD4:%Exhausted	267_CD4:%Exhausted	25	6	1	1263	3209	3956	6	1600	2140	2514	3668	4258	729	2732	2687	6	3005	30	372	101	660
3823_Systemic Lupus Erythematosus	3823_Systemic Lupus Erythematosus	25	6	1	2006	4670	76	2082	6	464	3666	404	1918	225	38	2170	211	20	3341	1454	3648	3926
2887_IL34 - Interleukin-34	2887_IL34 - Interleukin-34	25	6	1	3750	400	4446	415	2741	6	500	1744	919	1759	279	4028	282	852	2671	3612	3828	89
957_Total lipids in very large HDL	957_Total lipids in very large HDL	25	6	1	1674	3045	815	1012	3918	4590	6	37	1629	3078	407	192	4242	125	551	1102	78	2638
2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	2018_Lithium response in Bipolar I patients - Alda Scale of 7 to 8	25	6	1	15	1664	2382	187	191	2513	3105	6	3929	2552	2129	1016	1786	2832	4600	296	450	1093
843_::::X-14626	843_::::X-14626	25	6	1	626	1496	3688	3047	2391	147	503	3709	6	1239	1088	3793	2356	861	1564	4685	928	2522
3328_Diabetes (diagnosed by doctor)	3328_Diabetes (diagnosed by doctor)	25	6	1	648	503	25	380	74	1414	4257	2802	2186	6	56	540	285	689	1674	3238	67	1744
2031_Inflammatory Bowel Disease	2031_Inflammatory Bowel Disease	25	6	1	380	801	12	186	3161	2565	188	213	512	1657	6	1217	111	388	297	779	100	926
3198_Frequency of travelling from home to job workplace	3198_Frequency of travelling from home to job workplace	25	6	1	3200	4381	3679	1661	1690	2759	4665	2001	619	1011	3839	6	1734	973	2990	3748	1125	381
2069_FLT4 - Vascular endothelial growth factor receptor 3	2069_FLT4 - Vascular endothelial growth factor receptor 3	25	6	1	1711	676	4010	2776	851	4060	4163	1504	1849	3173	3499	831	2349	6	1138	4293	1825	4653
2874_CBX5 - Chromobox protein homolog 5	2874_CBX5 - Chromobox protein homolog 5	25	6	1	2681	951	3644	107	132	1197	254	2384	1163	860	3752	3517	1491	4202	6	3345	1476	1960
1090_Alcohol dependence	1090_Alcohol dependence	25	6	1	3614	100	204	2073	2774	34	2177	277	1443	29	1848	2223	190	1761	2531	6	805	4137
4_Autism spectrum disorder	4_Autism spectrum disorder	25	6	1	3589	47	4049	3511	66	3937	3375	1260	3305	2080	204	1664	950	3113	922	1347	6	897
3046_CD55 - Complement decay-accelerating factor	3046_CD55 - Complement decay-accelerating factor	25	6	1	3314	4668	1841	138	4465	536	25	2411	3607	936	374	233	51	2332	3093	2083	1376	6
4311_Diverticular disease	4311_Diverticular disease	25	7	1	7	7	3292	4444	1374	202	34	1460	114	570	81	274	2324	377	2439	1606	936	408
1194_Ulcerative colitis	1194_Ulcerative colitis	25	7	1	156	3409	7	307	911	2884	2337	2199	3308	35	9	1207	154	373	1227	2536	57	811
1203_Rheumatoid Arthritis	1203_Rheumatoid Arthritis	25	7	1	2895	2723	269	1264	7	450	525	393	2673	17	196	1063	400	1239	3633	1427	895	1173
3931_Monogalactosylation	3931_Monogalactosylation	25	7	1	3900	614	123	993	1645	7	4527	2553	2840	3296	3972	1550	1013	1116	3408	1886	1672	3235
887_Cholesterol esters in large HDL	887_Cholesterol esters in large HDL	25	7	1	1727	3565	2560	2775	4280	884	7	424	2875	803	183	629	2259	51	1411	264	77	2653
2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	2015_Lithium response in Bipolar I patients - Alda Scale of 4 to 5	25	7	1	476	1768	1002	1483	59	2497	192	7	2706	3007	2961	3829	2143	1347	3908	1355	25	3359
1982_Walking speed (at exam 7, FBAT)	1982_Walking speed (at exam 7, FBAT)	25	7	1	2170	1627	2389	1887	2341	998	295	1014	7	3400	2687	3279	4393	2811	116	1025	4228	240
3818_Asthma, hay fever or eczema	3818_Asthma, hay fever or eczema	25	7	1	4435	2550	57	3195	4031	1823	693	4496	2807	1948	7	95	162	32	38	2952	114	1799
2127_IL1RAP - Interleukin-1 Receptor accessory protein	2127_IL1RAP - Interleukin-1 Receptor accessory protein	25	7	1	2630	2364	104	17	4271	4632	2540	1852	4628	3698	518	7	10	1014	2704	2612	1236	481
995_Interleukin-8 (CXCL8)	995_Interleukin-8 (CXCL8)	25	7	1	1042	4425	3345	3158	2719	2932	348	900	2261	2224	4344	1123	667	7	318	2092	3942	1305
3921_Triglycerides cholesterol	3921_Triglycerides cholesterol	25	7	1	1049	549	750	3799	49	613	293	3118	3226	3422	863	453	4113	827	4097	7	1886	2622
479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	479_Lipid::Carnitine metabolism::cis-4-decenoyl carnitine	25	7	1	656	3494	358	3722	1650	3659	3540	1216	783	4030	973	546	3459	1078	16	536	7	2081
2826_FGF8 - Fibroblast growth factor 8 isoform A	2826_FGF8 - Fibroblast growth factor 8 isoform A	25	7	1	4273	1403	3555	1947	4604	1101	3484	3919	3592	337	3295	3879	2432	1554	1430	1685	4259	7
3093_SCARF2 - Scavenger receptor class F member 2	3093_SCARF2 - Scavenger receptor class F member 2	25	8	1	8	2743	1664	342	966	2969	1675	3580	931	127	449	216	1063	988	2827	2461	237	4499
428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	428_Amino acid::Valine, leucine and isoleucine metabolism::isobutyrylcarnitine	25	8	1	1694	8	1557	3685	1421	3154	99	1388	204	1188	1875	3285	4143	587	2773	3207	3085	2700
4414_Total IgA levels	4414_Total IgA levels	25	8	1	1178	2623	8	399	4324	3540	933	2965	227	900	4400	718	69	4695	834	2933	4629	474
3414_Birth weight	3414_Birth weight	25	8	1	4312	2767	707	8	3646	1312	2347	3015	371	4513	2823	26	14	241	3671	1656	704	3714
2743_IL6R - Interleukin-6 receptor subunit alpha	2743_IL6R - Interleukin-6 receptor subunit alpha	25	8	1	3361	2479	4292	3936	8	1993	543	4364	1373	3765	2231	4372	2779	1190	2269	1038	1049	1008
244_CD32 on mDC	244_CD32 on mDC	25	8	1	97	458	487	1398	2782	8	3261	1266	3205	1292	299	1338	788	3063	2000	1097	42	3696
4098_Total cholesterol	4098_Total cholesterol	25	8	1	3700	1201	2552	4480	1227	2294	8	3335	1247	4165	3255	256	2818	1866	4361	263	1413	3315
2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	2017_Lithium response in Bipolar I patients - Alda Scale of 6 to 7	25	8	1	179	1181	2878	3486	33	2224	194	8	3991	946	1307	1700	3273	1530	2758	2292	16	3840
2349_KLRK1 - NKG2-D type II integral membrane protein	2349_KLRK1 - NKG2-D type II integral membrane protein	25	8	1	1034	1306	3202	916	4249	467	209	1252	8	468	2436	765	2300	3215	4624	122	926	4425
763_::::X-12216	763_::::X-12216	25	8	1	1499	3493	2601	458	752	608	4326	2633	65	8	1557	21	1162	2547	1627	865	103	3112
4266_Asthma (child-onset)	4266_Asthma (child-onset)	25	8	1	3131	4292	34	1551	4111	2416	4422	4126	2867	1351	8	259	59	719	452	672	136	670
4193_PR interval	4193_PR interval	25	8	1	2680	2381	711	4714	4723	983	4596	160	4321	3294	3780	8	3980	3062	3470	1351	4366	4383
783_::::X-12524	783_::::X-12524	25	8	1	21	761	1333	26	1993	4066	116	2769	234	2702	1906	1212	8	1992	1919	373	2047	773
3902_Reticulocyte count (three-way meta)	3902_Reticulocyte count (three-way meta)	25	8	1	2631	1368	2956	4097	4705	373	1103	483	1119	683	1371	925	3881	8	1927	447	3544	2747
387_Amino acid::Histidine metabolism::histidine	387_Amino acid::Histidine metabolism::histidine	25	8	1	4280	2430	595	42	4366	198	1595	1666	2623	4273	4316	678	3517	303	8	1795	498	4733
4090_Family history of Alzheimer's disease	4090_Family history of Alzheimer's disease	25	8	1	952	2080	1532	1250	923	2975	4198	253	863	2565	1068	283	3843	421	65	8	4658	138
2026_Baseline positive affect factor score	2026_Baseline positive affect factor score	25	8	1	1120	784	1576	1929	353	1089	1135	27	1449	731	4652	4059	2667	272	4355	2528	8	836
2825_FGF16 - Fibroblast growth factor 16	2825_FGF16 - Fibroblast growth factor 16	25	8	1	3229	570	2228	1648	1110	1408	2301	3541	717	2602	4251	4116	1030	108	1620	289	1910	8
421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	421_Amino acid::Valine, leucine and isoleucine metabolism::2-methylbutyroylcarnitine	25	9	1	4247	9	2689	2150	35	3719	797	4628	917	2357	3177	1675	3002	2940	2302	2965	4078	2091
488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	488_Lipid::Essential fatty acid::docosahexaenoate (DHA; 22:6n3)	25	9	1	34	2382	9	50	68	1545	245	1341	460	76	749	20	19	2403	530	2498	4174	1388
2438_CST6 - Cystatin-M	2438_CST6 - Cystatin-M	25	9	1	375	1038	525	9	2621	3144	2176	1737	1202	510	1109	592	9	784	543	3695	651	3903
3196_Time employed in main current job	3196_Time employed in main current job	25	9	1	2584	3507	554	1777	9	2777	622	1661	1586	784	1170	1435	1718	4061	4396	4452	3485	2426
2203_IL17F - Interleukin-17F	2203_IL17F - Interleukin-17F	25	9	1	4397	4737	1954	2090	2293	9	978	889	1902	1231	883	3786	1987	394	3040	3270	1300	496
877_HDL diameter	877_HDL diameter	25	9	1	3391	3296	1408	2754	3347	922	9	266	3287	1313	349	505	1643	122	2667	533	180	3317
2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	2843_LRRTM1 - Leucine-rich repeat transmembrane neuronal protein 1	25	9	1	3277	826	2069	437	71	87	1035	9	1500	1369	967	417	249	10	18	2516	848	2347
1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1514_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	9	1	3699	4356	1206	2142	2460	3263	1312	1973	9	1240	2788	4580	2402	2953	1973	3058	1939	4307
4227_Immunosuppressants	4227_Immunosuppressants	25	9	1	617	3904	41	549	12	3135	280	163	405	9	43	1080	131	623	698	3869	199	459
2485_IL17RD - Interleukin-17 receptor D	2485_IL17RD - Interleukin-17 receptor D	25	9	1	951	1096	280	29	598	2082	1751	2950	3518	4713	4537	9	21	1587	1324	877	745	2217
2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	2770_AKR1A1 - Alcohol dehydrogenase [NADP(+)]	25	9	1	722	1764	4122	982	1309	3260	3508	630	2851	1375	427	360	1737	9	2932	194	501	2376
2960_IGHD  IGK@ IGL@ - Immunoglobulin D	2960_IGHD  IGK@ IGL@ - Immunoglobulin D	25	9	1	3105	313	536	483	2569	3835	2137	3531	247	1762	45	1355	116	2609	9	3713	396	4562
1227_Life span	1227_Life span	25	9	1	787	684	2779	4127	756	2398	612	2320	782	4104	1060	1262	1920	492	587	9	3827	741
1075_Leprosy	1075_Leprosy	25	9	1	32	1644	63	488	1540	623	4583	4618	4633	318	686	22	392	115	2456	1166	922	9
3947_11q deletion neuroblastoma	3947_11q deletion neuroblastoma	25	10	1	10	1822	166	181	3104	3731	3163	4326	4346	3365	2819	900	169	1561	317	1633	1531	3806
823_::::X-13549	823_::::X-13549	25	10	1	1600	10	983	158	2618	148	2828	429	108	1562	4743	268	3176	1403	2446	2908	261	1343
4017_Systemic Lupus Erythematosus	4017_Systemic Lupus Erythematosus	25	10	1	745	3176	10	1157	525	620	533	538	1931	644	228	2000	140	885	1272	2623	1127	4308
2256_TBP - TATA-box-binding protein	2256_TBP - TATA-box-binding protein	25	10	1	3958	865	834	564	10	4331	3801	3200	2349	817	559	2558	1364	2363	1800	3808	1131	3239
4737_Average across all tracts radial diusivities	4737_Average across all tracts radial diusivities	25	10	1	3770	4656	3862	2227	2993	10	3280	3460	2531	4703	3373	4294	1373	3690	640	2421	3603	232
888_Free cholesterol in large HDL	888_Free cholesterol in large HDL	25	10	1	2708	3094	699	4708	4578	1233	10	333	3810	861	223	1660	2379	144	1943	394	130	1842
1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1788_QT interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	10	1	1085	2835	324	2480	2954	3405	2298	10	1535	1691	2125	276	1368	4320	1836	1291	476	2692
4195_Diastolic Blood Pressure	4195_Diastolic Blood Pressure	25	10	1	1022	2164	1128	2521	1457	577	1028	1046	10	2116	3556	2515	1967	774	4261	734	803	374
3773_Anxiety - Recent worrying too much about different things	3773_Anxiety - Recent worrying too much about different things	25	10	1	1181	1071	1922	3156	2013	2171	3095	1022	1815	10	4660	1277	2852	2049	2849	2625	517	2483
1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	1015_Bone Ultrasound Attenuation (GEE, adjusted for multivariable)	25	10	1	1781	4340	1345	1389	3593	1666	1024	4005	100	2682	10	3327	3481	2325	1601	383	3477	577
2409_MEPE - Matrix extracellular phosphoglycoprotein	2409_MEPE - Matrix extracellular phosphoglycoprotein	25	10	1	4507	3968	3838	3216	2926	3130	1256	1229	3566	1470	979	10	3492	4613	925	3700	1349	467
2661_ESM1 - Endothelial cell-specific molecule 1	2661_ESM1 - Endothelial cell-specific molecule 1	25	10	1	2273	2523	4550	4476	70	1452	3741	1823	3330	558	2435	152	2927	4663	10	566	326	394
4094_Proxy and clinically diagnosed Alzheimer's disease	4094_Proxy and clinically diagnosed Alzheimer's disease	25	10	1	4311	4581	2436	960	1738	1199	4408	275	3589	2140	4324	165	2102	4182	343	10	734	120
854_ApoA1	854_ApoA1	25	10	1	1627	3836	482	4698	3392	1194	18	215	1046	726	52	395	2011	1718	1779	4020	10	2889
2522_GZMA - Granzyme A	2522_GZMA - Granzyme A	25	11	1	210	11	1510	2000	3622	208	3554	1785	1270	1615	4046	4457	119	266	2284	1144	1006	3883
3983_Type 2 Diabetes	3983_Type 2 Diabetes	25	11	1	666	98	11	149	3237	532	758	812	2522	2974	44	514	378	404	2756	2979	93	785
2338_MB - Myoglobin	2338_MB - Myoglobin	25	11	1	1073	709	528	11	4557	2308	4274	4152	1030	1636	1941	29	37	2977	4580	462	1565	862
2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	2693_ACP1 - Low molecular weight phosphotyrosine protein phosphatase	25	11	1	1449	1391	4724	2055	11	3192	698	189	550	4626	1159	3979	2457	4201	3505	522	1367	4721
1054_Amyotrophic lateral sclerosis	1054_Amyotrophic lateral sclerosis	25	11	1	93	2908	1958	3341	4289	11	2787	4730	2530	3344	2589	554	4152	3789	754	835	997	4496
908_LDL diameter	908_LDL diameter	25	11	1	1266	4612	3793	3549	4410	4141	11	440	4661	4200	82	1030	1005	67	1298	3128	107	833
3064_JAG2 - Protein jagged-2	3064_JAG2 - Protein jagged-2	25	11	1	3457	273	3061	4030	1008	3177	3271	11	4674	3537	4319	1155	1631	2597	2841	895	3580	3859
801_::::X-12771	801_::::X-12771	25	11	1	4448	2754	4666	813	4016	917	2294	2733	11	1221	3586	2965	82	1199	3380	169	4330	215
456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	456_Cofactors and vitamins::Tocopherol metabolism::gamma-tocopherol	25	11	1	133	471	1377	2252	3201	38	448	2311	3083	11	1851	2913	4426	2218	547	157	1898	4624
3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	3660_Cancer register - Histology of cancer tumour: Basal cell carcinoma, NOS	25	11	1	820	3477	59	598	67	2177	3256	3072	162	111	11	3295	79	554	13	3130	458	1583
2457_RGMB - RGM domain family member B	2457_RGMB - RGM domain family member B	25	11	1	1601	1669	3174	20	3532	703	887	1728	546	4617	1492	11	86	1982	3057	3342	2607	1032
3187_Standing height	3187_Standing height	25	11	1	2505	1012	3261	2470	3234	1161	2536	2370	2166	4691	458	2404	1552	11	4070	2118	2321	1687
1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	1957_Wide Range Achievement Test (GEE, adjusted for multivariable)	25	11	1	778	4261	517	1370	1504	1997	1281	220	70	2772	1420	1811	1138	2680	11	1455	3913	2926
4089_Maternal history of Alzheimer's disease	4089_Maternal history of Alzheimer's disease	25	11	1	2730	2145	2281	744	1862	1466	1926	208	79	1641	1996	1113	4542	759	1106	11	3711	101
1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	1334_Fasting HbA1c (at exam 7, FBAT, adjusted for age, sex and BMI)	25	12	1	12	1754	3763	799	112	58	68	126	4489	32	281	2526	1570	4562	4670	342	3815	1714
521_Lipid::Long chain fatty acid::myristate (14:0)	521_Lipid::Long chain fatty acid::myristate (14:0)	25	12	1	1568	12	1612	4254	1218	262	4428	3878	2977	170	4622	2973	1867	389	1251	776	3674	4205
3052_EPHB6 - Ephrin type-B receptor 6	3052_EPHB6 - Ephrin type-B receptor 6	25	12	1	3125	15	256	12	2564	611	4123	3829	3108	162	2111	16	24	199	103	577	3213	3701
585_Nucleotide::Purine metabolism, guanine containing::guanosine	585_Nucleotide::Purine metabolism, guanine containing::guanosine	25	12	1	1035	1859	3281	3322	635	12	1950	1196	4195	2920	1364	372	3876	4097	920	963	4516	1904
959_Phospholipids in very large HDL	959_Phospholipids in very large HDL	25	12	1	2500	4061	1086	595	3252	4613	12	57	4471	4470	255	345	4494	72	767	813	131	2762
3376_Number of stillbirths (female)	3376_Number of stillbirths (female)	25	12	1	1196	1389	3707	890	2707	3415	848	12	4570	304	68	3425	174	1778	3089	90	3114	2635
3474_Type of accommodation lived in: A house or bungalow	3474_Type of accommodation lived in: A house or bungalow	25	12	1	1824	4678	4106	1928	176	2032	2761	1370	12	3195	4126	606	3615	3213	4581	4205	4217	3029
1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	1322_Fasting plasma glucose (at exam 5, FBAT, adjusted for age, sex and BMI)	25	12	1	3901	3253	889	832	1587	1944	4321	931	315	12	2319	2032	335	2889	4629	2350	418	110
4236_Glucocorticoids	4236_Glucocorticoids	25	12	1	3036	2125	23	1226	203	1751	1326	2651	3470	506	12	2518	81	536	299	993	278	2733
2166_CCL25 - C-C motif chemokine 25	2166_CCL25 - C-C motif chemokine 25	25	12	1	1746	198	132	1618	3632	1827	335	4122	3915	15	507	12	151	3707	140	370	4309	455
1268_Epworth Sleepiness Scale (FBAT)	1268_Epworth Sleepiness Scale (FBAT)	25	12	1	1755	560	1129	22	3840	473	2315	742	2844	86	4315	3348	12	3469	51	684	31	969
3903_Reticulocyte fraction of red cells (three-way meta)	3903_Reticulocyte fraction of red cells (three-way meta)	25	12	1	2224	1233	2811	2715	4156	424	1152	556	1301	1070	1698	758	3622	12	1941	118	1987	3298
268_CD4:%TM (1)	268_CD4:%TM (1)	25	12	1	1699	3784	186	4490	3364	3757	2956	1876	320	1053	2287	1976	3375	1551	12	3694	1956	713
514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	514_Lipid::Long chain fatty acid::10-heptadecenoate (17:1n7)	25	12	1	3630	433	3367	3562	934	33	1513	3139	2104	4286	2452	2538	2135	3920	3201	12	4590	4319
978_Growth regulated oncogene (CXCL1)	978_Growth regulated oncogene (CXCL1)	25	12	1	4525	4462	2764	99	4632	144	4401	1231	1417	805	297	741	3513	40	889	327	12	321
1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	1240_Rate of decline of FEV1 (FBAT, adjusted for multiple covariates)	25	12	1	2324	1405	2673	3301	3937	1590	1601	2671	4052	622	1742	1236	3660	47	4001	3520	1396	12
4157_Focal Epilepsy	4157_Focal Epilepsy	25	13	1	13	1421	4383	2069	1681	3715	902	1998	3949	3185	4005	1054	995	4492	394	2813	1398	4709
2311_IL1RL2 - Interleukin-1 receptor-like 2	2311_IL1RL2 - Interleukin-1 receptor-like 2	25	13	1	2783	13	2908	759	2256	296	4346	566	1013	1370	3138	1828	2995	1184	577	1529	1512	4519
4608_Cerebellar vermal lobules I V	4608_Cerebellar vermal lobules I V	25	13	1	1381	2899	2411	13	519	4297	1217	890	3647	3351	2645	378	23	2539	4027	255	500	1720
4300_Vitiligo (early onset)	4300_Vitiligo (early onset)	25	13	1	718	2151	83	327	13	1595	1205	2675	3092	140	113	3109	239	4300	1671	1207	2264	2232
3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	3701_Diagnoses - secondary ICD10: M19 Other and unspecified osteoarthritis	25	13	1	517	2323	4695	3082	4739	13	2401	1047	4500	1120	2793	4031	1743	2599	56	1426	4099	3458
1055_Inflammatory Bowel Disease	1055_Inflammatory Bowel Disease	25	13	1	1221	3664	3653	4174	157	125	1593	13	620	2664	4610	2273	1001	3101	3982	2284	2145	3481
1149_Corrected insulin response	1149_Corrected insulin response	25	13	1	1323	1643	1341	531	4088	4112	404	877	13	1312	4417	675	1423	2761	2388	2189	2816	275
3373_Knee pain for 3+ months	3373_Knee pain for 3+ months	25	13	1	20	1370	821	128	4698	4234	1434	3243	592	13	125	1704	698	1019	4507	1215	1972	395
3552_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	3552_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Asthma	25	13	2	4441	3700	38	3208	838	959	4554	1083	3645	291	13	2118	65	1339	1571	886	415	2594
4674_Cingulum (hippocampus) axial diusivities	4674_Cingulum (hippocampus) axial diusivities	25	13	1	3967	1349	3564	227	1922	3302	4507	3050	3528	1898	501	13	3637	611	1021	1520	2921	290
2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	2346_FLT3LG - Fms-related tyrosine kinase 3 ligand	25	13	1	3782	2429	4584	31	750	2595	26	3273	335	3709	885	4034	13	2588	1686	2209	4519	3313
663_::::X-04500	663_::::X-04500	25	13	1	471	339	3711	4513	2198	771	1260	141	3463	1940	60	4184	2477	13	3899	4180	4089	3920
2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	2679_PTEN - Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	25	13	1	1798	1522	3482	3513	1812	2923	695	2871	3848	2111	1704	2536	3101	3119	3986	13	548	1853
4037_Autism spectrum disorder	4037_Autism spectrum disorder	25	13	1	2951	637	1866	124	1926	2315	2041	4141	3446	3535	635	665	405	1204	2015	199	13	1294
2607_NID2 - Nidogen-2	2607_NID2 - Nidogen-2	25	13	1	4662	4621	2456	93	2551	2189	1559	3236	809	2107	3513	2408	575	2716	3284	787	1089	13
1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	1316_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age and sex)	25	14	1	14	174	2558	574	3055	3227	803	2846	578	251	4282	2821	886	1906	502	1129	1226	55
2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	2632_CKB CKM - Creatine kinase M-type:Creatine kinase B-type heterodimer	25	14	1	2622	14	91	463	41	415	278	2548	4182	1057	121	89	881	1470	194	722	1994	449
3820_Type 1 Diabetes	3820_Type 1 Diabetes	25	14	1	2010	254	14	303	2439	1837	4609	2135	3408	53	31	365	173	27	2128	4193	816	2328
2517_EPHA3 - Ephrin type-A receptor 3	2517_EPHA3 - Ephrin type-A receptor 3	25	14	1	4394	1607	1909	14	1198	1761	4224	2044	2161	4706	3492	205	17	932	1049	3781	1295	1370
1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	1361_Total cholesterol (at exam 2, GEE, adjusted for age and sex)	25	14	1	752	4646	309	1327	14	2654	3532	2296	3053	1782	181	3254	878	4440	1347	4345	3937	2171
3960_Gestational weight gain (maternal, total)	3960_Gestational weight gain (maternal, total)	25	14	1	4207	3805	139	1844	985	14	3792	3319	748	302	3631	561	4066	1725	1247	731	3562	3194
886_Total cholesterol in large HDL	886_Total cholesterol in large HDL	25	14	1	1365	3525	1857	3844	4653	802	14	607	3295	724	178	1409	1660	62	1531	277	37	2251
1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	1590_Platelet aggregation to ADP (at exam 5, FBAT, adjusted for age and sex)	25	14	1	3811	114	3058	3472	550	1068	4246	14	2737	2598	1272	3011	3353	1478	4491	758	162	413
2062_CCL27 - C-C motif chemokine 27	2062_CCL27 - C-C motif chemokine 27	25	14	1	4738	2862	2118	2503	98	1893	3822	2738	14	1878	304	2488	261	3695	4200	1922	4702	1716
3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	3531_Never eat eggs, dairy, wheat, sugar: I eat all of the above	25	14	1	196	3900	35	157	1300	4436	1265	4504	590	14	57	36	130	131	1824	1757	337	259
356_IgG+B:%20+24+27+	356_IgG+B:%20+24+27+	25	14	1	1046	3265	3790	2748	503	315	467	2759	3720	771	3377	14	764	4161	4340	415	1180	645
1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	1974_Morbidity-free survival (at age 65, FBAT, adjusted for birth-cohort)	25	14	1	2740	1880	639	3226	1223	3854	4134	1940	953	885	681	1233	196	14	3315	2194	440	79
4451_Left inferior temporal	4451_Left inferior temporal	25	14	1	3830	2855	3266	3721	2152	1447	921	492	4343	4560	3636	1403	1326	4623	14	1246	4650	949
1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	1647_P-selectin (at exam 7, GEE, adjusted for age and sex)	25	14	1	2093	134	1157	3318	1423	2545	1907	2536	15	935	1788	3102	1893	427	2859	14	47	41
2006_Paternal transmission distortion	2006_Paternal transmission distortion	25	14	1	273	2337	2355	2087	25	4732	871	241	1254	3163	1475	3094	1311	1310	3149	1352	14	3436
4148_Left ventricular internal dimension in diastole	4148_Left ventricular internal dimension in diastole	25	14	1	433	4663	3546	205	122	232	84	418	643	3671	1354	2324	73	4310	145	117	363	14
4226_Thyroid preparations	4226_Thyroid preparations	25	15	1	1771	4536	15	61	237	4172	2132	1228	2896	702	77	772	29	214	2383	812	909	886
2084_KIT - Mast/stem cell growth factor receptor Kit	2084_KIT - Mast/stem cell growth factor receptor Kit	25	15	1	595	3277	1663	15	2523	2861	1681	4712	488	373	3859	71	27	175	3215	4125	2714	3011
3140_ELANE - Neutrophil elastase	3140_ELANE - Neutrophil elastase	25	15	1	2104	218	1529	3825	15	2181	4413	1856	3464	3967	3991	4560	4134	1572	3654	53	2624	2310
1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	1310_Fasting HbA1c (at exam 7, FBAT, adjusted for age and sex)	25	15	1	43	4134	2399	862	319	15	134	45	4303	20	177	935	1728	4430	3116	230	4743	795
958_Concentration of very large HDL particles	958_Concentration of very large HDL particles	25	15	1	3279	4376	1269	1558	3096	2992	15	197	1666	3183	198	209	4396	178	718	1055	73	2663
337_NKeff:%Kir+ (2)	337_NKeff:%Kir+ (2)	25	15	1	882	770	193	4080	780	772	2054	15	1187	4268	322	653	2688	914	1550	4381	3456	1400
3625_Treatment/medication code: levothyroxine sodium	3625_Treatment/medication code: levothyroxine sodium	25	15	1	434	2764	496	47	2626	2378	1775	2274	184	48	15	34	18	52	282	3096	1584	98
640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	640_Xenobiotics::Xanthine metabolism::1,3,7-trimethylurate	25	15	1	3315	4127	336	599	3428	1719	3766	3403	3797	3802	51	15	868	265	2588	3097	545	154
2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	2604_MAP2K2 - Dual specificity mitogen-activated protein kinase kinase 2	25	15	1	1890	2082	493	21	4672	610	1509	1773	1221	167	2858	38	15	4253	3780	3622	3269	4182
3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	3553_Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor: Hayfever, allergic rhinitis or eczema	25	15	1	1635	2549	87	2329	2600	41	492	4584	2862	4594	65	1743	1108	15	2165	3415	3838	4614
1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1461_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	15	1	2238	1116	1112	117	3333	2056	2707	1889	3261	3117	1599	3597	1177	1879	15	2336	2288	4657
4265_Ankylosing spondylitis	4265_Ankylosing spondylitis	25	15	1	3993	4644	1575	430	4259	1362	2304	4408	889	1115	4542	2860	479	94	359	15	2281	4269
2007_Parental transmission distortion	2007_Parental transmission distortion	25	15	1	225	1143	2354	1129	28	3642	749	134	2219	4677	2059	3076	3724	1357	3901	1398	15	2754
2530_KLK6 - Kallikrein-6	2530_KLK6 - Kallikrein-6	25	15	1	478	330	4491	55	3021	1463	4108	2609	241	3072	4303	1105	171	1710	1250	3586	267	15
1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	1629_Interleukin 6 (at exam 7, GEE, adjusted for multivariable)	25	16	1	16	3723	1337	3841	1050	1384	2125	1337	3412	1284	3168	4188	3290	1040	2497	889	1760	1770
4274_Short sleep	4274_Short sleep	25	16	1	1847	16	343	1386	204	1802	3636	3903	709	883	3664	3907	1039	1123	4189	1899	969	3299
2342_RETN - Resistin	2342_RETN - Resistin	25	16	1	4587	21	666	2433	16	867	1830	2133	4326	71	4004	169	566	2011	822	3264	322	3326
890_Concentration of large HDL particles	890_Concentration of large HDL particles	25	16	1	4694	3498	1369	3004	4379	663	16	248	2926	599	339	455	2144	197	1650	402	236	3853
1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	1503_Triglycerides (at exam 3, GEE, adjusted for age and sex)	25	16	1	3974	79	1514	251	796	992	1050	16	492	2860	3963	225	234	3504	261	2196	4392	1597
431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	431_Amino acid::Valine, leucine and isoleucine metabolism::leucine	25	16	1	1628	342	3559	2654	2572	1964	101	832	1198	16	3453	1887	1971	591	201	1415	2771	995
2415_SERPINE2 - Glia-derived nexin	2415_SERPINE2 - Glia-derived nexin	25	16	1	3066	506	823	379	2562	168	92	763	3771	3513	16	1634	325	1327	55	213	112	2857
2908_APOD - Apolipoprotein D	2908_APOD - Apolipoprotein D	25	16	1	669	1668	847	27	3736	2914	3052	2806	654	3534	4737	132	16	334	1743	109	53	2587
236_CD123 on pDC	236_CD123 on pDC	25	16	1	1188	20	3737	910	190	3287	4357	94	2329	651	4340	3723	2811	16	3378	1712	97	4550
2657_CKB - Creatine kinase B-type	2657_CKB - Creatine kinase B-type	25	16	1	3081	4316	656	4744	2619	2934	1133	4002	2281	2464	1845	106	1623	3858	864	16	2766	735
3381_Prospective memory test - Time to answer	3381_Prospective memory test - Time to answer	25	16	1	163	77	330	841	4407	3246	2434	247	183	25	3346	1003	3340	1825	197	127	305	16
3389_Friendships satisfaction	3389_Friendships satisfaction	25	17	1	17	1671	1250	3312	2875	1640	3416	1883	757	2528	3695	661	1068	3981	3321	2447	2336	3131
3618_Treatment/medication code: aspirin	3618_Treatment/medication code: aspirin	25	17	1	1660	17	3766	2097	3122	3392	243	1599	53	4491	600	3300	1256	617	3473	1449	1838	3043
1296_Adiponectin (FBAT, adjusted for age and sex)	1296_Adiponectin (FBAT, adjusted for age and sex)	25	17	1	637	119	803	4058	17	2173	640	3128	2160	3250	850	1966	4334	722	1735	33	4270	2807
1947_Visual memory composite score (GEE, adjusted for multivariable)	1947_Visual memory composite score (GEE, adjusted for multivariable)	25	17	1	282	1286	1640	1722	2209	17	769	1063	1114	793	3129	1944	2061	4086	1161	2667	1877	544
876_Total cholesterol in HDL	876_Total cholesterol in HDL	25	17	1	1949	3947	397	3372	1419	1583	17	190	1329	1828	72	380	1242	98	3106	1185	18	4336
68_Crohn's Disease	68_Crohn's Disease	25	17	1	4702	2865	2405	2214	137	2720	232	17	1767	2067	301	1744	4702	220	1096	364	3940	3930
3538_Attendance/disability/mobility allowance: Blue badge	3538_Attendance/disability/mobility allowance: Blue badge	25	17	1	4362	3212	755	3080	3855	2709	4069	3431	17	2764	1036	1324	4715	4379	4313	1998	4683	4183
3319_Wheeze or whistling in the chest in last year	3319_Wheeze or whistling in the chest in last year	25	17	1	4660	2121	55	726	2450	1294	3442	3869	4436	446	17	478	76	1980	122	1421	185	1435
3953_Amyotrophic lateral sclerosis (LMM)	3953_Amyotrophic lateral sclerosis (LMM)	25	17	1	1179	4033	1587	3247	2661	2121	1259	3217	3378	1914	3113	17	414	3053	3624	736	329	1768
3867_Reticulocyte fraction of red cells (two-way meta)	3867_Reticulocyte fraction of red cells (two-way meta)	25	17	1	1616	1738	2954	4541	2823	880	935	447	3894	2761	2913	342	2446	17	3479	560	3649	3915
627_Xenobiotics::Drug::p-acetamidophenylglucuronide	627_Xenobiotics::Drug::p-acetamidophenylglucuronide	25	17	1	177	645	26	3626	4594	1932	2875	3466	2108	1700	208	1463	2863	3916	392	17	3407	712
2005_Maternal transmission distortion	2005_Maternal transmission distortion	25	17	1	361	2062	2366	2085	24	4559	932	229	1157	2993	1779	3675	1391	1034	3144	1893	17	4695
1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1859_Neck cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	17	1	1848	2975	4703	170	1147	2156	321	3753	2364	3662	1130	4286	1279	1852	358	3917	1241	17
2199_CCL1 - C-C motif chemokine 1	2199_CCL1 - C-C motif chemokine 1	25	18	1	18	3180	3463	3981	3118	3948	1334	586	3901	4319	3739	1926	4188	4600	1359	1019	3252	1197
1034_Neck Section Modulus (FBAT, adjusted for multivariable)	1034_Neck Section Modulus (FBAT, adjusted for multivariable)	25	18	1	1897	18	1181	1890	2160	2765	3541	287	2372	2019	1065	2541	4401	2986	544	2568	1915	1177
490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	490_Lipid::Essential fatty acid::eicosapentaenoate (EPA; 20:5n3)	25	18	1	78	2993	18	143	2006	1750	4568	4034	1824	30	444	4469	242	4194	2146	1150	420	2092
3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	3118_MAP2K4 - Dual specificity mitogen-activated protein kinase kinase 4	25	18	1	144	1609	468	18	1530	1816	925	24	1890	18	4085	88	22	2118	886	3117	3040	4051
4009_Osteoarthritis of hip or knee (hospital diagnosed)	4009_Osteoarthritis of hip or knee (hospital diagnosed)	25	18	1	1116	41	113	1325	18	1231	542	3073	1945	2597	1687	3593	2590	2541	4042	1411	2736	1805
64_Insulin sensitivity index (adjusted for age, sex)	64_Insulin sensitivity index (adjusted for age, sex)	25	18	1	3228	3312	560	955	1522	18	3307	1315	67	973	665	3150	3346	2837	738	4568	3334	4173
3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	3490_Cereal type: Oat cereal (e.g. Ready Brek, porridge)	25	18	1	1477	103	2500	1150	3066	103	2574	18	486	665	2113	1541	1473	1905	236	71	210	537
4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4053_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	18	1	2101	3851	3322	2608	1943	530	2689	4558	18	3791	3541	371	1791	903	1061	2707	3797	4171
3695_Diagnoses - secondary ICD10: J45 Asthma	3695_Diagnoses - secondary ICD10: J45 Asthma	25	18	1	2605	1833	33	1138	83	3269	1241	1245	3064	438	18	3633	88	346	414	1607	365	1972
2572_CD40LG - CD40 ligand	2572_CD40LG - CD40 ligand	25	18	1	3082	2957	3968	1165	1051	346	4549	3362	710	3876	2854	18	973	1221	1508	180	4293	2441
600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	600_Peptide::Fibrinogen cleavage peptide::DSGEGDFXAEGGGVR*	25	18	1	105	4741	2071	3550	2721	2842	165	4087	628	2513	4527	4460	1093	2956	198	18	3820	498
1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1882_Shaft cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	18	1	2360	4157	4138	1168	4242	4207	177	1043	54	1810	1740	4344	2065	863	1024	63	1395	18
3042_ICOSLG - ICOS ligand	3042_ICOSLG - ICOS ligand	25	19	1	19	4542	2040	2068	4684	1880	3774	1105	166	481	1832	2149	3656	449	3519	1679	556	3959
1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	1753_Cystatin C (at exam 7, GEE, adjusted for multivariable)	25	19	1	835	19	1236	4736	3350	4242	3488	47	2696	2386	1236	937	4711	912	3731	1023	1114	4438
3937_Fucosylation	3937_Fucosylation	25	19	1	4158	4170	19	1228	777	2075	1193	1572	4133	3455	3006	3420	315	4399	2768	4383	1729	1494
2261_C7 - Complement component C7	2261_C7 - Complement component C7	25	19	1	3632	163	788	19	3454	2970	4491	2128	2465	299	610	32	43	1223	381	1095	3133	2368
3041_CD274 - Programmed cell death 1 ligand 1	3041_CD274 - Programmed cell death 1 ligand 1	25	19	1	1043	206	3694	3031	19	2423	1228	2423	3957	908	1888	2283	4525	1177	1474	4672	837	3590
3112_KIF23 - Kinesin-like protein KIF23	3112_KIF23 - Kinesin-like protein KIF23	25	19	1	792	4307	1491	2033	1585	19	1092	272	3130	3132	2312	4359	1248	4187	368	926	2191	891
1092_Gastric cancer	1092_Gastric cancer	25	19	1	4475	1675	295	2209	2828	3231	19	2372	4244	3503	4513	812	3394	2717	2244	2767	4621	42
4320_Positive affect (univariate)	4320_Positive affect (univariate)	25	19	1	1931	1560	3859	2384	2501	395	1479	19	3732	3260	787	3162	3558	548	3845	1841	44	4179
260_CD8:%TE	260_CD8:%TE	25	19	1	3099	3249	1716	2474	1808	2581	3765	3579	19	3602	2515	4201	1018	2985	3209	3729	2753	1411
1008_Stem cell growth factor beta	1008_Stem cell growth factor beta	25	19	1	902	4587	2484	4416	944	919	2520	1577	1094	19	1454	533	4025	3917	1282	196	631	375
1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1422_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	19	1	2757	199	3925	749	553	4490	969	1863	3715	3293	383	19	1745	146	2651	4729	3461	1295
997_Interferon gamma-induced protein 10 (CXCL10)	997_Interferon gamma-induced protein 10 (CXCL10)	25	19	1	631	2824	4743	4719	52	807	4695	752	207	3666	3345	2020	280	19	733	724	1070	4482
1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	1121_Pericardial adipose tissue volume (adjusted for height and weight, male)	25	19	1	3851	2995	745	760	2208	1020	430	2942	1143	604	3048	3617	2399	2191	1111	19	4679	3181
1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	1649_P-selectin (at exam 7, GEE, adjusted for multivariable)	25	19	1	3077	80	2735	504	4370	3913	1345	1224	360	557	2940	4726	148	898	2744	50	647	19
3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	3662_Cancer register - Behaviour of cancer tumour: Carcinoma in situ	25	20	1	2576	1285	20	35	3836	3647	4064	3307	788	1789	61	396	47	1358	809	4686	76	1185
1062_Psoriasis	1062_Psoriasis	25	20	1	4605	4076	1072	1217	20	4143	56	561	4394	1105	4313	3104	1155	3802	1266	3473	4737	3142
762_::::X-12212	762_::::X-12212	25	20	1	3893	3534	2316	3108	4460	20	3606	1963	1242	232	1302	1566	2256	2413	1127	1282	4167	1521
891_Phospholipids in large HDL	891_Phospholipids in large HDL	25	20	1	4650	2566	874	2103	3898	2086	20	260	1129	713	266	1332	1637	55	1586	802	51	3994
1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	1607_Viscosity I (at exam 5, GEE, adjusted for age and sex)	25	20	1	1123	1243	151	1501	116	3276	426	20	1193	1714	1617	1729	1196	3442	662	2301	1109	2521
1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	1405_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	20	1	629	1279	2066	1893	3565	4427	1007	1298	20	3678	2009	2493	167	1638	187	1662	1674	168
2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	2923_ITIH4 - Inter-alpha-trypsin inhibitor heavy chain H4	25	20	1	260	151	44	173	360	1516	3965	2346	2074	280	20	1148	353	46	181	1396	1235	2191
3829_Posterior cortical atrophy	3829_Posterior cortical atrophy	25	20	1	423	1951	31	33	3761	2766	2251	3788	4038	2544	2968	3761	20	1752	1725	991	1137	1357
2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	2670_IL12RB2 - Interleukin-12 receptor subunit beta-2	25	20	1	2450	3331	2408	585	3582	3929	2416	3928	2640	2844	3678	4078	267	2037	20	3920	3825	251
1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	1393_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	20	1	4229	2433	776	3523	581	3349	4693	3360	416	3374	4327	1692	1299	2040	1569	20	2541	1985
4680_Inferior fronto-occipital fasciculus axial diusivities	4680_Inferior fronto-occipital fasciculus axial diusivities	25	20	1	2300	2692	155	2060	3673	671	777	298	1889	4263	3204	2111	2827	610	412	2084	20	1348
1087_Age-related Macular Degeneration	1087_Age-related Macular Degeneration	25	20	1	2351	2530	729	1511	492	2662	1310	39	55	4109	375	3198	497	3941	847	3105	2269	20
1204_Rheumatoid Arthritis	1204_Rheumatoid Arthritis	25	21	1	870	1411	52	471	21	1074	1984	553	1456	21	30	1066	166	277	1489	1672	147	237
777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	777_Lipid::Long chain fatty acid::X-12442--5,8-tetradecadienoate	25	21	1	2471	36	401	116	1292	21	1363	2097	4496	1062	2138	420	214	171	1072	3683	2430	2543
2298_CTGF - Connective tissue growth factor	2298_CTGF - Connective tissue growth factor	25	21	1	4700	106	1461	2109	4580	3131	21	2447	706	2803	1422	2067	92	3009	2292	2389	279	594
4655_Fornix (column and body of fornix) fractional anisotropy	4655_Fornix (column and body of fornix) fractional anisotropy	25	21	1	2546	2001	3611	3522	3197	1850	123	1053	21	4007	1104	1158	289	2321	1126	424	3338	1118
1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1443_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	24	21	1	1137	1674	131	3186	3416	1807	2064	415	728	3229	114	4343	3235	21	751	134	3439	2439
1026_Femoral Neck Length (FBAT, adjusted for multivariable)	1026_Femoral Neck Length (FBAT, adjusted for multivariable)	25	21	1	680	3006	1638	2886	751	279	2919	1169	3157	2232	3079	2644	4612	415	21	2173	612	124
1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	1529_Remnant lipoprotein cholesterol (at exam 4, GEE)	25	21	1	2767	232	320	1068	3590	3676	1560	2004	723	1824	2960	383	212	4523	3474	21	975	1394
3634_Illnesses of father: Diabetes	3634_Illnesses of father: Diabetes	25	21	1	1789	478	84	1735	4052	710	635	692	1615	1624	176	1814	2121	2760	4258	2221	21	2268
243_CXCR3 on CD4n	243_CXCR3 on CD4n	25	21	1	2281	1246	526	69	3396	2831	39	2900	526	4211	1018	4007	63	2702	39	1579	2461	21
1056_Systemic Lupus Erythematosus	1056_Systemic Lupus Erythematosus	25	22	1	3395	22	71	70	328	1933	1402	3960	1868	2631	2548	1244	104	1328	3325	418	275	2205
3193_Number in household	3193_Number in household	25	22	1	3971	1559	684	314	22	2564	3984	774	2616	1315	2442	281	2588	4287	2149	454	177	898
1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	1711_Thyroid stimulation hormone (at exam 3, GEE, adjusted for age and sex)	25	22	1	3765	2355	3501	2198	1406	22	2279	2345	2495	2441	1103	4627	596	2098	2220	795	2874	1509
3920_Total cholesterol	3920_Total cholesterol	25	22	1	3693	3816	1170	1092	3866	4086	22	154	596	3548	464	481	2870	485	572	271	29	642
2023_Skin fluorescence	2023_Skin fluorescence	25	22	1	68	3854	1264	3645	84	2616	1324	22	228	1555	3976	4601	3833	4456	3357	1358	1100	1352
2751_PDGFB - Platelet-derived growth factor subunit B	2751_PDGFB - Platelet-derived growth factor subunit B	25	22	1	2867	3020	1982	4675	2197	75	1091	2510	22	2991	4716	3606	3592	3742	105	377	504	2401
3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	3670_Diagnoses - main ICD10: K29 Gastritis and duodenitis	25	22	1	127	3890	317	872	3109	353	1166	2129	510	22	1517	1793	2435	4509	3446	2593	700	716
3968_Asthma (fixed effect model)	3968_Asthma (fixed effect model)	25	22	1	4272	2738	77	1240	1779	1412	1744	2220	4665	134	22	2235	613	3914	816	626	301	1407
1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	1972_Morbidity-free survival (at age 65, FBAT, adjusted for multivariable)	25	22	1	2720	703	529	3091	1965	4428	3383	3985	754	630	793	1390	229	22	2132	4668	511	35
1113_Visceral sdipose tissue volume (female)	1113_Visceral sdipose tissue volume (female)	25	22	1	444	391	1015	3540	4218	996	1844	2082	149	3607	3986	4042	508	1854	22	249	362	3558
967_Phospholipids in very small VLDL	967_Phospholipids in very small VLDL	25	22	1	4416	1916	887	4637	3693	3911	283	2493	1436	1267	1464	228	4609	2693	245	22	1841	1576
953_VLDL diameter	953_VLDL diameter	25	22	1	3495	4323	1452	1120	1312	4248	611	1886	4271	2496	514	2530	1961	669	2271	3241	22	3474
2948_CASP2 - Caspase-2	2948_CASP2 - Caspase-2	25	22	1	2099	302	4551	1856	209	389	1558	1566	104	290	1592	127	480	1655	774	139	1880	22
1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	1732_Chronic kidney disease (at exam 7, FBAT, adjusted for multivariable)	25	23	1	23	3665	4312	3684	4553	4470	1348	1517	3121	1184	2812	620	2752	974	658	923	1386	3251
1167_HOMA-B	1167_HOMA-B	25	23	1	4554	23	4537	2585	1961	1718	4230	235	170	3279	4507	1509	739	936	4288	154	4321	4510
2036_Cisplatin-associated ototoxicity	2036_Cisplatin-associated ototoxicity	25	23	1	520	213	1335	1506	23	300	3002	3622	1665	3134	396	1724	317	2430	730	244	2032	4451
2758_TGFB2 - Transforming growth factor beta-2	2758_TGFB2 - Transforming growth factor beta-2	25	23	1	2017	1026	4684	4151	572	23	2469	3807	302	1163	262	2772	3948	4239	225	3071	438	2425
4345_Coronary artery disease and total cholesterol (bivariate)	4345_Coronary artery disease and total cholesterol (bivariate)	25	23	1	1889	1666	1653	3492	3188	2478	23	4418	1742	4376	619	945	3304	1299	522	326	535	705
1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1557_Mean common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	23	1	3121	1303	302	2409	769	4404	2069	23	1138	3106	508	1289	2277	580	2214	4726	1061	3277
1022_Neck Cross-Sectional Moment of Inertia (FBAT)	1022_Neck Cross-Sectional Moment of Inertia (FBAT)	25	23	1	4729	752	1682	2043	4165	3457	3168	4279	23	954	1005	712	2184	723	1071	3052	4419	1812
4217_Drugs used in diabetes	4217_Drugs used in diabetes	25	23	1	746	1236	28	135	53	1734	2207	4185	1597	23	78	387	201	573	1090	4008	89	1682
3438_Doctor diagnosed asthma	3438_Doctor diagnosed asthma	25	23	1	2964	1167	29	1682	126	2367	2836	1356	3604	344	23	1731	40	2141	659	473	243	2555
3957_Antisocial behavior	3957_Antisocial behavior	25	23	1	3302	3376	2701	422	2687	3093	2677	4291	239	1028	1857	23	67	99	2500	295	2966	884
3846_High light scatter reticulocyte count (two-way meta)	3846_High light scatter reticulocyte count (two-way meta)	25	23	1	3316	1294	3333	4398	2568	194	1243	678	3946	360	1657	1464	394	23	2617	2799	1645	582
2812_CST2 - Cystatin-SA	2812_CST2 - Cystatin-SA	25	23	1	4168	3434	1413	448	3595	81	853	987	1870	832	3650	1524	3758	1174	23	3743	4323	453
1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	1359_Total cholesterol (at exam 1, GEE, adjusted for age and sex)	25	23	1	306	3845	1538	1394	1458	2304	3135	86	3663	221	2581	589	3826	48	773	23	4048	1617
2727_FGF4 - Fibroblast growth factor 4	2727_FGF4 - Fibroblast growth factor 4	25	23	1	3690	2282	109	102	840	4564	786	967	2084	4610	1374	3516	93	1363	1069	2713	2244	23
1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	1349_Plasma Apolipoprotein B level (GEE, multivariate adjusted)	25	24	1	24	470	3948	266	3477	3469	2014	2506	2357	890	3208	1907	3688	107	1012	1288	2293	1396
618_Xenobiotics::Benzoate metabolism::hippurate	618_Xenobiotics::Benzoate metabolism::hippurate	25	24	1	643	24	3693	2714	4559	2386	3418	4434	630	3508	180	2027	2508	3314	994	770	258	870
3832_Vitiligo	3832_Vitiligo	25	24	1	1164	65	24	101	78	2715	396	1040	4366	1031	224	1580	210	57	2440	962	2408	1593
3152_DLL1 - Delta-like protein 1	3152_DLL1 - Delta-like protein 1	25	24	1	1253	512	952	24	2051	3739	1832	4713	1861	953	3715	43	35	2207	4582	3404	1118	187
815_Lipid::Fatty acid amide::X-13183--stearamide	815_Lipid::Fatty acid amide::X-13183--stearamide	25	24	1	2039	250	4130	2314	803	24	220	2739	3264	315	2582	506	3141	638	2179	3574	1250	2719
2614_DKKL1 - Dickkopf-like protein 1	2614_DKKL1 - Dickkopf-like protein 1	25	24	1	3821	214	3785	1191	2525	2400	24	1859	2967	3932	1943	3256	3816	1427	3134	104	1201	4688
2622_CFHR5 - Complement factor H-related protein 5	2622_CFHR5 - Complement factor H-related protein 5	25	24	1	1957	396	4626	4218	4180	1754	1606	589	24	1924	975	522	3295	2994	2399	987	2546	150
3308_Long-standing illness, disability or infirmity	3308_Long-standing illness, disability or infirmity	25	24	1	874	2280	72	557	177	1707	896	2035	4459	24	117	200	155	920	107	3451	175	697
4342_Moderate intesity (conditioning sex and BMI)	4342_Moderate intesity (conditioning sex and BMI)	25	24	1	4266	2822	222	2004	866	2261	3746	2546	407	1140	4586	24	1550	3366	2601	4121	3186	1083
2384_CA4 - Carbonic anhydrase 4	2384_CA4 - Carbonic anhydrase 4	24	24	1	3264	4512	434	438	400	1687	788	1489	452	100	67	552	31	24	186	2308	273	239
3679_Diagnoses - main ICD10: M54 Dorsalgia	3679_Diagnoses - main ICD10: M54 Dorsalgia	25	24	1	2323	1051	751	2158	232	215	1294	2604	4709	1594	2884	4134	3606	2758	24	2779	3260	4222
19_Ever versus never beeing a regular smoker	19_Ever versus never beeing a regular smoker	25	24	1	1090	3491	4727	1452	3635	893	4029	591	3469	4431	543	1045	3514	2808	1885	212	24	1104
4735_Anterior corona radiata radial diusivities	4735_Anterior corona radiata radial diusivities	25	24	1	3617	3389	4002	795	4412	579	3132	4729	837	2247	4611	2173	363	4538	2044	3231	2350	24
3557_Medication for pain relief, constipation, heartburn: Aspirin	3557_Medication for pain relief, constipation, heartburn: Aspirin	25	25	1	4492	25	1258	3649	3933	3295	74	2272	109	1095	3415	1736	3791	2233	863	87	1471	2704
2814_KLK3 - Prostate-specific antigen	2814_KLK3 - Prostate-specific antigen	25	25	1	1226	99	111	25	582	2799	4266	2913	4178	325	100	74	30	2951	35	2211	4039	883
1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	1719_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for age and sex)	25	25	1	354	3382	1060	2294	1465	25	2418	3914	3170	516	4388	3731	790	1320	4434	875	1248	2941
1933_Parietal brain volume (GEE, adjusted for age and sex)	1933_Parietal brain volume (GEE, adjusted for age and sex)	25	25	1	2258	3503	822	2050	1060	119	1728	25	594	1222	1460	181	4296	2752	538	4390	3420	4700
3372_Age hay fever, rhinitis or eczema diagnosed	3372_Age hay fever, rhinitis or eczema diagnosed	25	25	1	1525	4304	4381	1160	4521	107	546	2621	958	1086	25	914	2462	508	610	4339	90	2921
226_B Mem:%IgG	226_B Mem:%IgG	25	25	1	437	279	2527	1076	493	1904	2188	4733	2868	1344	3252	25	2527	2995	3486	4258	2651	2860
3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	3602_Non-cancer illness code, self-reported: hypothyroidism/myxoedema	25	25	1	75	4684	407	48	1521	2519	3450	4099	283	121	34	78	25	307	1373	2819	879	87
3942_HbA1c	3942_HbA1c	25	25	1	2468	3815	1691	3283	3325	544	1540	2872	2626	2658	565	3719	962	25	3623	3001	656	4687
2737_GZMB - Granzyme B	2737_GZMB - Granzyme B	25	25	1	1867	3688	2720	367	608	333	1566	1461	131	1465	3304	3618	371	3178	25	4218	2528	1229
2759_F2 - Thrombin	2759_F2 - Thrombin	25	25	1	2209	1810	1244	4135	2109	1134	2417	3095	1431	3329	1768	464	3033	2260	3052	25	3127	4581
4149_Left ventricular internal dimension in systole	4149_Left ventricular internal dimension in systole	25	25	1	1044	97	1449	79	55	35	223	1249	176	4129	3588	426	238	4499	1043	44	340	25
3119_MAPK9 - Mitogen-activated protein kinase 9	3119_MAPK9 - Mitogen-activated protein kinase 9	25	26	1	26	4125	3151	400	4342	1619	102	174	396	2327	167	149	417	1189	2085	2890	871	3940
2827_IFNL1 - Interferon lambda-1	2827_IFNL1 - Interferon lambda-1	25	26	1	4540	26	1590	3867	680	4211	4490	2670	2257	3790	1855	4153	4627	2228	2402	483	3236	331
1884_Shaft Width (FBAT, female, adjussted for multivariable)	1884_Shaft Width (FBAT, female, adjussted for multivariable)	25	26	1	449	2665	2718	2039	26	4645	96	2841	197	3451	4341	1366	1341	805	4091	1727	3191	3733
1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	1324_Fasting plasma glucose (at exam 7, FBAT, adjusted for age, sex and BMI)	25	26	1	96	309	226	1762	3223	26	1896	2998	4253	41	2880	62	2699	4055	4462	238	1662	655
2028_Cryptorchidism (group 2)	2028_Cryptorchidism (group 2)	25	26	1	1166	2894	922	1337	602	4015	805	26	579	742	327	3283	2105	504	4718	465	636	102
3505_Non-butter spread type details: Soft (tub) margarine	3505_Non-butter spread type details: Soft (tub) margarine	25	26	1	4410	1629	2544	2144	3046	1056	2319	2653	26	1191	431	655	3955	864	674	2475	4283	3516
1175_Excessive daytime sleepness	1175_Excessive daytime sleepness	25	26	1	1298	625	3957	341	2149	3743	1072	558	1311	26	3487	2473	898	730	248	1089	638	3368
3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	3673_Diagnoses - main ICD10: K57 Diverticular disease of intestine	25	26	1	4313	1488	686	900	643	2030	213	1364	40	4186	26	123	1950	522	3065	1486	666	2202
3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	3066_KIR2DL4 - Killer cell immunoglobulin-like receptor 2DL4	25	26	1	2669	2990	2438	230	671	3988	203	261	2188	3518	173	1705	26	73	276	996	303	1984
3845_High light scatter percentage of red cells (two-way meta)	3845_High light scatter percentage of red cells (two-way meta)	25	26	1	3837	1711	2369	3271	2793	188	3581	2982	4482	327	1358	3113	4392	26	3831	369	1270	1016
1005_Platelet derived growth factor BB	1005_Platelet derived growth factor BB	25	26	1	3665	4520	103	2277	465	1998	2369	226	2298	106	1532	569	2557	1938	26	737	3087	729
34_Alzheimer's disease	34_Alzheimer's disease	25	26	1	1423	3891	4636	2078	631	1569	1648	560	3840	2479	2667	196	1421	2463	1197	26	1132	284
693_::::X-11317	693_::::X-11317	25	26	1	2402	1980	4503	2250	3608	1684	867	1262	1814	4098	86	4554	2669	1134	813	62	26	4450
2992_ESD - S-formylglutathione hydrolase	2992_ESD - S-formylglutathione hydrolase	25	26	1	1175	789	1498	1249	3561	374	468	2086	64	4339	205	75	1999	378	4636	34	1027	26
3885_Lymphocyte percentage of white cells (three-way meta)	3885_Lymphocyte percentage of white cells (three-way meta)	25	27	1	27	1915	1511	3446	2715	3331	3382	4551	4062	3085	3219	2038	2974	1341	528	793	1637	4552
3000_GRN - Granulins	3000_GRN - Granulins	25	27	1	1463	27	3827	2524	1590	2825	3042	1903	3138	80	2027	811	655	543	281	2003	3388	1529
824_::::X-13553	824_::::X-13553	25	27	1	265	1267	4364	2978	27	2808	4494	2152	2773	710	603	1047	1855	3547	3675	666	1238	2349
2962_LIFR - Leukemia inhibitory factor receptor	2962_LIFR - Leukemia inhibitory factor receptor	25	27	1	551	1720	2652	587	2400	27	1040	1948	263	2424	3529	1088	2380	360	2989	3302	684	1014
4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	4348_Coronary artery disease and high-density lipoprotein cholesterol (bivariate)	25	27	1	1617	1504	292	3122	4593	4314	27	3338	885	2061	33	2638	3713	3172	581	1435	149	4430
2364_ULBP1 - NKG2D ligand 1	2364_ULBP1 - NKG2D ligand 1	25	27	1	2583	1503	1006	1282	954	4464	3899	3857	27	1816	945	2928	4368	3072	3557	4430	4406	1414
3652_Illnesses of siblings: Diabetes	3652_Illnesses of siblings: Diabetes	25	27	1	1097	316	40	229	85	1860	4236	3526	3612	27	40	618	144	161	1792	2028	148	173
2514_CMA1 - Chymase	2514_CMA1 - Chymase	25	27	1	2919	2547	2058	4199	1023	509	465	1650	4269	384	1198	27	2928	2183	130	3433	499	2063
399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	399_Amino acid::Phenylalanine & tyrosine metabolism::phenylalanine	25	27	1	166	2015	2329	1975	3439	193	3172	188	2650	1520	521	1303	4624	2467	27	42	4535	2583
2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	2717_MED1 - Mediator of RNA polymerase II transcription subunit 1	25	27	1	2067	2283	357	1449	3365	3075	3331	1860	392	2490	1143	2591	3486	1901	3661	27	1267	1102
2198_Human-virus - Protein Rev_HV2BE	2198_Human-virus - Protein Rev_HV2BE	25	28	1	28	1159	2243	3265	1952	2345	745	513	1236	1792	1349	2696	1171	4203	1884	642	1197	38
3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	3554_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Cholesterol lowering medication	25	28	1	4560	28	2036	4475	1448	3958	1304	299	3478	812	3759	413	4492	4686	3363	55	4472	3213
2805_TK1 - Thymidine kinase, cytosolic	2805_TK1 - Thymidine kinase, cytosolic	25	28	1	3326	3043	4608	28	3630	3619	578	1301	1507	2713	920	909	413	905	354	315	519	3975
239_CD24 on IgA+ B	239_CD24 on IgA+ B	25	28	1	950	4418	197	1793	615	28	4560	396	3321	311	1029	4239	3447	4105	2158	1444	586	3212
4135_Red blood cell count	4135_Red blood cell count	25	28	1	1245	1703	2619	1553	1237	985	1329	2968	28	1585	1271	1119	741	4631	1143	2886	4056	4134
3413_Fluid intelligence score	3413_Fluid intelligence score	25	28	1	2207	4322	1781	4267	1412	3959	2287	4702	4154	28	1325	337	1410	2772	3514	358	4267	1204
4020_Freckles	4020_Freckles	25	28	1	1935	2386	473	4362	1991	708	3005	2248	2082	1722	469	28	1263	2316	632	655	1774	201
2068_TGFB1 - Transforming growth factor beta-1	2068_TGFB1 - Transforming growth factor beta-1	25	28	1	995	1036	488	4203	3684	633	1662	2673	2227	2296	3528	4178	1923	28	3101	1981	3340	4566
472_Lipid::Bile acid metabolism::taurodeoxycholate	472_Lipid::Bile acid metabolism::taurodeoxycholate	25	28	1	1541	1086	931	3121	1937	2205	3241	3099	3101	3715	3767	4287	2687	2383	28	2158	455	3917
223_Mature B:%Memory	223_Mature B:%Memory	25	28	1	1994	4478	2493	146	2915	3483	3684	3065	278	2973	3134	1315	507	4263	1581	28	3616	892
4099_High-density-lipoprotein cholesterol	4099_High-density-lipoprotein cholesterol	25	28	1	4300	1649	2057	562	826	1971	314	1236	1181	3517	135	296	1862	1482	4137	858	28	2520
3167_CDH15 - Cadherin-15	3167_CDH15 - Cadherin-15	25	28	1	964	1592	2683	405	766	326	3330	3785	4613	331	1721	183	4391	735	125	186	255	28
3023_PRDX6 - Peroxiredoxin-6	3023_PRDX6 - Peroxiredoxin-6	25	29	1	673	29	2980	705	1389	3000	1962	365	423	4024	1094	3353	2729	2726	4032	3295	1091	3352
3445_Impedance measures - Body Mass Index (BMI)	3445_Impedance measures - Body Mass Index (BMI)	25	29	2	4687	2636	3262	1562	29	4527	900	2265	4158	769	4209	3953	2077	1661	2386	2345	4716	1059
4646_Total brain volume	4646_Total brain volume	25	29	1	925	4299	4454	1829	3261	29	4633	1225	2071	1794	2860	2037	1620	1491	2771	4615	2201	242
543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	543_Lipid::Lysolipid::1-palmitoylglycerophosphocholine	25	29	1	1215	2809	2170	4588	3562	2641	29	1076	820	485	3230	4315	3889	1610	1414	1564	4095	2255
2020_Adenocarcinoma (adjusted for age)	2020_Adenocarcinoma (adjusted for age)	25	29	1	1505	274	3182	578	54	2501	2174	29	4058	4251	2168	1093	2056	886	3910	630	50	3809
2362_PGF - Placenta growth factor	2362_PGF - Placenta growth factor	25	29	1	3895	2065	3554	1423	776	4245	3422	2854	29	2635	2314	828	2403	3000	870	4170	1389	461
4334_Asthma	4334_Asthma	25	29	1	3762	2661	610	3187	347	2104	2063	1352	3286	350	29	2548	1667	515	2854	1259	351	858
351_gdT:%CM (2)	351_gdT:%CM (2)	25	29	1	3163	3706	3349	3347	4721	2091	3680	3673	1997	2280	2119	2321	4415	3846	29	2185	3467	4111
70_Low-density lipoprotein cholesterol	70_Low-density lipoprotein cholesterol	25	29	1	4292	113	3329	1180	3186	4545	146	3975	810	4173	271	2976	2367	501	188	29	75	322
4739_Cingulum (cingulate gyrus) radial diusivities	4739_Cingulum (cingulate gyrus) radial diusivities	25	29	1	2978	3230	4132	1251	4137	519	4619	4254	1146	3572	974	1494	1262	2701	2763	1870	2192	29
261_CD8:%SCM	261_CD8:%SCM	25	30	1	30	1439	3896	2725	554	2452	1273	2348	101	923	1605	1017	80	2495	4044	3120	2142	2960
1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1517_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	30	1	3424	30	1516	3438	1344	216	3863	471	4208	2147	3970	3216	328	2000	996	2967	4534	1086
2741_IL25 - Interleukin-25	2741_IL25 - Interleukin-25	25	30	1	483	133	30	4589	666	131	330	1432	2025	101	240	55	555	454	329	31	141	4053
3812_CD3+ T cell level	3812_CD3+ T cell level	25	30	1	134	455	62	30	161	176	2621	2464	1317	90	66	44	36	1193	4659	107	675	249
249_CD27 on CD4 T	249_CD27 on CD4 T	25	30	1	2575	819	2028	2531	30	3084	2754	977	4587	4050	1737	84	3658	3692	472	1809	1788	2266
184_Waist-hip ratio (female)	184_Waist-hip ratio (female)	25	30	1	1757	165	572	64	3544	30	783	3639	1087	4383	3035	56	3478	2315	246	1869	3436	4746
2331_LGALS2 - Galectin-2	2331_LGALS2 - Galectin-2	25	30	1	1678	753	3392	2866	1319	732	30	136	1445	1932	1510	4618	4088	226	1181	3285	3621	775
2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	2832_ADAM12 - Disintegrin and metalloproteinase domain-containing protein 12	25	30	1	2560	4251	4237	1717	1598	236	110	30	677	3614	963	1670	1559	1064	1426	4702	2069	4455
520_Lipid::Long chain fatty acid::margarate (17:0)	520_Lipid::Long chain fatty acid::margarate (17:0)	25	30	1	66	1325	3600	811	3271	510	811	947	30	1042	1161	347	965	1622	4568	4139	1686	364
764_::::X-12217	764_::::X-12217	25	30	1	4380	2124	1175	1309	1827	1580	2126	1623	964	2017	1108	306	3446	30	3938	2493	2704	2687
4182_Low cholesterol lipoprotein	4182_Low cholesterol lipoprotein	25	30	1	1761	559	2103	1301	2354	1486	196	3165	436	3125	3659	1607	1690	170	2489	30	55	2708
859_CH2 groups in fatty acids	859_CH2 groups in fatty acids	25	30	1	1580	4065	2870	3676	2873	535	497	2712	2241	2125	37	3214	3839	1663	1207	451	30	4474
3550_Vascular/heart problems diagnosed by doctor: Angina	3550_Vascular/heart problems diagnosed by doctor: Angina	25	30	1	500	1231	3122	206	3270	4159	594	2800	1786	3900	1863	3842	784	1405	4217	1815	947	30
1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1394_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	31	1	31	2616	4074	3339	3717	696	4372	485	2376	3576	2901	3770	1192	1597	4704	1008	3418	4073
344_NKearly:%335+314-	344_NKearly:%335+314-	25	31	1	628	31	2300	2048	3502	4737	132	3841	3974	2143	1826	4358	1601	1784	2285	46	3367	217
10_Schizophrenia	10_Schizophrenia	25	31	1	2754	427	146	1904	1636	31	679	2501	3811	1318	39	2896	828	1413	779	2074	284	3394
4685_Splenium of corpus callosum axial diusivities	4685_Splenium of corpus callosum axial diusivities	25	31	1	941	3486	921	1175	1146	456	31	3822	3475	4318	102	316	3500	3532	2152	621	562	611
573_Lipid::Sterol, Steroid::cholesterol	573_Lipid::Sterol, Steroid::cholesterol	25	31	1	992	4223	4299	1121	765	1272	2141	31	2375	3476	3021	3439	2188	431	4099	1117	1536	1088
3757_Mania - Ever had period extreme irritability	3757_Mania - Ever had period extreme irritability	25	31	1	2507	4019	1428	4329	444	1499	4058	221	31	1183	421	3124	2672	3651	3180	2291	4130	2607
2640_SST - Somatostatin-28	2640_SST - Somatostatin-28	25	31	1	200	3036	1722	1719	1966	1783	3583	4365	1838	31	1960	1071	318	556	499	428	1540	75
292_CD4:%Act(PD1+)	292_CD4:%Act(PD1+)	25	31	1	3509	4135	3459	4564	1212	3426	1361	723	4110	234	3357	31	998	2075	1537	3397	2178	400
2633_IFNGR1 - Interferon gamma receptor 1	2633_IFNGR1 - Interferon gamma receptor 1	25	31	1	357	4022	1063	1715	953	2365	3786	3599	1235	534	2493	447	3829	248	628	4045	3383	31
3027_PSME1 - Proteasome activator complex subunit 1	3027_PSME1 - Proteasome activator complex subunit 1	25	32	1	3220	32	702	821	398	4111	1651	2772	2026	3305	3097	1618	87	444	2936	2589	1561	314
4045_Type 2 Diabetes	4045_Type 2 Diabetes	25	32	1	331	50	32	280	1018	1208	1653	328	1516	122	154	747	209	753	772	4185	347	1474
2083_APCS - Serum amyloid P-component	2083_APCS - Serum amyloid P-component	25	32	1	3695	296	837	32	2500	4513	3935	3956	3952	2586	996	69	648	3058	1653	1965	3546	3444
2189_C3 - Complement C3	2189_C3 - Complement C3	25	32	1	2543	3037	1313	360	32	3411	3364	2334	1068	1690	3092	2192	4683	671	937	2105	2260	4378
2835_CHST6 - Carbohydrate sulfotransferase 6	2835_CHST6 - Carbohydrate sulfotransferase 6	25	32	1	2848	2997	4730	2176	4127	3029	32	1190	106	854	1884	2112	744	1391	456	1933	985	986
4526_Left amygdala	4526_Left amygdala	25	32	1	4623	70	184	423	1820	907	2129	3772	32	4380	4082	695	364	401	850	1277	2429	327
2230_KLK4 - Kallikrein-4	2230_KLK4 - Kallikrein-4	25	32	1	1802	4702	373	58	3522	4725	2457	4137	3711	2509	4169	513	32	793	433	149	2171	324
2223_CD97 - CD97 antigen	2223_CD97 - CD97 antigen	24	32	1	3368	2185	2585	3052	4094	3723	1807	3153	3385	3841	2418	3821	2042	33	32	1949	3743	2760
4263_Ankylosing spondylitis	4263_Ankylosing spondylitis	25	32	1	4112	729	1039	416	3362	1075	3451	726	1446	1128	4017	3146	430	1050	2169	32	2960	1767
2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	2468_CAMK2A - Calcium/calmodulin-dependent protein kinase type II subunit alpha	25	32	1	211	1730	124	2733	2780	2090	3986	527	1234	1276	2382	355	256	2915	4334	2411	2925	32
2335_CXCL11 - C-X-C motif chemokine 11	2335_CXCL11 - C-X-C motif chemokine 11	25	33	1	33	3252	873	528	1056	2985	885	3864	1001	1980	1296	3908	2782	285	3574	624	1007	1490
296_CD4mem:%preTh17 (1)	296_CD4mem:%preTh17 (1)	25	33	1	3058	33	3573	1803	2705	527	2809	99	3413	4481	3328	4674	2243	4181	2812	1904	2247	3464
2288_PROC - Vitamin K-dependent protein C	2288_PROC - Vitamin K-dependent protein C	25	33	1	861	4389	641	2322	1138	583	33	3164	4123	1399	3224	1521	2680	2034	3216	2529	1032	2596
2010_High-density lipoprotein cholesterol	2010_High-density lipoprotein cholesterol	25	33	1	2811	3418	1126	2923	3001	2851	109	33	87	3316	4412	400	2895	4420	2603	1788	1216	2229
4724_Inferior fronto-occipital fasciculus mode of anisotropy	4724_Inferior fronto-occipital fasciculus mode of anisotropy	25	33	1	61	955	1349	3416	3549	206	212	2171	33	483	2366	4200	1776	330	1029	403	1631	64
2819_DAPK2 - Death-associated protein kinase 2	2819_DAPK2 - Death-associated protein kinase 2	25	33	1	4547	1484	405	1207	3700	440	1536	922	648	33	3625	4297	1789	748	219	214	619	821
1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	1729_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for multivariable)	25	33	1	2024	3076	1515	2590	3463	2607	514	4392	2959	3540	333	33	2511	1437	233	273	3966	121
2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	2879_DNAJC19 - Mitochondrial import inner membrane translocase subunit TIM14	25	33	1	3616	39	1125	183	4368	4459	621	3930	891	109	1686	591	33	4689	2421	1309	1844	960
4231_Salicylic acid and derivatives	4231_Salicylic acid and derivatives	25	33	1	2599	105	963	1499	800	1213	2356	937	3770	3149	4390	4170	1828	1890	33	4369	4616	3073
2072_BDNF - Brain-derived neurotrophic factor	2072_BDNF - Brain-derived neurotrophic factor	25	33	1	2903	2920	830	2146	2588	1140	1649	803	1839	4654	361	1829	383	1275	1763	1111	33	1498
1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1457_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	34	1	4218	34	1570	2318	539	2618	2807	2523	733	2892	1311	1090	817	1211	2256	870	991	4557
340_NKeff:%2+337-R7-	340_NKeff:%2+337-R7-	25	34	1	2692	2244	741	34	4635	3889	3832	4221	518	320	2164	1112	129	1662	3276	3402	2133	2372
2037_Immunoglobulin A deficiency	2037_Immunoglobulin A deficiency	25	34	1	1112	1255	225	2223	34	2403	727	436	1495	45	42	1775	428	80	3015	2472	2629	4569
290_CD4:%Act(DR+)	290_CD4:%Act(DR+)	25	34	1	3018	1888	2432	4205	998	538	4447	34	4136	3883	3720	2565	3856	1748	3691	3750	2102	3664
1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1448_Low-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	34	1	750	2761	1190	4631	1630	2411	915	1745	34	2402	1286	1442	654	1577	117	114	3949	525
3191_Number of treatments/medications taken	3191_Number of treatments/medications taken	25	34	1	970	4388	48	309	88	3673	366	1644	1327	34	53	726	160	533	589	3799	320	587
2155_C3 - Complement C3b, inactivated	2155_C3 - Complement C3b, inactivated	25	34	1	3586	3334	1188	156	1113	626	4174	2041	2615	823	2998	108	34	4390	2853	1364	2886	1986
1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1581_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	34	1	3751	757	1144	339	2855	4052	3875	3769	4351	4527	129	767	1939	34	363	2311	740	1626
4019_Age spot	4019_Age spot	25	34	1	825	3278	2637	4020	262	1347	1975	3506	2729	3232	4497	742	677	1060	34	1446	1920	515
864_22:6, docosahexaenoic acid (DHA)	864_22:6, docosahexaenoic acid (DHA)	25	34	1	1425	216	1259	937	863	2952	149	386	4413	628	243	1937	1921	2750	1448	2243	34	2375
75_Geographic atrophy	75_Geographic atrophy	25	34	1	2122	3048	879	1486	609	648	1067	199	38	3179	2030	3668	640	4715	2814	2974	4492	34
1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	1363_Total cholesterol (at exam 3, GEE, adjusted for age and sex)	25	35	1	35	4298	884	3872	4355	871	3456	61	1047	1228	3189	3574	1814	216	199	4352	2046	2666
2138_CDH3 - Cadherin-3	2138_CDH3 - Cadherin-3	25	35	1	3752	35	3607	189	2667	1586	888	1310	4669	4415	970	3941	252	496	2403	1168	2397	3308
2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	2844_LRRTM3 - Leucine-rich repeat transmembrane neuronal protein 3	25	35	1	1337	4403	1926	751	509	850	4455	35	2035	3729	2495	4306	3280	4605	3621	1942	607	2779
76_Neovascular disease	76_Neovascular disease	25	35	1	1059	2710	2891	1877	917	916	1338	128	35	3557	2063	2855	645	4134	1744	3958	3064	99
3410_Interpolated Year when non-cancer illness first diagnosed	3410_Interpolated Year when non-cancer illness first diagnosed	25	35	2	3049	3789	1694	1110	3476	3407	2950	3735	3776	2606	35	3493	468	2544	613	1457	2666	1283
4531_Right inferior lateral ventricle	4531_Right inferior lateral ventricle	25	35	1	540	1084	2466	1306	114	1796	581	2110	4217	1134	2349	35	1500	1902	3832	1307	4471	62
2849_SIGLEC1 - Sialoadhesin	2849_SIGLEC1 - Sialoadhesin	25	35	1	2769	1054	3417	4559	2171	1825	1883	855	2371	2822	4621	2502	1142	35	1852	780	581	4042
3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	3672_Diagnoses - main ICD10: K52 Other and unsp noninfective gastroenteritis and colitis	25	35	1	1934	814	3378	3771	1787	3013	3249	3561	2809	265	2979	1421	309	1441	2684	35	1038	690
4510_Left basal forebrain	4510_Left basal forebrain	25	35	1	3037	2023	1670	848	4318	3706	549	2332	1916	460	490	270	1273	564	1084	4357	35	2533
2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	2105_ROR1 - Tyrosine-protein kinase transmembrane receptor ROR1	25	36	1	36	1748	1031	3406	1236	1900	510	921	4293	2642	2664	3431	3007	2621	3191	816	3985	677
2092_CCL21 - C-C motif chemokine 21	2092_CCL21 - C-C motif chemokine 21	25	36	1	3485	3051	1504	36	72	235	2600	2470	735	2865	2136	1470	255	3552	911	1081	3128	2799
4457_Left middle temporal	4457_Left middle temporal	25	36	1	1378	2766	2483	665	36	716	297	1099	3621	3784	766	1876	1230	4392	1285	406	4588	4118
441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	441_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glucose	25	36	1	2862	1681	4216	1209	1070	36	1809	467	2624	3445	3621	4243	2441	476	195	3348	3350	4666
390_Amino acid::Lysine metabolism::pipecolate	390_Amino acid::Lysine metabolism::pipecolate	25	36	1	3535	4083	3201	3039	1505	269	36	3715	2203	1515	915	2639	46	4011	2646	3995	915	2745
3183_SNRPF - Small nuclear ribonucleoprotein F	3183_SNRPF - Small nuclear ribonucleoprotein F	25	36	1	927	121	3933	4728	4349	1498	1097	36	426	4231	2504	3737	474	158	4521	3157	890	169
3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	3090_SIGLEC14 - Sialic acid-binding Ig-like lectin 14	25	36	1	1054	1534	3514	4690	879	3891	1661	1270	36	1675	3871	2045	346	2600	969	1545	4139	4642
650_::::X-01911	650_::::X-01911	25	36	1	1480	4414	1343	823	2338	4609	2420	2258	223	36	3324	4597	1058	925	4140	2441	4170	2542
2654_CDH2 - Cadherin-2	2654_CDH2 - Cadherin-2	25	36	1	3276	887	671	4597	3505	225	2979	1332	4734	3158	3460	1010	3624	36	4112	3679	2027	464
4442_Epstein Barr Virus antigen EBNA IgG levels	4442_Epstein Barr Virus antigen EBNA IgG levels	25	36	1	4047	2712	66	118	2682	2838	1253	805	4703	1133	50	170	673	2008	36	3784	313	320
4329_Fractures	4329_Fractures	25	36	1	3884	1620	3070	1426	3062	2327	3693	968	2497	2109	536	3044	1272	2812	54	36	696	1553
2021_Squamous cell (adjusted for age)	2021_Squamous cell (adjusted for age)	25	36	1	3390	1485	1768	804	1103	4233	329	114	1462	950	3396	4636	4704	410	3143	911	36	605
2287_CFP - Properdin	2287_CFP - Properdin	25	36	1	1640	421	1360	2237	243	169	67	2749	152	858	2213	3248	2251	3283	4088	481	2050	36
4319_Life satisfaction (univariate)	4319_Life satisfaction (univariate)	25	37	1	37	4126	4173	3770	4589	2150	1020	3281	3752	4638	4455	868	4279	4220	4000	2840	3581	415
793_::::X-12717	793_::::X-12717	25	37	1	1182	1979	221	809	37	1917	1227	165	332	4055	1177	235	1408	880	584	170	689	780
4695_Cingulum (cingulate gyrus) mean diusivities	4695_Cingulum (cingulate gyrus) mean diusivities	25	37	1	4392	2659	3930	1859	2946	37	586	3942	1788	4070	3860	3708	1748	3286	1747	803	2228	125
4519_Left cerebellum exterior	4519_Left cerebellum exterior	25	37	1	1342	489	3217	1933	1743	3430	37	2978	4630	1489	906	50	4742	1843	4382	2288	1810	3895
1089_Alcohol dependence	1089_Alcohol dependence	25	37	1	2824	2018	1880	1432	2224	1368	4191	3643	37	4082	2343	1011	2496	4557	605	4669	203	3819
82_Lumbar Spine BMD (females)	82_Lumbar Spine BMD (females)	25	37	1	926	1657	1742	3834	3426	1872	692	1587	4727	37	887	1276	3369	3715	1538	2651	2030	3026
3468_Impedance measures - Trunk fat percentage	3468_Impedance measures - Trunk fat percentage	25	37	1	1876	1605	2838	3286	3101	4071	2463	971	4057	156	2399	37	1332	2991	3788	2386	4324	3691
3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	3101_PDE7A - High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	25	37	1	1040	2299	359	3203	1666	3339	643	4664	1349	4566	3080	3898	1203	37	2866	4514	447	241
4547_Left caudal middle frontal	4547_Left caudal middle frontal	25	37	1	4134	1443	1132	2567	457	185	3520	3756	559	1542	2747	3161	2472	411	37	3948	4514	2377
4128_C-reactive protein	4128_C-reactive protein	25	37	1	2667	2736	1981	922	50	956	1635	444	2608	4005	807	1102	2365	2442	3746	37	4729	4101
1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	1851_Neck average buckling ratio (GEE, female, adjussted for multivariable)	25	37	1	2358	229	125	253	2950	2857	1155	2668	3501	1468	3854	892	1166	4703	45	3365	3640	37
1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	1822_Inter-trochanteric buckling ratio (FBAT, female, adjussted for age)	25	38	1	38	3703	1809	358	2559	2098	4284	1339	877	1741	3990	687	2257	3379	2291	3767	4697	3882
346_NKearly:%337+335+2-	346_NKearly:%337+335+2-	25	38	1	4089	38	4240	263	47	3164	591	2732	3796	1846	3563	3791	2766	1216	585	79	1473	2805
4299_Vitiligo (late onset)	4299_Vitiligo (late onset)	25	38	1	2523	371	68	38	771	2141	4678	1257	1419	2562	1226	1173	125	1637	725	1114	3023	3485
461_Energy::Krebs cycle::succinylcarnitine	461_Energy::Krebs cycle::succinylcarnitine	25	38	1	1826	253	4035	1875	38	2461	62	3915	835	472	3147	3255	2859	2266	1485	1724	3925	4288
1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	1872_Shaft average buckling ratio (FBAT, male, adjussted for multivariable)	25	38	1	4544	608	4298	3775	2609	2809	38	3882	2231	1588	3350	2907	2553	1913	1495	943	1451	711
1193_Crohn's Disease	1193_Crohn's Disease	25	38	1	4631	2072	1655	3362	227	4261	397	38	1314	887	193	840	2616	637	1364	543	2342	4376
3332_Taking other prescription medications	3332_Taking other prescription medications	25	38	1	1713	2978	85	131	42	2741	2499	482	2422	38	58	634	108	233	836	2997	218	3156
251_CD27 on CD8 T	251_CD27 on CD8 T	25	38	1	3584	2583	437	688	4670	4373	869	4743	950	4529	462	2163	3690	1581	1018	4096	38	4418
240_CD27 on IgG+B	240_CD27 on IgG+B	25	39	1	39	2456	1153	894	111	651	2591	127	554	3584	3098	701	1352	1236	4156	4745	3528	3195
1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1941_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	39	1	1868	1108	94	39	2833	622	217	1361	253	1303	2659	1477	574	806	3105	1991	398	592
2824_FGF12 - Fibroblast growth factor 12	2824_FGF12 - Fibroblast growth factor 12	25	39	1	3167	856	4677	4413	2913	39	2840	901	766	3371	3426	2805	2538	3331	2217	638	4592	4539
706_::::X-11444	706_::::X-11444	25	39	1	1766	2556	796	3302	1753	3479	2998	499	39	4143	1319	414	4215	480	3145	625	72	3522
4418_Mumps seropositivity	4418_Mumps seropositivity	25	39	1	803	1744	2203	4403	287	2658	136	1649	597	39	2650	4309	2286	541	2683	487	3697	1854
1065_Schizophrenia	1065_Schizophrenia	25	39	1	514	4095	2820	3622	3964	4246	4741	3536	1728	2732	305	39	3957	2206	4622	1738	4596	2325
4179_Mean corpuscular hemoglobin concentration	4179_Mean corpuscular hemoglobin concentration	25	39	1	3573	347	3302	536	3701	276	1774	1759	4341	372	2474	3004	39	2623	2634	582	62	505
4673_Cingulum (cingulate gyrus) axial diusivities	4673_Cingulum (cingulate gyrus) axial diusivities	25	39	1	3534	466	1162	4711	4167	1146	407	1383	3841	3311	2956	1347	1133	39	2615	1366	3207	3149
2248_HAT1 - Histone acetyltransferase type B catalytic subunit	2248_HAT1 - Histone acetyltransferase type B catalytic subunit	25	39	1	4437	804	1011	509	2896	2674	466	4062	291	3902	608	3435	85	704	338	39	3160	3155
2763_TF - Serotransferrin	2763_TF - Serotransferrin	25	39	1	3825	122	1161	1450	248	4630	4400	3391	3768	2660	2243	1181	4268	3004	3687	2138	3666	39
4120_Alanine aminotransferase	4120_Alanine aminotransferase	25	40	1	40	2260	2732	456	1806	2945	3001	753	556	3702	3834	4375	4105	309	3422	1062	1705	533
2452_LY9 - T-lymphocyte surface antigen Ly-9	2452_LY9 - T-lymphocyte surface antigen Ly-9	25	40	1	2064	40	718	4482	194	2184	1539	2403	3456	3472	2621	3619	3200	2869	4709	2009	1586	1710
4024_Excessive hairiness	4024_Excessive hairiness	25	40	1	4206	4137	2751	40	4275	192	469	4124	759	4484	767	126	458	2404	4010	839	4088	74
464_Lipid::Bile acid metabolism::cholate	464_Lipid::Bile acid metabolism::cholate	25	40	1	3526	373	1591	2930	40	3306	4394	1113	4492	669	1548	1214	1671	3123	3512	1537	4072	985
3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	3540_Reason for glasses/contact lenses: For long-sightedness, i.e. for distance and near, but particularly for near tasks like reading (called 'hypermetropia')	25	40	1	547	2454	3846	1179	935	40	3585	1242	989	4421	1997	1400	705	481	2417	2490	3272	2059
960_Triglycerides in very large HDL	960_Triglycerides in very large HDL	25	40	1	1313	4363	3986	2576	996	1623	40	605	1340	2592	236	2386	4626	379	4049	2343	1797	3174
2029_Crohn's Disease	2029_Crohn's Disease	25	40	1	3839	2422	1082	4422	692	2200	302	40	530	1709	140	729	2280	133	3642	757	4694	937
4177_C-reactive protein	4177_C-reactive protein	25	40	1	390	285	2161	397	4277	4649	4320	3738	589	40	451	2831	464	1807	1427	256	465	1265
2429_CD109 - CD109 antigen	2429_CD109 - CD109 antigen	25	40	1	1094	1039	3903	194	4149	691	2134	3837	3988	1884	1397	40	393	2062	1332	3361	358	619
2999_GPC5 - Glypican-5	2999_GPC5 - Glypican-5	25	40	1	506	3446	2372	2226	3221	275	4324	2036	1948	4193	3335	3738	4023	4602	40	4604	4369	1880
233_Lymph:%T	233_Lymph:%T	25	40	1	2750	1240	4663	3313	2312	4535	3099	1246	3602	4116	89	2464	2180	385	1648	40	606	2639
2325_CAST - Calpastatin	2325_CAST - Calpastatin	25	40	1	280	2380	231	636	1940	2312	3916	1595	2854	603	1524	4475	3926	3907	4283	3452	40	3229
3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	3002_HNRNPK - Heterogeneous nuclear ribonucleoprotein K	25	40	1	1819	1582	198	3929	2440	1226	4258	4623	3775	1796	981	4446	737	3766	2494	173	2117	40
4032_Alcohol dependency (unrelated individuals)	4032_Alcohol dependency (unrelated individuals)	25	41	1	41	3989	927	4096	988	829	1759	3926	4289	2124	1459	1835	1640	1411	501	2735	2305	2057
3151_CCNB1 - G2/mitotic-specific cyclin-B1	3151_CCNB1 - G2/mitotic-specific cyclin-B1	25	41	1	1210	3625	3841	41	721	3849	1427	102	746	2046	1077	3560	1115	622	1757	1234	1013	2983
930_Phosphatidylcholine and other cholines	930_Phosphatidylcholine and other cholines	25	41	1	4211	4470	1851	1915	4164	3817	41	427	4022	3169	1273	4523	1989	4598	2602	3919	4316	2845
2019_Lung canger (adjusted for age)	2019_Lung canger (adjusted for age)	25	41	1	913	930	4737	769	258	1514	1043	41	3749	1556	1175	3942	2241	2565	2749	209	105	2238
2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	2882_FUT3 - Galactoside 3(4)-L-fucosyltransferase	25	41	1	1602	3913	3604	1651	2321	3395	4682	3836	41	4698	2257	3328	159	762	2877	4362	4455	4615
3967_Asthma (random effect model)	3967_Asthma (random effect model)	25	41	1	3006	2874	173	1940	1750	3291	3337	2583	4581	78	41	1622	707	3260	621	897	731	1856
3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	3688_Diagnoses - secondary ICD10: E78 Disorders of lipoprotein metabolism and other lipidemias	25	41	1	2134	1117	3443	861	2035	3482	1716	3366	4236	1677	2679	41	3289	1173	3423	175	2568	1000
1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	1709_Luteinizing hormone (at exam 3, GEE, adjusted for multivariable)	25	41	1	4373	4706	1586	971	150	2625	49	4690	852	610	4422	1822	41	3639	2406	2969	3658	1188
2163_PF4 - Platelet factor 4	2163_PF4 - Platelet factor 4	25	41	1	544	2649	1865	4471	3520	197	472	1088	4614	3850	1287	3454	1906	2345	41	510	597	1468
3386_Work/job satisfaction	3386_Work/job satisfaction	25	41	1	3223	1602	346	1985	4287	1160	4497	3085	2065	2924	242	1330	617	3783	2066	41	2772	3468
538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	538_Lipid::Lysolipid::1-linoleoylglycerophosphoethanolamine*	25	41	1	371	3671	2229	3499	613	51	135	2786	2711	2157	649	3806	521	756	1691	2252	41	1992
4463_Left pericalcarine	4463_Left pericalcarine	25	42	1	42	2794	527	166	1834	1906	1079	408	2606	1843	3790	1657	773	1839	4380	1125	491	4398
397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	397_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetate	25	42	1	318	42	4204	2317	1735	689	263	2829	3349	2870	3475	602	1382	4316	3376	4283	3890	287
4365_Moderate to vigorous physical activity levels	4365_Moderate to vigorous physical activity levels	25	42	1	4324	775	42	906	442	2214	2474	824	3710	172	1691	317	2404	4139	1005	3136	1871	4330
668_::::X-06246	668_::::X-06246	25	42	1	395	4731	4308	1408	2055	42	2678	2686	3397	3970	3220	3436	1426	3557	1066	2203	2869	3446
73_Total cholesterol	73_Total cholesterol	25	42	1	2254	1190	3651	4188	2877	3338	42	2746	4285	1116	891	484	2526	1668	1818	128	682	718
3254_Salt added to food	3254_Salt added to food	25	42	1	734	531	3193	1139	1764	461	4443	42	369	4727	4682	4574	2163	1238	3930	284	224	463
1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	1948_Visuospatial memory and organization (FBAT, adjusted for multivariable)	25	42	1	3574	2408	1629	959	479	3761	4219	1293	42	1865	669	1630	2876	1586	4128	2605	2417	3973
2012_Remission following 8-week treatment of MDD subjects	2012_Remission following 8-week treatment of MDD subjects	25	42	1	2106	4505	957	4592	3908	1886	4217	2618	2399	42	1051	4012	4073	4707	1119	49	3840	1664
487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	487_Lipid::Essential fatty acid::dihomo-linolenate (20:3n3 or n6)	25	42	1	1321	3337	2594	3070	1445	4144	966	2488	2064	4324	2910	42	2326	83	2350	3502	219	809
1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	1301_Fasting plasma glucose (at exam 7, GEE, adjusted for age and sex)	24	42	1	3658	2666	1338	2903	3728	4685	1316	2540	999	1889	3698	3266	3995	42	3199	1668	714	2228
2586_CHIT1 - Chitotriosidase-1	2586_CHIT1 - Chitotriosidase-1	25	42	1	305	821	1919	2196	4276	3374	1523	4737	751	102	2447	3873	258	276	42	1749	424	3560
4219_Vasodilators used in cardiac diseases	4219_Vasodilators used in cardiac diseases	25	43	1	4342	43	2225	1102	1021	4625	3856	439	346	3751	4065	1555	4390	696	2508	4227	4286	1377
1091_Alcohol dependence	1091_Alcohol dependence	25	43	1	3592	674	43	1117	685	190	4658	1797	2551	63	435	2602	594	4223	463	161	3994	983
183_Waist-hip ratio (female)	183_Waist-hip ratio (female)	25	43	1	1823	262	704	43	4155	43	565	4740	1186	3852	3178	52	3522	2273	202	1594	3877	3871
3280_Mother still alive	3280_Mother still alive	25	43	1	4620	3916	3792	3869	409	1779	43	2461	3689	3672	4167	834	1573	314	848	619	4497	923
3828_Primary biliary cirrhosis	3828_Primary biliary cirrhosis	25	43	1	382	1211	608	2606	2798	290	936	43	2974	2150	3370	2998	3844	1376	2549	3833	4608	1230
74_Age-related Macular Degeneration	74_Age-related Macular Degeneration	25	43	1	2250	3035	920	1528	870	869	1117	286	43	3114	1613	3508	666	3605	2816	2624	4412	44
3973_Total body BMD (45-60 years old)	3973_Total body BMD (45-60 years old)	25	43	1	3742	283	4400	775	521	3449	1412	4649	3579	43	3520	405	4080	2982	449	1431	540	3409
1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1579_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	43	1	3802	781	2376	313	4432	4502	4136	2705	2327	4390	130	1301	1811	43	253	3459	2421	1109
2848_RASA1 - Ras GTPase-activating protein 1	2848_RASA1 - Ras GTPase-activating protein 1	25	43	1	2955	1679	3858	2504	784	3176	662	1137	3495	1985	4224	1020	1698	4270	43	3992	920	874
503_Lipid::Fatty acid, ester::n-Butyl Oleate	503_Lipid::Fatty acid, ester::n-Butyl Oleate	25	43	1	3148	2718	1583	3710	2137	1420	2491	1596	1162	1447	3734	4328	1150	1135	2492	43	2882	3969
1168_HOMA-IR	1168_HOMA-IR	25	43	1	2109	1392	3984	1050	336	3068	1271	1866	744	4627	1322	76	3524	3926	4119	4680	43	2833
3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3703_Diagnoses - secondary ICD10: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	43	1	3940	2397	2426	390	1379	1766	3970	3060	82	502	1569	1788	1670	3240	1186	436	3834	43
3736_Depression - Impact of normal roles during worst period of depression	3736_Depression - Impact of normal roles during worst period of depression	25	44	1	44	1595	3965	4315	4025	953	476	4234	1166	2040	719	4241	1141	1716	1468	4450	1101	1934
4225_HMG CoA reductase inhibitors	4225_HMG CoA reductase inhibitors	25	44	1	4054	44	1425	2365	2859	3264	846	452	2481	1171	2522	226	3333	2324	4210	126	3880	2361
1050_Parkinson disease of unrelated individuals (tier 2a)	1050_Parkinson disease of unrelated individuals (tier 2a)	25	44	1	4610	4285	236	44	1116	990	1641	207	2015	592	3389	4010	142	538	108	3908	715	2623
4237_Antihistamines for systemic use	4237_Antihistamines for systemic use	25	44	1	3988	343	313	3075	44	669	1518	2631	1541	264	116	2478	332	313	3528	4405	1214	339
2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	2417_RET - Proto-oncogene tyrosine-protein kinase receptor Ret	25	44	1	1878	3181	2393	1833	4528	44	3104	3032	4243	3825	3980	4454	978	2903	1343	1413	1428	1973
4413_Total IgE levels	4413_Total IgE levels	25	44	1	3531	1658	3628	86	3266	4496	44	1709	3273	1481	2897	325	126	1934	2135	3498	4420	2248
700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	700_Amino acid::Phenylalanine & tyrosine metabolism::X-11423--O-sulfo-L-tyrosine	25	44	1	1839	4556	588	4131	968	4031	3298	44	3549	537	4578	2678	1291	3863	79	411	3987	1935
2297_CNTN1 - Contactin-1	2297_CNTN1 - Contactin-1	25	44	1	372	2199	4414	4515	4105	4119	3595	3647	44	1973	2175	4310	2720	1110	4055	662	4554	3136
1202_Rheumatoid Arthritis	1202_Rheumatoid Arthritis	25	44	1	3841	1508	127	412	564	1205	3223	2642	4156	44	2946	664	719	2215	166	2534	3539	1971
2152_EGFR - Epidermal growth factor receptor	2152_EGFR - Epidermal growth factor receptor	25	44	1	1578	586	820	4377	272	3073	4031	772	2158	4536	2764	3268	1236	3761	44	3554	2745	1068
1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	1585_D-dimer (at exam 6, GEE, adjusted for multivariable)	25	45	1	45	1803	2755	4396	969	1958	460	3075	1037	2221	4025	4095	4107	1816	1999	1587	1832	1916
3088_SEMA6A - Semaphorin-6A	3088_SEMA6A - Semaphorin-6A	25	45	1	1281	45	3229	1231	4626	1211	4404	741	3837	2025	755	1643	1731	1506	2022	443	4576	1172
569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	569_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 2*	25	45	1	798	241	2160	45	2038	4467	1668	502	1304	2712	2158	3815	411	1127	1774	2882	1724	3745
4027_Alcohol dependency (full discovery samples)	4027_Alcohol dependency (full discovery samples)	25	45	1	183	2759	3103	2195	45	1035	499	2322	2971	3397	924	2284	1861	1273	2227	1993	3029	2005
1197_Cerebrospinal fluid levels of amyloid-beta 1-42	1197_Cerebrospinal fluid levels of amyloid-beta 1-42	25	45	1	1511	4103	2231	1162	1728	45	3777	2627	2610	2706	2097	3183	4223	1505	2363	4268	572	2495
3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	3121_PDE2A - cGMP-dependent 3',5'-cyclic phosphodiesterase	25	45	1	1818	1132	2291	210	1269	234	45	4162	2480	3290	4208	3342	4142	681	3567	419	70	2170
2553_EPO - Erythropoietin	2553_EPO - Erythropoietin	25	45	1	1496	2114	2055	2694	3187	4628	4206	1979	45	1323	4669	1175	4305	1235	3745	2652	4669	4338
3835_Basophil percentage of granulocytes (two-way meta)	3835_Basophil percentage of granulocytes (two-way meta)	25	45	1	140	346	4063	4563	3531	4040	1421	1097	1213	359	661	45	1454	2652	94	3501	88	80
3139_F9 - Coagulation factor IXab	3139_F9 - Coagulation factor IXab	25	45	1	3656	3806	669	127	3404	1698	336	4212	4731	3238	694	605	45	1823	3983	1536	2709	1864
3271_Comparative height size at age 10	3271_Comparative height size at age 10	25	45	1	2937	995	2068	3993	2436	3023	2488	2606	1265	1988	248	1312	4496	45	3414	3188	4488	3475
4353_Tuberculosis	4353_Tuberculosis	25	45	1	906	1968	2428	2186	4045	982	1340	2030	361	3394	3696	2289	2299	4652	4484	2546	2996	45
2855_RPS27A - Ubiquitin	2855_RPS27A - Ubiquitin	25	46	1	46	642	3520	3140	1804	1033	1185	46	1591	1464	472	4571	3163	2904	1561	1169	3143	1787
3425_Ever smoked	3425_Ever smoked	25	46	1	3663	46	3676	3800	2567	2080	2720	2194	1736	1251	911	3379	3570	2796	508	3040	1044	559
2034_Primary sclerosing cholangitis	2034_Primary sclerosing cholangitis	25	46	1	3548	3445	46	300	136	1604	1183	1363	3672	377	513	2356	132	1095	4621	1674	1015	998
1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	1044_Bone Ultrasound Speed (FBAT, adjusted for multivariable)	25	46	1	474	2347	3406	46	180	3332	71	885	1959	2012	2325	442	441	2006	52	1547	2180	2309
2544_PRSS3 - Trypsin-3	2544_PRSS3 - Trypsin-3	25	46	1	1911	2846	180	428	719	46	281	917	3193	72	4379	2104	83	2064	3951	1311	1867	901
3606_Non-cancer illness code, self-reported: eczema/dermatitis	3606_Non-cancer illness code, self-reported: eczema/dermatitis	25	46	1	152	167	1091	292	423	3867	46	72	212	206	3969	3277	716	4534	597	353	4647	1852
4627_Left amygdala	4627_Left amygdala	25	46	1	4649	115	102	1500	4122	612	2467	3906	46	1009	2193	535	3192	235	2038	1197	4312	227
2648_PROC - Activated Protein C	2648_PROC - Activated Protein C	25	46	1	2275	4676	2699	774	3904	1562	4199	2784	3342	46	903	2376	529	4341	2083	3812	1639	656
3437_Doctor diagnosed hayfever or allergic rhinitis	3437_Doctor diagnosed hayfever or allergic rhinitis	25	46	1	2053	589	668	1042	486	1632	916	3048	770	4248	46	4206	651	300	525	2155	1433	2789
2935_VEGFA - Vascular endothelial growth factor A, isoform 121	2935_VEGFA - Vascular endothelial growth factor A, isoform 121	25	46	1	2035	3424	47	3623	3094	4044	736	2610	587	374	3051	46	105	242	947	2191	1509	3303
3610_Treatment/medication code: multivitamins	3610_Treatment/medication code: multivitamins	25	46	1	3212	763	1835	4342	2893	932	1934	2349	695	3319	847	3494	678	409	46	138	4441	4387
3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	3690_Diagnoses - secondary ICD10: F32 Major depressive disorder, single episode	25	46	1	4653	370	4721	4068	251	1668	1588	1585	245	284	191	2440	3868	3718	3443	3448	46	4020
2328_CLEC4M - C-type lectin domain family 4 member M	2328_CLEC4M - C-type lectin domain family 4 member M	25	46	1	1773	863	1783	2726	298	4278	975	1505	4552	4167	3816	829	4032	4590	3568	1986	3567	46
2545_DUSP3 - Dual specificity protein phosphatase 3	2545_DUSP3 - Dual specificity protein phosphatase 3	25	47	1	47	4006	1310	3233	469	3582	4506	4323	1484	3814	3686	2453	1809	3150	2982	3922	2565	3802
4701_Genu of corpus callosum mean diusivities	4701_Genu of corpus callosum mean diusivities	25	47	1	2585	3192	1735	2652	3654	47	3950	4093	758	3969	657	3999	1976	4168	818	1222	2757	111
1916_Temporal brain volume (FBAT, adjusted for multivariable)	1916_Temporal brain volume (FBAT, adjusted for multivariable)	25	47	1	479	3985	2003	489	4166	2062	47	621	3095	88	1756	1350	150	2916	2351	1225	453	2525
4551_Left inferior parietal	4551_Left inferior parietal	25	47	1	773	2700	1158	553	4323	4361	901	2650	47	2582	1766	293	603	1927	1806	1469	703	2066
2555_CXCL6 - C-X-C motif chemokine 6	2555_CXCL6 - C-X-C motif chemokine 6	25	47	1	719	529	2583	332	2775	437	147	1045	1653	47	1279	2338	888	2740	2611	247	459	179
3614_Treatment/medication code: ventolin 100micrograms inhaler	3614_Treatment/medication code: ventolin 100micrograms inhaler	25	47	1	4217	2390	129	4049	87	4203	3258	1353	1750	494	47	2204	197	337	2751	4499	512	764
4294_Chronotype	4294_Chronotype	25	47	1	1326	3748	3975	1112	1798	2529	3561	147	60	1029	1932	4491	1202	3994	47	1374	414	1755
740_::::X-11852	740_::::X-11852	25	47	1	1929	2170	4335	3061	1157	1458	3003	4401	258	747	919	1556	4726	4150	1169	47	1618	1340
4708_Superior corona radiata mean diusivities	4708_Superior corona radiata mean diusivities	25	47	1	3157	4357	2946	4737	4734	408	4561	2353	1833	3873	1039	3905	1022	4673	1565	3770	3512	47
3074_NCR1 - Natural cytotoxicity triggering receptor 1	3074_NCR1 - Natural cytotoxicity triggering receptor 1	25	48	1	48	4047	1738	122	2092	4461	158	2481	214	1051	2544	3201	1221	1443	2201	3780	1579	905
3097_HAVCR2 - Hepatitis A virus cellular receptor 2	3097_HAVCR2 - Hepatitis A virus cellular receptor 2	25	48	1	128	48	4290	3584	1291	3712	1708	4446	419	575	4279	1560	1995	3881	1087	337	1628	386
2193_FGF19 - Fibroblast growth factor 19	2193_FGF19 - Fibroblast growth factor 19	25	48	1	4704	3846	1366	1252	48	4449	387	2840	1076	51	3707	3156	4505	1815	3348	4341	3327	497
2714_LMNB1 - Lamin-B1	2714_LMNB1 - Lamin-B1	25	48	1	891	2284	2321	678	3716	48	3740	1222	2730	4569	134	3845	1771	3910	2750	3167	495	3395
3221_Time spent driving	3221_Time spent driving	25	48	1	413	3693	784	630	4506	4020	48	2544	4157	2547	2071	2914	300	2497	1668	2775	2863	361
2594_ECE1 - Endothelin-converting enzyme 1	2594_ECE1 - Endothelin-converting enzyme 1	25	48	1	1517	2571	4745	593	4696	3524	3536	703	48	1552	1567	2168	3322	3387	4613	2281	4540	1410
1102_High-density lipoprotein - Birth cohorts	1102_High-density lipoprotein - Birth cohorts	25	48	1	1750	2778	2141	3781	3626	3393	1690	4605	180	4740	48	3331	3756	1290	4591	3422	216	2629
4620_Left cerebellum exterior	4620_Left cerebellum exterior	25	48	1	3933	414	1166	1925	421	2797	53	1188	3850	3439	1571	48	2499	231	4339	3772	1650	4599
4501_Right superior frontal	4501_Right superior frontal	25	48	1	387	2119	1203	764	970	4409	2204	354	4453	4122	380	790	48	3089	3507	894	1430	2842
1998_Body Mass Index	1998_Body Mass Index	25	48	1	4454	2342	3987	3805	4007	4005	3433	4719	1478	4372	2611	4333	2098	4520	48	2828	2198	2731
2354_FGF5 - Fibroblast growth factor 5	2354_FGF5 - Fibroblast growth factor 5	25	48	1	2424	333	1808	2849	323	1878	1076	2699	3267	3199	1010	1676	3912	3571	784	48	979	2118
1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	1646_P-selectin (at exam 7, FBAT, adjusted for age and sex)	25	48	1	267	3218	3553	2684	563	56	4681	152	595	3383	3379	2259	349	2242	612	1589	48	2094
4361_Atrial fibrillation	4361_Atrial fibrillation	25	48	1	4209	2224	928	1218	3588	2244	2610	2283	2167	1959	932	3422	4463	4596	2339	4172	1946	48
1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	1014_Bone Ultrasound Attenuation (FBAT, adjusted for multivariable)	25	49	1	49	445	2680	2949	737	4193	3206	341	3839	1037	3269	470	2902	1465	1433	740	2206	1896
2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	2474_CDK8 CCNC - Cyclin-dependent kinase 8:Cyclin-C complex	25	49	1	3185	49	1289	4608	801	2046	3905	322	2655	1415	1100	4186	2001	4043	515	2736	4229	1432
3933_Galactosylation	3933_Galactosylation	25	49	1	3966	3710	49	404	316	4704	90	2773	3181	2953	2241	3292	322	1949	3461	2731	1805	4488
1907_Hippocampal volume (GEE, adjusted for multivariable)	1907_Hippocampal volume (GEE, adjusted for multivariable)	25	49	1	873	2247	583	49	2096	790	279	1805	472	1954	4576	4559	595	734	4060	1120	379	91
2502_TPSG1 - Tryptase gamma	2502_TPSG1 - Tryptase gamma	25	49	1	2926	956	2219	497	1625	49	522	2991	4092	92	258	4324	4522	3747	4374	167	622	3214
2096_POMC - Beta-endorphin	2096_POMC - Beta-endorphin	25	49	1	1432	225	4427	461	4293	4294	4557	49	3380	1877	4078	632	3321	1547	4247	3086	3575	3111
2206_CCL4L1 - C-C motif chemokine 4-like	2206_CCL4L1 - C-C motif chemokine 4-like	25	49	1	4115	2951	365	2067	2024	812	1723	140	49	307	1847	258	643	407	2589	3522	2929	475
2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	2722_PSMD7 - 26S proteasome non-ATPase regulatory subunit 7	25	49	1	4422	3246	1291	4288	4174	642	1303	3672	2477	49	3818	1433	2653	899	1510	3736	559	551
1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	1006_Regulated on Activation, Normal T Cell Expressed and Secreted (CCL5)	25	49	1	2197	2060	2508	4412	1121	3586	4237	181	1257	561	2600	49	2591	2136	960	1136	3035	954
3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	3685_Diagnoses - secondary ICD10: E03 Other hypothyroidism	25	49	1	117	3863	1418	100	1792	3399	1665	1947	441	105	74	415	49	406	2581	2375	1689	205
2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	2145_TNFRSF1A - Tumor necrosis factor receptor superfamily member 1A	25	49	1	142	693	3638	2289	254	3581	2190	291	2041	287	4138	2851	2838	49	2966	924	3807	657
442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	442_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::glycerate	25	49	1	2908	1104	250	288	2938	3095	385	4223	669	3550	2335	4209	1471	280	83	3648	598	49
3945_HbA1c	3945_HbA1c	25	50	1	50	1996	2574	2364	1888	3365	384	1916	1097	1493	4418	425	1020	513	806	2803	2994	784
2989_DSC3 - Desmocollin-3	2989_DSC3 - Desmocollin-3	25	50	1	2484	1893	50	3561	2118	1788	1664	2941	365	3804	2573	1325	2871	1031	4284	4632	1926	2826
359_mDC:%64-274-	359_mDC:%64-274-	25	50	1	2051	1771	2488	3127	2734	50	1634	755	2644	3955	840	1984	4354	2682	518	1610	436	2753
71_High-density lipoprotein cholesterol	71_High-density lipoprotein cholesterol	25	50	1	2801	1011	266	2099	2334	1603	50	902	506	1235	554	3188	4675	2102	2832	2012	2759	4419
3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	3034_SPTAN1 - Spectrin alpha chain, non-erythrocytic 1	25	50	1	4144	2035	217	2197	569	1435	861	50	3453	1672	580	2905	885	4573	4457	1490	452	3253
3611_Treatment/medication code: lisinopril	3611_Treatment/medication code: lisinopril	25	50	1	2506	640	1646	3035	2736	2369	2777	2951	50	2968	591	3056	3777	205	1349	4648	1940	539
3882_High light scatter reticulocyte count (three-way meta)	3882_High light scatter reticulocyte count (three-way meta)	25	50	1	2658	3113	2406	3743	3940	123	3279	4474	3733	50	2827	2442	470	239	3947	1022	1807	357
1138_Mother's age at death	1138_Mother's age at death	25	50	1	424	86	3571	114	1163	466	64	953	4064	746	1773	1597	50	3962	898	395	4560	1190
327_CD4mem:%Th9	327_CD4mem:%Th9	25	50	1	3546	1176	1051	2829	249	2131	600	1117	193	2155	1227	857	2049	50	3948	587	241	188
2202_IL16 - Interleukin-16	2202_IL16 - Interleukin-16	25	50	1	2411	4642	4545	864	4464	2051	337	2007	611	4083	2955	2633	2394	2974	50	1615	2329	2938
4714_Anterior limb of internal capsule mode of anisotropy	4714_Anterior limb of internal capsule mode of anisotropy	25	50	1	3419	2646	3893	2687	4485	2714	589	2084	4428	1662	4653	2418	2932	2526	1591	4597	4720	50
1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	1714_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for multivariable)	25	51	1	51	3548	4017	396	3095	1781	3607	1027	4186	671	1248	4442	106	2298	992	2818	3413	1132
2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	2492_PIK3CA PIK3R1 - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform:Phosphatidylinositol 3-kinase regulatory subunit alpha complex	25	51	1	4458	51	1858	1274	994	3909	3209	1955	2193	3686	2142	1722	368	3939	795	1353	234	832
495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	495_Lipid::Fatty acid metabolism (also BCAA metabolism)::propionylcarnitine	25	51	1	4722	1853	51	2149	1887	397	3505	1366	3541	2122	218	1951	4635	4001	257	3991	1122	1936
1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1440_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	51	1	2816	3635	2884	51	3457	2660	3475	180	3423	1006	2907	702	446	4234	4480	676	123	3625
3218_Time spent outdoors in winter	3218_Time spent outdoors in winter	25	51	1	3937	4339	2088	2349	51	4109	2245	564	1950	2317	2871	3733	2706	2656	4039	2048	4693	2510
3015_MSN - Moesin	3015_MSN - Moesin	25	51	1	4411	1209	3048	3876	920	555	51	3543	2235	1668	1883	4006	3397	1026	2078	480	2545	2244
4715_Average across all tracts mode of anisotropy	4715_Average across all tracts mode of anisotropy	25	51	1	164	1851	603	453	453	1448	955	51	771	692	3033	3195	636	4551	3000	3775	2839	2893
1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	1504_Triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	51	1	2277	1465	4137	3878	4741	1899	4016	4244	51	2351	539	3686	2580	901	2328	3871	404	3078
2008_Dapsone hypersensitivity syndrome	2008_Dapsone hypersensitivity syndrome	25	51	1	111	434	710	508	2659	646	183	4532	3036	2497	2602	51	408	867	1967	1217	2262	319
3657_Alcohol - Alcohol drinker status: Previous vs Current	3657_Alcohol - Alcohol drinker status: Previous vs Current	25	51	1	1472	1184	4373	2203	3030	841	2128	3693	1413	608	3135	2904	558	326	2479	51	4746	583
3726_Frequency of consuming six or more units of alcohol	3726_Frequency of consuming six or more units of alcohol	25	51	1	1433	1852	4082	2422	3025	306	3911	4493	2743	4197	2124	1691	4487	3190	1135	746	514	51
2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	2351_TNFSF13B - Tumor necrosis factor ligand superfamily member 13B	25	52	1	52	164	2030	1936	3314	303	1442	1497	1565	642	1148	805	3978	142	1025	3007	2578	1532
522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	522_Lipid::Long chain fatty acid::myristoleate (14:1n5)	25	52	1	4127	52	1756	2641	3028	873	1413	4693	1212	629	912	382	3647	4028	3696	3706	3058	3928
3638_Illnesses of mother: Heart disease	3638_Illnesses of mother: Heart disease	25	52	1	968	4516	2941	52	4579	4236	3992	1024	1486	1058	835	2398	2637	2184	2445	1436	4038	425
748_::::X-12038	748_::::X-12038	25	52	1	687	207	4370	3524	2229	52	740	172	66	521	3597	286	2578	3199	3375	1472	3897	4669
2058_Psoriasis	2058_Psoriasis	25	52	1	2620	362	1061	4276	119	2622	52	857	4458	3746	2799	1382	1695	1268	1640	2457	3685	4713
4410_Vaginal discharge: Smell	4410_Vaginal discharge: Smell	25	52	1	74	576	587	689	4509	2004	1976	52	185	4469	798	230	660	3156	3016	52	1442	210
4022_Eyebrows	4022_Eyebrows	25	52	1	3540	4094	276	225	2262	3576	1053	867	52	4302	1087	1022	94	2205	1222	4664	4733	2886
3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	3169_TNFRSF11A - Tumor necrosis factor receptor superfamily member 11A	25	52	1	2417	2768	185	1471	3666	2147	3502	3269	1898	52	1601	1241	3232	1312	647	3438	1246	4393
3091_SLAMF6 - SLAM family member 6	3091_SLAMF6 - SLAM family member 6	25	52	1	2935	2775	1233	330	910	82	2674	454	1688	3889	634	3329	52	56	396	752	302	2130
548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	548_Lipid::Lysolipid::1-stearoylglycerophosphoinositol	25	53	1	53	4218	2180	2502	2819	2208	938	2002	2519	459	2140	4140	1825	3841	537	4436	2543	1024
1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1459_Large low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	53	1	4571	53	933	4115	696	3277	3883	2844	3100	4214	542	859	489	1869	2511	414	577	4375
993_Interleukin-6	993_Interleukin-6	25	53	1	573	2527	53	571	3617	1460	1762	4033	2175	3454	4351	1571	1307	1620	2943	585	1415	2300
1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	1747_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for multivariable)	25	53	1	4504	811	3612	53	3868	1190	3380	265	444	776	3572	2620	184	4129	163	524	1691	3542
2947_PPP3CA PPP3R1 - Calcineurin	2947_PPP3CA PPP3R1 - Calcineurin	25	53	1	1228	1486	606	4141	3082	53	957	1248	356	4408	3082	2267	237	4472	3541	3166	2106	1552
481_Lipid::Carnitine metabolism::hexanoylcarnitine	481_Lipid::Carnitine metabolism::hexanoylcarnitine	25	53	1	304	2650	573	3010	174	2612	4547	53	582	2512	1842	4346	3823	2360	78	4396	406	3902
2558_IL17B - Interleukin-17B	2558_IL17B - Interleukin-17B	25	53	1	3869	3156	1915	2263	2972	4003	4361	2747	2250	118	1336	53	1296	3864	249	3938	976	3070
2938_F9 - Coagulation factor IX	2938_F9 - Coagulation factor IX	25	53	1	3356	1992	558	150	3285	1991	690	3866	3369	2563	655	2947	53	2110	1328	1471	2596	3708
4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	4727_Posterior thalamic radiation (include optic radiation) mode of anisotropy	25	53	1	4251	401	2626	2495	2544	187	1768	1961	120	1461	149	2441	757	53	2978	4618	2552	3923
393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	393_Amino acid::Phenylalanine & tyrosine metabolism::3-methoxytyrosine	25	53	1	149	1030	1492	144	422	705	3207	81	4445	1153	838	4640	395	4553	53	555	3052	1135
2872_PRSS22 - Brain-specific serine protease 4	2872_PRSS22 - Brain-specific serine protease 4	25	53	1	958	806	4526	193	3004	4446	3011	123	88	1764	2263	690	2448	4473	206	1067	4561	53
150_Body Mass Index (female <= 50 yrs)	150_Body Mass Index (female <= 50 yrs)	25	54	1	54	1320	2391	3234	478	3661	3626	1329	352	305	3223	893	1561	2879	2130	4271	2267	2644
2174_LAMA1 LAMB1  LAMC1 - Laminin	2174_LAMA1 LAMB1  LAMC1 - Laminin	25	54	1	3286	54	4319	2515	2467	4671	1288	759	3418	857	328	708	3530	2084	3894	3647	1247	122
2932_BMPR1A - Bone morphogenetic protein receptor type-1A	2932_BMPR1A - Bone morphogenetic protein receptor type-1A	25	54	1	1704	966	54	3104	1601	670	3603	4001	2518	4452	1372	3497	928	3274	687	3556	668	1296
3472_Age at cancer diagnosis	3472_Age at cancer diagnosis	25	54	1	3818	524	61	54	2409	1324	2571	542	3492	3084	3467	180	101	550	4373	2255	865	1729
497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	497_Lipid::Fatty acid, dicarboxylate::2-hydroxyglutarate	25	54	1	1117	1152	238	4271	1713	54	156	394	993	260	1261	2144	2567	4702	924	3158	4701	1844
3025_PGK1 - Phosphoglycerate kinase 1	3025_PGK1 - Phosphoglycerate kinase 1	25	54	1	322	2785	2305	1536	2831	2225	54	3774	1207	345	1295	1949	1904	3734	871	790	346	1189
3739_Depression - Ever had prolonged feelings of sadness or depression	3739_Depression - Ever had prolonged feelings of sadness or depression	25	54	1	1829	1477	3847	3636	4001	775	2037	54	2491	2677	2572	1267	3612	2448	4625	2302	245	2492
3966_Asthma (fixed effect model)	3966_Asthma (fixed effect model)	25	54	1	3553	3319	181	2230	1724	2990	2640	1941	4374	79	54	1803	650	3991	604	862	978	1393
3635_Illnesses of father: Alzheimer's disease/dementia	3635_Illnesses of father: Alzheimer's disease/dementia	25	54	1	204	204	335	3225	2397	4038	860	984	2237	3212	3133	54	2517	263	2234	272	282	1794
3633_Illnesses of father: High blood pressure	3633_Illnesses of father: High blood pressure	25	54	1	1538	1689	769	468	4252	3268	4725	3034	3739	3494	1092	1653	54	4672	3784	1936	2494	2117
3734_Depression - Duration of worst depression	3734_Depression - Duration of worst depression	25	54	1	1811	2919	4510	1099	2493	977	3763	4004	3712	3580	4063	2136	2733	54	2967	228	4371	116
341_NKeff:%314-R7-	341_NKeff:%314-R7-	25	54	1	1110	802	4508	737	4588	4153	75	4324	2287	3177	3186	3453	3669	3606	114	54	2692	108
982_Interleukin-12p70	982_Interleukin-12p70	25	54	1	237	641	2497	3925	4745	2973	3113	62	1883	1073	230	1499	2191	727	203	1756	54	3978
1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1274_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	54	1	1130	1293	2883	671	797	1775	159	795	1404	2076	1016	3351	2271	3885	531	3104	4294	54
298_CD4mem:%preTh17 (2)	298_CD4mem:%preTh17 (2)	25	55	1	55	1424	3788	197	2272	2829	2727	282	3420	4009	3812	4218	905	537	750	2697	1233	3885
2888_KIRREL3 - Kin of IRRE-like protein 3	2888_KIRREL3 - Kin of IRRE-like protein 3	25	55	1	1752	55	1789	1271	2463	3404	3323	1230	2587	3665	4442	3780	2006	1138	4322	147	4014	2656
105_Tanner scale (female)	105_Tanner scale (female)	25	55	1	2194	3594	3399	2913	2614	55	4736	3932	1118	4017	3917	3922	3110	1935	3120	999	4681	2861
1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	1866_Neck-Shaft Angle (FBAT, female, adjussted for multivariable)	25	55	1	2683	2327	3487	4194	131	2826	55	2156	425	837	2944	3649	1389	3934	4011	4487	3212	3845
4007_Osteoarthritis of hip (hospital diagnosed)	4007_Osteoarthritis of hip (hospital diagnosed)	25	55	1	554	4573	3353	556	2625	939	3857	55	2892	4393	3697	493	2024	2129	3833	2379	712	4109
4444_Cytomegalovirus IgG levels	4444_Cytomegalovirus IgG levels	25	55	1	4678	4178	3839	4612	2378	1369	1639	811	3293	55	531	1053	4642	3020	897	2927	484	3511
4392_Menstrual pain medicine use	4392_Menstrual pain medicine use	25	55	1	4322	3137	4395	1853	4505	2228	3831	1768	943	3003	55	760	1900	1993	3234	503	4129	1291
1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	1623_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for age and sex)	25	55	1	325	69	716	321	906	618	1010	3712	3512	3187	1865	2431	55	3496	3628	4545	3776	3341
1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	1354_Plasma Apolipoprotein C3 level (FBAT, adjusted for age and sex)	25	56	1	56	1881	1888	1206	2227	769	1426	2823	580	962	2705	769	3317	1744	3233	2246	565	944
4344_Sleep sedentary (conditioning sex and BMI)	4344_Sleep sedentary (conditioning sex and BMI)	25	56	1	1267	4704	56	1197	4074	101	2224	324	1322	1060	671	744	545	712	2678	2212	3051	411
1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1442_Low-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	56	1	1523	3752	2846	56	3784	2017	4059	410	2363	2483	4095	463	203	3662	3238	1960	252	2182
3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	3665_Diagnoses - main ICD10: C44 Other and unspecified malignant neoplasm of skin	25	56	1	2141	871	4485	4025	56	4323	2367	710	896	653	424	583	1897	1664	3347	3553	2958	855
1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	1508_Triglycerides (at exam 6, FBAT, adjusted for age and sex)	25	56	1	2302	2026	2129	207	239	2187	1139	56	3023	1166	3383	1485	582	1326	232	1778	472	1846
789_::::X-12680	789_::::X-12680	25	56	1	689	4662	4694	3001	3692	4518	4299	1576	56	3453	3773	1993	1712	2132	138	2765	1837	4390
86_Lumbar Spine BMD	86_Lumbar Spine BMD	25	56	1	1330	2097	2320	2672	3730	3037	485	1070	4556	56	592	531	2945	2858	185	1703	513	2348
865_Esterified cholesterol	865_Esterified cholesterol	25	56	1	1832	1930	342	2003	4220	3486	193	783	998	4575	643	3744	2048	1176	207	56	248	767
4744_Fornix (cres) / Stria terminalis radial diusivities	4744_Fornix (cres) / Stria terminalis radial diusivities	25	56	1	980	2416	3618	1983	1946	90	2597	1317	3266	1441	2593	2308	1482	1139	455	2280	56	1545
4360_Biliary atresia	4360_Biliary atresia	25	56	1	2775	3403	3702	4462	4402	1148	1013	4685	2021	3677	3964	4091	2676	849	3818	789	4569	56
606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	606_Peptide::gamma-glutamyl::gamma-glutamylphenylalanine	25	57	1	57	3654	1155	1788	1988	2563	3687	2021	2038	3870	1843	482	3920	3669	1823	3877	4643	3514
1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	1281_Sagittal diameter by CT (GEE, adjusted for age and sex)	25	57	1	457	57	3997	1078	471	61	4621	3390	2204	4035	63	2739	1629	2634	1211	2604	399	1098
3917_Adiponectin	3917_Adiponectin	25	57	1	352	2715	2248	57	2743	3511	4516	3180	4636	486	859	556	2358	1595	4524	564	2177	3688
4081_Waist-hip ratio (adjusted for BMI, male)	4081_Waist-hip ratio (adjusted for BMI, male)	25	57	1	3174	661	1260	1939	57	4041	425	2622	4083	4169	2905	4463	1237	3021	3617	3763	4565	590
587_Nucleotide::Purine metabolism, urate metabolism::allantoin	587_Nucleotide::Purine metabolism, urate metabolism::allantoin	25	57	1	2008	4347	585	983	4735	57	215	230	3371	1201	3644	2317	2841	710	2554	3561	4121	669
2128_IL10RB - Interleukin-10 receptor subunit beta	2128_IL10RB - Interleukin-10 receptor subunit beta	25	57	1	3467	550	944	3136	1132	1954	57	864	2067	3438	4069	246	3953	1893	656	4567	2126	725
4481_Right inferior parietal	4481_Right inferior parietal	25	57	1	4485	3359	3044	538	739	2905	501	3031	57	396	2878	996	1505	3139	3596	2405	1353	3218
2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	2319_SIGLEC9 - Sialic acid-binding Ig-like lectin 9	25	57	1	278	367	655	322	2607	2964	2855	1519	705	57	2429	1632	366	2094	310	681	856	182
3460_Impedance measures - Arm fat percentage (right)	3460_Impedance measures - Arm fat percentage (right)	25	57	1	1652	1687	1975	3979	618	4009	4659	2539	1738	237	3814	57	1033	4180	1726	4098	2014	2222
2920_Human-virus - gp41 C34 peptide, HIV	2920_Human-virus - gp41 C34 peptide, HIV	25	57	1	1317	1734	1205	59	817	2873	3062	238	76	96	1789	201	57	351	2370	3852	4160	2149
1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	1039_Neck-Shaft Angle (GEE, adjusted for multivariable)	25	57	1	4170	2414	2171	2512	1983	2022	2493	4422	791	1104	3480	2751	68	3808	57	4367	4180	2124
2975_ANXA2 - Annexin A2	2975_ANXA2 - Annexin A2	25	57	1	3939	284	4573	3449	4637	1512	4150	3090	435	2999	771	243	272	1973	3542	4434	3078	57
1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1447_Low-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	58	1	58	2485	3209	62	1675	2382	3408	1617	3312	1979	2669	4125	440	1080	1991	1787	2987	4441
2651_TEK - Angiopoietin-1 receptor, soluble	2651_TEK - Angiopoietin-1 receptor, soluble	25	58	1	4096	58	1652	204	485	1720	1267	1437	459	1848	3316	1598	299	2131	2626	1932	4016	2829
3932_Digalactosylation	3932_Digalactosylation	25	58	1	4409	2202	58	627	551	4644	2305	3840	980	3954	2202	3816	641	3444	4360	3621	3902	2874
4187_HbA1c	4187_HbA1c	25	58	1	194	4688	2771	1466	58	1198	2594	3367	1893	419	3494	241	835	4325	2687	3686	796	1067
3504_Non-butter spread type details: Flora Pro-Active or Benecol	3504_Non-butter spread type details: Flora Pro-Active or Benecol	25	58	1	2719	148	2084	3963	714	1228	58	1265	562	177	1969	1528	4405	86	3308	73	1128	955
273_CD8:%SCM	273_CD8:%SCM	25	58	1	3278	2706	723	152	4584	4429	944	58	1216	2754	4544	249	2165	744	4220	1424	3633	3628
862_Creatinine	862_Creatinine	25	58	1	4566	159	2933	1830	4189	3611	3085	725	58	3724	2251	1490	1773	201	1862	2356	2577	4563
408_Amino acid::Tryptophan metabolism::serotonin (5HT)	408_Amino acid::Tryptophan metabolism::serotonin (5HT)	25	58	1	1855	969	4499	2042	3056	1102	2561	242	3275	58	900	1085	2040	2190	1978	2847	2781	2330
3331_Other serious medical condition/disability (diagnosed by doctor)	3331_Other serious medical condition/disability (diagnosed by doctor)	25	58	1	2219	717	147	730	271	191	392	2010	4026	2389	1487	1344	58	4626	2613	4289	719	1803
4330_Postburn scar pliability	4330_Postburn scar pliability	25	58	1	4698	2017	4315	1594	4308	3560	775	3743	222	4611	3933	3058	1047	58	2478	1119	4208	1006
469_Lipid::Bile acid metabolism::hyodeoxycholate	469_Lipid::Bile acid metabolism::hyodeoxycholate	25	58	1	138	2268	4401	3938	3302	3009	515	1042	1085	462	3582	2694	1062	1222	58	4623	795	96
525_Lipid::Long chain fatty acid::palmitate (16:0)	525_Lipid::Long chain fatty acid::palmitate (16:0)	25	58	1	2744	573	3535	2125	2249	177	1943	4038	2669	4578	2344	1897	751	2934	2543	58	4235	4066
2283_IGF1 - Insulin-like growth factor I	2283_IGF1 - Insulin-like growth factor I	25	58	1	822	571	228	4700	392	3668	555	818	4624	3559	541	1871	2760	1179	3726	330	58	723
3692_Diagnoses - secondary ICD10: I20 Angina pectoris	3692_Diagnoses - secondary ICD10: I20 Angina pectoris	25	58	1	632	647	2784	167	1410	3527	3624	4263	868	1808	3002	2099	3851	3498	3997	1646	474	58
4433_Mumps IgG levels	4433_Mumps IgG levels	25	59	1	59	2979	484	4334	2684	3773	122	637	4715	3090	2157	305	3452	284	4008	242	782	255
3095_IL27RA - Interleukin-27 receptor subunit alpha	3095_IL27RA - Interleukin-27 receptor subunit alpha	25	59	1	3402	59	2133	2493	2219	4240	408	1392	2137	955	263	471	1838	2493	3974	141	4163	4305
4745_Genu of corpus callosum radial diusivities	4745_Genu of corpus callosum radial diusivities	25	59	1	2815	2928	4629	2388	2002	59	3516	3621	1900	3261	1697	2975	1277	2924	906	830	2402	384
3123_STK17B - Serine/threonine-protein kinase 17B	3123_STK17B - Serine/threonine-protein kinase 17B	25	59	1	4283	4082	4614	2170	4682	201	76	59	4529	2469	3804	4697	3568	724	304	3901	1580	1420
2179_NOV - Protein NOV homolog	2179_NOV - Protein NOV homolog	25	59	1	934	3889	467	2817	1494	273	2549	2223	59	1674	574	1314	1023	497	4236	361	705	2882
1108_Subcutaneous adipose tissue volume	1108_Subcutaneous adipose tissue volume	25	59	1	2946	2383	4245	2208	4200	529	4085	1556	1522	59	4099	3998	3830	1102	759	2859	2023	2199
2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	2108_TNFSF9 - Tumor necrosis factor ligand superfamily member 9	25	59	1	2068	4296	2691	2473	1179	848	411	2594	3597	664	59	1281	3460	3602	3434	1054	2548	977
1915_Parietal brain volume (GEE, adjusted for multivariable)	1915_Parietal brain volume (GEE, adjusted for multivariable)	25	59	1	3516	843	1267	3737	1231	1600	339	1448	1003	2500	950	59	970	1025	998	375	2612	3572
3333_Frequency of heavy DIY in last 4 weeks	3333_Frequency of heavy DIY in last 4 weeks	25	59	1	556	2116	1721	874	2632	1450	66	80	2019	1131	329	1589	3630	59	3058	4305	3932	438
2426_BGN - Biglycan	2426_BGN - Biglycan	25	59	1	2293	2464	4731	4624	1390	3079	3531	3124	2397	655	1389	1086	1499	1552	59	1948	1967	1652
996_Interleukin-9	996_Interleukin-9	25	59	1	3064	1313	1184	533	4495	407	2336	3223	1319	2274	520	2539	2149	2152	3174	59	1099	447
691_::::X-11299	691_::::X-11299	25	59	1	4097	368	1245	3657	1761	934	1781	460	3376	616	940	750	3456	682	129	1064	1575	59
592_Peptide::Dipeptide::cyclo(leu-pro)	592_Peptide::Dipeptide::cyclo(leu-pro)	25	60	1	60	4514	3092	83	3844	1113	3360	1826	3454	65	3995	2861	219	3116	4139	1729	1756	860
3016_NAMPT - Nicotinamide phosphoribosyltransferase	3016_NAMPT - Nicotinamide phosphoribosyltransferase	25	60	1	315	60	160	1148	3102	2025	3459	3849	2509	1439	2134	4350	2608	3397	3600	2559	2037	2098
1071_Diabetic Nephropathy in Type 1 Diabetes	1071_Diabetic Nephropathy in Type 1 Diabetes	25	60	1	3987	1000	60	526	1953	1239	4160	1259	571	2001	3732	1041	361	2566	3489	3510	613	2626
803_::::X-12786	803_::::X-12786	25	60	1	513	1119	1750	60	90	1192	3072	75	642	323	4552	2987	115	2749	882	197	593	2212
2860_C5 C6 - Complement C5b-C6 complex	2860_C5 C6 - Complement C5b-C6 complex	25	60	1	110	4717	3946	431	60	375	3956	3689	496	3062	3024	1703	4460	1317	3862	4387	3972	426
1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	1718_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for age and sex)	25	60	1	1031	416	4228	2820	3047	60	1257	4332	160	402	4049	3116	445	643	1195	846	1183	2718
3083_PRLR - Prolactin receptor	3083_PRLR - Prolactin receptor	25	60	1	2864	978	3164	733	3152	427	60	4351	225	3948	1472	4734	4006	1520	156	2024	232	4304
1756_Cancer (FBAT, adjusted for multivariable)	1756_Cancer (FBAT, adjusted for multivariable)	25	60	1	662	1199	4321	3174	2357	1332	1056	60	3726	1446	3851	4225	683	2468	2521	1565	1929	2703
3441_Impedance measures - Body fat percentage	3441_Impedance measures - Body fat percentage	25	60	1	1136	1289	3054	2688	1560	3701	1988	1618	2255	147	2742	60	980	2533	4638	2521	3982	3294
58_College completion	58_College completion	25	60	1	3609	3420	3837	84	4567	4708	2421	4276	2394	4094	3381	1646	60	1883	1281	80	3786	1419
3028_ADSL - Adenylosuccinate lyase	3028_ADSL - Adenylosuccinate lyase	25	60	1	4372	1327	1154	2549	1702	71	4451	1822	803	328	1566	3345	263	60	2219	692	2038	2220
392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	392_Amino acid::Phenylalanine & tyrosine metabolism::3-(4-hydroxyphenyl)lactate	25	60	1	1993	719	351	3815	575	1440	1019	2427	2222	1760	1808	339	530	1813	60	2603	3700	3006
2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	2472_CDK2 CCNA2 - Cyclin-dependent kinase 2:Cyclin-A2 complex	25	60	1	698	921	1223	246	2494	3766	304	1377	1300	645	2864	3376	812	3676	3509	60	1489	171
535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	535_Lipid::Lysolipid::1-eicosatrienoylglycerophosphocholine*	25	60	1	3538	4563	1854	323	3906	1955	645	2000	3250	2108	147	621	3502	1611	4536	2781	60	1925
4688_Superior longitudinal fasciculus axial diusivities	4688_Superior longitudinal fasciculus axial diusivities	25	60	1	1295	1961	3188	4572	1948	238	3549	4509	902	2244	2467	1707	4430	1107	2366	2247	749	60
1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	1751_Cystatin C (at exam 7, GEE, adjusted for age and sex)	25	61	1	3449	61	628	3845	3523	3848	950	137	1295	2083	1853	1489	4537	999	3250	4580	2879	4230
2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	2086_TNFSF12 - Tumor necrosis factor ligand superfamily member 12	25	61	1	771	2227	101	3465	61	3993	4241	1006	547	1285	437	314	2786	953	1752	842	479	190
2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	2961_ITGAV ITGB5 - Integrin alpha-V: beta-5 complex	25	61	1	4002	2658	2706	2692	916	2656	61	1389	1777	3200	3226	3430	4365	3312	3087	1252	3734	3984
3194_Number of vehicles in household	3194_Number of vehicles in household	25	61	1	3907	4594	555	4111	4301	561	3098	737	61	4266	560	3861	4076	4495	2061	1228	857	2448
4628_Left accumbens area	4628_Left accumbens area	25	61	1	4103	4565	1610	1607	2201	2852	2733	1275	1080	61	3536	4269	4367	3362	4037	2616	395	2550
4440_Hepatitis B HBc antigen IgG levels	4440_Hepatitis B HBc antigen IgG levels	25	61	1	4197	4648	870	182	2252	655	1900	1933	1675	1099	1013	61	2345	3807	244	4208	1652	1616
1955_Similarities raw score (GEE, adjusted for multivariable)	1955_Similarities raw score (GEE, adjusted for multivariable)	25	61	1	2260	4639	2669	90	4231	3307	1384	2845	4506	2959	2077	4413	61	840	4589	335	3470	1144
3099_UNC5C - Netrin receptor UNC5C	3099_UNC5C - Netrin receptor UNC5C	25	61	1	1398	3936	438	2248	1444	163	4726	727	1553	4591	3182	4277	815	61	756	1577	1120	543
3834_Basophil percentage of white cells (two-way meta)	3834_Basophil percentage of white cells (two-way meta)	25	61	1	159	314	3938	4643	3679	3477	1633	754	1298	560	417	92	767	1948	61	3337	87	170
3001_GSTA3 - Glutathione S-transferase A3	3001_GSTA3 - Glutathione S-transferase A3	25	61	1	4703	2678	2106	2256	1564	1565	4645	2925	1817	477	674	100	690	823	3314	61	4061	1447
2629_A2M - Alpha-2-macroglobulin	2629_A2M - Alpha-2-macroglobulin	25	61	1	1879	700	287	3778	1326	237	606	3546	2251	97	2258	2835	1583	3416	729	751	61	1621
4751_Splenium of corpus callosum radial diusivities	4751_Splenium of corpus callosum radial diusivities	25	61	1	2906	3106	1024	1639	4666	313	4015	1439	397	3670	1435	3386	2083	2478	238	1233	3406	61
2815_CLEC1B - C-type lectin domain family 1 member B	2815_CLEC1B - C-type lectin domain family 1 member B	25	62	1	62	958	3643	2102	79	1582	2997	1474	150	4396	2873	1310	205	4470	4263	2792	2734	243
422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	422_Amino acid::Valine, leucine and isoleucine metabolism::3-methyl-2-oxobutyrate	25	62	1	1232	62	3046	2968	2746	4366	1231	129	671	914	754	377	3661	1635	782	2432	3504	3547
4395_Menstruation quality of life impact: Acne	4395_Menstruation quality of life impact: Acne	25	62	1	231	4446	647	2032	62	2059	2330	1842	2369	688	2087	3269	2415	1518	682	1951	2179	4238
2593_DPP7 - Dipeptidyl peptidase 2	2593_DPP7 - Dipeptidyl peptidase 2	25	62	1	1955	735	4620	133	1129	62	2313	2723	840	2030	4015	3634	133	4328	1334	220	2928	4000
2818_ICAM1 - Intercellular adhesion molecule 1	2818_ICAM1 - Intercellular adhesion molecule 1	25	62	1	3484	4031	4254	470	4470	446	2300	1068	62	1735	158	4498	3042	3218	3021	3623	2632	109
2762_MMP2 - 72 kDa type IV collagenase	2762_MMP2 - 72 kDa type IV collagenase	25	62	1	1324	1494	818	3784	4546	2956	3409	4611	2461	62	822	1602	512	1052	3391	3518	3867	538
297_CD4mem:%Th22	297_CD4mem:%Th22	25	62	1	2637	2437	2617	3883	2822	2587	1580	1330	4192	3230	338	1196	62	3238	2577	3989	1852	3921
1072_Systemic Lupus Erythematosus	1072_Systemic Lupus Erythematosus	25	62	1	1371	723	575	82	1716	2112	828	3568	3920	978	1006	596	187	955	62	3764	1179	2181
2587_CHL1 - Neural cell adhesion molecule L1-like protein	2587_CHL1 - Neural cell adhesion molecule L1-like protein	25	63	1	63	363	3155	1181	412	3961	484	258	4697	1271	1862	2590	1909	2804	4022	2787	4079	4564
3613_Treatment/medication code: simvastatin	3613_Treatment/medication code: simvastatin	25	63	1	4557	63	2269	3555	2979	2832	1112	409	3547	863	4151	457	4011	3784	1270	176	2904	2743
259_CD8:%TM-like	259_CD8:%TM-like	25	63	1	2654	3164	3822	63	4599	1824	2680	2307	3729	3253	3722	4643	1520	3984	1338	2186	4504	1559
4034_Alcohol dependency (discovery)	4034_Alcohol dependency (discovery)	25	63	1	4377	2998	2831	3135	63	3945	3530	1451	2877	636	3491	1239	2753	112	4675	4665	3561	1443
4669_Anterior corona radiata axial diusivities	4669_Anterior corona radiata axial diusivities	25	63	1	1274	2690	2490	3647	4400	63	648	939	2425	701	347	4088	3933	2719	230	4543	292	895
2830_SLPI - Antileukoproteinase	2830_SLPI - Antileukoproteinase	25	63	1	4071	4150	3020	4418	2524	383	63	3280	1420	370	3211	4629	2808	363	692	3579	1425	1849
1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	1637_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for multivariable)	25	63	1	619	3898	2343	1052	1781	2262	3230	63	1826	1087	127	3267	911	2244	4092	1343	3210	1619
366_Amino acid::Alanine and aspartate metabolism::aspartate	366_Amino acid::Alanine and aspartate metabolism::aspartate	25	63	1	1105	4059	866	3457	2485	4028	361	2357	1579	2009	1957	63	1000	2514	1821	4463	4281	541
3850_Mean corpuscular hemoglobin concentration (two-way meta)	3850_Mean corpuscular hemoglobin concentration (two-way meta)	25	63	1	2328	2687	4077	3624	2866	2804	1336	906	3635	347	463	140	2989	63	228	1883	3596	1955
1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	1898_Troch Neck BMD (FBAT, female, adjussted for multivariable)	25	63	1	1894	1977	1647	1836	3348	2424	3803	478	3037	2005	376	4096	537	1563	2806	301	63	4204
1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	1867_Neck-Shaft Angle (GEE, female, adjussted for multivariable)	25	63	1	3079	4123	3870	2878	2057	672	3565	2486	3845	3740	2903	1272	4439	1297	1089	1523	3525	63
4424_Hepatitis B HBs antigen seropositivity	4424_Hepatitis B HBs antigen seropositivity	25	64	1	64	2088	2124	3516	142	1815	3944	992	3831	131	295	1283	1957	147	3219	4354	2213	2054
4072_First PC of the four riskly behaviours	4072_First PC of the four riskly behaviours	25	64	1	3766	64	1715	2013	715	2313	1878	1093	2007	1647	4113	2915	1763	3883	724	3381	1371	435
2032_Prognosis in Crohn's Disease	2032_Prognosis in Crohn's Disease	25	64	1	4681	3942	64	2666	745	4267	3738	1710	2843	1195	362	3754	222	1067	2558	4634	630	4068
2734_FGF6 - Fibroblast growth factor 6	2734_FGF6 - Fibroblast growth factor 6	25	64	1	386	345	2509	3377	64	3882	233	970	2081	144	2380	1202	3077	3899	535	339	2956	355
4704_Posterior limb of internal capsule mean diusivities	4704_Posterior limb of internal capsule mean diusivities	25	64	1	3045	2741	992	2964	1861	64	1154	1668	2442	1346	2092	4464	4274	3758	1229	3691	3725	470
4470_Left superior frontal	4470_Left superior frontal	25	64	1	4556	188	2422	3884	2019	1757	470	64	1353	1320	2670	2797	4084	3473	3475	2310	757	707
3878_Granulocyte percentage of myeloid white cells (three-way meta)	3878_Granulocyte percentage of myeloid white cells (three-way meta)	25	64	1	3716	3007	196	1813	3754	2457	130	3553	2462	64	1203	1482	2344	4396	1984	1573	3086	1507
3871_Basophil percentage of granulocytes (three-way meta)	3871_Basophil percentage of granulocytes (three-way meta)	25	64	1	1932	1481	2804	2535	1083	2743	343	169	503	2312	1386	64	804	3688	2170	3896	4361	512
2719_NAGK - N-acetyl-D-glucosamine kinase	2719_NAGK - N-acetyl-D-glucosamine kinase	25	64	1	3612	2204	2310	165	4675	774	2139	3042	4317	2647	210	1205	64	1711	2218	4195	1669	4717
4178_White blood cells	4178_White blood cells	25	64	1	4226	2765	4091	1075	222	675	1796	652	331	270	699	833	170	64	1477	1515	2344	336
1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1463_Small low-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	64	1	1831	1571	571	136	3916	2678	1820	2390	3643	4688	1840	2086	901	2101	64	4022	4307	2021
3919_Low-density lipoprotein cholesterol	3919_Low-density lipoprotein cholesterol	25	64	1	4172	265	4065	1463	4186	4264	494	3488	1100	3939	1078	1862	3954	910	731	389	64	974
753_::::X-12092	753_::::X-12092	25	65	1	65	3650	413	406	1771	2726	3960	1205	4332	2810	1129	1983	291	3921	761	879	2051	2237
2548_B2M - Beta-2-microglobulin	2548_B2M - Beta-2-microglobulin	25	65	1	3365	678	65	328	2974	1358	2946	4150	4220	389	2738	174	693	1709	918	210	240	2866
4042_Obsessive compulsive disorder	4042_Obsessive compulsive disorder	25	65	1	3740	3041	611	65	1737	4259	1986	69	1155	806	4425	4391	2825	3882	3293	3015	2587	398
3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	3727_Anxiety - Ever felt worried, tense, or anxious for most of a month or longer	25	65	1	4052	3163	1256	2430	65	1544	148	68	4648	3381	4297	1638	3225	2461	2002	2037	3816	2264
2644_CSF1 - Macrophage colony-stimulating factor 1	2644_CSF1 - Macrophage colony-stimulating factor 1	25	65	1	309	4689	2593	1263	4391	65	2496	249	3527	434	2919	3682	2988	3493	157	2538	228	4420
813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	813_Lipid::Essential fatty acid::X-12990--docosapentaenoic acid (n6-DPA)	25	65	1	2847	3583	2759	3350	1901	2643	65	1166	341	3304	1905	1042	4596	966	1091	3014	212	2815
1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1462_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	65	1	4674	3626	2019	3595	1783	411	2390	65	4153	382	2342	4644	75	2054	4497	561	4161	1919
603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	603_Peptide::gamma-glutamyl::gamma-glutamylisoleucine*	25	65	1	320	3778	1177	3316	1845	903	772	4306	4405	2207	1184	65	3894	495	1200	704	121	2410
336_NKeff:%2-158a+	336_NKeff:%2-158a+	25	65	1	88	765	919	4283	4746	3223	3237	2573	1066	878	96	1730	1238	445	2514	65	1753	414
867_OmegaL3 fatty acids	867_OmegaL3 fatty acids	25	65	1	4503	3304	1075	4360	2963	2328	151	994	3719	3579	70	791	2054	4357	2081	3628	65	2382
1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	1566_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for age and sex)	25	65	1	1707	1869	2331	4244	130	2383	4270	4642	146	515	2304	168	2780	3626	4048	1628	3083	65
4038_Schizophrenia	4038_Schizophrenia	25	66	1	1869	66	634	2592	1889	1031	3160	4471	2002	1832	132	4354	700	1245	3712	2517	137	4311
728_::::X-11792	728_::::X-11792	25	66	1	2716	3993	99	66	3131	2982	450	3924	3847	802	1846	351	293	188	4209	1373	214	3123
2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	2583_CAMK1 - Calcium/calmodulin-dependent protein kinase type 1	25	66	1	4132	118	2655	1172	1130	66	1811	3480	2565	3057	3519	1742	1006	1124	957	3080	2852	2990
3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	3592_Mineral and other dietary supplements: Fish oil (including cod liver oil)	25	66	1	4473	652	4139	1364	3125	1322	3773	66	217	2610	2402	4275	4611	1300	696	3573	242	3189
4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	4029_Alcohol dependency (random effect model for unrelated genotyped individuals)	25	66	1	233	1162	4120	1057	1837	2180	1148	1385	2485	66	4492	3871	143	2624	4268	2855	4396	1233
1196_Asthma (female)	1196_Asthma (female)	25	66	1	3364	447	4739	693	4015	3631	3958	3448	4702	789	851	2952	770	66	4668	3984	1000	3810
246_CD56 on NK eff	246_CD56 on NK eff	25	66	1	4739	3068	4279	2070	2820	3005	3828	2858	2466	1757	4091	3325	2952	3037	66	3771	2974	3578
4426_Epstein Barr Virus antigen EA seropositivity	4426_Epstein Barr Virus antigen EA seropositivity	25	66	1	72	92	3427	675	3571	2468	394	596	4288	1798	2453	2523	193	229	3599	66	938	1712
1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	1370_Total cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	66	1	2357	3114	1996	1938	963	2179	850	1072	1805	910	4128	2175	2633	2650	4026	86	2423	66
822_::::X-13548	822_::::X-13548	25	67	1	67	4506	378	3856	1693	3450	272	421	1467	2584	2547	3232	799	1214	651	595	1609	1654
2184_ULBP3 - NKG2D ligand 3	2184_ULBP3 - NKG2D ligand 3	25	67	1	1827	67	4642	3699	2050	4116	490	1112	987	324	3545	2025	4083	1267	4428	2919	2306	1497
1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	1628_Interleukin 6 (at exam 7, FBAT, adjusted for multivariable)	25	67	1	3117	648	3988	67	724	1077	1806	4562	327	3604	2178	879	284	3194	2463	1318	1175	4541
2638_PYY - Peptide YY	2638_PYY - Peptide YY	25	67	1	451	1806	797	2164	2343	67	3139	623	2992	2862	3311	4511	2342	1978	2359	594	553	1802
3808_Lymphocyte count	3808_Lymphocyte count	25	67	1	3886	1581	122	168	584	2105	1192	4125	475	67	286	318	145	1918	1643	4534	706	3007
4387_Epithelial ovarian cancer (Clear cell)	4387_Epithelial ovarian cancer (Clear cell)	25	67	1	1254	2477	1502	2160	3972	3597	3065	1981	194	2960	3305	67	2270	3954	2237	656	2146	312
2560_HAMP - Hepcidin	2560_HAMP - Hepcidin	25	67	1	4256	1755	435	3723	4467	1935	1545	1441	1543	939	1138	118	3619	384	67	2290	4177	2083
470_Lipid::Bile acid metabolism::taurochenodeoxycholate	470_Lipid::Bile acid metabolism::taurochenodeoxycholate	25	67	1	4106	2637	4090	4569	274	3416	3129	283	3150	1100	4090	4743	614	1967	1656	67	457	4249
4399_Menstruation quality of life impact: Depression	4399_Menstruation quality of life impact: Depression	25	67	1	904	2670	4556	4437	1158	4653	2895	794	72	4545	2264	1834	4364	2818	965	2635	4710	67
3777_Traumatic events - Diagnosed with life-threatening illness	3777_Traumatic events - Diagnosed with life-threatening illness	25	68	1	3437	68	3177	4407	2420	4473	3048	728	4164	1111	3395	1635	4179	1536	2830	3055	855	1530
1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	1868_Neck-Shaft Angle (FBAT, male, adjussted for multivariable)	25	68	1	1419	2953	3728	68	1995	3724	331	1021	3363	2430	479	2174	807	4291	634	323	2850	4216
1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	1300_Fasting plasma glucose (at exam 7, FBAT, adjusted for age and sex)	25	68	1	1106	686	134	1049	4263	68	4342	2717	3207	130	2146	223	1456	4186	2686	129	4119	706
3637_Illnesses of father: Prostate cancer	3637_Illnesses of father: Prostate cancer	25	68	1	893	2573	4289	899	1969	1468	1145	4000	68	145	3249	1746	1081	3641	883	4361	4682	228
3774_Traumatic events - Been in aconfiding relationship as an adult	3774_Traumatic events - Been in aconfiding relationship as an adult	25	68	1	4317	1864	4041	3948	3822	945	879	4627	1208	68	2702	2956	3349	3204	2054	4075	2765	97
3276_Facial ageing	3276_Facial ageing	25	68	1	3822	2811	1667	970	2801	2980	922	1129	4335	1014	2932	68	477	2898	3401	3720	2903	1049
4616_4th ventricle	4616_4th ventricle	25	68	1	3385	990	2829	750	2906	955	2363	1028	3474	3921	4317	1162	1040	68	1165	972	3295	4612
2439_DLL4 - Delta-like protein 4	2439_DLL4 - Delta-like protein 4	25	68	1	3671	3733	2104	2153	2199	1394	4047	2186	2062	4066	3027	3407	1752	3125	68	3143	1130	4525
455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	455_Cofactors and vitamins::Tocopherol metabolism::alpha-tocopherol	25	68	1	3854	2956	4592	4478	4551	2149	545	2969	1406	3796	3962	614	1525	1156	4393	68	2295	253
3906_Intraocular pressure	3906_Intraocular pressure	25	68	1	3295	2384	2018	4385	355	4257	2546	883	2094	1882	989	3473	3574	4643	3097	3937	1040	68
4640_Right amygdala	4640_Right amygdala	25	69	1	3961	2882	69	2698	4532	842	4091	2704	3065	3952	2721	2819	887	609	3036	1453	3271	1797
3456_Impedance measures - Leg fat percentage (left)	3456_Impedance measures - Leg fat percentage (left)	25	69	1	4007	4054	4079	1612	69	4048	418	714	4272	1022	1204	4202	2147	1485	2803	599	2203	1865
2265_CCL14 - C-C motif chemokine 14	2265_CCL14 - C-C motif chemokine 14	25	69	1	3204	2945	2045	933	659	69	3594	177	3213	3193	2587	817	4255	2120	3420	739	537	1903
4439_Hepatitis B HBs antigen IgG levels	4439_Hepatitis B HBs antigen IgG levels	25	69	1	744	2635	1231	3671	208	3740	69	1624	1904	453	857	2236	4721	1449	3074	3825	4689	1266
1111_Visceral sdipose tissue volume	1111_Visceral sdipose tissue volume	25	69	1	1076	950	703	4045	562	2377	4319	1360	69	2329	1333	1942	1634	4489	1546	4114	2646	770
1782_Artial fibrillation (FBAT, adjusted for multivariable)	1782_Artial fibrillation (FBAT, adjusted for multivariable)	25	69	1	172	1168	2603	794	2122	676	1567	786	2014	69	392	517	1105	490	843	1342	948	1080
3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	3658_Cancer register - Type of cancer: ICD10: C44 Other and unspecified malignant neoplasm of skin	25	69	1	801	2802	835	4002	268	286	2208	2804	136	1277	69	951	231	1700	146	4619	962	3248
3549_Mouth/teeth dental problems: Dentures	3549_Mouth/teeth dental problems: Dentures	25	69	1	2807	244	2989	1308	3250	1457	1337	497	128	2812	260	755	4085	69	2307	500	946	3050
1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	1633_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for multivariable)	25	69	1	4193	824	2918	1359	1411	3983	4545	1479	4736	3640	1814	2372	2170	3221	69	1717	4574	2890
1762_Prostate cancer (FBAT, adjusted for age)	1762_Prostate cancer (FBAT, adjusted for age)	25	69	1	1318	4510	4369	3202	1871	1436	504	3375	4601	4694	1169	1083	1774	1588	3222	69	1156	1608
929_Other polyunsaturated fatty acids than 18:2	929_Other polyunsaturated fatty acids than 18:2	25	69	1	1498	1088	4377	3706	2320	3852	289	200	3852	1803	1024	1206	1276	1421	2312	2108	69	2424
2475_CHEK2 - Serine/threonine-protein kinase Chk2	2475_CHEK2 - Serine/threonine-protein kinase Chk2	25	69	1	4320	1354	3745	1472	3974	1782	3297	3463	4472	1950	2772	3237	423	2976	405	4011	4134	69
594_Peptide::Dipeptide::leucylleucine	594_Peptide::Dipeptide::leucylleucine	25	70	1	70	2311	3657	3437	4004	3211	4314	3671	2283	2346	4683	1039	2092	2410	3775	1767	694	1327
3978_Lean body mass (appendicular)	3978_Lean body mass (appendicular)	25	70	1	1743	4547	70	783	435	4581	1105	479	822	960	703	1747	1587	1603	3407	1210	2253	285
3914_Disc area	3914_Disc area	25	70	1	603	3699	392	558	1337	70	2308	4019	319	2126	1320	3915	3228	2338	2484	193	2864	4345
2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	2773_VTA1 - Vacuolar protein sorting-associated protein VTA1 homolog	25	70	1	3491	4201	3750	694	4631	4548	70	2409	454	2365	2274	287	656	3522	4031	1141	2296	2619
3578_Social support - Leisure/social activities: Religious group	3578_Social support - Leisure/social activities: Religious group	25	70	1	416	3091	3720	3644	504	3763	3667	70	1762	205	3020	3852	2652	3162	826	3092	98	1723
4435_Influenza A IgG levels	4435_Influenza A IgG levels	25	70	1	763	149	422	2925	289	1415	2212	4307	1250	70	80	2023	557	129	602	4656	3255	3588
1780_Artial fibrillation (FBAT, adjusted for age and sex)	1780_Artial fibrillation (FBAT, adjusted for age and sex)	25	70	1	73	993	1076	3458	2426	218	299	2155	2658	243	285	70	1656	1950	2097	572	2606	1247
2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	2540_BIRC5 - Baculoviral IAP repeat-containing protein 5	25	70	1	3011	4450	2900	904	4387	1558	2425	3187	2952	2209	2137	3478	283	70	1271	392	648	2969
196_Estimated glomerular filtration rate based on serum creatinine	196_Estimated glomerular filtration rate based on serum creatinine	25	70	1	834	2939	4226	1355	1136	2584	2055	4055	1873	4598	944	3699	2103	2932	70	3005	1289	2100
1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	1501_Triglycerides (at exam 2, GEE, adjusted for age and sex)	25	70	1	3344	1042	1497	2141	4214	4160	1600	4373	4427	4411	836	3514	4411	155	606	70	1979	4459
2581_C1S - Complement C1s subcomponent	2581_C1S - Complement C1s subcomponent	25	70	1	2420	4351	3513	1896	3327	4447	1026	567	347	2177	1183	1369	2840	2712	1534	4414	3254	70
2103_MPO - Myeloperoxidase	2103_MPO - Myeloperoxidase	25	71	1	71	1943	1047	1222	4443	1223	3196	159	321	835	561	1872	3183	3739	144	581	2493	4718
79_Femoral Neck BMD (females)	79_Femoral Neck BMD (females)	25	71	1	2626	71	1964	1166	2762	3014	1187	671	4711	444	249	1623	2436	3831	2243	1839	190	4138
645_Xenobiotics::Xanthine metabolism::7-methylxanthine	645_Xenobiotics::Xanthine metabolism::7-methylxanthine	25	71	1	2452	3888	4327	71	464	3391	2970	4092	573	3878	428	491	451	4533	2052	227	2591	4353
310_CD4nv:%preTh17	310_CD4nv:%preTh17	25	71	1	664	2324	2627	310	419	3557	3287	71	2989	4612	2822	571	2414	2296	1483	2688	1744	2162
1887_Shaft Width (GEE, male, adjussted for multivariable)	1887_Shaft Width (GEE, male, adjussted for multivariable)	25	71	1	1774	4166	761	2421	2830	2474	4414	2241	71	3694	3647	2105	4181	4425	3815	1639	2280	1260
3346_Ever taken oral contraceptive pill (female)	3346_Ever taken oral contraceptive pill (female)	25	71	1	3141	1476	2380	2869	1002	1048	3553	2960	336	3910	71	4155	1857	1360	215	293	2932	1404
3063_JAG1 - Protein jagged-1	3063_JAG1 - Protein jagged-1	25	71	1	2865	3371	305	2346	514	1629	3588	4213	1099	470	2463	1192	2963	71	2473	4215	4266	3466
1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	1375_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for age and sex)	25	71	1	3529	1493	1730	4674	1755	1038	3057	565	2198	4046	3998	1588	659	2318	486	3184	4531	71
4314_Ever smoked regulary	4314_Ever smoked regulary	25	72	1	1444	72	4547	3607	1085	970	442	666	1369	317	2386	2498	967	2414	3214	336	2497	294
2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	2292_TNFSF15 - Tumor necrosis factor ligand superfamily member 15	25	72	1	2578	1082	1222	72	3464	3628	625	2700	2733	269	1382	1782	2235	4393	2776	878	1404	377
2615_TEC - Tyrosine-protein kinase Tec	2615_TEC - Tyrosine-protein kinase Tec	25	72	1	1165	1911	410	1080	1011	72	3660	2144	1044	2759	2183	330	2376	4090	3868	496	600	4732
1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	1583_D-dimer (at exam 6, GEE, adjusted for age and sex)	25	72	1	528	2326	3096	2095	313	4432	72	854	2539	1528	4411	1100	4416	1508	3033	1600	1928	3113
154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	154_Waist-hip ratio (female <= 50 yrs, adjusted for BMI)	25	72	1	2932	3547	331	3969	1669	2791	4727	4556	1476	1780	2510	72	2575	436	2708	1083	2678	3948
1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1425_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	72	1	4181	940	2061	4015	3045	1339	3140	4494	2622	3867	4728	2614	72	374	4149	2382	1817	3632
3768_Anxiety - Recent trouble relaxing	3768_Anxiety - Recent trouble relaxing	25	72	1	1189	3027	3471	2242	2553	4617	829	935	4139	2737	3063	1416	1280	4084	72	908	2163	848
4161_Focal Epilepsy, lesion negative	4161_Focal Epilepsy, lesion negative	25	72	1	1328	3719	370	3823	2478	1136	4216	2903	3333	107	3114	454	4114	1056	2868	72	4735	4406
3141_APOE - Apolipoprotein E (isoform E2)	3141_APOE - Apolipoprotein E (isoform E2)	25	72	1	1055	726	192	2357	3332	3878	255	2388	1466	1411	4376	3890	1881	498	1388	3255	917	72
4397_Menstruation quality of life impact: Increased appetite	4397_Menstruation quality of life impact: Increased appetite	25	73	1	1980	73	2252	1236	321	2232	2538	2453	1029	330	1341	1097	3607	941	2996	3200	286	3032
3190_Number of self-reported non-cancer illnesses	3190_Number of self-reported non-cancer illnesses	25	73	1	409	4561	73	268	113	1790	623	2729	830	74	168	307	337	1821	344	4585	263	1181
1217_Alcohol consumption (dichotomous, male)	1217_Alcohol consumption (dichotomous, male)	25	73	1	867	3750	3647	73	1659	4699	3390	4361	3741	4016	652	2071	118	4009	3859	3595	3046	4467
2577_AHSG - Alpha-2-HS-glycoprotein	2577_AHSG - Alpha-2-HS-glycoprotein	25	73	1	2030	4000	1276	4215	73	2818	1679	431	2150	2201	2507	3928	2181	3321	1598	2480	2614	3162
834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	834_Peptide::Dipeptide::X-14205--alpha-glutamyltyrosine	25	73	1	3910	404	451	1857	332	73	2086	3811	3215	3945	2384	3642	2836	1675	3915	3088	2089	606
711_::::X-11478	711_::::X-11478	25	73	1	4024	2120	4320	348	4426	1254	73	1676	995	4142	3017	3937	370	163	1798	3723	74	2461
4246_Right handed	4246_Right handed	25	73	1	256	3568	3808	952	372	380	2743	73	1191	2652	2977	1095	913	3291	1662	1940	571	1655
1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	1302_Fasting insulin (at exam 5, FBAT, adjusted for age and sex)	25	73	1	295	4326	1036	97	2083	4198	94	2765	73	407	1052	4234	172	419	1082	2287	4298	925
2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	2641_TNFRSF4 - Tumor necrosis factor receptor superfamily member 4	25	73	1	1030	3820	2273	2392	1999	3822	997	3245	2403	73	1070	2250	3383	761	3713	1317	2488	1612
1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	1497_Triglycerides (at exam 1, GEE, adjusted for multivariable)	25	73	1	2634	996	3233	2890	1727	1566	3964	886	1763	2362	73	2285	4573	3284	963	4040	2557	4139
3044_CD300C - CMRF35-like molecule 6	3044_CD300C - CMRF35-like molecule 6	25	73	1	1265	4632	340	2220	455	3199	420	225	295	2064	1641	73	1265	837	2555	3625	207	149
424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	424_Amino acid::Valine, leucine and isoleucine metabolism::4-methyl-2-oxopentanoate	25	73	1	3547	3417	1598	3170	1228	2437	1491	2231	2973	1431	2820	2970	1210	2962	73	2690	2348	3389
4733_Sagittal stratum mode of anisotropy	4733_Sagittal stratum mode of anisotropy	25	73	1	3978	4168	1204	3634	3665	3498	725	2208	1399	1639	4680	3276	2456	3470	2834	610	1717	73
3765_Anxiety - Recent feelings of foreboding	3765_Anxiety - Recent feelings of foreboding	25	74	1	2118	74	2663	1839	3578	1717	4683	2971	4166	1685	1344	1495	939	1703	1759	3180	4124	3536
2974_ANXA1 - Annexin A1	2974_ANXA1 - Annexin A1	25	74	1	222	1726	74	2122	1520	2557	2433	915	1335	1896	105	177	2788	3816	115	1382	602	743
2990_PI3 - Elafin	2990_PI3 - Elafin	25	74	1	3140	322	3849	74	1189	4571	1997	2226	182	1838	3046	743	98	1917	3349	2340	1673	4164
2669_IL11RA - Interleukin-11 receptor subunit alpha	2669_IL11RA - Interleukin-11 receptor subunit alpha	25	74	1	3925	282	1904	3471	4135	74	455	315	4225	1625	2724	4584	2175	2114	3452	3514	2865	3305
1849_Neck Section Modulus (GEE, male, adjusted for age)	1849_Neck Section Modulus (GEE, male, adjusted for age)	25	74	1	1272	3632	1252	1868	1080	4206	1436	74	157	4680	4503	2333	4034	1032	4330	4124	558	1721
1127_Visceral adipose tissue sttenutation (male)	1127_Visceral adipose tissue sttenutation (male)	25	74	1	1621	335	3152	354	3802	3256	2519	3135	74	1767	2423	218	2640	2252	2914	3144	691	1709
1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	1640_Myeloperoxidase (at exam 7, FBAT, adjusted for multivariable)	25	74	1	2368	542	4458	1630	184	416	167	376	125	4448	156	1753	74	368	389	4419	99	104
814_::::X-13069	814_::::X-13069	25	74	1	3075	2603	1173	2718	4534	4742	3125	2787	3996	4141	3298	2543	4096	1087	74	3642	1265	2961
2589_CNDP1 - Beta-Ala-His dipeptidase	2589_CNDP1 - Beta-Ala-His dipeptidase	25	74	1	775	3892	3324	2104	889	1182	3154	4026	1103	4317	1589	2746	3888	574	4532	74	2266	3421
1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	1283_Sagittal diameter by CT (GEE, adjusted for age, sex, smoking and menopause)	25	75	1	989	75	3357	1403	533	152	2984	3641	1924	2842	87	3555	1614	1968	1768	2858	737	1055
281_CD8:%Act(25+38+RO+)	281_CD8:%Act(25+38+RO+)	25	75	1	3170	4385	75	3980	3120	3396	3059	1367	2413	4589	2220	3990	3065	4352	4317	2429	4299	1115
853_Albumin	853_Albumin	25	75	1	314	2682	2220	75	644	122	2504	3486	3846	625	2116	943	743	3708	4490	3263	4373	3465
1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	1036_Neck-Shaft Angle (FBAT, adjusted for age and sex)	25	75	1	3778	643	964	1772	75	3118	125	4231	2567	1826	2018	1108	1653	2397	3135	1072	4498	291
1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	1966_MMSE score (at age 65, FBAT, adjusted for multivariable)	25	75	1	1687	1164	133	1054	80	2366	3678	1538	75	1088	2025	3740	979	985	159	390	2410	3605
1028_Neck Width (FBAT, adjusted for age and sex)	1028_Neck Width (FBAT, adjusted for age and sex)	25	75	1	3119	3873	2702	1524	2839	1167	534	1656	130	75	1767	4378	1767	733	553	1744	3550	3913
2637_PTH - Parathyroid hormone	2637_PTH - Parathyroid hormone	25	75	1	136	484	4008	277	3512	2279	1430	2934	4134	3213	75	248	2755	2106	1789	4683	3183	4054
4521_Left thalamus proper	4521_Left thalamus proper	25	75	1	1971	2402	3961	3554	677	2215	2332	1373	313	455	2811	1687	1131	75	286	2123	1142	834
540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	540_Lipid::Lysolipid::1-oleoylglycerophosphocholine	25	75	1	651	475	3169	4207	296	1834	577	2063	2846	1256	1047	3646	2401	3382	75	384	3356	2500
2360_IL18BP - Interleukin-18-binding protein	2360_IL18BP - Interleukin-18-binding protein	25	75	1	4575	3996	886	2327	2757	3138	2510	3026	2609	3219	3555	608	2905	1687	3939	75	4518	579
1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	1352_Plasma Apolipoprotein C3 level (FBAT, multivariate adjusted)	25	76	1	76	2559	3335	2501	1868	2175	2906	592	1171	366	819	299	2979	3459	495	3718	762	1376
4100_Low-density-lipoprotein cholesterol	4100_Low-density-lipoprotein cholesterol	25	76	1	452	76	1501	1358	1006	3034	764	1708	3300	3832	2090	91	3950	4527	1451	260	1397	4446
2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	2168_TNFSF18 - Tumor necrosis factor ligand superfamily member 18	25	76	1	3219	4740	3246	76	4591	1697	4421	3437	1795	1819	2415	2303	4127	2415	2160	3626	4203	3654
3667_Diagnoses - main ICD10: H26 Other cataract	3667_Diagnoses - main ICD10: H26 Other cataract	25	76	1	493	1420	1272	81	76	4385	2338	255	433	4472	3770	1908	1832	1528	3275	808	4469	2465
52_Number of children ever born (male)	52_Number of children ever born (male)	25	76	1	2348	3287	1910	1316	4451	76	3683	425	1036	4647	3987	2254	580	2178	2536	4270	1892	1272
1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	1532_Ankle-brachial index (at exam 6, FBAT, adjusted for multivariable)	25	76	1	2055	108	2295	2628	1857	3107	3512	76	2189	2760	1930	3486	4016	2722	2419	4385	1054	1323
860_CH2 groups to double bonds ratio	860_CH2 groups to double bonds ratio	25	76	1	2515	3082	561	1014	2159	367	1697	2066	899	1456	76	1469	4051	4311	1350	730	193	3732
3412_Sitting height	3412_Sitting height	25	76	1	3948	3866	2208	2513	440	1578	166	2090	2173	3252	1230	3387	3117	76	4005	2040	3653	2907
476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	476_Lipid::Carnitine metabolism::3-dehydrocarnitine*	25	76	1	1336	3617	3298	1094	2315	868	2577	3645	4224	4203	515	4668	3832	487	76	4110	2803	2423
3217_Time spend outdoors in summer	3217_Time spend outdoors in summer	25	76	1	4624	2101	4176	4366	782	3781	3403	395	3913	4331	1745	2269	2953	4452	1238	76	2907	3595
4121_Alkaline phosphatase	4121_Alkaline phosphatase	25	76	1	3863	4515	775	2300	411	3185	2166	1039	2968	418	2259	4461	2069	1666	507	550	3947	76
4119_Aspartate aminotransferase	4119_Aspartate aminotransferase	25	77	1	77	2562	2972	682	383	4684	2995	2657	4079	3697	1280	1723	3982	1865	2360	1509	2054	696
277_CD8:%Act(25+)	277_CD8:%Act(25+)	25	77	1	2410	2681	3312	361	77	428	473	4511	386	1944	1971	4645	1095	1051	2459	4474	1491	212
1024_Femoral Neck Length (FBAT, adjusted for age and sex)	1024_Femoral Neck Length (FBAT, adjusted for age and sex)	25	77	1	1277	3645	1445	2960	1187	77	2578	1507	4295	3006	2414	2123	919	3775	476	3552	3206	791
3007_LGALS3BP - Galectin-3-binding protein	3007_LGALS3BP - Galectin-3-binding protein	25	77	1	2925	1747	2828	1470	1074	3267	77	194	604	3347	4353	154	1200	196	3281	457	2450	4150
1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	1593_Log ADP platelet aggregation (at exam 5, GEE, adjusted for multivariable)	25	77	1	3512	688	1766	1592	3135	897	4525	77	884	2484	3578	3550	882	2299	4071	2219	3145	4001
2432_CD5L - CD5 antigen-like	2432_CD5L - CD5 antigen-like	25	77	1	607	3251	4417	1710	1211	1158	1520	1402	77	1812	4037	263	2765	3306	2909	2576	4304	1863
4104_Total protein	4104_Total protein	25	77	1	2241	1717	279	1022	3875	742	4629	2518	1395	77	3789	1882	1409	2348	506	951	2870	4742
4473_Left supramarginal	4473_Left supramarginal	25	77	1	4414	2181	1193	3448	3370	299	1169	1163	4155	1793	3874	77	3970	4561	3463	2036	3617	2370
4358_Diverticular disease	4358_Diverticular disease	25	77	1	426	464	2957	1146	312	3550	164	2039	246	577	94	780	945	77	4639	2399	361	825
3922_Heart rate variability (SDNN)	3922_Heart rate variability (SDNN)	25	77	1	1906	3557	2166	928	3993	1442	1189	2986	1845	2340	3206	4490	3253	3100	77	4556	877	4272
2205_LTF - Lactotransferrin	2205_LTF - Lactotransferrin	25	77	1	2092	2498	163	4092	4372	1625	4089	1551	1042	2670	1441	359	533	4368	2801	77	4490	207
1836_Neck width (FBAT, male, adjusted for multivariable)	1836_Neck width (FBAT, male, adjusted for multivariable)	25	77	1	405	3096	4110	1739	825	625	676	3092	116	4736	1615	87	2731	2875	3136	2678	2325	77
3204_Number of days/week walked 10+ minutes	3204_Number of days/week walked 10+ minutes	25	78	1	2057	78	2744	3063	536	4390	3124	4022	4091	4293	532	4205	3480	2625	3824	2377	794	3608
613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	613_Xenobiotics::Benzoate metabolism::4-ethylphenylsulfate	25	78	1	1297	129	78	547	4298	1058	2475	326	3936	1044	3331	686	122	731	1709	145	1849	627
844_::::X-14632	844_::::X-14632	25	78	1	2799	3941	781	78	2543	97	818	1491	2735	421	3259	1290	314	4244	84	1295	2382	4699
3883_Immature fraction of reticulocytes (three-way meta)	3883_Immature fraction of reticulocytes (three-way meta)	25	78	1	3924	2438	2359	306	1562	78	4161	2788	307	223	3729	1682	3798	268	1536	1206	1146	607
4276_Carpal tunnel syndrome	4276_Carpal tunnel syndrome	25	78	1	1487	844	161	495	216	4365	78	2420	1734	115	1653	1667	183	376	3331	4700	4610	2875
716_::::X-11521	716_::::X-11521	25	78	1	1730	4278	1859	1040	898	1945	471	78	103	705	2211	4547	3079	4508	106	4437	3557	88
2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	2915_SMPDL3A - Acid sphingomyelinase-like phosphodiesterase 3a	25	78	1	286	143	1961	3704	448	3379	2039	357	78	790	3192	1491	3095	227	3018	2326	3779	3209
2302_ESAM - Endothelial cell-selective adhesion molecule	2302_ESAM - Endothelial cell-selective adhesion molecule	25	78	1	1922	3628	1656	3487	1677	1179	4518	2192	704	2321	2722	1884	3695	78	1746	155	2654	1658
2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	2768_PGD - 6-phosphogluconate dehydrogenase, decarboxylating	25	78	1	3061	4241	3852	2749	4636	1411	3019	2429	2209	3275	957	4504	3580	2312	2869	78	624	803
3598_Non-cancer illness code, self-reported: angina	3598_Non-cancer illness code, self-reported: angina	25	78	1	700	290	3548	198	2522	2146	2104	2512	2293	1799	1669	4497	3523	4050	1549	3597	186	78
329_CD4Nv:%TFH (3)	329_CD4Nv:%TFH (3)	25	79	1	79	3697	1375	140	494	2159	1149	633	2983	4004	2026	1680	199	124	1466	3252	277	4062
3836_Sum basophil neutrophil count (two-way meta)	3836_Sum basophil neutrophil count (two-way meta)	25	79	2	610	2027	79	3190	2574	460	808	4370	979	1836	2103	2745	1306	3344	2216	1073	2844	4485
2260_SERPINA3 - Alpha-1-antichymotrypsin	2260_SERPINA3 - Alpha-1-antichymotrypsin	25	79	1	215	3147	1762	2965	922	79	1411	209	2516	2050	3885	3581	3314	1598	1205	2217	748	2371
4346_Coronary artery disease and triglyceride (bivariate)	4346_Coronary artery disease and triglyceride (bivariate)	25	79	1	3381	768	1043	3231	1278	4600	79	3345	1050	488	2430	2358	3582	120	1897	183	213	1777
1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1564_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	79	1	2287	231	3110	4066	888	3008	1961	79	3028	2233	3188	3800	2430	942	1901	4505	448	3961
3939_Body Mass Index	3939_Body Mass Index	25	79	1	418	4079	524	1778	1577	1934	1534	3147	2282	274	79	466	2313	3188	616	2842	702	3894
1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	1568_Maximum carotid artery stenosis (at exam 6, FBAT, adjusted for multivariable)	25	79	1	2985	584	278	2888	386	1725	3864	1994	1158	706	4478	79	4516	2874	3554	3858	3174	778
2326_CCL23 - Ck-beta-8-1	2326_CCL23 - Ck-beta-8-1	25	79	1	588	4146	4007	4733	2220	2035	4574	2440	4149	1395	4556	2712	2842	79	1404	2324	3430	999
4140_Mean corpuscular hemoglobin concentration	4140_Mean corpuscular hemoglobin concentration	25	79	1	4000	3668	3242	2163	1707	1540	4499	1430	690	643	623	2426	2408	4526	421	81	79	1537
3963_Gestational weight gain (offspring, total)	3963_Gestational weight gain (offspring, total)	25	80	1	80	732	3771	3796	580	3261	3495	2535	3899	2250	136	125	514	2516	2098	907	4398	4738
3930_N-glycosylation	3930_N-glycosylation	25	80	1	4303	3903	80	605	417	4538	1853	3000	859	4394	748	2941	1283	3717	4246	4061	1740	1758
3338_Years since last cervical smear test (female)	3338_Years since last cervical smear test (female)	25	80	1	4720	1676	638	80	1607	2413	720	4216	2676	4276	112	198	674	2510	348	4137	111	3503
4663_Splenium of corpus callosum fractional anisotropy	4663_Splenium of corpus callosum fractional anisotropy	25	80	1	1598	3022	3251	4568	3272	80	1767	3957	2114	3222	878	1412	1298	1951	1286	1145	4413	234
2466_ADRBK1 - beta-adrenergic receptor kinase 1	2466_ADRBK1 - beta-adrenergic receptor kinase 1	25	80	1	2829	3426	582	535	3788	2922	80	1026	4255	795	1160	1036	1257	2165	4397	174	3910	4399
1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	1994_Survival past average life expectancy (FBAT, adjusted for birth-cohort)	25	80	1	274	2606	951	4573	1580	2689	2175	89	80	2158	3225	2414	2812	631	403	1401	1569	423
2215_APOB - Apolipoprotein B	2215_APOB - Apolipoprotein B	25	80	1	1349	415	3323	3717	1483	2123	1949	1518	2391	1729	3194	80	4125	2268	1788	429	3016	3331
750_::::X-12040	750_::::X-12040	25	80	1	1139	2285	1473	878	110	295	2864	3222	2180	2063	4047	3408	3298	2528	80	3232	3003	2374
2912_TFF3 - Trefoil factor 3	2912_TFF3 - Trefoil factor 3	25	80	1	3858	1639	959	797	2079	1025	1021	655	1998	1630	1238	2052	418	4205	775	1549	80	2545
3362_Mother's age at death	3362_Mother's age at death	25	81	1	81	541	532	717	4711	915	1219	2963	3548	1861	4310	3670	472	249	3354	2022	330	824
2756_SELP - P-Selectin	2756_SELP - P-Selectin	25	81	1	243	81	130	1871	193	2651	873	4508	2390	1048	2346	4101	665	4297	1263	695	4510	881
2470_CA6 - Carbonic anhydrase 6	2470_CA6 - Carbonic anhydrase 6	25	81	1	1146	127	1834	1256	81	3265	1481	4691	1011	1664	2966	2088	1746	3440	2452	1432	727	3101
2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	2820_DYRK3 - Dual specificity tyrosine-phosphorylation-regulated kinase 3	25	81	1	3138	187	4249	1029	4130	3397	81	2204	1755	1362	2401	643	2595	614	2710	3542	4002	2321
1231_Usual weekday bedtime (GEE)	1231_Usual weekday bedtime (GEE)	25	81	1	173	3939	2386	525	884	3194	2133	4379	81	1392	4647	2932	1179	381	645	1971	2372	4065
3465_Impedance measures - Arm fat mass (left)	3465_Impedance measures - Arm fat mass (left)	25	81	2	919	3080	3181	2893	127	3517	4169	3438	4167	81	3237	278	1493	3533	1859	4047	2558	2043
3623_Treatment/medication code: atorvastatin	3623_Treatment/medication code: atorvastatin	25	81	1	2215	419	1218	2830	1935	4108	1444	1578	3565	1321	3613	81	1498	3359	3846	195	4250	1731
4202_Chronic kidney disease	4202_Chronic kidney disease	25	81	1	4636	3046	2708	3074	3048	2769	4563	4145	3171	2060	1701	3978	840	540	81	2242	838	4255
1051_Parkinson disease (tier 2b)	1051_Parkinson disease (tier 2b)	25	81	1	4612	1001	3685	1011	3244	3970	2042	259	199	432	3566	1000	502	117	209	1389	81	3348
1925_Hippocampal volume (GEE, adjusted for multivariable)	1925_Hippocampal volume (GEE, adjusted for multivariable)	25	81	1	850	3773	308	376	449	2361	260	2666	317	271	4001	3954	2742	1434	673	329	2425	81
1043_Shaft Width (GEE, adjusted for multivariable)	1043_Shaft Width (GEE, adjusted for multivariable)	25	82	1	82	1016	3078	2681	4678	1833	1151	2658	1061	3436	2588	4540	311	831	3601	3037	4172	2323
2000_Weight	2000_Weight	25	82	1	3331	82	2794	3997	3664	4127	1938	3509	1568	2748	264	1586	3045	1584	4077	1830	1005	1813
1061_Multiple Sclerosis	1061_Multiple Sclerosis	25	82	1	4736	307	82	466	341	497	338	2817	797	613	3853	4468	740	1377	1088	978	621	2527
1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	1749_Urinary albumin excertion (at exam 6, GEE, adjusted for multivariable)	25	82	1	220	870	164	129	82	4341	3236	934	2964	876	3319	4199	585	332	2857	1636	690	615
4181_High cholesterol lipoprotein	4181_High cholesterol lipoprotein	25	82	1	4242	4217	368	2931	4408	2734	82	1206	231	1156	1970	3432	3965	1027	2606	1402	967	3680
2965_AMH - Muellerian-inhibiting factor	2965_AMH - Muellerian-inhibiting factor	25	82	1	1261	657	4076	724	261	1449	1594	82	621	3390	226	3130	336	2905	2088	596	1850	1256
1099_C-reactive protein - Birth cohorts	1099_C-reactive protein - Birth cohorts	25	82	1	1724	3242	4662	909	652	1334	2010	2123	3358	82	1723	1040	536	331	1355	3174	2644	4697
2350_WISP1 - WNT1-inducible-signaling pathway protein 1	2350_WISP1 - WNT1-inducible-signaling pathway protein 1	25	82	1	708	177	3191	2081	4687	3905	4562	4698	3759	238	3239	82	292	2695	3510	2127	1625	1234
3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	3702_Diagnoses - secondary ICD10: R10 Abdominal and pelvic pain	25	82	1	4725	3236	4094	4184	3353	1472	482	744	318	2609	3948	3203	2234	82	4664	4002	2237	2841
4095_Atrial Fibrillation	4095_Atrial Fibrillation	25	82	1	195	2909	1044	1634	3040	154	812	2336	2837	3366	1509	2107	3986	595	82	4707	445	961
1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	1874_Shaft average buckling ratio (FBAT, female, adjussted for age)	25	82	1	2403	1630	1714	3755	2075	905	3110	1482	1674	3096	2629	2684	1043	3929	1719	82	155	3430
368_Amino acid::Butanoate metabolism::2-aminobutyrate	368_Amino acid::Butanoate metabolism::2-aminobutyrate	25	82	1	1176	2482	3947	635	4316	2614	3851	2016	1705	3052	4593	1953	3338	1454	3005	3488	82	2671
4710_Superior longitudinal fasciculus mean diusivities	4710_Superior longitudinal fasciculus mean diusivities	25	82	1	936	1329	3692	1931	3106	214	4009	3239	1798	1202	4646	4274	1437	875	1960	2504	3490	82
2337_MRC2 - C-type mannose receptor 2	2337_MRC2 - C-type mannose receptor 2	25	83	1	83	4439	2847	3579	3706	419	2127	3461	3763	1347	459	4098	1119	2111	3424	2368	1261	4092
3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	3345_Ever had stillbirth, spontaneous miscarriage or termination (female)	25	83	1	804	83	3502	2839	2430	2755	1086	973	866	3799	3681	4591	759	687	4154	4234	1311	3807
1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	1894_Shaft Section Modulus (FBAT, female, adjussted for multivariable)	25	83	1	214	644	1998	1799	1941	83	842	2485	4010	1772	1494	374	2794	855	4656	3662	968	2088
1184_High-density lipoprotein cholesterol	1184_High-density lipoprotein cholesterol	25	83	1	3814	914	766	4301	3718	2281	83	524	1371	542	572	2305	1319	509	3353	525	181	2490
468_Lipid::Bile acid metabolism::glycodeoxycholate	468_Lipid::Bile acid metabolism::glycodeoxycholate	25	83	1	3216	2751	3994	1404	1708	2374	140	4080	4234	1719	2766	83	559	3374	353	3303	2278	1042
4133_Monocyte count	4133_Monocyte count	25	83	1	2514	626	3303	4313	3100	325	2155	3024	3433	3564	2286	567	679	4726	2523	83	820	2645
197_Urinary albumin-to-creatinine ratio	197_Urinary albumin-to-creatinine ratio	25	83	1	3701	2709	3437	3005	4266	3982	4017	3680	3107	1839	4347	4123	3694	2311	2695	1612	83	1100
848_Xenobiotics::Food component/Plant::X-14977--vanillin	848_Xenobiotics::Food component/Plant::X-14977--vanillin	25	84	1	84	516	170	262	1661	4406	2966	138	1475	879	161	2542	2498	1732	2326	677	804	2486
3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	3705_Diagnoses - secondary ICD10: Z51 Encounter for other aftercare	25	84	1	1787	84	1365	1242	1153	634	1647	263	2540	4363	2736	1429	2007	4010	4472	3804	2365	3778
4123_Activated partial thromboplastin time	4123_Activated partial thromboplastin time	25	84	1	3462	2847	2421	3245	2758	84	340	2158	2793	774	2500	3578	1894	1170	1905	2317	2809	2396
1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	1635_Monocyte chemoattractant protein 1 (at exam 7, GEE, adjusted for age and sex)	25	84	1	339	4078	2145	871	1956	2111	4704	84	1096	383	164	4586	680	1640	3213	3490	4345	457
1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	1233_Usual weekday bedtime (GEE, adjusted for age, sex and BMI)	25	84	1	1009	4173	3163	1343	1183	3342	1483	3364	84	1462	2244	3776	1201	569	168	3829	4171	2966
3842_Granulocyte percentage of myeloid white cells (two-way meta)	3842_Granulocyte percentage of myeloid white cells (two-way meta)	25	84	1	4515	3053	239	1543	4523	2802	128	3665	2870	84	962	1886	1541	4225	1079	850	1399	1216
2816_SAA1 - Serum amyloid A-1 protein	2816_SAA1 - Serum amyloid A-1 protein	25	84	1	1024	1866	3521	1005	1977	3685	2898	2918	4265	3049	84	982	749	3849	1848	1586	1696	807
786_::::X-12627	786_::::X-12627	25	84	1	187	1365	3203	1565	1533	1789	1441	852	2721	3088	326	842	84	1764	3467	3316	4319	3180
3159_OMD - Osteomodulin	3159_OMD - Osteomodulin	25	84	1	4223	2318	1016	2380	4192	3086	3240	4235	3290	2444	3554	285	832	84	2889	3600	4400	2732
3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	3061_LILRB1 - Leukocyte immunoglobulin-like receptor subfamily B member 1	25	84	1	2262	4087	3784	1899	166	2182	1354	4372	1023	4285	1900	623	2910	2279	4631	84	3521	2792
671_::::X-06350	671_::::X-06350	25	84	1	4420	1123	3130	1644	1954	1264	1674	828	4228	139	1994	4557	2068	3143	1938	4029	84	1271
3318_Weight change compared with 1 year ago	3318_Weight change compared with 1 year ago	25	85	1	85	351	311	1645	3473	2604	1941	120	2526	1937	2336	3488	3767	1146	4248	1346	1067	4551
2134_MRC1 - Macrophage mannose receptor 1	2134_MRC1 - Macrophage mannose receptor 1	25	85	1	2705	85	4181	4427	2364	3691	845	661	3021	4350	1505	1859	3161	2100	3071	224	3523	4256
4679_Genu of corpus callosum axial diusivities	4679_Genu of corpus callosum axial diusivities	25	85	1	999	1606	2539	1124	141	85	1401	933	4090	4730	354	327	2579	359	3923	932	3635	3988
304_CD4mem:%Th1* (5)	304_CD4mem:%Th1* (5)	25	85	1	1157	1105	3332	2631	3864	2748	2107	3409	85	3369	606	3901	243	471	3055	4310	770	2174
1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	1356_Total cholesterol (at exam 1, FBAT, multivariate adjusted)	25	85	1	888	4534	402	647	2970	811	3836	115	2301	85	3607	3807	1103	2449	4415	3091	460	2421
1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	1727_Change in serum creatinine from exam 2 to 7 (GEE, adjusted for age and sex)	25	85	1	4012	2539	1062	1098	1131	3805	3388	4536	4393	1023	85	150	1518	111	1446	426	3569	283
1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	1696_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for multivariable)	25	85	1	2851	3976	2554	4659	3731	329	1215	2469	2660	3853	172	85	4526	1760	1676	2811	4137	2263
142_Height	142_Height	25	85	1	1587	1901	1131	4043	3345	647	2656	923	3581	4689	2012	2287	4717	85	4291	3915	984	3455
881_Total lipids in IDL	881_Total lipids in IDL	25	85	1	2079	2276	355	2352	3087	2509	449	4029	3043	4369	1763	389	4603	2243	234	85	1219	548
3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	3693_Diagnoses - secondary ICD10: I25 Chronic ischemic heart disease	25	85	1	427	741	4301	236	2959	906	2500	4660	655	4406	697	1225	2724	4658	2493	4012	85	466
980_Interferon-gamma	980_Interferon-gamma	25	85	1	4210	621	1224	1095	2266	451	3718	4025	593	759	2727	4238	3983	2501	1518	2980	1357	85
3374_Headaches for 3+ months	3374_Headaches for 3+ months	25	86	1	86	3021	1541	2205	730	3956	3670	1564	2229	1209	4518	3991	357	3074	1444	4277	3708	3796
1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	1403_High-density lipoprotein 3 cholesterol (at exam 4, GEE, adjusted for multivariable)	25	86	1	577	906	86	3620	4399	4302	2563	1138	89	110	1515	3891	412	1706	2595	1015	4040	178
4066_Educational attainment	4066_Educational attainment	25	86	1	1803	3428	4631	1796	86	1760	3251	1203	1210	4288	695	4190	2490	2424	2533	694	1754	3659
1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	1715_Thyroid stimulation hormone (at exam 3, GEE, adjusted for multivariable)	25	86	1	2949	2753	1581	1549	2514	86	656	2251	2464	4385	2181	1082	2671	4514	4309	4492	3172	3811
3678_Diagnoses - main ICD10: M23 Internal derangement of knee	3678_Diagnoses - main ICD10: M23 Internal derangement of knee	25	86	1	2902	1601	4044	419	1793	138	86	1792	3050	4051	187	2064	123	1370	1883	769	4358	376
989_Interleukin-2	989_Interleukin-2	25	86	1	351	465	1085	1571	3394	3245	1457	4731	86	2672	3809	2275	2388	4690	2981	4209	1516	1638
3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	3590_Medication for cholesterol, blood pressure or diabetes: Cholesterol lowering medication	25	86	1	3645	227	1832	2379	2225	3612	1451	833	3505	1455	2464	86	2369	2909	2481	102	3478	1240
350_gdT:%CM (1)	350_gdT:%CM (1)	25	86	1	3871	1160	2367	2296	4143	1396	405	4301	703	3501	4304	735	4546	2004	86	1878	3601	1945
857_Ratio of bisLallylic bonds to total fatty acids in lipids	857_Ratio of bisLallylic bonds to total fatty acids in lipids	25	86	1	3242	2345	1121	1336	2644	717	3745	4118	4606	1350	90	328	2938	2032	1297	2704	86	3206
1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	1740_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for multivariable)	25	86	1	4175	1441	144	1608	1938	1673	2982	777	539	624	2683	3446	1260	4649	1480	2565	2871	86
2276_CYP3A4 - Cytochrome P450 3A4	2276_CYP3A4 - Cytochrome P450 3A4	25	87	1	87	886	3043	1478	4294	614	3214	3500	2412	871	3603	3138	1545	583	938	3778	1988	2028
2732_CCL24 - C-C motif chemokine 24	2732_CCL24 - C-C motif chemokine 24	25	87	1	1974	87	1007	4324	1923	830	447	674	3677	2832	1726	861	1845	4729	4485	4199	851	4252
4653_Corticospinal tract fractional anisotropy	4653_Corticospinal tract fractional anisotropy	25	87	1	2153	1749	3764	3866	2676	2525	87	3115	2044	1114	3618	1802	2546	3502	4539	1895	754	2249
4382_Epithelial ovarian cancer (high -grade and low-grade serous)	4382_Epithelial ovarian cancer (high -grade and low-grade serous)	25	87	1	1025	1731	3426	2747	340	4287	3270	87	3135	4639	4364	3587	2942	802	4598	1458	1731	4181
475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	475_Lipid::Carnitine metabolism::2-tetradecenoyl carnitine	25	87	1	1026	779	2773	836	250	3458	2790	465	4627	87	991	956	561	4019	840	4638	4135	3744
486_Lipid::Carnitine metabolism::stearoylcarnitine	486_Lipid::Carnitine metabolism::stearoylcarnitine	25	87	1	1213	1482	2181	567	3615	3347	1082	4183	701	2277	3800	3601	3130	87	374	3240	3472	850
4111_Uric acid	4111_Uric acid	25	87	1	2059	2992	1262	1017	2989	921	3155	2285	1745	768	465	253	4124	3576	87	848	3548	1194
3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	3098_TNFRSF12A - Tumor necrosis factor receptor superfamily member 12A	25	88	1	3107	88	3705	324	1327	4064	1350	2498	1331	1597	2112	4514	4249	4332	3362	3752	1635	1284
4106_Non-albumin protein	4106_Non-albumin protein	25	88	1	4367	4279	88	1286	1030	2316	2396	1011	3490	1778	3708	1376	2179	3764	4117	799	4738	4217
2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	2873_BST1 - ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2	25	88	1	1745	2641	1967	88	460	1030	3781	405	2865	2956	2521	2078	684	2913	272	3156	4003	2962
1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	1952_Boston Naming Test score without cues (FBAT, adjusted for multivariable)	25	88	1	4719	1931	3888	3426	2550	88	4304	3562	1848	3341	4570	2323	3127	2457	2918	4670	1938	2621
680_::::X-09789	680_::::X-09789	25	88	1	2362	1379	4711	771	3452	1801	88	816	1243	2745	568	4462	2110	4417	2250	2150	644	3929
4325_Neuroticism (MA GWAMA)	4325_Neuroticism (MA GWAMA)	24	88	1	2764	1192	966	163	197	2375	2904	88	1659	2616	2008	3765	712	3144	2954	4173	2686	4397
2750_PAPPA - Pappalysin-1	2750_PAPPA - Pappalysin-1	25	88	1	1714	842	4030	2824	3466	3779	228	2827	190	659	88	3403	467	2016	3996	4673	2095	3949
118_Extreme Height	118_Extreme Height	25	88	1	1163	1531	909	2997	433	2744	2679	3127	2303	2722	2351	1072	3362	88	4114	4073	611	3712
1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	1981_Walking speed (at offspring exam 7 cohort exam 27, GEE)	25	88	1	2988	1868	3051	2957	1296	118	3847	1669	1774	1569	3501	367	1495	2086	88	4404	1823	1403
20_Number of cigarettes smoked per day	20_Number of cigarettes smoked per day	25	89	1	89	1125	4013	4688	2638	644	4097	3588	1911	1533	1339	3739	2683	2099	2306	3823	2458	3387
2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	2239_TIE1 - Tyrosine-protein kinase receptor Tie-1, soluble	25	89	1	1516	89	3285	2466	2748	1627	2721	3188	2325	4485	3014	3368	2709	2970	3141	3106	4295	879
1058_Amyotrophic lateral sclerosis	1058_Amyotrophic lateral sclerosis	25	89	1	2511	4140	89	948	1791	2441	567	3324	3606	1178	1607	1354	1399	4315	1132	3311	1230	2403
1830_Neck length (FBAT, female, adjusted for multivariable)	1830_Neck length (FBAT, female, adjusted for multivariable)	25	89	1	219	2341	3812	89	1835	4729	804	2117	1974	1754	2101	2823	3323	1633	2071	4347	4311	1541
4018_Systemic Lupus Erythematosus	4018_Systemic Lupus Erythematosus	25	89	1	4238	1892	199	3730	89	1682	2161	176	2687	554	253	4115	320	102	3503	1135	3408	1567
1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1435_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	89	1	2866	1175	255	3853	3097	89	1036	568	91	160	104	845	4709	721	2872	2351	2516	260
3918_High-density lipoprotein cholesterol	3918_High-density lipoprotein cholesterol	25	89	1	2314	2440	2325	3910	1811	1670	89	658	141	2266	1770	3009	4355	995	4259	1381	1129	2570
4229_Drugs affecting bone structure and mineralization	4229_Drugs affecting bone structure and mineralization	25	89	1	2046	919	743	366	2835	4417	388	1511	1241	89	497	3930	1742	4276	3779	153	2490	410
2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	2441_FCGR3B - Low affinity immunoglobulin gamma Fc region receptor III-B	25	89	1	810	1999	490	699	2728	1405	1075	3434	2331	2750	1426	4207	89	403	4124	274	2158	1579
4515_4th ventricle	4515_4th ventricle	25	89	1	2283	519	1261	698	2515	965	1269	1503	387	1293	3071	1812	2458	89	293	1686	3487	1575
2172_CSF3R - Granulocyte colony-stimulating factor receptor	2172_CSF3R - Granulocyte colony-stimulating factor receptor	25	89	1	1173	2442	2587	800	3430	1343	2452	3175	4580	3410	3651	630	4043	653	89	3705	869	2077
3915_Disc area	3915_Disc area	25	89	1	910	4180	843	351	2473	248	1695	4547	122	791	2606	3434	2774	4140	3524	89	1614	3378
1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	1351_Plasma Apolipoprotein B level (GEE, adjusted for age and sex)	25	90	1	90	1684	1484	2005	3629	722	3896	1946	1123	4690	3203	1958	2849	635	762	838	3675	401
3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	3047_TNFRSF6B - Tumor necrosis factor receptor superfamily member 6B	25	90	1	2810	90	446	1860	2802	2670	1879	468	3978	451	2182	4657	3988	4738	3382	3562	2407	691
1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1441_Low-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	90	1	990	2350	90	2605	1538	1674	521	632	650	4480	1021	2540	2224	516	342	530	3150	3457
382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	382_Amino acid::Glycine, serine and threonine metabolism::N-acetylthreonine	25	90	1	1455	830	4581	285	3755	1924	1290	90	1937	3547	3539	1519	765	4369	2863	4332	2764	1213
2733_CFB - Complement factor B	2733_CFB - Complement factor B	25	90	1	296	2863	727	3719	688	3592	1616	1193	3271	1180	626	4646	1302	90	1320	759	2716	1029
2542_THBS1 - Thrombospondin-1	2542_THBS1 - Thrombospondin-1	25	90	1	4275	4255	4029	4265	2918	112	2051	1264	2561	4635	4026	3790	1208	2829	90	146	2195	1047
1139_Body Mass Index (Dominance deviation model)	1139_Body Mass Index (Dominance deviation model)	25	90	1	1447	4215	3486	3520	244	2037	2915	2052	2993	1224	2663	1363	2160	4098	1718	1285	3899	90
2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	2425_TGFBI - Transforming growth factor-beta-induced protein ig-h3	25	91	1	91	4321	772	1886	374	713	3304	1685	778	3357	1351	3176	2100	1527	2414	4639	4687	238
2067_TIMP2 - Metalloproteinase inhibitor 2	2067_TIMP2 - Metalloproteinase inhibitor 2	25	91	1	854	91	260	4575	763	784	3761	93	4507	4084	4039	4633	2835	1590	1023	1433	410	4505
16_Posttraumatic stress disorder	16_Posttraumatic stress disorder	25	91	1	2743	2064	4728	4012	91	2407	1391	4565	1936	2942	3895	801	2798	857	91	3152	437	3375
3998_Tense / 'highly strung' (TENSE)	3998_Tense / 'highly strung' (TENSE)	25	91	1	4245	1323	1737	4232	3210	91	3199	1985	4267	2499	2192	563	4270	3683	1464	2500	3784	1228
2077_FGF10 - Fibroblast growth factor 10	2077_FGF10 - Fibroblast growth factor 10	25	91	1	1255	1797	421	1362	2813	4024	91	397	4728	3485	2088	4565	2513	140	3523	3307	3290	719
1783_Artial fibrillation (GEE, adjusted for multivariable)	1783_Artial fibrillation (GEE, adjusted for multivariable)	25	91	1	2566	1158	165	1763	636	282	2380	4697	2794	3020	1402	4398	4198	91	2349	2610	2642	4306
2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	2112_CRLF1 CLCF1 - Cytokine receptor-like factor 1:Cardiotrophin-like cytokine factor 1 Complex	25	91	1	4727	1665	4160	617	3867	3881	614	1409	2455	3857	1407	2221	2897	4558	533	91	1798	4470
2434_CNTN2 - Contactin-2	2434_CNTN2 - Contactin-2	25	91	1	4585	1362	2556	1091	1273	1842	4735	472	119	1129	467	2722	433	521	1399	1423	91	1625
4166_Body Mass Index	4166_Body Mass Index	25	92	1	92	1107	3625	2683	556	3369	3658	4535	2308	999	3317	1570	1212	3141	2474	4574	4645	3924
4004_Juvenile idiopathic arthritis with vs without uveitis	4004_Juvenile idiopathic arthritis with vs without uveitis	25	92	1	3688	221	92	139	1780	4483	3884	1087	3251	4163	2737	1457	2821	1830	126	1485	4101	4190
3076_NOTCH2 - Neurogenic locus notch homolog protein 2	3076_NOTCH2 - Neurogenic locus notch homolog protein 2	25	92	1	4042	212	1249	92	171	2126	155	3249	98	187	4606	4025	4652	357	2429	3981	229	3533
2123_HMOX2 - Heme oxygenase 2	2123_HMOX2 - Heme oxygenase 2	25	92	1	3989	1456	4709	579	92	764	4692	3349	3114	687	1562	553	1343	4143	521	2056	222	3441
3977_Lean body mass (whole body)	3977_Lean body mass (whole body)	25	92	1	466	2631	3508	2350	3745	92	1163	3959	3721	433	3835	740	281	2549	2033	132	1087	197
265_CD8:%RTE	265_CD8:%RTE	25	92	1	1559	1386	3741	4619	2078	3780	1194	92	3307	1296	4386	1530	3911	1607	3001	847	3013	2670
3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	3039_TNFAIP6 - Tumor necrosis factor-inducible gene 6 protein	25	92	1	1518	1154	632	3327	3992	1166	2704	4149	92	3696	1939	3023	4477	4344	1947	1975	3482	305
3512_Type of tobacco previously smoked: Manufactured cigarettes	3512_Type of tobacco previously smoked: Manufactured cigarettes	25	92	1	3788	851	2462	4005	1626	4415	2890	203	143	1172	92	1552	4464	1707	3469	710	3952	298
2893_PLXNC1 - Plexin-C1	2893_PLXNC1 - Plexin-C1	25	92	1	875	4012	1344	1580	829	737	1845	214	2459	2242	2753	1893	899	92	4359	557	233	3258
3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	3506_Non-butter spread type details: Olive oil based spread (eg: Bertolli)	25	92	1	3648	4416	2049	1927	2537	247	757	2401	2732	1638	1019	1745	2858	3501	92	235	4009	3071
4465_Left posterior cingulate	4465_Left posterior cingulate	25	92	1	482	1366	3507	2626	749	649	560	2916	1631	640	3680	640	1383	1782	568	92	1723	1491
3825_Osteoarthritis of hip	3825_Osteoarthritis of hip	25	92	1	362	3263	2168	3821	1385	357	2312	2601	763	1946	369	121	4699	1012	712	2921	92	1436
1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	1493_Remnant lipoprotein triglycerides (at exam 4, GEE, adjusted for age and sex)	25	92	1	356	3519	4232	2858	3277	2935	1873	2146	3762	3649	324	4355	1406	1036	3989	3030	2449	92
2943_WNT7A - Protein Wnt-7a	2943_WNT7A - Protein Wnt-7a	25	93	1	3165	93	352	2129	2359	541	3013	3603	975	1815	1399	2715	968	1499	3890	3744	2335	2591
1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1554_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	93	1	131	3015	93	2155	4456	1918	1676	1705	2212	964	4480	3426	3307	3268	1769	4519	570	2319
1307_Insulin sensitivity (GEE, adjusted for age and sex)	1307_Insulin sensitivity (GEE, adjusted for age and sex)	25	93	1	201	297	344	4270	93	4726	1295	233	3452	2370	234	1779	2992	946	3896	1475	941	2116
26_Agression	26_Agression	25	93	1	1712	4682	3831	3207	4232	93	2355	2758	4403	2315	1678	3241	4004	1911	1659	502	4337	1214
4459_Left paracentral	4459_Left paracentral	25	93	1	4689	3159	398	2610	1596	1614	93	2126	4516	388	2978	3851	1178	3485	1996	3620	4320	846
264_CD4:%SCM	264_CD4:%SCM	25	93	1	3325	1789	1494	2006	1343	1928	2657	4671	93	2289	3771	475	1868	3812	668	1956	2885	633
2414_PIGR - Polymeric immunoglobulin receptor	2414_PIGR - Polymeric immunoglobulin receptor	25	93	1	2736	3779	4047	638	3308	499	597	1440	1128	93	4181	3654	1840	690	437	3515	2625	3780
4163_Generalized epilepsy with tonic-clonic seizures	4163_Generalized epilepsy with tonic-clonic seizures	25	93	1	2373	3614	939	1755	1623	398	4247	1340	2472	3266	3694	1827	1984	93	4370	1049	4715	3785
3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	3513_Gas or solid-fuel cooking/heating: A gas hob or gas cooker	25	93	1	327	1809	4012	1504	1026	2516	1689	1996	3079	3035	3059	1591	2455	3412	93	2283	4637	4501
536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	536_Lipid::Lysolipid::1-heptadecanoylglycerophosphocholine	25	93	1	4434	986	3796	2084	414	3062	3025	4646	2534	2882	4155	2662	1926	562	1136	93	3161	3495
3803_Mean corpuscular hemoglobin	3803_Mean corpuscular hemoglobin	25	93	1	3624	1520	604	3228	3720	4523	2924	4171	4023	1966	3121	1101	1031	349	2076	1585	411	93
2850_SPARCL1 - SPARC-like protein 1	2850_SPARCL1 - SPARC-like protein 1	25	94	1	94	1877	1273	824	1347	213	3492	2140	932	3271	443	272	627	4324	1241	2759	1065	3661
1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1559_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	94	1	441	94	1321	3545	4339	2540	225	597	2900	1394	1725	700	844	2264	1909	2237	1074	4608
274_CD8:%TEM	274_CD8:%TEM	25	94	1	2639	3308	3477	94	2925	2302	2580	2566	1040	3606	4225	693	156	433	3369	1967	4112	3972
2191_FAM107A - Protein FAM107A	2191_FAM107A - Protein FAM107A	25	94	1	1015	501	1798	3801	3180	94	3922	458	1374	3629	4456	1831	288	1046	2225	2467	1254	4050
800_::::X-12749	800_::::X-12749	25	94	1	3040	1004	3708	2059	1541	2846	702	3313	94	4184	3675	284	519	1099	4658	318	4714	3380
3738_Depression - Lifetime number of depressed periods	3738_Depression - Lifetime number of depressed periods	25	94	1	4582	111	563	1284	2518	3414	1245	390	3179	94	3829	1701	1720	1131	231	689	3134	787
2547_AGT - Angiotensinogen	2547_AGT - Angiotensinogen	25	94	1	3666	1884	2930	687	169	1838	410	2515	2266	4716	841	94	3434	2143	2890	3559	4328	4577
3237_Smoking/smokers in household	3237_Smoking/smokers in household	25	94	1	307	2776	1243	2040	3854	4101	3009	1154	2479	1963	1483	4103	2684	1206	3451	94	1405	2399
3038_TYMS - Thymidylate synthase	3038_TYMS - Thymidylate synthase	25	94	1	107	2555	153	4382	3377	4631	4331	2533	631	929	3077	3296	1338	4719	2005	1760	1036	94
2242_AIF1 - Allograft inflammatory factor 1	2242_AIF1 - Allograft inflammatory factor 1	25	95	1	95	2800	3140	1704	2349	4299	3435	3395	527	1049	3016	2505	2726	4038	226	2331	2144	445
2082_CCL20 - C-C motif chemokine 20	2082_CCL20 - C-C motif chemokine 20	25	95	1	2977	95	549	681	4522	825	3631	555	2292	1804	3766	3172	1153	1308	2629	3541	1578	2504
2401_IDS - Iduronate 2-sulfatase	2401_IDS - Iduronate 2-sulfatase	25	95	1	391	672	95	3650	2274	3249	1383	1815	1669	3482	1069	1413	1821	1155	4555	2115	1980	3629
1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	1371_Total cholesterol (at exam 7, GEE, adjusted for age and sex)	25	95	1	1393	2902	1521	95	3420	967	2683	243	277	1593	400	197	110	860	4344	4547	3131	3342
4131_Eosinophil count	4131_Eosinophil count	25	95	1	4467	355	1466	2766	95	350	535	1905	1344	2148	1695	105	663	4483	2295	2915	4527	621
1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1810_Very low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	95	1	4030	1429	1672	1494	1928	95	2832	1435	2702	1766	1484	3923	781	2945	4713	2806	2100	4712
1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1427_Large high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	95	1	4270	605	3875	3433	2196	1694	95	4049	2239	3086	4146	3086	499	2481	945	598	196	1222
1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	1688_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for multivariable)	25	95	1	1914	3063	2760	3952	1182	1480	2375	95	3964	4067	2698	1939	1899	1569	208	1414	664	3864
3806_White blood cell count	3806_White blood cell count	25	95	1	353	4539	4603	924	4024	4022	350	4030	95	487	1586	2292	637	1366	2920	2064	1307	439
931_Phenylalanine	931_Phenylalanine	25	95	1	3897	1774	3420	3652	3121	231	1707	1465	2171	95	664	99	577	3330	4643	668	127	1523
4109_Serum creatinine	4109_Serum creatinine	25	95	1	3267	1740	241	1411	2739	3488	2918	1396	381	2183	95	2796	3114	260	3835	4695	2826	910
4602_Right superior frontal	4602_Right superior frontal	25	95	1	310	1569	3082	548	3241	2898	2839	2183	4388	2170	1516	435	95	593	4456	2962	1453	3484
3866_Reticulocyte count (two-way meta)	3866_Reticulocyte count (two-way meta)	25	95	1	3543	3093	1490	3089	640	3235	1624	2561	1895	3208	1612	1693	4639	95	4560	1016	3632	3905
247_CD56 on 2+NK eff	247_CD56 on 2+NK eff	25	95	1	4633	3937	4205	1631	3936	3786	3936	1183	3620	1888	2526	2624	3728	1984	95	3970	1443	2531
2323_SERPINF2 - Alpha-2-antiplasmin	2323_SERPINF2 - Alpha-2-antiplasmin	25	95	1	3237	1619	4073	2859	3849	1862	2113	1034	2975	4366	1627	4588	4629	542	1054	95	808	3950
505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	505_Lipid::Fatty acid, monohydroxy::2-hydroxystearate	25	95	1	4463	3140	1118	3591	785	156	199	1095	4065	2305	2947	3393	999	1016	309	3477	95	3735
2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	2910_PPIB - Peptidyl-prolyl cis-trans isomerase B	25	95	1	2961	493	4407	2537	3857	1879	3615	4200	529	2929	430	2524	1537	594	1019	2994	4113	95
1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1450_Low-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	96	1	1246	96	2379	2128	4075	542	1947	822	357	764	1403	832	503	582	3111	4427	211	2280
1147_Ratio of AUC insulin to AUC glucose	1147_Ratio of AUC insulin to AUC glucose	25	96	1	598	4064	96	226	1370	2174	529	1525	1518	4443	2530	713	1451	2020	4004	633	786	458
3745_Happiness and subjective well-being - General happiness	3745_Happiness and subjective well-being - General happiness	25	96	1	4023	3438	4385	96	2154	4190	2746	3453	4029	1968	1820	4539	1510	4576	980	791	2824	3143
2187_GDF5 - Growth/differentiation factor 5	2187_GDF5 - Growth/differentiation factor 5	25	96	1	389	182	4422	4449	343	96	1031	2484	1487	2753	3978	373	3682	392	2579	4189	4212	2332
2636_NPPB - Brain natriuretic peptide 32	2636_NPPB - Brain natriuretic peptide 32	25	96	1	1742	2795	950	905	2995	4168	481	96	1429	1067	1393	3616	1817	2142	2674	1279	1066	2408
31_Conscientiousness (NEO-FFI)	31_Conscientiousness (NEO-FFI)	25	96	1	3304	2934	3379	3211	1097	1297	2075	2359	96	4315	3810	762	1780	1309	2058	4204	3710	363
4532_Right cerebellum exterior	4532_Right cerebellum exterior	25	96	1	4706	477	850	3756	1515	2736	114	3584	4690	2819	2031	96	3922	640	3610	3946	815	4684
2914_OLFM4 - Olfactomedin-4	2914_OLFM4 - Olfactomedin-4	25	96	1	720	4396	4511	121	834	4422	3550	368	533	3745	3765	2866	96	1244	4416	686	982	1741
628_Xenobiotics::Drug::salicylate	628_Xenobiotics::Drug::salicylate	25	96	1	2150	1838	2004	876	1298	2057	912	2240	3163	3029	861	4302	225	96	1950	534	1064	4142
1078_Serum Iron concentration	1078_Serum Iron concentration	25	96	1	1161	1074	1271	2745	3501	4310	1869	1199	2216	4523	1324	1220	2150	3999	96	2459	4355	4141
1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	1332_Fasting HbA1c (at exam 5, FBAT, adjusted for age, sex and BMI)	25	97	1	635	1704	97	2624	3469	1407	547	4700	4479	2813	3289	2113	4438	1695	641	3333	4635	1339
624_Xenobiotics::Drug::hydroquinone sulfate	624_Xenobiotics::Drug::hydroquinone sulfate	25	97	1	4483	1020	871	625	1041	525	97	3108	1126	697	3542	3380	4689	512	1052	4643	1317	4489
4741_Corticospinal tract radial diusivities	4741_Corticospinal tract radial diusivities	25	97	1	1633	525	4470	2351	2286	2067	1140	97	501	2169	4413	1988	1503	824	564	2560	3163	2885
4059_Estimated glomerular filtration rate based on cystain C	4059_Estimated glomerular filtration rate based on cystain C	25	97	1	4419	2773	3132	3155	2457	1771	3017	3521	97	4225	3351	3053	3712	3196	4610	3521	3258	3386
2411_ASAH2 - Neutral ceramidase	2411_ASAH2 - Neutral ceramidase	25	97	1	4162	3643	2185	1334	3495	4035	735	2457	4391	700	97	3400	974	1162	3819	2032	1510	736
804_::::X-12798	804_::::X-12798	25	97	1	1373	298	3350	384	158	1977	2288	1558	4642	4220	1815	97	2021	4574	2115	3890	1298	890
2359_IL13 - Interleukin-13	2359_IL13 - Interleukin-13	25	97	1	1047	555	2353	691	3879	4405	1437	1357	599	572	1651	4268	97	3368	4228	1664	2567	2466
3364_Age last used hormone-replacement therapy (HRT) (female)	3364_Age last used hormone-replacement therapy (HRT) (female)	25	97	1	3492	3150	3264	1143	1172	3709	4521	1509	2046	380	4089	4063	4165	97	1505	1832	421	4659
870_Free cholesterol	870_Free cholesterol	25	97	1	1941	1834	235	3859	2461	3538	719	790	954	3977	143	1759	1693	3431	97	580	153	1007
1120_Pericardial adipose tissue volume (adjusted for height and weight)	1120_Pericardial adipose tissue volume (adjusted for height and weight)	25	97	1	1968	1322	2802	1790	1571	951	190	644	2778	500	2398	3039	1390	4519	1139	97	1167	3483
2049_Periodontal complex trait 4	2049_Periodontal complex trait 4	25	98	1	98	2354	685	3442	3923	2638	4733	352	1272	1939	3180	3534	2947	1180	780	4074	1458	1366
411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	411_Amino acid::Urea cycle; arginine-, proline-, metabolism::arginine	25	98	1	709	3191	98	4317	2324	4265	2373	2014	3764	4424	4590	236	2829	3481	1490	4736	4243	2959
875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	875_Glycoprotein acetyls, mainly a1Lacid glycoprotein	25	98	1	886	2063	4648	98	850	403	1207	1840	2586	322	3170	1291	2302	1390	1358	1856	529	603
4565_Left postcentral	4565_Left postcentral	25	98	1	4084	630	3787	940	3687	98	174	4633	4012	765	1425	3105	2317	654	3697	1443	2665	2454
530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	530_Lipid::Lysolipid::1-arachidonoylglycerophosphocholine*	25	98	1	3757	4308	3249	3581	4173	4388	98	240	3552	4018	189	939	4621	1802	1112	1962	659	2783
2177_NANOG - Homeobox protein NANOG	2177_NANOG - Homeobox protein NANOG	25	98	1	2016	1914	2506	3255	1581	469	1178	2626	163	98	484	2274	1014	4591	3895	1576	3137	3290
2538_SELE - E-Selectin	2538_SELE - E-Selectin	25	98	1	1004	463	3830	2057	4018	3999	3054	3003	1986	556	98	2531	4705	636	4476	1640	4165	4634
169_Waist circumference (male)	169_Waist circumference (male)	25	98	1	2607	4319	3658	2657	1814	2395	1195	3490	4440	168	3120	98	3453	4088	1529	3651	2806	4680
4590_Right parahippocampal	4590_Right parahippocampal	25	98	1	465	3145	1659	1000	195	2040	4140	2100	749	3227	3683	3636	3328	150	98	3288	4359	659
883_Phospholipids in IDL	883_Phospholipids in IDL	25	98	1	2391	3783	376	2937	2361	2708	416	4579	4115	4511	1991	476	4488	3581	851	98	1896	755
1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	1404_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	99	1	99	1875	423	407	264	1243	3016	1995	1070	4550	789	2365	3736	3073	545	1700	3267	4333
4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	4054_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	99	1	3847	425	2569	2826	99	3377	724	778	670	1074	1297	313	4700	897	3060	1514	783	4365
312_CD4nv:%Th1	312_CD4nv:%Th1	25	99	1	1385	3899	2383	4303	827	99	1659	3867	2768	1833	280	4319	4352	1404	1733	1896	3396	4370
2800_RAN - GTP-binding nuclear protein Ran	2800_RAN - GTP-binding nuclear protein Ran	25	99	1	3514	1576	948	374	699	3932	184	4068	99	2448	3490	408	573	2968	1879	1422	2511	3985
3213_Duration walking for pleasure	3213_Duration walking for pleasure	25	99	1	3303	874	1584	1822	2374	2487	2771	3337	4203	99	4080	2385	1457	2817	1755	2141	3188	2781
1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	1744_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for age and sex)	25	99	1	1457	892	1241	1828	571	4411	1732	2456	3550	2783	99	1170	1125	3989	2247	2314	1922	313
660_::::X-04495	660_::::X-04495	25	99	1	733	4526	2154	734	1392	2568	4541	3754	3806	2436	1122	1459	99	434	4292	3266	599	3449
2402_KLK12 - Kallikrein-12	2402_KLK12 - Kallikrein-12	25	99	1	2414	4109	942	4493	759	399	982	2602	1176	3389	726	1590	415	2984	99	1798	1642	2061
3278_Father still alive	3278_Father still alive	25	99	1	714	922	3922	3397	2904	1758	1855	1177	3583	2334	2550	947	4431	234	3482	99	841	4741
2408_MATN3 - Matrilin-3	2408_MATN3 - Matrilin-3	25	100	1	100	2508	2520	2740	2530	720	2859	3974	2857	3295	3947	590	3861	2229	1829	2833	1268	1052
1067_Type 1 Diabetes	1067_Type 1 Diabetes	25	100	1	4387	2639	100	2114	408	338	1467	3575	2949	538	4514	2281	4692	3796	776	3169	2007	3758
4101_Triglyceride	4101_Triglyceride	25	100	1	3820	170	1624	1460	100	653	1298	3023	3476	3964	3060	2459	4623	2723	4417	380	3893	794
9_Schizophrenia	9_Schizophrenia	25	100	1	3714	192	175	425	2340	100	2770	1798	1908	3788	390	142	369	797	3704	2300	187	1227
3096_TGFBR2 - TGF-beta receptor type-2	3096_TGFBR2 - TGF-beta receptor type-2	25	100	1	884	610	4647	3985	4202	2890	100	4176	348	188	4472	1199	2439	1201	4703	4030	1826	4009
2353_CTSB - Cathepsin B	2353_CTSB - Cathepsin B	25	100	1	2679	3454	137	426	1967	645	2283	100	2552	1649	548	4473	1185	338	3226	988	1542	3072
1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1540_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	100	1	398	1157	1331	913	4305	2396	1705	707	712	898	350	680	100	2793	1562	1516	3752	4339
2295_BMP7 - Bone morphogenetic protein 7	2295_BMP7 - Bone morphogenetic protein 7	25	100	1	369	534	1421	1304	2184	767	4196	4626	2924	235	482	2304	435	100	1965	2850	4199	3749
3822_Primary biliary cirrhosis	3822_Primary biliary cirrhosis	25	100	1	300	4276	218	4530	1399	228	3327	4665	4061	4254	408	3746	941	348	100	1620	1055	506
566_Lipid::Short chain fatty acid::valerate	566_Lipid::Short chain fatty acid::valerate	25	100	1	3095	3666	3923	459	2639	2390	3121	1484	443	3893	1898	3757	845	1314	377	100	1710	233
2064_TIMP1 - Metalloproteinase inhibitor 1	2064_TIMP1 - Metalloproteinase inhibitor 1	25	100	1	2355	3633	1837	1888	3480	2773	2435	664	1834	4661	768	3126	517	1724	3003	2637	4499	100
4040_Schizophrenia/Bipolar disorder	4040_Schizophrenia/Bipolar disorder	25	101	1	3128	101	2840	4583	4526	936	2335	3618	1032	3303	4367	4470	2045	781	366	4261	1876	3555
1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1329_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	101	1	793	2886	3929	2477	101	3899	4252	3430	1926	2519	3075	2517	750	4742	2860	4657	3965	3942
3811_Basophil count	3811_Basophil count	25	101	1	912	255	2337	3803	2465	1164	4101	101	627	866	2869	1663	1968	3995	395	2213	2967	4077
3195_Average total household income before tax	3195_Average total household income before tax	25	101	1	4111	3346	2326	3199	1395	4334	3051	1588	2889	3123	101	2051	2461	4510	4596	528	3280	1452
2608_OPCML - Opioid-binding protein/cell adhesion molecule	2608_OPCML - Opioid-binding protein/cell adhesion molecule	25	101	1	359	4046	1668	501	308	2218	899	1512	2322	1784	4235	264	4101	101	704	215	996	3774
3334_Duration of heavy DIY	3334_Duration of heavy DIY	25	101	1	4741	3197	4374	3057	619	1667	2552	616	4568	1326	235	1057	902	1735	101	152	3034	477
1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1392_High-density lipoprotein 2 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	102	1	102	1727	989	2113	3017	1202	713	603	2749	4586	4202	4607	808	1781	4552	1802	2290	3826
2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	2837_ENPP7 - Ectonucleotide pyrophosphatase/phosphodiesterase family member 7	25	102	1	3783	102	545	1623	3735	4579	2322	4714	3670	1893	1048	2586	3600	2486	262	1665	274	4462
1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1382_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	102	1	1276	1308	1351	4035	102	2926	2763	609	4009	2103	2623	1783	1396	2079	1910	1533	4633	3040
384_Amino acid::Glycine, serine and threonine metabolism::threonine	384_Amino acid::Glycine, serine and threonine metabolism::threonine	25	102	1	1441	3526	2843	3092	3662	102	1936	3885	1418	2620	1796	1005	1644	2145	3243	3116	3382	1783
4396_Menstruation quality of life impact: Agressiveness	4396_Menstruation quality of life impact: Agressiveness	25	102	1	1583	1055	1905	2642	2245	2081	3015	2479	4084	703	4402	102	929	1774	3464	2730	1824	1064
2534_PDGFRB - Platelet-derived growth factor receptor beta	2534_PDGFRB - Platelet-derived growth factor receptor beta	25	102	1	2359	3714	2115	1391	2442	3464	3650	4727	273	1529	3567	3789	102	1754	3304	1186	779	3740
1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	1511_Triglycerides (at exam 7, GEE, adjusted for age and sex)	25	102	1	608	2234	3777	3599	4395	1941	4711	4159	4421	722	1629	1406	2409	4288	102	2877	341	4426
1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	1587_Factor VII (at exam 5, GEE, adjusted for age and sex)	25	102	1	1235	4473	258	3055	2413	3800	1130	2689	2933	435	3546	335	3450	1276	1075	3003	102	1843
1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1384_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	103	1	103	1191	380	3453	2491	3368	200	166	897	1634	2603	2856	181	238	4113	2846	2096	1390
2840_FCRL3 - Fc receptor-like protein 3	2840_FCRL3 - Fc receptor-like protein 3	25	103	1	2766	1458	1145	103	2455	356	3386	3523	1578	3754	2163	543	2396	2633	4180	1813	2017	301
3388_Family relationship satisfaction	3388_Family relationship satisfaction	25	103	1	1212	3056	1092	4062	103	2562	2957	1814	267	2568	358	2949	3437	405	1158	316	1511	584
4633_Right cerebellum exterior	4633_Right cerebellum exterior	25	103	1	4664	319	1934	4138	1756	2784	103	2727	4623	2413	1600	124	3930	718	4051	4287	605	3896
4192_QRS interval	4192_QRS interval	25	103	1	2512	4110	955	2600	3029	3018	2876	4616	831	103	2652	315	634	952	4041	1004	392	2659
41_Educational attainment	41_Educational attainment	25	103	1	1545	2263	2467	2900	2691	1163	2742	2760	181	1226	103	1122	1848	1646	976	1451	184	2405
4522_Left caudate	4522_Left caudate	25	103	1	1424	536	3133	584	4257	1301	2786	873	2956	601	2149	103	549	4247	3129	2126	3860	429
1002_Monokine induced by interferon-gamma (CXCL9)	1002_Monokine induced by interferon-gamma (CXCL9)	25	103	1	670	1397	3224	441	3900	3300	1983	3208	3062	679	876	3390	103	350	3998	892	2301	1096
2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	2407_LYVE1 - Lymphatic vessel endothelial hyaluronic acid receptor 1	25	103	1	4149	2339	3527	1414	593	4567	3789	2228	1726	952	2293	2081	4257	103	3750	983	777	4727
254_CD3 on DN T	254_CD3 on DN T	25	103	1	2036	3213	552	3009	3825	4392	715	979	303	930	2280	4233	202	814	143	103	253	3177
2761_CFH - Complement factor H	2761_CFH - Complement factor H	25	103	1	316	3678	3991	736	3433	2135	3891	4436	1196	1653	1692	3149	1617	3195	3739	728	918	103
3849_Lymphocyte percentage of white cells (two-way meta)	3849_Lymphocyte percentage of white cells (two-way meta)	25	104	1	104	3267	2035	4657	3500	3129	4431	2304	4086	2145	2449	1067	3737	1975	292	3703	2957	3274
1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	1331_Insulin sensitivity (GEE, adjusted for age, sex and BMI)	25	104	1	4137	104	635	879	4159	3960	4181	1937	4144	261	735	1904	294	1788	2883	3293	2924	2247
1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	1662_Alanine transaminase (at exam 2, FBAT, adjusted for age and sex)	25	104	1	4535	780	2194	4179	104	4288	1293	236	502	1880	1878	1198	3190	2783	946	4212	3486	2759
256_CD32 on 11c+123+DC	256_CD32 on 11c+123+DC	25	104	1	1888	1737	232	1892	3661	104	730	1308	4573	449	3943	2612	463	2313	497	589	1573	3884
1136_Parents' age at death	1136_Parents' age at death	25	104	1	1101	1452	760	4656	2885	1870	104	329	1463	2377	2888	1656	4039	4120	2011	207	913	4548
2461_THBS4 - Thrombospondin-4	2461_THBS4 - Thrombospondin-4	25	104	1	1279	628	3594	770	163	3383	630	104	2663	1444	4043	1633	3009	3393	4298	977	4409	4327
2398_GNLY - Granulysin	2398_GNLY - Granulysin	25	104	1	2408	4378	3713	3278	4543	150	587	119	174	104	1368	131	720	2435	989	1118	2813	372
1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	1612_von Willebrand Factor (at exam 5, FBAT, adjusted for multivariable)	25	104	1	4542	2615	900	792	2030	1500	3689	2557	3022	4711	4613	104	1970	2172	516	151	339	3383
3071_SCARB2 - Lysosome membrane protein 2	3071_SCARB2 - Lysosome membrane protein 2	25	104	1	1343	4686	3456	3073	4717	413	1008	3440	292	333	1822	2161	2656	104	287	3921	4046	2151
373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	373_Amino acid::Cysteine, methionine, SAM, taurine metabolism::methionine	25	104	1	4668	1937	2602	3468	4583	245	129	758	2311	503	814	4519	3044	2292	104	1823	4677	2443
1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	1407_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	104	1	2494	2999	1753	2660	2063	2977	4738	732	2602	2010	184	4043	2210	3346	4249	1755	104	4363
2631_PLG - Angiostatin	2631_PLG - Angiostatin	25	105	1	3551	4468	105	4064	2545	2282	2131	3799	862	2787	522	1447	3316	2035	4281	3631	3103	636
2291_VCAM1 - Vascular cell adhesion protein 1	2291_VCAM1 - Vascular cell adhesion protein 1	25	105	1	1812	2412	3355	105	3947	3923	2292	3820	1649	606	4630	1300	4379	1410	4024	2385	524	1817
3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	3659_Cancer register - Type of cancer: ICD10: C50 Malignant neoplasm of breast	25	105	1	4018	750	3588	4170	105	1135	3216	1697	1877	2621	4040	392	2264	3016	1760	763	2838	460
4223_Calcium channel blockers	4223_Calcium channel blockers	25	105	1	2914	1733	2608	3036	1415	105	4222	3198	1219	3038	1231	4080	2078	3355	3035	4476	2479	347
1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	1943_White matter hyperintensity volume (GEE, adjusted for multivariable with APOE)	25	105	1	1382	4265	3744	3667	1168	1777	105	1184	991	4062	1218	1103	880	1349	4066	1356	2550	1251
4383_Epithelial ovarian cancer (high-grade serous)	4383_Epithelial ovarian cancer (high-grade serous)	25	105	1	1426	2335	4365	4178	154	2849	4308	105	2723	1302	2540	3810	4545	1196	2901	1308	907	2617
912_Free cholesterol in medium HDL	912_Free cholesterol in medium HDL	25	105	1	1759	2568	4202	521	1558	2148	2675	4620	105	3031	1383	460	2486	2246	1873	497	867	1736
2554_FGF17 - Fibroblast growth factor 17	2554_FGF17 - Fibroblast growth factor 17	25	105	1	3644	4441	1058	3715	2300	3493	1791	711	1132	3012	2497	1183	1281	105	740	4539	660	798
3200_Job involves mainly walking or standing	3200_Job involves mainly walking or standing	25	105	1	2623	2731	2142	3320	315	2722	2644	363	1593	3287	1154	3889	3979	4633	2938	105	4209	1402
3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	3591_Medication for cholesterol, blood pressure or diabetes: Blood pressure medication	25	105	1	4640	3540	1551	3299	3616	539	3074	251	282	3583	3889	4244	1834	2911	2178	2885	3938	105
3484_Spread type: Butter/spreadable butter	3484_Spread type: Butter/spreadable butter	25	106	1	106	2860	337	3953	4575	2508	2634	1810	1964	467	1171	877	4315	3912	2171	2771	3870	4423
187_Waist-hip ratio (male, adjusted for BMI)	187_Waist-hip ratio (male, adjusted for BMI)	25	106	1	3583	4681	106	132	4428	330	1738	2842	3653	1379	2792	3315	216	675	496	1437	2576	4676
1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1381_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	106	1	2798	3588	4001	106	2108	1252	750	2008	3997	1405	4193	974	1284	3300	865	3885	1025	991
4075_Body Mass Index (male)	4075_Body Mass Index (male)	25	106	1	2378	3435	1739	4206	106	4100	1089	3986	2726	138	2485	692	1048	2738	3485	1388	4390	1676
4722_Fornix (cres) / Stria terminalis mode of anisotropy	4722_Fornix (cres) / Stria terminalis mode of anisotropy	25	106	1	2944	2421	1041	2134	4292	106	3028	3792	4652	2639	4636	4569	1309	1282	2506	4460	1679	4174
1220_Mean Amygdala	1220_Mean Amygdala	25	106	1	699	1359	1488	3076	516	334	106	474	377	3269	2674	4405	4176	4248	4243	4435	2754	793
65_Insulin sensitivity index (adjusted for age, sex. Bmi)	65_Insulin sensitivity index (adjusted for age, sex. Bmi)	25	106	1	847	4499	4442	287	1547	2341	261	106	4746	2473	2268	2790	2082	4228	1367	4221	3872	1003
3969_Asthma (random effect model)	3969_Asthma (random effect model)	25	106	1	4028	4710	149	2803	787	4006	1077	2284	4368	182	106	2429	490	4206	489	476	822	1989
816_::::X-13215	816_::::X-13215	25	106	1	3047	2051	2711	1361	1495	472	1569	3129	929	1017	133	1248	1194	466	3490	106	614	2942
2861_FGF7 - Fibroblast growth factor 7	2861_FGF7 - Fibroblast growth factor 7	25	106	1	3162	3189	3789	2915	1759	2399	3144	3459	3787	1243	3623	4061	2776	989	4637	4508	3157	106
1079_Prostate cancer	1079_Prostate cancer	25	107	1	3949	107	4096	2299	3913	1550	3953	1534	2271	4270	3727	2155	2427	1385	3803	4246	276	1947
3259_Major dietary changes in the last 5 years	3259_Major dietary changes in the last 5 years	25	107	1	1547	3618	107	3751	933	3098	1787	2915	3520	3618	3676	3164	1181	3419	793	3547	3189	1965
4269_Neuroticism general factor	4269_Neuroticism general factor	25	107	1	4065	923	1251	238	107	1888	2841	839	2009	2962	3265	2670	822	1398	1403	4541	1779	1883
2701_TPT1 - Translationally-controlled tumor protein	2701_TPT1 - Translationally-controlled tumor protein	25	107	1	4332	1927	844	3768	3555	2901	107	4676	216	4137	3084	1612	3100	2343	3117	110	3709	652
1912_Occipital brain volume (FBAT, adjusted for multivariable)	1912_Occipital brain volume (FBAT, adjusted for multivariable)	25	107	1	3625	704	3256	2648	2453	2685	3281	107	3432	212	3585	3695	3903	4397	3468	3319	1332	3191
2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	2978_ERAP1 - Endoplasmic reticulum aminopeptidase 1	25	107	1	1260	4220	4588	1126	4500	3155	1289	522	107	2895	388	2219	4028	1379	1458	2836	2283	4251
375_Amino acid::Glutamate metabolism::glutamine	375_Amino acid::Glutamate metabolism::glutamine	25	107	1	2232	3849	2610	1582	2561	1502	1777	3726	4279	2972	1791	2115	107	2619	3632	1521	2086	4302
4080_Waist-hip ratio (adjusted for BMI)	4080_Waist-hip ratio (adjusted for BMI)	25	107	1	518	2465	2485	550	4695	1829	298	3182	4205	4653	526	2512	2466	1541	588	1463	110	107
4381_Epithelial ovarian cancer (all invasive)	4381_Epithelial ovarian cancer (all invasive)	25	108	1	108	4564	1454	1332	1886	1112	1027	4155	4140	2248	1621	2844	1835	4717	4255	130	1003	4595
2035_Central corneal thickness	2035_Central corneal thickness	25	108	1	2931	2964	108	4550	3251	3654	1817	426	221	3013	621	4531	3834	2667	332	1149	1035	221
3197_Length of working week for main job	3197_Length of working week for main job	25	108	1	1089	599	4696	108	792	4311	3668	2974	981	2101	3378	2661	4746	3024	4009	1270	315	1792
4310_Osteoarthritis of knee	4310_Osteoarthritis of knee	25	108	1	1779	2138	2679	4491	108	2847	928	3746	4087	4732	2153	4213	1869	1382	4171	3580	3911	4213
3944_HbA1c	3944_HbA1c	25	108	1	3524	1835	3301	3860	2318	108	1356	1808	4609	2342	868	2892	893	502	339	131	3651	4543
1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	1843_Neck Section Modulus (GEE, female, adjusted for multivariable)	25	108	1	1478	3108	2093	278	2337	2058	108	1738	4035	2487	3361	3713	581	3752	519	3649	1186	191
1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	1992_Survival past average life expectancy (FBAT, adjusted for multivariable)	25	108	1	228	769	4097	990	2295	358	2749	108	892	3566	1073	4068	2091	2329	1035	804	389	2079
2113_CST3 - Cystatin-C	2113_CST3 - Cystatin-C	25	108	1	550	3512	1185	2374	1548	4666	2643	585	1215	108	4163	3155	191	4261	4047	2708	3757	3445
1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	1608_Viscosity I (at exam 5, FBAT, adjusted for multivariable)	25	108	1	4395	2544	3068	772	373	4438	1311	769	2984	3095	108	3918	1581	1624	1484	2924	3908	3971
2245_CHEK1 - Serine/threonine-protein kinase Chk1	2245_CHEK1 - Serine/threonine-protein kinase Chk1	25	108	1	2892	2946	2433	3589	4083	4482	672	3112	268	1477	1574	3706	3545	1942	3038	108	4338	1103
1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1431_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	109	1	109	3481	2475	4431	1054	549	4435	487	4396	1127	2612	777	421	1798	3965	431	1088	1974
2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	2767_EIF4EBP2 - Eukaryotic translation initiation factor 4E-binding protein 2	25	109	1	1995	109	3009	2240	3624	1145	506	3880	2860	1696	1545	4283	3303	3618	170	1892	3677	3278
657_::::X-03094	657_::::X-03094	25	109	1	4343	1634	4318	109	1584	866	2669	2514	4039	3197	1388	2513	1551	3106	1771	2073	681	3530
2416_FOLH1 - Glutamate carboxypeptidase 2	2416_FOLH1 - Glutamate carboxypeptidase 2	25	109	1	3377	132	3245	213	109	1002	3923	1471	1031	2268	4166	2845	3418	1616	2232	2608	3115	1084
2182_SHH - Sonic hedgehog protein	2182_SHH - Sonic hedgehog protein	25	109	1	2342	2446	4549	2468	2935	109	4084	3373	2091	982	3333	3472	2615	1618	4510	3495	787	2146
4122_Gamma-glutamyl transferase	4122_Gamma-glutamyl transferase	25	109	1	1013	3767	4675	854	4406	173	2222	109	2426	3059	2806	4321	3442	3365	4495	3367	1677	3216
3972_Total body BMD (60 or older)	3972_Total body BMD (60 or older)	25	109	1	3248	3432	2639	4440	3556	4262	2555	3007	3390	597	4293	109	1898	2512	3777	1811	1604	3062
1921_Frontal lobe volume (GEE, adjusted for age and sex)	1921_Frontal lobe volume (GEE, adjusted for age and sex)	25	109	1	3423	2721	3129	4275	909	1429	1127	3595	3158	1261	1534	3334	4322	109	3536	706	710	209
4566_Left posterior cingulate	4566_Left posterior cingulate	25	109	1	221	2180	4189	3829	4251	896	1432	3744	2782	1045	1250	1007	3610	119	109	1297	2138	4056
3804_Mean corpuscular hemoglobin concentration	3804_Mean corpuscular hemoglobin concentration	25	109	1	4591	4044	934	3436	3981	729	4377	2742	156	1631	1635	3118	3583	4326	4297	2964	109	2173
3270_Comparative body size at age 10	3270_Comparative body size at age 10	25	110	1	738	110	691	3224	1047	1868	2234	2808	3976	2697	1824	2021	3663	1628	3334	1045	3991	3364
188_Waist-hip ratio (male, adjusted for BMI)	188_Waist-hip ratio (male, adjusted for BMI)	25	110	1	3241	4711	110	119	4600	291	2573	2162	1611	1075	1461	1424	200	1936	419	1913	2108	1209
1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1434_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	110	1	2398	2379	605	110	544	2430	1208	2750	2709	2902	445	1800	687	2897	2144	1875	927	4057
873_Glycerol	873_Glycerol	25	110	1	4589	701	3743	1445	997	110	2756	4507	645	2256	1418	2705	465	1066	4615	1583	4573	1873
1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1570_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	110	1	3234	3233	3063	975	3303	260	1477	110	2115	767	1874	3355	3194	2771	1107	819	2965	1248
374_Amino acid::Glutamate metabolism::glutamate	374_Amino acid::Glutamate metabolism::glutamate	25	110	1	414	4742	2822	4680	4168	3387	855	3098	110	807	1631	221	2550	621	2203	4449	1986	148
2790_NME1 - Nucleoside diphosphate kinase A	2790_NME1 - Nucleoside diphosphate kinase A	25	110	1	3269	2474	2463	1514	821	2727	3734	3282	3816	429	110	3892	1494	475	1604	2376	409	2462
3464_Impedance measures - Arm fat percentage (left)	3464_Impedance measures - Arm fat percentage (left)	25	110	1	2332	2111	2234	4387	951	3119	4345	1634	1828	427	2145	110	2208	4112	1711	4353	2563	3517
4303_Legs-leg fat ratio (male)	4303_Legs-leg fat ratio (male)	25	110	1	291	1518	3993	651	2323	1557	1001	2060	696	4648	833	955	1461	110	1998	2747	2323	2327
1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1516_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	110	1	1539	2360	3523	679	178	4442	3616	336	4141	981	1593	797	3152	189	110	1884	257	176
1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1432_High-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	111	1	2882	1029	2993	111	841	1710	3752	456	4691	634	118	1357	449	1082	4667	1882	2156	2905
2484_HCK - Tyrosine-protein kinase HCK	2484_HCK - Tyrosine-protein kinase HCK	25	111	1	2877	1129	3075	1448	276	111	4677	3432	711	1773	2833	1021	3217	3245	464	3364	735	387
2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	2440_FCGR2A FCGR2B - Low affinity immunoglobulin gamma Fc region receptor II-a/b	25	111	1	2137	2798	296	223	1594	179	111	3941	4089	4081	745	2693	2475	560	1811	3237	481	2058
1754_Cancer (FBAT, adjusted for age and sex)	1754_Cancer (FBAT, adjusted for age and sex)	25	111	1	2090	1032	2458	3785	2771	4688	646	111	2080	1249	4161	3361	426	2431	2059	861	2250	3461
485_Lipid::Carnitine metabolism::palmitoylcarnitine	485_Lipid::Carnitine metabolism::palmitoylcarnitine	25	111	1	1731	654	752	1149	2884	2675	3004	2509	111	1118	292	1554	1886	1811	1219	3018	1272	4641
2042_Attention function - Standard error of hit reaction time - Child	2042_Attention function - Standard error of hit reaction time - Child	25	111	1	1220	2726	3639	1672	3810	3887	2191	170	1380	2839	111	1218	4309	3608	1904	2878	119	1958
1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1575_Mean coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	111	1	717	2943	275	215	2277	3358	2700	314	641	4507	406	111	4256	801	336	184	547	782
608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	608_Peptide::gamma-glutamyl::gamma-glutamyltyrosine	25	111	1	4391	3392	936	4102	4629	166	2903	3730	3320	3413	1025	4009	2374	3523	111	2409	2755	2716
1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1454_Low-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	111	1	576	4370	1829	2699	1416	2191	4657	819	666	1652	831	1346	3638	3927	4162	111	1039	4655
1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1412_High-density lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	112	1	112	3907	501	4497	1143	2340	3392	690	689	3549	2055	3935	3731	3621	3024	3947	3118	2291
2551_CAT - Catalase	2551_CAT - Catalase	25	112	1	180	112	2825	284	2121	4575	1946	869	994	2663	1982	566	2502	4095	2753	3786	1016	2252
1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	1892_Shaft Section Modulus (FBAT, adjussted for multivariable)	25	112	1	4693	1008	112	2265	3380	778	2016	3954	3631	1238	630	4665	2577	3620	1509	1425	2311	2480
2185_INHBA - Inhibin beta A chain	2185_INHBA - Inhibin beta A chain	25	112	1	3069	575	2821	112	2670	1397	1006	1281	414	4360	1274	4278	664	1352	2182	3524	2217	3713
2085_TIMP3 - Metalloproteinase inhibitor 3	2085_TIMP3 - Metalloproteinase inhibitor 3	25	112	1	2673	4352	4740	974	648	4604	112	1157	730	1530	1810	2963	1144	4056	2074	2869	3730	2193
2115_EIF5 - Eukaryotic translation initiation factor 5	2115_EIF5 - Eukaryotic translation initiation factor 5	25	112	1	2249	1913	1179	1296	221	1064	1398	112	1865	2581	642	3653	1441	3869	2062	350	2538	709
1343_Resistin (GEE, adjusted for age, sex and BMI)	1343_Resistin (GEE, adjusted for age, sex and BMI)	25	112	1	2941	3695	2961	2762	147	2233	3351	535	112	3705	1057	2165	3804	4622	991	319	3693	2346
1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1383_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	112	1	2541	3810	1212	490	151	2621	673	807	3167	112	3626	681	147	3519	1847	2262	2663	263
3879_Hematocrit (three-way meta)	3879_Hematocrit (three-way meta)	25	112	1	2404	2861	4746	4246	4194	1776	4149	2233	4546	2703	3256	112	3384	3904	3252	4317	4081	2813
2936_ANG - Angiogenin	2936_ANG - Angiogenin	25	112	1	123	2533	354	873	1045	1731	1725	843	1775	1958	1805	4137	112	412	815	3046	725	1569
215_NK:%Eff	215_NK:%Eff	25	112	1	4009	2453	2535	2961	1293	1608	268	2468	2887	4210	782	3199	2638	1444	112	1805	2485	4071
42_Self-rated health	42_Self-rated health	25	112	1	2488	2042	2787	1587	4530	2110	1846	2367	2757	1212	1317	4546	1019	1462	4498	112	1508	556
275_CD8:%CM	275_CD8:%CM	25	112	1	1589	4305	1744	1720	1233	443	3460	2582	1994	2893	3629	4157	177	2799	1335	4154	4368	112
4126_Creatine kinase	4126_Creatine kinase	25	113	1	113	568	1281	1823	379	3026	1440	3464	4409	489	3028	1295	1072	162	1753	4655	1654	186
643_Xenobiotics::Xanthine metabolism::1-methylxanthine	643_Xenobiotics::Xanthine metabolism::1-methylxanthine	25	113	1	1288	2941	3165	113	3143	115	2785	2600	517	4663	4035	1562	4041	1103	1140	2937	3141	1380
4693_Average across all tracts mean diusivities	4693_Average across all tracts mean diusivities	25	113	1	3575	4198	1894	1153	3406	113	4721	1219	2852	2879	3884	3831	1485	4138	1520	3924	2713	403
934_Concentration of small HDL particles	934_Concentration of small HDL particles	25	113	1	1866	1570	683	3535	3503	2176	113	972	308	1289	4010	597	1130	2301	4190	2826	2785	2296
2022_Fibrotic idiopathic interstitial pneumonias	2022_Fibrotic idiopathic interstitial pneumonias	25	113	1	147	4355	1358	3026	947	1277	1239	113	244	248	826	526	4258	1215	1255	1862	115	244
1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	1619_CD40 Ligand serum (at exam 7, GEE, adjusted for age and sex)	25	113	1	1760	698	1900	1818	1531	3927	2170	495	113	602	4569	163	271	340	852	2021	2484	4704
4116_Phosphorus	4116_Phosphorus	25	113	1	3754	1277	2199	633	1460	1949	3874	292	2617	113	1604	2079	1128	2155	3653	1555	1925	3064
3261_Alcohol intake frequency	3261_Alcohol intake frequency	25	113	1	2049	4680	1997	3958	1334	4305	2911	3401	4689	965	4638	113	3908	3478	3154	3209	3995	2977
1188_Tetralogy of Fallot	1188_Tetralogy of Fallot	25	113	1	2709	663	177	435	1722	2684	2426	2065	3425	1291	438	2801	113	355	2068	1732	309	4461
1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1574_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	113	1	971	4256	1936	1749	1949	4096	4021	1922	4419	4391	244	2346	2095	113	743	3010	1450	3160
3923_Heart rate variability (RMSSD)	3923_Heart rate variability (RMSSD)	25	113	1	856	4159	2690	1123	2779	578	4332	2785	667	2056	3909	2484	3665	3320	113	2727	655	1603
3645_Illnesses of mother: Diabetes	3645_Illnesses of mother: Diabetes	25	113	1	162	1399	428	849	3176	2352	4030	430	165	239	169	2569	1546	2439	4256	3262	113	3673
2709_EEF1B2 - Elongation factor 1-beta	2709_EEF1B2 - Elongation factor 1-beta	25	113	1	438	3280	327	1678	2380	3579	464	2316	605	189	3466	1978	391	1856	2465	1492	220	113
2370_DIABLO - Diablo homolog, mitochondrial	2370_DIABLO - Diablo homolog, mitochondrial	25	114	1	114	1416	1064	1032	3136	421	2708	321	2955	3115	2187	3424	333	462	3377	1927	2174	4660
3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	3697_Diagnoses - secondary ICD10: K29 Gastritis and duodenitis	25	114	1	2596	3552	114	918	1955	4163	2400	4520	3784	4089	2072	1472	226	1471	4528	2720	194	216
4657_Genu of corpus callosum fractional anisotropy	4657_Genu of corpus callosum fractional anisotropy	25	114	1	3694	1635	4294	1642	1177	114	2545	3206	3896	2347	4662	3985	1035	2521	2960	1104	3057	948
3494_Coffee type: Ground coffee (include espresso, filter etc)	3494_Coffee type: Ground coffee (include espresso, filter etc)	25	114	1	1658	3300	4544	4109	1890	3974	1730	3952	2842	114	3968	161	1958	3975	3858	3084	4602	1874
170_Waist circumference (male)	170_Waist circumference (male)	25	114	1	2157	3739	3228	4483	2928	1350	1368	2397	935	252	3018	114	2339	4358	2210	3797	2723	1990
1935_Temporal brain volume (GEE, adjusted for age and sex)	1935_Temporal brain volume (GEE, adjusted for age and sex)	25	114	1	3383	1780	3894	218	439	1613	3075	3247	4590	2995	2810	3684	114	4666	3395	1785	4580	2806
3138_CCL11 - Eotaxin	3138_CCL11 - Eotaxin	25	114	1	1072	303	4152	201	1896	2036	2553	256	4297	3081	4466	2335	4277	114	2933	1283	4434	649
4606_Right transverse temporal	4606_Right transverse temporal	25	114	1	585	2503	384	2188	4587	401	1842	1879	601	969	2364	2578	2911	3895	1044	363	1770	114
2204_IL22 - Interleukin-22	2204_IL22 - Interleukin-22	25	115	1	115	2521	2660	972	2521	320	189	3499	2075	4495	738	1780	1526	416	2894	222	1308	1672
1909_Lateral ventricular volume (GEE, adjusted for multivariable)	1909_Lateral ventricular volume (GEE, adjusted for multivariable)	25	115	1	1850	2047	115	3792	824	736	1275	4003	1978	3248	2951	2871	3809	816	849	711	1802	2601
1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	1743_Urinary albumin excertion (at exam 6, GEE, adjusted for age and sex)	25	115	1	224	1028	301	115	275	4208	2116	179	2317	733	2108	2738	510	293	3918	1030	667	1717
605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	605_Peptide::gamma-glutamyl::gamma-glutamylmethionine*	25	115	1	1160	3356	2801	4129	115	2904	2897	787	2378	1309	1043	333	1807	1749	3781	1629	3545	4033
4700_Fornix (cres) / Stria terminalis mean diusivities	4700_Fornix (cres) / Stria terminalis mean diusivities	25	115	1	2367	2972	2632	443	4091	412	115	3875	330	2338	1208	2672	2494	1234	4130	4178	2036	3337
2845_MFGE8 - Lactadherin	2845_MFGE8 - Lactadherin	25	115	1	2553	2396	3821	188	1191	1259	3823	1988	115	4060	3423	3795	4387	200	3125	1698	191	1551
3844_Hemoglobin concentration (two-way meta)	3844_Hemoglobin concentration (two-way meta)	25	115	1	3702	557	613	3871	4023	3032	4121	4726	2027	1763	115	2058	1770	3794	2418	1357	885	3414
51_Number of children ever born (female)	51_Number of children ever born (female)	25	115	1	4237	2890	3699	4452	1703	485	1551	4710	1356	4180	1777	115	3790	4070	536	460	2454	4263
920_Phospholipids in medium LDL	920_Phospholipids in medium LDL	25	115	1	3327	224	2286	1926	3111	3120	2244	1540	3199	4351	1781	667	4378	2670	619	115	1223	433
3925_Coronary artery disease (SOFT definition including angina)	3925_Coronary artery disease (SOFT definition including angina)	25	115	1	2823	881	2041	3917	2023	2636	3938	3970	2285	4603	137	1373	1592	164	1182	4654	2154	115
981_Interleukin-10	981_Interleukin-10	25	116	1	116	264	2622	4241	1431	1266	239	1611	2861	4733	1849	823	3137	2690	3484	1881	695	4443
3377_Number of spontaneous miscarriages (female)	3377_Number of spontaneous miscarriages (female)	25	116	1	139	116	4356	1077	4576	1963	1018	4147	790	1930	1734	2832	1360	2399	1669	3243	518	938
1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1372_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	116	1	2269	817	116	478	3091	2613	4492	2848	2443	282	1114	3768	3805	1567	4544	3350	2221	4391
1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	1721_Mean thyroid stimulation hormone from exam 3 and 4 (GEE, adjusted for multivariable)	25	116	1	269	2298	1229	2273	1304	116	3963	4201	3910	663	3761	4435	948	1147	3530	1340	2220	2459
3747_Happiness and subjective well-being - Belief that own life is meaningfull	3747_Happiness and subjective well-being - Belief that own life is meaningfull	25	116	1	242	469	2646	3295	2058	3038	3962	116	2523	3109	2013	837	3207	528	426	664	886	2582
2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	2500_PTPN2 - Tyrosine-protein phosphatase non-receptor type 2	25	116	1	1383	332	4469	2358	4618	3096	4402	606	2923	116	3424	1894	986	206	3827	1420	763	412
1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	1328_Fasting insulin (at exam 7, FBAT, adjusted for age, sex and BMI)	25	116	1	3435	4271	3198	4458	3921	4014	2826	4050	3414	2912	4368	116	3601	4583	2998	2916	1762	2040
2310_IL18RAP - Interleukin-18 receptor accessory protein	2310_IL18RAP - Interleukin-18 receptor accessory protein	25	116	1	2383	259	2302	4679	1913	159	706	3894	4263	3306	1830	2600	930	116	1017	3867	2356	1021
1213_Alcohol consumption	1213_Alcohol consumption	25	116	1	207	3641	462	2543	1709	393	139	1241	1624	815	4713	738	689	2755	648	116	546	379
874_Glycine	874_Glycine	25	116	1	1300	3383	1307	2166	4267	4080	2798	3270	4680	708	4585	1190	3345	847	1362	331	116	3525
806_::::X-12830	806_::::X-12830	25	117	1	2228	117	2693	4415	1945	1150	1548	1722	4732	3428	2760	1497	4318	139	466	1251	708	1276
664_::::X-05426	664_::::X-05426	25	117	1	2936	3775	117	1285	2853	4703	1449	557	3737	2129	2385	3332	4261	323	3999	2378	3919	2278
2002_Serum YKL-40 level	2002_Serum YKL-40 level	25	117	1	1473	929	2671	1339	117	1325	1838	4257	3442	3642	1911	819	3083	4451	4194	4266	3934	4115
4339_Walking	4339_Walking	25	117	1	1233	202	4115	4104	1762	117	2325	1170	2550	3312	3251	1475	1375	2967	4381	1770	4062	2076
787_::::X-12644	787_::::X-12644	25	117	1	1656	832	1474	1118	3076	4145	117	173	1691	1398	1908	4251	2907	3211	591	4584	1103	2859
1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1473_Mean total cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	117	1	1405	4605	2600	3964	808	1706	3020	117	1501	1380	153	2022	4381	2046	1073	2401	2602	3480
4046_Rotator cuff injury	4046_Rotator cuff injury	25	117	1	3097	3119	4717	4268	476	2379	4390	3608	117	3215	756	3249	1017	2375	608	409	3431	753
4306_Trunk-trunk fat ratio (female)	4306_Trunk-trunk fat ratio (female)	25	117	1	205	690	1806	664	3070	433	1823	3097	493	117	344	273	2996	1055	1401	4559	2635	1051
4488_Right middle temporal	4488_Right middle temporal	25	117	1	2428	578	3260	1559	949	4410	2962	4168	1545	3726	1885	117	2134	4474	177	2323	3745	4187
1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	1634_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for age and sex)	25	117	1	1361	1024	2721	2612	1393	2380	2249	2567	2330	3487	3774	2585	117	1819	2316	2564	1543	3722
905_18:2, linoleic acid (LA)	905_18:2, linoleic acid (LA)	25	117	1	908	2054	3906	4022	2826	1875	351	1677	3009	1725	499	2717	2148	366	2568	975	117	4147
3905_Intraocular pressure	3905_Intraocular pressure	25	117	1	4048	4142	3937	3824	1193	3811	3305	1516	1990	1669	4061	3866	3244	3949	4588	584	3687	117
1013_Vascular endothelial growth factor	1013_Vascular endothelial growth factor	25	118	1	118	2836	4349	3656	436	1979	3302	820	4055	250	2574	3022	2713	1191	1034	2975	407	1035
2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	2382_ADAMTS1 - A disintegrin and metalloproteinase with thrombospondin motifs 1	25	118	1	1540	4269	2645	2387	118	1936	942	1220	138	1491	4496	2089	4375	3367	4421	3416	935	800
1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	1045_Bone Ultrasound Speed (GEE, adjusted for multivariable)	25	118	1	154	1565	1743	892	3983	404	118	343	786	1492	869	1594	1934	3617	3664	4626	4520	3000
4363_Strenuous sports or other exercises	4363_Strenuous sports or other exercises	25	118	1	1509	3255	3927	4134	3137	4027	4234	2309	118	4108	2801	3859	2230	1507	2454	1416	3620	1611
1215_Alcohol consumption (female)	1215_Alcohol consumption (female)	25	118	1	3428	3702	2128	3921	140	2303	2615	693	636	1039	2717	1028	3921	118	744	3782	356	3472
3523_Current employment status: Doing unpaid or voluntary work	3523_Current employment status: Doing unpaid or voluntary work	25	118	1	2826	1719	4738	4686	3658	2427	4128	1789	2174	1768	1355	2374	2159	1316	1393	2777	118	1162
1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	1738_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, FBAT, adjusted for age and sex)	25	118	1	569	444	145	3568	3961	3741	1701	3446	159	393	4451	2562	3240	3480	443	2263	2918	118
1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	1295_Diabetes incidence (GEE, adjusted for age, sex and BMI)	25	119	1	119	1369	4423	2757	307	3406	1531	1121	4138	4405	2569	2001	3413	3263	1011	1494	3871	742
2779_HSPA8 - Heat shock cognate 71 kDa protein	2779_HSPA8 - Heat shock cognate 71 kDa protein	25	119	1	2929	3492	119	3776	735	1520	3878	1002	2288	3834	1797	4351	4197	685	3039	2276	2492	2127
3293_Suffer from 'nerves'	3293_Suffer from 'nerves'	25	119	1	4037	246	2307	2509	4416	743	119	2149	236	1365	3750	954	2189	838	3185	1984	2699	2652
2794_PES1 - Pescadillo homolog	2794_PES1 - Pescadillo homolog	25	119	1	4360	3844	793	3142	541	2763	516	2280	4466	119	222	4193	3740	1714	3984	3269	1657	2932
164_Hip circumference (male, adjusted for BMI)	164_Hip circumference (male, adjusted for BMI)	25	119	1	1430	2970	3868	998	1864	4574	1225	1338	523	4625	119	3228	2958	751	4375	2422	2818	454
1218_Alcohol consumption (dichotomous, female)	1218_Alcohol consumption (dichotomous, female)	25	119	1	125	3995	454	4640	3861	604	2328	2652	3756	1900	269	119	3301	2105	284	3856	2113	1620
3545_Mouth/teeth dental problems: Painful gums	3545_Mouth/teeth dental problems: Painful gums	25	119	1	1002	4093	1544	3215	2072	2139	3370	2584	3190	267	948	2119	2646	230	119	899	4232	4129
1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1416_High-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	119	1	3618	1120	1726	4584	1171	3954	4205	4217	1359	4734	4572	358	4481	1766	2820	119	3416	2686
2164_PROS1 - Vitamin K-dependent protein S	2164_PROS1 - Vitamin K-dependent protein S	25	119	1	4412	3908	3716	3930	1221	1883	2874	3938	391	2022	4071	1178	4406	1679	3927	4480	2503	119
579_Lipid::Sterol, Steroid::lathosterol	579_Lipid::Sterol, Steroid::lathosterol	25	120	1	120	1257	3368	221	415	2531	1424	2319	129	4343	934	3480	1037	4460	239	2914	1559	2231
404_Amino acid::Tryptophan metabolism::indoleacetate	404_Amino acid::Tryptophan metabolism::indoleacetate	25	120	1	4298	120	3405	1006	1576	3100	894	3041	1253	1731	1482	1850	4050	2943	1059	2398	1062	1382
3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	3589_Types of physical activity in last 4 weeks: Heavy DIY (eg: weeding, lawn mowing, carpentry, digging)	25	120	1	2793	4475	120	642	4172	4306	1014	1078	2689	536	3323	3812	2711	2731	1237	3891	4374	2164
2356_GDF9 - Growth/differentiation factor 9	2356_GDF9 - Growth/differentiation factor 9	25	120	1	1644	1112	1027	120	859	3201	1895	1804	2762	3043	356	2853	961	4724	574	442	1719	3024
3382_Prospective memory test - Duration screen displayed	3382_Prospective memory test - Duration screen displayed	25	120	1	2081	454	1891	1171	3760	120	2636	3977	2149	862	1937	4713	2138	1431	2675	268	2524	316
3313_Hearing difficulty/problems	3313_Hearing difficulty/problems	25	120	1	1684	2310	974	4696	4240	4694	120	660	2277	974	3691	3523	1487	2651	3571	853	3821	3106
1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	1452_Low-density lipoprotein cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	120	1	2537	2881	4324	752	290	1184	3972	3022	2574	120	1270	3929	1367	2056	1597	1688	752	2012
1987_Age at natural menopause (GEE)	1987_Age at natural menopause (GEE)	25	120	1	527	773	3485	2520	349	4516	1733	1580	2903	870	120	3026	2717	3313	1152	3960	1138	1193
1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	1621_CD40 Ligand serum (at exam 7, GEE, adjusted for multivariable)	25	120	1	1908	2076	1965	1176	362	3151	2626	537	280	547	3679	120	528	1389	1339	604	1970	4045
4734_Uncinate fasciculus mode of anisotropy	4734_Uncinate fasciculus mode of anisotropy	25	120	1	4147	3792	3412	1443	4718	3281	3464	4354	651	2507	581	4740	3483	1910	120	2949	3579	2003
3390_Financial situation satisfaction	3390_Financial situation satisfaction	25	120	1	1871	2070	2551	4070	3211	2144	4065	1007	2165	1872	254	3205	2561	4319	1391	120	3727	3776
4577_Right caudal anterior cingulate	4577_Right caudal anterior cingulate	25	121	1	121	1310	1078	2450	1523	516	4152	2422	2434	849	3054	144	2027	4580	2378	4646	3113	3585
4343_Sleep sedentary	4343_Sleep sedentary	25	121	1	2475	3462	121	1952	146	184	4003	1637	1350	514	343	4610	3467	3129	1871	2417	4258	199
235_CD123 on mDC	235_CD123 on mDC	25	121	1	3562	3713	1928	4400	121	2216	751	297	558	1834	922	391	2547	4706	2999	136	1833	2679
2480_DKK4 - Dickkopf-related protein 4	2480_DKK4 - Dickkopf-related protein 4	25	121	1	2785	1064	2452	2985	4065	121	4153	548	229	1412	2461	1968	3902	1871	2983	2481	3984	1065
4732_Superior longitudinal fasciculus mode of anisotropy	4732_Superior longitudinal fasciculus mode of anisotropy	25	121	1	2722	3298	485	2891	389	3221	121	4270	4438	2884	2150	410	3205	1452	1318	4365	260	774
2264_CD22 - B-cell receptor CD22	2264_CD22 - B-cell receptor CD22	25	121	1	2853	3381	1330	2597	149	309	2609	121	4105	3864	1330	4453	834	2369	3079	4400	4722	1159
3394_Ever unenthusiastic/disinterested for a whole week	3394_Ever unenthusiastic/disinterested for a whole week	25	121	1	1357	4407	3962	2564	4435	1795	2058	4249	121	2099	1978	4335	3279	3530	2075	786	2172	3116
1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	1526_Remnant lipoprotein cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	121	1	827	3029	4141	498	3486	4589	1951	1757	682	2600	1026	1536	682	121	3534	3405	3243	1574
1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	1980_Walking speed (at offspring exam 7 cohort exam 27, FBAT)	25	121	1	4105	1147	3649	1476	3448	1873	832	554	224	4041	2729	3412	4718	4164	121	310	3095	271
3032_FAP - Seprase	3032_FAP - Seprase	25	121	1	3106	2796	1059	317	224	1864	248	779	2133	365	1785	528	1593	3102	660	121	3022	2691
1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	1725_Serum calcium (at exam 2, GEE, adjusted for age, sex and serum creatinine)	25	122	1	122	3707	1134	1924	3625	3627	762	1818	3684	2634	3505	2760	2125	1428	413	575	739	3092
3314_Hearing difficulty/problems with background noise	3314_Hearing difficulty/problems with background noise	25	122	1	1631	3141	2620	3552	3813	3608	1610	122	2966	1859	308	4418	2604	2777	2222	1407	4000	3108
1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	1660_Alkaline phosphatase (at exam 2, FBAT, adjusted for multivariable)	25	122	1	3728	191	2604	2093	1631	4680	2477	4012	3682	2381	122	354	1702	3077	3743	1256	1853	2823
1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	1961_Mean MMSE score for exam 5 and 7 (GEE, adjusted for multivariable)	25	122	1	472	1511	981	2106	3440	3436	2189	834	340	371	3868	122	619	1785	1308	4572	2386	1054
863_Double bonds in fatty acids	863_Double bonds in fatty acids	25	122	1	1912	3456	3364	2551	1120	680	1128	4650	3809	1929	274	346	2555	1976	2502	2958	122	3437
4016_Central corneal thickness	4016_Central corneal thickness	25	123	1	2653	123	2308	3886	1916	3964	2066	3995	814	1089	2292	1639	4118	3233	3249	1403	916	3832
381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	381_Amino acid::Glycine, serine and threonine metabolism::N-acetylglycine	25	123	1	4438	2159	3395	123	1740	4313	4171	3605	3125	1130	1292	4060	540	3322	2705	2455	198	1511
3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	3153_HNRNPA2B1 - Heterogeneous nuclear ribonucleoproteins A2/B1	25	123	1	2762	2275	3455	1268	123	4629	1071	905	3350	2485	3102	1287	1540	4356	3460	4017	1104	2386
2052_Age-related Macular Degeneration	2052_Age-related Macular Degeneration	25	123	1	3748	2024	1010	1945	488	1646	865	124	123	3963	3196	3628	563	3080	2630	1782	2705	136
3442_Impedance measures - Whole body fat mass	3442_Impedance measures - Whole body fat mass	25	123	1	1502	2086	4516	3570	781	4106	4026	4353	1961	123	4531	499	996	2167	4173	3950	4087	3245
3423_Trail making test - Duration to complete alphanumeric path (trail #2)	3423_Trail making test - Duration to complete alphanumeric path (trail #2)	25	123	1	3041	2081	3296	3894	2576	2164	4387	838	4550	3949	123	3867	2592	2564	2547	491	157	1416
2988_DPT - Dermatopontin	2988_DPT - Dermatopontin	25	123	1	4670	2075	2196	1061	3039	2268	3336	3285	3082	819	3733	2141	3735	123	1493	2159	1440	4320
991_Interleukin-4	991_Interleukin-4	25	123	1	3020	862	3001	4236	145	941	4296	422	1642	1800	764	548	4661	4414	123	3215	3517	1391
3030_RPS3 - 40S ribosomal protein S3	3030_RPS3 - 40S ribosomal protein S3	25	123	1	1920	1759	2818	1615	2185	265	677	756	1401	4546	3848	4261	734	858	1560	123	2223	310
1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	1327_Fasting insulin (at exam 5, GEE, adjusted for age, sex and BMI)	25	123	1	2172	1213	3967	3899	1155	3425	3982	1901	540	1092	1253	3868	4251	192	1098	453	4670	123
788_::::X-12645	788_::::X-12645	25	124	1	4189	124	876	2460	3414	4317	948	716	2314	2020	902	3544	1873	4365	3495	203	3165	448
2207_CCL3L1 - C-C motif chemokine 3-like 1	2207_CCL3L1 - C-C motif chemokine 3-like 1	25	124	1	701	2518	2887	3950	124	3678	446	1857	1867	230	1083	2731	1182	294	1492	2199	701	3734
1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1784_PR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	124	1	2650	1906	4153	4705	4011	124	1965	2145	906	124	3213	1820	2564	1493	1827	4538	2352	3817
59_Childhood IQ	59_Childhood IQ	25	124	1	3482	4225	3250	2651	2862	3845	124	305	1421	3010	871	1091	4077	2305	1696	2822	1913	3220
1319_Resistin (GEE, adjusted for age and sex)	1319_Resistin (GEE, adjusted for age and sex)	25	124	1	3427	1537	4656	3947	370	1861	1857	1455	124	4069	654	3603	3865	2160	958	239	1284	1053
1187_Parkinson disease	1187_Parkinson disease	25	124	1	4386	4486	3394	2934	3343	4434	2619	3293	1387	1617	124	4363	860	267	1046	701	4537	397
2217_ACVR1B - Activin receptor type-1B	2217_ACVR1B - Activin receptor type-1B	25	124	1	4128	2784	1676	722	2795	135	4243	2987	586	255	1427	3870	124	3554	987	3228	2241	575
140_Waist-hip ratio (male, adjusted for BMI)	140_Waist-hip ratio (male, adjusted for BMI)	25	124	1	3917	3168	1114	1563	4176	1494	1143	2253	3002	4171	784	1060	4225	565	124	2380	1045	2359
3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	3156_TNFSF14 - Tumor necrosis factor ligand superfamily member 14	25	124	1	2570	1053	2404	3735	1578	819	827	1719	401	2404	994	4037	3687	624	1225	124	231	152
1190_Mitral annular calcification	1190_Mitral annular calcification	25	124	1	4323	2203	4019	1397	2955	4454	4449	3706	2541	2066	1186	4527	4440	4734	2240	2110	124	2457
1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	1706_Luteinizing hormone (at exam 3, FBAT, adjusted for age and sex)	25	125	1	4614	125	2573	569	4364	547	3968	3940	2859	1078	4124	2676	496	2647	3607	1007	2531	3120
2403_KLK13 - Kallikrein-13	2403_KLK13 - Kallikrein-13	25	125	1	3373	1258	2536	125	1345	4562	3547	1646	3301	4013	452	662	1355	3585	1935	4712	3197	4210
398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	398_Amino acid::Phenylalanine & tyrosine metabolism::phenylacetylglutamine	25	125	1	3947	1022	1825	731	125	2496	755	3893	3228	2628	2651	1498	245	2353	492	4097	2743	1982
1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1453_Low-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	125	1	579	382	1270	654	4095	2770	153	125	4448	3236	1323	4045	365	3356	3301	568	4332	1226
262_CD8:%Naive	262_CD8:%Naive	25	125	1	4031	175	1013	2738	3300	808	1948	481	4406	125	2489	4053	3870	670	4632	4532	4086	2710
1123_Subcutaneous adipose tissue attenuation	1123_Subcutaneous adipose tissue attenuation	25	125	1	1479	397	842	3779	3748	674	1188	1754	1498	4086	2751	3948	4100	1738	4068	125	375	2089
3852_Mean corpuscular volume (two-way meta)	3852_Mean corpuscular volume (two-way meta)	25	125	1	4186	2871	2548	1932	1788	4458	2230	1568	2056	4172	4192	827	1127	882	4290	1160	125	1926
2321_TSLP - Thymic stromal lymphopoietin	2321_TSLP - Thymic stromal lymphopoietin	25	126	1	126	2450	3180	1588	3422	804	929	339	538	2115	2151	2807	1287	1775	4122	948	4665	4473
1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	1548_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for multivariable)	25	126	1	3202	126	1133	1245	1652	882	3343	218	1034	513	2509	4304	3563	1990	526	588	151	4638
3252_Bread intake	3252_Bread intake	25	126	1	4455	156	126	643	2520	372	2503	480	390	150	2022	437	3941	938	255	916	3025	2267
3291_Tense / 'highly strung'	3291_Tense / 'highly strung'	25	126	1	2571	595	1633	3989	4431	126	2581	1478	4517	2641	3198	745	4120	2418	1303	2355	4572	1205
2272_APOE - Apolipoprotein E (isoform E3)	2272_APOE - Apolipoprotein E (isoform E3)	25	126	1	182	649	4599	4451	1052	1483	126	4272	4310	1175	1396	231	4207	1771	3828	1631	4305	1178
3733_Depression - Thoughts of death during worst depression	3733_Depression - Thoughts of death during worst depression	25	126	1	3712	306	347	4521	2658	445	4425	146	126	351	2891	2344	2730	2558	1330	4300	1715	3454
4273_Long sleep	4273_Long sleep	25	126	1	905	4739	1415	3655	1542	4468	4221	2478	1623	126	2254	2552	4244	4156	3258	1931	1745	1245
152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	152_Waist-hip ratio (male <= 50 yrs, adjusted for BMI)	25	126	1	2613	3223	461	1125	3999	1088	3234	520	1078	2681	126	3291	2817	2554	320	3803	1482	2000
2431_CD48 - CD48 antigen	2431_CD48 - CD48 antigen	25	126	1	4215	1591	4490	2025	1496	4266	1743	2160	4104	3317	4444	2085	1255	126	415	1863	1291	1547
1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1373_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	126	1	3139	2378	1127	3126	2825	249	3033	457	951	3477	1881	1018	889	3392	136	1871	1343	126
1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	1641_Myeloperoxidase (at exam 7, GEE, adjusted for multivariable)	25	127	1	1018	2096	2138	2120	236	127	3778	1582	4176	492	454	541	3212	3824	2689	1989	4660	2613
2104_PRL - Prolactin	2104_PRL - Prolactin	25	127	1	2309	2102	1875	507	3680	3893	127	2720	2105	2774	510	3318	2254	1658	3587	958	3879	1113
1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	1544_White matter hyperintensity volume (FBAT, adjusted for multivariable)	25	127	1	178	1183	1856	866	4063	2129	1107	588	1083	715	389	1379	127	3430	1311	2523	3889	4402
108_Coronary artery disease	108_Coronary artery disease	25	127	1	2627	358	2410	1185	3192	2120	4062	2416	2699	915	163	2199	813	127	1287	4394	419	161
1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1433_High-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	127	1	253	2291	4702	1183	2517	2049	2548	4487	240	3314	4397	1659	486	2295	127	421	3967	2303
3995_Fed-up feelings (FED_UP)	3995_Fed-up feelings (FED_UP)	25	127	1	1345	2532	4300	3733	2905	1309	4118	1296	1744	4333	3354	349	4632	4314	1435	4564	1701	127
3924_Heart rate variability (pvRSA/HF)	3924_Heart rate variability (pvRSA/HF)	25	128	1	4541	128	3383	145	4531	4716	2834	1827	4475	2309	214	4122	2080	1681	549	1524	3449	1847
1126_Visceral adipose tissue sttenutation	1126_Visceral adipose tissue sttenutation	25	128	1	2647	612	128	3384	3560	4177	3117	3177	3876	1345	1648	2653	865	3922	277	3668	2314	835
2747_CCL13 - C-C motif chemokine 13	2747_CCL13 - C-C motif chemokine 13	25	128	1	1688	1800	1334	1303	128	4642	2340	4229	4498	909	2093	1035	1134	4611	1842	3834	1659	2741
3881_High light scatter percentage of red cells (three-way meta)	3881_High light scatter percentage of red cells (three-way meta)	25	128	1	4221	2904	2591	3214	4714	128	3931	2921	4437	151	2524	2953	516	352	3838	430	641	502
689_::::X-11247	689_::::X-11247	25	128	1	3507	1728	3816	2784	555	4437	3649	3049	2816	128	2607	2234	1741	4232	2804	4417	2664	1855
3880_Hemoglobin concentration (three-way meta)	3880_Hemoglobin concentration (three-way meta)	25	128	1	4715	722	596	3931	3078	2087	3303	4134	2183	1629	128	1826	1259	4113	3242	1360	1312	3381
231_mDC (2):%CD1c-	231_mDC (2):%CD1c-	25	128	1	1582	1242	1199	2843	3670	3645	489	4350	1390	2081	4278	128	1139	2307	3274	2137	2360	1167
3830_Amyotrophic lateral sclerosis (meta-analysis)	3830_Amyotrophic lateral sclerosis (meta-analysis)	25	128	1	2001	2867	2364	921	3815	1721	3889	3700	4327	2300	397	1246	128	4074	4620	2392	4411	726
303_CD4mem:%Th1* (4)	303_CD4mem:%Th1* (4)	25	128	1	370	2574	3950	1633	2128	3904	4220	1286	305	2282	2488	3951	188	128	1703	1794	3609	3808
4716_Body of corpus callosum mode of anisotropy	4716_Body of corpus callosum mode of anisotropy	25	128	1	764	4013	681	1807	1670	2706	274	2520	461	3942	4108	2241	4228	2803	128	3630	2884	2152
1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1794_RR interval (cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	128	1	1149	1067	2123	3818	4374	1261	582	167	1760	2294	2356	3886	1986	2200	2948	3049	3374	128
3089_ICAM5 - Intercellular adhesion molecule 5	3089_ICAM5 - Intercellular adhesion molecule 5	25	129	1	129	2425	882	608	3035	1320	2083	1456	4148	2149	268	3950	4204	1301	222	954	2914	2142
4750_Retrolenticular part of internal capsule radial diusivities	4750_Retrolenticular part of internal capsule radial diusivities	25	129	1	2870	1793	4525	3907	2931	129	2468	2869	3131	1454	613	4160	3576	371	4502	3675	3232	1281
2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	2775_EPS15L1 - Epidermal growth factor receptor substrate 15-like 1	25	129	1	432	152	3192	1313	4683	4611	144	1939	4223	129	2656	4612	1067	1240	2131	303	1374	1830
190_Waist-hip ratio (female, adjusted for BMI)	190_Waist-hip ratio (female, adjusted for BMI)	25	129	2	345	1548	4316	177	3368	217	3592	912	1595	1698	4079	129	3245	1515	977	2431	3524	3401
532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	532_Lipid::Lysolipid::1-arachidonoylglycerophosphoinositol*	25	129	1	2787	3160	3268	1603	2642	4526	2223	2885	1732	1817	231	1856	944	1876	1861	3076	129	3053
4268_Atrial Fibrillation	4268_Atrial Fibrillation	25	129	1	4013	360	2002	1862	352	2231	3171	3559	4706	4564	1558	4682	3025	935	982	2180	297	129
3874_Eosinophil count (three-way meta)	3874_Eosinophil count (three-way meta)	25	130	1	130	3764	3675	2589	1644	1711	2773	3951	1014	1711	4097	1963	2231	2036	1939	2561	4257	1460
1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1804_PNN50 HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	130	1	1403	130	3665	1627	4281	3725	3613	2360	1973	1531	2373	419	2090	2024	1236	4473	1297	2128
2040_Attention function - Excutive function - Child	2040_Attention function - Excutive function - Child	25	130	1	3412	2460	986	130	302	2965	1543	4641	1748	3198	4305	3792	1571	1355	2713	507	3976	4547
3223_Length of mobile phone use	3223_Length of mobile phone use	25	130	1	1772	3927	169	2243	3421	130	4008	2893	1680	231	3043	3857	2582	4360	2384	613	4457	1351
1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1542_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	130	1	4654	876	2290	884	2032	4607	1554	130	544	2260	1541	2870	975	3892	1412	1592	3261	972
649_Xenobiotics::Xanthine metabolism::theophylline	649_Xenobiotics::Xanthine metabolism::theophylline	25	130	1	1595	1412	1347	3753	3309	2289	2229	1179	2979	2548	637	3448	3407	130	1961	1410	533	1371
473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	473_Lipid::Bile acid metabolism::taurolithocholate 3-sulfate	25	130	1	4335	619	1870	4516	2929	4408	4053	1124	4640	4095	3577	160	3358	3862	3285	1955	2934	130
1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	1638_Myeloperoxidase (at exam 7, FBAT, adjusted for age and sex)	25	131	1	2185	131	2888	2850	1135	1828	206	1057	2414	3781	206	3131	583	4283	3848	2870	225	2939
4436_Herpes simplex virus 1 IgG levels	4436_Herpes simplex virus 1 IgG levels	25	131	1	4408	3660	3283	410	4621	914	131	925	914	4072	1105	4214	3258	483	2564	2790	1299	269
2224_COMMD7 - COMM domain-containing protein 7	2224_COMMD7 - COMM domain-containing protein 7	25	131	1	3459	4559	1450	603	2756	3222	175	131	2144	1844	2328	2916	2276	1175	1976	2566	2129	665
584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	584_Nucleotide::Purine metabolism, guanine containing::7-methylguanine	25	131	1	412	2037	1666	3728	2195	1426	137	491	2804	1490	131	4622	4531	1742	4738	2581	989	513
3974_Total body BMD (30-45 years old)	3974_Total body BMD (30-45 years old)	25	131	1	4346	3470	1962	1934	311	2834	2494	545	3044	308	3363	1216	2453	2021	131	3806	3061	3549
3422_Trail making test - Duration to complete numeric path (trail #1)	3422_Trail making test - Duration to complete numeric path (trail #1)	25	131	1	2142	812	224	3847	428	3078	3448	3078	3189	1708	3439	219	504	2015	265	168	3031	131
3809_Monocyte count	3809_Monocyte count	25	132	1	132	3016	1119	782	945	1665	532	2826	855	3258	4545	2033	4138	4498	2942	2719	4428	3637
2367_AURKA - Aurora kinase A	2367_AURKA - Aurora kinase A	25	132	1	3086	288	2441	2719	1789	132	1875	4255	151	1559	4557	615	3789	3225	2851	4229	4524	1152
2093_CCL5 - C-C motif chemokine 5	2093_CCL5 - C-C motif chemokine 5	25	132	1	2809	2016	1677	727	1167	3228	2214	132	3917	4311	4419	766	3672	2568	3656	1635	2581	4315
3267_Alcohol usually taken with meals	3267_Alcohol usually taken with meals	25	132	1	3387	3689	219	1216	4061	2336	4006	3350	132	1211	4036	1867	3749	4422	3128	4005	2161	980
440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	440_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,6-anhydroglucose	25	132	1	2636	638	1955	1865	3752	4268	3486	891	647	132	2605	2469	3655	894	431	3912	625	164
4305_Trunk-trunk fat ratio (male)	4305_Trunk-trunk fat ratio (male)	25	132	1	855	2277	4445	1671	4440	1593	891	4549	1025	4403	972	3406	1827	132	2505	3550	1590	3559
1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	1599_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for age and sex)	25	132	1	4519	135	3024	1293	513	1045	2885	3140	4664	949	2886	4279	1723	3174	132	3075	1626	2528
2516_EPHA1 - Ephrin type-A receptor 1	2516_EPHA1 - Ephrin type-A receptor 1	25	132	1	3032	3465	3003	2953	3920	2347	756	1080	1776	1018	1979	774	4068	198	2122	2629	1047	132
4421_Herpes simplex virus 1 seropositivity	4421_Herpes simplex virus 1 seropositivity	25	133	1	2198	2091	200	745	133	2631	4281	1651	3883	1152	1437	865	3746	3588	1291	1110	3069	924
1888_Shaft Width (FBAT, female, adjussted for age)	1888_Shaft Width (FBAT, female, adjussted for age)	25	133	1	2840	203	1787	984	278	344	133	724	4465	2314	315	2154	4024	1924	266	1995	2034	796
2340_CCL18 - C-C motif chemokine 18	2340_CCL18 - C-C motif chemokine 18	25	133	1	4555	2567	3696	2138	4654	3735	779	133	3504	986	977	3688	3571	2364	3278	4302	3068	1563
4443_Epstein Barr Virus antigen VCA IgG levels	4443_Epstein Barr Virus antigen VCA IgG levels	25	133	1	3832	4453	3374	2210	1248	2949	2001	536	133	619	150	1282	2824	414	638	2020	338	1085
2662_EPHA5 - Ephrin type-A receptor 5	2662_EPHA5 - Ephrin type-A receptor 5	25	133	1	1970	4645	298	4189	4413	2250	3913	517	769	133	1759	324	1915	1402	382	4015	1434	1747
1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	1577_Maximum coronary artery calcification - Agatston score (at exam 7, GEE, adjusted for age and sex)	25	133	1	1576	2313	214	257	2319	3360	2687	306	1059	4482	284	133	4240	822	322	202	532	717
3230_Morning/evening person (chronotype)	3230_Morning/evening person (chronotype)	25	133	1	634	774	1850	3282	2164	2550	3179	356	739	1079	1098	4374	4722	3289	133	4115	1195	2378
892_Total cholesterol in large LDL	892_Total cholesterol in large LDL	25	133	2	2015	528	4440	2072	2636	4023	1905	1263	3804	3991	2261	1062	4595	3810	3109	133	1975	1081
1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1527_Remnant lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	133	1	3593	746	4210	1018	2783	3833	895	997	3994	1247	873	2002	672	437	504	3435	133	3951
1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	1238_Rate of decline FEF25-75 (FBAT, adjusted for multiple covariates)	25	133	1	4450	4115	364	1001	2368	1657	2641	3611	3948	137	3455	884	546	477	981	489	2090	133
3951_Amyotrophic lateral sclerosis (LMM)	3951_Amyotrophic lateral sclerosis (LMM)	25	134	1	2982	2489	811	134	3280	4250	1981	4048	2834	3339	1873	2495	176	1526	3500	2888	3299	4435
3457_Impedance measures - Leg fat mass (left)	3457_Impedance measures - Leg fat mass (left)	25	134	1	2023	4398	4536	2370	134	3950	4239	3876	1580	166	4534	673	2052	4044	3260	1985	4333	768
4556_Left lingual	4556_Left lingual	25	134	1	2859	3606	4397	812	3378	134	3061	1371	1052	3901	1365	2828	4003	484	2156	810	2363	2647
623_Xenobiotics::Drug::4-acetaminophen sulfate	623_Xenobiotics::Drug::4-acetaminophen sulfate	25	134	1	1816	1180	1376	3542	2701	2811	242	4412	134	1665	4357	901	1892	1562	912	2934	3497	1196
4718_Cingulum (hippocampus) mode of anisotropy	4718_Cingulum (hippocampus) mode of anisotropy	25	134	1	3883	1705	3053	3260	1609	2402	3158	3493	2960	1154	1728	134	3412	4292	3494	3749	2733	420
1117_Pericardial adipose tissue volume	1117_Pericardial adipose tissue volume	25	134	1	1289	1007	4057	3037	1320	167	204	4020	1590	3931	1432	2665	134	1514	932	2332	2758	223
4238_Antiglaucoma preparations and miotics	4238_Antiglaucoma preparations and miotics	25	134	1	3608	3103	733	1300	2126	4164	2281	4592	262	4148	2397	2863	2850	134	800	3176	2894	214
2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	2810_PTPN6 - Tyrosine-protein phosphatase non-receptor type 6	25	134	1	3915	1261	4296	4248	339	1859	1532	164	3987	2560	2837	1739	966	2686	134	3165	4023	3319
1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	1484_Mean triglycerides from exam 1-7 (FBAT, adjusted for multivariable)	25	134	1	2487	3034	1708	1291	1106	980	2862	1711	2213	391	504	2156	1725	3048	2100	1983	134	4283
3848_Lymphocyte count (two-way meta)	3848_Lymphocyte count (two-way meta)	25	134	1	301	3711	1139	2786	3652	360	2542	3633	1225	4416	1551	3275	722	1903	2162	1731	4506	134
1129_Ratio of visceral-tosubcutaneous adipose tissue volume	1129_Ratio of visceral-tosubcutaneous adipose tissue volume	25	135	1	2676	3722	135	3334	1186	4083	517	1307	1667	220	4254	1587	2820	1168	3702	3699	3129	1534
409_Amino acid::Tryptophan metabolism::tryptophan	409_Amino acid::Tryptophan metabolism::tryptophan	25	135	1	3413	4736	2842	446	135	2972	1585	3917	2917	341	1938	2810	2690	3487	631	3013	483	1386
2533_POSTN - Periostin	2533_POSTN - Periostin	25	135	1	3603	3679	1526	2325	2486	3912	2293	135	514	2546	675	2974	3454	2027	1502	463	3587	1774
3826_Osteoarthritis of knee	3826_Osteoarthritis of knee	25	135	1	4338	4272	3734	2731	3751	1891	2782	2414	135	3598	914	906	708	282	517	976	2762	771
3307_Overall health rating	3307_Overall health rating	25	135	1	1841	340	3035	2591	3645	1884	1718	4711	1256	135	2222	3014	2176	961	3853	680	285	565
3022_PRDX5 - Peroxiredoxin-5, mitochondrial	3022_PRDX5 - Peroxiredoxin-5, mitochondrial	25	135	1	486	2022	1674	2711	1180	4424	2008	1914	3968	3750	4271	135	3814	1396	1015	2168	1869	918
1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	1707_Luteinizing hormone (at exam 3, GEE, adjusted for age and sex)	25	135	1	4567	2947	1796	1213	2165	2213	181	3221	2562	3525	4393	3186	135	2939	4744	902	1570	382
2071_APOE - Apolipoprotein E	2071_APOE - Apolipoprotein E	25	135	1	2276	2819	3114	3119	2921	3046	556	3592	2769	3673	3726	4087	3238	135	594	797	2087	4209
1057_Major depressive disorder	1057_Major depressive disorder	25	135	1	1081	3464	1746	1431	2939	2125	2258	3939	3998	984	519	2090	1912	322	135	3235	3541	2069
3209_Duration of vigorous activity	3209_Duration of vigorous activity	25	135	1	1052	1513	140	2016	1974	961	3690	2661	201	4668	296	3005	1833	2868	3893	1320	135	1285
228_Lymph:%DP T	228_Lymph:%DP T	25	135	1	2765	3085	4148	3328	2119	1794	663	4374	1496	3524	1594	933	2967	1313	1992	2019	956	135
1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	1237_Usual weekday sleep duration (GEE, adjusted for age, sex and BMI)	25	136	1	1412	136	349	4033	2997	4330	4454	1665	1686	1125	3117	2926	3401	1875	3813	4292	2923	1888
2151_TDGF1 - Teratocarcinoma-derived growth factor 1	2151_TDGF1 - Teratocarcinoma-derived growth factor 1	25	136	1	1733	2595	136	3965	3678	4472	2711	582	2532	2550	779	508	185	2681	3364	1766	4249	317
1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	1639_Myeloperoxidase (at exam 7, GEE, adjusted for age and sex)	25	136	1	1211	2420	4179	1526	229	136	4651	689	4151	647	538	572	3425	3767	2934	1697	4386	3613
2363_RARRES2 - Retinoic acid receptor responder protein 2	2363_RARRES2 - Retinoic acid receptor responder protein 2	25	136	1	2009	1462	1582	2293	4253	687	1490	980	362	136	3652	1902	2044	202	3812	971	3330	218
3241_Salad / raw vegetable intake	3241_Salad / raw vegetable intake	25	136	1	3784	1551	1380	690	1914	1234	3702	1272	3168	410	3867	136	3309	2890	2510	1624	1615	727
769_::::X-12253	769_::::X-12253	25	136	1	1492	3962	3465	3217	747	521	227	4247	2031	3401	4406	960	136	2768	4684	3709	3753	597
1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	1812_Biologic age by osseographic scoring system (FBAT, adjusted for multivariable)	25	136	1	3479	1187	154	2860	361	793	3572	2714	2342	1026	602	384	4741	136	2973	1599	2729	873
3655_Smoking status: Previous vs Current	3655_Smoking status: Previous vs Current	25	137	1	137	916	1189	420	3651	1914	288	1173	2847	2835	1652	1473	1895	2744	3861	647	637	3427
3361_Neck/shoulder pain for 3+ months	3361_Neck/shoulder pain for 3+ months	25	137	1	4712	137	2189	3664	3575	1585	395	195	684	3509	1328	1868	1506	518	345	4190	3017	2360
2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	2899_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 27	25	137	1	785	3839	4351	137	1316	2827	1614	4635	3575	3180	2780	4311	401	472	3962	1602	4351	2673
4324_Positive affect (MA GWAMA)	4324_Positive affect (MA GWAMA)	25	137	1	796	4048	4262	3103	2305	137	776	3157	2913	1752	3877	2148	3262	2366	3611	628	477	1041
165_Hip circumference (female, adjusted for BMI)	165_Hip circumference (female, adjusted for BMI)	25	137	1	1592	758	4735	503	3915	4384	3558	1210	137	4001	720	4683	4282	1649	3009	3796	2057	1895
4261_Facial attractiveness (male-coder, female samples)	4261_Facial attractiveness (male-coder, female samples)	25	137	1	4008	790	1286	3068	2237	678	2013	1522	4093	4572	4461	137	3173	425	4138	2107	898	1091
4721_Fornix (column and body of fornix) mode of anisotropy	4721_Fornix (column and body of fornix) mode of anisotropy	25	137	1	4333	2756	3137	3742	1274	660	163	4303	1433	2627	2085	3160	2657	137	1387	2932	846	2333
1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	1270_Epworth Sleepiness Scale (FBAT, adjusted for age, sex and BMI)	25	137	1	2214	4567	2140	2054	1893	949	438	1907	1821	3382	2323	3016	1783	2055	137	3546	3898	616
987_Interleukin-1-beta	987_Interleukin-1-beta	25	137	1	674	3921	960	1387	2674	1183	1613	3428	4328	420	4629	1671	2066	2471	4143	137	1835	3215
3288_Fed-up feelings	3288_Fed-up feelings	25	137	1	777	2648	3680	4278	4389	1244	4582	1082	3066	3906	4237	179	4159	4670	841	3940	1205	137
1192_Refractive error	1192_Refractive error	25	138	1	4076	138	3969	2258	3141	3796	4098	4280	3769	1179	3235	3884	4260	4431	790	1994	1630	4172
1182_Sleep duration (male)	1182_Sleep duration (male)	25	138	1	1801	2398	138	4646	211	2667	1719	210	3972	2311	2709	1919	2196	926	1101	3875	2688	2136
1934_Temporal brain volume (FBAT, adjusted for age and sex)	1934_Temporal brain volume (FBAT, adjusted for age and sex)	25	138	1	494	4056	3109	486	4422	1589	138	1146	3610	183	1923	1758	139	2014	2587	2396	688	1485
2281_PLA2G10 - Group 10 secretory phospholipase A2	2281_PLA2G10 - Group 10 secretory phospholipase A2	25	138	1	2645	607	794	1390	4558	289	2730	375	2573	656	138	3782	270	1043	2172	278	756	434
232_mDC (2):%CD1c+	232_mDC (2):%CD1c+	25	138	1	1448	1271	1255	2497	2994	3840	368	4042	1382	2285	2706	138	1147	3147	3650	3828	3289	1075
2666_FGR - Tyrosine-protein kinase Fgr	2666_FGR - Tyrosine-protein kinase Fgr	25	138	1	1982	311	3742	2530	2747	3851	774	3898	1676	1425	4443	1351	4358	138	3438	2913	3777	2433
2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	2652_ADAM9 - Disintegrin and metalloproteinase domain-containing protein 9	25	138	1	1729	2030	2799	2449	1817	2133	2012	4672	3546	4558	4620	3271	3096	2017	1893	1970	138	1154
1011_Tumor necrosis factor beta	1011_Tumor necrosis factor beta	25	139	1	1191	1139	2783	510	139	1700	3473	2489	2830	3333	4248	3191	2290	1608	1595	2063	3077	3653
2419_SEMA3A - Semaphorin-3A	2419_SEMA3A - Semaphorin-3A	25	139	1	4523	4286	2070	1053	2498	139	1766	2593	3510	3725	4137	2924	4508	2776	4177	1926	1681	1211
3772_Depression - Recent feelings of tiredness or low enery	3772_Depression - Recent feelings of tiredness or low enery	25	139	1	4055	1900	2936	1611	548	679	1644	139	4741	3988	4290	716	2504	4684	3797	2692	3971	1728
354_IgE+B:%27+20-38+	354_IgE+B:%27+20-38+	25	139	1	831	985	2111	1034	2033	1131	4000	959	2211	2336	139	761	2913	2527	734	3509	1414	2363
3860_Neutrophil percentage of white cells (two-way meta)	3860_Neutrophil percentage of white cells (two-way meta)	25	139	1	1722	4527	361	4459	2393	2792	4622	1943	1513	1015	4212	139	3506	2314	3991	3297	1479	4291
4407_Menstrual quality of life impact: Stiff neck	4407_Menstrual quality of life impact: Stiff neck	25	139	1	3865	1763	4055	701	2844	2858	1206	3008	3296	4704	3609	1791	1078	3230	139	939	2853	1918
1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	1700_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for multivariable)	25	139	1	574	1890	249	1048	3653	4743	889	918	4342	718	3639	4542	3743	3484	2818	1260	139	3489
1185_Low-density lipoprotein cholesterol	1185_Low-density lipoprotein cholesterol	25	139	1	3523	1281	2803	1811	3200	2170	185	3178	2761	2007	319	496	4472	1708	787	388	1134	139
3815_CD4:CD8 lymphocyte ratio	3815_CD4:CD8 lymphocyte ratio	25	140	1	2959	140	1906	2720	3990	517	2892	884	4739	550	1835	2492	866	1822	4566	468	3868	2797
4691_Anterior corona radiata mean diusivities	4691_Anterior corona radiata mean diusivities	25	140	1	2045	3570	2775	3115	2807	140	1519	1923	3227	4281	2392	3354	2087	4634	4743	761	2337	1058
3248_Beef intake	3248_Beef intake	25	140	1	3743	2160	174	807	2255	4286	1636	2312	140	3462	3685	4407	3320	1213	223	3193	2193	1691
4222_Beta blocking agents	4222_Beta blocking agents	25	140	1	1151	3379	2153	1115	662	2679	3427	3669	2572	2395	910	3912	427	1672	702	1539	1494	140
3433_Symbol digit substitution test - Duration to entering value	3433_Symbol digit substitution test - Duration to entering value	25	141	1	141	1098	263	4579	2656	964	3539	3076	714	4384	2844	3397	3849	3635	2124	1935	766	4460
3509_Reason for reducing amount of alcohol drunk: Illness or ill health	3509_Reason for reducing amount of alcohol drunk: Illness or ill health	25	141	1	4424	141	2253	487	664	4740	820	3190	3440	2725	3521	3559	916	2583	1137	1500	4268	1050
199_Urinary albumin-to-creatinine ratio (non-diabetic)	199_Urinary albumin-to-creatinine ratio (non-diabetic)	25	141	1	1352	974	141	2721	4048	4171	377	175	2734	1430	3718	3505	4650	3219	3156	4278	824	4568
3778_Traumatic events - Victim of physically violent crime	3778_Traumatic events - Victim of physically violent crime	25	141	1	4726	366	1191	141	1509	4676	1122	733	4600	3460	1146	2521	600	661	2127	1290	1486	146
2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	2318_PTPN1 - Tyrosine-protein phosphatase non-receptor type 1	25	141	1	3285	1300	3106	2498	632	141	1173	1108	3945	2636	1335	260	4357	3152	887	4454	3729	2917
1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	1588_Factor VII (at exam 5, FBAT, adjusted for multivariable)	25	141	1	921	3760	3635	2570	3050	770	141	3473	4426	3553	2965	1437	247	2358	1056	1392	3534	3674
1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	1379_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, GEE, adjusted for age and sex)	25	141	1	1843	2676	4568	3773	1245	4179	2719	4328	3870	141	2874	3067	1586	4532	2807	1405	873	1631
534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	534_Lipid::Lysolipid::1-eicosadienoylglycerophosphocholine*	25	141	1	4635	3219	4734	4499	531	4328	3546	1096	2678	3036	141	1445	3883	4133	2120	2596	575	1966
3232_Sleeplessness / insomnia	3232_Sleeplessness / insomnia	25	141	1	308	3117	3265	4001	1096	4524	376	428	3289	1268	3645	141	4283	3505	4305	1198	2470	3038
4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4056_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	141	1	2606	616	2349	302	3767	3563	2688	2530	1435	4479	1816	3683	141	4089	4353	2124	3642	3888
2317_PDCD1LG2 - Programmed cell death 1 ligand 2	2317_PDCD1LG2 - Programmed cell death 1 ligand 2	25	141	1	2119	1342	4331	950	1595	2863	951	2182	694	532	1972	4651	1843	141	681	2544	542	1424
101_Pubertal growth	101_Pubertal growth	25	141	1	3155	2155	403	3343	4132	1013	3676	1919	2566	2778	2147	4410	2459	911	141	2658	2892	2770
1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	1547_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for age and sex)	25	141	1	3012	2667	3438	1621	226	3918	1893	1888	2556	2337	801	2740	2796	907	334	2004	2396	141
1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	1827_Spine Neck BMD (GEE, female, adjusted for multivariable)	25	142	1	2071	142	2856	544	1550	858	1400	3845	629	590	3037	3916	345	888	838	3846	2197	1859
3360_Hearing aid user	3360_Hearing aid user	25	142	1	4330	2333	142	4472	523	616	257	2635	960	1655	2197	1861	2528	3002	180	2149	1466	3289
3282_Number of full brothers	3282_Number of full brothers	25	142	1	4344	664	2261	142	3688	1841	4553	1036	2648	3946	2673	1012	661	2794	3416	1567	1514	2750
2963_LYZ - Lysozyme C	2963_LYZ - Lysozyme C	25	142	1	1641	1059	1630	4101	686	142	4298	4173	1189	763	587	4235	3184	1498	4286	1941	1469	231
4453_Left lateral occipital	4453_Left lateral occipital	25	142	1	657	256	3531	1302	3572	342	142	346	1107	437	1880	2328	509	1504	3532	3190	4318	1785
3424_Symbol digit substitution test - Number of symbol digit matches made correctly	3424_Symbol digit substitution test - Number of symbol digit matches made correctly	25	142	1	4021	3182	3832	1211	257	3908	3751	142	2099	3033	595	4404	2055	159	1750	1675	239	2080
512_Lipid::Inositol metabolism::scyllo-inositol	512_Lipid::Inositol metabolism::scyllo-inositol	25	142	1	940	1693	2482	3928	4669	546	2439	4023	142	3847	1106	1714	2447	4033	1202	4134	1985	2125
4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	4028_Alcohol dependency (fixed effect model for unrelated genotyped individuals)	25	142	1	350	627	3632	1465	1361	3313	2022	1316	1218	142	4415	2719	204	1660	1615	2650	4109	997
272_CD4:%RTE	272_CD4:%RTE	25	142	1	522	1575	2139	4182	3381	1434	214	156	3105	2495	142	2557	4335	1859	600	982	3173	2352
3789_Morningness	3789_Morningness	25	142	1	841	1248	3339	3168	2800	3156	3682	862	1008	1517	1609	4503	3761	4464	142	3654	1098	1795
1105_Systolic Blood Pressure - Birth cohorts	1105_Systolic Blood Pressure - Birth cohorts	25	142	1	4637	4667	2082	1684	1260	2937	1132	1536	1075	3529	1030	2681	856	1874	703	142	1793	3267
1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	1496_Triglycerides (at exam 1, FBAT, adjusted for multivariable)	25	142	1	2772	2447	4313	1079	3732	493	1836	313	4377	367	1882	2514	2255	3043	1475	1784	142	1446
3884_Lymphocyte count (three-way meta)	3884_Lymphocyte count (three-way meta)	25	142	1	321	2563	2750	2943	3496	417	4444	3323	858	4425	1679	2888	565	1740	3100	822	3876	142
4560_Left paracentral	4560_Left paracentral	25	143	1	143	2272	1974	988	1323	1355	585	3246	534	574	1901	1805	1522	2423	2607	2618	3265	3945
1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	1771_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for multivariable)	25	143	1	1917	3032	143	4260	3069	2346	3127	4031	4718	825	4277	2806	1347	4516	2019	3726	3475	1108
4530_Right lateral ventricle	4530_Right lateral ventricle	25	143	1	2393	2053	4472	3693	143	1455	308	3594	3360	1589	707	1371	4150	1828	2566	2615	4473	4645
2059_Type 2 Diabetes	2059_Type 2 Diabetes	25	143	1	3934	942	3445	3235	1256	143	1789	4040	3836	4459	1037	3171	874	2815	302	1474	2589	1756
2901_IL6 - Interleukin-6	2901_IL6 - Interleukin-6	25	143	1	4032	4721	719	1654	4022	4149	143	870	609	4725	705	1194	518	4137	1949	356	1309	878
2183_CRLF2 - Cytokine receptor-like factor 2	2183_CRLF2 - Cytokine receptor-like factor 2	25	143	1	3425	1225	254	3762	2330	4599	3979	143	774	2729	4265	3054	4035	4151	540	531	2289	3228
253_CD123 on 11c+123+DC	253_CD123 on 11c+123+DC	25	143	1	1963	764	4391	2429	979	3503	1627	2707	3714	143	1973	4650	1027	2085	2067	837	2724	2725
4533_Right cerebellum white matter	4533_Right cerebellum white matter	25	143	1	4642	1352	3953	4181	3862	665	427	2889	2703	2949	2322	3605	3367	143	4379	3657	3102	1476
1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	1485_Mean triglycerides from exam 1-7 (GEE, adjusted for multivariable)	25	143	1	2161	2033	696	626	2404	4125	738	2843	3835	2916	3288	3732	1004	803	151	143	3869	2340
2598_HGFAC - Hepatocyte growth factor activator	2598_HGFAC - Hepatocyte growth factor activator	25	143	1	3518	1229	1594	856	1649	1942	2739	4399	373	1248	298	331	344	2814	263	181	143	1267
1902_Frontal lobe volume (FBAT, adjusted for multivariable)	1902_Frontal lobe volume (FBAT, adjusted for multivariable)	25	143	1	3576	894	3289	3455	385	2776	1445	1038	767	1252	709	1256	646	738	2560	3536	4648	143
4322_Depressive symptoms (univariate)	4322_Depressive symptoms (univariate)	25	144	1	751	144	2565	3024	3641	3232	168	881	2718	3089	1746	2993	3659	2598	4304	2249	1301	4325
568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	568_Lipid::Sterol, Steroid::4-androsten-3beta,17beta-diol disulfate 1*	25	144	1	2574	2109	4512	4484	144	1395	1656	3055	4629	4417	2853	4518	4267	2116	4578	4659	1860	4486
979_Hepatocyte growth factor	979_Hepatocyte growth factor	25	144	1	1413	561	4235	2788	3356	4033	2776	144	2020	4622	1554	3547	3520	3396	2016	1289	2159	2406
2649_PTGS2 - Prostaglandin G/H synthase 2	2649_PTGS2 - Prostaglandin G/H synthase 2	25	144	1	3725	498	3884	2145	1885	3836	1521	475	144	3992	1246	3843	1942	4654	1920	703	3117	1588
1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1475_Mean total cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	144	1	217	1617	3184	2629	1033	576	3770	387	3417	490	144	1817	1980	3334	4606	4389	176	3564
882_Concentration of IDL particles	882_Concentration of IDL particles	25	144	1	2349	2619	382	2398	3248	2719	530	4692	2791	4559	1477	402	4590	3337	375	144	1693	528
531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	531_Lipid::Lysolipid::1-arachidonoylglycerophosphoethanolamine*	25	144	1	3319	3517	3840	2728	3391	1689	345	433	448	3805	2624	549	1175	2080	1713	1946	144	1548
4660_Posterior limb of internal capsule fractional anisotropy	4660_Posterior limb of internal capsule fractional anisotropy	25	144	1	3588	3132	749	2929	3948	2072	2385	2173	3324	1818	4486	2988	717	3234	534	4019	2319	144
3744_Cannabis use - Ever taken cannabis	3744_Cannabis use - Ever taken cannabis	25	145	1	145	1896	2241	2519	3092	1896	276	3766	3040	153	2109	227	3951	408	4307	1588	2523	4651
1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	1591_Platelet aggregation to ADP (at exam 5, GEE, adjusted for age and sex)	25	145	1	1676	145	3577	895	1592	875	976	3602	1440	2690	2657	3925	1349	1271	2697	629	1262	2262
335_NKeff:%314-158a+	335_NKeff:%314-158a+	25	145	1	2184	1655	4488	4122	499	145	2148	1020	2957	2323	2644	2862	3373	4604	3078	1037	1965	2849
1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	1019_Lumbar Spine BMD (GEE, adjusted for multivariable)	25	145	1	2454	1953	4531	3185	4040	512	3476	252	145	3974	2477	1219	3011	544	2662	519	1866	3770
3941_Body Mass Index (female)	3941_Body Mass Index (female)	25	145	1	2476	2229	734	1743	4229	4098	2032	4443	1875	716	145	565	1387	3395	880	3636	244	1684
610_Peptide::Polypeptide::bradykinin, des-arg(9)	610_Peptide::Polypeptide::bradykinin, des-arg(9)	25	145	1	2117	3550	4473	662	188	377	180	1446	1561	1324	575	145	1060	607	1381	817	1664	507
4158_Generalised epilepsy	4158_Generalised epilepsy	25	145	1	570	300	2038	2966	165	3609	1769	899	421	4228	1180	2682	538	145	714	719	204	1829
4079_Waist-hip ratio (female)	4079_Waist-hip ratio (female)	25	145	1	2592	1779	4718	153	1537	2047	741	4161	3614	2762	1430	3165	3387	2361	409	738	145	2812
2539_STK16 - Serine/threonine-protein kinase 16	2539_STK16 - Serine/threonine-protein kinase 16	25	145	1	707	3608	4660	297	1159	1022	3846	2031	374	1340	3339	3193	809	468	2264	2824	3788	145
1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	1346_Plasma Apolipoprotein A-I level (FBAT, adjusted for age and sex)	25	146	1	146	4341	2487	4395	4545	3375	3467	3850	1947	4207	1782	2157	2491	4412	301	2058	468	2676
2889_KYNU - Kynureninase	2889_KYNU - Kynureninase	25	146	1	3488	146	3677	4658	2289	2027	1094	1761	4034	3082	4187	2598	3457	2798	373	990	1520	3529
4649_Average across all tracts fractional anisotropy	4649_Average across all tracts fractional anisotropy	25	146	1	4318	3770	4722	1345	559	146	4093	3929	1668	975	3819	3320	2357	4484	2080	4304	4644	828
2568_CCL17 - C-C motif chemokine 17	2568_CCL17 - C-C motif chemokine 17	25	146	1	924	3855	2697	2553	3289	2044	2921	3748	591	146	2511	240	3867	3977	1300	3024	1050	2175
1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	1828_Spine Neck BMD (FBAT, male, adjusted for multivariable)	25	146	1	3083	2790	4006	961	3552	1709	1147	3831	4273	2771	953	146	3138	902	4630	3127	1881	535
5_Bipolar disorder	5_Bipolar disorder	25	146	1	1575	1698	990	267	2902	4204	1482	1732	440	4676	588	4561	2298	2511	1594	3044	146	3960
1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	1731_Chronic kidney disease (at exam 7, GEE, adjusted for age and sex)	25	147	1	3348	147	3900	776	1565	3752	3344	3456	1324	4505	4249	1361	2696	1885	3004	182	801	595
3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	3669_Diagnoses - main ICD10: K21 Gastro-esophageal reflux disease	25	147	1	2535	217	348	147	223	1274	1120	3537	4020	1159	4096	4437	2467	4630	2134	844	4542	1417
492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	492_Lipid::Essential fatty acid::linolenate [alpha or gamma; (18:3n3 or 6)]	25	147	1	4036	4391	3753	3703	2630	1768	1887	1891	147	1032	4612	4400	1140	2386	3139	3202	1229	3834
4290_Frequent insomnia symptoms	4290_Frequent insomnia symptoms	25	147	1	581	636	1778	3580	1092	4654	796	969	3202	1121	2218	147	4183	1767	644	4324	4656	3879
707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	707_Lipid::Sterol/Steroid::X-11445--5-alpha-pregnan-3beta,20alpha-disulfate	25	147	1	823	1758	3756	1230	2610	1762	4007	4470	3175	723	1644	2817	3541	4052	147	3142	3790	4108
4534_Right thalamus proper	4534_Right thalamus proper	25	147	1	3137	4538	4219	619	1733	3768	3730	2989	206	3136	2818	2763	1603	677	361	3730	2231	147
3051_EPHB2 - Ephrin type-B receptor 2	3051_EPHB2 - Ephrin type-B receptor 2	25	148	1	148	3543	1639	2944	2231	2627	370	1899	2458	3505	3442	4270	864	4645	3229	1834	394	3649
1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1386_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	148	1	675	4420	148	1902	1944	2019	2660	3702	1537	244	1387	4353	3931	3698	2731	4279	1296	2027
2003_Plasma Lipoprotein A level	2003_Plasma Lipoprotein A level	25	148	1	2803	2457	2928	148	1149	2136	953	624	507	1522	785	846	3750	1808	2099	2117	3218	340
1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1786_QT interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	148	1	1685	4171	1816	1187	3008	3189	4363	148	3954	1871	2681	2584	1492	1472	2185	2362	3852	3170
811_::::X-12851	811_::::X-12851	25	148	1	406	3148	943	1976	2948	4351	2485	611	148	1122	1449	4482	2301	579	1741	2754	1699	1659
2876_CLU - Clusterin	2876_CLU - Clusterin	25	148	1	3824	4153	3648	325	1803	4595	4037	1060	1621	148	1690	4500	2072	4188	2089	4588	2949	1170
163_Hip circumference (male, adjusted for BMI)	163_Hip circumference (male, adjusted for BMI)	25	148	1	1325	3419	3278	1023	1970	4379	2078	734	613	3444	148	1734	2799	808	3786	1713	2703	563
3843_Hematocrit (two-way meta)	3843_Hematocrit (two-way meta)	25	148	1	994	2085	4638	4264	3980	1008	4415	2432	4389	2963	2693	148	2982	2350	4644	2361	2498	4017
2752_PLG - Plasmin	2752_PLG - Plasmin	25	148	1	4212	3954	4715	172	3508	376	553	153	3671	620	1694	308	179	148	1333	785	897	552
1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	1418_High-density lipoprotein cholesterol (at exam 7, FBAT, adjusted for age and sex)	25	148	1	2311	2303	2351	3541	2156	4407	1466	1443	2419	894	3038	4229	4622	4040	148	4382	3080	4617
3219_Time spent watching television (TV)	3219_Time spent watching television (TV)	25	148	1	1686	2156	2726	2036	1976	2429	1812	872	1108	3809	157	3021	1070	2710	3800	148	1347	2530
4516_Optic chiasm	4516_Optic chiasm	25	149	1	2436	4161	1971	1457	3031	149	2846	2850	3502	3298	1384	4635	906	872	2735	2711	4606	654
3378_Number of pregnancy terminations (female)	3378_Number of pregnancy terminations (female)	25	149	1	4464	1113	1083	502	693	1209	3229	149	1135	2353	471	1624	2384	1130	3733	2465	4102	2074
2397_GP6 - Platelet glycoprotein VI	2397_GP6 - Platelet glycoprotein VI	25	149	1	341	2432	3062	1593	733	1278	1608	1017	3467	149	4637	3210	3231	1773	3320	4735	3386	1360
2569_TGFB3 - Transforming growth factor beta-3	2569_TGFB3 - Transforming growth factor beta-3	25	149	1	2905	4440	999	382	919	1364	2747	1077	4692	3927	395	542	149	3069	3263	762	1154	3856
3700_Diagnoses - secondary ICD10: M13 Other arthritis	3700_Diagnoses - secondary ICD10: M13 Other arthritis	25	149	1	1532	2358	1613	3116	1532	3373	2518	1289	4152	4036	711	579	4452	149	367	4425	2793	440
1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1256_Percent predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	149	1	2693	1388	4380	1087	611	3784	3820	798	910	4153	564	2528	669	3258	149	965	1323	1182
2998_GP1BA - Platelet glycoprotein Ib alpha chain	2998_GP1BA - Platelet glycoprotein Ib alpha chain	25	150	1	1947	150	1861	1758	1471	2459	905	3994	1878	4392	1316	3813	2589	1256	950	716	1905	2179
2678_PDGFC - Platelet-derived growth factor C	2678_PDGFC - Platelet-derived growth factor C	25	150	1	4663	4653	150	249	2987	715	3918	1638	2654	3588	890	4083	3248	668	4345	3245	2778	3168
2369_MAPK1 - Mitogen-activated protein kinase 1	2369_MAPK1 - Mitogen-activated protein kinase 1	25	150	1	2791	4172	994	566	2832	4501	150	1780	1743	2410	2875	2406	295	4127	3968	1578	1387	4740
3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	3003_HPGD - 15-hydroxyprostaglandin dehydrogenase [NAD(+)]	25	150	1	1132	1239	735	773	1267	1617	3108	150	756	2047	2991	1606	547	2148	943	386	2302	1484
302_CD4mem:R6+	302_CD4mem:R6+	25	150	1	3792	1932	2577	1019	2215	617	3645	3798	2598	2179	3447	229	2109	1678	150	3027	1991	2758
907_Total cholesterol in LDL	907_Total cholesterol in LDL	25	150	1	3042	432	2381	2599	2142	3744	1382	1084	3524	3489	2225	843	3927	4528	1809	150	1933	698
1191_PGC cross disorder	1191_PGC cross disorder	25	150	1	4304	495	4424	2831	3827	963	1989	3895	536	800	159	2443	2201	3879	1258	3424	150	3783
541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	541_Lipid::Lysolipid::1-oleoylglycerophosphoethanolamine	25	151	1	151	964	457	3467	3402	2537	907	1120	2321	3521	1268	1168	4532	4173	4116	2648	3079	958
835_Peptide::Dipeptide::X-14208--phenylalanylserine	835_Peptide::Dipeptide::X-14208--phenylalanylserine	25	151	1	2549	1081	3934	151	2421	1869	2184	3762	3898	3170	1696	1965	2746	2047	3677	3408	1955	1319
1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	1686_Vitamin D plasma 25(OH)-D (at exam 6 or 7, FBAT, adjusted for age and sex)	25	151	1	2387	3480	4590	672	1758	151	3513	4265	4117	4614	3728	3775	630	2797	271	2527	1187	3211
3517_How are people in household related to participant: Husband, wife or partner	3517_How are people in household related to participant: Husband, wife or partner	25	151	1	348	357	4672	3594	1526	2908	2187	151	3483	4475	2273	4320	2659	4403	1007	3042	1778	3766
2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	2095_TNFRSF11B - Tumor necrosis factor receptor superfamily member 11B	25	151	1	4550	3226	1939	4683	3515	635	1346	590	977	412	151	534	609	1265	4561	2582	902	906
4108_Blood urea nitrogen	4108_Blood urea nitrogen	25	151	1	2461	3960	2469	363	2605	898	4467	1200	2470	2693	4100	151	3364	2089	158	4391	1513	1884
2075_CTSG - Cathepsin G	2075_CTSG - Cathepsin G	25	151	1	263	4524	1394	3807	335	3531	685	1378	2604	633	794	2782	3680	151	4338	687	627	2523
1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	1241_Rate of decline of FEV1 (GEE, adjusted for multiple covariates)	25	151	1	3794	514	3135	592	2325	1546	3265	484	1599	2006	2711	2446	4552	2417	3904	3892	1656	151
2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	2213_ALPL - Alkaline phosphatase, tissue-nonspecific isozyme	25	152	1	933	3250	152	4511	2144	1814	3841	1770	1981	4236	341	1268	254	4130	4489	2068	327	3858
1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1678_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	152	1	2264	755	512	3812	152	2324	658	1880	1633	1181	245	940	3924	2387	3540	614	576	1954
3185_Waist circumference	3185_Waist circumference	25	152	1	797	2103	4432	4562	1170	4036	3070	3666	2302	152	3635	647	2877	4004	2765	4614	2544	1475
1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	1950_Visual scanning and motor speed (FBAT, adjusted for multivariable)	25	152	1	1999	3880	453	190	1126	3554	4044	2225	251	157	152	1110	251	1545	2532	3250	4509	1221
1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1460_Small low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	152	1	4334	1654	673	3789	3545	2590	3637	1657	1975	1602	3795	4690	152	209	2318	809	3390	2158
1152_Incremental insulin 30 min	1152_Incremental insulin 30 min	25	152	1	4528	1142	4431	3230	2326	1156	2999	888	2162	3787	1450	3629	3698	152	1185	320	1266	4048
2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	2599_IL22RA1 - Interleukin-22 receptor subunit alpha-1	25	152	1	3452	3326	2371	3603	518	748	2698	1724	3151	1297	725	2921	3863	4026	152	1877	4033	2685
2981_CAPG - Macrophage-capping protein	2981_CAPG - Macrophage-capping protein	25	152	1	4716	240	3826	949	4026	3213	3991	1861	1275	3886	480	3735	4429	4222	2988	1806	152	3618
3648_Illnesses of siblings: Heart disease	3648_Illnesses of siblings: Heart disease	25	153	1	153	3001	542	912	4219	885	3036	2189	700	2335	3041	4681	3515	3076	4080	3256	3866	1465
1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	1674_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for age and sex)	25	153	1	3881	153	2709	3159	3153	4624	2413	4342	3327	293	3808	3460	3869	1225	1922	2821	2371	1180
370_Amino acid::Creatine metabolism::creatinine	370_Amino acid::Creatine metabolism::creatinine	25	153	1	3946	702	3717	4337	153	4492	2023	4484	2131	3674	2062	4086	696	3526	2047	1091	3393	2846
4621_Left cerebellum white matter	4621_Left cerebellum white matter	25	153	1	4248	760	4054	3243	2009	153	1380	2261	2902	4304	4648	3350	3021	763	4192	2761	2779	772
3526_Transport type for commuting to job workplace: Public transport	3526_Transport type for commuting to job workplace: Public transport	25	153	1	2952	1454	2688	964	2406	486	211	3414	153	2689	1735	2359	4230	4521	4125	1450	2055	3361
851_Acetate	851_Acetate	25	153	1	3846	1898	4462	2922	4042	4253	1209	1423	886	859	1512	153	3853	2031	1916	1452	262	1505
2427_C1R - Complement C1r subcomponent	2427_C1R - Complement C1r subcomponent	25	153	1	4108	1428	4119	515	3838	2879	2320	2805	4345	4651	2821	2779	153	2124	2255	3163	4533	570
3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	3539_Reason for glasses/contact lenses: For short-sightedness, i.e. only or mainly for distance viewing such as driving, cinema etc (called 'myopia')	25	153	1	2482	2750	3055	711	4482	2947	4687	2575	481	2542	3514	4485	1715	153	2390	2427	2825	4175
1841_Neck width (GEE, male, adjusted for age)	1841_Neck width (GEE, male, adjusted for age)	25	153	1	3734	591	1842	1564	547	2371	2124	4120	2089	2887	2774	619	1830	3108	153	4380	1181	1140
596_Peptide::Dipeptide::pro-hydroxy-pro	596_Peptide::Dipeptide::pro-hydroxy-pro	25	154	1	683	154	3295	1820	2631	4113	4322	1326	3564	1577	1152	3336	3879	1081	1171	2374	367	421
3146_S100A9 - Protein S100-A9	3146_S100A9 - Protein S100-A9	25	154	1	2297	3207	4252	2980	1109	2054	154	570	2289	3092	899	593	4095	4014	2789	2809	2083	315
2285_MMP8 - Neutrophil collagenase	2285_MMP8 - Neutrophil collagenase	25	154	1	2481	2994	3550	3493	418	3500	536	319	154	594	958	1678	473	1264	3053	1024	1763	2728
986_Interleukin-18	986_Interleukin-18	25	154	1	1048	1284	3072	4031	4000	4549	3293	771	1914	154	3791	1726	1079	1963	2426	164	486	3044
4180_Platelets	4180_Platelets	25	154	1	3188	2652	3951	3827	3543	4580	2392	1681	4171	3528	1212	3728	2915	2895	154	783	3722	2840
426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	426_Amino acid::Valine, leucine and isoleucine metabolism::beta-hydroxyisovalerate	25	154	1	711	1724	1070	3058	946	2020	4472	3368	2821	179	2355	2545	3818	2584	453	1303	154	3550
2377_IDUA - alpha-L-iduronidase	2377_IDUA - alpha-L-iduronidase	25	155	1	155	593	2311	2716	434	974	2515	1195	4357	3929	3738	986	806	1571	3695	1069	2829	3706
837_::::X-14374	837_::::X-14374	25	155	1	3890	155	570	178	238	3861	995	377	3559	3836	4717	1156	675	3968	655	4000	2123	1002
1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1807_SDNN HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	155	1	539	4447	3472	155	4106	1307	644	2232	2471	3538	2425	3803	3569	2732	1128	3807	951	2431
1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	1132_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI)	25	155	1	3240	3843	1295	1540	155	4381	746	3725	2207	1916	4242	656	1329	3202	1781	3990	4525	1195
434_Carbohydrate::Aminosugars metabolism::erythronate*	434_Carbohydrate::Aminosugars metabolism::erythronate*	25	155	1	895	1625	779	1311	2205	155	1750	2413	3989	3879	2841	1345	2057	4123	2448	2954	1056	674
662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	662_Amino acid::Butanoate metabolism::X-04499--3,4-dihydroxybutyrate	25	155	1	1770	205	2390	511	3219	3111	541	155	2686	2640	2972	938	2064	3903	2513	3635	3612	3762
3907_Intraocular pressure	3907_Intraocular pressure	25	155	1	4510	3393	2745	3157	3586	3953	4253	417	155	3350	3776	1565	1652	4309	910	2365	4632	2017
504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	504_Lipid::Fatty acid, monohydroxy::2-hydroxypalmitate	25	155	1	1420	3950	1049	3259	1420	3324	1335	3504	3110	155	4665	4440	3994	964	690	2062	3105	3478
291_CD4:%Act(DR+38+)	291_CD4:%Act(DR+38+)	25	155	1	3282	472	1417	2636	3597	1082	4581	550	3144	596	2517	155	2560	2736	1441	3321	4074	4013
2968_SHBG - Sex hormone-binding globulin	2968_SHBG - Sex hormone-binding globulin	25	155	1	3122	1278	2218	2577	3883	2938	3071	3934	2418	1512	4436	3647	4175	2188	155	1099	2320	3611
2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	2687_ETHE1 - Persulfide dioxygenase ETHE1, mitochondrial	25	155	1	1763	4469	2333	2167	4154	1621	4577	1932	3585	2667	2120	1818	2814	482	3430	4439	2495	155
1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	1720_Mean thyroid stimulation hormone from exam 3 and 4 (FBAT, adjusted for multivariable)	25	156	1	2956	2782	156	2527	3170	1015	1702	3353	178	499	2824	1279	883	3121	3614	2033	2176	3581
666_::::X-06126	666_::::X-06126	25	156	1	439	4038	211	4187	156	4635	4453	367	2305	4516	4034	4386	1371	627	3527	520	908	1999
1967_MMSE score (at age 65, GEE, adjusted for multivariable)	1967_MMSE score (at age 65, GEE, adjusted for multivariable)	25	156	1	945	594	852	1378	2506	3827	2311	3992	2194	405	3087	4396	4672	156	2970	1611	189	494
2014_Response following 8-week treatment of MDD subjects	2014_Response following 8-week treatment of MDD subjects	25	156	1	2074	866	3914	596	2579	3518	1153	4684	3780	4284	502	2802	1440	2678	2604	156	567	3823
3309_Wears glasses or contact lenses	3309_Wears glasses or contact lenses	25	156	1	2969	3769	2340	2514	2686	1141	590	4734	1432	4395	1619	4568	782	904	801	1838	156	675
1200_Genetic generalized epilepsy	1200_Genetic generalized epilepsy	25	156	1	900	1095	299	1290	1699	1155	2665	4593	2564	2549	4694	2878	4475	2181	3748	2320	2977	156
496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	496_Lipid::Fatty acid, branched::15-methylpalmitate (isobar with 2-methylpalmitate)	25	157	1	157	1344	1631	2528	2861	1096	2226	4241	2400	2398	1362	1504	2424	1977	2622	1517	3106	1745
1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	1489_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for multivariable)	25	157	1	3160	157	4025	1632	522	1306	4329	2399	4274	2013	2765	2106	1504	4415	3413	1730	2222	297
933_Total lipids in small HDL	933_Total lipids in small HDL	25	157	1	189	2622	157	4544	3084	702	222	1616	439	1485	2121	1203	2610	1118	2486	1042	3540	2380
3979_Estimated BMD	3979_Estimated BMD	25	157	1	317	4404	660	2284	804	157	1125	3508	806	1225	1463	157	1663	417	390	952	2332	3644
2273_APOE - Apolipoprotein E (isoform E4)	2273_APOE - Apolipoprotein E (isoform E4)	25	157	1	3255	304	763	2487	2025	3916	157	1458	4401	1869	2395	3913	2026	386	2612	3249	2273	863
3224_Weekly usage of mobile phone in last 3 months	3224_Weekly usage of mobile phone in last 3 months	25	157	1	3533	385	1980	1354	2489	1605	2225	3886	3288	4227	2421	4114	157	2393	1611	448	3274	4295
113_Height	113_Height	25	157	1	642	2273	1326	4378	3945	1024	1694	563	2003	1870	1193	899	2116	157	3373	2729	550	2982
1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	1746_Urinary albumin excertion in hypertensive enriched sample (at exam 6, FBAT, adjusted for multivariable)	25	157	1	3123	1260	3878	3023	4571	4157	626	1800	3818	3786	233	782	2263	2522	4646	2860	809	157
1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	1521_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, GEE, adjusted for age and sex)	25	158	1	1237	158	4593	2400	327	4655	3055	3998	3319	760	3827	574	801	4676	4319	2632	2467	3669
444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	444_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::pyruvate	25	158	1	3186	3204	158	4639	3659	4530	2405	1688	3744	3154	2755	340	2948	3876	3124	4453	2465	1467
1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	1617_CD40 Ligand plasma (at exam 7, GEE, adjusted for multivariable)	25	158	1	4219	2009	3891	294	2495	158	1428	4220	1144	4556	2633	907	439	1246	1125	1292	4026	4559
3927_Total-body lean mass	3927_Total-body lean mass	25	158	1	460	2669	4668	4390	3295	3321	1824	280	158	3430	2403	1146	3751	4376	2553	2509	3656	1409
3251_Cheese intake	3251_Cheese intake	25	158	1	227	2191	1405	2448	4651	3343	1592	3823	3024	158	1689	2778	4674	1558	1981	3111	4465	2986
1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1396_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	158	1	693	3758	1595	939	1555	1742	733	1333	600	3652	4272	158	604	651	1519	3831	4225	3690
3964_Gestational weight gain (offspring, early)	3964_Gestational weight gain (offspring, early)	25	158	1	3150	3399	4518	2685	4606	2892	3924	3801	1585	4477	881	1769	158	1233	2462	3497	4723	4424
2361_F10 - Coagulation factor Xa	2361_F10 - Coagulation factor Xa	25	158	1	869	1410	4712	2609	346	2942	1903	3834	698	2222	2337	1182	3795	922	1972	158	2805	1314
1177_Excessive daytime sleepness (female)	1177_Excessive daytime sleepness (female)	25	158	1	2107	2853	291	1881	595	2391	3894	2905	4395	1101	551	319	206	1682	1815	1359	1968	158
2690_MDH1 - Malate dehydrogenase, cytoplasmic	2690_MDH1 - Malate dehydrogenase, cytoplasmic	25	159	1	3481	632	159	1602	2273	308	277	4107	1355	2505	4473	2621	4541	2503	1010	744	1439	4639
3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	3535_Mental health - Illness, injury, bereavement, stress in last 2 years: Marital separation/divorce	25	159	1	879	1426	1817	159	1865	1111	3701	3815	1045	918	3805	2198	1106	2931	252	434	4030	2143
3853_Monocyte count (two-way meta)	3853_Monocyte count (two-way meta)	25	159	1	3795	1516	599	4557	159	1251	1162	4538	959	2867	2863	4074	2111	2638	2886	901	2622	1867
1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	1357_Total cholesterol (at exam 1, GEE, multivariate adjusted)	25	159	1	779	3294	1374	942	2805	1081	3679	1422	3356	159	2188	1727	3001	336	4323	374	4698	1335
1017_Femoral BMD (GEE, adjusted for multivariable)	1017_Femoral BMD (GEE, adjusted for multivariable)	25	159	1	1513	1035	4392	889	4273	1728	2286	642	4607	2408	3090	159	2643	3724	4063	2820	1244	1718
1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	1733_Chronic kidney disease (at exam 7, GEE, adjusted for multivariable)	25	159	1	1322	808	3609	372	3979	2855	3535	4294	2276	3975	4042	3992	671	2362	4168	159	894	519
935_Triglycerides in small HDL	935_Triglycerides in small HDL	25	159	1	4353	2043	3145	888	1455	2029	714	2521	2068	364	2994	2645	4060	1140	2342	760	159	885
4713_Anterior corona radiata mode of anisotropy	4713_Anterior corona radiata mode of anisotropy	25	159	1	2706	3826	746	2366	3798	4045	791	4190	2396	1642	3005	2617	4146	2571	3437	674	4347	159
4245_Left handed	4245_Left handed	25	160	1	160	3116	4102	1273	1015	552	638	385	290	2624	570	4478	3623	526	1122	229	960	3034
4218_Antithrombotic agents	4218_Antithrombotic agents	25	160	1	1534	160	2309	2154	2352	1471	3879	2365	1694	3995	2060	3121	1638	1439	2387	3527	3492	1330
4309_Osteoarthritis of hip	4309_Osteoarthritis of hip	25	160	1	3191	620	4528	160	2371	3091	1157	4377	1230	2501	2571	423	4646	290	4516	3962	4620	1535
3452_Impedance measures - Leg fat percentage (right)	3452_Impedance measures - Leg fat percentage (right)	25	160	1	4381	4224	4078	1616	160	4352	437	685	4505	1110	1501	4126	2599	1458	2593	593	2476	1941
4574_Left supramarginal	4574_Left supramarginal	25	160	1	1872	4631	1378	1741	4447	160	3266	3982	4730	1953	4064	724	1910	1592	2196	3551	1916	4119
3854_Monocyte percentage of white cells (two-way meta)	3854_Monocyte percentage of white cells (two-way meta)	25	160	1	4232	2787	514	3268	1112	1630	160	1867	2802	163	1649	3641	2221	3503	3852	1339	1683	1516
947_Sphingomyelins	947_Sphingomyelins	25	160	1	4573	2633	3886	3850	633	1759	327	2412	2093	780	160	4070	2364	2173	601	1488	4450	2563
4755_Sagittal stratum radial diusivities	4755_Sagittal stratum radial diusivities	25	160	1	885	2730	316	1917	625	294	851	1089	3540	2090	1298	4732	3831	160	1275	1888	3855	2451
2159_PLA2G2A - Phospholipase A2, membrane associated	2159_PLA2G2A - Phospholipase A2, membrane associated	25	160	1	3323	502	2827	1831	4660	4420	4442	1302	1110	1554	318	2444	3260	2061	160	868	3551	1667
1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	1997_MMSE score (at exam 7, GEE, adjusted for multivariable)	25	160	1	3015	730	3879	1681	3610	224	3039	2752	683	3420	843	1665	571	3309	306	160	1144	3145
549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	549_Lipid::Lysolipid::2-linoleoylglycerophosphocholine*	25	160	1	757	2110	2398	2202	4556	4702	2774	289	375	4221	357	2140	4339	3668	1002	1263	160	2517
111_Coronary artery disease	111_Coronary artery disease	25	160	1	3684	1085	705	3747	1767	2317	480	2218	2599	1990	1380	2213	803	380	785	529	955	160
2148_DCN - Decorin	2148_DCN - Decorin	25	161	1	161	2010	2000	370	1931	883	1761	3117	1888	3324	2394	2014	410	2438	824	4269	4005	4145
3236_Past tobacco smoking	3236_Past tobacco smoking	25	161	1	1973	161	3765	3144	4498	3951	1908	3967	1661	497	1000	4630	1983	1257	828	553	3558	628
449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	449_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,E)*	25	161	1	453	4744	4131	161	2865	3875	2472	3830	1856	1502	2028	2272	1977	2730	926	1046	1525	2339
4518_Left inferior lateral ventricle	4518_Left inferior lateral ventricle	25	161	1	2113	4266	670	4721	4107	161	1596	2180	740	3895	628	3667	628	4258	2475	1603	3358	779
2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	2513_CDC2 CCNB1 - Cyclin-dependent kinase 1:G2/mitotic-specific cyclin-B1 complex	25	161	1	3815	1230	644	2708	3737	2209	161	1032	839	3655	1409	1378	4071	318	2223	2895	423	1241
611_Peptide::Polypeptide::HWESASXX*	611_Peptide::Polypeptide::HWESASXX*	25	161	1	2177	4333	2991	4345	961	3821	823	161	615	253	355	3527	4155	3035	3634	1047	3100	629
315_CD8mem:%PD1+R6+	315_CD8mem:%PD1+R6+	25	161	1	3196	1455	3280	305	4187	3113	4208	4243	161	899	1032	1309	221	699	3088	2548	3203	1324
3622_Treatment/medication code: cod liver oil capsule	3622_Treatment/medication code: cod liver oil capsule	25	161	1	2521	3593	1022	3904	1340	1374	1620	4427	2264	161	2468	1320	1557	3780	1460	1596	507	4064
1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	1303_Fasting insulin (at exam 5, GEE, adjusted for age and sex)	25	161	1	1624	2701	2262	4498	2151	3525	2027	1030	2217	3741	486	2472	161	251	2042	469	1136	3893
818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	818_Lipid::Carnitine metabolism::X-13431--nonanoylcarnitine*	25	161	1	1667	1818	4467	1295	3202	2716	2046	1354	1442	2687	1727	3968	3673	3376	161	2944	2859	2701
3865_Red cell distribution width (two-way meta)	3865_Red cell distribution width (two-way meta)	25	161	1	1821	2462	1093	786	2017	2450	1795	3419	3081	3915	763	1327	2965	1583	196	918	161	943
938_Concentration of small LDL particles	938_Concentration of small LDL particles	25	162	1	614	162	1074	4294	3173	2060	3849	940	2579	2756	666	820	2325	2506	902	171	596	204
3011_MAPK12 - Mitogen-activated protein kinase 12	3011_MAPK12 - Mitogen-activated protein kinase 12	25	162	1	1093	1061	486	162	684	454	1375	493	2936	1349	936	1488	452	4303	4674	1535	4297	356
2167_SERPINA7 - Thyroxine-Binding Globulin	2167_SERPINA7 - Thyroxine-Binding Globulin	25	162	1	232	926	980	3934	162	4615	4306	583	3673	993	2556	326	4583	3333	2278	2812	2760	3736
4469_Left rostral middle frontal	4469_Left rostral middle frontal	25	162	1	4262	2258	3973	908	3949	162	544	543	1560	272	2159	679	2497	1574	321	4355	4024	1693
2668_FYN - Tyrosine-protein kinase Fyn	2668_FYN - Tyrosine-protein kinase Fyn	25	162	1	2545	4282	334	1679	2103	1021	162	2023	879	3153	2695	547	2051	1008	4654	1376	4627	1299
1205_Serum Thyroid-stimulating hormone level	1205_Serum Thyroid-stimulating hormone level	25	162	1	606	3615	2715	3090	1164	3191	649	162	854	1775	760	2122	4382	752	1264	777	3192	2295
2238_SPINT2 - Kunitz-type protease inhibitor 2	2238_SPINT2 - Kunitz-type protease inhibitor 2	25	162	1	4604	286	2188	696	3977	571	778	4312	3640	1168	162	427	3964	4058	1026	3815	2616	2010
1228_Parkinson Disease (additive model)	1228_Parkinson Disease (additive model)	25	162	1	1368	3302	1235	1527	2808	750	852	1134	1375	1495	714	162	2073	310	620	673	2953	2302
1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	1595_Platelet aggregation to collagen (at exam 5, GEE, adjusted for age and sex)	25	162	1	492	3798	1431	2343	1285	984	306	4405	4349	1706	4029	651	2493	399	162	1709	3392	1525
207_Gout	207_Gout	25	162	1	1494	3333	3290	1773	3269	345	834	3199	656	3336	4535	4621	3081	1776	561	162	3121	2256
1920_Frontal lobe volume (FBAT, adjusted for age and sex)	1920_Frontal lobe volume (FBAT, adjusted for age and sex)	24	162	1	2479	998	2879	2835	510	2326	2306	1494	585	808	416	1651	632	1644	2718	4420	2414	162
1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	1636_Monocyte chemoattractant protein 1 (at exam 7, FBAT, adjusted for multivariable)	25	163	1	4139	1384	3060	3172	1090	1285	3723	4238	3311	2138	2566	4317	163	4599	2381	3132	2285	3781
581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	581_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::inosine	25	163	1	3580	1398	1992	787	2549	988	1378	3701	2233	4178	4657	751	2605	3406	3979	163	971	4010
3029_RB1 - Retinoblastoma-associated protein	3029_RB1 - Retinoblastoma-associated protein	25	163	1	957	1155	4619	290	3130	3992	4638	1843	1444	3178	874	2627	4015	4025	3122	4432	163	1280
4221_Diuretics	4221_Diuretics	25	163	1	4150	4553	535	475	2095	739	4300	1890	3117	4092	1123	4016	1442	2240	2620	3304	3104	163
2618_BMPER - BMP-binding endothelial regulator protein	2618_BMPER - BMP-binding endothelial regulator protein	25	164	1	1482	2981	498	164	4285	1248	4473	3242	4306	2373	2927	2882	1609	2574	933	1344	1336	3432
601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	601_Peptide::gamma-glutamyl::gamma-glutamylglutamate	25	164	1	3927	2122	4284	3308	164	2334	372	2454	4024	1484	1591	809	1641	2823	3630	3769	3719	1313
2712_KPNB1 - Importin subunit beta-1	2712_KPNB1 - Importin subunit beta-1	25	164	1	1114	1837	2127	2932	3950	164	2613	1155	2421	4332	4159	3182	3250	3678	4576	2785	2272	261
2290_CLEC11A - Stem Cell Growth Factor-beta	2290_CLEC11A - Stem Cell Growth Factor-beta	25	164	1	3334	2910	2582	2148	2271	2837	2813	3458	164	1942	2842	4609	2845	4733	3294	3222	4623	1341
696_::::X-11374	696_::::X-11374	25	164	1	3834	1430	3208	1898	532	3844	3724	1539	1983	164	2776	2726	4212	391	4574	3276	354	1963
2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	2366_EDA2R - Tumor necrosis factor receptor superfamily member 27	25	164	1	374	895	2885	2213	3690	3716	588	3909	1454	4449	4623	164	4388	707	2199	2827	2483	3650
3501_Male-specific factors - Hair/balding pattern: Pattern 2	3501_Male-specific factors - Hair/balding pattern: Pattern 2	25	164	1	2069	3698	2461	335	1082	4335	1003	2839	455	3621	1795	3071	164	324	970	2312	431	4404
30_Agreablenes (NEO-FFI)	30_Agreablenes (NEO-FFI)	25	164	1	1061	2230	3489	2091	1726	4090	4242	3889	324	456	4735	1245	2951	4029	164	3512	3915	1169
2053_Advanced adenoma	2053_Advanced adenoma	25	164	1	1268	4521	3244	4038	4565	1439	2495	1820	3705	3982	2210	1880	940	683	469	966	164	1979
3168_CD27 - CD27 antigen	3168_CD27 - CD27 antigen	24	165	1	165	681	1552	929	4535	1786	924	4488	1625	169	211	4395	1282	3974	857	946	2209	3906
1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	1996_MMSE score (at exam 7, FBAT, adjusted for multivariable)	25	165	1	3399	4479	3187	2494	1302	165	3605	2980	4242	578	3151	1640	531	777	406	3759	832	4267
1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	1323_Fasting plasma glucose (at exam 5, GEE, adjusted for age, sex and BMI)	24	165	1	889	4728	539	1935	2769	1281	4410	2273	2024	165	4549	4345	3424	3788	4299	1831	1873	1429
2315_MBL2 - Mannose-binding protein C	2315_MBL2 - Mannose-binding protein C	25	165	1	4302	4073	2707	1497	4190	4657	2120	835	622	3908	165	2604	3343	2440	1461	1478	3457	609
462_Energy::Oxidative phosphorylation::acetylphosphate	462_Energy::Oxidative phosphorylation::acetylphosphate	25	165	1	667	2528	3178	3300	760	423	4256	2009	344	4444	1434	1191	810	165	1892	3421	1539	1520
263_DNT:%CD127+TEF	263_DNT:%CD127+TEF	25	165	1	3785	3730	2998	343	4554	1956	346	4063	3314	1329	2592	717	710	2671	165	3054	417	2577
3608_Non-cancer illness code, self-reported: high cholesterol	3608_Non-cancer illness code, self-reported: high cholesterol	25	165	1	3920	243	3872	4536	4145	4591	2246	1300	3717	1255	1903	474	4294	4343	1583	165	2074	1389
4656_Fornix (cres) / Stria terminalis fractional anisotropy	4656_Fornix (cres) / Stria terminalis fractional anisotropy	25	165	1	2513	3536	3786	4071	3291	615	3767	4426	3838	4074	2411	2137	3824	3377	1394	3059	165	2766
2801_RBM39 - RNA-binding protein 39	2801_RBM39 - RNA-binding protein 39	25	165	1	2550	1886	412	3285	3889	2835	3238	340	218	4506	2041	4094	1422	3540	2109	826	3992	165
655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	655_Amino acid::Polyamine metabolism::X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide	25	166	1	3595	166	3279	819	1628	3474	3086	3554	3176	868	534	2097	2785	1448	2545	1304	2105	624
4707_Splenium of corpus callosum mean diusivities	4707_Splenium of corpus callosum mean diusivities	25	166	1	332	270	1660	3298	2829	2199	4702	1198	720	3137	166	2588	1036	262	672	1666	3912	4041
3612_Treatment/medication code: ramipril	3612_Treatment/medication code: ramipril	25	166	1	3403	2245	1661	2856	3895	1491	3193	2585	1451	4410	1327	166	3269	1335	2159	3440	2259	1599
1903_Frontal lobe volume (GEE, adjusted for multivariable)	1903_Frontal lobe volume (GEE, adjusted for multivariable)	25	166	1	2489	3372	2876	2486	1053	1037	1262	3225	3111	1739	759	2135	2249	166	928	648	526	279
2449_IL24 - Interleukin-24	2449_IL24 - Interleukin-24	25	166	1	2595	4410	3630	1154	1833	2145	4709	2282	3600	3533	2672	363	4404	3316	2441	166	3841	2304
4362_Acceleration average	4362_Acceleration average	25	166	1	2742	1232	2806	473	2999	317	4381	353	1644	2881	852	3924	308	2331	2864	1322	166	278
1911_Temporal horn volume (GEE, adjusted for multivariable)	1911_Temporal horn volume (GEE, adjusted for multivariable)	25	166	1	1309	4498	2857	4023	3456	661	980	2034	4432	2454	3309	1349	4519	2408	1357	3114	1640	166
1226_Intracranial Volume	1226_Intracranial Volume	25	167	1	167	4705	4692	2304	4475	1137	1877	2298	1594	1626	1683	1874	3080	1862	4605	2515	2971	368
3965_Gestational weight gain (offspring, total)	3965_Gestational weight gain (offspring, total)	25	167	1	3828	483	167	4523	4262	2415	3780	1731	3209	2027	4215	3178	2973	2957	1707	1341	4593	1673
2507_IBSP - Bone sialoprotein 2	2507_IBSP - Bone sialoprotein 2	25	167	1	1551	2418	4213	1281	167	2194	613	3593	3172	184	2785	1235	1802	281	2105	4710	585	2765
2603_MMEL1 - Membrane metallo-endopeptidase-like 1	2603_MMEL1 - Membrane metallo-endopeptidase-like 1	25	167	1	3190	4611	1537	1732	2061	2161	3038	1379	167	2457	2310	2603	389	2010	184	1349	3600	777
3949_MYCN amplification neuroblastoma	3949_MYCN amplification neuroblastoma	25	167	1	2608	295	1995	3370	4434	4445	2951	640	4723	1659	4336	167	4461	568	2411	2236	2823	3568
2950_F5 - Coagulation Factor V	2950_F5 - Coagulation Factor V	25	167	1	3585	2312	442	219	2462	1602	347	1548	2123	2854	314	4631	498	167	404	1483	1147	2188
1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	1266_Residual from predicted FEV1/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	167	1	2817	1562	3391	1189	279	3702	1793	1589	1409	4522	633	1425	553	4705	167	2705	1189	1606
3310_Age started wearing glasses or contact lenses	3310_Age started wearing glasses or contact lenses	25	167	1	3090	1612	4222	1539	2759	3733	2673	184	4486	3612	3692	1839	972	2734	3433	3081	167	1361
3222_Drive faster than motorway speed limit	3222_Drive faster than motorway speed limit	25	167	1	1777	4089	2363	2184	558	1232	4409	1675	3761	3162	1166	595	4708	4281	4424	4548	1106	167
1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	1627_Interleukin 6 (at exam 7, GEE, adjusted for age and sex)	25	168	1	168	1970	2625	2185	854	794	2843	3155	2113	4447	2520	3520	4079	600	2871	3590	835	1349
2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	2890_BIRC7 - Baculoviral IAP repeat-containing protein 7 Isoform beta	25	168	1	1927	168	2096	1703	1477	887	1831	1475	187	2480	3768	4064	3261	1143	2951	3845	3956	2721
4658_Inferior fronto-occipital fasciculus fractional anisotropy	4658_Inferior fronto-occipital fasciculus fractional anisotropy	25	168	1	1569	3656	168	725	500	2676	4022	254	844	4441	3806	3700	2587	3354	2899	4343	3638	3586
3684_Diagnoses - main ICD10: R31 Hematuria	3684_Diagnoses - main ICD10: R31 Hematuria	25	168	1	3251	239	393	1816	168	500	637	4604	1546	934	3701	2708	2245	2488	3163	1032	2539	4481
3870_Basophil percentage of white cells (three-way meta)	3870_Basophil percentage of white cells (three-way meta)	25	168	1	2213	2190	4161	2736	2577	3839	403	168	982	3619	232	191	1116	4073	770	4291	1178	2046
1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	1813_Biologic age by osseographic scoring system (GEE, adjusted for multivariable)	25	168	1	728	3676	2275	2383	4706	1230	4141	677	168	3142	1632	810	2769	1291	1325	4522	3253	280
1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	1625_Intercellular adhesion molecule-1 (at exam 7, GEE, adjusted for multivariable)	25	168	1	2223	1275	4112	780	502	3754	664	3186	1991	3226	1858	195	168	4674	4118	2152	830	1249
2301_CXCL5 - C-X-C motif chemokine 5	2301_CXCL5 - C-X-C motif chemokine 5	25	168	1	3114	913	3768	766	3310	854	2501	1327	2152	1219	3811	3632	4259	168	3964	1647	1532	3147
1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1798_High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	168	1	1404	1812	1972	3794	1635	1095	1839	267	986	3575	1480	1227	3226	1149	3950	4031	168	1063
2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	2497_PTPN11 - Tyrosine-protein phosphatase non-receptor type 11	25	169	1	169	3755	1673	1373	1022	1425	1012	1159	1069	3994	848	289	4563	1003	3096	2014	2710	2920
494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	494_Lipid::Fatty acid metabolism (also BCAA metabolism)::butyrylcarnitine	25	169	1	3923	169	4208	3130	2150	879	2000	4084	2008	2439	2630	2908	2666	1670	3576	2065	1571	4184
2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	2286_EHMT2 - Histone-lysine N-methyltransferase EHMT2	25	169	1	4652	3499	4532	169	3675	1270	505	4420	4046	2984	4721	2580	778	369	1830	3203	3738	2413
4434_Measles IgG levels	4434_Measles IgG levels	25	169	1	1339	1567	3620	403	1160	4724	169	897	4677	2456	3042	217	1083	625	1839	4323	2887	2464
3961_Gestational weight gain (maternal, early)	3961_Gestational weight gain (maternal, early)	25	169	1	3404	1083	2557	4208	3697	591	267	389	169	4707	4708	1892	4707	3699	4213	840	981	2334
1781_Artial fibrillation (GEE, adjusted for age and sex)	1781_Artial fibrillation (GEE, adjusted for age and sex)	25	169	1	2321	1536	429	927	212	453	2713	4613	1632	2874	1014	1900	3918	169	1714	4288	1786	3262
932_Pyruvate	932_Pyruvate	25	169	1	4289	2735	995	1475	4333	434	1331	1415	4116	2946	4667	3069	2428	3097	169	261	2668	1893
3656_Alcohol - Alcohol drinker status: Never	3656_Alcohol - Alcohol drinker status: Never	25	169	1	3878	2235	764	4558	1240	1132	2844	3707	616	990	2499	3111	2293	3273	4061	2702	169	3750
4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	4030_Alcohol dependency (bayesian effect  for unrelated genotyped individuals)	25	170	1	170	992	2881	2611	2882	1053	2943	2721	4101	4341	3506	2595	2433	978	984	4592	425	1255
3936_Sialylation	3936_Sialylation	25	170	1	2022	4674	315	3700	170	1703	2386	416	1199	4601	4253	3540	576	2082	1204	4063	2274	4346
1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	1615_CD40 Ligand plasma (at exam 7, GEE, adjusted for age and sex)	25	170	1	2457	3975	3175	295	3259	170	3188	4643	364	4462	3096	1507	1509	4116	1424	2891	2125	3379
4376_Hypothyroidism	4376_Hypothyroidism	25	170	1	4371	2083	4651	1574	2139	2717	170	4314	2866	829	367	728	4321	1164	3990	4267	2258	3877
1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	1491_Plasma Apolipoprotein E level (at exam 5, GEE, adjusted for age and sex)	25	170	1	2794	1288	3631	2123	345	668	3231	1545	2915	2710	170	1717	2620	3887	3825	2680	249	211
2955_GSTP1 - Glutathione S-transferase P	2955_GSTP1 - Glutathione S-transferase P	25	170	1	1806	1690	3979	1238	828	931	3483	285	1526	657	4062	1538	714	3748	931	3614	170	4192
3348_Age when last used oral contraceptive pill (female)	3348_Age when last used oral contraceptive pill (female)	25	171	1	171	2496	2728	3183	936	4488	1000	2026	4383	4582	4184	4255	2822	4679	710	516	4084	4195
1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	1770_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for multivariable)	25	171	1	3430	171	1480	2574	2250	4710	4653	2798	250	3481	2694	2890	709	2688	4111	2977	3882	3420
612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	612_Xenobiotics::Benzoate metabolism::2-hydroxyhippurate (salicylurate)	25	171	1	4258	1500	171	629	3819	4272	2192	2271	2034	4176	1378	973	526	4404	204	541	430	1134
3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	3062_LILRB2 - Leukocyte immunoglobulin-like receptor subfamily B member 2	25	171	1	3835	236	4031	171	1322	2066	3084	4653	2570	615	1086	3213	706	1424	1660	4087	4381	1604
1143_Acute insulin response (adjusted for BMI)	1143_Acute insulin response (adjusted for BMI)	25	171	1	3760	954	1057	2051	3962	171	946	4679	2850	717	1668	2331	3604	319	3817	4458	3319	2712
4103_Hemoglobin A1c	4103_Hemoglobin A1c	25	171	1	2569	3576	3760	4057	3708	826	1332	171	2090	2205	3440	4357	1356	3414	794	347	374	3396
1098_Body Mass Index - Birth cohorts	1098_Body Mass Index - Birth cohorts	25	171	1	1736	845	1956	1666	1616	1250	3462	2292	171	4401	3663	1044	3651	4714	3867	3292	4210	3976
4289_PEF	4289_PEF	25	171	1	3187	3530	2592	1842	4659	3196	2894	1673	3221	171	1829	4329	3087	732	3811	2253	4712	1406
3784_Depression - Weight change during worst episode of depression	3784_Depression - Weight change during worst episode of depression	25	171	1	695	3541	1550	3386	630	1574	4292	3471	4433	3707	171	2940	3182	2519	1309	3916	736	3868
1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	1397_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for multivariable)	25	171	1	731	1528	3234	4527	3882	1451	1330	1690	1571	1596	1334	171	4115	3834	2183	3809	1529	598
3975_Total body BMD (15-30 years old)	3975_Total body BMD (15-30 years old)	25	171	1	1133	2206	3522	3971	1655	1287	1453	1344	3415	1928	3870	187	1217	1737	171	404	3111	1882
1082_Hemoglobin A1C level in conventional treatment group	1082_Hemoglobin A1C level in conventional treatment group	25	172	1	2007	172	721	2889	2365	3588	3764	3143	3068	524	687	1798	3952	3511	810	4321	368	3425
2386_CTSA - Lysosomal protective protein	2386_CTSA - Lysosomal protective protein	25	172	1	4676	1521	3880	2593	172	387	1051	3084	389	841	4437	839	2891	3428	1030	620	461	4686
3801_Hematocrit	3801_Hematocrit	25	172	1	2836	3201	3462	541	2189	172	307	2641	1943	4027	2339	642	4264	3373	4362	3277	2153	1591
3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	3588_Types of physical activity in last 4 weeks: Light DIY (eg: pruning, watering the lawn)	25	172	1	206	2308	1790	4332	1695	3587	172	4387	4696	546	4160	1721	2391	3347	458	3401	1789	1543
1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	1317_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age and sex)	24	172	1	2796	3926	3519	3532	1765	913	2202	928	172	3800	4430	4506	920	984	4663	1655	4230	222
3910_Vertical cup-disc ratio	3910_Vertical cup-disc ratio	25	172	1	2199	566	2473	2984	3458	943	4365	927	3828	2234	1488	172	2010	3677	4593	2773	3754	4312
1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1805_PNN50 HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	172	1	1159	1070	4554	2161	2492	553	1073	4477	3953	2471	3282	2450	926	172	4053	836	1901	4472
1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	1873_Shaft average buckling ratio (GEE, male, adjussted for multivariable)	25	172	1	3855	899	1456	3643	4123	3637	863	4637	1803	1603	1269	3914	4300	4013	172	3854	4211	1441
897_Phospholipids in large LDL	897_Phospholipids in large LDL	25	172	1	2296	633	2835	2643	2760	3791	1652	1875	3522	4312	2389	959	4598	3976	3147	172	2236	769
414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	414_Amino acid::Urea cycle; arginine-, proline-, metabolism::homocitrulline	25	172	1	4594	4306	3608	3018	2511	253	2900	602	1203	424	174	1786	2128	2842	2858	226	172	4219
1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	1153_Insulin response to glucose duing the first 30 min (adjusted for BMI)	25	172	1	725	1610	460	573	991	831	602	1560	2185	586	2262	2516	228	4435	435	1011	560	172
1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	1546_Maximum carotid artery bulb IMT (at exam 6, FBAT, adjusted for age and sex)	25	173	1	860	173	544	2108	1744	1996	641	2358	2890	1996	4540	4195	1940	1944	1833	2205	2318	1909
2303_LGALS4 - Galectin-4	2303_LGALS4 - Galectin-4	25	173	1	3642	982	1152	2338	173	2860	2611	1865	2895	2857	252	1460	2950	1017	386	749	3278	4414
2387_CTSD - Cathepsin D	2387_CTSD - Cathepsin D	25	173	1	340	4635	2612	1637	1908	3473	173	1834	465	2683	3700	1813	923	1730	3351	1235	3983	802
2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	2839_ENTPD5 - Ectonucleoside triphosphate diphosphohydrolase 5	25	173	1	2948	813	676	840	2953	1147	1721	1472	173	4290	4236	3089	1530	2117	4712	4469	2658	4662
3021_PARK7 - Protein DJ-1	3021_PARK7 - Protein DJ-1	25	173	1	1311	4655	4345	176	2937	2026	3790	2238	1965	173	4150	3630	4497	2425	3556	2701	1830	4736
3164_BRF1 - Transcription factor IIIB 90 kDa subunit	3164_BRF1 - Transcription factor IIIB 90 kDa subunit	25	173	1	2204	2961	3320	4081	1254	3826	2655	318	4316	2782	2216	173	3766	1041	939	3445	629	2784
2823_DHH - Desert hedgehog protein N-product	2823_DHH - Desert hedgehog protein N-product	25	173	1	3995	2040	2774	2583	404	3181	2532	1207	3773	3249	717	3389	2218	173	4440	2496	2020	416
1223_Mean Pallidum	1223_Mean Pallidum	25	173	1	1604	697	3758	1973	3769	3328	3928	4110	1383	1041	1131	4624	2269	4618	173	3363	4726	2289
301_CD4mem:%PD1-R6+	301_CD4mem:%PD1-R6+	25	173	1	3454	2693	3173	4504	1566	1255	3779	2490	2612	1610	2404	267	3191	3671	500	3591	173	3793
2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	2536_PRKACA - cAMP-dependent protein kinase catalytic subunit alpha	25	174	1	174	2535	1662	1640	2503	4067	2810	738	4021	821	2890	4536	1636	4501	3504	726	4624	1385
2742_IL20 - Interleukin-20	2742_IL20 - Interleukin-20	25	174	1	3171	1871	946	174	3081	1889	1048	697	4671	1429	3668	3129	195	1712	3432	4518	3094	196
173_Waist circumference (adjusted for BMI)	173_Waist circumference (adjusted for BMI)	25	174	2	2668	1497	2249	1402	806	174	3413	3258	1427	1580	805	1513	1122	3474	3631	2451	720	3584
3988_Heart rate recovery at 40 secnds	3988_Heart rate recovery at 40 secnds	25	174	1	4461	2426	3952	1243	3763	3106	1621	4258	192	174	2044	304	3704	3098	1886	3218	4468	4528
3443_Impedance measures - Whole body fat-free mass	3443_Impedance measures - Whole body fat-free mass	25	174	2	2440	4320	3221	2266	4090	779	1055	1824	2431	3385	1757	1280	1297	174	1028	1100	1796	1459
219_Lymph:%CD8	219_Lymph:%CD8	25	174	1	3786	1483	1140	1895	4610	3819	4575	1945	2436	4229	3479	3638	1684	1677	174	3140	993	491
723_::::X-11550	723_::::X-11550	25	174	1	3231	3135	4567	2424	3775	199	4675	2735	2925	3071	684	3715	3590	601	4133	1195	174	1724
1875_Shaft average buckling ratio (GEE, female, adjussted for age)	1875_Shaft average buckling ratio (GEE, female, adjussted for age)	25	174	1	1070	1652	3582	2295	4299	920	3797	2507	3406	662	2448	2803	567	4511	3313	3461	632	174
2964_CCL19 - C-C motif chemokine 19	2964_CCL19 - C-C motif chemokine 19	25	175	1	175	1974	521	4212	1099	4151	1498	688	876	1751	2362	1342	1069	1351	2198	2435	2433	295
238_CD27 on IgA+B	238_CD27 on IgA+B	25	175	1	197	292	1197	175	1870	1631	3888	827	3217	1734	4705	3955	4594	2134	1078	4153	2638	1066
2406_LTA4H - Leukotriene A-4 hydrolase	2406_LTA4H - Leukotriene A-4 hydrolase	25	175	1	489	2815	2182	2007	175	2464	256	704	1489	4679	1012	537	639	221	1592	1058	2634	2968
2355_LGALS3 - Galectin-3	2355_LGALS3 - Galectin-3	25	175	1	3919	2938	439	3269	3796	3620	3296	2890	175	2792	1433	1741	839	3424	1190	4671	1350	1044
347_CD8:%TM (1)	347_CD8:%TM (1)	25	175	1	2884	3291	2282	3022	3540	4494	1047	3070	2441	175	3150	2547	217	1783	1292	2112	4256	3187
1040_Shaft Width (FBAT, adjusted for age and sex)	1040_Shaft Width (FBAT, adjusted for age and sex)	25	175	1	953	810	2624	4277	1176	3623	4513	649	1963	750	2740	175	1416	1585	3706	2313	3273	1789
213_Lymph:%CD4	213_Lymph:%CD4	25	175	1	2777	1467	4375	3443	304	2229	3969	1527	4102	286	1959	1574	3800	659	175	1667	272	4518
4742_External capsule radial diusivities	4742_External capsule radial diusivities	25	175	1	961	2833	2873	4682	3481	492	1553	3357	905	2727	4274	1230	1911	1192	3421	4651	3154	175
1946_Visual memory composite score (FBAT, adjusted for multivariable)	1946_Visual memory composite score (FBAT, adjusted for multivariable)	25	176	1	176	1945	310	513	1752	997	287	993	1910	2522	3210	1184	935	4444	2415	1409	1058	2487
1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	1275_Epworth Sleepiness Scale (GEE, adjusted for age, sex, BMI, usual sleep duration and additional self-reported sleeping disorder)	25	176	1	1524	176	3464	375	2763	824	1059	764	702	3987	2803	2534	629	1318	3273	439	2744	2501
3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	3686_Diagnoses - secondary ICD10: E11 Type 2 diabetes mellitus	25	176	1	1619	1003	176	2901	1118	1175	2276	2477	946	197	783	4516	3745	3613	1342	3126	269	4407
3760_Depression - Recent feelings of inadequacy	3760_Depression - Recent feelings of inadequacy	25	176	1	1320	4571	3007	3229	2141	2018	176	2697	2944	406	1572	4259	3782	4299	1887	1220	2822	2978
3971_Total body BMD	3971_Total body BMD	25	176	1	4446	924	3306	1041	396	1417	2410	3399	4103	176	4409	684	2220	4110	498	997	657	4445
2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	2130_IL13RA1 - Interleukin-13 receptor subunit alpha-1	25	176	1	1442	2698	2805	4561	459	3567	2817	473	445	1106	2926	176	1916	3518	2012	1705	2819	1164
2552_CNTF - Ciliary Neurotrophic Factor	2552_CNTF - Ciliary Neurotrophic Factor	25	176	1	1367	2804	2545	3766	1072	1572	2596	850	3001	2724	3869	2049	3605	3282	176	2384	3433	4247
2922_COL8A1 - Collagen alpha-1(VIII) chain	2922_COL8A1 - Collagen alpha-1(VIII) chain	25	177	1	4234	1586	3660	3813	2135	2900	4385	1355	177	275	742	921	1029	839	661	4727	3672	2903
127_Height (female)	127_Height (female)	25	177	1	1467	1090	594	2038	1336	2397	2157	2142	2313	1360	1376	2026	2219	177	4085	3793	1418	3663
3281_Mother's age	3281_Mother's age	25	177	1	972	1807	1389	3565	1909	4346	4502	1502	3593	2055	1015	4661	2597	1343	4619	177	4672	2560
3172_NPPA - Atrial natriuretic factor	3172_NPPA - Atrial natriuretic factor	25	177	1	3664	521	3493	958	3914	4741	1530	2775	316	4232	399	2438	1555	2069	2116	3985	883	177
3574_Pain type(s) experienced in last month: Hip pain	3574_Pain type(s) experienced in last month: Hip pain	25	178	1	1557	178	2714	1376	2476	3139	1599	2679	4572	682	4050	4166	795	1153	1993	341	1252	2888
4731_Superior fronto-occipital fasciculus mode of anisotropy	4731_Superior fronto-occipital fasciculus mode of anisotropy	25	178	1	1407	359	178	2320	2695	3327	435	1660	2126	3556	739	3224	818	729	1782	3300	2955	1439
4129_White blood cell count	4129_White blood cell count	25	178	1	3709	4128	2448	1599	2711	178	4317	1122	3211	2715	2235	3174	849	2159	4364	234	2584	3165
4326_Depressive symptoms (MA GWAMA)	4326_Depressive symptoms (MA GWAMA)	25	178	1	762	827	633	3236	4014	1333	178	2062	3222	1357	2980	4253	3962	4497	2148	2005	574	3400
3407_Number of older siblings	3407_Number of older siblings	25	178	1	2288	3893	875	1454	755	1810	3264	178	4584	1417	3997	2910	374	4108	2241	466	2862	4034
1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1476_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	178	1	2012	2246	474	610	1556	776	2509	2054	4565	178	377	3656	279	456	1767	2539	2388	4282
1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	1299_Fasting plasma glucose (at exam 5, GEE, adjusted for age and sex)	24	178	1	1329	3549	677	2801	4288	3386	1623	781	878	4353	2933	178	2437	3983	1828	1070	2695	3159
2684_AIP - AH receptor-interacting protein	2684_AIP - AH receptor-interacting protein	25	178	1	3594	2127	4134	4638	4693	3565	1754	3066	3212	2403	3431	2889	2855	2058	178	1179	4068	3626
2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	2383_ADAMTS13 - A disintegrin and metalloproteinase with thrombospondin motifs 13	25	178	1	2333	1515	1773	2556	1289	2735	1327	3386	649	2886	3364	4380	1050	2303	1353	178	1687	1034
4417_Rubella seropositivity	4417_Rubella seropositivity	25	178	1	2682	379	2029	3736	3498	3755	1322	3582	1670	3276	4361	3988	2751	1565	430	3731	178	516
3641_Illnesses of mother: Bowel cancer	3641_Illnesses of mother: Bowel cancer	25	179	1	3889	179	2685	2249	1225	4506	4643	2783	1330	4338	2265	2769	2748	261	2282	2234	1666	3751
3642_Illnesses of mother: Breast cancer	3642_Illnesses of mother: Breast cancer	25	179	1	4512	3158	179	2906	4418	1615	2543	4041	2569	256	2377	1711	3662	4579	4678	4542	713	4583
107_Tanner scale	107_Tanner scale	25	179	1	3322	4531	1178	1745	179	4620	2692	2545	3519	4061	2491	1254	1943	3566	1455	1245	3384	2482
2478_CSK - Tyrosine-protein kinase CSK	2478_CSK - Tyrosine-protein kinase CSK	25	179	1	4225	2955	3343	4720	4227	272	179	2665	3844	2422	2434	3392	2715	1770	3682	4603	2679	2414
637_Xenobiotics::Food component, Plant::thymol sulfate	637_Xenobiotics::Food component, Plant::thymol sulfate	25	179	1	4536	4634	600	3514	4235	3804	4483	3658	179	3546	2298	4385	3855	4177	3609	2171	1339	3830
1932_Parietal brain volume (FBAT, adjusted for age and sex)	1932_Parietal brain volume (FBAT, adjusted for age and sex)	25	179	1	931	4603	3143	1083	4468	3794	4611	2502	853	2453	179	2723	2483	2535	2640	4135	4201	2794
2715_LDHB - L-lactate dehydrogenase B chain	2715_LDHB - L-lactate dehydrogenase B chain	25	179	1	3477	2814	732	4433	1529	1392	1286	4117	2901	1269	1983	4314	4540	179	2442	1511	1728	3788
4082_Waist-hip ratio (adjusted for BMI, female)	4082_Waist-hip ratio (adjusted for BMI, female)	25	179	1	3662	3780	2640	293	1816	3467	1645	2711	2168	4633	824	1387	1729	3408	179	458	221	936
3434_Numeric memory test - Maximum digits remembered correctly	3434_Numeric memory test - Maximum digits remembered correctly	25	179	1	819	1685	1761	388	1048	293	4461	523	1915	1867	931	3566	2476	2344	3878	179	2687	4476
483_Lipid::Carnitine metabolism::octanoylcarnitine	483_Lipid::Carnitine metabolism::octanoylcarnitine	25	179	1	4465	2252	1225	2533	830	2286	3269	650	4634	3345	651	1215	1143	1281	1690	3368	179	3402
1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1800_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	180	1	3197	180	569	1196	1472	4481	1249	1500	3601	2719	3598	1130	3372	535	3050	299	1897	1666
4589_Right middle temporal	4589_Right middle temporal	25	180	1	2790	1319	3714	180	450	3855	1963	3027	3887	3833	4360	2302	2900	4529	473	1177	4410	4692
4354_Infantile hypertrophic pyloric stenosis	4354_Infantile hypertrophic pyloric stenosis	25	180	1	646	1975	1828	2047	2187	180	847	2984	4695	3752	382	1059	3181	2258	3821	805	2428	407
2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	2697_RPS6KA5 - Ribosomal protein S6 kinase alpha-5	25	180	1	2421	2866	620	1348	1981	3117	4170	1881	1582	180	4479	3531	3380	4346	2413	1683	4583	391
2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	2395_WFIKKN1 - WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 1	25	180	1	1820	2828	1795	282	594	926	2241	2713	936	505	1803	2309	180	3665	752	4126	3073	818
1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	1494_Remnant lipoprotein triglycerides (at exam 4, FBAT)	25	180	1	3448	3415	4578	1646	4731	4735	767	2314	3059	3435	2598	3872	2193	180	2937	3349	2265	1681
2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	2703_UBE2L3 - Ubiquitin-conjugating enzyme E2 L3	25	180	1	3891	4630	1432	1429	2317	2682	2094	3121	3854	2065	2647	3853	2921	2979	1638	4118	4019	180
1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1429_Small high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	181	1	181	1177	3855	3484	2941	4696	2868	1894	4604	2356	1458	1432	1969	1683	4719	2438	653	2537
4060_Estimated glomerular filtration rate based on cystain C	4060_Estimated glomerular filtration rate based on cystain C	25	181	1	890	181	4685	4529	4069	1688	3611	3901	3708	4435	2584	1986	2337	4581	2367	3650	2669	4537
1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	1531_Ankle-brachial index (at exam 6, GEE, adjusted for age and sex)	25	181	1	828	4665	2859	1369	181	2526	4178	1382	3727	357	1965	4617	4455	4575	1851	2698	1918	1320
4340_Walking (conditioning sex and BMI)	4340_Walking (conditioning sex and BMI)	25	181	1	3921	210	762	3498	1194	181	3973	1935	3088	4222	2205	3971	1837	1601	2279	3309	3331	1101
436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	436_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::fructose	25	181	1	1825	215	502	3851	3227	3578	4487	3832	4181	181	3772	2485	3476	782	796	3843	3345	2804
3255_Tea intake	3255_Tea intake	25	181	1	2822	3476	1195	2767	3105	3649	2861	3626	1592	1382	3287	4702	3445	181	4002	3639	1029	4745
1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1401_High-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	181	1	425	1849	3359	291	1422	682	610	4166	266	3017	4298	294	466	585	384	1553	2229	181
427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	427_Amino acid::Valine, leucine and isoleucine metabolism::hydroxyisovaleroyl carnitine	25	182	1	4443	2954	182	2885	3636	4658	1248	3699	2297	4052	3813	1046	1981	1324	4737	4661	1777	2216
482_Lipid::Carnitine metabolism::laurylcarnitine	482_Lipid::Carnitine metabolism::laurylcarnitine	25	182	1	3060	538	3972	3909	182	3871	266	1740	1660	2204	893	3261	1608	3477	3829	3567	3120	3096
4058_Estimated glomerular filtration rate based on serum creatinine	4058_Estimated glomerular filtration rate based on serum creatinine	25	182	1	4677	3084	1280	4667	377	182	2106	2394	1697	1750	3671	1819	1268	1076	1582	2257	2401	815
677_::::X-09026	677_::::X-09026	25	182	1	1533	794	547	3880	3265	3344	182	4744	1598	3855	1502	3537	1359	3180	2263	4737	4734	3598
1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	1630_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for age and sex)	25	182	1	3143	3386	1847	2499	2540	3759	3111	182	1840	844	830	3827	1021	786	2682	1554	3047	521
3170_TNNI2 - Troponin I, fast skeletal muscle	3170_TNNI2 - Troponin I, fast skeletal muscle	25	182	1	1679	909	1822	329	3682	4476	3291	745	3707	2278	182	980	491	2659	4206	634	4042	353
3078_NOTCH3 - Neurogenic locus notch homolog protein 3	3078_NOTCH3 - Neurogenic locus notch homolog protein 3	25	182	1	1454	4027	3928	2313	1409	2092	1447	519	424	2580	956	182	2884	3793	4184	1876	2392	333
1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	1650_Tumor necrosis factor alpha (at exam 7, FBAT, adjusted for age and sex)	25	182	1	3029	2602	978	4671	3051	1652	1062	3667	4402	2837	4255	2434	182	1570	2014	3146	2008	3579
743_::::X-11876	743_::::X-11876	25	182	1	2179	2095	3759	3423	3166	3217	369	2856	3722	1732	3276	199	2883	182	4418	3212	4607	643
3383_Prospective memory test - Number of attempts	3383_Prospective memory test - Number of attempts	25	182	1	1380	1062	975	2489	538	392	3415	1765	3257	3051	2562	3385	3689	2727	182	832	4077	1533
2462_ABL1 - Tyrosine-protein kinase ABL1	2462_ABL1 - Tyrosine-protein kinase ABL1	25	182	1	366	4234	1424	4681	4657	4647	4520	1470	927	1660	1995	2215	4290	1009	4518	4337	182	3593
11_Schizophrenia	11_Schizophrenia	25	183	2	3338	183	1496	4621	4330	1046	2772	2294	1347	2612	555	4162	3775	418	4411	2318	3701	4429
3856_Myeloid white cell count (two-way meta)	3856_Myeloid white cell count (two-way meta)	25	183	1	2139	1387	183	1718	2710	371	710	3109	2085	4650	3687	1846	2946	4077	2826	2712	3199	4351
4480_Right fusiform	4480_Right fusiform	25	183	1	363	2689	2245	3837	183	2267	3083	3039	632	2869	1315	4301	4502	2728	2379	3137	2689	2364
2274_ARTN - Artemin	2274_ARTN - Artemin	25	183	1	2026	3992	2347	880	1502	183	583	3468	3031	4587	1750	3437	3472	4718	4386	1704	753	1504
1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	1572_Mean abdominal aortic calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable\)	25	183	1	4199	3940	4689	4660	1095	1154	2429	183	2415	712	1285	3270	2570	1414	243	376	1152	4193
4146_Interventricular septum thickness	4146_Interventricular septum thickness	25	183	1	1948	2089	1803	4439	2257	1764	1119	2874	719	1220	1856	787	2914	183	2048	1559	1800	4591
713_::::X-11485	713_::::X-11485	25	183	1	2688	2526	271	2236	1250	4122	4120	2047	3493	2443	4213	4741	2383	1868	183	2628	1682	1253
766_::::X-12231	766_::::X-12231	25	183	1	3598	4105	1388	867	2239	4298	2266	1240	1949	2486	2432	1137	4349	997	542	4076	183	202
3402_Fluid intelligence test - FI3 : word interpolation	3402_Fluid intelligence test - FI3 : word interpolation	25	183	1	3071	3350	3561	1738	560	2800	2040	1783	2437	675	2388	4383	4630	1891	4081	359	3493	183
2828_IFNL2 - Interferon lambda-2	2828_IFNL2 - Interferon lambda-2	25	184	1	184	4283	3211	4156	2482	1798	813	1723	3815	3941	3904	4144	2736	1513	2850	3204	892	2690
3564_Vitamin and mineral supplements: Vitamin D	3564_Vitamin and mineral supplements: Vitamin D	25	184	1	737	184	1710	814	2894	1421	4713	1791	4555	408	586	4543	1224	3094	890	438	4451	703
182_Waist-hip ratio (male)	182_Waist-hip ratio (male)	25	184	1	3184	2748	304	184	3085	640	1308	4416	1147	448	3175	501	324	4681	1384	3113	2317	1031
963_Phospholipids in very large VLDL	963_Phospholipids in very large VLDL	25	184	1	1997	4181	1040	442	798	2068	4260	2919	2692	3446	4587	184	3131	3842	4444	3411	1273	2033
3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	3694_Diagnoses - secondary ICD10: I48 Atrial fibrillation and flutter	25	184	1	3113	1140	3491	2751	1205	3124	3447	4209	4559	991	2718	2077	3668	311	923	2814	206	184
1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	1611_von Willebrand Factor (at exam 5, GEE, adjusted for age and sex)	25	185	1	185	4121	3111	1353	1490	2048	4210	3606	3697	4147	2575	4035	3734	4699	4450	1302	444	3867
3816_CD19+ B cell level	3816_CD19+ B cell level	25	185	1	4611	1936	1123	185	2210	1023	1131	3277	3332	4492	4431	3690	358	1035	3925	3822	2817	1518
1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	1609_Viscosity I (at exam 5, GEE, adjusted for multivariable)	25	185	1	2915	739	242	4605	185	2758	1367	2371	3858	801	4696	2979	1847	4398	2118	4609	4587	4047
3324_Relative age of first facial hair (male)	3324_Relative age of first facial hair (male)	25	185	1	464	749	265	3401	2967	468	2181	1999	3448	1033	2050	185	1998	2025	4198	1208	2380	442
342_NKearly:%337+335+R7-	342_NKearly:%337+335+R7-	25	185	1	3753	4362	4393	714	3870	3280	1377	4102	1812	2088	2859	4685	947	185	1478	3641	4612	3990
2045_Primary angle closure glaucoma	2045_Primary angle closure glaucoma	25	185	1	311	2839	2204	3390	338	348	524	294	1425	1377	937	739	4232	4174	625	185	1282	4734
1173_Chronotype (continuous)	1173_Chronotype (continuous)	25	185	1	1364	3092	4050	2581	3208	2820	3978	2882	1121	2349	2715	2101	4732	2993	839	646	2575	185
2194_FGF20 - Fibroblast growth factor 20	2194_FGF20 - Fibroblast growth factor 20	25	186	1	186	4132	4552	3153	3093	3994	2110	1019	836	375	4684	3141	2685	3296	2676	4364	264	1278
2808_TPI1 - Triosephosphate isomerase	2808_TPI1 - Triosephosphate isomerase	25	186	1	636	186	4456	3890	1241	2318	1403	1226	1930	721	696	759	1253	981	4542	187	1966	1862
1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	1471_Lipoprotein A (at exam 3, GEE, adjusted for age and sex)	25	186	1	2887	3170	1478	2355	186	3632	1671	4554	2278	4355	3115	2564	2350	743	3551	2076	1011	4243
1119_Pericardial adipose tissue volume (female)	1119_Pericardial adipose tissue volume (female)	25	186	1	1698	728	2590	3324	976	186	4313	2015	2187	2954	1266	2134	670	2048	3148	292	4405	3052
840_::::X-14541	840_::::X-14541	25	186	1	2336	2166	4505	3333	2303	664	186	2305	588	1756	2486	4360	3949	3815	2412	1880	4646	3543
328_CD4mem:%preTh17 (3)	328_CD4mem:%preTh17 (3)	25	186	1	3022	2679	1524	476	2629	3655	1584	186	4261	543	3321	2412	297	3189	4350	2002	2111	3803
1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	1741_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for multivariable)	25	186	1	795	1917	2499	2880	4012	3366	2374	2426	186	2934	4453	1375	863	2310	2824	4235	995	296
687_::::X-10810	687_::::X-10810	25	186	1	4490	712	3673	449	4707	1910	4578	2983	1414	186	4424	568	3175	3629	2919	4625	3535	2513
3583_Types of transport used (excluding work): Public transport	3583_Types of transport used (excluding work): Public transport	25	186	1	739	825	700	2918	2850	2664	3192	3925	625	3281	3593	186	4205	4227	4701	3290	3767	946
3147_CASP10 - Caspase-10	3147_CASP10 - Caspase-10	25	186	1	1884	1249	712	386	2316	3489	1688	4681	2715	2533	1352	666	186	4375	3405	4721	2263	1951
308_CD4nv:%Th0	308_CD4nv:%Th0	25	186	1	4564	1499	369	424	3876	488	2537	663	3669	4670	546	3673	3281	186	2468	3085	910	2432
2982_CA1 - Carbonic anhydrase 1	2982_CA1 - Carbonic anhydrase 1	25	187	1	3686	510	187	2704	365	384	3368	694	449	1849	3438	2729	2569	1688	3774	4504	3781	518
252_CD3 on CD8 T	252_CD3 on CD8 T	25	187	1	1084	2242	4247	259	187	1005	939	740	2905	4044	483	4556	2203	967	1957	2646	1839	915
1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	1341_28 year time-averaged Fasting plasma glucose (GEE, adjusted for age, sex and BMI)	24	187	1	4396	1775	1882	4041	1342	758	2589	187	300	2904	2692	4433	1087	2389	2961	3465	2787	362
1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	1717_Thyroid stimulation hormone (at exam 4, GEE, adjusted for multivariable)	25	187	1	4506	2852	3308	1781	3407	287	4041	3025	378	3633	3863	3805	3398	187	3809	2418	992	1642
4408_Vaginal discharge: Itching	4408_Vaginal discharge: Itching	25	188	1	188	807	303	349	283	438	1301	617	1810	281	1553	3677	534	641	3564	1808	3602	2602
1116_Visceral sdipose tissue volume (adjusted for BMI, female)	1116_Visceral sdipose tissue volume (adjusted for BMI, female)	25	188	1	3554	1165	188	2991	2483	2008	1524	1828	4147	1396	2557	3952	2641	3409	3988	3355	2243	2180
2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	2645_ITGA2B ITGB3 - Integrin alpha-IIb: beta-3 complex	25	188	1	3559	4228	4223	1800	2228	2742	1935	3255	188	295	4592	4722	2115	390	1911	548	4489	2964
1104_Low-density lipoprotein - Birth cohorts	1104_Low-density lipoprotein - Birth cohorts	25	188	1	3222	3732	1045	4100	1859	681	971	2107	3317	865	188	746	1553	3623	1429	2129	4552	2218
3379_Diastolic Blood Pressure (automated reading)	3379_Diastolic Blood Pressure (automated reading)	25	188	1	2432	3731	3239	4237	3967	3115	4094	4339	1576	3913	1535	188	1726	3065	741	4163	1107	4069
4427_Epstein Barr Virus antigen EBNA seropositivity	4427_Epstein Barr Virus antigen EBNA seropositivity	25	188	1	1605	3327	825	2061	2246	243	857	3817	4509	4509	1610	711	2602	1057	1535	2161	188	865
3473_Reported occurrences of cancer	3473_Reported occurrences of cancer	25	189	1	1023	189	4742	1212	1382	1128	1321	3581	2869	4275	4349	2193	1264	3661	3212	1710	3480	4625
36_Loneliness (multivariate)	36_Loneliness (multivariate)	25	189	1	565	410	189	2973	2848	3646	1557	3518	261	2849	3878	3099	3016	2969	4460	2642	4654	2714
3_Attention deficit hyperactivity disorder	3_Attention deficit hyperactivity disorder	25	189	1	294	4586	2546	4408	189	448	4311	2045	4074	541	4626	1931	2631	465	328	1958	799	4100
4153_Fractional shortening	4153_Fractional shortening	25	189	1	4713	1984	2559	3586	4029	189	1379	3311	2625	2230	439	2169	4145	2658	763	3800	3088	2001
3306_Ever had same-sex intercourse	3306_Ever had same-sex intercourse	25	189	1	4169	853	2301	3610	1982	847	3659	648	189	2396	4210	1956	1330	958	4691	4328	2769	4520
3263_Average weekly champagne plus white wine intake	3263_Average weekly champagne plus white wine intake	25	189	1	1977	1555	4064	2840	4699	1723	1314	2985	2831	3054	1608	189	1384	2317	4215	905	2814	880
4338_Sleep durataion (conditioning sex and BMI)	4338_Sleep durataion (conditioning sex and BMI)	25	189	1	1065	2278	2117	709	675	1003	3406	2922	1480	4577	3388	897	189	1084	2770	1538	2375	2265
4687_Superior fronto-occipital fasciculus axial diusivities	4687_Superior fronto-occipital fasciculus axial diusivities	25	189	1	2406	4106	3441	3732	1802	1597	2447	2053	4519	1868	4234	3343	3360	3691	189	4360	2261	2285
2336_CCL3 - C-C motif chemokine 3	2336_CCL3 - C-C motif chemokine 3	25	189	1	2577	3724	2914	1424	4071	4519	4584	3037	4073	1155	3931	2625	3616	2775	2925	189	3625	4153
3797_Depressive affect subcluster	3797_Depressive affect subcluster	25	189	1	3634	1741	2584	4145	3499	2687	1999	521	3480	4090	2141	756	4735	1673	1174	4616	1426	189
353_IgE+B:%27+	353_IgE+B:%27+	25	190	1	190	1432	3818	3016	2070	3991	1074	494	3535	2223	2494	3582	1092	1931	4595	1723	1948	1350
2087_ANGPT4 - Angiopoietin-4	2087_ANGPT4 - Angiopoietin-4	25	190	1	1124	190	841	1439	253	2702	511	1399	422	2923	2845	500	4353	3600	2944	4451	1411	1997
4740_Cingulum (hippocampus) radial diusivities	4740_Cingulum (hippocampus) radial diusivities	25	190	1	4691	320	190	3096	4499	2572	3987	3176	2450	423	3318	2766	4607	224	827	2526	2147	856
3730_Depression - Age at last episode of depression	3730_Depression - Age at last episode of depression	25	190	1	1740	1739	1924	3962	2680	1847	1469	2499	4322	190	1023	532	4720	3217	1870	2363	925	1306
702_::::X-11438	702_::::X-11438	25	190	1	2950	1474	557	4421	1101	2657	2361	3462	773	404	190	714	4586	4355	4105	3874	1783	2446
3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	3067_KIR3DL2 - Killer cell immunoglobulin-like receptor 3DL2	25	190	1	3911	3611	2638	2588	1620	3456	2530	4539	2943	4534	3955	3070	4169	190	2643	2039	250	1329
3909_Vertical cup-disc ratio	3909_Vertical cup-disc ratio	25	190	1	1307	558	533	235	3067	1389	1959	2710	1120	2889	1507	1321	262	302	190	3824	2880	3185
1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	1417_High-density lipoprotein cholesterol (at exam 6, GEE, adjusted for age and sex)	25	190	1	2975	3049	3650	4123	3527	2816	1615	951	289	3414	1682	3429	668	3990	1616	190	4334	2167
110_Coronary artery disease	110_Coronary artery disease	25	191	1	191	3283	675	2845	3587	4554	230	1142	3208	3950	846	3468	3866	2474	1269	2948	4044	731
708_::::X-11452	708_::::X-11452	25	191	1	1805	1545	191	3084	2539	2433	2901	619	393	2474	1630	2849	4184	2639	2965	4251	2835	3297
3950_Amyotrophic lateral sclerosis (logistic)	3950_Amyotrophic lateral sclerosis (logistic)	25	191	1	1817	2150	1298	191	1874	4646	2438	3775	4493	4237	2660	1627	377	1220	4686	2825	4671	3953
3004_HRG - Histidine-rich glycoprotein	3004_HRG - Histidine-rich glycoprotein	25	191	1	3096	2620	2813	3450	1065	1675	191	2446	3513	778	1967	320	3667	1298	1596	2985	746	2696
4162_Focal Epilepsy, other lesion	4162_Focal Epilepsy, other lesion	25	191	1	3899	3531	2505	1480	940	3057	1179	191	2339	4426	2476	1549	3229	4093	2760	3601	698	2276
467_Lipid::Bile acid metabolism::glycocholate	467_Lipid::Bile acid metabolism::glycocholate	25	191	1	3774	1200	3854	3240	1038	1587	2586	2676	191	3562	3507	212	2923	3738	4363	4717	3048	2367
1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1430_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	191	1	2498	725	495	1577	1679	534	3455	4358	3184	191	3864	3339	3146	1021	3638	4184	3682	3634
631_Xenobiotics::Food component, Plant::homostachydrine*	631_Xenobiotics::Food component, Plant::homostachydrine*	25	191	1	4228	3605	3806	3782	2888	2006	4240	3528	2822	3877	856	3037	3204	191	2333	2889	1490	4321
1180_Insomnia (female)	1180_Insomnia (female)	25	191	1	4070	321	391	2402	4720	3662	3810	3195	286	1480	332	2966	275	1365	191	492	4640	1531
893_Cholesterol esters in large LDL	893_Cholesterol esters in large LDL	25	191	1	2174	341	2763	2135	3591	3767	1706	2119	2316	4741	2036	749	4737	3704	1673	191	2094	520
420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	420_Amino acid::Valine, leucine and isoleucine metabolism::2-hydroxyisobutyrate	25	192	1	192	1840	4466	537	3744	2991	2118	4203	1051	4101	803	4466	1466	4179	4242	1671	385	1788
330_CD4mem:%R6+	330_CD4mem:%R6+	25	192	1	2651	551	1979	192	4085	3995	1039	2936	1988	3554	225	3100	3815	3237	3232	2492	3136	4361
3065_AMICA1 - Junctional adhesion molecule-like	3065_AMICA1 - Junctional adhesion molecule-like	25	192	1	3376	2618	1495	3519	754	2284	2506	4560	4262	192	2561	4039	3109	1519	935	743	3152	3184
471_Lipid::Bile acid metabolism::taurocholate	471_Lipid::Bile acid metabolism::taurocholate	25	192	1	2643	2694	1755	3780	1700	302	1742	814	4202	1436	192	4578	3272	4700	3700	957	2349	4303
3758_Anxiety - Recent easy annoyance or irritability	3758_Anxiety - Recent easy annoyance or irritability	25	192	1	272	868	3013	444	3126	1770	3811	270	1837	1488	4179	3433	192	1747	1737	211	769	1601
2446_SERPIND1 - Heparin cofactor 2	2446_SERPIND1 - Heparin cofactor 2	25	192	1	837	4419	4253	2763	695	1116	1780	477	2814	874	578	3703	755	3986	192	1769	2555	637
3343_Age at first live birth (female)	3343_Age at first live birth (female)	25	192	1	2366	2279	4495	3504	1001	3600	3754	3321	2275	1737	493	3048	1714	3019	814	192	999	3272
2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	2700_SGTA - Small glutamine-rich tetratricopeptide repeat-containing protein alpha	25	192	1	4488	539	3185	3660	1325	2694	3952	4344	1024	1628	1783	4452	3357	4650	4064	3468	3187	192
1033_Neck Section Modulus (GEE, adjusted for age and sex)	1033_Neck Section Modulus (GEE, adjusted for age and sex)	25	193	1	741	2921	381	1578	4538	3939	3445	193	569	1147	3482	2200	2617	1072	4045	1964	2049	1092
80_Femoral Neck BMD	80_Femoral Neck BMD	25	193	1	2778	1596	2447	4310	2570	4274	1244	1608	3932	193	277	2955	2968	4155	1155	2609	325	2427
3492_Coffee type: Decaffeinated coffee (any type)	3492_Coffee type: Decaffeinated coffee (any type)	25	193	1	4066	3157	2504	1215	4049	864	3398	2250	699	4400	1540	193	4656	1928	1117	4464	564	3938
2471_CA7 - Carbonic anhydrase 7	2471_CA7 - Carbonic anhydrase 7	25	193	1	993	1118	3497	1047	702	414	2948	4460	2801	349	700	1242	2762	193	1964	2491	872	2400
287_CD4:%Treg(73+)	287_CD4:%Treg(73+)	25	193	1	1129	2923	3476	3221	1710	991	1805	4295	3800	617	1529	3967	2934	629	193	821	3798	3426
3311_Other eye problems	3311_Other eye problems	25	194	1	2459	194	3253	320	567	1342	315	1334	1614	3147	511	3414	208	1399	3971	2620	2535	1550
3776_Traumatic events - Been in serious accident believed to be life-threatening	3776_Traumatic events - Been in serious accident believed to be life-threatening	25	194	1	4514	4155	194	1531	1503	1974	1450	1359	4007	1176	1264	3794	523	256	4101	4561	3639	3231
3890_Monocyte percentage of white cells (three-way meta)	3890_Monocyte percentage of white cells (three-way meta)	25	194	1	1989	4016	612	4673	1127	2634	197	4634	1880	194	2311	3181	2882	1613	3368	3385	3631	2558
3302_Seen a psychiatrist for nerves, anxiety, tension or depression	3302_Seen a psychiatrist for nerves, anxiety, tension or depression	25	194	1	1939	2931	747	3367	1760	2163	2983	1978	2976	2645	194	3455	2807	577	275	1298	2973	2133
3766_Depression - Recent thoughts of suicide or self-harm	3766_Depression - Recent thoughts of suicide or self-harm	25	194	1	2763	4242	4183	3809	2081	2364	1771	4709	4068	3956	3010	194	4617	4027	2491	4516	3886	4580
1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	1702_Follicle stimulating hormone (at exam 3, FBAT, adjusted for age and sex)	25	194	1	1481	1993	3172	269	4427	4746	1715	3278	4477	3110	4609	1118	194	4502	1543	2282	891	4121
571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	571_Lipid::Sterol, Steroid::7-alpha-hydroxy-3-oxo-4-cholestenoate (7-Hoca)	25	194	1	805	1423	4140	401	4006	845	1211	3779	900	4729	1056	477	1865	4275	884	2404	2168	194
1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1803_Low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	195	1	3877	195	4116	2471	2230	2960	356	1741	3421	3890	4494	616	2071	4107	3187	1316	663	2313
3728_Anxiety - Ever worried more than most people would in similar situation	3728_Anxiety - Ever worried more than most people would in similar situation	25	195	1	1194	3955	195	3810	1059	3016	3245	1174	2546	1845	4200	1763	4386	2513	2294	3357	4739	4196
4568_Left precuneus	4568_Left precuneus	25	195	1	2601	3222	4644	2619	3643	195	1087	887	2991	2239	2005	397	213	1408	4201	237	4476	3648
271_CD4:%CD244+ Naïve	271_CD4:%CD244+ Naïve	25	195	1	4290	2986	543	853	590	3025	195	401	1769	1934	3926	4110	3913	959	315	245	1902	3881
2621_COLEC12 - Collectin-12	2621_COLEC12 - Collectin-12	25	195	1	2128	3072	744	3375	2358	1487	2097	3713	195	2181	947	2783	381	4008	2346	405	323	908
2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	2904_CSF2 - Granulocyte-macrophage colony-stimulating factor	25	195	1	313	3514	3418	1951	3080	707	2631	3937	3437	195	3580	1079	1186	1158	1500	378	1593	1120
4355_IL-1beta in gingival crevicular	4355_IL-1beta in gingival crevicular	25	195	1	2910	1241	3959	4024	4297	839	3043	4557	482	4744	195	4615	3420	695	3453	980	4626	3410
2458_HFE2 - Hemojuvelin	2458_HFE2 - Hemojuvelin	25	195	1	238	3413	2284	2363	762	3248	2484	1397	3521	1902	481	4742	2867	195	4227	3063	3742	1358
4097_Colorectal cancer	4097_Colorectal cancer	25	195	1	3070	3391	3450	3029	2706	2479	4263	776	2583	2156	3985	4352	2537	1392	3455	1740	195	4023
1923_Hippocampal volume (GEE, adjusted for age and sex)	1923_Hippocampal volume (GEE, adjusted for age and sex)	25	195	1	323	3187	864	1037	4351	2559	1364	3604	297	395	2527	2153	4602	1374	1415	1827	2841	195
1605_tPA (at exam 5, GEE, adjusted for multivariable)	1605_tPA (at exam 5, GEE, adjusted for multivariable)	25	196	1	1874	196	3030	4118	2046	2167	2705	2327	2124	1895	3025	2491	2803	947	335	3619	3320	4484
309_CD4nv:%Th2	309_CD4nv:%Th2	25	196	1	3367	386	363	196	2810	563	979	2883	2972	3449	978	3736	4019	1028	2136	2788	4317	1097
1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1255_Percent predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	196	1	2641	2896	1884	2595	196	1206	538	3763	1334	3555	3468	4081	402	1739	2884	3955	1818	1879
4472_Left superior temporal	4472_Left superior temporal	25	196	1	977	1460	1159	4502	2328	196	2422	4105	4563	3231	1445	4183	4620	913	3881	3605	4196	820
1848_Neck Section Modulus (FBAT, male, adjusted for age)	1848_Neck Section Modulus (FBAT, male, adjusted for age)	25	196	1	967	3858	3964	3632	1115	2405	3203	196	3104	836	1920	350	3552	3786	1036	825	2343	3266
2716_MBD4 - Methyl-CpG-binding domain protein 4	2716_MBD4 - Methyl-CpG-binding domain protein 4	25	196	1	241	2336	3113	1967	1029	4495	1037	2452	2319	196	3495	4746	3886	3686	3442	3150	4389	4132
1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1458_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	197	1	1969	197	3138	732	1697	3869	800	1126	3367	2688	1099	3405	4535	982	1183	3391	4190	702
597_Peptide::Dipeptide::pyroglutamylglycine	597_Peptide::Dipeptide::pyroglutamylglycine	25	197	1	249	1468	3992	3481	770	795	1727	2444	997	1445	197	4217	3066	3402	369	871	2431	4103
1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	1512_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for multivariable)	25	197	1	1990	4086	4225	1447	3951	1539	4157	625	2688	3348	1813	4517	3049	4091	626	4346	197	1877
3548_Mouth/teeth dental problems: Toothache	3548_Mouth/teeth dental problems: Toothache	25	198	1	597	1151	3970	4576	198	3108	2240	986	368	4209	4233	4105	3008	836	402	755	4260	2434
2996_FGFR4 - Fibroblast growth factor receptor 4	2996_FGFR4 - Fibroblast growth factor receptor 4	25	198	1	1967	3822	4546	1289	4160	1908	198	518	1165	4440	1115	1715	3572	3438	573	574	1303	1753
1886_Shaft Width (FBAT, male, adjussted for multivariable)	1886_Shaft Width (FBAT, male, adjussted for multivariable)	25	198	1	2611	1448	967	4336	3932	765	1099	198	450	3930	3452	1323	2199	998	4514	225	3951	4560
3137_SLC25A18 - Mitochondrial glutamate carrier 2	3137_SLC25A18 - Mitochondrial glutamate carrier 2	25	198	1	2539	1438	4571	1433	3885	662	1370	504	198	4419	4522	364	4701	534	347	1333	3284	2044
2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	2778_SYNCRIP - Heterogeneous nuclear ribonucleoprotein Q	25	198	1	612	2598	2947	2027	4124	475	3947	334	254	761	2642	1009	198	3598	1951	650	3986	308
784_::::X-12544	784_::::X-12544	25	198	1	3027	276	338	2769	3014	3215	918	3723	3798	1970	3640	2382	2202	1497	576	198	1231	693
4333_Polycystic ovary syndrome	4333_Polycystic ovary syndrome	25	198	1	4316	2112	4659	3720	3911	4720	3060	2608	2507	1203	1318	4128	2450	3391	1425	2446	3589	198
123_Overweight	123_Overweight	25	199	1	199	1333	1238	3479	877	1441	2247	2833	4372	2989	4222	2777	2252	3046	1041	4599	3294	2839
2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	2054_Percentage improvement after 12 weeks of antidepressant treatment in MDD	25	199	1	3998	1337	3083	199	1123	2002	1357	2796	3650	2511	1206	2147	388	3535	1689	1268	3333	3606
4154_Ejection fraction	4154_Ejection fraction	25	199	1	4608	1316	3040	3109	199	637	1712	1287	1527	363	2865	3709	4631	634	324	698	958	1571
3036_TPM1 - Tropomyosin alpha-1 chain	3036_TPM1 - Tropomyosin alpha-1 chain	25	199	1	1119	2375	2737	2834	3757	1952	1643	4550	269	199	1252	4248	2132	4126	4131	3087	4641	3447
841_::::X-14588	841_::::X-14588	25	199	1	3246	3747	1807	3600	857	2586	3560	2716	1620	3504	199	2775	1707	3235	2840	1482	912	3979
2764_H2AFZ - Histone H2A.z	2764_H2AFZ - Histone H2A.z	25	200	1	568	1509	465	200	4429	2554	909	4376	2593	2888	2279	4018	937	3325	4745	355	3219	1526
4483_Right isthmus cingulate	4483_Right isthmus cingulate	25	200	1	1536	1622	2344	2573	200	1905	3897	3011	4358	1753	1706	3602	3005	2601	1900	4431	2849	2648
1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	1878_Shaft cross-sectional moment of inertia (FBAT, adjussted for multivariable)	25	200	1	983	721	591	3045	3204	200	963	2019	4688	2613	3654	1843	2070	4709	1283	4635	2029	3779
4641_Right accumbens area	4641_Right accumbens area	25	200	1	1863	4572	4354	1412	4677	1969	2109	3192	200	3624	1966	4477	798	1946	1844	4252	1697	1303
2329_FTH1 FTL - Ferritin	2329_FTH1 FTL - Ferritin	25	200	1	3926	487	1237	2011	1234	730	2150	1781	2225	200	1139	4179	276	2370	3649	1363	1208	2067
609_Peptide::gamma-glutamyl::gamma-glutamylvaline	609_Peptide::gamma-glutamyl::gamma-glutamylvaline	25	200	1	4355	2325	4084	3943	3504	1178	3148	2103	626	4728	200	4260	3220	2999	1654	3134	1795	358
973_Beta nerve growth factor	973_Beta nerve growth factor	25	200	1	3355	945	665	371	1405	3278	3356	1850	938	4073	4093	1936	1706	3166	200	539	3923	4558
2175_MICA - MHC class I polypeptide-related sequence A	2175_MICA - MHC class I polypeptide-related sequence A	25	200	1	3181	3005	4451	491	4051	1398	4186	1691	3123	3789	3844	3000	305	3110	2181	200	3248	2618
3926_Total-body less head BMD	3926_Total-body less head BMD	25	200	1	293	4519	2523	3113	4268	3925	985	3133	4201	3605	2177	2767	1621	879	2021	3768	200	3197
3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	3053_TNFRSF18 - Tumor necrosis factor receptor superfamily member 18	25	200	1	3270	3574	4522	2239	3888	2623	4001	2495	408	4014	3915	3244	3625	4308	4487	3949	435	200
1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	1487_Mean triglycerides from exam 1-7 (GEE, adjusted for age and sex)	25	201	1	1998	201	1386	2837	2548	1217	4685	2255	1043	1883	3146	966	1113	3950	400	2201	617	3282
121_Obesity class 2	121_Obesity class 2	25	201	1	1270	2579	2525	4677	201	1568	1794	1202	3889	2536	1953	4598	4195	3750	2567	3555	2383	4342
1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	1539_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	201	1	2760	2608	1681	4426	1683	910	201	657	1813	1341	2296	498	1189	1557	3140	2912	4239	1106
3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	3024_UCHL1 - Ubiquitin carboxyl-terminal hydrolase isozyme L1	25	201	1	431	3902	353	4121	367	3085	3681	1194	329	4130	201	4104	3037	921	3717	3359	3368	2009
2979_ATP5B - ATP synthase subunit beta, mitochondrial	2979_ATP5B - ATP synthase subunit beta, mitochondrial	25	201	1	730	4579	1813	3409	1855	1485	4508	399	4485	989	1949	4692	1159	642	1095	201	319	976
376_Amino acid::Glutamate metabolism::pyroglutamine*	376_Amino acid::Glutamate metabolism::pyroglutamine*	25	202	1	202	2391	4358	3725	882	2063	990	1944	4227	1564	2576	1604	1379	962	1980	270	4118	553
2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	2181_SIGLEC7 - Sialic acid-binding Ig-like lectin 7	25	202	1	3400	771	202	4006	3058	755	2716	212	3919	2905	1950	3512	1521	458	2663	324	1950	896
181_Waist-hip ratio (male)	181_Waist-hip ratio (male)	25	202	1	2131	3039	494	202	3216	533	2444	3883	1266	508	1244	670	329	2828	1033	2471	2139	916
4199_Waist-hip ratio (female)	4199_Waist-hip ratio (female)	25	202	1	3221	4701	1852	746	202	3472	1904	2884	3174	2925	1431	4676	2585	2227	1047	3487	312	3838
2131_IL2RG - Cytokine receptor common subunit gamma	2131_IL2RG - Cytokine receptor common subunit gamma	25	202	1	3729	3200	375	790	3214	1542	202	3301	1022	4076	2345	803	520	1692	2248	459	4004	4079
2973_AGR2 - Anterior gradient protein 2 homolog	2973_AGR2 - Anterior gradient protein 2 homolog	25	202	1	2814	1843	3912	1731	527	2591	4238	202	1540	966	1537	445	4637	4482	3352	3788	3447	2913
3576_Social support - Leisure/social activities: Sports club or gym	3576_Social support - Leisure/social activities: Sports club or gym	25	202	1	2038	4239	3715	4647	3637	735	1499	3757	202	1879	2405	2981	747	3770	1783	2983	2327	4280
770_::::X-12261	770_::::X-12261	25	202	1	1716	1638	322	3798	3156	515	2981	4018	4059	202	547	671	1913	2337	510	2691	807	1719
2308_IL1R1 - Interleukin-1 receptor type 1	2308_IL1R1 - Interleukin-1 receptor type 1	25	202	1	2966	867	4559	4086	2729	1391	2835	3657	2438	1546	202	2451	1497	3850	212	1430	3637	3739
2491_SERPINA5 - Plasma serine protease inhibitor	2491_SERPINA5 - Plasma serine protease inhibitor	25	202	1	3954	2152	1301	926	3199	4337	968	4445	1550	3785	1993	202	891	3513	1249	2270	4117	3875
590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	590_Nucleotide::Pyrimidine metabolism, uracil containing::uridine	25	202	1	3768	4096	1277	4649	2641	3309	1581	2246	2741	3209	4714	2655	1859	1005	1407	3638	202	3829
1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	1682_Brain natriuretic peptide (at exam 6, FBAT, adjusted for age and sex)	25	203	1	203	228	1215	3945	2598	4158	4597	3634	3188	217	2911	1221	1850	4125	407	1563	1153	3562
338_NKeff:%Kir+ (3)	338_NKeff:%Kir+ (3)	25	203	1	3605	2613	203	2169	793	1474	4155	4398	2812	1056	775	3687	4131	3670	766	4579	3377	1028
506_Lipid::Glycerolipid metabolism::choline	506_Lipid::Glycerolipid metabolism::choline	25	203	1	878	1918	215	203	2346	1040	3538	1445	4518	1670	272	715	1781	2714	1191	432	4532	1212
3244_Oily fish intake	3244_Oily fish intake	25	203	1	1340	1033	867	4534	883	203	4212	1051	882	3360	317	4655	4493	4628	2092	2928	3426	4104
1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1439_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	203	1	3892	1137	2867	4019	655	3721	441	2179	203	903	4649	1851	416	2944	341	236	446	3513
3143_CD70 - CD70 antigen	3143_CD70 - CD70 antigen	25	203	1	3674	2476	1636	2207	967	1677	4289	2977	3843	203	3602	4388	779	1860	2195	513	3414	4188
517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	517_Lipid::Long chain fatty acid::arachidonate (20:4n6)	25	203	1	1903	2013	1300	641	3956	2939	3957	809	2928	1229	3850	203	1871	1218	1148	2541	4007	2524
2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	2374_TNFRSF1B - Tumor necrosis factor receptor superfamily member 1B	25	203	1	287	389	1020	951	344	4626	3181	4394	2521	3328	2309	821	4161	203	1588	2619	2303	225
3045_CRTAM - Cytotoxic and regulatory T-cell molecule	3045_CRTAM - Cytotoxic and regulatory T-cell molecule	25	203	1	497	2827	388	2092	3804	2783	3053	246	1754	3924	4580	4662	4638	4661	3131	935	473	203
2956_GOT1 - Aspartate aminotransferase, cytoplasmic	2956_GOT1 - Aspartate aminotransferase, cytoplasmic	25	204	1	2040	967	4048	560	656	204	1571	2595	1698	4042	4614	1461	4281	603	3389	282	509	1964
3208_Number of days/week of vigorous physical activity 10+ minutes	3208_Number of days/week of vigorous physical activity 10+ minutes	25	204	1	749	4175	362	4055	1960	2944	3731	204	1474	3150	1715	3169	4045	204	278	2598	1165	3504
556_Lipid::Medium chain fatty acid::caproate (6:0)	556_Lipid::Medium chain fatty acid::caproate (6:0)	25	204	1	4104	3203	2156	2394	2381	3501	4018	1559	220	204	2870	3721	1324	3888	1912	2042	2035	388
2200_IGFBP1 - Insulin-like growth factor-binding protein 1	2200_IGFBP1 - Insulin-like growth factor-binding protein 1	25	204	1	4126	2142	350	686	3517	281	3183	3327	3395	2523	855	204	1353	2608	3715	4078	1603	4202
974_Cutaneous T-cell attracting (CCL27)	974_Cutaneous T-cell attracting (CCL27)	25	204	1	1088	3981	2564	1261	461	277	3589	3215	1929	3105	2020	2679	635	1794	649	204	578	471
2393_TMPRSS15 - Enteropeptidase	2393_TMPRSS15 - Enteropeptidase	25	205	1	2326	1058	205	4506	1479	745	488	3266	583	2921	2716	1224	605	1330	3241	1241	723	1171
701_::::X-11437	701_::::X-11437	25	205	1	4254	656	387	2633	205	3529	729	2244	1269	4117	4577	379	3581	874	3133	4491	403	2344
2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	2842_HNRNPAB - Heterogeneous nuclear ribonucleoprotein A/B	25	205	1	4119	4464	3149	4453	4184	205	1703	1699	3160	1386	640	2597	3822	2385	3418	4493	2214	3041
2933_BMPR2 - Bone morphogenetic protein receptor type-2	2933_BMPR2 - Bone morphogenetic protein receptor type-2	25	205	1	663	2003	1427	1030	1093	1159	3685	205	3253	3047	1041	1584	375	2482	830	279	4058	4620
2896_SLITRK5 - SLIT and NTRK-like protein 5	2896_SLITRK5 - SLIT and NTRK-like protein 5	25	205	1	4497	2113	2244	1335	1997	4622	782	347	205	4463	941	2246	691	1619	4376	2080	3644	2311
3827_Osteoarthritis of hip and/or knee	3827_Osteoarthritis of hip and/or knee	25	205	1	1193	226	4622	4495	3524	1310	884	761	3893	498	670	3882	3257	2373	205	4141	247	4572
1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1561_Maximum internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	205	1	1882	2916	4639	3110	3806	301	2871	629	4353	3688	690	2082	2612	3271	1869	205	1271	1308
3432_Symbol digit substitution test - Number of symbol digit matches attempted	3432_Symbol digit substitution test - Number of symbol digit matches attempted	25	205	1	3641	3580	1442	1342	1546	2222	4310	1515	3364	2281	1249	4567	2551	2133	2037	4255	205	1290
2984_CTSZ - Cathepsin Z	2984_CTSZ - Cathepsin Z	25	206	1	769	4252	206	4323	255	4174	1320	4607	957	1185	804	705	3654	657	1580	2477	3909	913
4445_Left caudal anterior cingulate	4445_Left caudal anterior cingulate	25	206	1	3003	2545	565	3149	3361	3363	1991	206	3746	587	4028	2054	2310	1387	2129	4738	2481	1477
4747_Posterior corona radiata radial diusivities	4747_Posterior corona radiata radial diusivities	25	206	1	671	2131	3334	2002	2112	878	3635	701	3173	3880	535	206	1232	2607	1360	3039	1477	3911
1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	1355_Plasma Apolipoprotein C3 level (GEE, adjusted for age and sex)	25	206	1	4745	3833	4530	1235	1275	2889	3308	1777	270	2583	3240	2999	1739	4165	1804	206	1002	282
4191_QT interval	4191_QT interval	25	206	1	1282	900	1838	4582	266	341	3222	829	549	2935	2437	3773	805	843	1431	1387	761	206
88_Type 2 Diabetes	88_Type 2 Diabetes	25	207	1	713	3553	207	2659	3996	886	1408	936	3153	3507	2564	3854	4157	2919	3046	4101	1782	1653
1206_Longevity (>= 90 yrs vs < 65 yrs)	1206_Longevity (>= 90 yrs vs < 65 yrs)	25	207	1	1706	4354	2904	3041	3226	207	814	2494	4685	2971	3753	2108	1568	553	3175	1180	4481	332
1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	1543_White matter hyperintensity volume (GEE, adjusted for age and sex)	25	207	1	2422	3786	1071	4073	1665	2653	207	2341	2157	3561	1074	1545	3012	3543	1316	2121	1558	3051
1913_Occipital brain volume (GEE, adjusted for multivariable)	1913_Occipital brain volume (GEE, adjusted for multivariable)	25	207	1	1291	796	566	3908	1917	4085	4088	4473	3008	207	3034	4005	447	742	2980	3611	3615	3623
3491_Cereal type: Muesli	3491_Cereal type: Muesli	25	207	1	4452	3368	3069	2111	1401	1968	2092	2931	3778	1509	2777	207	2212	4265	2985	349	3999	2627
4462_Left pars triangularis	4462_Left pars triangularis	25	207	1	4682	1015	1546	2454	1689	2523	1325	898	3907	4496	2883	577	207	250	4384	3183	2194	1250
4088_Paternal history of Alzheimer's disease	4088_Paternal history of Alzheimer's disease	25	207	1	2603	350	1135	2410	2034	3879	4245	868	431	2235	3232	1031	4194	207	3387	287	238	3703
135_Waist circumference (female, adjusted for BMI)	135_Waist circumference (female, adjusted for BMI)	25	208	1	208	4699	3585	1469	4112	4165	2397	293	1894	4374	3347	3399	1490	3643	1819	2169	1617	2830
2404_KLK5 - Kallikrein-5	2404_KLK5 - Kallikrein-5	25	208	1	4109	208	2581	2896	2158	4026	1568	1584	4210	1123	1197	1094	2031	3351	441	1944	1811	2646
4220_Antihypertensives	4220_Antihypertensives	25	208	1	1522	4213	208	1277	965	2476	3211	1581	338	1117	1251	1797	2851	2398	512	2151	3926	485
2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	2927_TNFRSF10A - Tumor necrosis factor receptor superfamily member 10A	25	208	1	2885	1782	2268	208	1510	4661	1597	3516	1252	2016	4044	1617	599	1344	2723	2474	3245	3574
2307_IFNG - Interferon gamma	2307_IFNG - Interferon gamma	25	208	1	2229	3282	1933	1067	3016	2910	208	3346	2893	2695	4041	1385	1613	3182	3995	4197	4315	588
1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	1364_Total cholesterol (at exam 4, FBAT, adjusted for age and sex)	25	208	1	3301	833	1812	2175	3003	1133	2171	489	208	882	2006	2128	301	1525	2647	1157	1949	1215
767_::::X-12236	767_::::X-12236	25	208	1	2928	2805	2507	1545	3741	940	2178	3552	3239	208	3274	2709	2158	4445	4378	4301	3780	370
2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	2886_HDGFRP2 - Hepatoma-derived growth factor-related protein 2	25	208	1	2327	2466	4601	3435	2311	2597	4185	4472	2717	4257	3009	208	3371	2888	1442	1546	4207	1378
620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	620_Xenobiotics::Drug::2-hydroxyacetaminophen sulfate*	25	208	1	4717	4590	1820	3242	2130	4603	3260	4148	2803	3594	4681	2445	756	208	1193	2573	3532	4310
4264_Ankylosing spondylitis	4264_Ankylosing spondylitis	25	208	1	3590	2436	471	451	2102	2204	2781	760	2270	1001	4732	3557	399	1636	1457	208	3312	1959
4523_Left putamen	4523_Left putamen	25	208	1	1976	1587	4521	4221	4514	3317	605	4403	508	1068	2804	2733	3140	1895	1470	1532	208	3577
4278_FEV1	4278_FEV1	25	208	1	2405	4338	1443	3213	1785	2705	2508	1323	1504	2833	3852	521	4286	3299	3178	3982	4296	208
2787_L1CAM - Neural cell adhesion molecule L1	2787_L1CAM - Neural cell adhesion molecule L1	25	209	1	209	3572	4178	1170	1443	1611	4608	3229	4309	381	1361	2070	4227	4662	3870	1513	2685	4296
554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	554_Lipid::Medium chain fatty acid::5-dodecenoate (12:1n7)	25	209	1	1269	209	2085	2904	293	901	3716	1090	1909	794	4704	968	1607	3760	4383	3738	1804	4250
4609_Cerebellar vermal lobules VI VII	4609_Cerebellar vermal lobules VI VII	25	209	1	2852	1523	209	1044	3795	3146	3093	3564	1701	4205	4306	3931	3838	2226	4285	3064	2682	2879
1761_Breast cancer (GEE, adjusted for age and BMI)	1761_Breast cancer (GEE, adjusted for age and BMI)	25	209	1	960	2177	1209	209	1383	298	1210	825	1731	4045	895	2743	355	2975	4357	1654	251	4122
1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	1239_Rate of decline FEF25-75 (GEE, adjusted for multiple covariates)	25	209	1	1741	850	1214	2088	3242	209	2130	1700	741	3228	2459	3144	3788	1894	1487	4573	2530	4279
1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	1538_White matter hyperintensity volume (FBAT, adjusted for age and sex)	25	209	1	4167	1141	2025	2063	2412	4455	2430	228	209	3074	1199	4305	949	3329	2621	765	3491	666
4033_Alcohol dependency (unrelated genotyped individuals)	4033_Alcohol dependency (unrelated genotyped individuals)	25	209	1	1488	2137	3408	1122	2101	479	451	1486	3348	209	1042	2164	485	2485	3076	2801	699	667
2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	2776_HSD17B10 - 3-hydroxyacyl-CoA dehydrogenase type-2	25	209	1	4368	1212	2909	2702	2363	4130	3817	4274	737	3184	209	3933	1823	1004	4094	3534	4522	1012
2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	2980_C1QBP - Complement component 1 Q subcomponent-binding protein, mitochondrial	25	209	1	3232	4554	2072	4296	1474	3545	1307	4059	1618	1771	3481	800	246	4122	1083	490	209	359
2210_MMP7 - Matrilysin	2210_MMP7 - Matrilysin	25	210	1	4695	4116	210	4112	3023	2021	3989	3250	2143	4359	3477	2392	2323	2213	778	4465	1712	2156
1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	1243_Mean FEV1 from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	210	1	1168	2410	1012	967	210	1214	2255	4322	3416	2459	1760	4219	3388	3549	3529	449	2235	2259
2783_LCMT1 - Leucine carboxyl methyltransferase 1	2783_LCMT1 - Leucine carboxyl methyltransferase 1	25	210	1	1958	4484	3388	4262	3330	210	3494	4227	2772	3026	598	3513	3845	4017	3162	3540	2187	3497
4499_Right rostral anterior cingulate	4499_Right rostral anterior cingulate	25	210	1	3801	3260	1732	4016	3163	2617	210	747	807	3379	3166	4552	2801	3042	3873	2995	4322	4199
684_::::X-10500	684_::::X-10500	25	210	1	770	4129	625	685	847	3621	305	3408	210	1288	334	2232	933	4588	4387	2876	3305	1715
2796_GPI - Glucose-6-phosphate isomerase	2796_GPI - Glucose-6-phosphate isomerase	25	210	1	1677	1594	4275	3284	4563	3915	4612	1594	2848	210	4027	4402	513	3399	3186	3571	4282	4582
1042_Shaft Width (FBAT, adjusted for multivariable)	1042_Shaft Width (FBAT, adjusted for multivariable)	25	210	1	2282	482	312	1360	2778	1071	3493	2387	1636	4570	4718	2886	3491	210	2046	3745	1412	2798
4508_Cerebellar vermal lobules VI VII	4508_Cerebellar vermal lobules VI VII	25	211	1	3611	211	845	594	2268	3947	3198	2032	1984	2899	3952	858	3285	2202	3886	3057	3432	4343
2625_MSR1 - Macrophage scavenger receptor types I and II	2625_MSR1 - Macrophage scavenger receptor types I and II	25	211	1	2027	2783	1457	211	1551	361	4343	4482	2763	2975	925	2100	4013	2284	3262	3972	944	4028
4648_Anterior limb of internal capsule fractional anisotropy	4648_Anterior limb of internal capsule fractional anisotropy	25	211	1	4017	4335	3897	1674	881	211	2146	2830	4457	1746	4114	1725	456	2942	877	3360	1080	1355
1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	1298_Fasting plasma glucose (at exam 5, FBAT, adjusted for age and sex)	25	211	1	3244	622	4359	1709	1310	2372	4083	211	215	941	1570	1616	792	2074	2694	2662	369	2102
2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	2389_ENTPD1 - Ectonucleoside triphosphate diphosphohydrolase 1	25	211	1	1942	4685	394	3014	1046	3308	4204	373	211	1699	4102	1943	1956	3429	1439	4553	1014	4095
2508_BTK - Tyrosine-protein kinase BTK	2508_BTK - Tyrosine-protein kinase BTK	25	211	1	3358	2287	2465	3461	2660	1052	709	1444	1388	211	1451	4736	4072	3343	4251	2591	2208	3372
4065_Gait speed	4065_Gait speed	24	211	1	726	3725	1645	2579	3268	3674	687	1186	732	2429	896	211	2217	2199	1923	4219	2212	3210
3238_Exposure to tobacco smoke at home	3238_Exposure to tobacco smoke at home	25	211	1	2755	2898	1100	645	2048	264	2108	4069	1222	818	1303	3590	3915	211	3581	357	1239	4039
945_Serum total cholesterol	945_Serum total cholesterol	25	211	1	2341	4578	345	2371	2560	2647	674	4534	2811	4720	2719	467	4527	4128	211	219	1870	622
4482_Right inferior temporal	4482_Right inferior temporal	25	212	1	212	3004	2368	683	727	3049	2465	3946	2727	4422	2701	2951	3091	305	2664	3119	1644	1949
180_Waist-hip ratio	180_Waist-hip ratio	25	212	1	4227	2128	212	1136	1436	3179	4600	3145	2759	4541	4152	2560	3584	2724	1410	2070	2240	722
1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	1477_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for multivariable)	25	212	1	1836	3474	2116	3517	4062	212	1045	4349	1753	786	1764	1847	4501	2381	4020	4035	3496	3202
796_::::X-12728	796_::::X-12728	25	212	1	463	2469	3990	3166	1906	1188	3961	1349	1787	1213	212	1979	4325	809	3254	764	3166	4287
2379_APP - Amyloid beta A4 protein	2379_APP - Amyloid beta A4 protein	25	212	1	2395	1613	4708	3701	2275	820	2453	2777	3351	4223	4741	1131	3821	212	357	2999	2984	2214
4308_Osteoarthritis of hit or knee	4308_Osteoarthritis of hit or knee	25	213	1	213	1234	4285	429	4644	4565	4540	2451	1622	3539	3842	1709	2419	327	2356	2929	4222	3252
833_Peptide::Dipeptide::X-14189--leucylalanine	833_Peptide::Dipeptide::X-14189--leucylalanine	25	213	1	2565	1632	213	4594	587	4608	4636	486	3142	1740	4643	4589	907	2840	1593	4587	3997	4696
4234_Antidepressants	4234_Antidepressants	25	213	1	1607	507	2459	1392	4353	4487	231	1227	213	2919	3891	1386	956	3653	2114	3740	3920	389
799_::::X-12740	799_::::X-12740	25	213	1	1856	662	1239	995	1425	2819	3137	1390	1956	213	4628	3762	2866	4730	4459	1609	246	3596
130_Hip circumference (male, adjusted for BMI)	130_Hip circumference (male, adjusted for BMI)	25	213	1	3991	905	3273	1418	1308	2805	893	1508	1228	782	213	4308	3158	3160	3253	3437	4445	957
4729_Splenium of corpus callosum mode of anisotropy	4729_Splenium of corpus callosum mode of anisotropy	25	213	1	3879	3256	2020	2386	4099	495	1573	4309	4233	1938	4706	213	4054	2928	539	1682	650	1218
3256_Coffee intake	3256_Coffee intake	25	213	1	2291	4643	1711	3141	2425	2927	2257	4007	2309	4742	4230	3945	3308	213	4358	4590	2374	3247
1983_Walking speed (at exam 7, GEE)	1983_Walking speed (at exam 7, GEE)	25	213	1	1695	4309	4220	1884	2663	285	1937	2175	1938	928	1827	1479	3299	460	213	3155	1634	4002
3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	3668_Diagnoses - main ICD10: I25 Chronic ischemic heart disease	25	213	1	502	1453	3773	352	1640	3832	3472	3839	2045	2255	815	2699	3593	4266	4702	4026	295	213
1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	1742_Urinary albumin excertion (at exam 6, FBAT, adjusted for age and sex)	25	214	1	1972	2238	2596	214	4256	1882	4403	1841	1555	4204	2086	495	1582	1117	365	1362	743	3249
72_Triglycerides cholesterol	72_Triglycerides cholesterol	25	214	1	3844	1608	4670	532	214	1057	4125	3392	3644	3210	1155	1510	1797	4353	874	4494	2926	2477
3453_Impedance measures - Leg fat mass (right)	3453_Impedance measures - Leg fat mass (right)	25	214	1	2268	4243	4589	2919	704	3874	2617	4115	3879	214	3011	1006	1419	1549	3637	1367	2701	3999
1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	1537_Ankle-brachial index (at exam 7, GEE, adjusted for multivariable)	25	214	1	3619	2543	2836	2015	3758	1042	619	1233	3790	257	2021	214	2154	2083	2692	2097	426	4524
3161_SEMA3E - Semaphorin-3E	3161_SEMA3E - Semaphorin-3E	25	214	1	2337	3364	1760	3013	2172	4475	4028	3036	2940	1748	4374	2354	1439	4047	214	3112	1392	1649
1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1387_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	215	1	975	1390	216	2787	1035	927	4061	2719	4251	215	3749	3052	608	244	3754	4662	2413	1203
1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	1499_Triglycerides (at exam 1, GEE, adjusted for age and sex)	25	215	1	4487	1487	4630	2977	2082	4047	2916	722	2713	3396	215	2133	3923	2454	420	1101	2821	3872
2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	2673_MAPKAPK5 - MAP kinase-activated protein kinase 5	25	215	1	3409	1146	3478	763	4340	734	4588	2814	1608	2649	1413	215	4295	1801	2409	2594	4548	1665
2078_FGF8 - Fibroblast growth factor 8 isoform B	2078_FGF8 - Fibroblast growth factor 8 isoform B	25	216	1	997	1828	1455	216	901	2333	3044	3791	1678	1704	668	904	384	3829	2400	970	1194	2834
2305_CXCL3 CXCL2 - Gro-beta/gamma	2305_CXCL3 CXCL2 - Gro-beta/gamma	25	216	1	3842	2739	2318	628	2280	1445	216	3655	4030	1983	473	2902	3149	1553	3192	3135	3422	4410
128_Hip circumference (male)	128_Hip circumference (male)	25	216	1	2472	3696	3700	4176	3276	3466	3080	3749	1038	216	3031	3477	2460	4522	1305	2597	1409	2223
4684_Retrolenticular part of internal capsule axial diusivities	4684_Retrolenticular part of internal capsule axial diusivities	25	216	1	2551	2599	2844	3150	4564	439	1542	1273	3625	4547	216	3035	3221	3730	2759	3019	1196	4154
4683_Posterior thalamic radiation (include optic radiation) axial diusivities	4683_Posterior thalamic radiation (include optic radiation) axial diusivities	25	216	1	495	4722	1101	3659	2531	503	2664	459	3641	1282	1809	4606	2032	596	216	3472	4391	4507
1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	1712_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for age and sex)	25	216	1	4393	1583	4504	2180	3110	762	3372	1320	3605	4746	884	2532	1703	2821	3720	216	1204	4194
576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	576_Lipid::Sterol, Steroid::dehydroisoandrosterone sulfate (DHEA-S)	25	217	1	1720	325	4498	1538	217	258	1731	2136	4222	4710	2795	1845	4606	4204	251	3911	1470	2452
2279_CFD - Complement factor D	2279_CFD - Complement factor D	25	217	1	853	3295	4163	270	3382	4683	269	217	4704	2739	391	448	745	1446	481	2989	4314	1345
1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	1942_White matter hyperintensity volume (FBAT, adjusted for multivariable with APOE)	25	217	1	397	1796	1530	1137	4195	2277	2990	874	808	816	217	451	307	3615	2754	1681	4168	3730
1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1426_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	217	1	1429	4474	778	2653	2094	2203	2044	2674	1976	4714	3458	2724	1611	217	3595	3816	3856	4161
4168_Open-angle glaucoma (fixed-effect model)	4168_Open-angle glaucoma (fixed-effect model)	25	217	1	2285	1450	997	1417	2872	4418	1171	1284	895	813	4407	1298	2113	1546	217	851	3990	254
3587_Types of physical activity in last 4 weeks: Strenuous sports	3587_Types of physical activity in last 4 weeks: Strenuous sports	25	217	1	1077	1381	2042	4669	3779	2507	3453	4151	1223	4464	387	3711	1354	3524	4425	217	3024	2787
1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	1690_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for age and sex)	25	217	1	4733	3297	1596	4468	2698	2034	3726	3616	3678	422	2105	1360	1312	269	722	4187	217	2242
3179_SRC - Proto-oncogene tyrosine-protein kinase Src	3179_SRC - Proto-oncogene tyrosine-protein kinase Src	25	218	1	218	1259	3662	1982	3320	3940	4469	3955	691	4308	2677	1563	3587	956	3577	2778	1667	1901
1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1246_Mean FEV1/FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	218	1	2058	1752	912	3868	218	2117	3294	1766	2753	772	877	3665	2520	4373	2778	4485	1498	3863
1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	1545_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	218	1	4457	4397	1713	3846	1280	2894	218	1075	1966	2052	800	1377	3627	2887	3724	573	1820	3768
293_CD4:%Act(PD1+127+39-73-)	293_CD4:%Act(PD1+127+39-73-)	25	218	1	3363	2419	623	2779	3385	2211	1968	4098	3096	218	4697	641	1453	876	3636	1361	3122	1734
94_Birth weight	94_Birth weight	25	218	1	1150	2046	3356	2905	2936	609	1258	1342	3220	1459	2043	3664	218	1053	4185	2416	4631	1739
2208_CCL8 - C-C motif chemokine 8	2208_CCL8 - C-C motif chemokine 8	25	218	1	4597	3315	1574	817	2214	2311	3247	2821	3194	3440	2898	3645	334	218	4607	603	3235	2155
3285_Miserableness	3285_Miserableness	25	218	1	2923	1463	4435	3033	4388	1982	2067	1256	1358	4049	4031	2735	3400	2813	218	1183	2756	431
1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1565_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	218	1	4425	4429	1784	1178	4205	432	3395	1288	4237	1137	3278	1531	2145	750	1777	218	2915	3347
4524_Left pallidum	4524_Left pallidum	25	219	1	2480	219	1824	4595	2933	4359	4434	531	3805	1553	1528	2799	1227	1826	3043	3392	4213	2324
333_NKeff:%337+	333_NKeff:%337+	25	219	1	442	4413	2460	4599	219	4057	3771	2909	3693	4280	3988	509	3609	2446	3417	308	1589	2916
2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	2254_RAC1 - Ras-related C3 botulinum toxin substrate 1	25	219	1	4577	4507	3939	4061	2265	219	240	2101	2995	4409	1136	2968	4086	4550	3077	3997	4486	3013
2841_GREM1 - Gremlin-1	2841_GREM1 - Gremlin-1	25	219	1	2496	3523	406	897	4489	856	219	1305	918	1684	3741	1140	3126	3820	973	4507	3510	509
1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1552_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	219	1	2400	3502	396	3577	1380	2393	3436	219	1720	4219	1913	1208	3602	2593	1937	3272	1923	2855
2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	2154_HSPD1 - 60 kDa heat shock protein, mitochondrial	25	219	1	2989	1356	2886	4409	2106	4342	349	1048	219	2192	3489	1058	3720	3706	2472	906	4678	3440
81_Lumbar Spine BMD (males)	81_Lumbar Spine BMD (males)	25	219	1	3318	3321	2213	2752	4013	1672	3719	4070	2125	219	1135	366	3499	1835	480	4526	772	1488
1847_Neck Section Modulus (GEE, female, adjusted for age)	1847_Neck Section Modulus (GEE, female, adjusted for age)	25	219	1	3259	736	3876	3451	1043	2605	3434	222	2226	1091	219	3029	1875	3737	4197	4571	1497	446
1839_Neck width (GEE, female, adjusted for age)	1839_Neck width (GEE, female, adjusted for age)	25	219	1	2618	1983	1035	3888	517	4672	1799	659	2010	2801	1058	1837	2360	219	1284	1848	4425	3769
2153_HGF - Hepatocyte growth factor	2153_HGF - Hepatocyte growth factor	25	219	1	2303	4384	3982	4146	2722	2882	4743	2266	1648	266	3242	4707	1148	2276	1642	959	2979	219
1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1560_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	220	1	4426	220	2192	4717	3812	4039	2851	1552	2824	1646	4153	3777	1402	909	1858	3667	1495	3230
2994_PTK2 - Focal adhesion kinase 1	2994_PTK2 - Focal adhesion kinase 1	25	220	1	691	3099	220	632	4140	2749	4261	4518	1229	2532	3261	3848	4664	3694	2917	3577	2294	792
1137_Father's age at death	1137_Father's age at death	25	220	1	2872	4138	2609	220	3072	1813	930	4132	768	2110	4280	1410	1765	4380	4708	1266	931	3370
3746_Happiness and subjective well-being - General happiness with own health	3746_Happiness and subjective well-being - General happiness with own health	25	220	1	3964	392	2798	3373	220	3745	2959	684	3487	1857	1912	3568	3331	2026	3892	2550	3238	2624
3940_Body Mass Index (male)	3940_Body Mass Index (male)	25	220	1	261	2449	360	2500	1279	1222	2722	3979	1274	249	220	558	2177	881	2916	2583	494	4480
2515_CSNK2A1 - Casein kinase II subunit alpha	2515_CSNK2A1 - Casein kinase II subunit alpha	25	220	1	2087	2671	3473	4716	4272	2183	3628	1003	342	2182	4258	220	3266	2753	2691	1816	1961	1796
3862_Platelet distribution width (two-way meta)	3862_Platelet distribution width (two-way meta)	25	220	1	3809	4203	2586	845	3823	498	1783	4481	3772	1519	2473	4263	220	356	679	253	3592	3487
457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	457_Cofactors and vitamins::Vitamin B6 metabolism::pyridoxate	25	220	1	2886	2058	4572	1421	1676	3965	2800	3871	3461	3002	1486	1265	653	3852	220	3251	4736	3996
98_Height SDS	98_Height SDS	25	220	1	3669	2625	2272	1200	4354	3714	2342	295	3660	3916	639	808	2805	4256	1214	535	778	220
4692_Anterior limb of internal capsule mean diusivities	4692_Anterior limb of internal capsule mean diusivities	25	221	1	1319	3834	4707	1911	2416	221	1564	2745	2766	1143	4516	2437	1323	3865	399	2960	1071	971
1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	1541_White matter hyperintensity volume (GEE, adjusted for multivariable)	25	221	1	1280	3472	1797	2988	1346	911	221	2087	2049	2213	1739	1577	1057	2289	3221	2273	3442	1130
1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1478_Mean high-density lipoprotein cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	221	1	545	1490	836	667	2348	1811	3576	296	2078	1452	221	1781	224	507	1568	2316	1894	2777
3609_Treatment/medication code: omega-3/fish oil supplement	3609_Treatment/medication code: omega-3/fish oil supplement	25	221	1	922	2365	3299	3748	324	1708	3156	919	3623	539	2458	725	2732	4264	221	2752	2248	632
1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1799_High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	221	1	2845	4582	1472	2115	2490	1067	1825	1204	1544	3928	4011	1019	397	2856	3751	221	4594	839
151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	151_Waist-hip ratio (male > 50 yrs, adjusted for BMI)	25	222	1	3014	222	754	434	3471	1093	3402	4531	2051	2877	905	1121	1054	3318	4564	1130	880	2163
28_Extraversion (NEO-FFI)	28_Extraversion (NEO-FFI)	25	222	1	1984	677	1963	222	2066	1276	1476	2946	2770	3837	3143	2814	265	2195	3869	3122	2441	3309
4475_Left insula	4475_Left insula	25	222	1	887	3411	4736	4628	2392	222	462	2551	1626	2587	1085	2007	2800	747	1727	947	1560	757
3970_GLP-1 stimulated insulin secretion	3970_GLP-1 stimulated insulin secretion	25	222	1	1979	3602	3579	1163	736	4219	2968	1116	970	222	3941	4628	2937	674	3752	4582	3419	2680
2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	2450_LRIG3 - Leucine-rich repeats and immunoglobulin-like domains protein 3	25	222	1	4565	2734	2051	1344	3189	3558	4114	1858	406	842	689	222	1849	3969	3980	606	4601	868
3671_Diagnoses - main ICD10: K40 Inguinal hernia	3671_Diagnoses - main ICD10: K40 Inguinal hernia	25	222	1	766	490	2740	2710	4017	3764	2750	907	1060	3112	1405	277	1842	222	1585	257	687	1362
209_Intelligence	209_Intelligence	25	223	1	223	1636	2221	1003	1561	4353	2996	1786	4197	2585	2762	1947	1705	2998	2677	1680	2000	1126
1289_Waist circumference by CT (GEE, adjusted for age and sex)	1289_Waist circumference by CT (GEE, adjusted for age and sex)	25	223	1	1830	223	4305	3086	3619	586	831	1663	3284	1003	1127	2298	649	1650	4746	3139	3459	2056
1927_Lateral ventricular volume (GEE, adjusted for age and sex)	1927_Lateral ventricular volume (GEE, adjusted for age and sex)	25	223	1	2425	3573	223	4464	318	2296	3975	4570	1318	2121	3911	4441	4448	2458	2625	2286	3854	4400
2692_PRDX1 - Peroxiredoxin-1	2692_PRDX1 - Peroxiredoxin-1	25	223	1	783	2488	3036	1223	1778	223	1025	1833	4579	2405	3531	3621	1952	2908	1260	592	888	2286
1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	1553_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for multivariable)	25	223	1	1174	1041	646	1328	687	2541	2151	223	1150	2743	468	2179	2908	240	2212	4116	1046	4380
4654_External capsule fractional anisotropy	4654_External capsule fractional anisotropy	25	223	1	3957	4075	4682	408	1860	2219	3691	2703	3699	1648	2735	1877	223	2492	1630	2717	1407	2154
825_::::X-13619	825_::::X-13619	25	223	1	4665	1148	4267	4201	4616	3072	2944	598	1725	2914	1011	2876	3094	223	3684	3818	1465	2937
879_Total cholesterol in IDL	879_Total cholesterol in IDL	25	223	1	2376	2654	738	1481	4350	2381	328	3194	3515	4342	1299	422	3644	2153	283	223	914	734
2561_LTA LTB - Lymphotoxin alpha1:beta2	2561_LTA LTB - Lymphotoxin alpha1:beta2	25	223	1	4093	1247	2786	4228	1867	3806	2168	1982	4714	3862	386	2646	4601	3593	941	2139	223	2511
969_Total lipids in chylomicrons and extremely large VLDL	969_Total lipids in chylomicrons and extremely large VLDL	25	224	1	484	4248	3913	224	832	4712	3758	1957	1488	3167	928	757	2806	1022	2911	3996	3049	4516
602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	602_Peptide::gamma-glutamyl::gamma-glutamylglutamine	25	224	1	2540	1069	443	1961	1266	3443	224	3339	1637	1523	1446	3230	4427	3506	1606	1139	544	3965
2316_NCR3 - Natural cytotoxicity triggering receptor 3	2316_NCR3 - Natural cytotoxicity triggering receptor 3	25	224	1	2441	1861	2862	1510	723	3388	2473	224	2112	2375	2480	2011	564	2402	4597	2677	776	378
3075_RTN4R - Reticulon-4 receptor	3075_RTN4R - Reticulon-4 receptor	25	224	1	3935	3727	839	2750	3774	4469	2608	4181	3357	224	2318	4493	3914	3250	2658	3394	2728	4350
4623_Left caudate	4623_Left caudate	25	224	1	622	252	2839	421	4153	2155	2667	1345	2930	1013	1709	224	771	4192	4320	1758	3812	369
3876_Eosinophil percentage of granulocytes (three-way meta)	3876_Eosinophil percentage of granulocytes (three-way meta)	25	224	1	1765	2147	4311	2811	2089	733	1788	3010	1079	4133	4022	1938	827	844	224	981	4659	3084
1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1455_Low-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	224	1	3513	2105	4307	652	3179	505	359	1463	1403	911	4195	1500	894	4481	4470	2046	3403	224
2197_HPX - Hemopexin	2197_HPX - Hemopexin	25	225	1	2486	3963	2259	519	225	2488	809	366	339	2941	3974	2247	1903	2170	4121	4054	2444	307
300_CD4mem:%Th1* (3)	300_CD4mem:%Th1* (3)	25	225	1	1648	4074	1849	4139	3620	818	4051	1211	2273	2215	3032	2566	313	225	2174	3939	2828	763
285_CD4:%Treg(39+)	285_CD4:%Treg(39+)	25	226	1	226	3264	1323	753	657	1690	1376	400	3042	2757	3906	2629	2985	1011	1736	2592	3728	3137
4304_Legs-leg fat ratio (female)	4304_Legs-leg fat ratio (female)	25	226	1	897	3044	1067	695	2628	226	4248	4519	284	1999	1493	1593	1599	1058	3958	3443	3954	2965
731_::::X-11799	731_::::X-11799	25	226	1	2703	1547	4177	1419	3574	1854	226	3793	271	2648	3111	4090	588	3714	2094	1928	953	1166
25_Internalizing	25_Internalizing	25	226	1	2632	269	1029	723	3739	2331	870	1725	226	2502	3665	4709	3132	2627	964	1969	2569	3717
3749_Traumatic events - Someone to take to doctor when needed as a child	3749_Traumatic events - Someone to take to doctor when needed as a child	25	226	1	3328	3173	3723	4125	637	526	1044	2326	2407	226	1992	3002	2354	4587	2668	346	2310	3343
4282_FEV1	4282_FEV1	25	226	1	3225	3309	2902	4735	3975	1701	4632	4075	2474	4321	4396	456	4059	2523	1584	4622	4202	226
4548_Left cuneus	4548_Left cuneus	25	227	1	1358	247	227	2425	1349	3112	2985	3583	1656	3103	3086	1307	4040	3978	2680	3513	2509	4337
4706_Retrolenticular part of internal capsule mean diusivities	4706_Retrolenticular part of internal capsule mean diusivities	25	227	1	384	1380	3467	4291	4415	227	2858	2262	3362	2744	662	3921	2586	1544	4275	3331	2088	2087
3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	3561_Medication for pain relief, constipation, heartburn: Laxatives (e.g. Dulcolax, Senokot)	25	227	1	2485	3762	910	2179	1878	4435	2163	227	4708	439	4073	3817	3178	4589	846	2578	1375	929
2831_SFTPD - Pulmonary surfactant-associated protein D	2831_SFTPD - Pulmonary surfactant-associated protein D	25	227	1	2804	1335	1353	3381	3828	3931	4103	2794	1411	227	1947	4136	1091	3091	3912	2907	718	3433
3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	3560_Medication for pain relief, constipation, heartburn: Omeprazole (e.g. Zanprol)	25	227	1	3637	777	1534	3967	3518	2995	2735	2328	3880	2467	227	2749	2060	519	2121	4151	4501	2891
4337_Sleep durataion	4337_Sleep durataion	25	227	1	1032	1205	4172	945	406	1253	3521	4462	4276	3558	4270	768	227	963	2623	1560	2010	2183
279_CD8:%39+	279_CD8:%39+	25	227	1	3308	1350	3284	2917	2601	3170	3189	244	4544	3937	2172	2960	4561	1674	227	1920	3026	2015
1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	1279_Sabuctaneous fat by CT (GEE, adjusted for age, sex, smoking and menopause)	25	227	1	1651	2868	2533	3194	4520	2839	3866	3968	612	1372	562	3471	1167	2703	4628	3980	227	4126
413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	413_Amino acid::Urea cycle; arginine-, proline-, metabolism::dimethylarginine (SDMA + ADMA)	25	228	1	2279	4051	3039	228	426	3751	4333	3783	3751	1361	2696	3272	382	829	4084	4457	3689	3719
2869_PDGFA - Platelet-derived growth factor subunit A	2869_PDGFA - Platelet-derived growth factor subunit A	25	228	1	3340	1072	1614	1503	228	1403	3757	3400	257	1214	3742	3062	3554	1361	1481	1031	2652	2895
2571_VIP - Vasoactive Intestinal Peptide	2571_VIP - Vasoactive Intestinal Peptide	25	228	1	4337	2516	1925	4300	3516	2223	1510	3033	1531	228	2713	3655	1610	581	1417	4023	471	3358
385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	385_Amino acid::Guanidino and acetamido metabolism::4-acetamidobutanoate	25	228	1	2735	2801	2392	331	2692	2859	4646	3348	4266	268	3164	2357	2019	228	376	1743	732	3619
245_CD34 on Stem	245_CD34 on Stem	25	229	1	229	1017	3074	1736	273	1123	4555	3806	3542	2154	4561	573	2390	3801	3277	250	4197	1269
1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	1389_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for multivariable)	25	229	1	1555	4090	229	3528	4598	3208	926	4630	367	1193	609	3352	4651	3814	4557	2007	3281	754
3303_Able to confide	3303_Able to confide	25	229	1	1574	3768	1482	4220	3841	229	2381	1641	2639	573	4129	4501	1308	4145	1447	3817	4584	801
122_Obesity class 3	122_Obesity class 3	25	229	1	2416	4481	3706	3404	1853	1026	229	3166	1842	2816	4221	2599	2572	1746	804	4719	1784	2499
217_NKT:%4+R5-	217_NKT:%4+R5-	25	229	1	4655	430	881	3913	2620	2089	2879	3847	2223	229	2229	1954	2678	4364	3477	2943	4402	268
3869_Basophil count (three-way meta)	3869_Basophil count (three-way meta)	25	229	1	1234	747	1643	703	1252	1649	816	2205	403	2776	229	344	500	3959	3506	3444	2566	4456
4705_Posterior thalamic radiation (include optic radiation) mean diusivities	4705_Posterior thalamic radiation (include optic radiation) mean diusivities	25	229	1	2401	1791	2162	3919	2847	631	2598	496	2645	4185	3372	2188	1604	703	4267	1898	3308	229
3475_Type of accommodation lived in: A flat, maisonette or apartment	3475_Type of accommodation lived in: A flat, maisonette or apartment	25	230	1	230	2176	4471	3637	667	2258	1251	1197	617	1643	4619	1778	1335	2456	2893	807	2969	2165
4644_Gray matter	4644_Gray matter	25	230	1	4213	230	4570	1838	2441	2728	1901	859	4376	2227	1076	3716	1901	4065	4395	1158	342	4237
4422_Herpes simplex virus 2 seropositivity	4422_Herpes simplex virus 2 seropositivity	25	230	1	1791	655	230	1650	2177	954	722	549	1564	442	1981	870	676	3625	1068	2981	1622	1980
48_Age at first birth (female)	48_Age at first birth (female)	25	230	1	985	2720	3397	4295	230	3607	669	3162	692	3762	351	1402	2627	2629	4496	422	1750	3340
1085_Behcet disease	1085_Behcet disease	25	230	1	1896	3497	1367	316	1263	230	3872	2698	3765	2655	4355	1229	339	2572	789	267	1359	1486
3630_Illnesses of father: Lung cancer	3630_Illnesses of father: Lung cancer	25	230	1	794	3582	3942	3424	438	1844	1978	509	230	3201	4051	2704	2192	1348	1908	4601	3506	1885
1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	1710_Thyroid stimulation hormone (at exam 3, FBAT, adjusted for age and sex)	25	230	1	542	2772	4529	1219	676	1143	1134	1054	3149	753	1531	4165	230	3298	3658	4198	4097	1800
781_::::X-12465	781_::::X-12465	25	230	1	2843	1106	499	1636	3171	4673	513	3009	657	2503	1283	3567	3755	3011	1603	4062	230	3952
2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	2786_MDM2 - E3 ubiquitin-protein ligase Mdm2	25	230	1	1143	2541	4561	803	3002	1986	862	4723	2000	1035	4691	3475	548	3611	2036	3398	4699	230
4364_Vigorous physical activity	4364_Vigorous physical activity	25	231	1	1512	1273	513	231	3340	1303	2005	1189	3969	1135	420	4156	814	1888	3177	1626	862	1881
4584_Right isthmus cingulate	4584_Right isthmus cingulate	25	231	1	3210	660	1487	3169	231	1072	4039	4016	4414	1218	4644	4510	1507	1346	4641	4231	4275	2307
54_Subjective well being	54_Subjective well being	25	231	1	2245	352	3223	4508	1262	400	3825	231	238	1689	503	3538	4254	1758	4494	2563	1168	2172
895_Total lipids in large LDL	895_Total lipids in large LDL	25	231	1	2261	1049	2765	2635	1911	3729	1640	2170	3616	3842	2433	836	4490	4426	3268	231	2183	523
55_Neuroticism	55_Neuroticism	24	232	1	4156	2281	970	232	416	3530	3489	310	4239	3962	4702	2345	1377	4022	3296	3205	4142	1456
557_Lipid::Medium chain fatty acid::caprylate (8:0)	557_Lipid::Medium chain fatty acid::caprylate (8:0)	25	232	1	3480	3852	551	3332	960	2084	3219	232	2525	4738	3216	3085	3629	644	4279	1632	3516	982
166_Hip circumference (female, adjusted for BMI)	166_Hip circumference (female, adjusted for BMI)	25	232	1	1520	592	4192	381	3807	1361	4669	1605	232	3718	676	4369	4513	1332	2957	2584	2827	2737
533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	533_Lipid::Lysolipid::1-docosahexaenoylglycerophosphocholine*	25	232	1	4276	2680	3781	2548	3453	741	596	4429	3825	4329	616	232	2341	2274	2797	2393	568	845
1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	1879_Shaft cross-sectional moment of inertia (GEE, adjussted for multivariable)	25	232	1	2208	793	4539	2267	2226	4668	2275	2057	1292	2675	1082	2407	232	2239	968	2784	2883	3934
2858_C3 - Complement C3b	2858_C3 - Complement C3b	25	232	1	3670	4189	3724	963	2991	685	236	1908	832	2794	1306	1985	736	232	1514	2408	1031	3709
896_Concentration of large LDL particles	896_Concentration of large LDL particles	25	232	1	1661	2328	2043	2344	2744	4326	752	4614	2037	4521	2208	658	4389	4594	894	232	2377	700
3020_PLA2G7 - Platelet-activating factor acetylhydrolase	3020_PLA2G7 - Platelet-activating factor acetylhydrolase	25	233	1	2350	233	4399	4007	2533	3089	3762	2768	3422	1777	1102	3057	3423	4668	3012	2025	2696	1848
1198_Phosphorylated Tau at position 181	1198_Phosphorylated Tau at position 181	25	233	1	4746	2106	233	1948	1545	1083	1622	2466	4338	3708	3502	2692	3649	1960	487	2674	4138	4331
729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	729_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::X-11793--oxidized bilirubin*	25	233	1	859	4636	4151	233	3009	2850	4043	3083	4596	727	3376	1991	2694	1805	1406	1846	2246	4301
2278_ESR1 - Estrogen receptor	2278_ESR1 - Estrogen receptor	25	233	1	2466	1111	4394	1550	233	2299	4742	490	4649	1703	2967	696	4507	2479	2903	1764	3680	3346
4419_Measles seropositivity	4419_Measles seropositivity	25	233	1	2433	3655	3033	4192	4586	233	2920	768	4561	4561	1278	3038	3528	1438	2450	920	2500	4206
1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	1399_High-density lipoprotein 2 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	233	1	1304	1347	4020	2873	4744	4633	2511	2851	233	2199	1560	2375	4193	4525	2654	1369	595	1669
4114_Chloride	4114_Chloride	25	233	1	3179	2747	3689	3290	4343	244	4511	1821	3551	233	495	4073	3820	3279	2722	1670	964	2221
2464_SERPINC1 - Antithrombin-III	2464_SERPINC1 - Antithrombin-III	25	233	1	417	3429	4295	2444	4420	268	2964	2191	1941	2132	2123	4594	233	3861	379	2488	2255	3494
510_Lipid::Inositol metabolism::chiro-inositol	510_Lipid::Inositol metabolism::chiro-inositol	25	234	1	234	1127	414	815	491	3788	461	3585	2190	2998	365	2716	590	3151	1009	748	3584	3336
3795_Neuroticism	3795_Neuroticism	25	234	1	4200	234	2415	2286	2041	4505	977	3126	2796	2926	4641	4284	3393	2107	1469	3517	4022	2674
1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	1556_Mean common carotid artery IMT (at exam 6, FBAT, adjusted for multivariable)	25	234	1	3870	2838	234	2557	1685	3442	4057	3047	4716	4242	1710	2127	3411	1863	1453	2233	287	3890
3131_ABL2 - Abelson tyrosine-protein kinase 2	3131_ABL2 - Abelson tyrosine-protein kinase 2	25	234	1	3284	2049	2453	234	3550	4700	1246	3021	4367	4213	533	3307	586	1038	3397	3322	1601	2342
3220_Time spent using computer	3220_Time spent using computer	25	234	1	2136	2903	2283	2952	234	1073	1626	337	2916	1333	1565	3850	2174	3294	3184	1021	1169	1614
1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	1038_Neck-Shaft Angle (FBAT, adjusted for multivariable)	25	234	1	2345	805	417	2924	288	4065	234	4516	2755	4552	2363	4428	3595	1870	3771	2250	3018	437
1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	1745_Urinary albumin excertion in hypertensive enriched sample (at exam 6, GEE, adjusted for age and sex)	25	234	1	3587	2274	1556	755	907	3704	4366	234	4643	618	4720	1077	1856	4448	1657	1281	4582	4681
1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	1881_Shaft cross-sectional moment of inertia (GEE, female, adjussted for multivariable)	25	234	1	1312	305	1990	378	1614	4440	2877	2051	4382	2379	528	234	274	2617	3419	1850	2224	2565
2730_BPI - Bactericidal permeability-increasing protein	2730_BPI - Bactericidal permeability-increasing protein	25	235	1	4361	235	2675	4505	3986	749	354	4313	1872	3793	624	2546	4189	4214	273	3839	4041	2869
1118_Pericardial adipose tissue volume (male)	1118_Pericardial adipose tissue volume (male)	25	235	1	4291	2445	3829	1835	235	3447	4667	3303	2864	519	2326	1806	4572	4032	3570	4326	957	3292
1030_Neck Width (FBAT, adjusted for multivariable)	1030_Neck Width (FBAT, adjusted for multivariable)	25	235	1	1776	2664	4583	1410	4446	4129	235	4256	402	2669	3104	894	1176	4556	4633	3315	3028	1448
772_::::X-12405	772_::::X-12405	25	235	1	3864	953	2312	1864	3907	3996	3496	699	235	2123	617	1169	3538	3756	3961	2533	3156	3114
1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1523_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	235	1	2173	3782	4693	1045	3689	2419	4503	713	908	3302	4464	404	235	1952	2352	1267	4262	2411
2543_NTRK1 - High affinity nerve growth factor receptor	2543_NTRK1 - High affinity nerve growth factor receptor	25	235	1	2129	1819	1517	4551	1386	489	1454	765	2554	3246	450	2352	2328	4334	235	1867	1315	4590
3371_Chest pain or discomfort when walking uphill or hurrying	3371_Chest pain or discomfort when walking uphill or hurrying	25	235	1	3166	1955	642	336	2683	3604	3444	1909	498	3079	892	4021	1676	2447	3137	3830	235	1027
4749_Posterior thalamic radiation (include optic radiation) radial diusivities	4749_Posterior thalamic radiation (include optic radiation) radial diusivities	25	235	1	4374	1307	991	2340	2449	589	877	335	1679	3654	3559	2759	1962	1182	3497	660	2720	235
2708_DYNLL1 - Dynein light chain 1, cytoplasmic	2708_DYNLL1 - Dynein light chain 1, cytoplasmic	25	236	1	236	4610	3943	2231	3253	3696	3806	1457	2808	2622	618	485	360	2091	3688	3053	4360	3675
2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	2442_FCGR1A - High affinity immunoglobulin gamma Fc receptor I	25	236	1	4286	1446	4187	1380	3425	1061	824	1386	3872	236	1684	3818	2843	3389	1681	1462	850	4334
3985_Heart rate recovery at 10 secnds	3985_Heart rate recovery at 10 secnds	25	236	1	3745	3587	1804	1188	924	4276	2186	3728	326	1683	311	989	3925	236	916	1911	3466	3367
1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	1692_Vitamin K plasma phylloquinone (at exam 6 or 7, FBAT, adjusted for multivariable)	25	236	1	2776	1449	1019	3560	2566	1359	4587	2640	2996	313	302	3894	3898	3310	1421	4028	2110	236
4571_Left superior frontal	4571_Left superior frontal	25	237	1	2745	237	2875	1517	2267	857	4203	309	1577	2042	809	3710	3329	4500	4430	1159	842	585
2639_SCT - Secretin	2639_SCT - Secretin	25	237	1	1659	1978	237	3385	4381	4214	1992	4278	4423	4298	1699	2256	3169	2762	3544	912	4193	4218
93_Birth length	93_Birth length	25	237	1	3247	2157	2335	237	3328	4201	4135	1874	4504	2900	2469	2582	420	4282	4492	4557	1193	3443
4255_Sleep efficiency	4255_Sleep efficiency	25	237	1	1700	2376	1578	1590	1742	1804	237	4381	1841	970	3065	2117	4148	2645	3944	3757	1684	4214
186_Waist-hip ratio (adjusted for BMI)	186_Waist-hip ratio (adjusted for BMI)	25	237	2	1915	2078	1607	523	2578	2465	4464	237	870	4532	4262	1767	4359	3175	461	3735	2748	4670
2373_IL2RA - Interleukin-2 receptor subunit alpha	2373_IL2RA - Interleukin-2 receptor subunit alpha	25	237	1	593	3467	2712	3835	2809	639	1146	3846	237	3815	3380	1946	3763	4385	1153	3453	3538	2947
3416_Bipolar and major depression status	3416_Bipolar and major depression status	25	237	1	3579	2066	2526	1322	405	972	2642	1542	4384	1633	237	848	4299	2346	2017	4689	1550	3638
2482_FETUB - Fetuin-B	2482_FETUB - Fetuin-B	25	237	1	4628	2188	3747	3786	2725	2771	1563	875	1410	1974	2746	237	483	3870	1175	3073	538	4245
2327_CD209 - CD209 antigen	2327_CD209 - CD209 antigen	25	237	1	2429	4182	2063	2199	1439	1894	4197	432	3029	1233	491	873	3287	237	3255	569	2104	2384
2178_NCR2 - Natural cytotoxicity triggering receptor 2	2178_NCR2 - Natural cytotoxicity triggering receptor 2	25	237	1	2831	3083	795	2382	4668	1622	2456	325	4198	1077	1581	1001	1417	1986	237	2857	3147	4019
1922_Hippocampal volume (FBAT, adjusted for age and sex)	1922_Hippocampal volume (FBAT, adjusted for age and sex)	25	238	1	814	238	326	1579	703	2731	4070	2560	2224	4705	3291	3902	825	2216	2437	1908	2351	3569
665_::::X-05907	665_::::X-05907	25	238	1	523	2996	4149	3102	4044	925	238	4232	4577	544	4171	604	4128	1772	1758	1328	1079	1354
4730_Superior corona radiata mode of anisotropy	4730_Superior corona radiata mode of anisotropy	25	239	1	239	2061	4058	3739	3966	568	3426	2731	2427	2797	849	1331	2478	775	797	1747	2847	1578
3742_Depression - Feelings of tiredness during worst episode of depression	3742_Depression - Feelings of tiredness during worst episode of depression	25	239	1	250	3365	272	239	480	2998	4618	4596	256	848	1714	4221	453	720	3445	1012	1337	601
4634_Right cerebellum white matter	4634_Right cerebellum white matter	25	239	1	3736	1535	2109	3425	1846	239	2149	1733	3224	3272	4058	4211	2904	1386	3916	1550	3325	1302
47_Age at first birth	47_Age at first birth	25	239	1	4053	4497	1592	2690	291	3134	1885	2482	736	3068	239	3623	2474	4131	3193	600	893	1466
2332_GFAP - Glial fibrillary acidic protein	2332_GFAP - Glial fibrillary acidic protein	25	239	1	3120	1788	2081	264	501	3720	4634	4407	487	2276	3833	239	1075	2745	4239	3036	1947	1143
126_Height (male)	126_Height (male)	25	240	1	240	3997	2943	1610	3336	712	4647	2221	2563	4450	1009	2253	830	2137	1456	521	818	2821
3913_Cup area	3913_Cup area	25	240	1	4253	2455	240	3702	443	1659	1342	1346	411	2098	913	3860	1768	2810	2976	3175	2435	2993
2919_CMPK1 - UMP-CMP kinase	2919_CMPK1 - UMP-CMP kinase	25	240	1	1306	785	4605	240	2960	4075	4436	2404	2614	4155	2549	4299	3291	2884	2374	3563	2730	4221
4212_Glycine level (male)	4212_Glycine level (male)	25	240	1	2987	2808	4246	1998	240	738	4075	4065	4494	1146	3660	699	4419	4254	3987	3414	875	2655
4520_Left cerebellum white matter	4520_Left cerebellum white matter	25	240	1	3493	820	3440	3388	2924	240	1863	998	1843	3362	4391	4111	3118	608	3436	3006	1749	1033
3186_Hip circumference	3186_Hip circumference	25	240	1	4382	3637	4052	3325	2717	3389	3742	3795	1628	240	3483	1084	1888	4370	3863	4688	2112	4276
1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	1704_Follicle stimulating hormone (at exam 3, FBAT, adjusted for multivariable)	25	240	1	843	2984	1089	838	2410	3547	4350	3860	1588	3118	4742	4680	240	4401	4614	2306	847	1346
805_::::X-12816	805_::::X-12816	25	240	1	3704	2020	2907	1158	474	4029	4056	453	3056	3406	3161	3946	1669	3216	240	1616	977	2168
562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	562_Lipid::Monoacylglycerol::1-linoleoylglycerol (1-monolinolein)	25	240	1	4063	500	730	3152	2163	4546	2203	2937	2320	927	812	2522	3972	2236	4067	240	2025	4511
904_Triglycerides in large VLDL	904_Triglycerides in large VLDL	25	241	1	1865	4310	1973	241	878	1105	3458	2865	4514	3601	4423	385	3626	1827	2896	2390	1895	2851
3518_How are people in household related to participant: Son and/or daughter (include step-children)	3518_How are people in household related to participant: Son and/or daughter (include step-children)	25	241	1	3517	1189	3377	2622	241	747	2351	954	4318	2741	433	2185	3047	4609	3095	2091	328	2997
4404_Menstrual quality of life impact: Nervousness	4404_Menstrual quality of life impact: Nervousness	25	241	1	1552	2737	3225	2131	2942	241	2143	3790	4400	2092	1958	4069	958	2508	582	2439	4055	3822
192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	192_Estimated glomerular filtration rate based on serum creatinine (diabetes positive)	25	241	1	3733	734	3466	2632	921	3341	241	2442	2052	1745	4553	611	1157	3997	2737	2202	609	1508
501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	501_Lipid::Fatty acid, dicarboxylate::octadecanedioate	25	241	1	2894	3680	1771	2373	2414	3031	4475	1647	3977	241	4429	4022	4245	3104	3472	2135	2098	3878
2895_SH2D1A - SH2 domain-containing protein 1A	2895_SH2D1A - SH2 domain-containing protein 1A	25	241	1	4059	2844	3746	1144	4089	3949	2914	4317	2810	3552	241	1785	694	2548	3118	3783	4661	2006
2479_CTSV - Cathepsin L2	2479_CTSV - Cathepsin L2	25	241	1	1155	4331	3902	875	3346	2648	629	3196	462	1607	3781	1313	241	3736	1000	3862	580	689
988_Interleukin-1 receptor antagonist	988_Interleukin-1 receptor antagonist	25	241	1	4296	1718	2501	518	1589	2891	2847	863	1316	3767	3587	1832	3904	1047	241	3789	1524	1920
3341_Number of live births (female)	3341_Number of live births (female)	25	241	1	3960	3885	3347	3828	3805	4677	2025	2644	4257	2950	2528	2257	4548	3025	4090	241	1082	1586
4461_Left pars orbitalis	4461_Left pars orbitalis	25	242	1	2499	242	4270	4209	309	1010	1065	2993	4185	1356	2454	3864	2815	2407	1368	1716	1596	3816
1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	1502_Triglycerides (at exam 3, FBAT, adjusted for age and sex)	25	242	1	3726	2363	4388	242	691	2602	2697	2894	3204	920	1111	4117	1188	4639	1131	3836	864	877
2060_C4A C4B - Complement C4b	2060_C4A C4B - Complement C4b	25	242	1	4325	2797	4291	3898	242	4602	3073	1062	3609	245	898	4632	1170	2595	2875	1071	2561	3614
2682_TLR2 - Toll-like receptor 2	2682_TLR2 - Toll-like receptor 2	25	242	1	4341	299	3540	364	3057	242	371	338	2950	4457	331	2062	532	2109	4003	4179	256	2166
721_::::X-11540	721_::::X-11540	25	242	1	784	3453	427	1025	578	2640	1967	3948	242	2559	411	4544	306	3768	700	252	592	2192
3847_Immature fraction of reticulocytes (two-way meta)	3847_Immature fraction of reticulocytes (two-way meta)	25	242	1	3110	1923	3146	2970	3005	948	2489	1715	968	242	2057	4427	1542	1286	2180	1248	433	514
168_Waist circumference	168_Waist circumference	25	242	1	1838	2843	2756	4650	2190	1319	1473	2115	833	495	2230	242	2889	3118	1675	4152	3423	2568
4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	4347_Coronary artery disease and low-density lipoprotein cholesterol (bivariate)	25	242	1	2748	518	1288	4745	4573	1821	251	2972	618	3429	330	2252	4523	3183	242	283	413	941
3080_NRXN1 - Neurexin-1-beta	3080_NRXN1 - Neurexin-1-beta	25	243	1	3111	4460	243	3505	3007	2538	3326	1658	4373	1199	3989	3888	3645	4402	4021	3873	1990	1988
4393_Menstrual fever	4393_Menstrual fever	25	243	1	1187	3019	816	243	246	1079	1586	4423	3785	355	4677	3012	443	1965	1289	354	3194	4241
2371_VEGFC - Vascular endothelial growth factor C	2371_VEGFC - Vascular endothelial growth factor C	25	243	1	4288	4315	813	1966	2279	1556	1200	4720	243	2190	2148	2470	3525	736	3385	4247	1185	864
3329_Cancer (diagnosed by doctor)	3329_Cancer (diagnosed by doctor)	25	243	1	3332	1210	1833	4436	2388	950	4737	2706	2881	4139	1187	3457	3787	243	3047	2630	2242	4549
2791_NUDCD3 - NudC domain-containing protein 3	2791_NUDCD3 - NudC domain-containing protein 3	25	243	1	1006	4311	915	2228	1166	3688	1752	3467	3339	379	2224	1353	4739	3953	1459	243	3652	2873
132_Waist circumference (male)	132_Waist circumference (male)	25	244	1	244	2427	1617	3885	3257	1424	554	1837	1348	609	2428	4653	2198	2426	2029	2434	357	4160
2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	2251_MAP2K1 - Dual specificity mitogen-activated protein kinase kinase 1	25	244	1	2612	1680	244	4593	331	4421	4662	2078	1800	2570	346	850	943	2530	2221	1804	791	3795
2643_CTSH - Cathepsin H	2643_CTSH - Cathepsin H	25	244	1	297	687	2644	244	711	4226	2940	1404	747	4474	544	887	462	4152	1589	2595	300	1273
3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	3102_PRKAA1 PRKAB1  PRKAG1 - AMP Kinase (alpha1beta1gamma1)	25	244	1	4356	4030	1523	2768	3869	4701	244	4480	2514	2654	1506	3904	3664	1122	4035	1445	2951	4075
970_Concentration of chylomicrons and extremely large VLDL particles	970_Concentration of chylomicrons and extremely large VLDL particles	25	244	1	2372	3374	1274	612	1077	2786	3838	3016	2310	2716	3883	244	3588	4068	4269	3417	1419	2478
2911_PDIA3 - Protein disulfide-isomerase A3	2911_PDIA3 - Protein disulfide-isomerase A3	25	245	1	245	650	4733	1598	2147	1295	3182	384	1587	2768	2361	1476	4474	2876	2077	4105	1599	1292
2011_Remission following treatment of MDD subjects	2011_Remission following treatment of MDD subjects	25	245	1	1198	245	899	3729	2047	1950	1666	3103	3187	2416	2269	2875	2677	1142	1150	2177	1868	4024
1930_Occipital brain volume (FBAT, adjusted for age and sex)	1930_Occipital brain volume (FBAT, adjusted for age and sex)	25	245	1	283	3793	245	3854	1629	2251	3319	281	3000	1355	2541	4014	3636	3562	1679	345	1522	3992
2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	2611_LRPAP1 - alpha-2-macroglobulin receptor-associated protein	25	245	1	3697	609	1387	245	1705	2515	2144	960	2691	1908	4283	3028	268	3709	3969	281	3286	1939
4543_Gray matter	4543_Gray matter	25	245	1	2095	2348	2814	2407	245	3758	1773	1125	4410	2730	257	648	1974	3304	4635	4636	1048	3460
1046_Trochanter BMD (FBAT, adjusted for multivariable)	1046_Trochanter BMD (FBAT, adjusted for multivariable)	25	245	1	1258	4192	1700	3998	356	2432	3785	245	4172	1496	3993	1052	3877	4262	2544	1476	2942	2261
1088_Neuroblastoma	1088_Neuroblastoma	25	245	1	3667	2850	1485	2855	2069	1594	2769	3120	2290	4590	3807	245	4745	4732	3793	4272	1021	3030
715_::::X-11497	715_::::X-11497	25	245	1	2820	2933	2717	4501	4081	2789	2967	4187	1397	3795	4339	4004	1126	245	2991	3847	4107	3470
4035_Alcohol dependency (unrelated individuals)	4035_Alcohol dependency (unrelated individuals)	25	245	1	408	3120	1853	966	603	3546	3977	904	608	4632	2330	626	2136	1415	4043	3377	1217	245
3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	3514_Gas or solid-fuel cooking/heating: A gas fire that you use regularly in winter time	25	246	1	246	579	1361	3619	831	2552	2471	451	4647	2638	2838	1109	2444	1114	1064	1271	4383	2024
3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	3714_Diagnoses - secondary ICD10: Z90 Acquired absence of organs, not elsewhere classified	25	246	1	1577	3485	246	4155	3313	566	4340	2861	1829	4434	2206	3317	4676	1007	1268	3682	3469	2667
4006_Osteoarthritis (hospital diagnosed)	4006_Osteoarthritis (hospital diagnosed)	25	246	1	4067	754	993	3476	3491	246	3842	2763	2501	600	987	4011	993	606	676	3865	899	661
2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	2559_ITGA1 ITGB1 - Integrin alpha-I: beta-1 complex	25	246	1	519	1050	4104	4467	2735	271	246	4067	566	2269	2058	1365	2084	4491	2519	360	2065	1824
3899_Platelet count (three-way meta)	3899_Platelet count (three-way meta)	25	246	1	563	3421	3321	2871	836	1477	4142	2834	965	1854	246	1896	3335	2923	2422	2008	1551	4663
1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	1406_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for multivariable)	25	246	1	4204	743	2629	1368	4179	1895	2558	511	2323	3989	4314	2227	260	246	1423	3017	669	2297
968_Triglycerides in very small VLDL	968_Triglycerides in very small VLDL	25	246	1	3333	2468	1966	1016	2772	1459	317	1764	2006	1532	1821	1451	2015	2127	2355	246	2012	2177
1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	1335_Fasting HbA1c (at exam 7, GEE, adjusted for age, sex and BMI)	25	246	1	4484	4600	1346	650	938	1236	2007	3184	753	2524	3511	2024	552	602	4650	4581	811	246
1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	1694_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, FBAT, adjusted for age and sex)	25	247	1	247	4049	1147	4607	3859	1715	3995	2660	2410	2840	2001	4528	2853	969	2209	2101	3929	2928
3935_Disialylation	3935_Disialylation	25	247	1	3275	3640	247	299	993	3004	2889	1426	973	310	3893	598	1086	1079	2666	3861	2079	4401
3317_Falls in the last year	3317_Falls in the last year	25	247	1	3807	2580	2151	3348	247	3837	2371	2810	1450	2936	4589	3751	2250	1659	2855	3100	3661	2020
237_CD32 on pDC	237_CD32 on pDC	25	247	1	4701	2634	4687	1901	3194	2210	247	4413	2260	568	4345	1760	3550	4170	1230	2098	1410	1300
4107_Albumin/globulin ratio	4107_Albumin/globulin ratio	25	247	1	1898	4482	281	2741	2587	3380	2056	3405	2697	247	3130	2894	1870	2792	3616	1162	1113	996
2550_CXCL13 - C-X-C motif chemokine 13	2550_CXCL13 - C-X-C motif chemokine 13	25	247	1	3982	4525	1034	2218	1899	4271	2604	775	2405	3063	247	2102	2642	549	1099	4253	4440	3526
3901_Red cell distribution width (three-way meta)	3901_Red cell distribution width (three-way meta)	25	247	1	1590	1829	1542	1541	942	3868	798	2938	2670	3247	2054	247	2936	3762	879	3312	393	1760
2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	2985_BIRC3 - Baculoviral IAP repeat-containing protein 3	25	247	1	3541	2724	480	1395	1891	3990	3471	622	1055	3536	3244	4393	1575	247	708	909	1535	1696
2343_PRSS1 - Trypsin-1	2343_PRSS1 - Trypsin-1	25	247	1	3044	3894	1308	2615	3443	2109	3092	1774	3280	3424	811	1164	853	4216	247	4104	4195	1309
2804_SPON1 - Spondin-1	2804_SPON1 - Spondin-1	25	247	1	326	3991	1110	4090	4304	2114	3170	3354	1737	2160	2365	2421	2442	3813	888	1418	1161	247
539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	539_Lipid::Lysolipid::1-myristoylglycerophosphocholine	25	248	1	248	251	1513	3094	914	3583	1393	2257	2253	995	3861	853	2334	3023	3759	3328	523	3622
2109_ANGPT2 - Angiopoietin-2	2109_ANGPT2 - Angiopoietin-2	25	248	1	268	248	2250	1570	515	2264	2562	4362	1384	3692	3136	773	1452	2432	2787	1278	3555	2236
216_NKT:%4-8-	216_NKT:%4-8-	25	248	1	2854	1358	248	2302	4424	602	2658	1438	4422	3914	2332	1603	2691	1289	622	3283	1517	4242
1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	1467_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for age and sex)	25	248	1	1335	3397	3168	248	2062	2255	318	2055	1226	3748	3435	3571	351	1753	1037	623	697	990
339_NKeff:%Kir+ (4)	339_NKeff:%Kir+ (4)	25	248	1	1764	2092	445	1535	4003	1903	2969	1678	248	1802	641	586	2655	3731	4115	1957	3107	776
3005_EIF4A3 - Eukaryotic initiation factor 4A-III	3005_EIF4A3 - Eukaryotic initiation factor 4A-III	25	248	1	289	2032	3257	1656	2384	1007	386	344	1672	1322	348	487	248	4024	2784	794	386	3671
2499_TBK1 - Serine/threonine-protein kinase TBK1	2499_TBK1 - Serine/threonine-protein kinase TBK1	25	248	1	2148	4694	2606	4204	3686	2041	2215	2259	3534	3124	2970	1661	1295	3003	985	248	4276	3652
673_::::X-07765	673_::::X-07765	25	248	1	1594	2334	1896	2472	4222	3063	3400	3911	2954	3637	776	4224	4663	1269	1252	3751	3981	248
1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1242_Mean FEV1 from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	249	1	2200	249	3584	3881	802	4215	3529	4184	2990	2576	3294	3059	4654	2502	4260	4043	2617	1929
2188_C1QA C1QB  C1QC - Complement C1q subcomponent	2188_C1QA C1QB  C1QC - Complement C1q subcomponent	25	249	1	1639	2002	2964	308	1078	724	249	996	4415	1890	4334	2695	1679	555	1307	928	2517	2019
56_Depressive symptoms	56_Depressive symptoms	25	249	1	1702	3126	2346	1267	1061	928	2378	3814	249	2875	414	1223	875	3275	3251	2834	3977	3537
971_Phospholipids in chylomicrons and extremely large VLDL	971_Phospholipids in chylomicrons and extremely large VLDL	25	250	1	1767	3248	1657	250	1197	1144	3926	2386	3758	4100	1675	599	2925	3247	2495	3419	1862	4668
372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	372_Amino acid::Cysteine, methionine, SAM, taurine metabolism::cysteine	25	250	1	2234	3121	1889	3405	1452	250	954	2636	2600	2557	4321	3701	1246	667	1728	3420	2775	2038
2157_IGFBP6 - Insulin-like growth factor-binding protein 6	2157_IGFBP6 - Insulin-like growth factor-binding protein 6	25	250	1	3510	473	3801	3686	2306	3921	4389	250	3675	2661	2170	421	1266	4671	1724	820	2812	3178
3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	3676_Diagnoses - main ICD10: M16 Osteoarthritis of hip	25	250	1	2517	4657	4646	3280	3988	3841	325	1796	3045	4678	250	3832	2197	990	2331	2072	3698	947
2694_PSMA1 - Proteasome subunit alpha type-1	2694_PSMA1 - Proteasome subunit alpha type-1	25	250	1	1230	603	4372	418	3178	596	2080	4144	725	1294	4371	584	250	2978	1632	3022	475	2484
3891_Mean platelet volume (three-way meta)	3891_Mean platelet volume (three-way meta)	25	250	1	3999	2264	3738	1711	3282	482	3934	1102	3911	2633	2658	2389	2747	3805	250	4644	1322	740
575_Lipid::Sterol, Steroid::cortisone	575_Lipid::Sterol, Steroid::cortisone	25	250	1	526	4400	3344	2729	1330	2893	4305	668	398	3631	1780	3133	3947	3507	4711	4263	3041	250
2320_TGFBR3 - Transforming growth factor beta receptor type 3	2320_TGFBR3 - Transforming growth factor beta receptor type 3	25	251	1	251	1891	2816	3991	4234	1678	4364	2556	1074	4135	1466	1992	1320	2390	1652	2469	4132	3852
4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	4352_Male pattern baldness (BOLT LMM non-infinitesimal mixed model)	25	251	1	3239	1301	251	1467	4066	773	2045	2410	1131	3818	3977	3598	2749	4552	1875	1543	1302	3544
4670_Anterior limb of internal capsule axial diusivities	4670_Anterior limb of internal capsule axial diusivities	25	251	1	1238	848	3212	4381	4649	251	2038	3842	4397	348	2065	3106	3825	3248	3805	4426	2605	1835
2967_MMP13 - Collagenase 3	2967_MMP13 - Collagenase 3	25	251	1	2256	1292	2937	2275	1413	2561	4290	402	485	3292	251	2508	3874	365	2714	2884	2359	4265
4467_Left precuneus	4467_Left precuneus	25	251	1	949	4493	1717	3692	3376	406	1494	2696	3269	2135	1685	251	287	1202	4570	554	2936	4078
3017_AK1 - Adenylate kinase isoenzyme 1	3017_AK1 - Adenylate kinase isoenzyme 1	25	251	1	2656	1804	2906	2800	606	718	2523	1849	1112	526	3367	2923	837	3223	2395	251	2946	3540
3603_Non-cancer illness code, self-reported: migraine	3603_Non-cancer illness code, self-reported: migraine	25	252	1	252	1995	3384	781	2085	3410	2882	1884	3027	1336	1343	4008	611	2365	3228	2143	1692	3338
179_Waist-hip ratio	179_Waist-hip ratio	25	252	1	2289	1614	252	985	2086	508	1642	3600	3438	3943	4292	334	3945	3305	2405	2132	4065	1704
4336_Overall activity (conditioning sex and BMI)	4336_Overall activity (conditioning sex and BMI)	25	252	1	3596	4576	2519	252	1514	318	1913	851	1016	2947	1255	3323	725	3360	4512	4206	588	1413
3211_Frequency of stair climbing in last 4 weeks	3211_Frequency of stair climbing in last 4 weeks	25	252	1	3849	329	3800	887	252	2730	3855	982	1583	2820	976	1836	1612	3407	719	992	859	1764
2760_PLAU - Urokinase-type plasminogen activator	2760_PLAU - Urokinase-type plasminogen activator	25	252	1	2299	4361	1772	4531	1813	252	770	2256	2063	566	4174	1440	2887	1841	3014	1005	3288	2788
3819_Multiple Sclerosis	3819_Multiple Sclerosis	25	252	1	3646	3228	792	2933	4476	3966	252	1698	4622	413	4120	2937	4167	4172	3359	2006	2832	1471
2233_MET - Hepatocyte growth factor receptor	2233_MET - Hepatocyte growth factor receptor	25	252	1	590	1618	4045	4128	2944	4610	2235	4156	252	674	1568	1683	1321	2504	3639	942	843	662
489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	489_Lipid::Essential fatty acid::docosapentaenoate (n3 DPA; 22:5n3)	25	252	1	898	3953	1777	3975	2005	4510	633	4198	2383	748	2813	252	1465	1249	4602	1527	344	617
2541_MPL - Thrombopoietin Receptor	2541_MPL - Thrombopoietin Receptor	25	252	1	3464	2826	4595	1347	1073	4030	718	2165	4375	1998	3547	1950	488	252	3031	3934	3549	337
3395_Ever highly irritable/argumentative for 2 days	3395_Ever highly irritable/argumentative for 2 days	25	252	1	2244	3089	2107	3759	3694	987	3242	576	548	3810	1661	449	1556	2589	2157	1092	2028	252
1763_Prostate cancer (GEE, adjusted for age)	1763_Prostate cancer (GEE, adjusted for age)	25	253	1	2538	2965	3817	1270	681	1938	253	999	1663	1587	1174	4423	3564	2113	995	1419	3568	2614
2698_SBDS - Ribosome maturation protein SBDS	2698_SBDS - Ribosome maturation protein SBDS	25	253	1	3471	1138	2429	618	4496	2848	1538	4475	4284	2992	1165	2930	253	1667	1356	2872	2378	933
4446_Left caudal middle frontal	4446_Left caudal middle frontal	25	253	1	3680	2385	1325	3249	585	1978	3452	4568	3704	3690	2613	2334	4628	253	532	1854	3979	2554
4112_Sodium	4112_Sodium	25	254	1	254	961	650	1225	929	3427	4556	2992	913	4657	3437	2984	1450	393	1817	1060	2072	4208
654_::::X-03003	654_::::X-03003	25	254	1	410	1375	3171	707	3890	254	4723	2222	3716	1710	3394	2098	1478	531	258	904	3928	4271
4632_Right inferior lateral ventricle	4632_Right inferior lateral ventricle	25	254	1	1669	4532	3080	2669	1910	2065	3867	2224	4464	1769	3432	254	1240	4635	1799	1864	3850	3056
3171_TNNI3 - Troponin I, cardiac muscle	3171_TNNI3 - Troponin I, cardiac muscle	25	254	1	2205	544	1416	3575	2752	834	1700	4224	4077	1935	1294	523	1879	254	2685	4370	3819	3763
936_Total cholesterol in small LDL	936_Total cholesterol in small LDL	25	254	1	3035	679	2374	2613	1500	3771	1691	1165	3572	3045	2070	793	3797	4429	1982	254	1764	486
697_::::X-11381	697_::::X-11381	25	254	1	1283	4456	1407	3288	3318	3212	3870	2395	2674	1443	1241	4730	2420	4735	2520	3537	254	4374
396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	396_Amino acid::Phenylalanine & tyrosine metabolism::phenol sulfate	25	255	1	255	546	3681	2559	4640	1341	364	2300	4008	1376	2689	2808	1056	1384	4508	1299	1709	3551
3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	3715_Diagnoses - secondary ICD10: Z92 Personal history of medical treatment	25	255	1	2874	3556	2205	255	1480	455	1023	1960	2076	4058	1429	2040	304	4148	423	3560	3373	4200
3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	3126_PDE3A - cGMP-inhibited 3',5'-cyclic phosphodiesterase A	25	255	1	2146	708	880	1036	4487	255	1802	4667	1423	1002	4070	1600	982	3239	1895	391	1553	4508
1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	1162_Fasting proinsulin (adjusted for fasting insulin, age and sex)	25	255	1	2655	4422	4344	4616	4469	1237	773	2632	255	1420	2408	942	738	960	4690	2947	896	3208
808_::::X-12844	808_::::X-12844	25	255	1	4617	3269	3176	1978	1398	1843	3311	932	2986	3586	3281	255	1860	4274	450	796	1934	3288
4711_Sagittal stratum mean diusivities	4711_Sagittal stratum mean diusivities	25	255	1	703	2673	2605	3028	1964	297	1579	3388	4019	2508	1852	4262	2662	255	4016	3060	3409	3362
4428_Epstein Barr Virus antigen VCA seropositivity	4428_Epstein Barr Virus antigen VCA seropositivity	25	256	1	1053	3360	1741	256	4171	3451	999	342	4051	1206	2040	1516	4168	4092	4433	3737	2873	2936
2870_CLEC11A - Stem Cell Growth Factor-alpha	2870_CLEC11A - Stem Cell Growth Factor-alpha	25	256	1	4294	1912	3534	2100	256	4547	4654	1408	1920	4110	3315	4434	2262	4384	1994	890	3573	3855
3320_Chest pain or discomfort	3320_Chest pain or discomfort	25	256	1	4584	2448	736	1234	3079	256	4023	2483	4451	2264	550	4432	2037	2843	337	891	840	1705
53_Educational attainment	53_Educational attainment	25	256	1	2202	1222	4233	2561	628	2358	876	1247	2055	2903	256	3462	461	3823	962	1147	2878	4098
1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	1272_Epworth Sleepiness Scale (FBAT, adjusted for age, sex, BMI and usual sleep duration)	25	256	1	3298	2875	4723	1765	1525	1269	360	2243	2714	3280	622	2047	2767	1882	256	2553	2702	292
1216_Alcohol consumption (dichotomous)	1216_Alcohol consumption (dichotomous)	25	256	1	2863	3658	2633	2233	2499	1513	4348	4079	3488	1112	1662	898	2983	3404	3406	683	1329	256
1063_Schizophrenia	1063_Schizophrenia	25	257	1	257	3183	3883	260	2575	2376	4011	3996	3884	2541	2096	915	3015	3844	2104	900	1287	1748
1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	1291_Waist circumference by CT (GEE, adjusted for age, sex, smoking and menopause)	25	257	1	1362	257	2271	4402	4117	607	617	1917	2488	1795	731	1952	921	1092	4468	3927	2453	975
4454_Left lateral orbitofrontal	4454_Left lateral orbitofrontal	25	257	1	678	3726	257	1700	697	761	4307	3173	1853	2295	1128	1755	897	3948	3798	1939	3740	2987
1855_Neck average buckling ratio (GEE, female, adjussted for age)	1855_Neck average buckling ratio (GEE, female, adjussted for age)	25	257	1	2143	467	1475	1051	297	257	3220	301	4111	368	2923	3579	4613	3839	3322	718	281	441
2735_FN1 - Fibronectin	2735_FN1 - Fibronectin	25	257	1	399	864	2651	1114	2403	4544	2334	257	2752	1264	3830	3521	890	3278	260	1905	798	871
1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	1977_Hand grip (at offspring exam 7 cohort exam 27, GEE)	25	257	1	1668	3124	4390	4116	3020	1120	2905	2740	1168	1325	4331	257	1994	308	3240	1734	3515	799
1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	1576_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for age and sex)	25	257	1	1680	3906	2694	1968	2732	4715	4717	2247	4015	4486	582	4411	1630	257	2173	3988	2339	4724
692_::::X-11315	692_::::X-11315	25	258	1	258	4417	4164	2376	3010	4239	683	4400	4615	4224	4038	4723	4706	4114	1521	1079	3731	4457
1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	1601_Platelet aggregation to Epinephrine (at exam 5, GEE, adjusted for multivariable)	25	258	1	4075	258	1696	2152	402	1871	4213	3566	4160	1645	4145	3416	3692	3803	314	1272	1380	4711
1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1451_Low-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	258	1	944	3935	1914	258	805	4213	4644	1312	4169	3574	757	3906	1524	4323	611	444	1847	2786
3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	3515_Gas or solid-fuel cooking/heating: An open solid fuel fire that you use regularly in winter time	25	258	1	524	3023	1860	4159	2836	1290	874	3476	363	258	3116	1601	2562	4267	1805	2285	3119	1685
1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	1490_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for age and sex)	25	258	1	2048	2675	447	1513	647	1797	1918	4267	3038	877	4205	516	444	258	3198	3494	4247	1656
1135_Eczema	1135_Eczema	25	258	1	1293	407	2983	957	2911	4309	4716	2383	2698	714	2554	2501	2744	3315	4692	258	4491	3310
4141_Platelet count	4141_Platelet count	25	259	1	259	3647	1220	765	1987	1017	2252	4245	3450	3806	4106	1860	3639	4564	615	4147	1276	4428
362_1c+mDC:%32+	362_1c+mDC:%32+	25	259	1	2325	2008	259	4335	629	2482	1468	1682	3489	996	2985	2059	2846	3436	4458	3860	4690	2984
593_Peptide::Dipeptide::glycylvaline	593_Peptide::Dipeptide::glycylvaline	25	259	1	1918	1760	3510	2183	259	912	2264	2148	880	1666	1712	2773	2618	2436	355	3899	4740	1648
2219_ANGPT1 - Angiopoietin-1	2219_ANGPT1 - Angiopoietin-1	25	259	1	3085	1324	1465	2875	2059	259	598	4386	3990	339	2748	732	2038	291	2846	3613	4100	1224
3077_NOTCH1 - Neurogenic locus notch homolog protein 1	3077_NOTCH1 - Neurogenic locus notch homolog protein 1	25	259	1	3577	1786	2922	4405	3203	1098	4498	1918	259	4553	2800	748	1733	2372	4587	338	2540	631
1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	1752_Cystatin C (at exam 7, FBAT, adjusted for multivariable)	25	259	1	2102	1195	456	3612	3793	2438	962	4337	3882	2637	259	3218	4384	3940	948	1909	3304	4366
2738_HBEGF - Heparin-binding EGF-like growth factor	2738_HBEGF - Heparin-binding EGF-like growth factor	25	259	1	4241	3406	3751	2225	1111	2817	4592	2081	1017	2824	964	4189	259	785	3008	3851	3044	4664
1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	1814_Femoral Neck BMD (FBAT, female, adjusted for multivariable)	25	259	1	807	1642	715	4355	2532	1318	2953	1749	2505	810	2984	4133	4696	259	2153	2200	1004	812
3292_Worry too long after embarrassment	3292_Worry too long after embarrassment	25	259	1	3207	3107	4250	3536	3279	1039	3555	2952	1333	584	3404	3344	2956	4593	259	2400	3195	3204
3006_JAK2 - Tyrosine-protein kinase JAK2	3006_JAK2 - Tyrosine-protein kinase JAK2	25	259	1	1870	3152	1543	4732	1034	1001	1800	1972	2440	2237	2165	4026	1796	1974	2627	259	2799	4146
3833_Basophil count (two-way meta)	3833_Basophil count (two-way meta)	25	259	1	2962	1922	3288	1701	2751	1576	2119	327	2815	777	834	295	1207	4142	805	2703	259	342
826_::::X-13658	826_::::X-13658	25	260	1	1107	260	2397	3987	3183	2151	4040	1553	4569	507	4201	2611	3222	4642	2600	1519	1555	1905
1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	1445_Low-density lipoprotein cholesterol (at exam 2, GEE, adjusted for age and sex)	25	260	1	3019	364	643	973	260	410	3861	1895	1792	3044	3916	2847	4026	2030	4427	2532	724	1495
727_::::X-11787	727_::::X-11787	25	260	1	2808	1185	297	3365	3611	760	1493	3300	260	340	2551	4652	2008	1037	701	1434	2981	4514
2740_IL17D - Interleukin-17D	2740_IL17D - Interleukin-17D	25	261	1	3560	261	3976	2625	3721	2961	3145	1570	2294	3322	2514	3752	2215	3889	4742	4220	940	1868
1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	1308_Fasting HbA1c (at exam 5, FBAT, adjusted for age and sex)	25	261	1	334	4715	261	1010	3749	4569	1255	3736	4095	2440	1546	4448	2632	3342	1058	3503	1819	3967
925_Concentration of medium VLDL particles	925_Concentration of medium VLDL particles	25	261	1	2917	2163	3905	261	285	1488	3204	2355	4523	3220	4359	931	4106	3018	3061	4621	1890	4701
555_Lipid::Medium chain fatty acid::caprate (10:0)	555_Lipid::Medium chain fatty acid::caprate (10:0)	25	261	1	1938	374	4018	898	1721	261	1914	1425	3574	1281	287	2754	2363	807	3593	2684	1258	953
3347_Age started oral contraceptive pill (female)	3347_Age started oral contraceptive pill (female)	25	261	1	3673	2214	2797	296	617	2307	3030	2728	745	3998	261	3132	857	2306	513	1540	1275	1889
3357_Likelihood of resuming smoking	3357_Likelihood of resuming smoking	25	261	1	3833	3952	3038	496	3963	3282	3325	2458	2086	1964	821	261	1547	795	2365	4216	3634	1818
1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	1365_Total cholesterol (at exam 4, GEE, adjusted for age and sex)	25	262	1	262	1290	3683	1922	1951	2153	3441	882	1850	2718	3058	1186	1677	1469	3841	2178	3943	2197
2626_MFRP - Membrane frizzled-related protein	2626_MFRP - Membrane frizzled-related protein	25	262	1	1248	971	262	4429	2068	861	2822	1547	2146	1755	4259	636	733	927	2254	4740	2963	1018
2958_CGA CGB - Human Chorionic Gonadotropin	2958_CGA CGB - Human Chorionic Gonadotropin	25	262	1	1446	2932	674	455	4334	4669	262	896	2111	2596	4131	2195	478	2396	3857	2636	3892	1464
3253_Cereal intake	3253_Cereal intake	25	262	1	3578	3373	2112	3460	1268	4515	1323	262	3902	1437	1017	1849	3860	4147	4351	4036	427	4035
2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	2430_FCER2 - Low affinity immunoglobulin epsilon Fc receptor	25	262	1	1003	2409	3360	1244	3905	1966	1854	443	1180	262	2512	950	662	3509	3256	1448	1274	1791
972_Triglycerides in chylomicrons and extremely large VLDL	972_Triglycerides in chylomicrons and extremely large VLDL	25	262	1	2458	3199	1352	602	482	677	3686	2377	3755	3838	3407	262	2468	2005	3977	2543	1945	3054
544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	544_Lipid::Lysolipid::1-palmitoylglycerophosphoethanolamine	25	262	1	846	1219	319	4632	2415	4441	988	1403	3688	3326	2375	4240	2117	4226	2070	262	4169	2683
1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	1959_MMSE score (at exam 5, GEE, adjusted for multivariable)	25	262	1	4340	2529	2048	767	2796	870	2333	1721	4621	461	858	2318	843	2668	2347	3254	336	262
198_Urinary albumin-to-creatinine ratio (diabetes positive)	198_Urinary albumin-to-creatinine ratio (diabetes positive)	25	263	1	4129	263	631	4547	1239	1327	1868	2778	4551	2673	923	2758	3909	1208	959	2634	3803	4607
1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	1573_Mean abdominal aortic calcification - Agatston score (at exam 7, GEE, adjusted for multivariable)	25	263	1	2533	3047	4413	3583	263	3679	1459	4663	1153	579	2662	2648	2272	660	2273	867	906	1610
109_Coronary artery disease	109_Coronary artery disease	25	263	1	1937	4409	783	2887	4221	263	301	1839	1655	3235	1444	486	1854	2972	1526	2849	2961	710
2857_SERPING1 - Plasma protease C1 inhibitor	2857_SERPING1 - Plasma protease C1 inhibitor	25	263	1	2520	1149	1097	2723	4109	2723	3902	3818	1613	263	3362	3136	4498	2649	2435	4503	4053	3286
2854_TPM2 - Tropomyosin beta chain	2854_TPM2 - Tropomyosin beta chain	25	264	1	264	3737	4158	3641	2731	2043	1798	4527	4361	2763	4088	3319	1566	3871	4120	3093	2107	3846
1321_Adiponectin (GEE, adjusted for age, sex and BMI)	1321_Adiponectin (GEE, adjusted for age, sex and BMI)	25	264	1	1783	879	264	2045	3445	725	1478	3219	2693	4330	1242	4717	3172	1516	4592	2066	3285	3771
3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	3033_SIRT2 - NAD-dependent protein deacetylase sirtuin-2	25	264	1	2582	3427	3844	1428	4639	4081	264	2529	3282	425	708	1865	1645	2769	4609	4214	3056	1005
349_CD8:%TM (2)	349_CD8:%TM (2)	25	264	1	747	4677	1902	4645	1283	3543	642	264	2764	2617	1153	2811	977	2249	707	852	2436	810
2348_IL4R - Interleukin-4 receptor subunit alpha	2348_IL4R - Interleukin-4 receptor subunit alpha	25	264	1	1930	1068	2841	4230	764	2645	548	2816	264	1085	4441	650	3935	933	1371	4743	4675	530
4554_Left lateral occipital	4554_Left lateral occipital	25	264	1	3698	3430	4357	2664	2125	562	1891	349	322	278	2618	2608	264	2715	3466	4013	4393	3645
2081_IL12A IL12B - Interleukin-12	2081_IL12A IL12B - Interleukin-12	25	264	1	4347	2321	2454	1698	725	684	2696	2528	1077	3650	1050	1962	356	264	624	2672	2395	4127
2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	2881_FLRT1 - Leucine-rich repeat transmembrane protein FLRT1	25	264	1	4743	1831	2899	337	2143	370	1009	1313	434	1910	2532	2593	4567	4685	264	4379	1562	963
2090_EFNB3 - Ephrin-B3	2090_EFNB3 - Ephrin-B3	25	264	1	3352	479	1839	411	1646	1552	1433	2050	606	3532	276	3834	302	812	1149	362	1159	264
1186_Triglycerides cholesterol	1186_Triglycerides cholesterol	25	265	1	1141	344	1395	1262	265	2338	2427	3397	2088	987	1326	3594	1407	4342	2571	4161	3829	1635
812_::::X-12855	812_::::X-12855	25	265	1	1197	3791	2294	2558	2689	4042	1570	1625	265	1004	4257	4370	3532	3568	1498	484	487	4211
3375_Time since last prostate specific antigen (PSA) test	3375_Time since last prostate specific antigen (PSA) test	25	265	1	3396	912	4664	3439	1122	2355	973	3343	2389	4358	265	406	2647	3145	978	2764	1249	1161
4611_Left basal forebrain	4611_Left basal forebrain	25	265	1	1964	1883	1052	1108	3372	2725	1017	1966	708	2344	1067	265	1090	692	2072	1751	408	1943
3070_LAG3 - Lymphocyte activation gene 3 protein	3070_LAG3 - Lymphocyte activation gene 3 protein	25	265	1	3857	2758	1207	969	3209	4102	3079	2656	825	4322	4284	1974	1316	2698	755	265	1364	3055
1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	1415_High-density lipoprotein cholesterol (at exam 5, GEE, adjusted for age and sex)	25	265	1	2121	3375	4719	3863	545	4307	1514	746	2496	279	530	3357	3053	3061	2330	417	265	2709
1285_Visceral fat by CT (GEE, adjusted for age and sex)	1285_Visceral fat by CT (GEE, adjusted for age and sex)	25	265	1	3008	2854	1370	1482	3548	2987	2462	1400	3570	3768	1811	3648	511	299	3092	579	3918	265
1178_Insomnia	1178_Insomnia	25	266	1	266	1941	1363	3393	4346	2061	1837	1803	904	2313	2019	462	2445	993	438	2160	3906	648
3626_Treatment/medication code: bendroflumethiazide	3626_Treatment/medication code: bendroflumethiazide	25	266	1	4118	266	1704	720	4250	331	3705	4506	3384	1576	2758	1023	3603	3445	2308	4569	2422	532
4460_Left pars opercularis	4460_Left pars opercularis	25	266	1	3342	3677	3451	3749	722	266	4515	488	491	4514	4687	3418	4135	1642	3098	1470	3563	2290
516_Lipid::Long chain fatty acid::adrenate (22:4n6)	516_Lipid::Long chain fatty acid::adrenate (22:4n6)	25	266	1	2248	3240	3327	1596	2934	3585	1064	2398	1832	612	2130	266	1274	3528	636	1057	685	2312
2663_FGF23 - Fibroblast growth factor 23	2663_FGF23 - Fibroblast growth factor 23	25	266	1	4064	3585	1054	4200	2608	1510	3115	510	3766	2288	2131	1273	2689	4252	4178	266	821	2956
2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	2469_CAMK2B - Calcium/calmodulin-dependent protein kinase type II subunit beta	25	266	1	4680	1034	911	4528	3129	1980	3696	3711	1115	4246	492	3032	1429	633	953	3655	266	1001
1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	1353_Plasma Apolipoprotein C3 level (GEE, multivariate adjusted)	25	266	1	1390	4451	3241	2621	1610	2739	1687	2289	1232	3699	2876	775	1938	4034	4398	4050	1527	266
2228_IL27 EBI3 - Interleukin-27	2228_IL27 EBI3 - Interleukin-27	25	267	1	443	267	3525	417	2444	4439	4312	507	658	2174	2616	430	1007	1851	2057	4741	485	2529
3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	3031_CD163 - Scavenger receptor cysteine-rich type 1 protein M130	25	267	1	3504	327	267	2538	2260	3011	4012	646	2998	3843	741	1879	1941	2570	4129	4658	4013	3023
2711_HINT1 - Histidine triad nucleotide-binding protein 1	2711_HINT1 - Histidine triad nucleotide-binding protein 1	25	267	1	630	496	2845	1544	267	1822	1392	2463	1619	1043	2770	4576	4366	3036	583	1000	2151	1048
4296_Thinness	4296_Thinness	25	267	1	1657	1897	2476	1921	4072	267	296	2682	679	4427	2171	3875	4271	3084	2762	1503	1211	1325
3863_Platelet count (two-way meta)	3863_Platelet count (two-way meta)	25	267	1	445	3066	3179	3430	992	1462	3601	3254	1211	2218	267	2791	2718	4336	2410	1912	1594	4679
2294_AREG - Amphiregulin	2294_AREG - Amphiregulin	25	267	1	3189	4730	1354	1746	995	1124	428	1655	3582	1076	737	4058	3934	1378	2786	3107	2501	267
1109_Subcutaneous adipose tissue volume (male)	1109_Subcutaneous adipose tissue volume (male)	25	268	1	4616	268	1248	989	2117	3384	2162	2964	1312	1917	2228	2946	3040	859	1801	3966	1218	3580
241_CD161 on CD4mem	241_CD161 on CD4mem	25	268	1	1852	1777	2538	333	2067	2118	2934	268	3576	2159	2367	3236	3293	2577	3112	2512	3380	1869
3959_Antisocial behavior (female)	3959_Antisocial behavior (female)	25	268	1	2602	2696	1898	4211	4562	2426	1954	1743	309	332	1680	1334	3733	2009	268	1255	3533	1996
1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1792_RR interval (male, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	268	1	3408	2825	3381	3783	1924	3422	3136	1171	3681	1177	4350	3474	1844	3508	768	3864	268	3561
1835_Neck width (GEE, female, adjusted for multivariable)	1835_Neck width (GEE, female, adjusted for multivariable)	25	269	1	1353	1697	2097	3672	269	1773	628	762	1412	4630	496	1448	1041	800	1579	1085	1944	2287
4328_Estimated bone mineral density from heel ultrasounds	4328_Estimated bone mineral density from heel ultrasounds	25	269	1	1395	2803	614	1413	773	336	2624	2178	678	756	2579	269	2036	1849	1053	697	863	4130
3821_Celiac disease	3821_Celiac disease	25	269	1	3473	828	988	3677	1376	892	992	508	3851	4602	1216	600	269	1075	749	2810	1982	335
2483_GZMH - Granzyme H	2483_GZMH - Granzyme H	25	269	1	4240	2090	4706	1492	284	2599	1229	3081	2985	3256	1132	403	2728	4728	269	1013	1576	2201
4132_Basophil count	4132_Basophil count	25	269	1	1287	4169	3627	2868	1202	478	4145	3059	2746	4064	4571	1932	495	2371	715	269	3858	1560
1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	1845_Neck Section Modulus (GEE, male, adjusted for multivariable)	25	270	1	270	2158	3411	1299	1772	3020	2873	2976	644	4508	3605	4648	1668	3105	891	3835	2519	2240
4505_Right transverse temporal	4505_Right transverse temporal	25	270	1	1344	2604	270	2691	4236	796	1374	1929	2475	356	2106	4487	4265	2367	1145	340	4340	630
3911_Cup area	3911_Cup area	25	270	1	1504	1357	2977	597	270	1348	2036	612	325	1712	4440	663	2933	1643	1854	1992	2944	4650
1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	1708_Luteinizing hormone (at exam 3, FBAT, adjusted for multivariable)	25	270	1	2558	3055	2416	718	445	270	1929	3104	1508	3808	2470	2293	438	649	1840	4130	3514	1501
1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	1736_Serum phosphorus (at exam 2, FBAT, adjusted for multivariable)	25	270	1	781	890	1616	1560	2497	2521	270	1483	4191	3807	854	4392	3640	755	4445	2315	3395	3047
357_earlyB:%27+38-	357_earlyB:%27+38-	25	270	1	4191	1909	4038	1333	3541	3816	507	355	1217	528	270	1650	992	1625	2618	3672	1373	2735
3840_Eosinophil percentage of granulocytes (two-way meta)	3840_Eosinophil percentage of granulocytes (two-way meta)	25	270	1	2076	1885	3916	1132	2840	1662	1054	3733	1160	1414	2299	2360	2316	270	607	2214	4158	1622
4699_Fornix (column and body of fornix) mean diusivities	4699_Fornix (column and body of fornix) mean diusivities	25	270	1	3271	1341	4086	4574	1475	4277	1197	3261	3140	4735	4439	1996	3543	828	270	2920	2304	2592
3404_Fluid intelligence test - FI6 : conditional arithmetic	3404_Fluid intelligence test - FI6 : conditional arithmetic	25	270	1	1375	4235	3105	3395	2211	2768	3578	1968	1471	2577	293	3878	2787	3336	2907	290	270	3765
1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	1287_Visceral fat by CT (GEE, adjusted for age, sex, smoking, menopause)	25	270	1	3433	2487	1401	1365	3668	3504	2303	2143	3249	4692	1672	4339	493	339	2874	639	3716	270
4240_Latent naming speed	4240_Latent naming speed	25	271	1	271	3109	4317	1891	4414	2690	2560	3777	4106	2564	2374	2468	4558	3537	753	937	1809	1878
2149_CAPN1 CAPNS1 - Calpain I	2149_CAPN1 CAPNS1 - Calpain I	25	271	1	4034	271	1451	3970	2557	1897	2850	2325	4598	3168	4363	2486	2896	1958	3876	3386	1429	3916
900_Free cholesterol in large VLDL	900_Free cholesterol in large VLDL	25	271	1	2089	4374	2092	271	918	1104	3322	2897	4571	3647	4447	461	3671	1837	2931	2510	1908	2948
4102_Blood sugar	4102_Blood sugar	25	271	1	2832	2296	4206	719	3621	3372	271	894	3935	2856	1914	2635	597	980	550	2360	4145	3627
4598_Right precentral	4598_Right precentral	25	271	1	3135	4501	2121	3718	4086	981	1851	271	1789	1548	2407	4445	3540	1639	319	1860	2742	2337
2653_ANGPTL4 - Angiopoietin-related protein 4	2653_ANGPTL4 - Angiopoietin-related protein 4	25	271	1	2449	3410	2648	2746	789	4730	3524	1025	4323	1305	4165	271	1420	923	1694	3549	2149	1640
3470_Impedance measures - Trunk fat-free mass	3470_Impedance measures - Trunk fat-free mass	25	271	1	3132	1845	3480	1990	2666	2388	440	3044	2724	4071	1117	1804	1710	271	1032	1194	3737	2011
1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1410_High-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	271	1	4444	1969	2303	991	2084	4401	4077	871	912	1475	1332	2544	1479	2960	290	3681	271	4597
1931_Occipital brain volume (GEE, adjusted for age and sex)	1931_Occipital brain volume (GEE, adjusted for age and sex)	25	272	1	2973	272	3797	1326	943	1203	1527	2069	1283	1511	552	2093	316	1466	2082	538	3179	573
946_Serum total triglycerides	946_Serum total triglycerides	25	272	1	2070	4523	2435	272	700	1443	3153	2819	4530	4503	4559	709	4089	1699	3067	2346	1995	4158
4630_Left vessel	4630_Left vessel	25	272	1	1956	4500	2173	4137	4729	3853	748	4021	272	1682	4329	941	1336	3292	2591	2053	1480	888
1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	1613_von Willebrand Factor (at exam 5, GEE, adjusted for multivariable)	25	273	1	3176	3674	273	3163	2356	2812	4701	3331	4130	1497	2757	1061	2535	3251	2290	2082	1191	1769
901_Total lipids in large VLDL	901_Total lipids in large VLDL	25	273	1	965	4196	2568	273	1215	1275	2603	4329	2382	4580	2289	1431	3769	1167	3239	1982	868	3552
1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	1312_HOMA-IR (at exam 5, FBAT, adjusted for age and sex)	25	273	1	3274	4184	4022	1453	407	2571	273	4741	3279	1406	571	2610	2909	1573	1363	2388	4147	1661
2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	2503_UFC1 - Ubiquitin-fold modifier-conjugating enzyme 1	25	273	1	2352	4426	3094	3790	1643	3286	324	2214	2347	273	3713	4307	2306	3930	2133	2109	3501	1095
1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	1969_MMSE score (at age 65, GEE, adjusted for birth-cohort)	25	273	1	1833	1757	4671	646	3709	1948	3945	1873	1214	3682	1837	2686	273	3420	2974	1821	3349	406
3471_Impedance measures - Trunk predicted mass	3471_Impedance measures - Trunk predicted mass	25	273	1	2097	2236	3874	1690	1902	751	1358	1151	2498	3441	1205	1264	1154	273	1022	979	2735	2612
4545_Total brain volume	4545_Total brain volume	25	273	1	2849	3581	4450	4455	2761	441	1390	1529	1917	2831	2941	1910	3963	2677	2711	3199	3857	273
3841_Granulocyte count (two-way meta)	3841_Granulocyte count (two-way meta)	25	274	2	1531	1525	274	1660	2519	435	768	4192	1977	4613	3253	1990	3546	4063	2805	2654	2707	3754
1000_Macrophage colony-stimulating factor	1000_Macrophage colony-stimulating factor	25	274	1	3451	778	4037	274	2124	872	1474	1374	1072	3128	4483	2481	1528	4616	4400	3539	3185	2110
4323_Life satisfaction (MA GWAMA)	4323_Life satisfaction (MA GWAMA)	25	274	1	4671	3237	3815	3920	4321	274	790	1469	3934	4696	2964	3600	2920	790	4420	4462	942	1702
583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	583_Nucleotide::Purine metabolism, adenine containing::N1-methyladenosine	25	274	1	959	3965	3099	3932	3224	429	2358	274	2874	2527	1289	3895	2980	2543	4569	1622	4571	2013
3651_Illnesses of siblings: High blood pressure	3651_Illnesses of siblings: High blood pressure	25	274	1	865	1043	4587	2159	4357	4175	1829	300	274	2167	4726	1336	4729	2707	3765	3413	4429	1596
33_Extraversion (IRT)	33_Extraversion (IRT)	25	274	1	4027	4219	4384	761	2285	2193	2173	2914	860	2131	2920	2636	1751	274	1184	2835	530	1814
137_Weight (female)	137_Weight (female)	25	274	1	3710	2413	2911	3043	2389	1390	4671	4432	2489	1969	3330	2422	1350	1921	274	2542	3193	1566
4754_Superior longitudinal fasciculus radial diusivities	4754_Superior longitudinal fasciculus radial diusivities	25	274	1	507	2914	4243	4216	4722	280	2724	2774	1512	3255	3459	4362	1403	887	853	3145	4630	274
3896_Neutrophil percentage of white cells (three-way meta)	3896_Neutrophil percentage of white cells (three-way meta)	25	275	1	275	1628	419	2216	4367	1976	3596	2020	1185	2871	3159	919	2660	1394	2845	2845	747	3567
4373_Free thyroxine (FT4, male)	4373_Free thyroxine (FT4, male)	25	275	1	4472	275	4697	2094	1313	1220	3816	2425	3375	1335	4178	3727	3330	3642	1695	3217	4236	4521
4087_Neuroticism	4087_Neuroticism	24	275	1	4194	2044	607	275	452	1360	3348	449	851	1866	3012	3415	610	1445	2828	4230	3065	3775
4350_Nonischemic cardiomyopathy	4350_Nonischemic cardiomyopathy	25	275	1	2671	941	3542	2105	3283	2732	275	2664	3636	2575	4711	4336	2540	3044	4627	3928	2064	2178
129_Hip circumference (female)	129_Hip circumference (female)	25	275	1	3087	3257	1911	3497	1338	1029	1909	3511	275	3695	3924	1446	3061	2641	3776	4708	4028	2755
162_Hip circumference (adjusted for BMI)	162_Hip circumference (adjusted for BMI)	25	275	2	530	381	4071	4614	4296	2420	4086	1806	1012	2830	275	4013	3134	1113	2155	2508	3747	1630
460_Energy::Krebs cycle::malate	460_Energy::Krebs cycle::malate	25	275	1	2178	4494	2039	4054	732	1200	1078	3927	1825	942	1736	275	2628	929	3723	3455	4015	3163
1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	1528_Remnant lipoprotein cholesterol (at exam 4, FBAT)	25	275	1	3856	3544	4412	893	3557	806	763	1067	428	571	2472	4182	1216	275	4435	4631	826	3207
515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	515_Lipid::Long chain fatty acid::10-nonadecenoate (19:1n9)	25	275	1	4327	301	1172	702	507	3981	2623	2617	1528	3940	3782	4367	2172	358	3488	275	988	4335
3228_Sleep duration	3228_Sleep duration	25	276	1	276	617	328	779	990	2137	1874	3274	458	3656	1564	4349	2104	2434	2517	741	1813	1257
902_Concentration of large VLDL particles	902_Concentration of large VLDL particles	25	276	1	1200	3457	2427	276	654	2138	3642	3148	4532	3722	4299	720	4117	1833	2835	2569	2245	4082
4174_Social support - Leisure/social activities: Religious group	4174_Social support - Leisure/social activities: Religious group	25	276	1	883	816	548	2536	4448	1381	1605	276	1519	3773	3754	3396	4293	2368	1699	1522	1757	2502
619_Xenobiotics::Chemical::glycerol 2-phosphate	619_Xenobiotics::Chemical::glycerol 2-phosphate	25	276	1	2768	2329	2861	2292	2671	837	3419	4345	276	2531	4094	4019	3092	2189	1398	4448	1951	1556
3081_NRXN3 - Neurexin-3-beta	3081_NRXN3 - Neurexin-3-beta	25	276	1	396	3307	1679	1318	2678	3532	4144	3964	4129	276	3643	2225	1436	3985	1558	3196	1620	3594
2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	2706_CAMKK1 - Calcium/calmodulin-dependent protein kinase kinase 1	25	276	1	3631	4698	390	289	3213	3064	2424	4717	2334	2977	3195	4603	3885	4083	3903	276	2499	4594
2852_CHST15 - Carbohydrate sulfotransferase 15	2852_CHST15 - Carbohydrate sulfotransferase 15	25	276	1	404	4287	2338	1278	1895	1380	1892	573	640	3463	3616	1989	4559	4467	1787	2545	1758	276
4315_Cigarettes per day	4315_Cigarettes per day	25	277	1	277	2883	956	4742	999	4686	4209	3355	2777	2136	762	3982	3754	3029	4740	4090	1213	1995
616_Xenobiotics::Benzoate metabolism::benzoate	616_Xenobiotics::Benzoate metabolism::benzoate	25	277	1	2562	277	1194	2954	1863	3320	3116	1160	3511	548	3185	1025	4341	4176	1738	1257	4155	1628
2243_ARG1 - Arginase-1	2243_ARG1 - Arginase-1	25	277	1	1734	1935	2034	1352	277	1890	3501	4341	2633	2836	2805	2010	3263	3124	3897	4138	4342	1730
4188_Fasting insulin	4188_Fasting insulin	25	277	1	826	353	1593	1810	973	1446	3533	2361	755	277	2894	2270	1517	2871	1240	3774	4070	1418
1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	1133_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, male)	25	277	1	3965	2222	3634	1779	887	2288	2449	2415	2300	4702	3934	412	277	1063	2482	3596	3002	4112
4167_Parkinson disease of sibling pairs (tier 1)	4167_Parkinson disease of sibling pairs (tier 1)	25	277	1	3290	3923	3869	1908	1567	4347	4358	4594	2262	564	1178	628	3681	453	860	845	1140	277
2623_IGF2R - Cation-independent mannose-6-phosphate receptor	2623_IGF2R - Cation-independent mannose-6-phosphate receptor	25	278	1	4121	278	472	2024	2456	3097	753	4425	775	484	2917	1305	1732	563	4030	1781	2807	1473
2658_CST4 - Cystatin-S	2658_CST4 - Cystatin-S	25	278	1	1901	356	3557	2898	4338	278	3091	2669	3381	1081	3374	963	3430	4615	3396	2339	652	3175
2757_TNC - Tenascin	2757_TNC - Tenascin	25	278	1	3636	2757	4124	1991	624	559	2329	278	2417	1547	3484	3734	4728	2560	1114	3663	2116	3279
4010_Amyotrophic lateral sclerosis	4010_Amyotrophic lateral sclerosis	25	278	1	2561	4152	2077	1275	761	1375	4215	750	1985	4120	1543	3108	278	3726	3081	1196	1447	1128
4057_Estimated glomerular filtration rate based on serum creatinine	4057_Estimated glomerular filtration rate based on serum creatinine	25	278	1	1618	4601	1468	3630	3212	3293	4550	4239	3400	2421	1817	2384	4667	278	2946	2557	1162	3716
3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	3754_Traumatic events - Felt very upset when reminded of stressful expresince in past month	25	279	1	279	3402	3049	3744	4371	2781	3090	2185	3481	3000	1232	625	2075	4293	2186	518	972	1907
927_Triglycerides in medium VLDL	927_Triglycerides in medium VLDL	25	279	1	2147	4402	2661	279	794	721	1475	4563	3047	3274	2186	1484	4685	741	4331	1741	316	1790
4286_FEV1	4286_FEV1	25	279	1	4489	2592	1651	4743	2093	4117	3712	279	3950	2590	1896	983	1788	2751	3755	1990	2390	1886
1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	1330_Insulin sensitivity (FBAT, adjusted for age, sex and BMI)	25	279	1	3621	532	3551	4633	2299	2527	4591	1393	279	3919	320	654	831	1522	4145	3456	1548	4682
4528_Left ventral DC	4528_Left ventral DC	25	279	1	555	1186	579	3048	3685	2466	4739	4210	2098	1263	4416	279	4579	3993	3585	4257	4567	571
1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1449_Low-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	279	1	1256	1544	1439	4611	3198	766	2565	618	1818	4138	1331	3288	578	279	2275	675	1816	1950
2606_CADM3 - Cell adhesion molecule 3	2606_CADM3 - Cell adhesion molecule 3	25	279	1	3661	920	1398	2598	391	4156	1487	3342	3897	4264	3056	4161	1096	2626	279	1065	3364	1421
3235_Current tobacco smoking	3235_Current tobacco smoking	25	280	1	894	280	2621	2021	1217	1745	2831	2476	898	1090	825	2326	1944	3520	2288	641	1163	1038
4573_Left superior temporal	4573_Left superior temporal	25	280	1	4590	530	2209	4147	280	666	355	2757	1062	2535	4426	3799	4738	4132	4244	2304	1533	4592
242_PD1 on CD4mem	242_PD1 on CD4mem	25	280	1	4282	1942	1226	1999	2812	2828	1939	4406	2629	565	360	280	1885	684	4300	2047	1545	1334
4458_Left parahippocampal	4458_Left parahippocampal	25	280	1	2497	4349	1318	1858	3215	2628	1894	4512	457	4279	4048	617	407	2807	280	1903	2031	3002
582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	582_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::xanthine	25	280	1	3394	4119	4681	3795	2173	1481	2199	1920	4209	3733	3190	4654	2469	1647	3169	280	2521	4731
1759_Breast cancer (GEE, adjusted for age)	1759_Breast cancer (GEE, adjusted for age)	25	280	1	4607	2818	1304	789	1378	284	3544	1574	2555	3646	648	1662	568	1476	1166	1305	280	1454
2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	2846_PCSK7 - Proprotein convertase subtilisin/kexin type 7	25	281	1	281	3537	3404	1374	4119	2790	1734	4397	3584	531	2315	1231	4119	4743	4558	3149	4166	1528
2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	2892_PLCG1 - 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1	25	281	1	3023	281	4613	2492	3837	1328	3892	1684	1811	1400	2334	3175	1313	1488	1419	3362	1707	2748
2686_DYNLRB1 - Dynein light chain roadblock-type 1	2686_DYNLRB1 - Dynein light chain roadblock-type 1	25	281	1	2504	689	1759	281	928	3967	2663	3742	1408	3245	4740	2529	1931	4727	2434	2452	1544	1365
4275_Glycine level	4275_Glycine level	25	281	1	3206	2205	4443	3946	281	2050	3329	3515	4320	1560	1754	459	1562	1593	370	3685	1342	2515
4137_Hematocrit	4137_Hematocrit	25	281	1	4601	3819	3128	3911	1828	314	4474	3227	281	1903	2723	3926	4273	510	3244	880	3005	1646
2710_EIF5A - Eukaryotic translation initiation factor 5A-1	2710_EIF5A - Eukaryotic translation initiation factor 5A-1	25	281	1	4656	2820	3216	3726	3989	2134	670	3678	1009	1138	3284	3725	3405	3177	3648	4677	3922	281
2171_EPOR - Erythropoietin receptor	2171_EPOR - Erythropoietin receptor	25	282	1	2686	4633	282	2861	1339	1224	4079	1001	680	1236	761	4044	2710	1422	4196	727	839	1540
2969_STC1 - Stanniocalcin-1	2969_STC1 - Stanniocalcin-1	25	282	1	1027	1495	4266	624	2370	1323	282	2168	1559	3780	2578	3030	2200	3207	571	367	3875	2315
542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	542_Lipid::Lysolipid::1-palmitoleoylglycerophosphocholine*	25	282	1	3685	2067	3393	2271	2270	2342	3277	1468	598	719	282	3445	2544	1450	3114	3957	2976	3498
3617_Treatment/medication code: atenolol	3617_Treatment/medication code: atenolol	25	283	1	3887	3741	283	4555	2673	1962	2993	1434	1278	4709	4603	3846	1764	3132	1855	3760	1330	2037
2524_HIPK3 - Homeodomain-interacting protein kinase 3	2524_HIPK3 - Homeodomain-interacting protein kinase 3	25	283	1	4599	1253	924	283	2235	1911	2236	865	2134	811	569	362	3905	4178	2065	1036	3507	638
321_CD8mem:%R6+PD1+161-	321_CD8mem:%R6+PD1+161-	25	283	1	3050	3407	2982	4042	2951	283	1541	4543	2058	1758	288	4489	2725	3136	1040	2600	1102	3059
578_Lipid::Sterol, Steroid::estrone 3-sulfate	578_Lipid::Sterol, Steroid::estrone 3-sulfate	25	283	1	1010	4294	1623	1848	3946	3901	2296	1107	1718	283	1141	2785	2600	1602	2862	3840	2845	1158
1_Attention deficit hyperactivity disorder	1_Attention deficit hyperactivity disorder	25	283	1	1082	3292	2481	2324	3634	3522	334	866	2072	4640	283	3222	1534	2483	3931	827	817	2345
3079_NRCAM - Neuronal cell adhesion molecule	3079_NRCAM - Neuronal cell adhesion molecule	25	283	1	1527	4690	1265	4252	4208	3152	4201	3884	298	4336	506	2581	505	296	1856	2723	283	2430
4601_Right rostral middle frontal	4601_Right rostral middle frontal	25	284	1	284	2695	4460	3525	896	1925	2670	2111	963	3151	3229	2187	3193	2841	2007	4144	4695	2771
2926_SELL - L-Selectin	2926_SELL - L-Selectin	25	284	1	2519	1578	284	919	2183	501	1517	4542	2411	4297	567	3610	1435	3449	2972	4149	2843	1069
1602_tPA (at exam 5, FBAT, adjusted for age and sex)	1602_tPA (at exam 5, FBAT, adjusted for age and sex)	25	284	1	2691	2168	2449	2121	2339	1151	284	1784	1548	3176	316	2043	3699	2022	3741	4072	1737	3869
4249_Diurnal inactivity duration	4249_Diurnal inactivity duration	25	284	1	3177	3945	4157	805	4150	2088	704	284	2236	2489	4354	3528	1249	2450	3247	4701	2897	3349
283_CD4:%Treg(39+73-)	283_CD4:%Treg(39+73-)	25	285	1	285	1972	559	2328	577	731	1344	926	4189	1457	2162	1099	2986	499	323	1761	4426	4604
3158_NLGN4X - Neuroligin-4, X-linked	3158_NLGN4X - Neuroligin-4, X-linked	25	285	1	3823	2173	285	3966	3140	1681	4648	3171	3219	4215	2439	3398	2693	1475	1658	1098	1981	4585
878_Histidine	878_Histidine	25	285	1	1045	829	2833	1622	2846	2412	285	860	1056	1337	3414	903	1625	939	3941	3050	3726	3620
773_::::X-12407	773_::::X-12407	25	285	1	3309	1150	518	743	3896	1693	835	3201	285	2679	4511	2786	4556	1144	3295	1966	2851	1561
1201_Focal epilepsy	1201_Focal epilepsy	25	285	1	1728	2481	2919	2958	2633	1655	2557	4575	1479	285	2329	2405	3613	3345	4371	4242	2986	852
203_Chronic kidney disease	203_Chronic kidney disease	25	285	1	3388	3357	1641	3146	4679	1461	4535	4738	1362	1316	935	1858	1165	3751	285	2966	2316	2739
2836_COLEC11 - Collectin-11	2836_COLEC11 - Collectin-11	25	285	1	2563	393	3422	2640	2996	3195	2860	4271	1019	959	3886	3943	3104	686	823	285	3931	2672
2795_PFDN5 - Prefoldin subunit 5	2795_PFDN5 - Prefoldin subunit 5	25	286	1	3647	3054	286	1096	1329	777	4218	3116	2358	2292	1656	1013	3256	2663	3481	1833	738	3134
944_Triglycerides in small VLDL	944_Triglycerides in small VLDL	25	286	1	2483	2877	3087	286	1069	1857	1577	4172	2596	2944	2786	886	3742	1397	4401	1115	750	4253
2051_Periodontal complex trait 5	2051_Periodontal complex trait 5	25	286	1	702	2052	3291	4274	286	2906	2299	2637	2023	4665	2201	2209	3310	3589	2043	3721	2207	2764
749_::::X-12039	749_::::X-12039	25	286	1	761	4577	3390	4311	3326	2339	286	3510	1366	2804	1118	3692	1558	2676	3883	2903	4538	3844
1225_Mean Thalamus	1225_Mean Thalamus	25	286	1	4639	873	2348	2554	843	4104	1175	2391	4392	3659	3756	4192	286	2405	1952	3670	4438	3548
294_CD4mem:%Th1* (1)	294_CD4mem:%Th1* (1)	25	286	1	3442	3802	2443	1629	3792	4095	4529	533	418	4088	605	2084	731	286	2912	4299	2409	1742
1070_Familial Parkinson Disease	1070_Familial Parkinson Disease	25	286	1	4233	1998	1977	1292	1516	1995	2588	3086	2460	319	2752	3142	2284	4190	3790	286	1304	4433
4662_Retrolenticular part of internal capsule fractional anisotropy	4662_Retrolenticular part of internal capsule fractional anisotropy	25	286	1	2060	3596	2872	3237	1843	1204	3365	3424	4299	3046	908	2887	1369	2053	4160	2875	4570	286
2782_IL1RL1 - Interleukin-1 receptor-like 1	2782_IL1RL1 - Interleukin-1 receptor-like 1	25	287	1	1739	287	2809	505	1017	3083	2201	3427	3982	3225	381	3442	1533	2203	2557	1131	3247	2442
614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	614_Xenobiotics::Benzoate metabolism::4-hydroxyhippurate	25	287	1	1715	3153	2396	3483	3534	1216	1489	2550	287	4134	3653	2698	543	2050	3205	934	1177	2508
2650_STX1A - Syntaxin-1A	2650_STX1A - Syntaxin-1A	25	287	1	2878	4390	1003	1145	2386	2650	1085	3287	2704	2537	3478	2765	3119	287	2268	2973	1260	4561
3954_Ankle injury (fixed effect)	3954_Ankle injury (fixed effect)	25	288	1	288	3604	4167	1944	1747	1805	3405	4142	1514	2573	3897	3148	2283	1966	2431	4060	987	2305
407_Amino acid::Tryptophan metabolism::kynurenine	407_Amino acid::Tryptophan metabolism::kynurenine	25	288	1	2713	4167	288	1685	4627	924	2870	3922	3155	2432	4598	1478	954	3277	3318	800	2975	4087
3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	3707_Diagnoses - secondary ICD10: Z72 Problems related to lifestyle	25	288	1	3126	1269	663	1635	1657	288	1511	2904	4655	3205	4410	3693	3621	2406	3090	1438	3032	4081
3547_Mouth/teeth dental problems: Loose teeth	3547_Mouth/teeth dental problems: Loose teeth	25	288	1	4350	880	3932	826	682	2370	2521	288	1752	1876	3693	1789	4446	1840	3309	2580	1958	2379
3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	3689_Diagnoses - secondary ICD10: F17 Nicotine dependence	25	288	1	298	1110	2858	2368	2581	1638	947	3573	288	3819	4562	2150	455	4255	1094	2638	4357	2132
369_Amino acid::Creatine metabolism::creatine	369_Amino acid::Creatine metabolism::creatine	25	288	1	4099	3598	4679	1038	2790	3061	4493	3046	1957	288	1189	923	1882	746	1729	941	1227	2660
1115_Visceral sdipose tissue volume (adjusted for BMI, male)	1115_Visceral sdipose tissue volume (adjusted for BMI, male)	25	288	1	4440	4408	1221	4489	4030	3243	1884	981	2666	530	540	288	2155	4069	3211	898	661	547
2749_NTF4 - Neurotrophin-4	2749_NTF4 - Neurotrophin-4	25	288	1	4643	854	1930	2326	1671	2241	1299	4123	2337	839	2936	3576	2826	288	3854	1059	2478	1912
1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	1631_Urinary isoprostanes/creatinine (at exam 7, GEE, adjusted for age and sex)	25	288	1	4613	2216	4611	1894	3554	2242	4182	1153	1326	980	2275	1160	2311	4322	288	3557	986	1116
3781_Depression - Trouble falling asleep	3781_Depression - Trouble falling asleep	25	288	1	2666	1673	3732	756	2513	1168	2165	3213	4054	1408	3408	1529	854	2653	2313	288	352	4258
1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	1464_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for multivariable)	25	288	1	2343	668	1320	2408	905	4318	1353	3351	4360	1676	2990	4227	1975	740	4365	1254	288	1206
1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	1236_Usual weekday sleep duration (FBAT, adjusted for age, sex and BMI)	25	289	1	3626	289	4678	2696	4365	1898	2172	929	3074	4346	3599	1543	1024	3450	663	3530	4036	1506
4251_M10 timing	4251_M10 timing	25	289	1	4531	4712	289	2764	3791	4674	2198	2095	2965	626	629	2570	4312	3579	2599	4608	2443	683
3290_Worrier / anxious feelings	3290_Worrier / anxious feelings	25	289	1	2509	818	2634	1062	3985	3190	3159	2473	3073	289	702	1980	3018	3859	4150	2518	1936	2636
1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1883_Shaft cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	289	1	692	3818	3592	2044	4380	1523	4393	1450	1857	880	289	4481	601	3418	2594	3918	1651	1759
2959_HBA1 HBB - Hemoglobin	2959_HBA1 HBB - Hemoglobin	25	289	1	3873	2876	2444	2488	1894	558	2939	3234	446	3352	1752	1982	1782	289	3709	1736	2307	564
3786_Insomnia	3786_Insomnia	25	289	1	312	1872	3259	3941	1582	2606	1856	635	2503	3888	2462	3483	3759	4389	289	4203	2279	1749
4113_Potassium	4113_Potassium	25	289	1	1991	4007	856	2676	4608	2745	3574	3628	2994	3332	3313	4212	4304	1665	364	2256	2672	289
1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	1423_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for age and sex)	25	290	1	290	2451	1108	3673	1364	1465	1826	3635	380	906	3912	1959	3408	514	1677	3531	768	3020
850_Acetoacetate	850_Acetoacetate	25	290	1	1768	2717	290	4606	1714	3842	4024	3990	1962	2808	3822	1391	1749	987	4680	2832	649	4285
928_MonoLunsaturated fatty acids	928_MonoLunsaturated fatty acids	25	290	1	3411	2154	1604	3576	2327	3933	290	876	4743	3196	1838	3135	2697	4411	3372	1924	1381	4186
4546_Left caudal anterior cingulate	4546_Left caudal anterior cingulate	25	290	1	3956	4727	2267	1113	3366	2113	2277	290	4446	847	4101	2971	4112	4603	4369	644	1394	3265
1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1278_Sabuctaneous fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	290	1	780	2515	1932	1381	2536	1535	1234	470	752	1724	290	2815	2543	3779	2777	1641	492	1270
1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1400_High-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	290	1	3657	1079	3314	1547	4536	1240	3049	2202	3939	4078	1003	290	1117	924	2200	1061	3571	2706
3898_Platelet distribution width (three-way meta)	3898_Platelet distribution width (three-way meta)	25	290	1	3943	3134	2287	1174	4601	442	2021	3997	4214	677	2440	3227	290	546	514	343	4047	3792
85_Femoral Neck BMD	85_Femoral Neck BMD	25	290	1	3418	1135	4535	3441	1799	3157	1296	2979	3259	361	306	917	2295	3297	1567	2061	290	1149
1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	1530_Ankle-brachial index (at exam 6, FBAT, adjusted for age and sex)	25	291	1	3687	291	2826	555	2982	3513	3994	3006	576	1526	4291	913	2307	2864	1208	859	3454	1585
2680_PTK6 - Protein-tyrosine kinase 6	2680_PTK6 - Protein-tyrosine kinase 6	25	291	1	3781	4435	4574	1802	4664	3526	291	4629	3099	3014	1559	3580	1225	2156	2761	3624	3570	2519
2803_SPHK1 - Sphingosine kinase 1	2803_SPHK1 - Sphingosine kinase 1	25	291	1	3134	4708	2110	4167	1208	2874	1598	2491	4145	1479	291	3489	442	3583	2460	3427	1338	1392
2570_CGA TSHB - Thyroid Stimulating Hormone	2570_CGA TSHB - Thyroid Stimulating Hormone	25	291	1	2732	1990	2810	2022	1396	1584	2497	4057	3411	1955	2376	291	3428	2121	1704	3511	3502	4571
3178_SLAMF7 - SLAM family member 7	3178_SLAMF7 - SLAM family member 7	25	291	1	920	3563	3828	3670	3107	1090	1977	374	3885	1383	4399	3311	762	3153	291	526	4234	2967
1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1408_High-density lipoprotein 3 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	291	1	3172	1842	1302	1283	1639	2794	4407	4497	442	1330	2773	816	3426	4503	2050	291	797	562
1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	1524_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, FBAT, adjusted for age and sex)	25	291	1	4092	1444	916	534	1306	2798	4489	721	2070	569	3561	4256	4658	3437	944	1294	291	2883
2655_CA9 - Carbonic anhydrase 9	2655_CA9 - Carbonic anhydrase 9	25	292	1	292	3801	2050	844	2049	2055	2791	2924	3329	1187	370	1075	1937	4377	1223	3492	1481	1750
1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	1817_Femoral Neck BMD (GEE, male, adjusted for multivariable)	25	292	1	4439	1010	3421	3466	292	3382	2030	2417	3655	3048	2236	2673	2854	3965	2487	1561	3244	4545
1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	1594_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for age and sex)	25	292	1	2180	2647	4449	3060	2060	292	3378	1336	2789	3207	1539	502	1719	4512	1877	3153	2718	2065
1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	1642_Osteoprotegerin (at exam 7, FBAT, adjusted for age and sex)	25	292	1	1121	3058	724	1954	3357	805	292	963	3674	1413	3570	1392	1231	3193	2507	3715	3311	2586
3009_MMP14 - Matrix metalloproteinase-14	3009_MMP14 - Matrix metalloproteinase-14	25	292	1	1205	1714	2748	891	2234	4514	1388	2048	4085	3766	3441	292	1219	1315	562	2627	686	1009
2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	2847_PDPK1 - 3-phosphoinositide-dependent protein kinase 1	25	292	1	640	3175	2889	2639	3490	2154	4660	3627	4656	2307	4002	1890	1269	292	3329	3219	834	3232
1840_Neck width (FBAT, male, adjusted for age)	1840_Neck width (FBAT, male, adjusted for age)	25	293	1	4125	293	1392	4202	2699	304	3672	2997	1065	4471	722	3502	1009	491	1081	3318	1285	1582
1155_Insulin sensitivity index	1155_Insulin sensitivity index	25	293	1	1207	3115	293	462	2065	2421	1507	4074	1922	2202	2688	1319	4582	4476	4565	1855	2313	3597
3621_Treatment/medication code: metformin	3621_Treatment/medication code: metformin	25	293	1	4431	975	4437	2235	3663	4154	875	2624	293	4490	4689	1801	2834	3133	4545	3863	1518	1480
2952_ENG - Endoglin	2952_ENG - Endoglin	25	293	1	1854	711	648	3232	4226	1650	4564	3848	3052	4695	1284	3624	1736	2927	1437	2925	293	1387
1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	1820_Inter-trochanteric buckling ratio (FBAT, male, adjussted for multivariable)	25	294	1	4057	294	3659	3253	576	3294	1686	1351	4679	585	4346	1794	3028	1988	4419	632	587	3028
1114_Visceral sdipose tissue volume (adjusted for BMI)	1114_Visceral sdipose tissue volume (adjusted for BMI)	25	294	1	3793	3821	294	2568	2886	3359	2393	3615	707	4015	3896	1434	2395	2477	3336	1950	4511	4356
2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	2129_IL12RB1 - Interleukin-12 receptor subunit beta-1	25	294	1	4124	3244	4075	666	294	1920	1106	1964	1790	401	2655	1049	1535	1542	1715	2899	2514	2331
2928_EPHA2 - Ephrin type-A receptor 2	2928_EPHA2 - Ephrin type-A receptor 2	25	294	1	4518	2056	3899	1770	498	1926	294	4454	2284	4238	3123	3423	1325	3577	1512	2448	4150	2970
158_Hip circumference (male)	158_Hip circumference (male)	25	294	1	4517	3451	4056	3916	4463	307	4576	3638	294	1237	997	4377	1322	2042	1001	4156	4181	3014
2257_TOP1 - DNA topoisomerase 1	2257_TOP1 - DNA topoisomerase 1	25	294	1	1092	4383	2860	3638	4686	2023	1927	3654	1049	294	777	4099	2880	2961	3115	2443	1660	4072
3831_Amyotrophic lateral sclerosis (linear mixed model)	3831_Amyotrophic lateral sclerosis (linear mixed model)	25	294	1	3398	3959	3005	1663	2129	976	3366	4578	3638	3668	294	2607	359	539	4193	1548	1676	618
3486_Bread type: Brown	3486_Bread type: Brown	25	294	1	4732	1048	366	4463	3408	4561	4652	4541	4735	3005	3398	668	2093	3465	294	3171	4116	4735
4093_Verbal-numerical reasoning	4093_Verbal-numerical reasoning	25	294	1	2999	2184	2143	4428	886	1043	987	2531	4067	992	3036	3264	1757	2214	732	294	3614	857
2495_PLK1 - Serine/threonine-protein kinase PLK1	2495_PLK1 - Serine/threonine-protein kinase PLK1	25	295	1	694	2207	1247	2507	295	2009	2406	1412	1506	869	4087	3251	2955	3022	2443	3211	1340	2641
523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	523_Lipid::Long chain fatty acid::nonadecanoate (19:0)	25	295	1	2729	1331	3119	3366	3719	3125	2601	955	2354	1901	590	2205	1580	295	1452	4583	2322	4268
3794_Snoring	3794_Snoring	25	295	2	2018	1820	3305	1508	3573	4739	1216	2071	2192	2731	3535	3640	541	1873	295	3701	921	3695
4064_Estimated glomerular filtration rate based on cystain C	4064_Estimated glomerular filtration rate based on cystain C	25	296	1	4370	2925	3389	1702	2983	3541	2512	3759	296	3617	4105	2244	2017	3045	2344	2122	2063	613
1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	1510_Triglycerides (at exam 7, FBAT, adjusted for age and sex)	25	296	1	1895	4112	1953	673	4454	1755	1002	3538	2116	296	2843	1487	1576	1909	986	869	1024	3679
3366_Age at menopause (last menstrual period) (female)	3366_Age at menopause (last menstrual period) (female)	25	296	1	470	4207	3034	1039	1673	3747	1190	4027	563	850	1001	1455	296	3728	3072	3229	3998	984
3352_Age started smoking in former smokers	3352_Age started smoking in former smokers	25	296	1	490	2817	3004	1310	3579	2300	352	2159	323	2894	3285	312	3144	2319	296	1258	1815	309
856_Ratio of bisLallylic bonds to double bonds in lipids	856_Ratio of bisLallylic bonds to double bonds in lipids	25	296	1	3501	2587	2733	1850	2131	952	2349	4091	4347	2917	933	1441	2790	1010	868	3728	296	4672
2410_METAP1 - Methionine aminopeptidase 1	2410_METAP1 - Methionine aminopeptidase 1	25	297	1	4462	1346	2009	1930	1493	1647	3267	3288	3003	2427	4433	297	2574	2222	4057	1746	2790	508
4043_Height	4043_Height	25	297	1	3108	2243	2516	1314	2596	483	421	4586	3819	2908	817	3427	1646	297	442	3754	3063	2742
1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	1486_Mean triglycerides from exam 1-7 (FBAT, adjusted for age and sex)	25	297	1	4690	1318	2073	2076	4201	2520	1462	2581	1063	1065	2498	4230	3516	3301	854	297	561	673
4366_Fraction of accelerations	4366_Fraction of accelerations	25	298	1	1966	2520	4661	298	2459	4300	2289	2131	468	3738	3329	2291	1481	3370	3403	4237	2219	1336
630_Xenobiotics::Food component, Plant::ergothioneine	630_Xenobiotics::Food component, Plant::ergothioneine	25	298	1	3068	2513	2949	4161	4290	752	3371	1776	3392	298	3401	3533	3762	4612	3282	4540	4154	2185
1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	1901_Troch Neck BMD (GEE, male, adjussted for multivariable)	25	298	1	2568	563	1969	4393	1148	3283	3915	3670	3436	4644	3247	298	3548	1834	4266	1447	1627	3100
1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	1265_Residual from predicted FVC for latest exam (GEE, adjusted for multiple covariates)	25	298	1	4388	2239	1770	1184	326	1249	659	4218	3080	1334	4582	4065	298	648	4155	4566	3438	2075
4423_Helicobacter pylori seropositivity	4423_Helicobacter pylori seropositivity	25	298	1	1443	3505	3668	914	2292	2269	1285	4624	1071	1906	1220	826	436	298	1346	2756	2061	1369
2266_IL4 - Interleukin-4	2266_IL4 - Interleukin-4	25	298	1	3775	349	4463	3697	3766	814	2881	1104	2409	2983	688	2039	951	1210	298	2786	3736	854
880_Free cholesterol in IDL	880_Free cholesterol in IDL	25	298	1	2320	4111	630	1787	3722	1852	382	4032	3276	3037	2543	825	3783	3088	713	298	900	1938
1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	1739_Urinary albumin excertion of at least 30 in enriched hypertensive sample (at exam 6, GEE, adjusted for age and sex)	25	298	1	2447	2123	1525	1375	4473	4534	3570	4320	1197	3971	969	2771	3708	1848	2111	1837	298	4074
3356_Number of unsuccessful stop-smoking attempts	3356_Number of unsuccessful stop-smoking attempts	25	299	1	299	4247	832	2446	3568	3737	1682	631	1852	3214	4007	866	494	1436	1963	3756	4050	1036
4036_Alcohol dependency (unrelated genotyped individuals)	4036_Alcohol dependency (unrelated genotyped individuals)	25	299	1	475	4513	1885	1659	299	4598	4514	1372	1161	3905	2914	1567	2482	2611	2524	3747	1057	390
2498_STAB2 - Stabilin-2	2498_STAB2 - Stabilin-2	25	299	1	3537	4533	1232	4375	3018	2321	4045	4177	299	2217	4493	1087	2229	402	4402	433	1515	2176
1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	1482_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for age and sex)	25	299	1	2335	1076	3820	3164	1518	2718	4374	3491	1602	4345	3262	2065	4459	2204	2873	1372	299	3193
2739_IGHE IGK@ IGL@ - Immunoglobulin E	2739_IGHE IGK@ IGL@ - Immunoglobulin E	25	299	1	2382	1651	3636	3469	1303	3319	4330	1037	3377	2105	4395	1702	1163	2689	2802	1264	4589	299
1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	1865_Neck cross-sectional moment of inertia (GEE, male, adjussted for age)	25	300	1	3152	3646	300	3605	3260	1099	4558	4100	2728	2452	3956	2859	3382	799	3692	3588	2341	2837
4074_Body Mass Index	4074_Body Mass Index	25	300	1	2907	2653	954	2815	300	4456	1164	3920	4653	595	4250	1998	2431	2806	2266	4479	4399	2506
2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	2616_TLR4 LY96 - Toll-like receptor 4:Lymphocyte antigen 96 complex	25	300	1	1514	365	3227	1600	3954	1344	300	1528	1999	824	1859	361	2576	1987	949	1619	497	405
580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	580_Nucleotide::Purine metabolism, (hypo)xanthine, inosine containing::hypoxanthine	25	300	1	2904	3348	4224	791	3600	480	2745	3235	1239	300	780	2248	3351	4249	1108	4586	3412	1268
1041_Shaft Width (GEE, adjusted for age and sex)	1041_Shaft Width (GEE, adjusted for age and sex)	25	300	1	3845	486	1873	2516	1763	4736	320	1239	794	4641	300	3461	1694	3932	4481	4001	502	3479
2945_GCG - Glucagon	2945_GCG - Glucagon	25	300	1	1606	4624	2074	1771	1470	4667	333	1950	4645	3568	1247	300	915	1406	2725	1510	4010	4487
1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	1716_Thyroid stimulation hormone (at exam 4, FBAT, adjusted for multivariable)	25	300	1	4459	3342	1879	851	3910	4460	1749	383	781	3874	1500	3499	4489	4000	3703	300	2684	3977
3991_Mood swings (MOOD)	3991_Mood swings (MOOD)	25	300	1	3447	4695	4404	3937	2233	2335	4395	2591	4359	2543	3817	1453	2650	3597	2309	2941	1166	300
2496_REN - Renin	2496_REN - Renin	25	301	1	3360	2834	3670	301	1848	3957	2652	4468	4294	4717	2091	1210	1966	819	4282	464	3805	3798
906_Lactate	906_Lactate	25	301	1	4249	4209	1937	485	301	4238	1098	682	4576	1352	3996	4148	4410	4694	4106	4720	3428	383
4416_Toxoplasmosis seropositivity	4416_Toxoplasmosis seropositivity	25	301	1	4051	1045	1146	2278	4223	1637	2232	892	301	3515	672	674	343	845	3508	1221	3204	4266
1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1420_Intermediate high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	301	1	3382	692	3147	3895	363	3140	3590	4133	2381	301	4631	3940	1051	3988	3888	1327	3465	2811
3234_Daytime dozing / sleeping (narcolepsy)	3234_Daytime dozing / sleeping (narcolepsy)	25	301	1	3563	1645	2563	4195	2696	3433	4478	3259	1057	2180	2784	301	1065	1460	4134	3979	874	919
4155_E/A ratio	4155_E/A ratio	25	301	1	3880	2028	1566	2369	1605	365	4110	581	2873	3638	3131	3822	718	301	956	3627	2890	2326
3497_Hair colour (natural, before greying): Light brown	3497_Hair colour (natural, before greying): Light brown	25	302	1	302	4041	789	1533	3674	1492	3417	2198	4502	4371	4591	1787	1464	1487	3566	2319	2564	1634
2253_PRKCD - Protein kinase C delta type	2253_PRKCD - Protein kinase C delta type	25	302	1	605	3871	1799	1173	2563	2560	1549	302	2451	1956	927	3671	4262	3616	3045	3905	527	4097
2532_LYN - Tyrosine-protein kinase Lyn	2532_LYN - Tyrosine-protein kinase Lyn	25	302	1	3397	3138	1048	2418	1831	3142	3412	3111	1651	4712	3508	302	1462	854	3757	2195	3598	354
3398_Leg pain on walking	3398_Leg pain on walking	25	302	1	903	4275	692	2367	861	3591	4055	3457	3743	3866	816	2839	1681	2965	2780	302	1503	1449
4464_Left postcentral	4464_Left postcentral	25	302	1	2455	1203	753	3011	4471	311	570	1453	4537	611	3760	1078	3468	4230	2790	2147	733	302
2296_CD36 - Platelet glycoprotein 4	2296_CD36 - Platelet glycoprotein 4	25	303	1	303	1296	636	1199	1854	2073	2180	767	1874	3820	3308	2288	4734	4539	3936	2551	662	3376
388_Amino acid::Lysine metabolism::glutaroyl carnitine	388_Amino acid::Lysine metabolism::glutaroyl carnitine	25	303	1	3799	987	1512	3059	303	1990	4301	3692	4014	2175	1508	946	4585	3236	1390	591	3074	3291
2116_EFNA4 - Ephrin-A4	2116_EFNA4 - Ephrin-A4	25	303	1	1462	3938	3757	3380	2968	4605	303	3656	1325	3034	2892	3073	1799	2696	2289	2483	3723	3539
3305_Lifetime number of sexual partners	3305_Lifetime number of sexual partners	25	303	1	3021	405	1216	1233	2411	3640	4262	303	4430	4437	3050	3110	2288	3114	3850	4443	1164	3066
2578_ARSA - Arylsulfatase A	2578_ARSA - Arylsulfatase A	25	303	1	4307	994	2008	4074	3997	3689	3736	1793	1101	303	597	4340	3555	3229	961	1735	3205	2572
3264_Average weekly beer plus cider intake	3264_Average weekly beer plus cider intake	25	303	1	3938	4640	4652	3198	4603	2447	4034	4096	2908	2657	303	1655	4511	1634	4295	2640	767	4198
4367_Coronary artery disease in diabetes	4367_Coronary artery disease in diabetes	25	303	1	1468	2094	2990	1783	3317	3323	3619	4219	1184	1975	1598	303	4657	387	2717	3441	3237	4008
1765_Heart failure (free of MI, GEE, adjusted for age and sex)	1765_Heart failure (free of MI, GEE, adjusted for age and sex)	25	303	1	2957	999	785	2046	3164	3641	2767	2206	3539	2279	3584	1921	303	2088	4463	1306	3749	4463
1183_Sleep duration (female)	1183_Sleep duration (female)	25	303	1	1167	4661	1793	2951	3765	3172	3431	3868	4298	4272	1214	2296	1197	4669	303	1218	4528	3592
4698_External capsule mean diusivities	4698_External capsule mean diusivities	25	303	1	4255	4002	3613	1066	4114	821	2350	3352	3098	2024	3264	3965	398	2489	811	4111	1591	303
984_Interleukin-16	984_Interleukin-16	25	304	1	2965	3500	3802	304	3969	2192	716	3688	4280	520	1308	4424	4666	2140	4324	4351	3895	3225
2774_DCTN2 - Dynactin subunit 2	2774_DCTN2 - Dynactin subunit 2	25	304	1	4151	2688	1959	4692	3134	1475	1417	304	3070	1850	4420	3280	3421	1417	1434	2503	1943	1444
2039_Attention function - Orienting - Child	2039_Attention function - Orienting - Child	25	304	1	2953	3712	2327	494	4197	2013	2461	4476	304	3278	4247	1768	1101	2169	2885	3687	2155	3008
2970_F3 - Tissue Factor	2970_F3 - Tissue Factor	25	304	1	1411	2624	1683	2976	2597	2494	2575	1267	3089	512	3019	2734	2025	304	2819	2660	3006	550
2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	2170_AIMP1 - Endothelial monocyte-activating polypeptide 2	25	304	1	1007	4733	3432	3369	2470	2751	4124	4037	2432	4465	2604	2299	1514	3262	3561	304	1288	3998
1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	1722_Serum calcium (at exam 2, FBAT, adjusted for age and sex)	25	304	1	2625	2352	2313	3293	3931	843	1921	1565	3466	4628	1544	4701	918	4278	1687	4280	304	3259
4752_Superior corona radiata radial diusivities	4752_Superior corona radiata radial diusivities	25	304	1	600	2640	3895	4629	1384	783	2838	3314	3477	2229	4164	4379	3063	2322	2719	2366	1828	304
1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	1472_Mean total cholesterol from exam 1-7 (FBAT, adjusted for multivariable)	25	305	1	1566	3830	3671	4590	305	4648	4334	2337	2871	4428	1209	3404	4521	1832	1688	1319	1290	4373
4485_Right lateral orbitofrontal	4485_Right lateral orbitofrontal	25	305	1	3827	3478	4367	788	447	305	3760	4138	4564	1606	4325	2980	1392	1696	2661	1582	4711	517
4379_BRCA1/2-negative breast cancer	4379_BRCA1/2-negative breast cancer	25	305	1	1060	1722	2768	2385	3386	4166	1022	2996	1459	3918	1503	1339	2292	3332	305	567	1600	482
919_Concentration of medium LDL particles	919_Concentration of medium LDL particles	25	305	3	2187	565	2749	2127	2784	3717	2049	2239	2359	4278	1864	698	4599	4209	1831	305	1891	341
2519_FN1 - Fibronectin Fragment 4	2519_FN1 - Fibronectin Fragment 4	25	306	1	3738	4260	2793	859	306	4281	332	2876	4682	3423	1137	1185	4317	2459	4446	1773	4370	2198
2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	2137_PAFAH1B2 - Platelet-activating factor acetylhydrolase IB subunit beta	25	306	1	4003	3972	4386	4718	586	3818	3843	4657	306	2152	701	3240	3993	4418	3830	4356	4153	1699
1031_Neck Width (GEE, adjusted for multivariable)	1031_Neck Width (GEE, adjusted for multivariable)	25	306	1	765	453	3697	1425	2733	3298	1049	411	4554	306	1479	4067	3942	1701	479	3376	4301	2138
4357_Albuminuria	4357_Albuminuria	25	306	1	4259	403	3205	1350	3263	4167	4533	3874	3060	1472	3571	1855	3557	306	952	4461	4187	3422
3579_Social support - Leisure/social activities: Adult education class	3579_Social support - Leisure/social activities: Adult education class	25	306	1	1554	2115	1669	3531	1989	3028	3720	1493	4693	4568	455	4273	2016	1068	3203	306	1117	3300
2924_TXNDC12 - Thioredoxin domain-containing protein 12	2924_TXNDC12 - Thioredoxin domain-containing protein 12	25	306	1	3597	783	3603	3804	3142	1961	4232	3068	2268	1982	2260	1364	4057	4030	3531	1086	306	664
3337_Years since last breast cancer screening / mammogram (female)	3337_Years since last breast cancer screening / mammogram (female)	25	306	1	3009	4476	3415	1518	1583	1596	3620	3902	474	2141	3039	1135	1585	4530	2045	2333	1808	306
1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1940_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	307	1	2225	1077	307	1708	1745	2549	3468	2912	687	3687	1061	3885	900	3082	1306	2572	2585	360
4277_Meconium ileus in cystic fibrosis	4277_Meconium ileus in cystic fibrosis	25	307	1	2898	2349	1626	2172	3585	1162	551	307	4290	3218	2836	416	3427	1579	1765	3110	2419	465
4252_Number of sleep episodes	4252_Number of sleep episodes	25	307	1	4022	533	2677	2894	1501	4183	3638	2286	2631	2861	307	2577	816	4653	316	3191	1009	3244
4052_25-Hydroxyvitamin D level	4052_25-Hydroxyvitamin D level	25	307	1	358	4672	3761	3310	4474	4289	4656	1526	3999	745	2728	4066	4285	4102	307	3189	2507	2140
2244_C5 - C5a anaphylatoxin	2244_C5 - C5a anaphylatoxin	25	307	1	1549	2006	3823	3107	871	569	4625	4165	1179	1727	1049	3717	3806	2822	3257	307	1318	2277
985_Interleukin-17	985_Interleukin-17	25	307	1	2493	1641	2260	2563	3594	2642	498	3802	3115	735	1536	885	3292	3880	1808	4129	307	3399
4184_Total cholesterol	4184_Total cholesterol	25	308	1	4421	308	4341	3611	2445	4689	836	3018	2508	884	3149	338	2405	3886	4302	471	3315	909
114_Waist-hip ratio (adjusted for BMI)	114_Waist-hip ratio (adjusted for BMI)	25	308	1	1125	3221	3616	4734	1463	3599	3663	308	451	1487	1200	2415	4659	2784	1245	4094	4598	3439
551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	551_Lipid::Lysolipid::2-palmitoylglycerophosphocholine*	25	308	1	3683	2261	4402	3210	4457	2534	2443	3601	1127	2668	1055	2339	1012	4277	308	1397	1018	3657
1159_Fasting insulin main effect	1159_Fasting insulin main effect	25	308	1	2388	2099	2747	2110	713	1680	2975	1990	4495	2331	4256	1034	989	1148	1826	1819	308	473
1978_Hand grip (at exam 7, FBAT)	1978_Hand grip (at exam 7, FBAT)	25	309	1	2374	4174	2537	1729	2943	1620	309	2511	4301	2769	3399	3666	2658	1945	1867	2722	4326	2698
2937_C3 - Complement C3d fragment	2937_C3 - Complement C3d fragment	25	309	1	4470	4566	1436	3760	1178	2410	1923	4683	4574	309	2938	2872	869	2765	2404	1508	1822	2250
299_CD4mem:%Th1* (2)	299_CD4mem:%Th1* (2)	25	309	1	812	2307	2474	432	2056	3017	1485	3569	1048	2139	309	1465	2793	2262	1463	3287	963	3075
2455_NTN4 - Netrin-4	2455_NTN4 - Netrin-4	25	309	1	1655	1794	1409	2827	3155	1541	3509	419	1307	3474	901	309	2998	2067	1482	2419	4006	1184
3762_Anxiety - Recent inability to stop or control worying	3762_Anxiety - Recent inability to stop or control worying	25	310	1	2963	310	3311	474	3671	1702	3598	3214	4676	1785	796	1014	3198	4496	1374	4704	1110	2971
511_Lipid::Inositol metabolism::myo-inositol	511_Lipid::Inositol metabolism::myo-inositol	25	310	1	2800	1776	2974	4357	310	2856	1111	3897	933	2516	2775	3961	3716	2878	1513	3125	2621	1807
4096_Open-angle glaucoma	4096_Open-angle glaucoma	25	310	1	3764	2895	3287	3392	1365	310	4107	844	2249	4039	4252	3006	2242	598	2724	4472	919	1766
3136_SHC1 - SHC-transforming protein 1	3136_SHC1 - SHC-transforming protein 1	25	310	1	2470	3161	883	2484	3551	2986	310	3492	3533	4686	949	977	3185	3272	4722	649	1158	2756
2620_PPP3R1 - Calcineurin subunit B type 1	2620_PPP3R1 - Calcineurin subunit B type 1	25	310	1	4466	1114	2304	1461	3390	4016	2702	4609	310	1422	3430	3383	3073	2854	1377	1953	1372	1200
2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	2345_FASLG - Tumor necrosis factor ligand superfamily member 6, soluble form	25	310	1	4349	2434	2319	740	4291	1478	843	1318	2452	2054	310	3117	4306	524	4337	1999	2549	1434
588_Nucleotide::Purine metabolism, urate metabolism::urate	588_Nucleotide::Purine metabolism, urate metabolism::urate	25	310	1	4148	1216	4005	1837	2956	4412	914	2043	4096	1384	1353	310	2673	4710	1092	910	3473	2023
1856_Neck average buckling ratio (FBAT, male, adjussted for age)	1856_Neck average buckling ratio (FBAT, male, adjussted for age)	25	310	1	2025	1736	2332	3452	4667	2235	4351	3470	3434	2906	1916	2268	310	4366	4648	4610	1085	371
2275_CYCS - Cytochrome c	2275_CYCS - Cytochrome c	25	310	1	4432	2780	3160	577	330	792	2260	4327	1105	3018	3163	3583	3585	3127	1617	1146	310	1119
924_Total lipids in medium VLDL	924_Total lipids in medium VLDL	25	311	1	2591	3883	2727	311	956	1177	2317	4298	3937	3596	4021	872	3890	2029	3487	2295	1369	4683
615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	615_Xenobiotics::Benzoate metabolism::4-vinylphenol sulfate	25	311	1	4135	3431	814	3306	786	4573	311	1664	3730	4048	1667	2812	1250	3599	2528	1669	4474	2412
4172_Social support - Leisure/social activities: Pub or social club	4172_Social support - Leisure/social activities: Pub or social club	25	311	1	3810	2707	4100	1683	1062	4058	806	311	4124	2517	1867	2428	3575	1726	2321	2222	3746	3538
3155_KRT18 - Keratin, type I cytoskeletal 18	3155_KRT18 - Keratin, type I cytoskeletal 18	25	311	1	677	1244	3461	2644	3060	1066	526	4242	311	2481	625	688	3895	1463	2032	3533	3144	1114
2619_CDH12 - Cadherin-12	2619_CDH12 - Cadherin-12	25	311	1	2687	3931	2515	1161	1287	2101	1944	4129	1386	362	1563	311	606	1578	2039	2909	833	3057
3858_Neutrophil percentage of granulocytes (two-way meta)	3858_Neutrophil percentage of granulocytes (two-way meta)	25	311	1	4609	2823	4447	2895	2978	1560	616	3761	3313	3221	4014	2657	1951	883	311	1581	2328	1683
377_Amino acid::Glutathione metabolism::5-oxoproline	377_Amino acid::Glutathione metabolism::5-oxoproline	25	311	1	790	582	580	4340	1880	554	4275	2263	2029	3120	2288	4079	2916	2973	326	4570	1094	311
2624_KLK14 - Kallikrein-14	2624_KLK14 - Kallikrein-14	25	312	1	4400	312	3504	936	2077	2764	2423	3485	2016	4096	1986	1374	3938	4687	3822	3897	806	2665
1100_Diastolic Blood Pressure - Birth cohorts	1100_Diastolic Blood Pressure - Birth cohorts	25	312	1	1564	4202	2242	312	382	2518	4522	4113	4174	4588	573	1255	554	725	3787	1123	3135	1977
2977_ARPP19 - cAMP-regulated phosphoprotein 19	2977_ARPP19 - cAMP-regulated phosphoprotein 19	25	312	1	2380	4608	1107	3032	4466	312	2729	1702	2961	3346	1866	3964	4163	656	2742	2154	1493	1698
1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	1549_Maximum carotid artery bulb IMT (at exam 6, GEE, adjusted for multivariable)	25	312	1	4696	3951	2494	3336	451	1490	312	1831	410	2368	4238	3529	3611	567	4687	4158	1889	4191
3266_Average weekly fortified wine intake	3266_Average weekly fortified wine intake	25	312	1	1242	3595	4596	1416	1819	3314	4179	312	3603	3425	1555	3304	481	1492	4202	4164	4245	3031
1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1683_Brain natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	312	1	3556	4372	3505	1312	4118	3900	3800	4283	312	414	3832	2120	1271	4606	3796	2963	520	3089
2269_PCNA - Proliferating cell nuclear antigen	2269_PCNA - Proliferating cell nuclear antigen	25	312	1	1290	841	4334	1288	1282	1169	840	4695	2234	312	2010	2897	342	3943	3814	2685	3268	500
2143_PLAUR - Urokinase plasminogen activator surface receptor	2143_PLAUR - Urokinase plasminogen activator surface receptor	25	312	1	4208	2319	618	2269	2914	3074	2074	1005	2879	3904	312	2124	3282	1955	2303	3952	775	2491
4335_Overall activity	4335_Overall activity	25	312	1	2193	1924	2780	546	4658	1256	3146	407	2524	2662	3128	2985	312	3582	1979	1084	709	602
722_::::X-11546	722_::::X-11546	25	312	1	2330	1100	1620	3321	2878	3418	3244	371	4620	3011	752	2626	4213	312	3804	1852	4505	2785
4595_Right pericalcarine	4595_Right pericalcarine	25	312	1	4673	4293	4353	2927	2910	2273	1174	437	3265	1736	2523	3310	2130	3324	312	486	1747	483
4307_Osteoarthritis	4307_Osteoarthritis	25	312	1	679	2059	4199	3434	4163	2629	3103	3805	1465	4217	955	1681	2635	2666	4019	312	1675	1948
3958_Antisocial behavior (male)	3958_Antisocial behavior (male)	25	313	1	4091	3609	2240	2510	1305	1110	313	1952	3822	4543	2039	624	768	1698	1544	3953	1776	746
1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1580_Mean coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	313	1	4595	1217	4201	2171	4577	4232	4303	1762	1020	4499	313	4085	1310	977	471	969	3905	3947
418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	418_Amino acid::Urea cycle; arginine-, proline-, metabolism::trans-4-hydroxyproline	25	313	1	2171	2586	659	865	2664	810	4631	3244	1897	2272	470	2035	3283	697	313	1479	4432	4084
1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	1391_High-density lipoprotein cholesterol (at exam 1, GEE, adjusted for age and sex)	25	314	1	589	2930	314	2841	376	3197	2050	4582	4369	3283	3306	1159	1428	3087	1970	3838	4114	1156
2306_HIST1H1C - Histone H1.2	2306_HIST1H1C - Histone H1.2	25	314	1	1147	2722	2044	3690	314	1387	1366	908	2395	1190	373	752	3608	950	2026	2402	4152	1199
2190_C3 - C3a anaphylatoxin des Arginine	2190_C3 - C3a anaphylatoxin des Arginine	25	314	1	3405	2129	947	3412	3322	3252	4148	2098	314	4442	4607	2461	3536	3446	2416	4319	4052	2930
2671_PRKCQ - Protein kinase C theta type	2671_PRKCQ - Protein kinase C theta type	25	314	1	3180	1997	3587	4542	4727	2747	3646	1779	2478	314	3157	3572	1286	3464	657	427	4254	4120
3409_Education - Qualifications	3409_Education - Qualifications	25	314	1	2063	4589	4389	3814	894	2443	3528	2730	3254	3450	337	3377	2452	1503	2660	314	889	3138
2249_HDAC8 - Histone deacetylase 8	2249_HDAC8 - Histone deacetylase 8	25	315	1	4498	1982	2211	315	1088	599	4416	388	2756	3334	1258	1411	873	2012	747	4145	1748	3329
1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	1703_Follicle stimulating hormone (at exam 3, GEE, adjusted for age and sex)	25	315	1	3016	4570	807	941	875	3092	4335	2269	4045	4296	1968	1501	4102	315	3366	608	2985	2317
1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1421_Intermediate high-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	316	1	2295	3229	2292	1861	2136	316	1081	1091	531	2961	1119	3036	338	737	2112	379	2298	1738
3861_Plateletcrit (two-way meta)	3861_Plateletcrit (two-way meta)	25	316	1	3767	2950	1520	1767	634	890	316	1147	469	2225	2132	1857	4443	2685	652	3813	3020	2111
363_Mono:%11c-16-274+	363_Mono:%11c-16-274+	25	316	1	2788	1027	858	3019	4647	3802	984	316	2012	2788	3181	3356	2012	3433	4572	2254	3964	3201
2255_RAD51 - DNA repair protein RAD51 homolog 1	2255_RAD51 - DNA repair protein RAD51 homolog 1	25	316	1	1401	4664	1479	3389	1486	2201	595	1175	2722	2189	413	1420	3840	316	4553	3967	3585	3602
1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	1938_Hippocampal volume (FBAT, adjusted for multivariable with APOE)	25	317	1	2308	317	1348	2526	2091	2869	3593	1009	3824	4609	693	2656	1120	2096	3358	2816	1501	2808
659_::::X-04494	659_::::X-04494	25	317	1	3294	1065	598	2668	1838	4070	3401	317	3856	1518	2782	1278	1055	954	1985	3026	1997	1850
4021_Double eyelid	4021_Double eyelid	25	317	1	3996	3475	4251	1525	665	4008	3787	1696	4194	4487	1869	2297	3817	317	4399	4607	1502	4348
3355_Ever stopped smoking for 6+ months	3355_Ever stopped smoking for 6+ months	25	317	1	1690	3169	3980	2066	1441	3684	1415	420	2352	3273	3254	2371	3678	3142	3760	317	1821	2392
1125_Subcutaneous adipose tissue attenuation (female)	1125_Subcutaneous adipose tissue attenuation (female)	25	317	1	4364	1440	4125	802	3389	3613	3750	653	4452	1449	3954	2774	870	3205	1608	1354	317	2008
4302_Arms-arm fat ratio (female)	4302_Arms-arm fat ratio (female)	25	318	1	1271	1215	318	3396	565	4738	412	2236	3183	1599	2707	4704	3381	2614	4640	2772	3881	3635
3912_Cup area	3912_Cup area	25	318	1	1458	1478	809	318	941	3699	4708	575	1657	2048	1063	1842	903	1442	529	3904	2136	2254
937_Total lipids in small LDL	937_Total lipids in small LDL	25	318	1	4375	426	3236	2204	2466	3666	1996	1977	3503	4269	1265	560	4209	3170	1097	499	376	318
2162_PSPN - Persephin	2162_PSPN - Persephin	25	319	1	319	1355	4669	2403	1539	3296	2762	2662	2032	4555	2024	2920	1448	3657	2063	4731	2910	3759
4151_Left ventricular mass index	4151_Left ventricular mass index	25	319	1	1933	1792	3541	1986	718	319	4565	3029	3906	631	3855	394	1484	3628	1234	3578	3198	2746
4635_Right thalamus proper	4635_Right thalamus proper	25	319	1	2227	2755	1650	452	420	4000	319	2902	3792	621	3089	544	2832	968	1242	3798	4615	492
4272_Sleep duration	4272_Sleep duration	25	320	1	1526	2536	531	465	320	1497	2121	1772	1372	2629	1385	1810	3014	2308	3826	2659	1086	1457
3277_Maternal smoking around birth	3277_Maternal smoking around birth	25	320	1	2392	3812	2848	2173	2647	3888	558	2362	793	3399	1936	576	1529	320	3051	3131	1378	4628
2038_Attention function - Alerting - Child	2038_Attention function - Alerting - Child	25	321	1	2954	1682	321	2525	368	4714	3575	4619	3011	4087	4655	348	4468	2487	2673	3881	4636	3200
676_::::X-08988	676_::::X-08988	25	321	1	2604	2494	4612	2678	3797	321	2123	2492	3347	352	2750	2034	4662	3350	1445	2049	2093	3933
622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	622_Xenobiotics::Drug::3-(cystein-S-yl)acetaminophen*	25	321	1	4561	2840	2375	4029	610	1091	3929	2343	3090	2878	321	1120	2289	678	2368	1947	2631	2862
1053_Neuroblastoma	1053_Neuroblastoma	25	321	1	2195	2388	4207	516	1637	3187	4470	3134	3679	2418	4232	321	2205	2896	1488	2071	1646	1191
4170_Loneliness (MTAG)	4170_Loneliness (MTAG)	25	321	1	587	3994	3235	4687	2776	851	4297	3382	1589	4723	3504	3561	1963	321	1086	4033	1937	2870
830_::::X-14056	830_::::X-14056	25	321	1	4442	2841	1371	3179	4274	2387	2579	3495	1794	3100	2354	1414	1470	1166	1146	321	1012	2637
961_Total lipids in very large VLDL	961_Total lipids in very large VLDL	25	321	1	553	2338	2510	623	1388	3476	2760	4352	4048	1807	556	4471	2119	1112	3701	2976	321	3997
125_Body Mass Index (female)	125_Body Mass Index (female)	25	322	1	710	461	672	3558	322	3361	1448	4104	1960	3747	3473	2822	2305	1947	2008	3299	2165	1806
3162_SET - Protein SET	3162_SET - Protein SET	25	322	1	3980	898	1864	2819	3631	1351	322	2525	846	2267	2250	3441	877	770	2175	702	1787	4693
714_::::X-11491	714_::::X-11491	25	322	1	3565	3554	4186	1665	3903	2867	2073	4175	4744	3091	2832	322	4082	2480	1530	4612	4717	875
3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	3122_PPIF - Peptidyl-prolyl cis-trans isomerase F, mitochondrial	25	322	1	3990	2959	1957	2309	3034	4254	919	1967	4016	1514	2358	3504	1044	3259	760	322	3417	1367
3572_Pain type(s) experienced in last month: Back pain	3572_Pain type(s) experienced in last month: Back pain	25	323	1	4069	323	4028	4715	3633	3419	1650	4640	2435	415	4488	3767	3208	739	1194	998	1546	1455
2699_SEZ6L2 - Seizure 6-like protein 2	2699_SEZ6L2 - Seizure 6-like protein 2	25	323	1	3384	2510	323	2722	2296	908	4548	2475	2377	985	4661	1480	4186	361	3919	882	590	2404
2704_ARID3A - AT-rich interactive domain-containing protein 3A	2704_ARID3A - AT-rich interactive domain-containing protein 3A	25	323	1	458	2507	4409	2758	1104	323	415	3835	1768	4187	466	1852	3363	3596	1684	514	3360	549
96_Height SDS (female at age 10)	96_Height SDS (female at age 10)	25	323	1	3628	3437	3981	1907	3298	1419	323	1065	1772	4739	1579	4619	892	1900	2477	4645	1714	4322
604_Peptide::gamma-glutamyl::gamma-glutamylleucine	604_Peptide::gamma-glutamyl::gamma-glutamylleucine	25	323	1	2340	2478	1055	2303	3917	4594	4641	323	2430	3055	845	4414	4042	1323	4483	4375	903	1187
2647_MMP10 - Stromelysin-2	2647_MMP10 - Stromelysin-2	25	323	1	2858	4156	4282	4654	1430	3288	1176	1906	3353	3578	323	3333	2837	672	1764	1980	1157	1356
3082_CD200 - OX-2 membrane glycoprotein	3082_CD200 - OX-2 membrane glycoprotein	25	323	1	3723	2167	2566	1338	799	436	508	4121	2953	3152	3565	323	4338	1302	1124	953	2655	1401
759_::::X-12188	759_::::X-12188	25	323	1	813	402	2230	4166	2985	1044	429	4599	4545	4091	3403	3712	323	2846	3483	3070	3011	4567
3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	3717_Diagnoses - secondary ICD10: Z96 Presence of other functional implants	25	323	1	3446	3131	3881	3151	1668	4508	4356	4545	3129	921	2973	1924	1902	1228	1050	4175	3208	323
4127_Lactate dehydrogenase	4127_Lactate dehydrogenase	25	324	1	324	2704	4193	3682	1731	352	3194	4451	3652	4645	1597	2700	861	4480	1265	2111	2457	1900
3037_PRSS2 - Trypsin-2	3037_PRSS2 - Trypsin-2	25	324	1	367	324	908	3188	2012	3292	4615	4442	2139	2114	791	4541	1554	3868	1810	2682	2076	1510
2057_Ulcerative colitis	2057_Ulcerative colitis	25	324	1	736	3917	3226	2821	4141	324	4287	2954	4305	2104	2460	1004	1358	3476	1261	1528	4279	2203
1156_Fasting glucose main effect	1156_Fasting glucose main effect	25	324	1	2633	2471	3100	3820	1037	548	3259	2751	3240	2766	715	1728	3464	3057	4525	3593	324	3126
3500_Male-specific factors - Hair/balding pattern: Pattern 1	3500_Male-specific factors - Hair/balding pattern: Pattern 1	25	325	1	3953	901	325	649	4110	3254	4456	1771	1136	4047	3412	4474	1954	4704	4469	1018	1313	1821
3524_Transport type for commuting to job workplace: Car/motor vehicle	3524_Transport type for commuting to job workplace: Car/motor vehicle	25	325	1	2992	705	452	1363	325	1227	487	4587	2232	2208	3992	4084	3565	2271	3220	1261	3764	1483
1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	1750_Cystatin C (at exam 7, FBAT, adjusted for age and sex)	25	325	1	1796	948	819	2771	4125	2630	3753	3082	2605	1192	325	1853	3946	916	4618	4248	2653	4413
3886_Mean corpuscular hemoglobin concentration (three-way meta)	3886_Mean corpuscular hemoglobin concentration (three-way meta)	25	325	1	4593	4609	4420	2823	2973	3866	2695	461	3128	1806	2297	928	4052	1109	325	964	1773	2954
4559_Left parahippocampal	4559_Left parahippocampal	25	325	1	1751	1226	1994	1406	2555	1836	1872	4367	3630	2023	1004	2942	3717	4101	1525	325	970	1898
1906_Hippocampal volume (FBAT, adjusted for multivariable)	1906_Hippocampal volume (FBAT, adjusted for multivariable)	25	326	1	1389	326	475	700	2377	4713	2925	673	358	2927	2749	3189	842	3383	4218	1706	1914	1570
3987_Heart rate recovery at 30 secnds	3987_Heart rate recovery at 30 secnds	25	326	1	2646	4518	2101	326	3703	4380	2004	2809	2373	411	1956	1372	3494	2610	3914	2838	1963	2801
3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	3709_Diagnoses - secondary ICD10: Z82 Family history of certain disabilities and chronic diseases (leading to disablement)	25	326	1	3737	1353	3646	1653	4046	3695	326	3776	3086	4498	2783	1107	1806	3490	1302	4373	3873	761
2906_EPB41 - Protein 4.1	2906_EPB41 - Protein 4.1	25	326	1	3918	3266	3341	2260	1881	4150	2715	2849	2701	326	2508	4296	2187	2637	1123	1885	1794	3891
1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	1398_High-density lipoprotein 2 cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	326	1	1717	2029	1985	3400	1975	1376	1522	2898	3178	4144	1987	2017	326	2465	1206	4676	3365	4341
4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	4385_Epithelial ovarian cancer (Mucinous invasive and borderline mucinous)	25	326	1	2460	2179	3153	4172	814	4394	2269	813	3291	1886	4495	2427	422	1252	3073	3910	2683	326
4535_Right caudate	4535_Right caudate	25	327	1	4216	3086	3014	3351	1972	327	2987	1111	1901	3714	2815	3679	2702	3763	4377	2414	1734	3363
1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	1037_Neck-Shaft Angle (GEE, adjusted for age and sex)	25	327	1	3798	4743	1453	2870	3441	3825	1552	1128	2672	1467	2219	2129	327	1745	3970	1155	1306	3312
4738_Body of corpus callosum radial diusivities	4738_Body of corpus callosum radial diusivities	25	327	1	2737	1729	3453	801	1704	2803	3050	2310	890	4063	3162	2525	1172	1555	327	2547	3606	3354
38_Verbal-numerical reasoning	38_Verbal-numerical reasoning	25	328	1	328	2762	2796	637	2958	4695	2408	3617	2110	2855	3656	3546	1149	1796	2499	2125	4271	2419
21_Age of smoking initiation	21_Age of smoking initiation	25	328	1	2462	328	2099	1609	1192	2880	4355	1910	3618	3764	4110	4638	1798	975	3032	4059	4075	2288
3108_GCKR - Glucokinase regulatory protein	3108_GCKR - Glucokinase regulatory protein	25	328	1	381	3370	1940	1889	3222	328	937	413	2581	1348	4543	1695	1211	2820	1816	3951	3699	4576
3629_Illnesses of father: Stroke	3629_Illnesses of father: Stroke	25	328	1	4644	4145	701	4286	484	726	3737	3429	328	4127	1498	4236	983	1085	4328	3454	2233	1542
3568_Why stopped smoking: Health precaution	3568_Why stopped smoking: Health precaution	25	328	1	3235	4598	3218	2187	1196	4221	2526	3257	3619	1273	336	874	2081	2747	1014	328	2573	2357
4576_Left insula	4576_Left insula	25	328	1	1305	1647	2672	1321	3290	816	400	2487	2119	1319	2214	1115	1567	3198	2779	1152	1051	328
3525_Transport type for commuting to job workplace: Walk	3525_Transport type for commuting to job workplace: Walk	25	329	1	1786	3398	329	4078	2897	1517	3826	4369	1156	1951	2368	794	3060	1407	3034	2881	1072	1317
3393_Number of depression episodes	3393_Number of depression episodes	25	329	1	3386	3318	3863	2760	329	3102	1100	1802	551	2070	3469	3705	1064	2827	2329	2463	1431	2456
3946_HbA1c	3946_HbA1c	25	329	1	767	3330	3926	1221	1184	3444	4500	2687	1195	329	1961	2114	3474	848	3267	4544	3963	3782
167_Waist circumference	167_Waist circumference	25	329	1	892	1047	2098	3687	753	1055	700	4675	1175	1306	3300	329	3029	4731	2069	3446	2935	3508
1146_Peak insulin response (adjusted for BMI)	1146_Peak insulin response (adjusted for BMI)	25	329	1	2830	587	2178	2253	3776	601	540	4639	4066	1119	3250	2632	4655	329	4410	3684	2189	3063
4143_Diastolic Blood Pressure	4143_Diastolic Blood Pressure	25	329	1	809	2596	2967	1687	1958	3019	920	2460	3692	2814	4380	2417	2222	2052	2357	3476	3845	329
3400_Noisy workplace	3400_Noisy workplace	25	330	1	330	2368	987	4353	4548	2212	3374	627	1092	695	1587	3524	1591	1656	2425	4696	3313	610
4171_Loneliness	4171_Loneliness	25	330	1	429	1661	2742	2434	4716	402	3794	330	721	4191	3517	4687	685	1074	3716	4048	1149	4368
1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1377_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	25	330	1	337	2143	4062	3788	3973	4304	4579	3344	541	3377	3849	4138	330	4106	2767	4211	2437	444
3165_LEPR - Leptin receptor	3165_LEPR - Leptin receptor	25	330	1	447	3439	4036	1159	651	594	1833	695	1532	2258	3935	2409	3254	1429	330	3340	4151	3640
1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	1618_CD40 Ligand serum (at exam 7, FBAT, adjusted for age and sex)	25	330	1	1542	949	1384	1409	2014	3257	3707	525	3366	3126	4745	4029	4592	3996	4665	3389	3664	330
4391_Dysmenorrhea (quality of life impact)	4391_Dysmenorrhea (quality of life impact)	25	331	1	4598	331	1648	4217	3306	3334	3599	1713	3136	4379	4109	2053	2359	4537	2108	4730	2854	3325
1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	1466_Low-density lipoprotein particle size by NMR (at exam 4, FBAT, adjusted for age and sex)	25	331	1	4085	4541	680	2569	1222	2458	3890	331	2758	1678	3857	4416	2173	1322	2573	3159	1160	2269
2221_BCAM - Basal Cell Adhesion Molecule	2221_BCAM - Basal Cell Adhesion Molecule	25	331	1	2169	1414	3073	1815	3667	860	4259	1984	3485	2574	2080	4689	331	2023	901	578	2411	4453
2001_Height	2001_Height	25	331	1	591	1295	2442	2772	1181	585	3710	4648	3567	944	4445	4129	2510	2235	331	750	1314	2447
2220_AGRP - Agouti-related protein	2220_AGRP - Agouti-related protein	25	331	1	863	1436	400	710	926	789	4139	2449	3525	3408	563	3552	1619	3746	639	1200	331	866
1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	1870_Shaft average buckling ratio (FBAT, female, adjussted for multivariable)	25	332	1	1011	4259	332	3200	3292	418	3850	2083	3137	3520	2396	3247	386	1490	742	640	422	3954
417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	417_Amino acid::Urea cycle; arginine-, proline-, metabolism::proline	25	332	1	2032	4229	3740	738	3177	332	3798	4625	4143	3224	1044	969	1397	1524	771	2873	4727	1998
780_::::X-12456	780_::::X-12456	25	332	1	3330	3143	1033	1346	4302	1865	2043	332	1058	2166	1124	2912	1891	2852	2190	3161	1969	2927
27_Neuroticism (NEO-FFI)	27_Neuroticism (NEO-FFI)	25	332	1	1883	875	3124	640	1553	394	2941	1012	3955	392	1924	332	4090	4184	2137	511	618	2847
940_Free cholesterol in small VLDL	940_Free cholesterol in small VLDL	25	332	1	2921	1377	3568	1100	2427	1399	1995	4287	1567	2738	1801	1928	4449	1615	3924	332	1172	3566
4452_Left isthmus cingulate	4452_Left isthmus cingulate	25	332	1	4615	3400	339	2482	4146	4348	1505	3358	4170	2659	589	910	1100	2604	1997	3109	332	4431
2448_IGFBP7 - Insulin-like growth factor-binding protein 7	2448_IGFBP7 - Insulin-like growth factor-binding protein 7	25	333	1	333	3123	2910	1372	2376	2448	3577	1562	564	691	636	890	3937	2076	1465	4386	930	468
4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	4351_Male pattern baldness (BOLT LMM infinitesimal mixed model)	25	333	1	2795	1756	333	1427	4300	768	2028	1593	1021	3935	4477	4181	3017	4211	1612	1774	998	3166
465_Lipid::Bile acid metabolism::deoxycholate	465_Lipid::Bile acid metabolism::deoxycholate	25	333	1	4077	1256	2361	2459	333	3625	908	1639	3076	529	1522	944	3703	2729	1340	4306	3993	940
1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1801_Low/High frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	333	1	4711	4718	4184	4425	1459	1382	1397	2901	333	2450	2639	3589	1107	2880	3064	3069	1842	1430
1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	1500_Triglycerides (at exam 2, FBAT, adjusted for age and sex)	25	333	1	1503	4063	3509	2270	3349	3809	2302	1695	2043	1059	4170	1686	3359	4268	1003	333	1423	4538
1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	1366_Total cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	333	1	3076	2074	2999	1953	668	935	821	1253	1683	1912	4408	1486	2878	2643	3799	2487	333	476
4014_Major depressive disorder	4014_Major depressive disorder	25	334	1	3073	334	2874	4367	3206	3357	3275	2572	3248	3972	4218	1710	3675	4096	4230	1825	2053	1039
1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	1869_Neck-Shaft Angle (GEE, male, adjussted for multivariable)	25	334	1	3838	1699	3857	334	3847	4511	3100	4259	2997	3080	1530	1981	1405	3906	769	3047	4408	3188
2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	2180_SIGLEC6 - Sialic acid-binding Ig-like lectin 6	25	334	1	768	685	3047	3680	334	4094	1537	1158	842	1149	4573	3808	1187	2194	2887	3716	2761	635
3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	3111_PDK1 - [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial	25	334	1	1315	2371	2054	4158	3871	3799	1061	2864	334	3953	4384	1749	4324	3732	1701	1187	4274	1263
286_CD4:%Treg(39-73+)	286_CD4:%Treg(39-73+)	25	334	1	349	3591	4060	4699	2479	3749	2607	1954	2888	334	3929	3995	2903	1933	439	709	4529	3438
2263_CCL28 - C-C motif chemokine 28	2263_CCL28 - C-C motif chemokine 28	25	334	1	1758	574	3892	4388	1265	2681	362	4530	3203	901	678	3774	3631	4545	4567	334	463	3987
821_::::X-13496	821_::::X-13496	25	334	1	2819	2201	984	1870	1797	1616	3106	2859	1345	4183	3099	2830	1475	1093	2423	2676	334	2455
4513_CSF	4513_CSF	25	334	1	2075	3215	2274	3227	3367	3127	607	2519	2779	781	4700	1252	3907	2499	4188	3032	4731	334
4471_Left superior parietal	4471_Left superior parietal	25	335	1	335	659	3158	4404	495	4533	3818	4319	4113	1600	3763	4389	3440	4298	2795	643	3717	1662
741_::::X-11858	741_::::X-11858	25	335	1	1664	3869	1087	4648	1507	335	3338	2080	2504	2811	3171	1397	2096	4518	792	597	3303	3241
3799_Red blood cell count	3799_Red blood cell count	25	335	1	2994	1373	4293	3118	1832	2028	1199	3844	489	335	3212	1337	1794	2938	3670	1568	4251	2472
846_::::X-14662	846_::::X-14662	25	335	1	4328	1650	4368	2222	2980	4210	4066	2138	1260	4637	335	2703	2355	2839	671	1321	2367	4710
416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	416_Amino acid::Urea cycle; arginine-, proline-, metabolism::ornithine	25	335	1	969	4297	2616	4223	661	3159	3893	4722	3951	1862	685	4172	3561	335	1147	1725	1713	4328
3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	3696_Diagnoses - secondary ICD10: K21 Gastro-esophageal reflux disease	25	335	1	3158	3081	1907	1601	4442	3497	3729	4612	1170	3749	1513	3265	3270	3056	1436	3944	335	2397
3976_Total body BMD (15 or younger)	3976_Total body BMD (15 or younger)	25	336	1	336	1844	4297	3791	2693	4414	1911	2419	2182	3340	2632	1139	1658	3609	4135	3929	3810	1462
148_Body Mass Index (male <= 50 yrs)	148_Body Mass Index (male <= 50 yrs)	25	336	1	721	336	2094	3628	1554	2782	2090	4310	1715	457	4326	2230	4351	2622	3459	4309	2103	4648
1077_Attention deficit hyperactivity disorder	1077_Attention deficit hyperactivity disorder	25	336	1	4629	2609	2837	1430	3465	3258	443	3125	464	336	410	353	1483	820	4257	4259	4433	987
1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1797_RR interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	336	1	1067	849	1764	2983	496	2957	2587	2364	470	2446	713	336	3633	1321	3785	3606	2442	932
4293_Depression	4293_Depression	25	337	1	435	337	3271	3564	4713	3043	1496	2347	1188	3590	1868	2829	4551	4716	4717	2900	800	2749
4196_Hypertension	4196_Hypertension	25	337	1	1348	4191	694	2404	337	694	4109	669	887	864	710	957	2756	3905	1319	2911	1259	1752
1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	1944_Total cerebral brain volume (FBAT, adjusted for multivariable with APOE)	25	337	1	411	3469	3084	2435	1076	957	2003	705	337	3743	2995	4030	1993	1353	4159	3379	3130	3285
599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	599_Peptide::Fibrinogen cleavage peptide::ADSGEGDFXAEGGGVR*	25	338	1	2021	338	1038	1649	3715	575	2712	1321	3700	443	379	512	4087	1098	903	2244	1857	3616
4441_Epstein Barr Virus antigen EA IgG levels	4441_Epstein Barr Virus antigen EA IgG levels	25	338	1	2784	3369	4484	338	3451	3738	3224	2597	2197	853	3984	4733	4445	341	2730	4315	3250	1609
4002_Guilty feelings (GUILT)	4002_Guilty feelings (GUILT)	25	338	1	1886	1417	3435	2534	2708	1413	2638	719	4740	2796	3040	2271	2530	769	2093	1505	4349	338
3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	3069_KLRF1 - Killer cell lectin-like receptor subfamily F member 1	25	339	1	3942	4629	449	2416	4728	339	3246	1375	1271	2799	1059	2706	1161	3128	1732	4734	3903	2293
923_Free cholesterol in medium VLDL	923_Free cholesterol in medium VLDL	25	340	1	1491	3129	2681	340	1098	1501	1096	4525	2537	3827	1722	1064	3334	1292	4689	1165	554	4038
4709_Superior fronto-occipital fasciculus mean diusivities	4709_Superior fronto-occipital fasciculus mean diusivities	25	340	1	4581	4650	4474	4175	589	340	1952	1546	4247	4291	3975	1997	1477	2809	2013	3198	3808	904
4230_Opioids	4230_Opioids	25	340	1	1096	2677	2007	3246	3953	4194	1279	2500	1246	2146	340	1553	2719	3008	1375	1151	1549	859
736_::::X-11845	736_::::X-11845	25	340	1	1953	1102	4598	977	1597	4431	4419	3163	3849	4314	2868	2864	340	3898	1344	3225	3714	4148
3897_Plateletcrit (three-way meta)	3897_Plateletcrit (three-way meta)	25	340	1	3500	2627	918	1814	705	1567	1041	1561	1441	2970	758	3147	4370	2531	340	4711	3832	2341
3202_Job involves shift work	3202_Job involves shift work	25	341	1	3898	1549	341	1657	1360	4679	2507	1232	429	3030	2110	3417	2412	846	4513	4510	2708	2119
915_Phospholipids in medium HDL	915_Phospholipids in medium HDL	25	341	1	2370	1264	3430	2157	2347	2297	341	1010	2494	4404	3029	1439	2873	2569	4367	1978	2504	1013
3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	3094_TNFRSF19 - Tumor necrosis factor receptor superfamily member 19	25	341	1	1014	2406	1568	4356	1341	3437	2015	3796	3558	1913	3905	341	4170	3693	490	843	4367	951
2695_PSMA6 - Proteasome subunit alpha type-6	2695_PSMA6 - Proteasome subunit alpha type-6	25	342	1	342	4369	2011	1384	3860	2449	3243	2896	1612	1830	889	4312	748	745	1626	4069	4700	1811
3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	3116_NR1D1 - Nuclear receptor subfamily 1 group D member 1	25	342	1	1726	2777	1747	1437	342	3163	1102	435	1899	2434	2628	3797	2978	1550	1173	1028	3498	1991
3543_Eye problems/disorders: Cataract	3543_Eye problems/disorders: Cataract	25	342	1	2091	4619	3490	3148	4108	1967	342	1524	1740	2100	3965	2313	3996	597	360	721	3762	1657
4071_Number of sexual partners	4071_Number of sexual partners	25	342	1	1563	409	3042	1760	605	4333	2096	4651	2101	342	2179	3326	3732	4691	2652	2871	1095	3182
1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	1606_Viscosity I (at exam 5, FBAT, adjusted for age and sex)	25	342	1	4299	2108	3595	692	1978	3226	2250	3877	3868	2094	342	4120	1756	4488	4372	4285	4546	2135
1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	1829_Spine Neck BMD (GEE, male, adjusted for multivariable)	25	343	1	343	4211	4448	4485	4540	2993	681	2614	3859	3466	4673	785	2047	473	3019	1192	2226	1433
4455_Left lingual	4455_Left lingual	25	343	1	1409	2509	1942	3508	4376	343	3454	2939	1758	3934	4301	4699	3893	3792	1865	1122	2673	759
3010_MAPK11 - Mitogen-activated protein kinase 11	3010_MAPK11 - Mitogen-activated protein kinase 11	25	343	1	3372	2663	2090	2804	2635	2500	2945	1376	343	1474	4465	799	2416	2328	3265	4359	3765	3727
3487_Bread type: Wholemeal or wholegrain	3487_Bread type: Wholemeal or wholegrain	25	343	1	1239	997	2108	2649	683	4084	2528	3827	1627	343	1520	2571	2312	1258	2740	3968	1483	1163
646_Xenobiotics::Xanthine metabolism::caffeine	646_Xenobiotics::Xanthine metabolism::caffeine	25	343	1	1996	3535	2078	3646	1957	2544	4194	3758	1808	1566	3515	343	1233	3652	2910	4044	4404	3861
149_Body Mass Index (female > 50 yrs)	149_Body Mass Index (female > 50 yrs)	25	343	1	782	1262	877	2813	3167	4231	3974	4237	3403	4656	3743	3128	1678	343	4065	3884	539	4262
2584_CASP3 - Caspase-3	2584_CASP3 - Caspase-3	25	343	1	2259	933	3090	4063	4703	3315	4133	1989	2872	741	4405	2212	1190	347	3355	4691	343	4555
4525_Left hippocampus	4525_Left hippocampus	25	343	1	1192	1967	4553	1557	1447	1302	1871	2193	1907	2203	2529	4583	3666	1889	4586	1315	4384	343
1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	1465_Low-density lipoprotein particle size by NMR (at exam 4, GEE, adjusted for multivariable)	25	344	1	344	3745	2235	1605	3725	3814	699	1098	2894	436	4188	2936	2613	2518	460	3366	1237	2872
3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	3109_CSNK2A1 CSNK2B - Casein kinase II 2-alpha:2-beta heterotetramer	25	344	1	2725	3404	2345	344	2174	3161	1678	2058	4592	2526	2074	1165	908	4421	3439	2089	4685	1816
4118_Zinc sulfate turbidity test	4118_Zinc sulfate turbidity test	25	344	1	1693	2500	409	1906	1435	859	344	608	2136	696	1091	1815	1883	424	921	2489	4550	1857
4667_Sagittal stratum fractional anisotropy	4667_Sagittal stratum fractional anisotropy	25	344	1	3813	3884	968	4225	927	378	1508	1131	3185	4190	3375	4112	1878	344	2154	2694	1283	728
632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	632_Xenobiotics::Food component, Plant::N-(2-furoyl)glycine	25	344	1	1926	4545	2631	1696	2754	3626	2899	2363	2341	3523	1081	763	2407	4285	4529	344	3202	488
4647_Anterior corona radiata fractional anisotropy	4647_Anterior corona radiata fractional anisotropy	25	345	1	3730	2140	2492	345	1591	2757	3151	2293	1992	1995	1267	4656	726	4647	599	1274	2346	894
4561_Left pars opercularis	4561_Left pars opercularis	25	345	1	3280	3630	1471	1385	669	849	4496	345	3966	2826	3632	3936	1564	2060	4699	2725	4221	3575
790_::::X-12696	790_::::X-12696	25	345	1	1634	1037	941	1995	3699	3971	3165	2790	345	4320	2420	1684	1992	2065	3480	4286	3505	647
1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	1311_Fasting HbA1c (at exam 7, GEE, adjusted for age and sex)	25	345	1	3305	3194	1477	570	3042	1139	4092	3613	3944	1613	345	753	1110	4648	2655	3761	4603	2070
1176_Excessive daytime sleepness (male)	1176_Excessive daytime sleepness (male)	25	345	1	4423	2491	2315	4227	4243	1196	3161	2725	2385	1687	368	3763	3249	345	1345	2079	4452	3738
2309_IL17RA - Interleukin-17 receptor A	2309_IL17RA - Interleukin-17 receptor A	25	345	1	1860	3149	2317	4514	2161	3318	801	2569	3753	4743	1707	1296	1380	2038	1396	696	345	1969
4677_Fornix (column and body of fornix) axial diusivities	4677_Fornix (column and body of fornix) axial diusivities	25	345	1	4428	4596	3362	3870	2947	3924	1861	1537	2228	4194	3958	1605	3215	1108	706	1959	1328	345
4689_Sagittal stratum axial diusivities	4689_Sagittal stratum axial diusivities	25	346	1	346	4649	768	1090	4230	2931	3479	1847	4713	4161	4467	2332	2856	4229	1322	950	3318	737
964_Triglycerides in very large VLDL	964_Triglycerides in very large VLDL	25	346	1	2052	3911	1228	346	729	420	2539	4009	2061	2758	3558	418	2516	1329	4293	2206	626	3886
172_Waist circumference (female)	172_Waist circumference (female)	25	346	1	543	4099	1805	3661	2742	4114	838	3079	2446	346	2992	488	2533	2093	1639	3872	2856	3453
4159_Childhood Absence Epilepsy	4159_Childhood Absence Epilepsy	25	346	1	2896	3721	1183	2877	3461	3664	4068	3058	3343	1549	509	896	2107	1477	3291	2923	3434	346
2106_VEGFA - Vascular endothelial growth factor A	2106_VEGFA - Vascular endothelial growth factor A	25	347	1	1439	2611	3139	347	2964	1554	3551	4240	1499	1742	904	3245	851	2691	737	1557	2773	3591
4636_Right caudate	4636_Right caudate	25	347	1	2712	4438	4191	2137	1875	347	1717	1140	3078	4643	1702	4660	3041	4387	4069	2364	3099	2409
2859_C4A C4B - Complement C4	2859_C4A C4B - Complement C4	25	347	1	4404	3273	1706	2124	1876	3259	2971	442	1310	649	2637	4055	347	3633	1990	2867	610	4169
1924_Hippocampal volume (FBAT, adjusted for age and sex)	1924_Hippocampal volume (FBAT, adjusted for age and sex)	25	348	1	1327	348	1357	1693	1622	2868	2685	3406	430	1923	2413	3366	1792	2309	2150	1569	1875	3339
383_Amino acid::Glycine, serine and threonine metabolism::serine	383_Amino acid::Glycine, serine and threonine metabolism::serine	25	348	1	2726	4210	828	479	348	3602	580	2177	962	2433	3187	4113	876	1669	623	2586	388	4434
4321_Neuroticism (univariate)	4321_Neuroticism (univariate)	24	348	1	4271	988	791	392	381	2221	4458	348	4370	3897	3662	2643	1424	2883	1959	3278	3067	1383
2048_Periodontal complex trait 3 - Aa trait	2048_Periodontal complex trait 3 - Aa trait	25	348	1	1579	3915	2704	4032	3650	597	825	826	3106	1730	4168	1669	348	620	904	3410	3688	4720
1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	1001_Macrophage migration inhibitory factor (glycosylation-inhibiting factor)	25	348	1	601	378	3162	2261	2816	2844	2142	4163	1389	1258	1207	3542	3531	1604	1471	348	3594	1259
1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	1515_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 2, GEE, adjusted for age and sex)	24	348	1	1203	979	1379	545	3006	2392	1785	4250	1664	3965	4401	2016	2552	1340	4341	747	4477	348
2358_IL2 - Interleukin-2	2358_IL2 - Interleukin-2	25	349	1	4261	714	3267	2049	1986	349	4398	3910	394	4584	4596	3139	460	4099	1891	756	3066	3448
2809_DCTPP1 - dCTP pyrophosphatase 1	2809_DCTPP1 - dCTP pyrophosphatase 1	25	349	1	1028	4072	4429	3553	3830	1714	4175	662	349	3711	4504	1641	4191	3039	4199	4006	4568	3684
3999_Worry too long after embarrassment (WORR-EMB)	3999_Worry too long after embarrassment (WORR-EMB)	25	349	1	3078	3877	4209	3642	2471	937	3782	3447	1469	646	3740	3079	2872	4459	349	3227	2276	3711
3520_Current employment status: Retired	3520_Current employment status: Retired	25	349	1	3289	1404	2031	414	3821	1279	1957	2780	400	466	1217	356	2506	2421	1294	2665	349	808
4614_CSF	4614_CSF	25	349	1	4572	4018	1149	1195	3873	513	2880	1813	1177	4620	960	357	1223	2885	2187	2445	4253	349
4076_Body Mass Index (female)	4076_Body Mass Index (female)	25	350	1	3329	3746	894	3901	350	4205	2486	2875	4650	2786	3543	3522	4697	2201	1443	2800	4136	3273
2043_Bipolar disorder	2043_Bipolar disorder	25	350	1	1252	1539	2440	3831	4529	1051	1546	350	2819	3660	4342	3958	3936	4039	3173	2709	3733	4067
678_::::X-09108	678_::::X-09108	25	350	1	4358	377	2027	827	674	1685	3805	1555	350	605	1481	2206	1801	1985	4642	4576	4704	1123
3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	3661_Cancer register - Histology of cancer tumour: Adenocarcinoma, NOS	25	350	1	1800	4562	4142	4539	852	2933	945	501	499	591	1478	4047	350	443	3070	2395	1356	3390
3855_Mean platelet volume (two-way meta)	3855_Mean platelet volume (two-way meta)	25	350	1	3088	2209	2202	1351	4097	385	3840	1311	4560	3083	1438	1384	3058	4655	350	4053	1690	939
647_Xenobiotics::Xanthine metabolism::paraxanthine	647_Xenobiotics::Xanthine metabolism::paraxanthine	25	350	1	4436	680	1988	2200	646	1238	2929	1897	1654	2425	517	3975	1820	457	4278	1132	350	2355
2802_NAPA - Alpha-soluble NSF attachment protein	2802_NAPA - Alpha-soluble NSF attachment protein	25	351	1	3755	2439	861	1294	351	1242	1101	4561	3823	3323	2034	3696	3157	4094	4438	4244	4076	2035
755_::::X-12094	755_::::X-12094	25	351	1	2587	3352	2288	4114	855	351	4122	1569	1891	2173	3614	4032	2758	1971	1218	1213	1155	4016
2525_IL15RA - Interleukin-15 receptor subunit alpha	2525_IL15RA - Interleukin-15 receptor subunit alpha	25	351	1	1571	2948	444	1442	1482	4280	4532	351	2515	1126	2999	1920	896	2001	2527	2167	1577	4673
1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1380_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	351	1	3570	3510	3196	2194	3729	3173	4616	2356	351	1246	2471	867	3873	3131	4103	4168	1145	3820
3839_Eosinophil percentage of white cells (two-way meta)	3839_Eosinophil percentage of white cells (two-way meta)	25	351	1	754	3317	4302	1097	1190	1951	1319	2436	1684	2466	2567	2567	1896	940	351	1105	3885	3065
4717_Cingulum (cingulate gyrus) mode of anisotropy	4717_Cingulum (cingulate gyrus) mode of anisotropy	25	351	1	653	394	1499	3413	2542	3910	2098	2406	2668	1644	778	3034	2023	1412	446	351	1060	4588
3559_Medication for pain relief, constipation, heartburn: Paracetamol	3559_Medication for pain relief, constipation, heartburn: Paracetamol	25	351	1	2657	3193	3623	2675	4590	2015	3133	4139	2740	2996	2626	2243	2558	1820	2559	4596	3405	351
1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	1668_Aspartate aminotransferase (at exam 2, FBAT, adjusted for multivariable)	25	352	1	3660	3013	448	4454	4643	1456	3657	4580	3359	3839	352	3824	3473	2500	3604	4099	4718	1828
311_CD4nv:%R6+R4-	311_CD4nv:%R6+R4-	25	352	1	2573	4008	985	3613	3128	1265	2502	3565	1517	2979	4338	352	1589	1925	2879	2044	1346	2688
2617_KDR - Vascular endothelial growth factor receptor 2	2617_KDR - Vascular endothelial growth factor receptor 2	25	352	1	3371	3569	3996	3374	3397	4308	557	1720	3857	464	2381	3881	352	2851	3975	2187	1996	3847
4403_Menstruation quality of life impact: Loss of concentration	4403_Menstruation quality of life impact: Loss of concentration	25	352	1	2212	420	1037	1063	869	3241	4639	1672	2876	3616	2882	1573	2133	3979	352	4344	1126	4436
1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	1657_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for multivariable)	25	352	1	851	3254	1168	2244	1476	4662	4285	2099	412	2328	746	4038	2634	486	3200	352	4458	2227
2939_F10 - Coagulation Factor X	2939_F10 - Coagulation Factor X	25	352	1	1921	893	2352	3578	2849	3421	401	1600	3404	3680	2855	961	2899	3269	2455	461	4741	352
2660_DMP1 - Dentin matrix acidic phosphoprotein 1	2660_DMP1 - Dentin matrix acidic phosphoprotein 1	25	353	1	918	756	3748	353	1866	4707	3807	964	4478	3028	3824	3145	1206	1751	2424	3192	854	4490
2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	2422_WFIKKN2 - WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2	25	353	1	1184	1867	504	1714	690	3240	353	3653	874	1809	3320	1522	3878	3323	2644	4530	3397	3907
2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	2270_TNFSF11 - Tumor necrosis factor ligand superfamily member 11	25	353	1	2304	4546	1540	2359	701	3873	1677	3361	353	3835	3085	2166	2171	1844	4007	1768	2270	1458
2262_CTF1 - Cardiotrophin-1	2262_CTF1 - Cardiotrophin-1	25	353	1	4095	3463	3576	1317	4239	2357	457	1787	4286	353	2209	1106	3020	2921	716	4679	2611	1219
3431_Fluid intelligence test - Fluid intelligence score	3431_Fluid intelligence test - Fluid intelligence score	25	353	1	4058	2343	4024	4438	2418	986	3812	983	2665	2320	353	2658	2237	971	4136	601	382	3035
435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	435_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::erythrose	25	353	1	836	4592	757	2071	3771	788	2384	2563	3087	4059	3821	3092	1061	353	3196	498	2594	2131
3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	3723_Frequency of needing morning drink of alcohol after heavy drinking session in last year	25	354	1	4136	354	2971	3303	1366	683	3058	3057	4287	390	4045	4062	2966	2270	3612	4647	1983	2383
4622_Left thalamus proper	4622_Left thalamus proper	25	354	1	4263	2004	720	4142	354	2691	1562	730	2083	686	3158	1970	3236	2193	739	2657	4453	1287
3142_F2 - Prothrombin	3142_F2 - Prothrombin	25	354	1	755	3749	1315	4620	621	354	998	3870	2247	1504	3413	1771	4543	1278	2380	3103	4539	2717
3133_CALR - Calreticulin	3133_CALR - Calreticulin	25	354	1	4082	897	3093	4341	3863	431	1970	2625	354	540	2067	1427	3859	2335	2839	366	3262	4151
4084_Type 2 Diabetes (adjusted for BMI)	4084_Type 2 Diabetes (adjusted for BMI)	25	354	1	2943	795	568	383	1839	2959	2938	2815	2820	2779	1375	2320	354	870	2139	1027	1487	3424
1297_Adiponectin (GEE, adjusted for age and sex)	1297_Adiponectin (GEE, adjusted for age and sex)	25	354	1	1508	1876	1285	1882	2688	1385	4607	3054	869	3416	2830	3308	1469	354	3549	3868	3169	3908
1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	1728_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for multivariable)	25	355	1	355	2292	4127	1542	2649	4019	2219	359	3482	4467	3427	3369	2532	3208	4052	1296	3813	3831
667_::::X-06226	667_::::X-06226	25	355	1	3178	2878	1618	355	2919	4243	3695	1531	2490	1385	577	564	701	4242	4182	2170	3758	4114
3325_Relative age voice broke (male)	3325_Relative age voice broke (male)	25	355	1	817	3235	2395	4183	454	355	2650	3729	3538	1423	751	1895	2146	619	4660	495	726	979
3480_Milk type used: Full cream	3480_Milk type used: Full cream	25	355	1	4020	2172	2190	938	868	3448	3478	4696	355	2988	4239	1032	2701	2586	3010	2131	2406	2485
2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	2107_TNFRSF9 - Tumor necrosis factor receptor superfamily member 9	25	356	1	1091	3925	356	3077	4101	3769	784	1449	4212	4289	4617	4334	2274	1128	4356	1287	974	2159
4447_Left cuneus	4447_Left cuneus	25	356	1	510	1715	2491	356	2969	944	363	500	941	2219	4173	3554	425	1272	3816	2655	759	3127
1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	1748_Urinary albumin excertion (at exam 6, FBAT, adjusted for multivariable)	25	356	1	1103	3288	2210	580	2031	1114	3859	4694	1761	1853	3823	778	1985	3711	356	1170	1119	3741
1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	1939_Hippocampal volume (GEE, adjusted for multivariable with APOE)	25	357	1	937	1170	371	357	3994	1984	2605	3091	1098	2085	3622	2510	2370	3658	4062	4515	2354	2115
1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1248_Percent predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	357	1	2924	2162	1169	2467	357	4403	4382	930	3873	2566	2099	4408	3348	2801	1180	3888	2471	3974
2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	2240_RPS27A - Ubiquitin+1, truncated mutation for UbB	25	357	1	2365	965	1846	1791	2930	3394	357	2040	1249	2733	753	895	2258	4536	2031	823	1613	695
1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	1326_Fasting insulin (at exam 5, FBAT, adjusted for age, sex and BMI)	25	358	1	2389	450	2713	1668	358	4222	703	587	382	1139	3297	2046	852	2537	748	1464	4618	3874
211_Insomnia (male)	211_Insomnia (male)	25	358	1	1051	1589	4565	4099	2001	1423	358	4275	1710	1257	2237	2579	3547	1150	1379	2749	3168	3198
201_Estimated glomerular filtration rate based on serum creatinine	201_Estimated glomerular filtration rate based on serum creatinine	25	358	1	658	3584	4350	3173	3145	3727	2988	358	3214	4446	1275	4420	4648	4505	2551	4525	678	3521
2033_Cluster headache	2033_Cluster headache	25	358	1	3283	2987	2614	3949	2694	1927	819	2685	2141	358	1110	779	4719	2630	593	1897	603	1922
942_Concentration of small VLDL particles	942_Concentration of small VLDL particles	25	359	1	1682	2857	2807	359	2351	1433	1849	4610	1979	3488	2000	813	3395	1097	4391	654	522	4570
4618_Left lateral ventricle	4618_Left lateral ventricle	25	359	1	1828	3104	4607	1963	359	3838	744	2472	4450	1160	3908	4691	4724	3970	4073	1812	2900	844
2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	2634_CDKN1B - Cyclin-dependent kinase inhibitor 1B	25	359	1	2554	2985	1539	3559	2104	359	4446	362	664	4012	4574	3479	1066	2326	3227	2769	1977	2576
2229_KLK11 - Kallikrein-11	2229_KLK11 - Kallikrein-11	25	359	1	2363	3166	2514	3196	3642	1298	1630	1630	359	998	2295	2487	1156	3857	1576	1874	3132	1820
2784_LIN7B - Protein lin-7 homolog B	2784_LIN7B - Protein lin-7 homolog B	25	359	1	4378	1895	3316	1957	4116	1564	3088	2853	4137	4606	359	1520	2881	1489	2049	2136	1792	3545
524_Lipid::Long chain fatty acid::oleate (18:1n9)	524_Lipid::Long chain fatty acid::oleate (18:1n9)	25	359	1	2707	1894	1279	1573	3235	409	2907	3100	4543	2120	2939	545	3084	362	4429	745	359	1860
3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	3104_NMT1 - Glycylpeptide N-tetradecanoyltransferase 1	25	360	1	360	4511	1686	3489	1971	4664	2091	3623	3451	2827	3523	3204	1829	474	3641	2621	674	3144
3060_IL7R - Interleukin-7 receptor subunit alpha	3060_IL7R - Interleukin-7 receptor subunit alpha	25	360	1	4284	4431	1079	2805	4486	2128	3347	360	1806	3625	3209	2504	819	4251	4501	4422	4331	1374
4000_Suffer from 'nerves' (SUF-NERV)	4000_Suffer from 'nerves' (SUF-NERV)	25	361	1	1792	361	4600	2912	2583	1679	4071	910	513	2249	2456	4093	4473	4245	2261	4565	3178	3694
2628_ALB - Serum albumin	2628_ALB - Serum albumin	25	361	1	4107	1321	2942	2808	3037	1367	3119	361	2030	1718	866	1917	4408	450	3138	2728	1893	2556
371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	371_Amino acid::Cysteine, methionine, SAM, taurine metabolism::2-hydroxybutyrate (AHB)	25	362	1	2123	4348	4540	362	2474	3167	4214	3532	2982	4438	2128	3674	406	3800	4464	3859	954	1762
117_Extreme Body Mass Index	117_Extreme Body Mass Index	25	362	1	1204	823	1950	3100	1084	3549	4699	2188	1139	3573	2599	3093	362	440	4612	4429	1564	4223
3654_Smoking status: Never	3654_Smoking status: Never	25	362	1	2431	748	3409	3012	4737	4230	2852	1306	3886	397	2771	4626	2918	3006	362	1253	1115	1079
4288_FEV1/FVC ratio	4288_FEV1/FVC ratio	25	363	1	3874	3450	1143	3220	3535	363	2737	4081	726	4259	2849	4265	3932	3243	4216	1039	3361	3077
1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	1020_Neck Cross-Sectional Moment of Inertia (FBAT, adjusted for age and sex)	25	363	1	1057	2983	1136	2882	3158	4002	1360	3002	4508	1473	363	3297	4177	2721	2908	2793	3622	3835
2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	2506_BMX - Cytoplasmic tyrosine-protein kinase BMX	25	364	1	364	4035	424	2836	3472	3556	2794	2230	2760	895	2189	2312	3313	4565	1682	833	3814	4589
4048_Plantar fasciitis	4048_Plantar fasciitis	25	364	1	2127	2749	4438	2362	364	1308	4684	950	3588	2394	2899	4024	3171	4219	3410	989	4289	738
1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	1536_Ankle-brachial index (at exam 7, FBAT, adjusted for multivariable)	25	364	1	1905	4411	3446	2347	1579	364	4412	3224	3191	3490	2017	1677	2739	2379	569	4021	4423	2538
598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	598_Peptide::Fibrinogen cleavage peptide::ADpSGEGDFXAEGGGVR*	25	364	1	3169	4336	3372	3491	2022	1653	4328	364	2747	2740	3775	3784	4154	1964	4108	3714	1767	3098
1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	1276_Sabuctaneous fat by CT (FBAT, adjusted for age and sex)	25	364	1	1100	1939	476	3695	3759	2003	766	1023	1379	3432	364	2465	3973	578	2902	1078	432	2793
2451_LRP8 - Low-density lipoprotein receptor-related protein 8	2451_LRP8 - Low-density lipoprotein receptor-related protein 8	25	364	1	1363	515	799	3038	2213	2663	2271	4526	802	1317	3026	2511	1651	364	4096	2181	2366	3217
4527_Left accumbens area	4527_Left accumbens area	25	364	1	1892	1305	2628	2552	3329	3162	2441	4315	1273	988	2033	1628	1701	2139	3342	4627	364	2581
2505_BCL2A1 - Bcl-2-related protein A1	2505_BCL2A1 - Bcl-2-related protein A1	25	365	1	365	2786	2022	2008	1985	1054	2994	943	2544	3845	3661	4245	4236	3840	1450	4660	2968	3079
1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	1693_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for multivariable)	25	365	1	4235	3452	1927	365	2469	3942	678	2959	509	2911	2391	948	4247	2277	2055	1597	383	1431
2946_C3 - C3a anaphylatoxin	2946_C3 - C3a anaphylatoxin	25	365	1	840	786	3300	2506	1417	2997	365	2195	4069	2366	4003	2310	448	3255	1863	1972	2340	4061
2477_CHRDL1 - Chordin-like protein 1	2477_CHRDL1 - Chordin-like protein 1	25	365	1	2839	3988	4625	4069	2876	2966	3748	3209	2553	2240	2986	4149	3449	4286	1929	365	377	945
2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	2165_TNFRSF13B - Tumor necrosis factor receptor superfamily member 13B	25	365	1	3819	4238	2555	3506	2611	4457	3901	3304	545	4306	3448	4509	2294	4721	3326	4551	1781	365
4586_Right lateral orbitofrontal	4586_Right lateral orbitofrontal	25	366	1	2413	2459	2373	1035	366	700	2902	4567	4307	2809	3579	2280	3976	2323	3572	984	3669	720
1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1793_RR interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	366	1	4657	387	3277	3988	1040	366	2270	3379	2118	3925	3425	2152	1907	3372	1486	4725	2991	1186
4497_Right precentral	4497_Right precentral	25	366	1	1391	2576	1390	4039	1102	2796	2365	438	366	3065	3574	2266	3854	432	603	903	1992	1793
565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	565_Lipid::Monoacylglycerol::1-stearoylglycerol (1-monostearin)	25	366	1	2098	4551	3194	3556	1128	2836	1843	382	1801	3896	366	3969	2541	4447	462	3933	3000	2153
4011_Broad depression	4011_Broad depression	25	366	1	1988	1753	4260	3521	2417	4529	561	2892	3241	4660	644	473	3511	2320	3921	1699	2091	366
2753_PLG - Plasminogen	2753_PLG - Plasminogen	25	367	1	2339	2377	367	2618	2307	4659	794	2543	1237	2964	1192	4222	3812	3565	4163	1752	2438	2606
909_Leucine	909_Leucine	25	367	1	503	2302	1774	4343	467	4382	367	2354	1771	3367	3072	2554	579	2737	3976	1386	1528	432
4563_Left pars triangularis	4563_Left pars triangularis	25	367	1	2741	4593	2960	2541	1872	3920	3284	2973	2557	3701	1899	1157	367	469	4683	2261	1403	819
591_Peptide::Dipeptide::aspartylphenylalanine	591_Peptide::Dipeptide::aspartylphenylalanine	25	367	1	1546	1374	1810	1949	912	4386	2077	1495	2215	3308	2089	4675	4625	367	2540	4477	932	1492
4728_Retrolenticular part of internal capsule mode of anisotropy	4728_Retrolenticular part of internal capsule mode of anisotropy	25	367	1	4632	4193	1410	2999	984	3272	452	4128	1952	4585	1421	4390	4266	2819	3794	4722	3678	367
4437_Herpes simplex virus 2 IgG levels	4437_Herpes simplex virus 2 IgG levels	25	368	1	368	2254	3898	2238	4008	4260	3854	3988	4076	896	2207	3909	1300	791	2332	887	584	4207
3048_DSG2 - Desmoglein-2	3048_DSG2 - Desmoglein-2	25	368	1	2674	1130	4066	368	1294	2686	2952	3912	850	1279	4322	694	2005	873	1731	2986	2256	1231
3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	3706_Diagnoses - secondary ICD10: Z53 Persons encntr hlth serv for spec proc & trtmt, not crd out	25	368	1	3054	4141	2618	3463	3193	368	584	505	3113	2361	3417	1738	1572	2287	1038	1188	2043	2918
1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	1624_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for multivariable)	25	368	1	1646	3408	2851	1628	3434	3214	2935	2743	992	3023	2597	368	2764	4692	3602	2848	3847	3821
2246_MAPK3 - Mitogen-activated protein kinase 3	2246_MAPK3 - Mitogen-activated protein kinase 3	25	368	1	1033	3990	1848	1210	2304	763	414	2163	1770	3811	3600	3316	2716	4693	2848	368	3766	760
2101_CCL2 - C-C motif chemokine 2	2101_CCL2 - C-C motif chemokine 2	25	369	1	4117	369	1644	3617	543	2510	1726	2863	2336	1614	3275	438	1692	3288	3297	2428	4272	2085
1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	1597_Platelet aggregation to collagen (at exam 5, GEE, adjusted for multivariable)	25	369	1	2034	4641	3131	369	1905	1549	684	4485	1987	1941	3973	1201	2246	422	866	2768	1900	1872
447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	447_Cofactors and vitamins::Ascorbate and aldarate metabolism::ascorbate (Vitamin C)	25	369	1	1169	4585	2122	3765	369	4018	3835	4522	4042	2823	4719	3466	3165	1768	3086	2669	3564	1524
672_::::X-06351	672_::::X-06351	25	369	1	2516	4227	2064	2853	4309	369	3609	1751	1863	2864	1147	2214	4397	4477	563	4478	2725	2534
1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	1520_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 5, FBAT, adjusted for age and sex)	25	369	1	1109	2370	4231	1298	588	1314	2991	4505	1709	369	4470	4667	927	3630	1110	2198	823	574
2231_KLK8 - Kallikrein-8	2231_KLK8 - Kallikrein-8	25	369	1	3112	3496	2570	1713	2401	1493	4569	2342	1027	3541	2253	369	4248	4637	2249	2555	2749	962
2862_IL3RA - Interleukin-3 receptor subunit alpha	2862_IL3RA - Interleukin-3 receptor subunit alpha	25	370	1	1183	3705	688	4525	537	2795	731	370	4387	3543	3474	4180	3410	4555	3370	4132	2901	3827
1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	1277_Sabuctaneous fat by CT (GEE, adjusted for age and sex)	25	370	1	1780	1089	3373	1266	3724	1863	4362	3797	370	1805	432	1474	587	1227	4167	4641	601	2557
1096_Pulse pressure	1096_Pulse pressure	25	370	1	2243	509	4519	1699	2965	1563	2592	615	2891	1170	3405	550	3230	370	2637	3033	4595	436
751_::::X-12056	751_::::X-12056	25	370	1	4309	2561	1156	4026	4138	1529	964	3745	2242	922	1794	3569	1314	530	3189	2462	370	2951
2435_CNTN4 - Contactin-4	2435_CNTN4 - Contactin-4	25	371	1	4029	492	4558	3882	371	4073	3775	2877	2208	1084	3961	2809	4374	2947	4672	3090	2361	3910
1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1785_PR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	371	1	2132	1663	1096	1869	3521	3367	4729	3167	2618	4335	371	1777	2639	1039	3782	1096	2364	1976
3562_Vitamin and mineral supplements: Vitamin B	3562_Vitamin and mineral supplements: Vitamin B	25	371	1	3144	3811	2667	3906	4151	4525	3721	4555	3930	1409	740	2282	1826	4443	371	2853	2308	2507
453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	453_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::biliverdin	25	371	1	3776	1857	1293	2276	3628	3985	4406	1235	3586	523	4066	3158	3503	2591	3535	371	4579	2272
4083_Type 2 Diabetes	4083_Type 2 Diabetes	25	371	1	3675	1136	436	3668	3669	4147	2470	1782	2628	4299	4172	3830	952	2219	2642	3429	371	568
3298_Frequency of unenthusiasm / disinterest in last 2 weeks	3298_Frequency of unenthusiasm / disinterest in last 2 weeks	25	372	1	3591	372	3845	4738	3319	4275	3882	2857	4071	2134	2565	3899	3429	2672	2345	4174	3043	1942
1971_MMSE score (at exam 7, GEE, adjusted for age)	1971_MMSE score (at exam 7, GEE, adjusted for age)	25	372	1	1642	4108	372	1795	2105	3865	3320	1514	2073	1598	4686	3681	3352	673	2107	1574	3045	1538
3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	3068_KIR3DS1 - Killer cell immunoglobulin-like receptor 3DS1	25	372	1	3343	1524	2950	4661	2634	4295	3839	372	1712	4218	2590	388	4533	3081	909	884	2830	3710
3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	3128_PDE5A - cGMP-specific 3',5'-cyclic phosphodiesterase	25	372	1	3173	1334	725	3653	1004	2583	1657	3576	372	527	1410	1825	396	4212	972	4398	1854	2902
1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	1844_Neck Section Modulus (FBAT, male, adjusted for multivariable)	25	372	1	1857	925	2503	4524	614	1832	2909	3642	3234	971	372	3772	3533	2452	2314	3659	2675	4093
3173_ALCAM - CD166 antigen	3173_ALCAM - CD166 antigen	25	372	1	2319	1585	4278	3154	772	2332	2789	1401	3245	2721	614	1251	372	1734	372	1219	1292	3219
794_::::X-12719	794_::::X-12719	25	372	1	3744	3011	1460	2251	3925	3220	3205	3062	1122	3571	1765	2770	1073	372	1587	1143	1457	790
911_Cholesterol esters in medium HDL	911_Cholesterol esters in medium HDL	25	372	1	436	1823	1562	2419	4053	2724	1371	3152	4399	3496	1927	3017	3710	3439	1946	4517	372	3450
3873_Sum eosinophil basophil count (three-way meta)	3873_Sum eosinophil basophil count (three-way meta)	25	373	1	373	4428	1111	3358	3077	3790	1218	3945	3633	3327	2167	4575	625	4060	2906	2910	4108	935
220_T:%Vd1	220_T:%Vd1	25	373	1	696	1795	1608	1909	950	4105	373	4453	1137	924	4548	4693	3776	3167	2585	1775	1935	2045
1142_Sleep duration	1142_Sleep duration	25	373	1	4329	418	3254	3000	3182	2344	3612	3294	1102	4693	2305	555	2548	2072	3075	1914	373	3662
63_Age at menarche	63_Age at menarche	25	373	1	3817	1332	432	3602	4279	1097	4438	3768	2429	3310	1877	529	2168	1171	3954	1613	1069	373
4702_Inferior fronto-occipital fasciculus mean diusivities	4702_Inferior fronto-occipital fasciculus mean diusivities	25	374	1	3440	3607	374	2582	716	1959	856	3567	4416	1962	3950	3207	1539	2491	1874	3678	4126	1678
670_::::X-06307	670_::::X-06307	25	374	1	3859	602	2120	4346	2045	2936	374	1541	1831	1921	2594	2242	1753	2041	1462	1093	2148	2640
828_::::X-13741	828_::::X-13741	25	375	1	2976	375	801	3371	4561	1393	2185	423	3244	3881	4468	1270	1015	3757	4657	3666	683	2336
3810_Eosinphil count	3810_Eosinphil count	25	375	1	4198	1409	1444	1903	375	4480	1972	1912	3613	2785	3022	4458	3378	2115	4252	1930	4335	2463
3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	3176_PRKCB - Protein kinase C beta type (splice variant beta-II)	25	375	1	3843	2332	1571	3161	4185	1218	375	3652	432	1259	4068	4634	2351	2992	1528	3894	3917	921
3419_Pairs matching test - Number of correct matches in round	3419_Pairs matching test - Number of correct matches in round	25	375	1	2759	3881	1968	1229	2730	2266	1612	1670	2641	1428	4679	375	2207	3059	1812	4406	541	1451
1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	1492_Remnant lipoprotein triglycerides (at exam 4, FBAT, adjusted for age and sex)	25	375	1	760	4021	2280	3806	2984	1028	2154	2630	3278	2698	1730	2958	3683	375	2470	2239	2950	3003
3788_Insomnia (female)	3788_Insomnia (female)	25	376	1	376	1466	1585	3924	430	2611	1355	1606	4097	3040	3112	494	3277	3241	845	4228	3526	2398
3759_Anxiety - Reccent feelings or nervousness or anxiety	3759_Anxiety - Reccent feelings or nervousness or anxiety	25	376	1	508	376	851	1142	3614	3204	3641	1927	2681	1050	1713	776	1683	4466	4590	3637	643	1364
4208_Blood urea nitrogen	4208_Blood urea nitrogen	25	376	1	454	1648	652	2941	1057	4619	4158	1756	376	2789	4438	1889	2371	1654	3605	2841	1402	3870
782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	782_Amino acid::Amino fatty acid::X-12510--2-aminooctanoic acid	25	376	1	521	1506	3431	3049	4512	2305	711	2724	1268	376	558	1973	4333	983	1176	2482	1084	2751
4068_Automobile speeding propensity	4068_Automobile speeding propensity	25	376	1	3676	3735	4405	1383	931	995	4392	2570	849	3223	4136	376	3974	3130	3272	4169	1068	965
4666_Superior longitudinal fasciculus fractional anisotropy	4666_Superior longitudinal fasciculus fractional anisotropy	25	376	1	505	3980	3749	539	2843	809	3485	1974	525	3427	2759	2877	376	1020	4671	4742	4513	418
1604_tPA (at exam 5, FBAT, adjusted for multivariable)	1604_tPA (at exam 5, FBAT, adjusted for multivariable)	25	377	1	377	724	1328	4164	813	3491	423	4047	1434	2555	1802	2795	2226	3327	3444	2479	2542	1598
3339_Age when periods started (menarche) (female)	3339_Age when periods started (menarche) (female)	25	377	1	4177	1431	377	4710	1372	582	3278	2025	2370	3898	2987	480	3010	3137	2561	2590	3604	1375
921_Total cholesterol in medium VLDL	921_Total cholesterol in medium VLDL	25	377	1	1723	2976	2572	377	1719	1473	1765	4658	2246	3519	1744	998	3439	1152	4394	679	510	4063
1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	1509_Triglycerides (at exam 6, GEE, adjusted for age and sex)	25	378	1	378	2880	4105	1208	2200	1080	1456	4214	2788	2428	4427	911	3121	4711	2325	4408	785	1487
847_::::X-14745	847_::::X-14745	25	378	1	2529	3378	3586	2974	378	3777	4207	2879	4481	2238	4558	1142	4144	4238	4166	1512	2662	1871
2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	2797_PEBP1 - Phosphatidylethanolamine-binding protein 1	25	378	1	1497	3729	2599	3618	1276	1118	378	3984	2195	2026	860	4710	3929	2045	3740	2644	4422	956
1009_Stromal cell-derived factor-1 alpha (CXCL12)	1009_Stromal cell-derived factor-1 alpha (CXCL12)	25	378	1	1885	2593	1412	3456	4648	2920	917	378	3637	2212	4584	4231	4591	3819	1931	4520	2660	1026
1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	1479_Mean high-density lipoprotein cholesterol from exam 1-7 (GEE, adjusted for age and sex)	25	378	1	3600	3897	3318	1534	4131	4687	1264	2949	828	378	3516	2991	4736	3636	4342	4739	814	4743
1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	1726_Change in serum creatinine from exam 2 to 7 (FBAT, adjusted for age and sex)	25	378	1	3080	3546	4117	850	641	4721	1930	2303	1167	4517	378	2764	1624	3276	4326	1810	2855	2603
2917_GSN - Gelsolin	2917_GSN - Gelsolin	25	378	1	3498	2444	1434	4653	1354	3475	4427	2335	2218	3282	3880	1776	3697	3491	378	1658	2218	3183
3817_CD56+ NK cell level	3817_CD56+ NK cell level	25	378	1	1572	1870	1268	903	3547	2272	890	3376	4168	1852	3690	3112	1444	3482	4541	1189	378	3841
4073_General risk tolerance	4073_General risk tolerance	25	379	1	379	4102	3142	3507	4067	3417	2115	3858	4119	3318	1645	2048	3614	1953	3763	4245	1485	2925
3724_Frequency of inability to cease drinking in last year	3724_Frequency of inability to cease drinking in last year	25	379	1	4087	2685	379	1691	4204	3402	4276	842	1575	2400	2808	4558	1960	3936	1386	1796	3864	3261
2227_SPINT1 - Kunitz-type protease inhibitor 1	2227_SPINT1 - Kunitz-type protease inhibitor 1	25	379	1	2876	1817	3779	3275	4662	379	1123	840	4657	1744	4240	3487	1933	4462	705	1103	3901	2564
3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	3055_IL1RAPL2 - X-linked interleukin-1 receptor accessory protein-like 2	25	379	1	571	4245	455	2852	4555	3944	379	1447	1370	1463	875	3994	4263	3705	2286	2050	1718	3205
4529_Left vessel	4529_Left vessel	25	379	1	3476	4638	2478	4494	2027	3022	2394	2024	379	1173	3302	1213	2123	2174	885	2142	1384	2016
3406_Fluid intelligence test - FI8 : chained arithmetic	3406_Fluid intelligence test - FI8 : chained arithmetic	25	379	1	802	2617	3123	4124	4404	728	1737	2943	2659	3909	842	1026	379	2669	2578	1634	3775	1275
443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	443_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::lactate	25	380	1	459	380	4000	589	962	1207	4606	546	934	447	2648	3840	1152	4271	3310	1997	2512	2600
4675_Corticospinal tract axial diusivities	4675_Corticospinal tract axial diusivities	25	380	1	3746	788	2834	3968	380	3885	3185	3472	990	3288	2682	4100	3707	1896	3165	1148	2895	3956
2156_IGFBP5 - Insulin-like growth factor-binding protein 5	2156_IGFBP5 - Insulin-like growth factor-binding protein 5	25	380	1	4252	1600	2417	777	1996	2259	380	2166	1169	736	1134	1719	3218	2097	670	1593	3861	1765
2724_SNX4 - Sorting nexin-4	2724_SNX4 - Sorting nexin-4	25	380	1	2062	2050	3506	3887	3835	3883	1224	380	3933	2196	2916	3371	4731	1999	2888	2001	2801	1722
2396_CNDP2 - Cytosolic non-specific dipeptidase	2396_CNDP2 - Cytosolic non-specific dipeptidase	25	380	1	1875	2139	3752	1194	3935	3070	2632	3413	1308	1989	4490	4512	380	1059	4179	3373	4676	2906
3619_Treatment/medication code: ibuprofen	3619_Treatment/medication code: ibuprofen	25	380	1	1744	3443	3843	3826	1698	4543	4380	574	1995	1623	1347	3313	4647	3319	380	3570	2582	4708
4213_Glycine level (female)	4213_Glycine level (female)	25	380	1	4026	3509	824	1919	1527	2467	1535	4569	4146	3761	4370	835	3652	4446	3597	2204	380	3257
1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	1975_Morbidity-free survival (at age 65, GEE, adjusted for birth-cohort)	25	381	1	3497	1339	1373	499	4335	381	1555	1365	1671	4502	865	2736	2795	2648	2738	811	4664	1363
872_Glutamine	872_Glutamine	25	381	1	3375	3495	2065	818	3015	3446	381	1398	4005	1993	1097	4721	3534	4340	1794	3658	1361	4444
2744_IL7 - Interleukin-7	2744_IL7 - Interleukin-7	25	381	1	4471	1254	2095	3274	4736	4597	671	1571	738	3704	2614	381	2939	1054	3279	537	4460	2099
2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	2900_ADCYAP1 - Pituitary adenylate cyclase-activating polypeptide 38	25	381	1	2344	2165	1635	3356	3814	3665	986	3241	1492	2293	604	559	1251	1453	3151	381	1942	3980
4490_Right paracentral	4490_Right paracentral	25	381	1	2672	3425	3352	2630	3157	2984	2451	1464	3985	2561	3530	1561	4327	4741	1933	1326	381	3042
4228_Anti-inflammatory and antirheumatic products, non-steroids	4228_Anti-inflammatory and antirheumatic products, non-steroids	25	382	1	2837	2952	4457	3855	3148	382	3582	1049	4668	3119	2204	3063	1008	3774	3898	3945	1333	1131
3462_Impedance measures - Arm fat-free mass (right)	3462_Impedance measures - Arm fat-free mass (right)	25	382	2	1662	2271	3413	2017	4665	550	2019	2793	4721	4364	1034	2325	1363	382	2995	775	1251	2589
3321_Ever had bowel cancer screening	3321_Ever had bowel cancer screening	25	382	1	3649	3122	4135	2030	546	3184	3210	4097	3120	1109	1892	2674	1793	3964	2632	382	4123	831
3764_Depression - Recent poor appetite or overeting	3764_Depression - Recent poor appetite or overeting	25	383	1	383	4206	748	1331	2789	1121	4115	1620	1133	2918	2733	1114	4340	4071	4310	1128	4348	671
2921_LPO - Lactoperoxidase	2921_LPO - Lactoperoxidase	25	383	1	422	383	4382	1740	678	786	759	2930	2754	1521	2492	4663	2565	4345	3945	4418	2592	3280
3385_Happiness	3385_Happiness	25	383	1	3808	4654	383	3571	431	2688	4538	2068	2800	2520	781	3197	3991	1090	699	2804	3451	4189
4517_Left lateral ventricle	4517_Left lateral ventricle	25	383	1	1814	3831	4241	3473	712	3574	383	2503	4088	1501	4269	4496	4436	3822	2870	1499	2460	1145
4432_Rubella IgG levels	4432_Rubella IgG levels	25	383	1	1586	4188	1844	4479	1718	3658	3130	1938	383	4571	952	1302	622	1685	2913	4313	1581	2682
214_NK:%Term	214_NK:%Term	25	383	1	2100	3010	481	3363	4134	833	651	1213	1645	581	1304	465	3139	3558	383	2502	1351	1650
278_CD8:%Act(25+38+)	278_CD8:%Act(25+38+)	25	384	1	2934	3322	678	2246	384	3962	1349	3416	2679	4006	475	1308	3760	1207	2215	2354	3865	3631
3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	3600_Non-cancer illness code, self-reported: gastro-oesophageal reflux (gord) / gastric reflux	25	384	1	1987	1263	2207	3709	1219	3066	2483	1442	384	2387	1590	4000	2750	1512	3386	4070	4578	3452
62_Age at menopause	62_Age at menopause	25	384	1	1507	4366	4032	2107	1145	3535	3632	2333	3864	2236	384	3179	1447	3400	3159	2537	1556	4533
1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	1663_Alanine transaminase (at exam 2, GEE, adjusted for age and sex)	25	384	1	3985	2182	1355	3346	2464	2014	1114	1069	1819	2498	2835	1074	1028	3915	3303	3082	384	2071
1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	1519_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, GEE, adjusted for age and sex)	25	385	1	385	852	1068	911	758	1006	2341	3533	2121	2058	2487	3491	432	396	2900	1035	3444	2853
4509_Cerebellar vermal lobules VIII X	4509_Cerebellar vermal lobules VIII X	25	385	1	1063	2423	385	559	4270	3782	4590	4742	2592	3728	916	2263	1839	3854	3770	1172	728	4698
3986_Heart rate recovery at 20 secnds	3986_Heart rate recovery at 20 secnds	25	385	1	3604	2317	1560	385	4147	4216	2156	2619	3382	553	1064	1226	3726	702	2375	4250	2554	3505
4062_Urinary albumin-to-creatinine ratio	4062_Urinary albumin-to-creatinine ratio	25	385	1	4505	1314	2698	2101	3024	4532	2205	2961	385	1435	453	3456	1393	566	2986	1562	1598	4332
1169_Leptin	1169_Leptin	25	385	1	1567	4249	1397	3478	1224	803	479	4380	4281	385	2371	434	4122	3394	2231	1630	3443	2768
4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	4384_Epithelial ovarian cancer (low-grade serous and borderline serous)	25	385	1	4532	2719	3006	3740	3090	2206	1270	1997	3622	2704	385	912	1738	493	4700	3308	1436	4690
458_Energy::Krebs cycle::alpha-ketoglutarate	458_Energy::Krebs cycle::alpha-ketoglutarate	25	385	1	582	3623	3807	4110	4646	1735	3177	1291	4497	720	683	4431	385	3791	783	4113	2604	765
2375_CD33 - Myeloid cell surface antigen CD33	2375_CD33 - Myeloid cell surface antigen CD33	25	385	1	1778	3353	2401	600	4511	3635	897	1350	4503	938	718	2249	909	3285	3023	385	1379	2122
1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	1468_Lipoprotein A (at exam 3, FBAT, adjusted for multivariable)	25	385	1	618	3804	1311	3716	2194	1730	3776	1136	3695	3651	1889	2186	2862	2291	2706	2602	4652	385
2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	2169_CNTFR - Ciliary neurotrophic factor receptor subunit alpha	25	386	1	1671	1994	386	3836	3172	1753	1987	2999	4467	4361	1611	4495	4593	3371	1917	4682	3075	4070
1917_Temporal brain volume (GEE, adjusted for multivariable)	1917_Temporal brain volume (GEE, adjusted for multivariable)	25	386	1	2534	857	3337	4602	1321	386	3026	1862	4211	3309	3110	3007	4433	3201	2207	1623	4651	2258
625_Xenobiotics::Drug::ibuprofen	625_Xenobiotics::Drug::ibuprofen	25	386	1	1862	891	1437	2846	1199	1780	859	4721	1562	386	1149	2919	3967	500	3448	3067	2978	3520
2635_TNF - Tumor necrosis factor	2635_TNF - Tumor necrosis factor	25	386	1	1012	2729	2183	2117	3435	2963	822	2623	3206	4019	3862	386	2089	4189	1629	2000	861	4144
3577_Social support - Leisure/social activities: Pub or social club	3577_Social support - Leisure/social activities: Pub or social club	25	387	1	4004	3501	3297	387	3952	3356	2676	3336	4658	2880	2555	2929	3038	3587	2451	2464	3830	3546
4583_Right inferior temporal	4583_Right inferior temporal	25	387	1	848	1519	2125	1436	387	3616	2237	1877	2700	1036	2195	1599	4462	1419	3155	2096	2560	1858
2347_HP - Haptoglobin	2347_HP - Haptoglobin	25	387	1	3013	2366	3995	2989	663	2240	568	414	2258	387	677	3956	686	3753	678	1385	4437	646
884_Triglycerides in IDL	884_Triglycerides in IDL	25	387	1	2844	1402	530	1586	3712	1076	552	2301	1860	693	446	1708	1145	2559	387	586	1255	2049
2195_FGF9 - Fibroblast growth factor 9	2195_FGF9 - Fibroblast growth factor 9	25	387	1	3453	2897	2684	1920	3112	537	1063	1081	4461	2411	3606	2768	3444	3924	3207	387	2239	4359
2535_BCAN - Brevican core protein	2535_BCAN - Brevican core protein	25	387	1	4110	2011	1283	3977	4569	2477	3993	712	3326	957	3433	2675	699	4682	1134	4316	387	1073
3349_Ever used hormone-replacement therapy (HRT) (female)	3349_Ever used hormone-replacement therapy (HRT) (female)	25	388	1	388	2789	2892	1522	1161	4197	3288	4103	4578	4675	2369	1698	623	2759	4471	2175	1989	2068
3546_Mouth/teeth dental problems: Bleeding gums	3546_Mouth/teeth dental problems: Bleeding gums	25	388	1	4477	388	3977	4722	483	2248	3510	2028	659	3443	3815	2535	3774	1044	3680	2606	604	2108
1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1791_QT interval (female, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	388	1	3256	2872	2668	2791	388	2954	1461	2137	675	2701	984	918	4619	1791	2253	4103	1624	589
2267_MDK - Midkine	2267_MDK - Midkine	25	388	1	1846	1475	433	1979	2281	2979	849	4017	388	4685	2537	2456	2471	1333	1590	2936	1293	2681
2691_NACA - Nascent polypeptide-associated complex subunit alpha	2691_NACA - Nascent polypeptide-associated complex subunit alpha	25	388	1	3668	1304	2147	4448	2207	4120	2961	4299	3799	2747	2668	1869	802	994	388	4511	442	2566
1342_Resistin (FBAT, adjusted for age, sex and BMI)	1342_Resistin (FBAT, adjusted for age, sex and BMI)	25	389	1	2697	567	389	877	4503	846	1840	3574	3032	4226	2114	854	1709	2197	2233	2140	1455	4060
898_Total cholesterol in large VLDL	898_Total cholesterol in large VLDL	25	389	1	2377	3332	2611	389	1391	1902	2639	4188	2202	3622	2798	949	3977	1277	3840	798	1028	4086
949_Total phosphoglycerides	949_Total phosphoglycerides	25	389	1	3001	3949	2580	1479	4479	3432	389	2578	1967	3996	3689	1068	3062	1912	3182	2466	665	1595
1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1257_Percent predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	390	1	4398	390	4489	1064	3753	4462	3876	1496	2919	2380	3786	3282	735	1375	875	801	531	1565
4603_Right superior parietal	4603_Right superior parietal	25	390	1	3816	694	3617	3340	390	2069	2002	3838	2087	2802	3745	781	4116	2304	491	1651	3509	2553
1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	1535_Ankle-brachial index (at exam 7, GEE, adjusted for age and sex)	25	390	1	2233	991	4089	1897	1272	390	3919	2120	4694	799	1224	444	3807	3845	3742	3993	4308	3373
1212_Type 2 Diabetes	1212_Type 2 Diabetes	25	390	1	4407	2917	426	4309	3892	1575	390	2497	3694	4533	1257	4673	2609	503	667	723	3583	3186
869_OmegaL7 and L9 and saturated fatty acids	869_OmegaL7 and L9 and saturated fatty acids	25	390	1	4502	1678	3195	1647	1884	4076	445	1405	2164	1835	4635	390	2975	4136	4515	2456	4551	4043
738_::::X-11849	738_::::X-11849	25	390	1	4645	4746	4098	440	3627	1383	3359	3751	1190	2488	1755	2380	390	3687	1179	1968	1093	1445
899_Cholesterol esters in large VLDL	899_Cholesterol esters in large VLDL	25	391	1	1308	2974	2413	391	1973	1282	1084	1748	817	3364	1156	2290	3402	1251	4688	576	521	2998
1195_Asthma (male)	1195_Asthma (male)	25	391	1	2614	1274	1986	3569	3577	391	1801	1583	2882	3076	4520	3595	2661	1991	3626	3599	1680	2148
3417_Neuroticism score	3417_Neuroticism score	25	391	1	3787	504	3199	2393	432	2916	391	2868	801	2686	4127	4572	2714	1998	803	3987	2185	3091
1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	1522_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 6, FBAT, adjusted for age and sex)	25	391	1	3930	928	3154	3209	1446	3116	1818	391	4660	1537	2450	4295	2451	1141	1366	1608	4530	2933
3227_Usual side of head for mobile phone use	3227_Usual side of head for mobile phone use	25	391	1	2312	2816	838	512	4038	1014	2476	1654	2607	1136	1787	4337	1388	1096	391	3282	4585	2473
4536_Right putamen	4536_Right putamen	25	391	1	2589	1959	2365	3428	791	3596	3727	3328	662	1204	2807	1317	1427	2182	393	3138	391	2664
2659_CST5 - Cystatin-D	2659_CST5 - Cystatin-D	25	392	1	392	3224	4188	716	2052	2162	3391	3420	4314	1654	971	1311	2622	2163	2239	4140	3385	3839
4248_Parkinson's disease age at onset	4248_Parkinson's disease age at onset	25	392	1	2624	911	2662	1020	1739	1330	2751	392	2836	3004	3358	2220	2568	3672	4388	441	2121	1786
1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	1620_CD40 Ligand serum (at exam 7, FBAT, adjusted for multivariable)	25	392	1	1747	1351	996	1964	3924	4176	4411	676	2344	1695	3342	3801	4703	4595	2562	2892	1698	392
2986_CRK - Adapter molecule crk	2986_CRK - Adapter molecule crk	25	393	1	393	2589	1414	2948	3419	1598	3930	3151	1515	1705	4588	3876	4725	3804	2371	2054	3959	4665
3134_GRAP2 - GRB2-related adapter protein 2	3134_GRAP2 - GRB2-related adapter protein 2	25	393	1	4501	1173	3597	393	4320	4463	2599	2061	3983	3300	2900	4076	2398	3220	3062	2179	1059	3417
4025_Excessive sweating	4025_Excessive sweating	25	393	1	4734	3644	2214	3138	393	3523	4032	2318	2934	1911	2227	1253	4544	4301	975	3598	845	2852
1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	1734_Serum phosphorus (at exam 2, FBAT, adjusted for age and sex)	25	393	1	901	1874	3112	1697	3976	1503	393	1168	3561	4375	1602	4177	2804	944	2376	1284	2358	3899
3396_Other sociodemographic factors - Private healthcare	3396_Other sociodemographic factors - Private healthcare	25	393	1	1581	718	2246	4706	2623	4089	2887	1825	3909	2075	393	1359	4061	821	4152	3564	3176	4517
1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	1325_Fasting plasma glucose (at exam 7, GEE, adjusted for age, sex and BMI)	24	393	1	2888	3031	4059	3822	2269	4142	1852	2408	2613	2650	4378	2727	3156	551	2385	393	4227	4526
4607_Right insula	4607_Right insula	25	393	1	4709	1721	2324	1955	2155	426	1042	2046	1141	3165	1176	2825	2362	2123	3085	1276	4544	393
720_::::X-11538	720_::::X-11538	25	394	1	394	4503	667	639	2428	4474	4288	1601	1563	3159	3053	2403	2434	3967	2843	2585	4133	2064
2237_ICAM2 - Intercellular adhesion molecule 2	2237_ICAM2 - Intercellular adhesion molecule 2	25	394	1	4260	4691	872	394	1068	3601	2033	1942	2401	1573	2117	2702	1880	1793	3132	635	3582	2914
3210_Usual walking pace	3210_Usual walking pace	25	394	1	2353	3673	2776	1918	394	3166	2339	796	3180	3801	1834	3783	4098	2830	4146	657	2184	1686
681_::::X-10346	681_::::X-10346	25	394	1	562	2774	3578	1013	3427	2594	2345	1395	438	394	1359	706	1488	3163	1921	1625	3474	4529
868_OmegaL6 fatty acids	868_OmegaL6 fatty acids	25	394	1	2508	4068	3536	2417	4152	4578	459	544	3093	654	394	3459	3180	2664	1154	1872	1083	3698
3199_Distance between home and job workplace	3199_Distance between home and job workplace	25	395	1	3975	395	790	2950	4625	3423	4480	1427	1939	1567	1940	4658	2823	2259	3560	933	4674	3128
688_::::X-11204	688_::::X-11204	25	395	1	3486	4148	395	4540	3601	1733	2556	1622	1510	4414	2035	3996	4512	1920	3913	1728	3811	762
926_Phospholipids in medium VLDL	926_Phospholipids in medium VLDL	25	395	1	1849	3515	2647	395	1929	1525	1932	4659	2318	3609	1807	1002	3484	1304	4347	771	563	4037
2339_SPARC - SPARC	2339_SPARC - SPARC	25	395	1	3876	1091	4330	3364	395	4586	2620	2646	4586	580	3716	2506	2239	891	2004	3855	4149	3506
2144_MAPT - Microtubule-associated protein tau	2144_MAPT - Microtubule-associated protein tau	25	395	1	1859	1018	4483	1846	4689	1855	4146	3218	722	2393	2014	2943	1760	395	2716	1212	3342	907
4736_Anterior limb of internal capsule radial diusivities	4736_Anterior limb of internal capsule radial diusivities	25	396	1	4647	1976	3935	2001	1454	396	2194	4464	693	4337	1301	1824	1501	4461	3280	1491	2009	3048
2821_NGF - beta-nerve growth factor	2821_NGF - beta-nerve growth factor	25	396	1	2298	2912	3581	830	1206	4471	4255	2094	1525	4478	1954	2561	3275	3956	1231	396	3955	2900
2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	2300_EDAR - Tumor necrosis factor receptor superfamily member EDAR	25	396	1	4456	3384	4534	677	2166	1479	3809	1041	2013	452	658	3920	1642	1100	643	4181	4244	396
2289_PTHLH - Parathyroid hormone-related protein	2289_PTHLH - Parathyroid hormone-related protein	25	397	1	2442	3590	1476	568	397	993	2808	3661	2906	469	2535	3659	1691	1915	2140	3016	2833	3837
1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	1469_Lipoprotein A (at exam 3, GEE, adjusted for multivariable)	25	397	1	4146	4583	2530	2650	526	3952	1920	3529	1796	1198	837	3883	4345	397	3493	929	1256	4259
3336_Ever had breast cancer screening / mammogram (female)	3336_Ever had breast cancer screening / mammogram (female)	25	397	1	1864	2486	2076	943	481	1599	1881	4463	1259	3567	2640	4524	785	4436	397	925	4515	2573
1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	1723_Serum calcium (at exam 2, GEE, adjusted for age and sex)	25	397	1	1943	2093	1077	2627	2438	4285	1144	1965	4313	4504	2671	3635	821	3027	786	397	3904	1141
2161_PECAM1 - Platelet endothelial cell adhesion molecule	2161_PECAM1 - Platelet endothelial cell adhesion molecule	25	397	1	3635	3616	515	4190	964	560	1646	2321	427	2397	4156	1875	1648	1652	825	2225	397	751
3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	3163_TNFRSF13C - Tumor necrosis factor receptor superfamily member 13C	25	398	1	1410	398	1508	747	2241	2071	665	799	633	3911	3107	2462	2050	4506	3181	1649	2081	2953
3793_Sleep duration	3793_Sleep duration	25	398	1	586	494	767	398	672	1292	1912	4513	520	4460	2789	3447	2539	2342	3302	2505	1632	1453
553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	553_Lipid::Medium chain fatty acid::10-undecenoate (11:1n1)	25	398	1	3601	3247	1944	3272	3478	2158	398	3764	2191	4202	820	3518	1345	3680	4488	4037	1438	2975
4412_Total IgM levels	4412_Total IgM levels	25	398	1	2397	4130	3398	953	2452	2197	3481	398	2962	2852	4452	4700	2629	2948	1860	3178	1432	4509
574_Lipid::Sterol, Steroid::cortisol	574_Lipid::Sterol, Steroid::cortisol	25	398	1	712	1197	2239	1276	3607	3694	3976	1149	1277	398	3778	4705	2743	2684	955	2577	853	1482
698_::::X-11412	698_::::X-11412	25	398	1	4157	4039	739	4503	4515	895	2824	1799	2548	4068	398	1844	2079	1254	3933	4082	451	3010
4409_Vaginal discharge: Metrorrhagia	4409_Vaginal discharge: Metrorrhagia	25	398	1	2901	665	4436	1107	1749	2853	3122	4433	1928	2376	2649	398	1089	1777	2624	3814	4503	2980
1025_Femoral Neck Length (GEE, adjusted for age and sex)	1025_Femoral Neck Length (GEE, adjusted for age and sex)	25	398	1	2163	4187	3511	2717	983	855	2726	2995	4308	1702	3627	1143	1929	398	2926	3914	3471	555
1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	1689_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for multivariable)	25	398	1	2731	604	2753	3727	490	4563	1632	3230	3229	3386	3845	2311	3034	2748	398	4080	3530	3264
4538_Right hippocampus	4538_Right hippocampus	25	398	1	1975	1599	4403	1937	1900	3675	723	2911	928	2348	2744	3284	2343	2247	4276	398	3446	424
3779_Traumatic events - Witnessed sudden violent death	3779_Traumatic events - Witnessed sudden violent death	25	399	1	2536	399	2695	2540	3256	3975	708	1348	1291	1242	4245	1422	3154	4260	3343	1763	945	837
2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	2868_NCAM1 - Neural cell adhesion molecule 1, 120 kDa isoform	25	399	1	3561	1981	399	2603	1528	4180	4025	4431	4162	1141	3094	1766	855	1853	971	2587	3038	2196
724_::::X-11552	724_::::X-11552	25	399	1	4389	3177	2938	2182	399	1729	3010	1592	3657	3634	3898	1335	4243	3998	2823	2372	2861	3668
2705_ASGR1 - Asialoglycoprotein receptor 1	2705_ASGR1 - Asialoglycoprotein receptor 1	25	399	1	2061	3394	2254	4349	4331	3453	399	529	4380	2938	3601	1718	4350	4035	2293	2579	3339	2649
4650_Body of corpus callosum fractional anisotropy	4650_Body of corpus callosum fractional anisotropy	25	399	1	3380	3909	3206	2645	1844	598	4703	3439	399	3478	2847	1881	3470	4210	1063	3330	3279	1845
1230_Usual weekday bedtime (FBAT)	1230_Usual weekday bedtime (FBAT)	25	399	1	3606	1686	1319	2916	1498	3206	3548	2766	1346	399	4302	3127	4688	1717	2952	1495	2648	3344
1107_Blond hair in Solomon Islanders	1107_Blond hair in Solomon Islanders	25	399	1	4141	431	1527	3832	1359	3980	2200	1452	4608	3587	3296	399	4190	3893	3146	3008	3670	2282
2878_PPBP - Connective tissue-activating peptide III	2878_PPBP - Connective tissue-activating peptide III	25	399	1	3149	3208	2468	4570	1348	942	2992	2962	4675	1550	2937	1234	789	1119	575	399	4417	978
4232_Anilides	4232_Anilides	25	399	1	3894	4504	805	4339	2329	2864	604	3859	3895	4179	4189	2594	2157	1800	2847	2038	3692	399
3057_IL20RA - Interleukin-20 receptor subunit alpha	3057_IL20RA - Interleukin-20 receptor subunit alpha	25	400	1	400	4614	4477	4697	1544	2348	2487	3708	969	3190	1181	2055	1948	835	4104	1973	2898	4313
2467_BMP1 - Bone morphogenetic protein 1	2467_BMP1 - Bone morphogenetic protein 1	25	400	1	446	1878	1836	4487	4642	2596	913	4252	1341	400	4286	4426	3803	931	3176	2567	1170	2407
2511_CA13 - Carbonic anhydrase 13	2511_CA13 - Carbonic anhydrase 13	25	400	1	2112	4465	679	2701	3355	1018	3218	1498	4499	3001	3703	4456	811	400	3622	4444	1008	4654
3426_Fluid intelligence test - FI3 : word interpolation	3426_Fluid intelligence test - FI3 : word interpolation	25	400	1	2301	3882	4710	4354	858	3238	2728	1414	2981	916	429	2028	1803	2679	1666	400	3180	2292
2_Attention deficit hyperactivity disorder	2_Attention deficit hyperactivity disorder	25	400	1	3629	1514	1752	4707	2653	3312	3232	3394	1485	3545	3503	3123	2139	972	4669	2230	400	2894
1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	1818_Inter-trochanteric buckling ratio (FBAT, female, adjussted for multivariable)	25	401	1	401	1469	3528	3105	811	2585	1660	4478	505	843	1902	2744	2166	1812	1273	927	3663	4116
820_::::X-13477	820_::::X-13477	25	401	1	2084	2892	1429	1033	401	2471	3881	990	1416	2470	2478	2378	1595	3495	1645	1240	3301	1897
3997_Worrier / anxious feelings (WORRY)	3997_Worrier / anxious feelings (WORRY)	25	401	1	1217	436	4494	663	2652	1999	3694	3505	2632	684	401	3003	3404	3328	4634	1918	1406	4314
2258_UBE2I - SUMO-conjugating enzyme UBC9	2258_UBE2I - SUMO-conjugating enzyme UBC9	25	401	1	1346	2980	1558	3289	1332	565	650	4078	4599	1611	1145	401	4554	1362	3672	2721	1365	626
712_::::X-11483	712_::::X-11483	25	401	1	4321	3243	998	2272	2432	3972	1673	1331	2117	3510	3081	844	2500	1356	401	3499	3251	1641
4567_Left precentral	4567_Left precentral	25	401	1	487	3631	1213	3914	2724	1000	2569	4598	3740	2102	3730	4145	2266	4302	1918	401	1020	3001
642_Xenobiotics::Xanthine metabolism::1-methylurate	642_Xenobiotics::Xanthine metabolism::1-methylurate	25	401	1	1461	3896	540	2378	4050	2704	2048	4732	1766	4458	1312	4513	3271	2791	2202	2879	401	3295
861_Citrate	861_Citrate	25	402	1	402	2356	1665	947	4261	686	2379	810	2296	3307	1603	1316	1333	4045	1881	778	3835	1580
2931_IL1A - Interleukin-1 alpha	2931_IL1A - Interleukin-1 alpha	25	402	1	4579	4358	3232	402	1358	4325	1439	1481	792	698	3045	652	2332	2494	1749	2770	4436	3943
2201_IL10 - Interleukin-10	2201_IL10 - Interleukin-10	25	402	1	4357	3829	3580	4247	842	2435	402	3825	2685	2838	2895	4174	1094	4405	2535	4159	1358	3873
2940_GDF2 - Growth/differentiation factor 2	2940_GDF2 - Growth/differentiation factor 2	25	402	1	2239	4421	1786	2321	424	1644	1276	1535	2482	3265	402	2110	4196	459	2204	4486	4310	4631
810_::::X-12850	810_::::X-12850	25	402	1	3677	4325	1017	3698	849	3325	1282	3160	3690	3075	736	3440	2944	1845	485	1530	402	3857
1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	1823_Inter-trochanteric buckling ratio (GEE, female, adjussted for age)	25	402	1	3613	1121	1881	4331	3123	2085	2616	3905	3516	4348	516	930	1168	4109	1613	4260	2732	402
406_Amino acid::Tryptophan metabolism::indolepropionate	406_Amino acid::Tryptophan metabolism::indolepropionate	25	403	1	403	3728	1605	4369	1451	3316	1236	4385	2423	1540	2609	570	2833	605	3261	1477	4362	1347
1891_Shaft Width (GEE, male, adjussted for age)	1891_Shaft Width (GEE, male, adjussted for age)	25	403	1	2727	4233	3574	3955	403	3907	882	909	3164	1578	1112	2827	754	1230	3017	3525	828	1517
2573_DKK1 - Dickkopf-related protein 1	2573_DKK1 - Dickkopf-related protein 1	25	403	1	2237	601	759	2413	706	4220	4250	403	1453	4325	3723	2615	2067	3454	934	2322	3759	4416
992_Interleukin-5	992_Interleukin-5	25	403	1	3544	499	2528	3518	3506	2845	3824	878	1549	403	2317	4401	2681	2078	627	1293	2196	3473
2991_ERP29 - Endoplasmic reticulum resident protein 29	2991_ERP29 - Endoplasmic reticulum resident protein 29	25	403	1	3735	744	3263	2730	2090	2895	3862	995	3890	1359	403	882	1361	1115	484	1790	1538	3021
3580_Social support - Leisure/social activities: Other group activity	3580_Social support - Leisure/social activities: Other group activity	25	403	1	3973	554	3669	588	2407	2669	3527	3295	826	1460	2479	3609	403	4237	4407	3479	3355	4479
3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	3532_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault to yourself	25	404	1	984	1376	404	2693	1437	3734	2845	1135	2326	2618	2438	646	1846	2708	4050	2808	4034	3103
2898_PPY - Pancreatic hormone	2898_PPY - Pancreatic hormone	25	404	1	1158	3232	1137	1186	528	4423	3067	791	404	940	2303	1668	3808	1979	1670	2887	4439	3534
2574_DDC - Aromatic-L-amino-acid decarboxylase	2574_DDC - Aromatic-L-amino-acid decarboxylase	25	404	1	1286	456	4645	1694	3660	1181	3569	2838	1073	2345	404	1977	1700	2628	2947	1301	3552	3431
3387_Health satisfaction	3387_Health satisfaction	25	404	1	4493	1991	3310	2010	2475	4137	2323	3980	4213	2033	1718	3972	404	2166	2703	2041	3170	1318
100_Pubertal growth (male)	100_Pubertal growth (male)	25	404	1	1285	2441	562	2399	4382	4652	1819	2480	996	2358	2166	1237	2318	3828	2833	4371	980	404
1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	1713_Thyroid stimulation hormone (at exam 4, GEE, adjusted for age and sex)	25	405	1	548	1858	859	2529	1904	405	3466	4206	1006	1494	1676	3153	2141	1393	3218	3102	1234	1399
1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	1666_Aspartate aminotransferase (at exam 2, FBAT, adjusted for age and sex)	25	405	1	3955	3966	627	3223	4585	838	4599	3256	3103	3475	405	3375	2777	1540	2608	3324	4336	3016
2100_LEP - Leptin	2100_LEP - Leptin	25	405	1	2702	2845	1202	2116	4550	2710	3717	4395	4626	4154	1233	4672	4571	1956	3230	4239	405	2350
1064_Bipolar disorder	1064_Bipolar disorder	25	406	1	4285	406	2266	2465	2766	4503	4688	2127	4460	1310	2431	2229	4291	2095	3545	788	536	2225
2225_EDA - Ectodysplasin-A, secreted form	2225_EDA - Ectodysplasin-A, secreted form	25	406	1	2717	800	3126	2505	4492	1094	406	2074	3013	2572	3233	2130	976	3919	3123	2335	4523	2825
2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	2473_CDK5 CDK5R1 - Cyclin-dependent kinase 5:Cyclin-dependent kinase 5 activator 1 complex	24	407	1	407	2590	1046	609	3229	1126	983	1150	798	3483	1101	3301	1853	1106	4404	3470	3059	1061
752_::::X-12063	752_::::X-12063	25	407	1	3236	4387	1065	2897	1660	1049	4327	4498	4188	2957	4639	407	2340	4567	1385	3802	2068	1405
4247_Ambidextrousness	4247_Ambidextrousness	25	407	1	800	1063	4263	3862	4295	2246	1141	2079	4179	699	4231	3464	2768	2700	554	407	4278	4162
1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1787_QT interval (male, cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	408	1	3708	2564	408	2614	4310	3928	4690	978	4381	4119	4615	676	4469	2824	427	1209	1446	4220
3894_Neutrophil percentage of granulocytes (three-way meta)	3894_Neutrophil percentage of granulocytes (three-way meta)	25	408	1	3638	3367	3877	1134	3460	2119	454	4072	3608	2506	3267	1318	3594	1627	408	2562	3961	1074
962_Concentration of very large VLDL particles	962_Concentration of very large VLDL particles	25	409	1	729	4289	3023	409	1007	1507	2377	4108	1457	4000	1329	4146	1772	447	3170	973	488	4554
1834_Neck width (FBAT, female, adjusted for multivariable)	1834_Neck width (FBAT, female, adjusted for multivariable)	25	409	1	963	4200	2598	3663	1156	2840	409	2381	2898	4097	2533	2837	871	2073	2861	1618	3691	2476
2609_OCIAD1 - OCIA domain-containing protein 1	2609_OCIAD1 - OCIA domain-containing protein 1	25	409	1	3262	3648	1382	582	3800	2548	3795	3299	409	518	4525	2654	791	772	1609	915	716	701
157_Hip circumference (male)	157_Hip circumference (male)	25	409	1	2399	3765	4159	4694	4246	1041	1463	2139	1251	409	1040	1149	1812	1589	1105	4376	3415	4012
212_Insomnia (female)	212_Insomnia (female)	25	409	1	4130	3202	3641	4094	3245	2356	2872	4706	2942	641	409	2393	2594	2401	2701	1531	2800	2979
3249_Lamb/mutton intake	3249_Lamb/mutton intake	25	409	1	4163	1166	597	4163	3236	3677	4426	3426	4469	4456	2416	409	3772	1502	2299	1204	670	3557
1086_Pancreatic cancer	1086_Pancreatic cancer	25	409	1	2329	2461	3803	2056	1511	1130	2672	1763	1289	3263	786	3570	2248	771	1067	2766	3559	409
295_CD4mem:%Th17	295_CD4mem:%Th17	25	410	1	1388	4726	1818	1512	410	572	2744	4419	2838	1027	3488	902	4553	2176	1228	2535	4377	4492
2099_IGFBP3 - Insulin-like growth factor-binding protein 3	2099_IGFBP3 - Insulin-like growth factor-binding protein 3	25	410	1	531	1692	3834	1965	1027	1793	512	1119	829	1788	2064	3897	2315	3856	410	1133	1884	829
3207_Duration of moderate activity	3207_Duration of moderate activity	25	410	1	2518	4588	3739	3262	2677	1867	696	547	1946	1373	2545	4499	3129	2234	2977	410	3787	2126
4372_Free thyroxine (FT4)	4372_Free thyroxine (FT4)	25	411	1	4482	411	2710	2940	3467	2713	2460	3686	3210	2605	3744	1697	4409	2466	3094	2931	4248	4412
3800_Total blood hemoglobin	3800_Total blood hemoglobin	25	411	1	3569	2007	411	1566	2657	3495	4048	2373	552	2291	4268	3858	3214	4317	2496	3758	3673	4049
550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	550_Lipid::Lysolipid::2-oleoylglycerophosphocholine*	25	411	1	1351	1847	4156	1752	3492	2505	2734	3306	2712	4466	3103	411	4520	1954	1553	3505	2082	4096
222_B:%Mature	222_B:%Mature	25	411	1	4460	1473	470	762	2447	1060	904	3365	2163	1558	1196	926	4670	1560	411	3508	4057	3743
4625_Left pallidum	4625_Left pallidum	25	412	1	2818	412	2131	3399	1513	4139	4432	1073	3200	1525	1179	2842	1362	1359	3747	4066	4200	3500
2268_CCL23 - C-C motif chemokine 23	2268_CCL23 - C-C motif chemokine 23	25	412	1	1940	872	2777	4672	2593	1289	4573	412	4542	2976	2828	3510	3199	3541	4301	4666	2916	2922
1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	1656_Tumor necrosis factor receptor II (at exam 7, FBAT, adjusted for multivariable)	25	412	1	4646	2597	3599	3774	2138	2178	4746	3632	4515	3960	412	2691	4201	4660	2799	2554	1790	4299
437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	437_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannitol	25	412	1	3214	2534	1684	2086	1200	1923	792	1419	1039	2684	4033	3729	1666	3134	3943	3765	412	931
2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	2546_XPNPEP1 - Xaa-Pro aminopeptidase 1	25	413	1	2145	413	2083	1821	3733	969	4336	3297	3049	4157	476	3043	1344	4656	2838	2197	1845	4411
1306_Insulin sensitivity (FBAT, adjusted for age and sex)	1306_Insulin sensitivity (FBAT, adjusted for age and sex)	25	413	1	3602	3636	888	413	3383	2239	675	4552	4491	1516	2248	436	2949	666	4170	2732	4269	2444
661_::::X-04498	661_::::X-04498	25	413	1	4045	1960	2723	4149	413	2263	2210	1975	2513	3094	1245	3588	3842	1350	1838	1461	516	2824
839_::::X-14473	839_::::X-14473	25	413	1	455	4459	508	1617	1927	3812	413	1487	4043	3022	1194	2233	1685	3012	2619	1262	4559	1910
2866_KNG1 - Kininogen-1	2866_KNG1 - Kininogen-1	25	413	1	4405	3828	1176	4663	1373	4448	3166	2923	413	1632	829	3115	569	3434	3042	4102	751	3269
3250_Pork intake	3250_Pork intake	25	413	1	2638	2849	802	2301	2927	2579	2217	1609	3402	3627	1314	2995	2735	413	2793	1380	1316	1148
2211_PPBP - Neutrophil-activating peptide 2	2211_PPBP - Neutrophil-activating peptide 2	25	413	1	2710	3210	3125	965	1261	1743	1196	1254	3410	2350	3510	3055	997	4548	1428	413	1171	2190
4175_Heel bone mineral density	4175_Heel bone mineral density	25	415	1	415	3306	477	1655	795	1624	799	3589	911	2214	2482	578	2152	1631	596	782	1199	2615
2765_TG - Thyroglobulin	2765_TG - Thyroglobulin	25	415	1	1206	837	415	4374	1907	4479	4005	1276	4215	2297	1125	4017	3306	2043	3582	2275	3437	3334
1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	1483_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for age and sex)	25	415	1	1608	1530	1005	2511	2940	2542	2135	1706	415	3775	1526	1304	3674	2816	4467	2988	1150	1338
2612_RBP4 - Retinol-binding protein 4	2612_RBP4 - Retinol-binding protein 4	25	416	1	2590	1526	416	1643	2345	4484	3610	4703	3484	2817	1793	2116	2522	1787	3108	1693	3276	1139
1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	1895_Shaft Section Modulus (GEE, female, adjussted for multivariable)	25	416	1	2579	4163	2455	621	1563	4062	2081	2042	1336	416	4508	1294	681	3982	2734	4217	589	3887
2677_PAK6 - Serine/threonine-protein kinase PAK 6	2677_PAK6 - Serine/threonine-protein kinase PAK 6	25	416	1	4310	1781	3015	907	2223	1288	4595	3710	1286	4684	1700	3395	3019	2872	3960	416	1941	3350
1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1253_Percent predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	417	1	4545	417	1893	2847	3488	4727	3955	2741	3014	1897	3581	2983	1432	2524	2436	860	1345	1412
66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	66_Insulin sensitivity index (combined influence of the genotype effect adjusted for BMI and the interaction effect between the genotype and BMI on ISI)	25	417	1	704	936	2762	517	2857	1379	417	706	2575	4722	2176	1136	1474	2248	2537	955	2836	608
699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	699_Nucleotide::Purine metabolism, (hypo)xanthine/inosine containing::X-11422--xanthine	25	417	1	2714	1326	3918	581	4690	799	1604	4333	417	4102	3199	4525	1818	2254	3839	1541	3578	3889
1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1684_Brain natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	417	1	1387	3184	1951	3391	2952	4303	3341	3586	2196	417	3837	2396	1305	3185	3083	2607	4216	2791
307_CD4mem:%cFTH (3)	307_CD4mem:%cFTH (3)	25	417	1	4480	1604	2934	653	3393	2097	793	1304	983	945	3127	958	4550	463	417	4238	2930	730
91_Childhood obesity	91_Childhood obesity	25	417	1	907	1563	1599	2406	3567	1245	1735	1406	1255	1008	3939	1614	3850	3462	4354	1332	1621	417
3019_NCK1 - Cytoplasmic protein NCK1	3019_NCK1 - Cytoplasmic protein NCK1	25	418	1	1614	1457	418	1808	2288	2254	1396	2866	1204	4105	1188	609	1228	4629	1708	3418	4379	1210
2696_RPS7 - 40S ribosomal protein S7	2696_RPS7 - 40S ribosomal protein S7	25	418	1	1650	2600	3726	1140	4692	3705	1011	4739	3431	4260	418	2978	2912	892	2641	2998	1840	3720
559_Lipid::Medium chain fatty acid::laurate (12:0)	559_Lipid::Medium chain fatty acid::laurate (12:0)	25	418	1	3362	4246	4563	2254	958	2350	3131	2744	2528	4377	1738	1104	2745	889	418	968	2373	3333
4619_Left inferior lateral ventricle	4619_Left inferior lateral ventricle	25	419	1	419	1214	3387	2452	4715	2099	3362	1679	1104	1801	985	3018	1247	4307	3107	3464	2011	3764
4284_FEV1/FVC ratio	4284_FEV1/FVC ratio	25	419	1	3567	2969	3370	1591	653	3071	419	893	1520	2945	4241	4728	4369	470	1321	3902	3481	1023
3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	3154_TNFRSF14 - Tumor necrosis factor receptor superfamily member 14	25	419	1	4522	1394	2480	3678	4284	1357	4117	4699	4386	3171	419	3177	1687	1576	2721	4746	3761	749
3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	3014_SOD2 - Superoxide dismutase [Mn], mitochondrial	25	419	1	1675	3808	3889	3143	3790	706	841	1788	4356	3592	4688	3976	419	4054	1062	4395	4462	1962
3743_Depression - Feelings of worthlessness during worst period of depression	3743_Depression - Feelings of worthlessness during worst period of depression	25	419	1	3074	4164	2649	4289	3151	1874	1109	2767	1145	4483	3769	1878	612	1538	565	1552	4186	419
4594_Right pars triangularis	4594_Right pars triangularis	25	420	1	420	4552	4379	2555	3191	1913	4604	4281	4521	2818	1452	4397	2648	4713	1400	4083	1484	4031
4250_L5 timing	4250_L5 timing	25	420	1	3265	3185	420	4609	2648	1406	2268	3826	4017	2043	1373	530	3507	2112	3502	4549	4599	1946
3358_Father's age	3358_Father's age	25	420	1	578	3059	3407	4269	1930	4499	1764	539	420	678	3268	689	4376	3638	2921	3343	1022	797
1164_Glucose levels 2 h after an oral glucose challenge	1164_Glucose levels 2 h after an oral glucose challenge	25	421	1	421	497	1878	1797	4709	3058	3421	4119	1871	3480	727	1866	3024	3875	4346	4131	1882	2246
1318_Resistin (FBAT, adjusted for age and sex)	1318_Resistin (FBAT, adjusted for age and sex)	25	422	1	1738	422	1748	3101	4652	1404	1302	4051	1881	4294	2615	802	2885	937	1807	2617	2182	3746
3342_Birth weight of first child (female)	3342_Birth weight of first child (female)	25	422	1	3048	3862	3444	1093	707	422	781	2433	776	2412	1549	3095	2865	4224	3879	3608	937	3512
2518_FN1 - Fibronectin Fragment 3	2518_FN1 - Fibronectin Fragment 3	25	422	1	821	2829	2236	1247	1044	2833	422	2187	542	779	1345	1111	1215	3809	1563	3543	3341	4347
3493_Coffee type: Instant coffee	3493_Coffee type: Instant coffee	25	422	1	2900	2900	2017	1415	3542	2077	3834	831	3126	3858	422	3747	3670	639	1631	2183	2445	4236
2413_NRP1 - Neuropilin-1	2413_NRP1 - Neuropilin-1	25	422	1	2510	4353	4624	4432	2360	1280	3482	2200	3426	739	1921	1706	3259	1296	422	3732	4194	2420
3340_Had menopause (female)	3340_Had menopause (female)	25	422	1	639	3285	4459	2297	2290	4728	858	4576	3861	907	2542	3563	988	2631	4583	1952	3817	422
1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	1680_Atrial natriuretic peptide (at exam 6, FBAT, adjusted for multivariable)	25	423	1	4390	423	2264	3902	1210	2207	2357	1237	3537	787	3657	587	1446	4547	4705	636	3519	2243
4668_Uncinate fasciculus fractional anisotropy	4668_Uncinate fasciculus fractional anisotropy	25	423	1	549	4270	4248	2189	3695	1454	3487	2375	2365	4473	423	3225	2304	4085	3048	1673	3110	2887
572_Lipid::Sterol, Steroid::androsterone sulfate	572_Lipid::Sterol, Steroid::androsterone sulfate	25	423	1	2897	798	1794	2234	1559	1939	4459	2886	731	2891	1772	4046	2440	423	2287	3594	2526	804
3466_Impedance measures - Arm fat-free mass (left)	3466_Impedance measures - Arm fat-free mass (left)	25	423	2	1062	1934	4269	2663	4212	458	1736	2164	3102	4445	1262	1163	1947	655	1129	423	1202	1629
90_Body Mass Index - Child	90_Body Mass Index - Child	25	424	1	1705	424	2513	2219	897	2506	2628	3106	3687	3829	457	3651	4022	1814	4503	1558	2776	3693
365_Amino acid::Alanine and aspartate metabolism::asparagine	365_Amino acid::Alanine and aspartate metabolism::asparagine	25	424	1	516	1908	4168	606	3455	3834	424	3231	2920	4029	3615	1934	593	708	4442	4484	3148	4656
2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	2838_ENTPD3 - Ectonucleoside triphosphate diphosphohydrolase 3	25	424	1	1565	2742	2791	2774	2891	3273	3522	1411	2483	2749	1462	3917	424	3725	1618	3538	1700	4605
2385_CTSC - Dipeptidyl peptidase 1	2385_CTSC - Dipeptidyl peptidase 1	25	424	1	2371	751	1303	1812	4120	1186	2816	1061	1106	1207	4555	2184	4314	2592	424	3733	3586	3393
747_::::X-12029	747_::::X-12029	25	425	1	1515	4186	425	4014	2580	3253	1994	3001	937	845	990	4537	2879	3570	2453	3609	3109	4166
4610_Cerebellar vermal lobules VIII X	4610_Cerebellar vermal lobules VIII X	25	425	1	1078	2668	737	2655	425	1812	2099	2290	1337	1927	4601	1751	2763	2857	2782	1525	1957	920
2443_FCN2 - Ficolin-2	2443_FCN2 - Ficolin-2	25	425	1	987	960	3911	1438	2864	425	2646	1016	2214	1823	4333	3615	2906	2704	2992	2961	965	3573
629_Xenobiotics::Drug::salicyluric glucuronide*	629_Xenobiotics::Drug::salicyluric glucuronide*	25	425	1	3829	1709	4200	829	2538	4489	1488	3435	3435	2254	425	2258	4075	2920	4176	3197	454	4744
2372_CD4 - T-cell surface glycoprotein CD4	2372_CD4 - T-cell surface glycoprotein CD4	25	425	1	4495	2740	3448	2586	3826	4013	2977	2147	1491	3342	3314	1398	4331	3028	425	1977	3744	4004
2463_ACY1 - Aminoacylase-1	2463_ACY1 - Aminoacylase-1	25	426	1	2621	1502	2005	3418	4596	1215	3142	751	3571	426	3892	3157	1704	2787	1008	2971	4246	2963
1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	1616_CD40 Ligand plasma (at exam 7, FBAT, adjusted for multivariable)	25	426	1	1645	4101	885	3533	1220	904	571	2549	1533	2515	426	3042	1649	2735	629	3475	2140	4155
2073_FGFR1 - Fibroblast growth factor receptor 1	2073_FGFR1 - Fibroblast growth factor receptor 1	25	426	1	4417	2005	2725	2998	977	523	3358	1208	2476	994	1476	1595	4063	426	1378	2683	4634	1174
761_::::X-12206	761_::::X-12206	25	427	1	789	4158	3041	427	1524	2291	1928	3443	4121	3734	2379	3047	4137	2063	483	1466	3363	1870
2597_GNS - N-acetylglucosamine-6-sulfatase	2597_GNS - N-acetylglucosamine-6-sulfatase	25	427	1	1696	4194	3619	4279	427	3544	4271	2776	4080	2382	1404	2858	1430	3971	3792	546	2389	3463
2139_PRKCA - Protein kinase C alpha type	2139_PRKCA - Protein kinase C alpha type	25	427	1	3773	3174	3319	3793	1543	4560	1515	1100	1682	831	2252	2145	2708	1609	2922	3267	4285	427
1928_Temporal horn volume (FBAT, adjusted for age and sex)	1928_Temporal horn volume (FBAT, adjusted for age and sex)	25	428	1	428	2962	2893	2793	1108	2492	1502	4686	1220	3384	2959	4614	2981	3060	3618	2424	1242	1373
3367_Ever had hysterectomy (womb removed) (female)	3367_Ever had hysterectomy (womb removed) (female)	25	428	1	4413	428	2674	4725	3832	3548	1232	2439	1673	1367	679	3114	3685	3254	1262	2748	642	3935
2683_UFM1 - Ubiquitin-fold modifier 1	2683_UFM1 - Ubiquitin-fold modifier 1	25	428	1	1354	1282	3517	1867	2716	2038	2160	3137	3460	2709	1577	428	1622	1461	4033	2133	1688	1127
3247_Poultry intake	3247_Poultry intake	25	428	1	2278	1691	4514	2969	1311	2813	3373	3433	4206	2198	3122	2471	1372	428	2211	1690	2331	1692
3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	3691_Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	25	428	1	732	2014	1749	492	2203	2385	3313	1223	4031	2072	938	4625	850	2585	428	3484	1633	869
448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	448_Cofactors and vitamins::Ascorbate and aldarate metabolism::threonate	25	428	1	3853	1811	3799	3281	738	4601	537	3944	4319	1040	2929	4714	4398	1395	617	3826	428	3715
230_mDC:%X-Presenting	230_mDC:%X-Presenting	25	429	1	2477	429	4557	4740	3538	1778	4360	1659	3124	4604	3248	1971	4528	3112	2444	3258	3613	1297
1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	1338_HOMA-IR (at exam 7, FBAT, adjusted for age, sex and BMI)	25	429	1	4429	441	4415	3085	429	1027	2986	2655	827	2553	3799	469	4103	626	3929	3306	2486	3518
2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	2672_MAPKAPK2 - MAP kinase-activated protein kinase 2	25	429	1	572	981	2595	2810	833	1537	1212	4510	3594	3597	1758	429	2734	2742	3476	3314	551	1632
3502_Male-specific factors - Hair/balding pattern: Pattern 3	3502_Male-specific factors - Hair/balding pattern: Pattern 3	25	429	1	4627	1268	913	1878	2552	1317	4019	4745	1724	1132	4469	3506	429	4330	2962	1858	3968	4298
1052_Ischemic stroke	1052_Ischemic stroke	25	429	1	1464	4136	2871	1554	3569	452	3369	1971	1617	855	929	3862	1229	2081	429	896	3400	3655
626_Xenobiotics::Drug::metoprolol acid metabolite*	626_Xenobiotics::Drug::metoprolol acid metabolite*	25	429	1	3951	3195	1030	2756	4126	711	2833	4491	3147	2360	4529	1540	4320	1383	1246	2874	429	3610
120_Obesity class 1	120_Obesity class 1	25	430	1	430	3225	1117	3585	601	1504	1696	2920	3814	2290	2483	2950	3023	2161	791	3210	4144	2684
1999_Hip circumference	1999_Hip circumference	25	430	1	1056	545	430	1789	3648	1973	3699	3320	3077	4216	2015	1795	2775	2453	1244	4488	3378	2973
1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1795_RR interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	430	1	4015	4466	431	901	1717	430	3268	634	3041	762	1033	3753	1578	592	876	4550	4545	4197
3604_Non-cancer illness code, self-reported: depression	3604_Non-cancer illness code, self-reported: depression	25	430	1	1108	2781	3029	3305	4193	3496	4119	3550	4541	2538	2619	770	4414	430	3428	2571	2747	1150
2212_SOD1 - Superoxide dismutase [Cu-Zn]	2212_SOD1 - Superoxide dismutase [Cu-Zn]	25	430	1	644	3444	2195	3903	4104	1736	2927	4553	3667	1064	3881	855	1414	452	2060	3506	4745	430
8_Major depressive disorder	8_Major depressive disorder	25	431	1	501	4055	2495	2975	4645	3141	3006	3991	437	431	3840	4602	3099	3563	2283	1849	4306	3408
2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	2119_ERBB3 - Receptor tyrosine-protein kinase erbB-3	25	431	1	3831	3657	1393	2910	885	3978	4339	541	1793	658	4651	431	3072	2831	2143	1052	2405	3045
1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	1437_Intermediate-density lipoprotein by NMR (at exam 4, GEE, adjusted for multivariable)	25	431	1	2322	937	2877	4435	930	2701	1786	2317	1639	4235	3838	2413	431	2275	831	478	1711	2992
3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	3712_Diagnoses - secondary ICD10: Z87 Personal history of other diseases and conditions	25	432	1	661	3600	1792	4676	1627	2577	432	445	1886	925	3949	3312	1841	4378	1209	4629	793	3993
1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	1789_QT interval (cohort exam 11 offspring exam 1, GEE, adjusted for age nad RR)	25	432	1	942	1363	3170	3331	1795	1299	3997	1180	1610	775	3638	432	3246	4507	2616	4188	4140	2838
2665_FGFR3 - Fibroblast growth factor receptor 3	2665_FGFR3 - Fibroblast growth factor receptor 3	25	432	1	1152	2572	1081	2065	1830	727	3880	1387	3892	3491	2079	4430	2935	2211	432	1800	3900	3678
3908_Vertical cup-disc ratio	3908_Vertical cup-disc ratio	25	433	1	2434	523	895	433	1519	3354	2254	2012	515	4554	3451	1542	1615	713	1295	2342	3410	503
3647_Illnesses of mother: Severe depression	3647_Illnesses of mother: Severe depression	25	433	1	3633	4179	2159	2938	4082	2661	433	2380	4268	3297	1984	3470	2470	3266	2726	3356	3844	2306
1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1681_Atrial natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	433	1	3483	3313	2089	978	2834	2881	1429	1115	2649	1933	2925	433	867	992	2305	1801	2905	2994
1209_FVC	1209_FVC	25	434	1	1466	3659	4704	1583	2681	2875	434	1778	663	4646	1890	1285	1588	1459	3922	1617	3009	2121
6_Anxiety disorder (case/control)	6_Anxiety disorder (case/control)	25	434	1	4600	4268	3186	2139	4009	3180	1955	4331	4053	3398	434	3384	1606	4381	1795	2057	3647	3004
3399_Tinnitus	3399_Tinnitus	25	434	1	3789	977	2223	3360	1307	1746	3906	2181	742	4539	2595	1898	434	4144	896	2415	2092	4475
4070_Ever smoker	4070_Ever smoker	25	434	1	3466	1360	2060	4322	4213	2115	3697	956	4348	893	3979	1551	1930	3210	434	1963	2881	4535
4489_Right parahippocampal	4489_Right parahippocampal	25	434	1	1247	3329	2739	3056	1257	1340	4388	1506	3063	4526	3670	3013	3189	4549	557	1066	434	3237
1937_Total cerebral brain volume (GEE, adjusted for age and sex)	1937_Total cerebral brain volume (GEE, adjusted for age and sex)	25	435	1	758	435	4421	3539	1947	2632	1998	2613	1646	2176	1377	3575	658	4597	1337	1776	2593	4405
2063_COL18A1 - Endostatin	2063_COL18A1 - Endostatin	25	435	1	1615	4732	854	4328	3059	1989	2136	1234	2468	1300	3762	2550	3069	435	2769	527	4184	2389
3785_Intelligence	3785_Intelligence	25	435	1	3324	3971	4509	3761	880	1258	3517	4189	3479	4576	1416	2176	2244	1867	2930	435	1768	625
1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	1876_Shaft average buckling ratio (FBAT, male, adjussted for age)	25	436	1	4721	4232	661	1246	1277	3746	883	1930	2886	2694	436	3050	796	2886	3025	3887	3458	2544
1145_Insulin secretion rate (adjusted for BMI)	1145_Insulin secretion rate (adjusted for BMI)	25	436	1	4006	2728	1297	4210	2098	1212	564	4024	1921	2011	2851	4072	2624	986	436	3221	4556	1237
2050_Periodontal complex trait 5 - Pg trait	2050_Periodontal complex trait 5 - Pg trait	25	437	1	2242	437	3633	1367	1619	2754	1576	4196	1765	2806	2942	3015	1744	2580	1157	2348	3712	3721
4023_Hair (Straight/curly)	4023_Hair (Straight/curly)	25	437	1	2649	3681	2419	1569	437	2185	4524	4127	3457	3774	2118	2642	859	3441	3730	616	4466	1359
1964_MMSE score (at exam 5, FBAT, adjusted for age)	1964_MMSE score (at exam 5, FBAT, adjusted for age)	25	437	1	2105	675	4582	3378	4264	4722	2253	1050	1606	2518	1963	924	437	3257	1837	3712	4575	1823
49_Age at first birth (male)	49_Age at first birth (male)	25	437	1	735	1461	4261	4133	807	3570	493	1052	3344	2625	2184	1790	1213	4463	1942	437	1464	942
682_::::X-10395	682_::::X-10395	25	438	1	2014	438	2167	2550	3065	2574	830	4191	750	588	2635	997	3701	890	1215	2797	1530	2210
1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	1589_Factor VII (at exam 5, GEE, adjusted for multivariable)	25	439	1	4683	439	507	3361	591	1856	697	2789	673	4075	2242	1154	2868	1311	2280	1163	552	3501
2565_PRTN3 - Myeloblastin	2565_PRTN3 - Myeloblastin	25	439	1	3261	4544	4257	439	4211	4356	734	4035	4635	3759	4618	683	4311	1061	1476	1236	2355	3642
2807_TKT - Transketolase	2807_TKT - Transketolase	25	439	1	4043	1161	2446	1444	1295	690	439	4467	2542	1046	2445	788	3276	1023	3932	1659	3354	1310
2971_EREG - Epiregulin	2971_EREG - Epiregulin	25	439	1	1936	2966	4069	2602	3938	1409	4231	2093	1925	2790	4385	439	2999	4153	3877	1845	1496	1442
3796_Depressive symptoms	3796_Depressive symptoms	25	439	1	2253	1299	2276	2963	2114	3703	996	3387	3365	1280	2969	4361	3136	439	3928	2556	3399	1244
450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	450_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (E,Z or Z,E)*	25	439	1	534	1762	3402	3025	2535	3603	3385	1703	2017	2494	4685	3720	3634	1762	3028	2153	439	3955
3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	3418_Fluid intelligence test - Number of fluid intelligence questions attempted within time limit	25	440	1	4142	440	4515	1182	4592	3713	3545	2270	2547	4745	3910	1535	3981	4367	2766	4117	1906	443
1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	1772_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for age and sex)	25	440	1	2426	3488	440	3252	4215	3508	2614	4325	1279	3211	1225	2616	3748	3246	2458	3336	1563	1927
3763_Depression - Recent feelings of depression	3763_Depression - Recent feelings of depression	25	440	1	2738	3914	2792	4507	4452	528	4078	4499	4006	440	4566	4585	2695	3561	1974	2023	707	3083
4492_Right pars orbitalis	4492_Right pars orbitalis	25	440	1	1017	2259	771	1248	2145	2589	1452	613	923	2643	440	4143	1003	1367	1977	1182	1206	1587
2865_IL12B IL23A - Interleukin-23	2865_IL12B IL23A - Interleukin-23	25	440	1	4707	1802	3709	1959	4020	4196	1343	4010	1542	652	4198	440	4402	2766	558	4690	3401	4408
3875_Eosinophil percentage of white cells (three-way meta)	3875_Eosinophil percentage of white cells (three-way meta)	25	440	1	1098	4160	4433	1259	1094	2493	1940	4054	1174	3663	4186	677	2003	3700	440	2075	2990	2668
4008_Osteoarthritis of knee (hospital diagnosed)	4008_Osteoarthritis of knee (hospital diagnosed)	25	440	1	3550	4714	4274	2637	1162	1432	1870	2496	3921	2069	691	2572	3579	3601	1692	440	1034	4601
401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	401_Amino acid::Phenylalanine & tyrosine metabolism::tyrosine	25	441	1	4295	2699	441	4510	1485	801	4694	4571	1711	2039	3907	3543	3729	3646	683	3486	2169	4626
2995_FCAR - Immunoglobulin alpha Fc receptor	2995_FCAR - Immunoglobulin alpha Fc receptor	25	441	1	566	3754	2400	868	441	2276	1756	3158	976	902	1578	3081	4202	3947	688	1925	904	2209
3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	3105_PDE9A - High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A	25	441	1	3607	1662	3605	4397	982	3101	2681	441	4644	4664	3525	1029	2797	3745	1934	3425	1861	1913
1989_Age at death (GEE, adjusted for multivariable)	1989_Age at death (GEE, adjusted for multivariable)	25	441	1	1316	1987	3909	3861	2624	1115	3904	1958	1650	441	4547	3820	2970	4018	3172	3734	3270	1479
2132_LAYN - Layilin	2132_LAYN - Layilin	25	441	1	4735	543	645	1872	4510	2238	2111	4076	3578	3019	441	3637	2464	1693	4651	3182	2597	2604
2772_CFL1 - Cofilin-1	2772_CFL1 - Cofilin-1	25	441	1	1636	4386	3560	4154	3897	3494	3819	1297	4667	4520	3222	441	4020	1120	684	3978	788	2585
4401_Menstruation quality of life impact: Headache	4401_Menstruation quality of life impact: Headache	25	441	1	3349	3864	3998	4419	2817	3984	3150	3061	2221	3544	4226	4173	1560	441	4585	4483	3623	2579
2934_NTRK2 - BDNF/NT-3 growth factors receptor	2934_NTRK2 - BDNF/NT-3 growth factors receptor	25	441	1	2331	3579	2174	2401	2892	4270	1619	2588	1053	4156	4608	2609	1244	796	2028	3025	441	3937
4562_Left pars orbitalis	4562_Left pars orbitalis	25	442	1	2354	442	4569	4601	3043	4369	1168	1846	4597	3658	1974	1568	4616	4166	1599	1156	2752	3813
1229_Parkinson Disease	1229_Parkinson Disease	25	442	1	2670	3064	4154	1874	2217	4282	3747	3102	3061	1295	2341	691	3059	442	2161	4650	4617	3157
1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	1962_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for age)	25	443	1	2893	443	4340	4046	2792	2608	615	4334	4699	3887	3088	4421	3780	1181	2950	4703	3945	4240
4258_Facial attractiveness (male-coder, male samples)	4258_Facial attractiveness (male-coder, male samples)	25	443	1	2394	4432	976	1505	2655	817	4076	446	1000	4310	4300	443	1605	3515	855	3201	2802	1894
3503_Male-specific factors - Hair/balding pattern: Pattern 4	3503_Male-specific factors - Hair/balding pattern: Pattern 4	25	443	1	1156	3506	1597	661	4238	3174	3886	1845	1430	1827	3876	3672	1927	3931	4038	1243	443	1019
4198_Waist-hip ratio (male)	4198_Waist-hip ratio (male)	25	444	1	3201	3886	2940	1269	3891	2929	444	3279	1084	4136	4676	2986	560	4386	3317	1199	4526	927
674_::::X-08402	674_::::X-08402	25	444	1	4050	1510	4026	447	2146	3285	4567	1591	2129	977	4381	4141	2209	1071	444	2113	4719	2470
3239_Exposure to tobacco smoke outside home	3239_Exposure to tobacco smoke outside home	25	445	1	2663	4032	4657	445	649	1519	1692	3650	777	4241	1229	4566	2893	3521	1102	815	1772	2273
1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	1685_Brain natriuretic peptide (at exam 6, GEE, adjusted for multivariable)	25	445	1	1837	3324	1025	615	3354	4087	3350	1343	3252	445	2778	1967	1059	1089	2522	3439	4060	586
2755_SERPINA3 - alpha-1-antichymotrypsin complex	2755_SERPINA3 - alpha-1-antichymotrypsin complex	25	445	1	4619	878	937	2794	456	1430	1470	3465	1919	1278	1414	2139	1386	4455	445	3964	591	1763
3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	3166_TNFRSF21 - Tumor necrosis factor receptor superfamily member 21	25	445	1	1284	3922	4577	3309	4615	3610	1409	3418	4659	3203	4595	4289	4363	1930	2556	445	2160	4719
4600_Right rostral anterior cingulate	4600_Right rostral anterior cingulate	25	446	1	4740	446	1458	4047	4425	1543	2531	815	865	2462	2320	2997	3562	4057	4616	2289	2899	1668
658_::::X-04357	658_::::X-04357	25	446	1	2247	4280	3836	1106	446	1712	2331	3862	2662	3830	1625	4106	1579	1733	4422	4558	3686	612
4041_Schizophrenia vs Bipolar disorder	4041_Schizophrenia vs Bipolar disorder	25	446	1	3981	3262	2670	684	2768	2913	4309	4205	2053	4669	2861	446	4491	3648	2304	3572	4387	1577
2098_IGFBP2 - Insulin-like growth factor-binding protein 2	2098_IGFBP2 - Insulin-like growth factor-binding protein 2	25	446	1	1697	3000	2114	4420	1414	1915	3749	3455	2243	1301	4594	2349	2941	446	2106	1786	4558	2569
4067_Cognitive performance	4067_Cognitive performance	25	446	1	3718	4318	2119	4304	2976	1610	2527	2691	3742	2530	2357	3246	1218	706	2897	446	2418	838
3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	3114_HMGCR - 3-hydroxy-3-methylglutaryl-coenzyme A reductase	25	447	1	3777	4162	3248	2945	4021	447	2169	3896	3904	1102	4104	2836	4515	2665	454	2485	3292	3639
3201_Job involves heavy manual or physical work	3201_Job involves heavy manual or physical work	25	447	1	2474	3577	2901	3319	1173	1356	4370	1959	2127	2390	447	3140	4178	4003	3917	556	901	1288
3805_Platelet count	3805_Platelet count	25	447	1	650	858	938	3485	1408	1840	1953	3290	974	752	4550	981	2712	4554	447	4155	3196	576
391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	391_Amino acid::Phenylalanine & tyrosine metabolism::3-(3-hydroxyphenyl)propionate	25	448	1	448	2372	3610	3270	3044	4477	624	1328	4631	2955	4330	3010	4483	511	3563	1074	3513	3121
529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	529_Lipid::Long chain fatty acid::stearidonate (18:4n3)	25	448	1	1038	448	657	2490	2434	4399	3024	2445	4712	3175	1945	818	1511	1280	940	2741	2677	3176
1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	1897_Shaft Section Modulus (GEE, male, adjussted for multivariable)	25	448	1	535	4017	1094	3527	3851	2053	2145	466	1091	1971	448	737	780	4067	3972	3358	3072	715
1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	1764_Heart failure (free of MI, FBAT, adjusted for age and sex)	25	448	1	3904	3179	4095	2587	1632	514	3568	3963	3553	2118	4567	3974	2041	448	559	4034	4655	3049
1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	1655_Tumor necrosis factor receptor II (at exam 7, GEE, adjusted for age and sex)	25	448	1	2675	4004	2597	712	4650	1092	1922	3253	4340	2965	1985	562	957	3051	448	944	1704	4504
2799_PSMA2 - Proteasome subunit alpha type-2	2799_PSMA2 - Proteasome subunit alpha type-2	25	449	1	3706	449	4338	4392	3119	4582	807	2755	3071	4697	3846	4131	4055	4504	2382	3923	2740	2354
4506_Right insula	4506_Right insula	25	449	1	2547	2351	3452	4056	1369	449	3424	681	1332	4605	4701	1911	3718	4394	4040	1238	2286	593
364_Amino acid::Alanine and aspartate metabolism::alanine	364_Amino acid::Alanine and aspartate metabolism::alanine	25	449	1	978	1554	810	482	4417	1732	3461	3705	3995	4261	3751	3260	2287	527	3063	1826	449	4176
3144_ANXA6 - Annexin A6	3144_ANXA6 - Annexin A6	25	450	1	450	791	3088	1446	689	1354	854	2323	2931	2514	2190	2857	3711	3595	2732	523	3511	1004
1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	1131_Ratio of visceral-tosubcutaneous adipose tissue volume (female)	25	450	1	4131	3867	450	2523	2422	4155	949	770	1846	2720	1348	4049	2810	2272	2125	1473	1053	1056
176_Waist circumference (male, adjusted for BMI)	176_Waist circumference (male, adjusted for BMI)	25	450	2	4481	2582	2955	450	4730	1505	3069	3681	3468	2194	4449	987	1538	4313	1925	1789	1492	2816
686_::::X-10510	686_::::X-10510	25	450	1	3230	1706	2766	3139	4206	4585	3274	450	4231	744	4320	2387	3679	1792	1109	3680	4407	1057
171_Waist circumference (female)	171_Waist circumference (female)	25	450	1	498	3098	1426	3398	1317	4202	1057	3560	2433	450	2271	515	2514	1065	1762	3332	3234	2694
1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	1644_Osteoprotegerin (at exam 7, FBAT, adjusted for multivariable)	25	450	1	1041	1957	2033	1105	2903	2967	486	1410	3398	4240	4377	450	3300	2333	1027	1481	2988	3027
1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1562_Mean internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	450	1	2126	713	713	2412	3431	2921	2888	2213	3617	2191	3783	4450	450	1480	3381	2661	3076	4542
3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	3674_Diagnoses - main ICD10: K62 Other diseases of anus and rectum	25	450	1	2842	1237	1257	3008	4676	1992	1160	1217	4673	2656	1121	3367	2118	4235	3153	450	4470	2878
2729_AGER - Advanced glycosylation end product-specific receptor, soluble	2729_AGER - Advanced glycosylation end product-specific receptor, soluble	25	450	1	2739	2605	925	3986	2818	2989	2395	3993	4474	3284	4460	2401	3693	1416	2837	1598	2590	450
3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	3058_IL22RA2 - Interleukin-22 receptor subunit alpha-2	25	451	1	3299	451	1115	2936	4504	3203	2411	1362	3465	3143	4083	588	2094	2349	1880	1929	4291	567
2486_KLK7 - Kallikrein-7	2486_KLK7 - Kallikrein-7	25	451	1	3109	3740	2923	2391	4059	4731	3262	2209	3152	3760	2704	4071	4049	451	3683	2100	3370	1776
3992_Miserableness (MIS)	3992_Miserableness (MIS)	25	451	1	4293	2267	3563	3427	4258	1538	1407	2339	727	2332	3836	1941	4691	1596	451	1902	2846	641
570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	570_Lipid::Sterol, Steroid::5alpha-androstan-3beta,17beta-diol disulfate	25	451	1	2042	3751	1791	3534	4724	3507	3959	1701	1305	2172	4111	4057	1431	817	1778	4335	2164	451
1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1260_Residual from predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	452	1	2889	452	4673	3178	3064	2883	2541	3685	4190	1397	2083	2447	4269	2068	1775	3466	3705	1425
2916_FAM107B - Protein FAM107B	2916_FAM107B - Protein FAM107B	25	452	1	2013	1393	2932	2192	1850	3454	868	3648	729	3742	2745	452	4012	2196	907	2104	1706	1252
3243_Dried fruit intake	3243_Dried fruit intake	25	452	1	2255	4267	4741	4603	2646	1059	3212	3741	2059	2829	2506	2463	3519	1331	4452	452	3771	2450
3354_Age stopped smoking	3354_Age stopped smoking	25	452	1	1880	3670	4628	2287	4663	2074	2450	3284	4539	1500	993	1596	3882	2860	2792	4108	1602	452
452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	452_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::heme*	25	453	1	1769	2057	2013	2445	3786	2217	2274	3296	453	2306	4273	4054	2584	1342	2235	1501	3164	1500
2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	2494_AKT1 AKT2 AKT3 - Protein kinase B alpha/beta/gamma	25	454	1	1952	4143	2024	2353	4572	2446	2428	2277	4226	454	3049	3759	4021	3227	3900	2359	870	3892
345_NKearly:%337+	345_NKearly:%337+	25	454	1	1925	972	3718	4165	4347	1221	2492	715	1596	2845	772	1166	454	1426	2258	3407	3217	1928
2412_NID1 - Nidogen-1	2412_NID1 - Nidogen-1	25	455	1	3253	710	4258	3546	4336	4319	2100	455	2398	4118	3470	1362	3765	1626	3926	467	2613	4432
1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	1705_Follicle stimulating hormone (at exam 3, GEE, adjusted for multivariable)	25	455	1	2152	4368	3783	1241	673	1305	3895	3947	4304	2263	2839	4696	3917	789	3808	455	1738	2187
717_::::X-11529	717_::::X-11529	25	456	1	456	3416	961	1265	506	2122	2360	2017	561	2308	2185	1713	2099	1137	2572	4649	2982	3789
1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	1976_Hand grip (at offspring exam 7 cohort exam 27, FBAT)	25	456	1	2318	4472	4654	1071	2248	1806	456	2579	3025	2319	4275	4197	2352	2087	1389	4254	4091	2294
4164_Juvenile Absence Epilepsy (JAE)	4164_Juvenile Absence Epilepsy (JAE)	25	456	1	2315	1445	577	2028	952	4718	2804	4288	456	3744	3368	2008	2213	2925	3054	2232	3343	3609
4389_Bust size	4389_Bust size	25	456	1	3436	2136	1819	659	3740	3707	2651	821	1035	3776	456	1929	3700	4081	1055	4191	3826	3958
2918_SERPINA6 - Corticosteroid-binding globulin	2918_SERPINA6 - Corticosteroid-binding globulin	25	456	1	2629	4262	1871	2411	1142	2672	2370	4193	2408	2569	663	881	2333	464	1499	456	4098	3388
1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1790_QT interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	456	1	4731	1732	2279	3407	2502	3441	3180	4687	1152	3268	2281	1940	4231	1509	1551	2776	456	1819
2066_PROK1 - Prokineticin-1	2066_PROK1 - Prokineticin-1	25	457	1	560	457	2966	1084	2007	4061	2482	3396	1695	4597	2307	4532	3642	494	3615	2486	2403	4386
3323_Ever had prostate specific antigen (PSA) test	3323_Ever had prostate specific antigen (PSA) test	25	457	1	2166	2821	3396	457	4411	3435	4423	3377	2922	1584	4715	3749	3702	4437	3659	888	2284	4587
1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	1600_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for multivariable)	25	457	1	1887	4070	1531	2667	1301	457	3515	2554	1557	463	1291	1266	2112	1846	856	617	573	1160
4405_Menstrual quality of life impact: Pressure in the breasts	4405_Menstrual quality of life impact: Pressure in the breasts	25	457	1	4060	1637	1826	1883	1478	1063	3250	1181	821	968	3569	1249	457	4284	3029	2436	2040	2549
3299_Frequency of tenseness / restlessness in last 2 weeks	3299_Frequency of tenseness / restlessness in last 2 weeks	25	457	1	3508	2265	4174	4348	1841	1931	2282	4284	3927	3626	4307	978	2847	3902	457	3051	1971	1395
1235_Usual weekday sleep duration (GEE)	1235_Usual weekday sleep duration (GEE)	25	458	1	2619	468	458	2665	974	3353	3799	528	2937	1298	3534	1945	3089	1630	1557	1660	4668	2897
2405_KREMEN2 - Kremen protein 2	2405_KREMEN2 - Kremen protein 2	25	458	1	1086	3876	2256	981	458	2095	603	2873	4082	3527	3595	3592	642	2556	929	4308	4284	1660
2141_GDI2 - Rab GDP dissociation inhibitor beta	2141_GDI2 - Rab GDP dissociation inhibitor beta	25	458	1	685	4734	2357	1128	1247	580	1776	1729	920	458	1168	3119	1114	3353	2794	4600	4164	2864
4341_Moderate intesity	4341_Moderate intesity	25	458	1	3116	3344	624	1712	1086	2475	4338	3069	560	1107	4512	458	1088	3338	2300	2601	3704	623
1904_Hippocampal volume (FBAT, adjusted for multivariable)	1904_Hippocampal volume (FBAT, adjusted for multivariable)	25	459	1	946	459	1109	842	1933	3168	4229	1294	824	3648	2583	3064	1220	2186	1651	4314	2128	1956
3522_Current employment status: Unable to work because of sickness or disability	3522_Current employment status: Unable to work because of sickness or disability	25	459	1	4279	2967	459	4473	616	3778	4452	1418	1095	3060	897	976	4649	1836	3283	3602	4037	3275
2080_PLA2G5 - Calcium-dependent phospholipase A2	2080_PLA2G5 - Calcium-dependent phospholipase A2	25	459	1	3707	4454	780	1581	4345	459	2805	4566	3577	4352	1164	3184	3209	1455	1734	1286	4480	2388
194_Estimated glomerular filtration rate based on cystain C	194_Estimated glomerular filtration rate based on cystain C	25	459	1	2435	670	4346	697	1672	4634	1060	3630	2750	3966	4343	4590	459	2302	1751	2854	4493	3328
2490_PAK7 - Serine/threonine-protein kinase PAK 7	2490_PAK7 - Serine/threonine-protein kinase PAK 7	25	459	1	2857	3073	2547	2201	1786	3877	4105	2771	819	3392	3152	660	1042	764	459	4527	3950	546
3050_EPHA10 - Ephrin type-A receptor 10	3050_EPHA10 - Ephrin type-A receptor 10	25	460	1	4538	460	2075	2390	3965	2762	3639	3040	1780	3363	806	3120	2480	4515	4447	2272	2137	2744
4696_Cingulum (hippocampus) mean diusivities	4696_Cingulum (hippocampus) mean diusivities	25	460	1	4277	1396	2567	460	3824	2100	2029	3698	3201	4724	3879	1426	1445	2208	567	3089	2706	1176
4697_Corticospinal tract mean diusivities	4697_Corticospinal tract mean diusivities	25	460	1	1222	651	3532	2336	4183	4126	528	975	2578	792	460	3286	4467	2971	3520	3123	1420	1636
143_Body Mass Index	143_Body Mass Index	25	461	1	461	1950	3012	3261	1005	3094	3437	3302	3391	1266	2879	3877	2228	1418	3590	3406	2715	3604
4150_Left ventricular mass	4150_Left ventricular mass	25	461	1	3028	3961	3652	2908	1165	507	2595	3731	1723	3380	461	4323	3451	726	832	4039	3404	2657
2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	2725_UBE2N - Ubiquitin-conjugating enzyme E2 N	25	461	1	3731	3759	1141	3752	3929	2502	967	463	3127	1960	3843	2961	4210	461	1016	2102	2118	1236
3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	3720_Frequency of failure to fulfil normal expectations fue to drinking alcohol in last year	25	462	1	3406	462	4147	4003	4076	4531	4488	2880	537	3186	1643	869	2353	2359	2878	864	2770	1129
1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	1592_Log ADP platelet aggregation (at exam 5, FBAT, adjusted for multivariable)	25	462	1	4049	1944	1814	4598	462	4140	4054	614	2447	4189	3922	4526	3958	4395	3660	1043	1279	3876
4142_Systolic Blood Pressure	4142_Systolic Blood Pressure	25	462	1	1436	1956	3795	816	3676	3065	2818	462	1276	2445	3174	2061	721	4333	2745	3462	1541	2850
1832_Neck length (FBAT, male, adjusted for multivariable)	1832_Neck length (FBAT, male, adjusted for multivariable)	25	462	1	2491	3343	855	1382	3360	2024	4168	946	1391	1723	1642	4118	4424	3574	4148	1737	462	2796
4748_Posterior limb of internal capsule radial diusivities	4748_Posterior limb of internal capsule radial diusivities	25	462	1	2120	3561	576	2700	3683	632	1500	880	1364	2755	4398	3697	2223	3034	1144	2990	4653	462
3868_White blood cell count (two-way meta)	3868_White blood cell count (two-way meta)	25	463	1	1021	3794	463	3250	2423	4338	3394	2906	3429	1943	1440	2660	732	2620	2267	1176	3801	1772
3018_CLIC1 - Chloride intracellular channel protein 1	3018_CLIC1 - Chloride intracellular channel protein 1	25	463	1	2594	944	3231	4314	463	4537	1242	3913	4040	1961	4081	3020	4584	1621	2929	3646	1736	2516
1150_Corrected insulin response (adjusted for insulin sensitivity index)	1150_Corrected insulin response (adjusted for insulin sensitivity index)	25	463	1	2813	2643	4212	1420	1840	463	1753	948	1735	1829	4605	4325	787	2341	2959	3265	639	3224
2983_CA2 - Carbonic anhydrase 2	2983_CA2 - Carbonic anhydrase 2	25	463	1	3439	3110	923	4365	4032	2978	463	4378	4330	3452	2505	504	858	2122	3298	4312	2628	1426
4430_Varicella Zoster Virus IgG levels	4430_Varicella Zoster Virus IgG levels	25	463	1	1418	667	3141	1440	4282	3398	3557	1420	463	3516	750	3702	4187	705	1382	3983	2580	2630
2146_NTRK3 - NT-3 growth factor receptor	2146_NTRK3 - NT-3 growth factor receptor	25	464	1	1983	3178	464	1806	4019	2243	4375	3873	3393	3405	3797	3957	1662	3673	1664	4004	3139	1917
2531_LCK - Tyrosine-protein kinase Lck	2531_LCK - Tyrosine-protein kinase Lck	25	464	1	3145	4042	4111	464	1825	4665	4610	2628	2374	4672	1031	3289	1425	2576	1304	3179	2867	1743
4575_Left transverse temporal	4575_Left transverse temporal	25	464	1	1145	2922	862	3066	1154	2220	3310	464	1722	2188	3497	1436	4432	4493	4389	3776	4414	3254
225_B Mem:%IgE	225_B Mem:%IgE	25	464	1	2752	1723	2657	2955	3175	2862	2101	1816	3007	3102	3677	2948	3392	1600	1392	4497	464	3158
3180_STIP1 - Stress-induced-phosphoprotein 1	3180_STIP1 - Stress-induced-phosphoprotein 1	25	465	1	567	3190	4649	1981	913	465	1465	739	1523	3958	3576	3294	4347	2990	2119	1691	4067	3656
3780_Depression - Did your sleep change?	3780_Depression - Did your sleep change?	25	465	1	4166	1153	2882	4600	3041	3053	4526	3267	2601	465	1473	3515	3336	2767	2915	4602	3846	851
4415_Varicella Zoster Virus seropositivity	4415_Varicella Zoster Virus seropositivity	25	465	1	1080	2480	1018	2892	2099	2278	653	4546	4567	3495	1891	4127	3984	3575	465	1566	3263	1908
1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1880_Shaft cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	466	1	2530	3284	466	4157	4362	511	1533	3983	3294	2133	3936	953	2368	2882	3882	2746	3314	2541
2656_CA3 - Carbonic anhydrase 3	2656_CA3 - Carbonic anhydrase 3	25	466	1	1591	3216	1505	4566	466	4132	4151	785	3777	2463	4157	1517	1459	1932	3290	2972	3239	1779
855_ApoB	855_ApoB	25	466	1	4352	671	3385	1845	2868	3030	2061	1671	4534	4607	2370	991	4453	4349	1100	1164	466	692
2173_IL37 - Interleukin-37	2173_IL37 - Interleukin-37	25	467	1	467	3809	4371	2935	1998	781	4269	4248	2958	4124	3724	4303	4246	1212	4332	2794	2992	2677
1103_Insulin - Birth cohorts	1103_Insulin - Birth cohorts	25	467	1	2993	3311	2541	2075	2854	894	3282	1686	467	4510	2831	3235	2463	2509	3887	2403	2937	3318
4645_White matter	4645_White matter	25	467	1	3084	2411	896	3873	1124	2592	1684	4415	4131	3402	1527	1840	3872	467	1834	4165	3181	2832
480_Lipid::Carnitine metabolism::decanoylcarnitine	480_Lipid::Carnitine metabolism::decanoylcarnitine	25	467	1	3791	2288	2897	2436	1829	3067	3715	1844	883	2933	1825	2013	3477	2713	1683	2055	467	2416
3012_MAPK13 - Mitogen-activated protein kinase 13	3012_MAPK13 - Mitogen-activated protein kinase 13	25	468	1	468	3396	3220	3973	1462	4103	1038	1055	4219	2437	3236	3755	2373	709	1402	4423	3565	531
3451_Impedance measures - Impedance of arm (left)	3451_Impedance measures - Impedance of arm (left)	25	468	1	1334	4144	3016	3352	468	4372	4424	1018	2767	1275	3445	4620	4417	1981	3643	3607	2120	2104
425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	425_Amino acid::Valine, leucine and isoleucine metabolism::alpha-hydroxyisovalerate	25	468	1	3422	2584	2754	2332	1201	504	2699	2116	3192	3770	2066	468	2917	1809	3789	2783	2132	4469
1877_Shaft average buckling ratio (GEE, male, adjussted for age)	1877_Shaft average buckling ratio (GEE, male, adjussted for age)	25	468	1	2167	4147	4705	4623	1230	4074	3858	4154	1816	4349	1423	3444	1151	1582	468	1375	1370	3369
2944_POMC - Corticotropin	2944_POMC - Corticotropin	25	469	1	469	3259	2293	4703	542	2227	742	1218	2350	4031	4703	3741	1357	1818	3522	1017	1257	4627
3824_Celiac disease	3824_Celiac disease	25	469	1	4499	1839	469	2755	2615	3509	1394	793	762	897	478	2838	1226	3634	2565	2410	633	2475
4539_Right amygdala	4539_Right amygdala	25	469	1	4155	3709	4203	469	1363	1683	2432	2541	1494	738	4289	2260	2062	957	3565	1465	2782	3416
84_Forearm BMD	84_Forearm BMD	25	469	1	4222	4433	903	831	487	3987	3643	469	4248	1254	3207	4023	3841	1159	2167	2468	4343	4099
2746_XCL1 - Lymphotactin	2746_XCL1 - Lymphotactin	25	469	1	4016	3788	3769	2478	975	1835	4650	1629	3004	1331	4309	2423	469	3946	4730	3587	1281	4289
1160_Fasting insulin main effect (adjusted for BMI)	1160_Fasting insulin main effect (adjusted for BMI)	25	469	1	3460	3261	1642	3167	2586	4091	1506	4179	1864	551	4288	3973	2607	3032	4289	712	469	1372
3284_Mood swings	3284_Mood swings	25	469	1	2696	4264	3974	3609	1678	2310	3292	3012	3875	3848	3197	1492	3227	3560	2270	3172	1139	469
3790_Daytime sleepiness / dozing	3790_Daytime sleepiness / dozing	25	470	1	4014	3314	1547	668	470	2951	2544	1510	2351	4208	2974	3019	3764	2428	4183	1496	2099	1536
4659_Posterior corona radiata fractional anisotropy	4659_Posterior corona radiata fractional anisotropy	25	470	1	4509	3070	3556	1103	3225	2455	3178	1156	1002	1774	4019	4228	4252	2855	470	3565	3091	489
3260_Variation in diet	3260_Variation in diet	25	470	1	1414	2069	3190	1733	1805	2968	3273	1832	3595	1265	1929	4318	2791	1765	1555	470	2789	748
4438_Helicobacter pylori IgG levels	4438_Helicobacter pylori IgG levels	25	470	1	1140	2118	4144	4108	2592	2265	1658	4590	3926	4525	4654	3545	2770	571	1409	3281	470	3320
977_Granulocyte colony-stimulating factor	977_Granulocyte colony-stimulating factor	25	471	1	4401	2357	590	4239	4375	471	991	3879	1018	2275	2690	878	2169	4568	757	1230	2609	2782
1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	1918_Total cerebral brain volume (FBAT, adjusted for multivariable)	25	471	1	559	2982	4543	2298	1039	1559	1770	1640	471	3854	3456	3394	1199	4638	4234	4210	3140	2772
3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	3132_BCAR3 - Breast cancer anti-estrogen resistance protein 3	25	472	1	3415	4195	774	472	2395	3439	1720	3933	2416	4667	3777	2840	506	3326	3874	3148	3097	3833
2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	2674_MAPKAPK3 - MAP kinase-activated protein kinase 3	25	472	1	3091	1986	1282	1340	472	4376	1814	4583	966	3681	4057	1838	2573	2545	1235	4368	4231	2134
1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	1626_Interleukin 6 (at exam 7, FBAT, adjusted for age and sex)	25	472	1	4530	2000	4665	4461	3818	1522	4510	4591	1134	3978	2441	472	3691	1188	1327	4182	4611	853
2160_OSM - Oncostatin-M	2160_OSM - Oncostatin-M	25	472	1	2108	4003	503	3175	1574	4237	3027	3138	688	1314	3007	4694	1654	1543	1361	472	3944	1326
4301_Arms-arm fat ratio (male)	4301_Arms-arm fat ratio (male)	25	472	1	3366	3684	4121	2372	3358	3468	2654	4043	1581	1030	4053	3194	4342	3455	2485	4143	4096	472
3895_Neutrophil count (three-way meta)	3895_Neutrophil count (three-way meta)	25	473	1	473	3592	1580	4695	4393	4362	2243	4447	3648	4174	3957	3259	1204	4079	2747	1822	2583	2628
1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	1395_High-density lipoprotein 2 cholesterol (at exam 4, GEE, adjusted for age and sex)	25	473	1	1199	2702	2186	986	473	4539	4082	1549	1201	3719	3153	4419	1657	4141	2396	4744	2227	1478
1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	1773_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for age and sex)	25	473	1	2930	1624	3189	1572	2132	3512	972	3374	473	2751	3446	2063	2393	4665	3772	3592	3453	1107
2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	2907_HSD17B1 - Estradiol 17-beta-dehydrogenase 1	25	473	1	2029	3601	2339	1021	1634	3485	2732	1753	3724	473	2620	2251	2488	3966	474	1684	4240	2547
3582_Types of transport used (excluding work): Walk	3582_Types of transport used (excluding work): Walk	25	474	1	1861	474	1780	2291	540	4555	3673	2037	1685	3824	494	2201	1315	1632	1440	678	3907	4527
4371_Thyroid-stimulating hormone (female)	4371_Thyroid-stimulating hormone (female)	25	474	1	806	1766	1811	1989	1711	474	3235	3619	2520	1931	3787	3549	2053	3826	3399	3133	1388	3227
451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	451_Cofactors and vitamins::Hemoglobin and porphyrin metabolism::bilirubin (Z,Z)	25	474	1	1273	2708	4304	4693	4458	2928	474	2006	2560	1618	1144	3959	3039	811	2391	1954	1801	2106
1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	1775_Coronary heart disease (MI, CI or CHD death, GEE, adjusted for multivariable)	25	474	1	1703	3964	726	3263	2589	3830	1925	3045	2797	474	2617	2854	4581	1989	2438	607	2464	747
3300_Frequency of tiredness / lethargy in last 2 weeks	3300_Frequency of tiredness / lethargy in last 2 weeks	25	474	1	2677	1948	689	1576	2313	4733	4286	1013	3458	3301	474	2399	2195	4078	1060	2085	4288	1627
29_Openness to Experience (NEO-FFI)	29_Openness to Experience (NEO-FFI)	25	475	1	862	4025	3183	3490	475	4001	3793	4195	2306	3563	1919	2519	3770	2618	1213	2991	3818	4149
1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1550_Maximum common carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	475	1	4399	556	1459	1131	4010	3820	475	2538	2499	2284	1533	3223	2182	1743	3517	4374	4027	902
3948_1p deletion neuroblastoma	3948_1p deletion neuroblastoma	25	475	1	1944	2537	4418	2902	650	3941	3908	1215	1296	475	3882	1243	4716	3472	3773	2093	3888	4215
3149_CKAP2 - Cytoskeleton-associated protein 2	3149_CKAP2 - Cytoskeleton-associated protein 2	25	475	1	4730	2859	1253	3666	3027	1579	965	651	3260	4439	3858	3823	475	1303	4716	3643	905	3085
202_Estimated glomerular filtration rate based on cystain C	202_Estimated glomerular filtration rate based on cystain C	25	475	1	2050	596	3309	1490	2675	746	576	3263	4344	4531	2122	1648	2389	3960	475	2540	3240	534
2236_FRZB - Secreted frizzled-related protein 3	2236_FRZB - Secreted frizzled-related protein 3	25	475	1	1396	2864	4146	1977	2986	1201	866	952	638	3415	3280	4465	2232	3410	4164	475	4224	3130
3496_Hair colour (natural, before greying): Red	3496_Hair colour (natural, before greying): Red	25	476	1	4686	476	3865	4578	2654	4292	4004	1209	3006	852	3100	3338	1655	4383	3884	2094	2487	3681
1128_Visceral adipose tissue sttenutation (female)	1128_Visceral adipose tissue sttenutation (female)	25	476	1	2236	2935	511	3639	1331	476	4127	3442	2453	2795	4372	1180	931	3339	1635	4109	4517	1415
306_CD4mem:%cFTH (2)	306_CD4mem:%cFTH (2)	25	476	1	4243	3461	2905	4543	592	3896	3295	476	2473	1217	3736	1228	2426	4218	1164	3099	557	1911
990_Interleukin-2 receptor, alpha subunit	990_Interleukin-2 receptor, alpha subunit	25	476	1	515	3785	1897	3177	1350	823	4433	2564	476	4493	1370	4163	3813	616	1199	2420	2271	3476
1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	1953_Boston Naming Test score without cues (GEE, adjusted for multivariable)	25	476	1	3692	2495	1876	4106	3342	4235	4460	1480	1231	476	3923	2060	3835	2496	2709	1708	4382	4725
1151_Disposition index	1151_Disposition index	25	476	1	2922	3717	4479	3287	1019	2320	4728	2516	4602	1581	3903	2944	476	4678	3555	3369	4707	2245
4466_Left precentral	4466_Left precentral	25	477	1	477	4457	550	3128	2487	1438	3361	2279	2591	1066	4640	3388	1761	4362	3518	784	1075	2896
4332_Erectile dysfunction	4332_Erectile dysfunction	25	477	1	4044	2225	2032	477	520	3335	4183	4140	1290	4701	612	2448	1973	3385	4479	1792	1661	614
1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	1632_Urinary isoprostanes/creatinine (at exam 7, FBAT, adjusted for multivariable)	25	477	1	532	4496	2984	4326	477	3595	3514	3662	4724	3980	3617	1752	3819	2914	4174	4533	4464	1381
3521_Current employment status: Looking after home and/or family	3521_Current employment status: Looking after home and/or family	25	477	1	659	4485	905	1992	872	477	4368	4357	2153	4719	2277	4347	729	3231	1748	1113	1173	4234
1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	1778_Heart failure (censored at interval MI, FBAT, adjusted for multivariable)	25	477	1	3928	1855	1868	2724	2021	3289	477	1872	2818	2442	1638	2631	3068	3740	4325	3493	2980	2876
3035_SSRP1 - FACT complex subunit SSRP1	3035_SSRP1 - FACT complex subunit SSRP1	25	477	1	4621	3241	4283	634	4079	1547	2936	942	477	3457	1836	4698	3975	1279	2354	3568	887	1503
1179_Insomnia (male)	1179_Insomnia (male)	25	477	1	2191	4176	2258	2458	1402	2406	2327	1736	2856	1215	1636	723	3465	3542	477	829	1278	3384
983_Interleukin-13	983_Interleukin-13	25	477	1	2445	4295	3481	2562	2990	2962	4354	2106	1749	951	4103	3305	1124	3451	3374	477	3824	4385
3527_Transport type for commuting to job workplace: Cycle	3527_Transport type for commuting to job workplace: Cycle	25	478	1	1610	3441	478	1109	2335	3266	4180	2701	805	766	4446	1685	1822	1510	1723	602	3241	3122
1919_Total cerebral brain volume (GEE, adjusted for multivariable)	1919_Total cerebral brain volume (GEE, adjusted for multivariable)	25	478	1	509	2869	2457	3254	3489	1641	478	1064	676	2057	832	4271	820	2288	2945	1580	3553	4156
3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	3585_Types of physical activity in last 4 weeks: Walking for pleasure (not as a means of transport)	25	478	1	1264	846	3361	4617	3398	1591	2359	1250	478	2967	1221	3330	775	917	3583	1487	635	1782
2713_ING1 - Inhibitor of growth protein 1	2713_ING1 - Inhibitor of growth protein 1	25	478	1	1904	1126	3767	4072	1434	756	4391	2366	4159	478	1894	2813	1438	1943	3957	3794	3008	2999
2953_LGALS8 - Galectin-8	2953_LGALS8 - Galectin-8	25	478	1	4385	3910	1984	1074	740	3052	3653	1760	2638	2303	3069	1833	3796	478	555	2078	1751	4640
1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	1610_von Willebrand Factor (at exam 5, FBAT, adjusted for age and sex)	25	478	1	3101	1773	3529	2797	2617	4252	4734	1936	4488	1424	3193	527	1489	3525	478	2902	2681	4140
644_Xenobiotics::Xanthine metabolism::3-methylxanthine	644_Xenobiotics::Xanthine metabolism::3-methylxanthine	25	478	1	1596	3458	1689	3502	2029	1476	2671	1563	3334	3569	1046	2449	484	1105	2242	1891	478	3404
4639_Right hippocampus	4639_Right hippocampus	25	478	1	1460	683	4476	1619	1251	3400	1004	4384	1558	2228	1640	2750	3164	2662	685	917	4421	478
4555_Left lateral orbitofrontal	4555_Left lateral orbitofrontal	25	479	1	955	4375	479	4226	867	1791	993	3105	4241	1389	879	1750	2487	1941	3764	2829	2085	2919
651_::::X-02249	651_::::X-02249	25	479	1	1452	629	3825	2041	2264	822	1565	683	479	493	525	3347	2020	1088	4072	2639	1200	1727
2954_PLA2G1B - Phospholipase A2	2954_PLA2G1B - Phospholipase A2	25	479	1	1386	1836	622	1667	4405	3210	707	2176	3560	479	1717	2490	4549	2958	1825	1338	1507	4658
3731_Depression - Difficulty concentrating during worst ddepression	3731_Depression - Difficulty concentrating during worst ddepression	25	479	1	2786	2963	1278	3307	4286	1176	2980	1139	4705	3685	646	479	1460	3773	3685	2893	1435	1264
4136_Hemoglobin	4136_Hemoglobin	25	479	1	1224	598	3955	2990	2043	2787	2182	3572	3642	4518	965	1200	3643	479	4315	3257	3863	1775
1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	1474_Mean total cholesterol from exam 1-7 (FBAT, adjusted for age and sex)	25	479	1	3528	3781	2087	1315	1822	1174	2256	1962	2120	3133	3944	2096	4471	2394	1678	479	2917	952
3289_Nervous feelings	3289_Nervous feelings	25	479	1	2116	2644	2132	3368	3338	4557	4073	2330	1342	3166	4220	2718	3738	2743	3573	4546	4475	479
4500_Right rostral middle frontal	4500_Right rostral middle frontal	25	480	1	480	4258	3363	3474	2645	2483	3340	4577	2527	4198	3436	4555	3504	3014	3837	2347	3221	2004
3262_Average weekly red wine intake	3262_Average weekly red wine intake	25	480	1	1394	480	2678	2822	4210	2696	3504	1015	3624	4011	2061	4599	4014	4351	2353	4524	4613	2877
4291_Asthma	4291_Asthma	25	480	1	1573	2733	4716	480	2028	2896	2893	4602	3508	4731	2631	3040	1038	1259	1663	2647	2919	4170
491_Lipid::Essential fatty acid::linoleate (18:2n6)	491_Lipid::Essential fatty acid::linoleate (18:2n6)	25	480	1	2375	1573	4430	1502	4378	2546	3309	1718	480	1063	3353	1125	2518	1994	3299	1109	1566	2809
3989_Heart rate recovery at 50 secnds	3989_Heart rate recovery at 50 secnds	25	480	1	2724	2752	3515	572	3262	4327	632	1269	2263	480	1408	806	3526	2395	3022	2330	1437	3365
4678_Fornix (cres) / Stria terminalis axial diusivities	4678_Fornix (cres) / Stria terminalis axial diusivities	25	480	1	4274	3627	800	2833	2764	1988	495	3784	888	4037	1054	2202	1123	1457	3807	4333	480	1876
771_::::X-12329	771_::::X-12329	25	480	1	2797	3651	2126	4126	3063	4269	4200	1904	1438	2316	3428	2006	4645	794	1898	1718	2002	480
1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1254_Percent predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	481	1	481	2346	2439	1156	1449	1826	1655	4500	4259	838	2761	4210	3871	4746	3157	3575	4069	3791
3511_Reason for reducing amount of alcohol drunk: Other reason	3511_Reason for reducing amount of alcohol drunk: Other reason	25	481	1	3353	481	4211	4017	3231	2491	1889	4390	3509	4451	3369	3202	3628	976	4517	1868	1393	3311
4671_Average across all tracts axial diusivities	4671_Average across all tracts axial diusivities	25	481	1	2000	3825	2430	2914	2665	481	2912	3119	2379	3951	3557	3678	4310	1494	1706	1489	3936	2578
1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1555_Mean common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	482	1	3490	3448	1383	3408	1980	3863	3290	2577	3514	482	3967	2314	3177	4272	3801	1859	3324	2810
1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	1584_D-dimer (at exam 6, FBAT, adjusted for multivariable)	25	482	1	3672	2551	3161	1970	3154	3858	3040	1693	1700	4387	2501	905	482	2863	1649	774	3799	3482
2987_DBNL - Drebrin-like protein	2987_DBNL - Drebrin-like protein	25	482	1	3432	2791	2929	2361	3410	844	3571	2352	521	3792	576	3627	1979	834	482	4563	1043	2481
3430_Fluid intelligence test - FI8 : chained arithmetic	3430_Fluid intelligence test - FI8 : chained arithmetic	25	482	1	3345	4628	1707	3330	3258	1633	4519	3549	3632	1260	1158	2551	2296	3224	4368	482	4093	639
2065_PLAT - Tissue-type plasminogen activator	2065_PLAT - Tissue-type plasminogen activator	25	482	1	3530	1964	2255	4712	3596	1107	1108	2559	4449	3270	3873	1129	3210	3171	2265	4652	482	1680
3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	3586_Types of physical activity in last 4 weeks: Other exercises (eg: swimming, cycling, keep fit, bowling)	25	483	1	690	4036	4698	1852	3750	3521	483	4389	4420	948	3290	1048	3620	572	1503	4202	1220	1301
3216_Frequency of friend/family visits	3216_Frequency of friend/family visits	25	483	1	3922	3957	1324	917	4255	2442	4536	1033	483	4323	2308	1423	1922	1907	1948	3496	2338	3676
1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	1658_Alkaline phosphatase (at exam 2, FBAT, adjusted for age and sex)	25	483	1	2186	513	2158	1152	1782	1747	3933	837	3786	4413	487	483	3686	1799	1239	3661	2834	3190
2324_FGF2 - Fibroblast growth factor 2	2324_FGF2 - Fibroblast growth factor 2	25	484	1	2390	2697	1122	484	1139	584	4106	3056	4364	2807	3126	3599	1348	3835	4655	2894	3381	4018
2004_Primary biliary cirrhosis	2004_Primary biliary cirrhosis	25	484	1	4516	3112	1734	1116	1489	484	3034	2340	3500	582	4583	4548	570	4002	3591	1088	2059	1689
1767_Heart failure (free of MI, GEE, adjusted for multivariable)	1767_Heart failure (free of MI, GEE, adjusted for multivariable)	25	484	1	3582	1973	697	3410	3789	2166	4112	3393	484	3736	4414	2885	2387	2918	1698	558	1743	3316
4642_Right ventral DC	4642_Right ventral DC	25	484	1	1144	1962	1004	1519	4247	3590	3397	4153	2620	2245	3348	952	1936	1045	3161	3378	4415	484
1144_Disposition index (adjusted for BMI)	1144_Disposition index (adjusted for BMI)	25	485	1	485	3797	3219	1726	2858	522	3796	2736	2781	3182	500	4449	3943	2952	560	551	1725	3524
360_mDC:%32+	360_mDC:%32+	25	485	1	3552	485	3978	3935	2278	2551	2153	4064	2047	4106	4463	1174	4008	3187	3183	4455	2623	3601
1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	1333_Fasting HbA1c (at exam 5, GEE, adjusted for age, sex and BMI)	25	485	1	1913	3144	3400	3567	1534	3350	3507	1322	1702	3514	485	1720	2524	2059	2584	2519	1702	3385
2929_CSF3 - Granulocyte colony-stimulating factor	2929_CSF3 - Granulocyte colony-stimulating factor	25	487	1	3311	1188	567	863	3493	487	2407	3965	2393	1082	4267	852	2423	599	1716	1820	3070	3119
1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	1596_Platelet aggregation to collagen (at exam 5, FBAT, adjusted for multivariable)	25	487	1	3520	1171	3642	3062	3943	592	3567	2201	1285	3403	1342	4553	487	4725	3292	2476	2052	4532
102_Late pubertal growth (female)	102_Late pubertal growth (female)	25	487	1	4468	552	4406	1232	3580	2076	4195	945	4378	1837	2255	985	713	1804	3210	2265	4029	487
1905_Hippocampal volume (GEE, adjusted for multivariable)	1905_Hippocampal volume (GEE, adjusted for multivariable)	25	488	1	488	1971	4714	527	3475	2593	2866	3853	4701	2685	4261	4641	2465	3411	3708	3792	2455	814
2465_AURKB - Aurora kinase B	2465_AURKB - Aurora kinase B	25	488	1	1562	488	3524	3098	3207	3519	4087	1819	2487	3644	4475	3163	3463	2018	3580	2381	2204	3583
2140_PRKCZ - Protein kinase C zeta type	2140_PRKCZ - Protein kinase C zeta type	25	488	1	3532	839	2849	1473	2599	3593	2093	1598	686	3817	488	3519	3940	2330	2466	3832	4223	4036
1760_Breast cancer (FBAT, adjusted for age and BMI)	1760_Breast cancer (FBAT, adjusted for age and BMI)	25	488	1	3719	2905	654	4411	860	4187	1745	4253	1799	4528	2247	1399	895	488	726	2437	4265	3222
430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	430_Amino acid::Valine, leucine and isoleucine metabolism::isovalerylcarnitine	25	488	1	1075	809	1553	3767	2087	2877	2947	1285	3530	3828	4149	2142	501	2779	488	4330	3201	1146
3428_Fluid intelligence test - FI5 : family relationship calculation	3428_Fluid intelligence test - FI5 : family relationship calculation	25	488	1	3263	3918	1362	1958	1442	2469	2570	2781	3651	2093	872	3779	2601	1959	2377	488	882	928
2436_CNTN5 - Contactin-5	2436_CNTN5 - Contactin-5	25	489	1	915	2505	489	843	4306	4358	2089	1648	2181	3984	3145	1969	1516	3361	4449	2106	3090	2129
4214_Type 2 Diabetes	4214_Type 2 Diabetes	25	489	1	1050	3905	4555	3112	489	4340	3656	3474	3281	1390	2625	2003	4530	1858	1697	2258	4467	4131
2942_CCL7 - C-C motif chemokine 7	2942_CCL7 - C-C motif chemokine 7	25	489	1	1392	4393	2550	1723	2332	1947	3503	512	3197	2793	489	3438	3103	3772	3885	2067	2347	4565
2124_Human-virus - Protein E7_HPV16	2124_Human-virus - Protein E7_HPV16	25	489	1	2188	1066	2986	1434	2738	1291	1865	2302	2244	4557	2948	489	1754	1432	592	2470	2927	3731
683_::::X-10429	683_::::X-10429	25	489	1	818	1202	2187	4051	1586	4355	2087	2441	2683	1697	1844	2432	3112	489	1370	3423	3123	2722
1172_Heart rate	1172_Heart rate	25	489	1	3545	3471	2772	3314	1918	899	4067	1892	873	4206	2424	2496	3475	2151	1420	1140	489	2844
1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	1598_Platelet aggregation to Epinephrine (at exam 5, FBAT, adjusted for age and sex)	25	490	1	2728	4237	1309	4338	1063	490	2084	2812	3628	2130	1490	1579	1997	2256	942	501	1320	501
725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	725_Cofactors and vitamins::Ascorbate and aldarate metabolism::X-11593--O-methylascorbate*	25	490	1	2292	1603	602	4238	3539	1548	3318	1544	490	4283	3119	2898	4173	1996	2102	1919	1716	1726
1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	1369_Total cholesterol (at exam 6, GEE, adjusted for age and sex)	25	490	1	575	2403	2424	2783	3677	1070	4159	1752	3971	3976	1395	3532	1502	3860	4563	3879	3796	490
2972_RPSA - 40S ribosomal protein SA	2972_RPSA - 40S ribosomal protein SA	25	491	1	491	3763	3315	1913	3160	3326	1471	3697	789	2907	1436	2556	2204	3148	4732	1265	2001	3724
1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1252_Percent predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	491	1	3717	491	4566	4150	3525	2107	2823	4182	2828	3542	1497	4436	1800	2470	4477	4058	4219	3097
3242_Fresh fruit intake	3242_Fresh fruit intake	25	491	1	3211	1541	491	4259	2504	1506	3885	1631	4511	2828	2779	3551	2926	2894	4523	4687	4020	1344
4388_Epithelial ovarian cancer (Endometrioid)	4388_Epithelial ovarian cancer (Endometrioid)	25	491	1	2700	3622	1287	896	4484	491	1637	3202	4698	3512	3711	2066	1193	1260	566	1203	1848	2865
634_Xenobiotics::Food component, Plant::quinate	634_Xenobiotics::Food component, Plant::quinate	25	491	1	4190	2208	3547	1680	1754	3060	491	2824	2103	2821	862	2454	823	3135	2650	4433	1124	4522
1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	1691_Vitamin K plasma phylloquinone (at exam 6 or 7, GEE, adjusted for age and sex)	25	491	1	4469	3162	1332	758	4622	2609	4640	2692	3942	491	3755	4282	1340	945	3235	936	3793	2539
4585_Right lateral occipital	4585_Right lateral occipital	25	492	1	2176	4557	492	2790	4005	1851	3711	515	2549	1007	2004	4291	969	3222	2774	2791	4614	4593
2592_DKK3 - Dickkopf-related protein 3	2592_DKK3 - Dickkopf-related protein 3	25	492	1	1376	2183	2328	3192	2362	2319	668	4066	4027	3581	4707	492	4220	2859	4207	1661	1931	2358
737_::::X-11847	737_::::X-11847	25	492	1	4040	831	898	3848	903	1912	1142	1769	1566	672	3674	2083	492	2542	862	3327	2533	3702
4312_White matter hyperintensities	4312_White matter hyperintensities	25	493	1	3478	1400	3433	493	4612	3239	1220	1251	1125	1821	3714	4077	1245	4449	2147	3959	3641	1099
1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	1518_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 4, FBAT, adjusted for age and sex)	25	493	1	1804	682	3615	613	3052	3698	1431	1986	3555	4309	3078	4342	539	3403	493	2059	860	3238
134_Waist circumference (male, adjusted for BMI)	134_Waist circumference (male, adjusted for BMI)	25	493	1	3443	1407	3966	855	3307	840	1741	2988	967	4300	870	1050	522	3001	590	493	2808	994
3301_Seen doctor (GP) for nerves, anxiety, tension or depression	3301_Seen doctor (GP) for nerves, anxiety, tension or depression	25	493	1	4269	1056	3719	3464	4494	2499	1969	792	4585	1196	844	2989	3441	1486	3300	4663	493	1838
3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	3530_Never eat eggs, dairy, wheat, sugar: Sugar or foods/drinks containing sugar	25	493	1	4164	2048	3150	2308	3514	4692	3898	4589	4013	3470	1708	3152	3431	4416	570	4025	3599	493
4139_Mean corpuscular hemoglobin	4139_Mean corpuscular hemoglobin	25	494	1	1681	4415	2472	604	2259	494	2710	3598	4078	1820	2446	2756	2614	3173	2809	4575	3328	1183
4579_Right cuneus	4579_Right cuneus	25	494	1	1835	3766	2201	2206	1400	973	1263	1094	494	1713	4509	2424	2164	3897	1248	1526	1671	3636
4746_Inferior fronto-occipital fasciculus radial diusivities	4746_Inferior fronto-occipital fasciculus radial diusivities	25	494	1	616	3118	1883	1046	823	3345	4624	2450	3812	2458	4191	4649	3696	2300	494	3906	2416	2301
4298_Thin vs extreme obese	4298_Thin vs extreme obese	25	495	1	1992	1480	1627	3414	2814	958	2321	2831	495	1579	3307	3509	2864	4582	2574	1175	4339	2139
3312_Electronic device use - Plays computer games	3312_Electronic device use - Plays computer games	25	495	1	4123	767	4610	2481	3902	1193	2566	2207	2159	1786	4008	1544	1724	711	4500	2742	1831	495
2610_OLR1 - Oxidized low-density lipoprotein receptor 1	2610_OLR1 - Oxidized low-density lipoprotein receptor 1	25	496	1	496	3946	3804	2342	3032	3534	1778	2504	3827	1977	802	4718	2778	650	1790	3449	983	4323
4456_Left medial orbitofrontal	4456_Left medial orbitofrontal	25	496	1	4606	939	1654	1496	4450	496	3306	1662	3256	2119	1390	3984	3632	2356	3937	3696	1417	2041
4613_Brain stem	4613_Brain stem	25	496	1	4500	847	1697	3204	4507	3370	496	1543	3310	4430	2518	633	4326	3640	3758	3371	4512	1045
1970_MMSE score (at exam 7, FBAT, adjusted for age)	1970_MMSE score (at exam 7, FBAT, adjusted for age)	25	496	1	3043	1179	1869	2151	3339	4512	4534	4490	1647	496	2045	1092	2377	2997	2315	4358	4430	4392
1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	1507_Triglycerides (at exam 5, GEE, adjusted for age and sex)	25	496	1	1131	1005	578	2437	1732	1607	2884	4266	2057	3899	4223	1370	1543	810	988	4496	496	2843
2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	2902_HIBADH - 3-hydroxyisobutyrate dehydrogenase, mitochondrial	25	497	1	1347	2036	497	4095	579	1628	1386	3614	921	2241	2102	2509	984	3830	2596	3095	2579	4465
4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	4661_Posterior thalamic radiation (include optic radiation) fractional anisotropy	25	497	1	1807	4066	2370	2469	497	909	3352	1290	4355	2086	1823	4124	1887	698	3889	2018	929	2207
976_Basic fibroblast growth factor	976_Basic fibroblast growth factor	25	497	1	3142	3511	3910	4466	4733	2775	3480	3597	1601	2465	2680	497	1633	3853	758	4014	3316	3842
2433_CFC1 - Cryptic protein	2433_CFC1 - Cryptic protein	25	498	1	2652	3508	2965	2986	4574	3555	3107	498	2486	3361	2011	3306	1804	1790	820	590	3153	2186
3783_Depression - Waking too early	3783_Depression - Waking too early	25	498	1	2364	1272	4039	543	981	3551	1740	3329	1116	1831	498	4092	942	2988	3946	922	3298	4500
4720_External capsule mode of anisotropy	4720_External capsule mode of anisotropy	25	499	1	499	1283	2743	2661	639	3036	3954	3904	2332	552	1666	3626	1443	4199	2369	2344	4563	4270
4039_Bipolar disorder	4039_Bipolar disorder	25	499	1	2294	3578	3483	554	1318	1521	2883	1811	3372	1145	4421	3098	1996	1380	808	2210	2868	499
400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	400_Amino acid::Phenylalanine & tyrosine metabolism::phenyllactate (PLA)	25	500	1	1299	1343	500	1489	3606	714	592	4435	2200	3192	4476	2167	1327	1101	3629	1214	4495	3152
1073_Parkinson disease	1073_Parkinson disease	25	500	1	973	2107	4342	500	4710	4486	4601	2683	3959	3234	2918	2030	2206	2675	1888	732	773	536
2891_NXPH1 - Neurexophilin-1	2891_NXPH1 - Neurexophilin-1	25	500	1	4236	1889	2615	2221	1117	1262	2585	1775	500	2246	2513	2794	1616	4391	4151	2901	4085	2494
1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	1294_Diabetes incidence (FBAT, adjusted for age, sex and BMI)	25	501	1	1986	2194	3778	4140	1351	3133	3333	3610	3419	501	3277	3484	1680	2472	2168	4046	1334	3615
1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1245_Mean FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	502	1	3168	4543	3516	3990	4742	502	3252	3703	4204	3826	3397	3722	4253	4657	1702	4413	2078	2608
3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	3751_Traumatic events - Avoided activities or situations because of previous stressful experience in past month	25	502	1	3519	1169	649	2319	3254	2495	502	687	1935	4418	4659	4613	3162	4312	2530	3236	2056	1440
1084_Hemoglobin A1C level	1084_Hemoglobin A1C level	25	503	1	1799	1683	1336	847	790	3336	4265	3317	3396	3812	653	4371	2043	2039	503	3481	1111	3767
922_Cholesterol esters in medium VLDL	922_Cholesterol esters in medium VLDL	25	503	1	2890	3069	3590	882	2437	1692	2825	4533	2517	3016	2173	975	3219	1001	4534	651	503	4011
3640_Illnesses of mother: Lung cancer	3640_Illnesses of mother: Lung cancer	25	504	1	504	1415	1391	3218	3702	3077	3784	1991	4662	2206	999	639	786	2135	3710	715	2404	2995
1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	1336_HOMA-IR (at exam 5, FBAT, adjusted for age, sex and BMI)	25	504	1	2103	3316	1723	1341	848	1534	3379	991	504	1692	4698	2762	3650	4542	2096	2906	2693	841
155_Hip circumference	155_Hip circumference	25	504	1	2920	3624	2247	4604	2612	1866	1306	3833	4252	504	2908	580	3128	4012	1578	3882	3039	4106
4318_Anti-Mullerian hormone	4318_Anti-Mullerian hormone	25	504	1	3272	902	4410	3134	900	557	2797	1462	4557	1858	1933	3511	4005	1923	1121	504	949	823
1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1456_Large low-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	505	1	3103	505	977	2282	1925	3506	1603	1282	1830	2699	1453	3299	4437	2706	1187	3043	4159	599
866_Fatty acid length	866_Fatty acid length	25	505	1	1111	3125	505	1169	2314	4182	2196	4393	4128	891	1518	880	1222	3733	1057	699	1116	1121
3059_IL23R - Interleukin-23 receptor	3059_IL23R - Interleukin-23 receptor	25	505	1	4596	3133	2257	4105	505	4723	1945	3755	4484	1299	1075	3190	3997	4433	1628	2514	2603	3683
1985_Age at natural menopause (GEE, adjusted for multivariable)	1985_Age at natural menopause (GEE, adjusted for multivariable)	25	505	1	2567	3335	3885	2432	1125	3902	4517	1613	2511	1438	505	4737	1647	2739	1438	3850	3969	912
1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	1376_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 2, FBAT, adjusted for age and sex)	25	505	1	4348	1750	787	1089	1426	4209	2070	2508	3545	1343	1424	1796	3255	505	3856	2558	2627	4157
1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	1821_Inter-trochanteric buckling ratio (GEE, male, adjussted for multivariable)	25	505	1	3722	4626	2623	2807	3417	1119	3980	1801	3247	709	2519	3724	3966	3033	505	3717	4035	2974
3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	3556_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Hormone replacement therapy	25	505	1	3908	3683	4355	4119	3713	3431	3755	1735	2392	1244	3902	2933	4136	3489	3749	505	4179	1037
1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	1263_Residual from predicted FEV1 for latest exam (GEE, adjusted for multiple covariates)	25	505	1	3094	934	2150	2580	1790	2543	4537	3421	3341	4002	2731	2753	1400	1722	2645	1441	505	988
2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	2822_INHBA INHBB - Inhibin beta A chain:Inhibin beta B chain heterodimer	25	506	1	3147	3669	506	3627	3809	595	1964	3212	4120	1388	4389	3219	3786	4100	4725	2671	1685	1933
941_Total lipids in small VLDL	941_Total lipids in small VLDL	25	506	1	2860	1542	2700	506	2556	1555	1739	3852	1773	2728	1467	1466	3093	1914	4715	540	1151	4452
1157_Fasting glucose main effect (adjusted for BMI)	1157_Fasting glucose main effect (adjusted for BMI)	25	506	1	2600	4052	3776	3003	1473	506	2691	2695	4292	4277	1126	1081	3179	2579	3160	4441	1123	3989
586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	586_Nucleotide::Purine metabolism, guanine containing::N2,N2-dimethylguanosine	25	506	1	986	3130	2823	2440	4419	3697	4505	506	1739	783	3173	4596	3043	676	4645	2758	711	2795
4429_Cytomegalovirus seropositivity	4429_Cytomegalovirus seropositivity	25	506	1	2802	983	3460	2956	1796	2504	3285	1429	3803	1418	790	2637	2336	506	2276	4459	1224	2548
943_Phospholipids in small VLDL	943_Phospholipids in small VLDL	25	506	1	1672	3165	4118	828	2176	1366	2261	3555	1951	3885	2203	1240	3239	1151	4509	506	774	4055
3330_Fractured/broken bones in last 5 years	3330_Fractured/broken bones in last 5 years	25	506	1	2548	2626	3686	3273	959	3566	2612	1550	1338	3710	4739	1559	3067	4135	1903	1275	506	580
334_NKeff:%Kir (1)	334_NKeff:%Kir (1)	25	507	1	4539	2492	1649	3354	4073	4618	3066	2467	823	4313	1366	507	4499	2265	3393	2238	1467	3356
1158_Fasting glucose interaction (adjusted for BMI)	1158_Fasting glucose interaction (adjusted for BMI)	25	508	1	3130	508	3498	2348	1016	1363	1724	2761	1882	3595	3901	3180	4344	2785	1168	1762	3411	4396
4502_Right superior parietal	4502_Right superior parietal	25	508	1	4145	2393	4276	3488	508	2740	2233	3899	2657	3144	2516	1172	4000	4627	829	2088	3924	3428
2460_THBS2 - Thrombospondin-2	2460_THBS2 - Thrombospondin-2	25	508	1	3945	3301	4478	4685	3255	3569	1191	4088	3718	2619	2945	1772	4276	951	4175	1866	508	4606
1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	1665_Alanine transaminase (at exam 2, GEE, adjusted for multivariable)	25	509	1	1475	2942	509	3512	3321	1352	4732	4411	3026	3816	3688	3893	2029	4296	4271	2223	1703	3067
498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	498_Lipid::Fatty acid, dicarboxylate::3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF)	25	509	1	1673	2389	4674	3621	937	2533	509	3159	2725	2415	659	3614	2153	2692	1221	2148	2357	3726
3469_Impedance measures - Trunk fat mass	3469_Impedance measures - Trunk fat mass	25	509	1	2751	3597	3401	680	596	1386	3175	4164	3277	509	2867	622	1917	4124	3594	4675	3732	2740
3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	3479_Own or rent accommodation lived in: Rent - from private landlord or letting agency	25	509	1	2734	3038	2549	614	4630	2454	2701	3425	3760	3395	4499	4505	4400	3384	509	3469	3229	2025
2150_CKM - Creatine kinase M-type	2150_CKM - Creatine kinase M-type	25	509	1	2918	3860	1632	4053	915	643	4349	3310	4165	1747	959	3766	4081	2126	1336	509	2130	4177
2949_COTL1 - Coactosin-like protein	2949_COTL1 - Coactosin-like protein	25	510	1	1484	2506	510	3470	1921	2841	2922	2400	3888	734	3355	1548	4272	3806	1331	4177	2119	3848
3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	3534_Mental health - Illness, injury, bereavement, stress in last 2 years: Death of a close relative	25	510	1	3962	1672	3010	3344	3958	570	1484	3640	4687	1667	2052	510	2566	3054	2764	930	2368	4286
1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	1470_Lipoprotein A (at exam 3, FBAT, adjusted for age and sex)	25	510	1	956	3328	1095	3956	3190	3492	4027	514	3938	2858	1749	3075	2830	3115	3516	4378	3335	510
402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	402_Amino acid::Tryptophan metabolism::3-indoxyl sulfate	25	511	1	2463	511	3454	3359	4708	2753	3443	3275	942	3882	1163	1462	2861	783	1989	3011	679	3962
1224_Mean Putamen	1224_Mean Putamen	25	511	1	1451	3385	1483	4060	511	1219	1683	2688	3826	563	2953	2379	2682	3644	3208	4411	583	1539
1094_Systolic Blood Pressure	1094_Systolic Blood Pressure	25	511	1	1754	1418	3089	3858	4058	3652	910	3660	511	1453	2675	2622	4033	3146	4272	3383	2906	1804
2667_FCN3 - Ficolin-3	2667_FCN3 - Ficolin-3	25	511	1	1603	766	2278	2792	1604	1739	1435	4439	2077	511	4076	4444	3598	2437	873	1002	2661	3932
795_::::X-12726	795_::::X-12726	25	511	1	2490	4477	3442	514	1469	3859	3339	2970	1394	3116	3748	511	2151	2185	2030	700	4313	4022
1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1802_Low frequency power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	511	1	3979	1052	3204	3893	4691	2226	3134	604	2259	2651	1419	1948	1919	4572	511	717	1449	1839
1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	1506_Triglycerides (at exam 5, FBAT, adjusted for age and sex)	25	511	1	3679	1019	3583	529	717	4349	3227	4449	2424	1619	4052	3402	4126	3957	4385	4318	1424	511
1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1811_Very low frequency power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	512	1	512	1656	3544	1775	2753	1654	3000	667	2448	3041	882	1116	1118	1926	2569	1003	1521	2774
3563_Vitamin and mineral supplements: Vitamin C	3563_Vitamin and mineral supplements: Vitamin C	25	512	1	4314	4719	4109	4701	512	2368	2930	3113	3473	1144	3669	1343	3247	3293	3714	3669	1198	2909
994_Interleukin-7	994_Interleukin-7	25	512	1	2684	2126	731	808	4283	3224	1516	3612	1407	1478	512	2477	1808	2382	954	4329	3435	4136
3148_CPE - Carboxypeptidase E	3148_CPE - Carboxypeptidase E	25	512	1	2984	2045	1329	3251	2529	1892	2228	3966	2533	4596	2641	2909	2654	4469	895	512	1769	3982
3344_Age at last live birth (female)	3344_Age at last live birth (female)	25	515	1	1506	1701	4083	3819	2221	3122	3355	4178	1913	2015	712	3196	2122	3302	4158	515	2230	2060
104_Late pubertal growth	104_Late pubertal growth	25	515	1	3102	1947	3134	4320	3887	853	1328	4601	1993	4196	2160	2784	4046	3556	1369	3118	515	1671
3184_Esophageal squamous cell carcinoma	3184_Esophageal squamous cell carcinoma	25	516	1	4474	2832	516	768	3286	3010	4484	3384	2018	4512	4287	3303	1740	1157	3728	4482	1081	3728
2488_LYN - Tyrosine-protein kinase Lyn, isoform B	2488_LYN - Tyrosine-protein kinase Lyn, isoform B	25	516	1	2270	3875	2023	3543	748	2983	1525	516	4710	3216	4502	1578	3347	1423	4461	4446	1454	1499
3212_Frequency of walking for pleasure in last 4 weeks	3212_Frequency of walking for pleasure in last 4 weeks	25	516	1	3444	517	2952	2646	3833	4616	2706	1586	516	1783	4484	1737	4062	4544	3492	4537	3483	752
1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1808_Total power HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	517	1	3610	1338	3985	3538	3926	593	994	3918	813	517	3140	2276	2320	1104	1224	3399	2633	554
2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	2780_EIF4G2 - Eukaryotic translation initiation factor 4 gamma 2	25	517	1	4568	1824	3067	1849	1873	3711	2792	1835	3649	3426	3160	2237	1965	517	3727	2329	2657	1701
916_Total cholesterol in medium LDL	916_Total cholesterol in medium LDL	25	517	1	3997	1174	2409	2476	1613	4121	1526	1653	3900	2595	2076	672	4192	4458	2191	517	876	596
3644_Illnesses of mother: High blood pressure	3644_Illnesses of mother: High blood pressure	25	518	1	3759	2991	3272	4037	4098	518	2065	4654	1205	1952	4228	3694	1758	1198	899	3698	2473	843
115_Variability of Body Mass Index	115_Variability of Body Mass Index	25	518	1	849	4113	1028	4251	1720	923	518	2693	4681	2137	823	2659	1515	3228	892	1645	881	4421
975_Eotaxin (CCL11)	975_Eotaxin (CCL11)	25	518	1	1470	2927	1448	2420	2251	4393	4531	2038	2675	822	2347	518	4298	3249	2103	3220	2070	3704
1831_Neck length (GEE, female, adjusted for multivariable)	1831_Neck length (GEE, female, adjusted for multivariable)	25	519	1	2721	1425	519	4273	549	1142	970	552	2199	1476	2378	992	3108	1919	4608	1001	4073	1040
1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	1409_High-density lipoprotein 3 cholesterol (at exam 5, GEE, adjusted for age and sex)	25	519	1	3306	2213	3626	1994	4619	3279	519	4666	1982	1354	4666	3613	2413	2877	4229	3841	1803	4125
951_Urea	951_Urea	25	519	1	3976	635	1342	3526	3304	1508	4302	2385	519	3434	2825	1153	3006	2853	2892	3294	3012	3199
2122_IL6ST - Interleukin-6 receptor subunit beta	2122_IL6ST - Interleukin-6 receptor subunit beta	25	520	1	2218	520	4150	3477	4481	3872	1460	2616	2912	1885	3283	2366	1699	3603	3744	913	2962	3061
4044_Body Mass Index	4044_Body Mass Index	25	520	1	2996	3050	520	1987	2508	2389	3332	2268	2719	797	1917	988	2211	798	1352	2426	2506	4643
153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	153_Waist-hip ratio (female > 50 yrs, adjusted for BMI)	25	520	1	3936	2395	4303	520	1216	3936	4546	647	3821	1534	1637	2563	1366	4372	1559	854	1232	2695
17_Anorexia nervosa	17_Anorexia nervosa	25	520	1	2711	1336	965	4285	3375	520	2034	2956	3866	4567	2982	3220	3999	4427	1853	1719	2810	1781
4694_Body of corpus callosum mean diusivities	4694_Body of corpus callosum mean diusivities	25	520	1	3475	3258	1198	1435	4633	1225	520	2331	1721	1148	1485	2742	1121	3610	1542	2750	2039	678
4281_PEF	4281_PEF	25	520	1	4224	3358	4196	2241	2350	800	1118	1058	2069	1253	1167	2050	4093	3052	520	4064	2697	1078
499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	499_Lipid::Fatty acid, dicarboxylate::dodecanedioate	25	522	1	844	522	2224	2079	3371	3262	3128	1747	4032	743	1879	2162	2410	3192	3379	2982	2698	3801
432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	432_Amino acid::Valine, leucine and isoleucine metabolism::levulinate (4-oxovalerate)	25	522	1	3916	4395	522	4197	2616	4500	1704	2382	3874	4258	1240	3101	4216	3836	677	3403	3376	2952
903_Phospholipids in large VLDL	903_Phospholipids in large VLDL	25	522	1	2144	4392	2222	522	835	1034	3349	2407	4625	4021	4597	783	3365	1855	3011	2321	2202	3327
4588_Right medial orbitofrontal	4588_Right medial orbitofrontal	25	522	1	580	2270	4517	3843	3842	3787	2630	3534	522	2002	601	4488	4413	3380	1914	3347	1574	2157
4604_Right superior temporal	4604_Right superior temporal	25	522	1	2664	3879	4492	2080	2488	4430	4325	3540	2765	3731	4337	2474	1074	4117	4408	4298	790	522
1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	1679_Atrial natriuretic peptide (at exam 6, GEE, adjusted for age and sex)	25	523	1	3867	2309	523	3816	1356	4244	4710	3089	2312	3851	2155	4373	3676	3958	4082	3346	4110	3927
595_Peptide::Dipeptide::phenylalanylphenylalanine	595_Peptide::Dipeptide::phenylalanylphenylalanine	25	523	1	2556	3796	2808	2232	2852	2899	523	654	2684	4592	585	838	657	1253	3270	2588	3389	1594
965_Total lipids in very small VLDL	965_Total lipids in very small VLDL	25	523	1	1737	4700	1433	1855	4327	4678	1317	2027	1481	1541	523	1527	4680	2687	541	1393	1188	3151
675_::::X-08766	675_::::X-08766	25	523	1	4708	1903	1862	3509	3147	3137	2775	2005	2148	2834	2921	2954	3376	523	1120	2045	3684	2329
1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	1816_Femoral Neck BMD (FBAT, male, adjusted for multivariable)	25	523	1	2880	2248	3621	4386	4054	2070	3543	2807	1708	3073	647	1352	2285	3510	523	3279	764	3941
1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	1871_Shaft average buckling ratio (GEE, female, adjussted for multivariable)	25	524	1	3217	2197	3286	1135	524	1353	4512	534	4336	2162	2451	4451	763	4348	2702	3664	1344	3677
4370_Thyroid-stimulating hormone (male)	4370_Thyroid-stimulating hormone (male)	25	524	1	3245	1725	1106	3050	873	524	2436	2690	4041	525	4125	2977	3969	3017	1776	4606	3317	4623
269_CD4:%TM (2)	269_CD4:%TM (2)	25	524	1	2525	3533	1165	1776	2662	3462	3627	4158	524	2053	1989	2189	1914	664	4222	4166	2768	4080
1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	1945_Total cerebral brain volume (GEE, adjusted for multivariable with APOE)	25	524	1	816	1556	1740	2174	3970	2600	1589	562	1536	3189	524	4142	1339	4162	1672	754	3618	4702
1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	1809_Total power HRV (cohort exam 18 offsprint exam 3, GEE, adjusted for age and HR)	25	524	1	2271	1115	2913	1863	4148	2555	3399	532	2671	4649	765	524	1241	2873	1956	1171	543	2981
4349_Heart failure	4349_Heart failure	25	524	1	3640	4423	4361	4379	4725	2142	4439	2405	4463	2299	2003	3360	524	3667	4728	1650	1452	566
2736_FST - Follistatin	2736_FST - Follistatin	25	524	1	1907	597	3853	2864	2433	2190	3045	4228	1923	3140	1771	1383	1433	4614	524	3618	3184	1217
1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	1018_Lumbar Spine BMD (FBAT, adjusted for multivariable)	25	524	1	1431	3687	4452	3951	4423	971	2009	2455	3747	881	3710	1506	2438	2400	1517	2549	4094	524
3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	3928_Total-body less head BMD and total body lean mass (bivariate meta-analysis)	25	525	1	525	4177	3755	1155	3782	1957	2788	2085	3491	2388	3001	1933	925	4428	3068	2739	3347	3563
4629_Left ventral DC	4629_Left ventral DC	25	525	1	4578	1716	1227	1688	1706	1235	2035	4572	4339	725	3191	525	2425	2640	3711	4340	3379	2230
4651_Cingulum (cingulate gyrus) fractional anisotropy	4651_Cingulum (cingulate gyrus) fractional anisotropy	25	525	1	3257	2745	2502	2571	3181	531	943	1436	4589	804	3257	607	525	1970	4303	2626	1326	1761
4578_Right caudal middle frontal	4578_Right caudal middle frontal	25	525	1	4239	3586	1368	1031	2880	1724	3852	1421	3532	1620	1210	4688	3944	525	1822	3478	1557	4584
1166_Fasting insulin	1166_Fasting insulin	25	525	1	1356	1761	4101	1652	1984	3207	3630	698	3544	740	4482	2555	1708	1829	2087	4490	525	2034
4487_Right medial orbitofrontal	4487_Right medial orbitofrontal	25	526	1	4101	526	2232	4136	3609	3614	3425	2022	3373	3009	2302	2172	2178	3341	3625	3021	760	3964
1010_Tumor necrosis factor alpha	1010_Tumor necrosis factor alpha	25	526	1	2834	1848	3663	1193	2424	4640	1385	526	713	2302	1547	2373	1112	3203	3206	3002	1448	3773
694_::::X-11327	694_::::X-11327	25	526	1	1893	1590	1920	1297	4093	3890	636	1325	1303	3632	2767	3151	1874	3675	1647	3164	4344	526
204_Urinary albumin-to-creatinine ratio	204_Urinary albumin-to-creatinine ratio	25	527	1	1599	527	3860	1130	3696	1609	4278	3204	3165	4008	1089	1575	1374	1229	3584	3634	730	4293
1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	1651_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for age and sex)	25	527	1	839	4724	3533	834	1314	4383	527	4360	1281	3042	3655	1631	2058	4006	2188	1711	742	1062
136_Weight (male)	136_Weight (male)	25	527	1	1543	3567	3104	3927	4533	1740	657	2237	3374	627	527	3185	3050	2019	881	3519	3427	4089
3567_Why stopped smoking: Illness or ill health	3567_Why stopped smoking: Illness or ill health	25	527	1	3182	2973	1296	1026	2054	3884	1070	620	1858	4453	3913	557	2977	2384	527	1772	831	4600
3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	3708_Diagnoses - secondary ICD10: Z80 Family history of primary malignant neoplasm	25	527	1	3994	3171	3064	540	4142	1247	608	1712	3940	963	1964	1754	4636	715	2310	1497	4628	527
2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	2769_AKR7A2 - Aflatoxin B1 aldehyde reductase member 2	25	528	1	727	1856	651	4067	1152	3605	1362	2112	528	4150	792	3836	3489	1369	4443	2856	1606	1827
4211_Glycine level	4211_Glycine level	25	528	1	1588	2330	1053	1451	2180	3088	4318	4707	4663	2363	4515	929	3233	4487	2582	1687	528	3699
3322_Most recent bowel cancer screening	3322_Most recent bowel cancer screening	25	529	1	529	720	3774	3027	4047	2902	3648	3436	4163	1568	3779	4264	728	2427	2720	2868	2268	3322
807_::::X-12833	807_::::X-12833	25	529	1	2054	2893	2137	3087	529	2322	4277	1109	2279	3753	3310	2455	3725	2937	4649	2984	672	640
1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	1578_Maximum coronary artery calcification - Agatston score (at exam 7, FBAT, adjusted for multivariable)	25	529	1	4384	4529	2334	2874	1169	4465	2221	1915	1064	4699	529	4666	1376	559	812	956	3233	1342
3446_Impedance measures - Basal metabolic rate	3446_Impedance measures - Basal metabolic rate	25	529	1	1128	3305	3645	2679	4027	543	2263	1521	3094	4307	2226	814	1991	529	900	563	646	1157
1027_Femoral Neck Length (GEE, adjusted for multivariable)	1027_Femoral Neck Length (GEE, adjusted for multivariable)	25	529	1	1794	4026	1938	3874	2773	2007	1618	2957	3662	1471	4118	971	3900	884	3324	4578	2931	529
1110_Subcutaneous adipose tissue volume (female)	1110_Subcutaneous adipose tissue volume (female)	25	530	1	3724	1382	3484	4730	530	1400	4479	3030	3336	3713	1195	3608	4067	3872	2891	2303	3448	4530
3421_Pairs matching test - Time to complete round	3421_Pairs matching test - Time to complete round	25	530	1	1749	2779	4326	3662	1575	3480	1422	530	3233	3717	2638	3970	3719	2285	3550	4637	2700	2036
2676_MAPK8 - Mitogen-activated protein kinase 8	2676_MAPK8 - Mitogen-activated protein kinase 8	25	531	1	1219	2025	3882	2789	2472	2698	531	3093	2500	1811	1439	3833	1209	1817	4551	2520	3948	4381
1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	1021_Neck Cross-Sectional Moment of Inertia (GEE, adjusted for age and sex)	25	532	1	3010	1696	2650	648	2064	2484	2778	1000	532	4256	3666	3652	2361	4169	1217	1329	4706	2394
858_3Lhydroxybutyrate	858_3Lhydroxybutyrate	25	532	1	4447	2851	2830	2854	4497	4453	2535	4116	653	1161	1140	4341	753	532	2813	3773	2626	4389
3215_Duration of light DIY	3215_Duration of light DIY	25	532	1	3438	1653	1821	2842	3726	4195	1575	3794	624	4595	4744	2132	1889	4031	3007	532	1042	3660
1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	1659_Alkaline phosphatase (at exam 2, GEE, adjusted for age and sex)	25	533	1	3772	3238	2575	997	818	1767	2989	2852	3445	533	3083	638	4547	586	2084	1041	2466	2298
1993_Survival past average life expectancy (GEE, adjusted for multivariable)	1993_Survival past average life expectancy (GEE, adjusted for multivariable)	25	534	1	2310	2087	534	4299	3149	1651	1124	3389	4444	4026	1035	3536	703	1077	3753	768	3353	3510
3889_Monocyte count (three-way meta)	3889_Monocyte count (three-way meta)	25	534	1	2968	3271	1779	1487	534	3145	1161	4199	543	1925	3573	3541	3862	3015	3866	2264	3332	2096
2811_AMN - Protein amnionless	2811_AMN - Protein amnionless	25	534	1	896	2262	1073	4371	2604	1853	3759	4222	3091	758	1711	3302	3286	2138	997	1082	534	3140
4086_Type 2 Diabetes (adjusted for BMI)	4086_Type 2 Diabetes (adjusted for BMI)	25	535	1	3468	535	849	2798	3656	2915	3354	4277	4218	3628	918	4443	1594	2192	3690	2796	1960	1384
3756_Mental distress - Ever suffered mental distress preventing usual activities	3756_Mental distress - Ever suffered mental distress preventing usual activities	25	535	1	914	3025	1561	4361	535	1129	1611	858	1892	3782	3095	4425	3747	576	4666	2423	3627	3737
3013_MAPK14 - Mitogen-activated protein kinase 14	3013_MAPK14 - Mitogen-activated protein kinase 14	25	535	1	911	4703	3144	3415	4455	1103	1068	1092	535	3720	2465	4151	4219	3925	4012	2599	2446	3250
2388_CTSS - Cathepsin S	2388_CTSS - Cathepsin S	25	535	1	2011	4488	914	4272	4401	4651	631	2825	3683	535	3537	3258	1395	3832	4603	1889	4680	3919
415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	415_Amino acid::Urea cycle; arginine-, proline-, metabolism::N-acetylornithine	25	535	1	3503	1401	2402	3383	4121	3007	4476	3587	3523	1387	1799	2087	535	1285	3627	4322	3062	2373
2234_MMP17 - Matrix metalloproteinase-17	2234_MMP17 - Matrix metalloproteinase-17	25	536	1	536	3516	1066	4196	4488	3329	4344	3333	1783	2435	4175	2160	4027	1165	2051	3387	2199	3459
4233_Antimigraine preparations	4233_Antimigraine preparations	25	536	1	627	669	3655	1516	1133	4224	4552	938	4240	598	2591	536	2503	3386	2679	2880	3962	1930
4078_Waist-hip ratio (male)	4078_Waist-hip ratio (male)	25	537	1	2175	537	1124	4689	2786	3193	1772	1520	1730	1108	3705	4376	2507	1962	2372	1404	3371	806
1035_Neck Section Modulus (GEE, adjusted for multivariable)	1035_Neck Section Modulus (GEE, adjusted for multivariable)	25	537	1	1670	4489	537	2879	2115	1530	4570	3690	4311	3981	3552	3362	3022	2552	3415	2034	3004	4379
3056_IL17RB - interleukin-17 receptor B	3056_IL17RB - interleukin-17 receptor B	25	538	1	538	3033	4564	1400	1684	3459	4190	2351	2454	3727	2797	789	4171	1904	2546	3467	3387	745
1284_Visceral fat by CT (FBAT, adjusted for age and sex)	1284_Visceral fat by CT (FBAT, adjusted for age and sex)	25	538	1	1422	3685	538	1824	4128	1686	3791	3074	4745	3531	3227	2527	1787	1187	2141	3273	3522	3944
4541_Right ventral DC	4541_Right ventral DC	25	538	1	774	1677	1609	3097	3470	4391	2117	2151	3405	1080	3981	538	2792	1373	3454	4275	2167	578
4124_Prothrombin time	4124_Prothrombin time	25	539	1	2756	2594	860	3574	2385	918	539	1817	4455	1498	4523	3498	1049	4005	2090	2413	3171	1915
4200_Height	4200_Height	25	539	1	2381	3842	3503	2396	3098	4324	1005	1573	799	4233	2372	539	3396	4361	3340	1745	1221	3700
1755_Cancer (GEE, adjusted for age and sex)	1755_Cancer (GEE, adjusted for age and sex)	25	540	1	4250	3967	3330	920	2765	540	2272	961	4264	4328	4474	1644	3142	4306	3791	3528	4619	3236
4605_Right supramarginal	4605_Right supramarginal	25	540	1	1810	3738	3908	2438	1751	4336	3887	540	1124	3600	4141	3887	3422	3656	4526	2051	4350	2590
4552_Left inferior temporal	4552_Left inferior temporal	25	540	1	864	2926	3258	3582	865	4185	3900	2638	3387	4181	888	3658	2664	2540	2229	2449	4521	540
4313_Age of initiation of regular smoking	4313_Age of initiation of regular smoking	25	541	1	541	3835	3704	4446	1570	1940	2353	1221	4547	680	3562	2846	4185	2409	1786	2863	3735	3825
2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	2218_ADAMTS4 - A disintegrin and metalloproteinase with thrombospondin motifs 4	25	541	1	3715	3575	541	4117	3880	4517	4116	2782	2907	1586	818	4535	4485	4149	4235	3246	2641	2435
2913_AFM - Afamin	2913_AFM - Afamin	25	542	1	2443	1615	4162	542	4462	3171	2158	989	4441	4149	583	4108	742	3200	835	2744	3837	3456
4507_Cerebellar vermal lobules I V	4507_Cerebellar vermal lobules I V	25	542	1	3154	3814	1785	4293	561	2940	1252	610	3146	2339	4067	3137	3858	1033	1178	542	616	2620
3448_Impedance measures - Impedance of leg (right)	3448_Impedance measures - Impedance of leg (right)	25	542	1	2473	1593	2403	4644	3878	3042	4691	4483	2792	3979	2427	4530	3046	1916	2939	2807	3654	542
2726_DDR1 - Epithelial discoidin domain-containing receptor 1	2726_DDR1 - Epithelial discoidin domain-containing receptor 1	25	544	1	3227	1954	3066	2491	3584	2428	4417	3330	2172	1402	4197	2884	544	850	3663	4136	1619	3129
2158_MIA - Melanoma-derived growth regulatory protein	2158_MIA - Melanoma-derived growth regulatory protein	25	544	1	594	1933	3917	2796	1535	4258	3411	3542	4742	3593	4185	4406	4743	2232	3398	544	2534	3697
2378_METAP2 - Methionine aminopeptidase 2	2378_METAP2 - Methionine aminopeptidase 2	25	545	1	3950	4458	2676	1912	2777	545	3082	3052	3409	1640	2596	3364	4200	2773	3409	1694	3681	3413
160_Hip circumference (female)	160_Hip circumference (female)	25	545	1	1753	4445	2148	4132	3839	1326	1029	3719	916	545	2152	594	4644	3492	1006	4213	2889	1815
966_Concentration of very small VLDL particles	966_Concentration of very small VLDL particles	25	545	1	3506	2290	1312	1942	4087	4444	688	958	1574	856	545	1620	4690	2347	556	883	1572	4007
1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	1385_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 6, GEE, adjusted for age and sex)	25	545	1	1445	4647	929	715	1281	3002	1574	846	2022	1565	4020	4677	1467	545	1955	1161	4508	3725
3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	3704_Diagnoses - secondary ICD10: Z37 Outcome of delivery	25	545	1	1721	2146	2217	1422	1428	4419	958	1610	2745	2008	1944	3025	4250	1501	3934	545	2797	1225
2282_IGFBP4 - Insulin-like growth factor-binding protein 4	2282_IGFBP4 - Insulin-like growth factor-binding protein 4	25	546	1	546	4606	3086	3839	3944	4161	3732	4355	2428	3061	2212	3562	3501	3765	3323	3329	1534	1568
4077_Waist-hip ratio	4077_Waist-hip ratio	25	546	1	3307	3079	546	886	4181	933	1748	4305	2835	3861	3070	3465	2167	3184	4240	1324	2615	685
2596_FCN1 - Ficolin-1	2596_FCN1 - Ficolin-1	25	546	1	4559	2727	4040	3323	4115	3520	2923	4167	1855	2928	3890	3212	2957	3963	546	3390	836	3398
519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	519_Lipid::Long chain fatty acid::eicosenoate (20:1n9 or 11)	25	547	1	1278	547	904	3382	1134	2157	4280	4089	3389	827	4318	2623	1169	1957	2817	1250	2427	2958
1048_Type 2 Diabetes	1048_Type 2 Diabetes	25	547	1	2850	1540	1356	2560	2890	1050	2768	3535	4207	809	2387	3065	1574	547	859	2069	1647	3046
3594_Mineral and other dietary supplements: Calcium	3594_Mineral and other dietary supplements: Calcium	25	547	1	3420	3423	1751	4443	620	2824	705	3136	1689	1726	1665	3966	3589	2881	4423	547	3159	1090
2097_CFI - Complement factor I	2097_CFI - Complement factor I	25	548	1	868	548	1254	3724	4360	3236	1090	2663	2947	3101	3215	3322	4336	3075	2831	919	1245	2835
4285_PEF	4285_PEF	25	548	1	3652	3840	4190	2262	2044	797	1201	848	1835	798	1053	2732	4133	2912	548	4171	2376	1175
1234_Usual weekday sleep duration (FBAT)	1234_Usual weekday sleep duration (FBAT)	25	549	1	2235	882	1050	1561	3288	2948	3254	4736	674	549	1976	3558	3013	1209	3729	2522	990	2546
1076_Pancreatic cancer	1076_Pancreatic cancer	25	549	1	1333	2424	2782	3754	1119	4332	1165	3999	1971	1922	549	3676	551	3253	4262	1377	4066	1780
1124_Subcutaneous adipose tissue attenuation (male)	1124_Subcutaneous adipose tissue attenuation (male)	25	549	1	2958	2517	3008	4098	1397	4350	1917	2726	3388	1174	3266	4152	1955	1521	1913	549	1582	676
4160_Focal Epilepsy, hippocampal sclerosis (HS)	4160_Focal Epilepsy, hippocampal sclerosis (HS)	25	549	1	2274	4014	2388	4729	4681	2417	4131	579	565	3868	3560	3707	2381	4723	2842	1753	549	2120
44_Household income	44_Household income	25	550	1	3421	733	2795	4587	2975	3775	550	1707	3394	639	3757	3856	4383	3987	3842	3115	2527	4466
1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	1768_Cardiovascular disease (MI, CI, CHD death or ABI, FBAT, adjusted for age and sex)	25	550	1	3118	1801	3213	3972	2510	3048	3500	4677	1054	1637	1580	3274	550	1129	3237	1224	2920	1368
3135_MMP16 - Matrix metalloproteinase-16	3135_MMP16 - Matrix metalloproteinase-16	25	551	1	1978	3639	3735	551	3928	1635	2622	4336	3664	2985	2002	4611	1779	3797	4076	2090	3092	1353
2957_CCL16 - C-C motif chemokine 16	2957_CCL16 - C-C motif chemokine 16	25	551	1	3441	3571	4585	1943	3036	4693	4283	3479	1377	1681	808	551	4574	1892	4734	1873	2875	2387
224_B Mem:%IgA	224_B Mem:%IgA	25	552	1	3336	836	3238	552	2243	1495	1556	3855	3498	3464	1550	2589	2253	4290	1575	1173	2896	2935
4260_Facial attractiveness (female-coder)	4260_Facial attractiveness (female-coder)	25	552	1	2217	4467	1322	4665	4311	619	1184	672	2050	1721	1071	3903	4044	552	4165	1974	3577	1953
1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1551_Maximum common carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	552	1	3161	2493	1872	4000	1856	4466	2399	1921	2941	1150	3137	2316	2781	3471	552	3943	1785	3033
289_CD4:%Act(25+127+)	289_CD4:%Act(25+127+)	25	552	1	2912	745	1506	3054	3138	3801	4465	3276	3801	2074	2200	3604	991	4641	1163	552	810	3082
92_Birth weight	92_Birth weight	25	553	1	2933	553	1601	3114	3507	2052	2572	3478	3807	2545	4054	2730	4510	1237	4531	2898	884	1328
131_Hip circumference (female, adjusted for BMI)	131_Hip circumference (female, adjusted for BMI)	25	553	1	623	1745	616	2703	4656	2354	2248	924	553	3286	2246	3986	3510	701	2940	670	758	4603
3770_Depression - Trouble falling or staying asleep. or sleeping too much	3770_Depression - Trouble falling or staying asleep. or sleeping too much	25	553	1	1338	2367	3121	4399	1066	1573	2209	3005	1113	1283	553	883	4608	4450	3166	4445	4541	4394
1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	1495_Remnant lipoprotein triglycerides (at exam 4, GEE)	25	555	1	3511	4537	765	3614	3061	1470	1093	2639	555	851	3594	612	3892	1755	4466	2531	3795	1670
159_Hip circumference (female)	159_Hip circumference (female)	25	555	1	1537	4053	2046	4651	3799	1335	1291	3716	734	555	1946	601	4634	4007	1093	3428	2784	1801
802_::::X-12776	802_::::X-12776	25	555	1	1259	2642	1008	2732	2216	658	1528	4170	2795	1590	2056	4587	3810	557	4493	856	555	2562
3643_Illnesses of mother: Chronic bronchitis/emphysema	3643_Illnesses of mother: Chronic bronchitis/emphysema	25	556	1	1584	3067	556	4571	2668	3568	2740	4701	4527	1270	3400	2012	994	1468	3287	618	4045	1105
4676_External capsule axial diusivities	4676_External capsule axial diusivities	25	556	1	4264	3090	3698	2018	891	556	3064	2471	4603	3679	3628	2091	1180	2108	598	4467	3060	781
3872_Sum basophil neutrophil count (three-way meta)	3872_Sum basophil neutrophil count (three-way meta)	25	557	1	557	2949	1563	2707	4248	4592	3698	3444	3399	3155	4382	2036	774	4059	3698	1807	3346	1733
3353_Number of cigarettes previously smoked daily	3353_Number of cigarettes previously smoked daily	25	557	1	2526	2130	1014	2802	557	4223	1590	2571	4216	2791	1942	2618	4713	4382	2341	3961	4484	816
1929_Temporal horn volume (GEE, adjusted for age and sex)	1929_Temporal horn volume (GEE, adjusted for age and sex)	25	557	1	2628	4679	3325	1220	1769	4097	4315	4289	557	4562	2666	3525	1711	2833	2935	3576	2232	2720
778_::::X-12443	778_::::X-12443	25	558	1	558	1667	593	858	1588	2994	4617	2599	1905	2805	3619	4522	793	3548	3367	3632	2166	4026
3459_Impedance measures - Leg predicted mass (left)	3459_Impedance measures - Leg predicted mass (left)	25	558	2	2077	4713	4667	4372	2372	2619	4072	3800	3112	2841	907	3082	3741	558	1814	1134	3215	3246
3787_Insomnia (male)	3787_Insomnia (male)	25	558	1	740	1611	3674	3021	566	1401	732	4523	3590	1021	4112	4483	2705	3378	675	1551	4008	558
2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	2126_HSP90AA1 HSP90AB1 - Heat shock protein HSP 90-alpha/beta	25	559	1	4558	3071	1441	1805	1725	1553	559	3146	1604	1945	4323	4052	1381	4337	4559	4630	2674	1522
3769_Anxiety - Recent restlessness	3769_Anxiety - Recent restlessness	25	559	1	4445	2117	4699	1393	2193	3487	844	559	2156	754	2267	1096	2603	4677	1548	2298	4507	1111
144_Body Mass Index (male)	144_Body Mass Index (male)	25	559	1	1402	2241	4114	4522	989	1699	1497	3732	4490	559	2042	603	2267	1243	3543	2823	3921	4362
2798_P4HB - Protein disulfide-isomerase	2798_P4HB - Protein disulfide-isomerase	25	559	1	2698	2645	3494	4662	2454	3114	833	3808	4122	933	4599	4020	4164	1381	2457	559	4686	3276
4406_Menstrual quality of life impact: Sleepiness	4406_Menstrual quality of life impact: Sleepiness	25	560	1	1115	4332	2414	3311	2000	2878	3903	2715	3218	2551	2700	2395	1735	1161	3847	2737	1843	560
145_Body Mass Index (female)	145_Body Mass Index (female)	25	561	1	561	3206	857	4517	932	2127	1669	2917	3865	4126	1806	2969	3577	2327	1220	3351	2326	4278
4570_Left rostral middle frontal	4570_Left rostral middle frontal	25	561	1	2532	4043	2588	1529	3000	3528	3907	2928	4333	4454	1151	1830	1876	2469	3646	3313	3624	561
758_::::X-12116	758_::::X-12116	25	562	1	4534	562	2571	4384	1621	719	2498	638	2636	4662	4524	4208	4578	1756	1756	3762	3112	4737
2136_MST1R - Macrophage-stimulating protein receptor	2136_MST1R - Macrophage-stimulating protein receptor	25	562	1	2695	4444	3419	2053	4732	4051	562	4071	668	2252	1655	2483	2997	3913	3069	3883	4025	680
484_Lipid::Carnitine metabolism::oleoylcarnitine	484_Lipid::Carnitine metabolism::oleoylcarnitine	25	562	1	2226	2915	2512	1960	4634	3977	1230	4260	838	562	4244	1761	3213	3759	781	2146	3055	4647
3653_Illnesses of siblings: Severe depression	3653_Illnesses of siblings: Severe depression	25	562	1	3393	3024	2969	4287	2291	3979	1591	4414	4540	4020	3057	4001	562	2989	1797	3544	3220	2763
403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	403_Amino acid::Tryptophan metabolism::C-glycosyltryptophan*	25	563	1	3297	4480	2486	563	3816	1009	2848	4718	4100	4056	3074	2865	2009	2460	2226	2245	2299	3330
3981_25-Hydroxyvitamin D level	3981_25-Hydroxyvitamin D level	25	564	1	564	1735	4107	1523	2806	2252	3469	2102	4737	1544	1975	1637	4529	4696	2006	2795	3151	1493
3802_Mean erythrocyte cell volume	3802_Mean erythrocyte cell volume	25	564	1	2617	564	1533	2375	3228	1173	826	1931	4109	2460	853	1396	1413	3453	2550	653	2292	805
3092_SCARF1 - Scavenger receptor class F member 1	3092_SCARF1 - Scavenger receptor class F member 1	25	564	1	3474	3217	2450	4153	2110	564	4663	4251	3931	3846	2082	2121	3326	3682	4533	4088	3489	2314
1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	1669_Aspartate aminotransferase (at exam 2, GEE, adjusted for multivariable)	25	565	1	4521	4540	1765	565	4269	3490	655	1459	1717	2705	1116	2479	3211	4646	2997	1937	1505	4716
1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	1419_High-density lipoprotein cholesterol (at exam 7, GEE, adjusted for age and sex)	25	565	1	3977	1207	1246	2942	1568	3594	3511	3483	1534	1304	939	2881	3471	4409	4034	565	3946	1695
636_Xenobiotics::Food component, Plant::stachydrine	636_Xenobiotics::Food component, Plant::stachydrine	25	566	1	3450	903	3059	3191	3942	3136	566	2234	3166	4362	4392	2606	3529	1750	1416	1696	1720	3607
1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	1558_Maximum internal carotid artery IMT (at exam 6, FBAT, adjusted for age and sex)	25	566	1	2761	1309	827	2316	2679	3420	2220	2975	1393	2003	566	3226	2046	3103	3269	3436	3874	3541
3181_SPOCK1 - Testican-1	3181_SPOCK1 - Testican-1	25	566	1	3175	2630	4360	1060	3901	740	3197	1727	3231	4579	3611	2701	4570	4546	3959	1325	566	3086
2394_GAS1 - Growth arrest-specific protein 1	2394_GAS1 - Growth arrest-specific protein 1	25	567	1	583	3856	2157	3957	1394	567	903	2003	3069	1965	4130	637	1665	4432	2636	3907	4241	3799
2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	2493_PIK3CG - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	25	567	1	1981	1447	2091	591	1025	4339	2018	2313	567	3983	645	2295	2275	1694	1988	2917	3108	1961
37_Loneliness (case/control)	37_Loneliness (case/control)	25	567	1	3769	4675	3167	2522	2702	3255	634	1911	2102	567	3604	3103	3355	2071	3620	3977	2877	3407
775_::::X-12435	775_::::X-12435	25	568	1	1626	1218	2524	1974	568	3438	1583	4008	2054	2491	2552	3535	3709	4280	2389	855	4233	2270
4279_FVC	4279_FVC	25	568	1	2155	3002	1745	4327	3899	3340	686	2125	568	1363	3091	4582	2194	2212	1962	2494	4263	2322
2580_BMP10 - Bone morphogenetic protein 10	2580_BMP10 - Bone morphogenetic protein 10	25	569	1	1919	1621	4623	3206	642	3218	569	2462	4473	3331	4177	2240	2784	3702	4098	2782	2300	2924
3294_Loneliness, isolation	3294_Loneliness, isolation	25	569	1	584	1815	574	3291	4613	1661	1313	569	2627	4151	2739	3365	2501	1898	4123	3926	849	4167
1081_Alzheimer's disease	1081_Alzheimer's disease	25	569	1	3872	3286	3011	1916	846	723	3228	1530	1630	2089	2539	1329	3992	4015	3266	1754	569	1155
4203_End stage renal disease	4203_End stage renal disease	25	569	1	3321	2889	3727	1962	3909	3651	3827	3887	4646	1364	2684	1055	3792	1523	3849	1894	3572	569
1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	1481_Mean low-density lipoprotein cholesterol fromexam 1-7 (GEE, adjusted for multivariable)	25	570	1	2221	1879	979	2634	1315	4583	3617	4202	570	4023	2676	1187	3773	3244	4204	1312	2101	1557
4512_Brain stem	4512_Brain stem	25	570	1	1708	1479	1196	3994	3487	2463	660	2203	3912	4683	1338	1401	3302	570	1770	4471	3662	1082
446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	446_Carbohydrate::Nucleotide sugars, pentose metabolism::threitol	25	570	1	2997	2810	4053	3131	2188	3346	3743	2702	2362	2164	2943	4348	3078	1824	1276	570	3082	4212
3748_Traumatic events - Felt loved as child	3748_Traumatic events - Felt loved as child	25	571	1	2263	3620	3346	4376	2167	1321	3602	3720	1609	1342	4448	3309	960	3650	1496	571	3554	2042
1060_Breast cancer	1060_Breast cancer	25	572	1	3215	2251	2819	3294	2591	4542	572	1870	804	1658	1748	1539	3521	4158	1212	3271	2804	4635
4504_Right supramarginal	4504_Right supramarginal	25	572	1	2438	4379	2894	1798	2917	3969	2466	572	1209	3613	3658	4529	4412	2922	4520	1915	3322	3624
2642_BMP6 - Bone morphogenetic protein 6	2642_BMP6 - Bone morphogenetic protein 6	25	572	1	3650	3932	4690	3978	1481	3337	4720	3695	572	3986	4675	841	3120	3735	4058	4377	4449	2571
95_Birth weight	95_Birth weight	25	572	1	3030	957	2968	3182	2851	1012	618	903	2386	1707	2284	4706	572	1922	2987	1678	4742	3321
4356_Menstrual cycle length	4356_Menstrual cycle length	25	572	1	4672	3245	3492	1880	3409	3639	1274	2418	1677	2615	4730	1999	1769	3825	4406	3065	3676	572
2591_DDR2 - Discoidin domain-containing receptor 2	2591_DDR2 - Discoidin domain-containing receptor 2	25	573	1	811	3542	3031	3912	809	573	1990	2210	3731	2324	4450	3463	4097	2954	3030	3147	2947	2275
1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	1643_Osteoprotegerin (at exam 7, GEE, adjusted for age and sex)	25	573	1	1241	1044	2665	3326	1091	2703	573	2378	948	2815	1293	1284	4557	2893	3942	4128	3242	4675
1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	1622_Intercellular adhesion molecule-1 (at exam 7, FBAT, adjusted for age and sex)	25	574	1	4102	1094	1987	1742	574	2168	4571	1123	2036	2922	3234	3495	1717	1757	3328	1900	1445	3918
3205_Duration of walks	3205_Duration of walks	25	574	1	3359	3634	2015	1851	1664	574	3101	3625	2787	3456	3682	889	1290	934	872	1365	2393	1932
776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	776_Lipid::Eicosanoid::X-12441--12-hydroxyeicosatetraenoate (12-HETE)	25	574	1	786	2531	2067	2031	1757	3710	574	853	2346	4581	4510	685	2074	2180	2821	4264	4442	4117
4316_Smoking cessation	4316_Smoking cessation	25	574	1	3747	1078	2705	2414	2107	4322	1974	3381	574	2589	3945	2619	1173	1961	709	4363	3626	2415
4183_Triglyceride	4183_Triglyceride	25	575	1	4363	3756	1815	575	600	2635	3625	3122	3580	4152	3449	754	2014	3649	1432	3963	2387	2474
3990_Neuroticism sum score	3990_Neuroticism sum score	25	575	1	4569	581	4538	3817	1407	2532	575	2754	1509	1892	3747	3771	3778	2002	798	4372	3667	2226
2070_C5 - Complement C5	2070_C5 - Complement C5	25	575	1	1201	2501	2172	2356	1418	3003	989	2374	575	1005	656	1654	3368	1219	2246	3317	1663	3931
156_Hip circumference	156_Hip circumference	25	575	1	3005	4658	2360	4488	1662	1831	1172	2779	4618	583	3464	575	3004	3159	1552	4481	3329	4046
1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	1645_Osteoprotegerin (at exam 7, GEE, adjusted for multivariable	25	575	1	1037	3347	4650	4316	741	1877	680	3154	4278	2378	1904	2182	2621	575	4195	2358	1670	2526
1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	1505_Triglycerides (at exam 4, GEE, adjusted for age and sex)	25	576	1	4196	2557	3805	576	3536	975	3367	3851	4512	3393	2422	1467	2563	2419	4698	806	2774	4619
2444_GFRA1 - GDNF family receptor alpha-1	2444_GFRA1 - GDNF family receptor alpha-1	25	576	1	2130	2359	1565	2062	1651	4017	4184	1431	1746	576	1741	2996	2757	3666	1372	2271	1668	3665
2133_LTBR - Tumor necrosis factor receptor superfamily member 3	2133_LTBR - Tumor necrosis factor receptor superfamily member 3	25	577	1	1180	1266	2716	4414	1729	4577	3342	577	779	931	732	2301	1635	1559	4186	1748	1026	4382
2777_FER - Tyrosine-protein kinase Fer	2777_FER - Tyrosine-protein kinase Fer	25	577	1	4451	4120	3500	3099	1549	2539	4002	2306	577	4378	4158	3828	1267	1629	1623	1051	1872	1398
3481_Milk type used: Semi-skimmed	3481_Milk type used: Semi-skimmed	25	578	1	4383	1553	1463	3923	4544	3219	3772	578	2307	2431	942	3209	4597	4197	2193	2029	1733	1562
3675_Diagnoses - main ICD10: K80 Cholelithiasis	3675_Diagnoses - main ICD10: K80 Cholelithiasis	25	578	1	2586	1311	4170	2168	2015	1561	3345	1271	2039	1371	3959	1975	4239	1864	578	2935	4688	2633
3575_Pain type(s) experienced in last month: Knee pain	3575_Pain type(s) experienced in last month: Knee pain	25	579	1	4188	3281	4444	3857	4527	2517	579	2264	3449	4356	584	3826	3399	3209	1637	2996	2022	2949
1032_Neck Section Modulus (FBAT, adjusted for age and sex)	1032_Neck Section Modulus (FBAT, adjusted for age and sex)	25	579	1	716	3817	1855	4406	4385	3770	1115	3014	3774	2073	579	1625	2721	1048	4405	1429	3266	2584
2527_CXCL8 - Interleukin-8	2527_CXCL8 - Interleukin-8	25	579	1	684	1204	3386	2224	4265	2188	1828	2647	3779	3418	4362	4223	4576	2930	579	2817	3494	3753
3107_PSME3 - Proteasome activator complex subunit 3	3107_PSME3 - Proteasome activator complex subunit 3	25	579	1	4453	2512	2948	796	2431	4691	4440	4085	1323	3676	4546	3825	1928	1850	4579	4067	579	786
3370_Duration of other exercises	3370_Duration of other exercises	25	580	1	2201	580	4533	2453	3054	4558	3007	3750	3148	3285	3788	3321	1697	3422	2876	4402	802	1461
1068_Bipolar disorder	1068_Bipolar disorder	25	580	1	2317	3018	1385	4434	4542	3870	4477	580	2963	1427	631	2224	4241	646	867	1701	2939	3382
1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	1766_Heart failure (free of MI, FBAT, adjusted for multivariable)	25	580	1	1813	4560	1680	4746	4421	1388	4352	4083	2805	1194	4645	4276	2545	2902	580	2182	3822	3757
3877_Granulocyte count (three-way meta)	3877_Granulocyte count (three-way meta)	25	581	2	1171	2361	581	4282	3485	2567	2976	4631	2897	3157	3124	1558	917	3423	4538	1642	3768	4468
229_mDC:%CD1c+	229_mDC:%CD1c+	25	581	1	2661	1702	4103	4263	1602	581	1529	3169	3599	3669	1356	4215	4447	1266	2277	4554	3282	4395
3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	3476_Own or rent accommodation lived in: Own outright (by you or someone in your household)	25	581	1	2723	1075	1945	2987	3217	3795	2011	1953	581	3146	4602	1870	1160	2673	1745	1844	3989	4439
4503_Right superior temporal	4503_Right superior temporal	25	581	1	1718	3667	2789	4585	2253	2652	4177	4669	1759	2257	2935	2497	4229	2475	3394	2763	781	581
1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	1267_Residual from predicted FEV1/FVC for latest exam (GEE, adjusted for multiple covariates)	25	582	1	4588	590	4185	1015	4203	2431	2231	849	3292	2885	3326	4368	829	815	951	1116	582	1832
97_Height SDS (male at age 12)	97_Height SDS (male at age 12)	25	583	1	1775	583	1372	810	1203	2152	3654	4135	2829	1991	2406	1762	1816	1372	3949	3801	2588	3742
910_Total cholesterol in medium HDL	910_Total cholesterol in medium HDL	25	583	1	2492	3912	4609	583	3558	1960	2280	4058	893	1332	4098	3206	1184	930	3920	1518	1105	4254
3767_Depression - Recent lack of interenst of pleasure in doing things	3767_Depression - Recent lack of interenst of pleasure in doing things	25	583	1	876	3691	3276	3007	583	3732	3845	584	4199	1311	886	3045	4140	1371	4214	3548	2972	3141
2390_F7 - Coagulation Factor VII	2390_F7 - Coagulation Factor VII	25	584	1	1822	1208	584	4298	4191	1696	2550	1855	1200	4399	1357	3452	1034	3878	3084	3430	2763	3095
2284_CGA LHB - Luteinizing hormone	2284_CGA LHB - Luteinizing hormone	25	584	1	2610	4290	2736	3394	2181	3898	2958	3043	4591	2113	3141	3788	4329	584	2320	2574	4591	4058
705_::::X-11442	705_::::X-11442	25	585	1	3089	585	4419	1669	4070	2234	1280	4581	4525	3589	1417	2057	4479	3795	2023	1657	3770	3226
4756_Uncinate fasciculus radial diusivities	4756_Uncinate fasciculus radial diusivities	25	585	1	2280	2217	4325	2464	4084	3251	3996	3341	724	1972	1020	585	841	4273	4548	1428	2044	4694
4197_Waist-hip ratio	4197_Waist-hip ratio	25	586	1	3805	4709	831	586	2690	1336	4623	2153	4081	1608	4487	4581	3379	1294	1600	1273	3531	1906
4201_Body Mass Index	4201_Body Mass Index	25	587	1	1521	4528	1420	2457	899	587	1609	4011	4717	4468	3273	2669	2644	1684	2971	4728	2004	4044
3573_Pain type(s) experienced in last month: Stomach or abdominal pain	3573_Pain type(s) experienced in last month: Stomach or abdominal pain	25	588	1	1961	2161	1823	1224	1912	588	2738	2753	3331	3582	4135	4167	621	4410	2657	2043	1959	4239
2723_SKP1 - S-phase kinase-associated protein 1	2723_SKP1 - S-phase kinase-associated protein 1	25	588	1	4580	4208	4195	2345	3073	3090	4504	3714	3923	2369	2996	2143	1099	588	1479	2495	2680	3105
4241_Rapid alternating stimulus test for letters/numbers	4241_Rapid alternating stimulus test for letters/numbers	25	589	1	3000	1772	589	4010	778	2016	754	4428	1183	4182	2049	4417	2924	2392	1162	2689	765	3429
87_Asthma	87_Asthma	25	589	1	2805	3562	1628	2306	3768	1410	3123	4383	634	589	3356	3839	1632	1451	3449	1029	1385	4244
809_::::X-12847	809_::::X-12847	25	589	1	3249	3527	3558	1151	3159	3362	4337	3170	3010	3860	3794	2667	589	1231	3673	1861	3326	2488
1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	1675_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for age and sex)	25	589	1	682	738	2206	1737	1599	4181	609	641	4221	2940	1925	1891	1404	589	3778	3216	2731	3787
3741_Depression - Professional informed about depression	3741_Depression - Professional informed about depression	25	590	1	3233	3097	3000	1613	2727	590	2403	1717	2315	3291	3052	4237	1104	3038	1539	1865	4125	4274
1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	1533_Ankle-brachial index (at exam 6, GEE, adjusted for multivariable)	25	590	1	2210	4401	3488	3353	1079	1606	2193	4597	2545	892	1732	1395	3252	590	2260	2955	4327	2551
1170_Leptin (adjusted for BMI)	1170_Leptin (adjusted for BMI)	25	592	1	592	1584	1827	2212	2685	1785	4323	2132	3980	2915	3801	2816	2308	1929	2815	4560	2722	3107
2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	2880_EMR2 - EGF-like module-containing mucin-like hormone receptor-like 2	25	592	1	1195	2374	592	2996	2480	3903	960	2862	3054	1483	3201	2939	3265	1705	4083	4531	3970	3818
2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	2520_FLT3 - Receptor-type tyrosine-protein kinase FLT3	25	592	1	4602	2405	3545	4219	1243	4010	2736	3557	4300	3099	4142	4563	592	1224	3872	4274	1456	2274
61_Age at menarche	61_Age at menarche	25	593	1	3655	634	1830	1885	4225	1087	593	2835	796	785	3826	876	3241	2790	723	2706	620	789
3269_Breastfed as a baby	3269_Breastfed as a baby	25	593	1	3720	3979	1430	3758	1663	2624	1808	593	1885	2994	2266	1258	2630	3790	2488	3208	1390	4464
133_Waist circumference (female)	133_Waist circumference (female)	25	593	1	1095	2588	1559	4731	2153	3815	2863	2124	1007	593	1028	2537	4744	694	4729	3341	2249	1940
4564_Left pericalcarine	4564_Left pericalcarine	25	593	1	1985	1145	2341	2743	2507	3792	2583	1261	3507	3174	593	4242	3714	4659	4327	2552	2353	1076
1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	1858_Neck cross-sectional moment of inertia (FBAT, female, adjussted for multivariable)	25	594	1	1945	4312	4015	2215	3294	1453	3655	594	2176	2359	2912	2688	3960	2935	3598	3301	2124	2369
4493_Right pars triangularis	4493_Right pars triangularis	25	594	1	4513	1929	1976	3040	2672	4146	1315	2878	4553	3944	594	1098	3000	679	4025	2269	3853	3828
757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	757_Amino acid::Tryptophan metabolism::X-12100--hydroxytryptophan*	25	594	1	2827	4037	2387	2456	2298	4638	2928	2907	2140	4530	2710	1642	3419	2377	1928	2144	594	2730
4144_Mean arterial pressure	4144_Mean arterial pressure	25	595	1	1374	1767	2975	785	2584	3860	1758	595	1159	3730	4454	2239	711	4167	1693	4591	2608	2032
305_CD4mem:%cFTH (1)	305_CD4mem:%cFTH (1)	25	595	1	2971	2686	3025	968	3519	2445	4397	4466	1493	4542	1573	1773	3653	3206	595	4667	1984	3009
939_Total cholesterol in small VLDL	939_Total cholesterol in small VLDL	25	596	1	1379	696	3622	3379	4441	3575	2372	3950	4063	1034	596	2728	3998	2865	1533	1733	1052	2356
3934_Monosialylation	3934_Monosialylation	25	597	1	1135	1546	1187	2463	597	3041	2440	1335	2535	2951	1753	2076	847	4494	1516	4384	3650	2320
1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	1313_HOMA-IR (at exam 5, GEE, adjusted for age and sex)	25	598	1	1370	4623	2925	3713	3982	3274	2309	3969	4127	1083	1096	908	598	2340	2095	834	2309	2281
4572_Left superior parietal	4572_Left superior parietal	25	599	1	599	1031	4425	4305	746	3099	3633	3644	3306	1124	2154	2278	3567	4191	4274	2193	4713	2436
4753_Superior fronto-occipital fasciculus radial diusivities	4753_Superior fronto-occipital fasciculus radial diusivities	25	599	1	2290	2226	2979	2814	599	1036	4614	2832	1972	3822	4505	4216	938	1354	2993	2130	1355	4534
1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	1960_Mean MMSE score for exam 5 and 7 (FBAT, adjusted for multivariable)	25	599	1	1240	1958	945	1556	2949	3828	599	4595	1784	3798	3004	2834	1686	2655	2788	767	634	4629
4292_Asthma	4292_Asthma	25	599	1	3194	3776	3572	4678	1014	2453	3404	599	3340	4659	3450	3837	1597	2380	3669	2716	1735	2084
509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	509_Lipid::Glycerolipid metabolism::glycerophosphorylcholine (GPC)	25	599	1	3494	2806	1688	1357	2718	1660	2849	782	2338	2091	599	2159	4218	4607	1013	3976	2600	1784
4194_Systolic Blood Pressure	4194_Systolic Blood Pressure	25	600	1	858	600	863	1761	2714	3572	3788	3563	3177	2330	3154	3229	3288	3226	1954	3956	4394	1841
3718_Amount of alcohol drunk on a typical drinking day	3718_Amount of alcohol drunk on a typical drinking day	25	600	1	3258	2511	2356	4034	1775	600	3579	4725	1182	4274	3093	2680	4480	3176	3679	3842	1597	604
4186_Coffee cups per day	4186_Coffee cups per day	25	600	1	1153	4300	2529	3696	3783	874	3167	600	637	3069	4563	3349	3573	1872	1605	2614	1858	4300
1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	1769_Cardiovascular disease (MI, CI, CHD death or ABI, GEE, adjusted for age and sex)	25	600	1	4728	1422	906	1356	1593	2666	2661	3454	1779	2478	3793	4176	2559	3527	3264	3323	3593	600
1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	1963_Mean MMSE score for exam 5 and 7 (GEE, adjusted for age)	25	601	1	724	1769	601	3879	1701	4690	2218	3961	1573	2981	3422	2343	2738	2070	2512	4475	2330	788
827_::::X-13671	827_::::X-13671	25	601	1	706	727	2407	601	1800	989	2686	3646	3877	1936	2708	1913	3341	2412	2670	4123	1648	1921
3415_Reaction time test - Mean time to correctly identify matches	3415_Reaction time test - Mean time to correctly identify matches	25	601	1	4744	2629	1913	3982	3705	4072	601	2091	2637	3378	3667	2231	3337	3901	3756	3388	1135	2381
1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	1347_Plasma Apolipoprotein A-I level (GEE, adjusted for age and sex)	25	601	1	4184	4257	2903	930	2053	2078	1438	601	4072	1232	1674	4267	2034	1368	3978	3335	2447	1675
1890_Shaft Width (FBAT, male, adjussted for age)	1890_Shaft Width (FBAT, male, adjussted for age)	25	602	1	602	3545	3710	1969	3655	3718	2796	3524	716	4373	2794	3960	3166	1194	1958	818	3529	2503
745_::::X-12007	745_::::X-12007	25	602	1	1748	3774	4126	2544	3071	4123	1971	1636	602	2909	3612	3565	3111	2177	4710	3280	1277	3090
3231_Nap during day	3231_Nap during day	25	602	1	3615	3513	2832	4537	1869	688	3920	2104	4483	690	1499	2306	602	1483	2205	960	1874	966
950_Tyrosine	950_Tyrosine	25	603	1	3254	2940	1489	1984	4312	603	2195	2396	614	2059	4176	2075	2076	2963	3164	2327	3488	3860
552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	552_Lipid::Lysolipid::2-stearoylglycerophosphocholine*	25	603	1	3984	1057	1675	4352	2170	2996	3439	1667	603	4420	2862	2466	2651	2351	4023	713	1552	3469
284_CD4:%Act(38+)	284_CD4:%Act(38+)	25	604	1	1643	2628	4744	931	604	1618	4154	4444	3783	2372	721	3482	1337	4636	4075	2780	3783	2053
355_IgG+B:%27+	355_IgG+B:%27+	25	605	1	4201	2304	4034	3842	2712	605	3173	3551	1026	681	3015	2818	2737	1838	4437	1124	1761	1472
4664_Superior corona radiata fractional anisotropy	4664_Superior corona radiata fractional anisotropy	25	605	1	2464	1298	4461	1507	3598	1257	4295	2748	1804	4244	3673	1995	2961	4400	4308	605	4292	1011
4327_Well-being spectrum	4327_Well-being spectrum	25	606	1	4574	606	2561	4173	2113	2823	1931	3722	1460	4347	1234	2879	3559	2780	4723	3741	3645	2818
2664_FGFR2 - Fibroblast growth factor receptor 2	2664_FGFR2 - Fibroblast growth factor receptor 2	25	606	1	2980	3610	1908	3093	2867	606	4450	2184	2456	888	3485	3993	3779	680	1926	4489	1041	3081
116_Variability of Height	116_Variability of Height	25	607	1	1435	2607	4602	607	4373	621	3420	717	1719	1381	4077	3458	1351	3696	2001	3805	1855	4040
1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	1936_Total cerebral brain volume (FBAT, adjusted for age and sex)	25	607	1	917	797	4072	1595	1141	1848	2368	665	607	4412	1379	3298	1398	3722	4647	2524	4431	3914
3650_Illnesses of siblings: Breast cancer	3650_Illnesses of siblings: Breast cancer	25	607	1	3250	3057	2658	2190	2957	754	3376	4316	3033	607	864	3450	964	749	4318	1484	4703	3804
3275_Childhood sunburn occasions	3275_Childhood sunburn occasions	25	607	1	3183	1919	2086	3162	1362	3946	1834	4286	4277	3375	607	2095	838	1334	3195	3965	1610	1238
1885_Shaft Width (GEE, female, adjussted for multivariable)	1885_Shaft Width (GEE, female, adjussted for multivariable)	25	607	1	3682	927	2890	3648	3834	2287	1399	2368	1713	1761	4123	4015	607	1495	3538	4409	2640	4671
4686_Superior corona radiata axial diusivities	4686_Superior corona radiata axial diusivities	24	608	1	2806	910	1411	3608	4216	4556	4379	3501	1690	1368	1561	3726	4235	1806	4482	4716	608	1590
2333_IL19 - Interleukin-19	2333_IL19 - Interleukin-19	25	609	1	609	888	3294	3015	1107	3671	4347	4225	1244	4132	1391	3077	4211	3684	4314	4160	3914	2778
648_Xenobiotics::Xanthine metabolism::theobromine	648_Xenobiotics::Xanthine metabolism::theobromine	25	609	1	2522	3234	609	4148	2860	4092	3012	2532	949	1097	4214	3257	2321	1728	2467	3004	3019	1133
2186_AZU1 - Azurocidin	2186_AZU1 - Azurocidin	25	609	1	1438	3065	2134	2566	2966	3330	3384	3131	2611	1894	3476	2573	3361	2158	609	2309	1878	3496
4015_Central corneal thickness	4015_Central corneal thickness	25	609	1	1218	1238	932	1086	2821	1642	2481	1898	3986	1749	2622	4719	1394	4347	646	609	4353	934
652_::::X-02269	652_::::X-02269	25	610	1	3515	3227	2692	2979	1536	2788	1672	736	610	4687	3246	2005	1158	3817	2432	1107	2948	4498
838_Peptide::Dipeptide::X-14450--phenylalanylleucine	838_Peptide::Dipeptide::X-14450--phenylalanylleucine	25	610	1	877	822	664	3345	3649	759	4462	1976	772	1327	4435	610	3857	2515	2189	3999	3751	3862
4484_Right lateral occipital	4484_Right lateral occipital	25	611	1	611	2200	3348	3125	3331	2946	747	2770	1782	1538	2496	3008	1759	3079	837	2103	2005	3109
177_Waist circumference (female, adjusted for BMI)	177_Waist circumference (female, adjusted for BMI)	25	611	2	3051	611	3447	3355	2838	2750	2758	675	4296	1448	1952	4579	2481	2198	2956	1604	1643	2022
439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	439_Carbohydrate::Glycolysis, gluconeogenesis, pyruvate metabolism::1,5-anhydroglucitol (1,5-AG)	25	611	1	2990	3521	3116	611	4078	628	2516	1807	2033	2775	2215	862	4444	2119	3171	693	827	2353
730_::::X-11795	730_::::X-11795	25	611	1	4319	3442	3304	4724	1809	1315	2645	2295	1640	1241	611	2457	4356	1537	2394	2373	4730	2362
4549_Left entorhinal	4549_Left entorhinal	25	611	1	3463	3447	3326	2290	3088	1489	3112	4448	4670	2049	4734	1428	1252	3727	2665	611	4657	2422
633_Xenobiotics::Food component, Plant::piperine	633_Xenobiotics::Food component, Plant::piperine	25	612	1	1609	3704	1788	2658	3991	4498	4594	2899	901	3840	3062	1188	2000	612	2503	2077	2525	1438
280_CD8:%DR+73+39-25-	280_CD8:%DR+73+39-25-	25	612	1	4710	1270	3851	3044	2191	2472	2684	4606	1282	1019	2754	3170	1661	1293	2882	612	2599	1147
1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	1806_SDNN HRV (cohort exam 18 offsprint exam 3, FBAT, adjusted for age and HR)	25	613	1	4074	3351	3313	1072	1353	3040	974	1755	1173	1000	1733	613	1342	1517	3049	2394	2013	1624
2521_FSTL3 - Follistatin-related protein 3	2521_FSTL3 - Follistatin-related protein 3	25	613	1	2615	4151	2425	1147	3808	4218	4495	3096	1287	4093	706	4549	4466	613	3289	2013	2508	3360
779_::::X-12450	779_::::X-12450	25	614	1	4403	3930	2423	3896	4002	4273	3221	3272	3536	614	4627	3962	2554	3427	3864	2570	933	1677
617_Xenobiotics::Benzoate metabolism::catechol sulfate	617_Xenobiotics::Benzoate metabolism::catechol sulfate	25	615	1	1570	615	1703	656	2192	1019	1782	2586	3012	4188	2098	4220	3596	4632	2693	3739	2277	1232
141_Waist-hip ratio (female, adjusted for BMI)	141_Waist-hip ratio (female, adjusted for BMI)	25	615	1	2072	2211	615	4229	3384	3789	2088	1130	2935	1227	2725	3835	3202	1197	4681	1917	3536	3281
1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	1513_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 1, GEE, adjusted for multivariable)	25	615	1	2446	3555	3032	1784	3195	978	4052	2837	1693	1113	615	3669	2137	3181	3992	3811	3739	1584
3482_Milk type used: Skimmed	3482_Milk type used: Skimmed	25	615	1	4718	1623	4306	4234	1654	4370	3677	4060	2420	2211	1300	3281	615	3955	3589	3056	1228	1071
3956_Ankle injury (random effect)	3956_Ankle injury (random effect)	25	615	1	930	3638	2323	1905	3968	3182	2955	3767	3958	3922	3633	4266	2802	615	2110	2391	2532	2678
798_::::X-12734	798_::::X-12734	25	615	1	2838	3742	1403	4580	3602	2655	1790	4073	4187	757	1495	2029	2479	4066	3456	615	2472	3582
3359_Age high blood pressure diagnosed	3359_Age high blood pressure diagnosed	25	615	1	3312	4288	1210	1604	1696	2854	1158	1201	2265	3645	660	2911	4307	4517	1843	1193	615	3154
3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	3716_Diagnoses - secondary ICD10: Z95 Presence of cardiac and vascular implants and grafts	25	616	1	697	1178	2869	616	3185	3656	4036	4174	787	3194	1800	2411	1935	4175	4147	3028	825	1286
2013_Response following treatment of MDD subjects	2013_Response following treatment of MDD subjects	25	616	1	1756	1302	1983	992	2336	865	4731	3226	3486	1574	4116	4439	616	1288	3515	4224	4443	3019
2721_PDXP - Pyridoxal phosphate phosphatase	2721_PDXP - Pyridoxal phosphate phosphatase	25	617	1	2158	3040	617	1792	4513	2699	1420	4421	3860	755	4122	2757	1864	1203	3521	872	2026	2351
3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	3710_Diagnoses - secondary ICD10: Z85 Personal history of malignant neoplasm	25	618	1	808	618	4256	3974	4363	4377	3109	4410	3272	3188	4674	4288	2114	3938	1051	1643	4597	1931
1023_Neck Cross-Sectional Moment of Inertia (GEE)	1023_Neck Cross-Sectional Moment of Inertia (GEE)	25	618	1	715	2760	4579	1520	3418	2646	2783	1299	4379	1881	4117	4356	618	4740	3126	3903	4375	2505
774_::::X-12428	774_::::X-12428	25	618	1	4305	2746	1941	3124	3395	4627	1960	3251	3162	1245	1213	4671	3366	618	927	938	2170	1502
3103_KRAS - GTPase KRas	3103_KRAS - GTPase KRas	25	619	1	1784	3211	619	4243	4352	1304	4291	4106	1643	3251	4600	4147	4275	2929	2707	3819	2400	3060
2456_PGLYRP1 - Peptidoglycan recognition protein 1	2456_PGLYRP1 - Peptidoglycan recognition protein 1	25	620	1	620	782	4221	3501	902	2695	1373	4308	845	1433	1007	3804	638	2281	1314	2052	1240	950
1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	1899_Troch Neck BMD (GEE, female, adjussted for multivariable)	25	620	1	2307	2189	3118	620	2554	4107	2062	2615	1299	3689	4579	4252	3391	3013	630	4697	2152	3912
3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	3507_Non-butter spread type details: Polyunsaturated/sunflower oil based spread (eg: Flora)	25	620	1	4486	4107	1720	4347	3411	3505	1233	3383	3961	4600	2023	1582	620	1831	1773	2693	780	3797
2046_Periodontal complex trait 1 - Socransky trait	2046_Periodontal complex trait 1 - Socransky trait	25	620	1	1148	1172	3963	2883	2097	654	923	3740	3323	3620	2763	1024	3267	3681	2476	3000	4237	620
1910_Temporal horn volume (FBAT, adjusted for multivariable)	1910_Temporal horn volume (FBAT, adjusted for multivariable)	25	621	1	621	1434	1921	1567	1608	2172	2295	3525	864	2982	3334	3939	2665	3064	4221	2119	1421	1968
3351_Had other major operations	3351_Had other major operations	25	621	1	4688	2705	621	4245	775	1636	3176	823	1953	1947	2601	4415	2959	3771	4132	1412	2033	4403
1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	1673_Bilirubin (at exam 2, GEE, adjusted for multivariable)	25	622	1	2346	947	1687	622	1892	2064	2479	1597	1887	3148	4296	1134	797	3627	1504	1771	3643	4358
1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	1337_HOMA-IR (at exam 5, GEE, adjusted for age, sex and BMI)	25	622	1	2940	1385	3629	1734	3278	2274	1670	691	1206	3421	3856	2383	3961	1789	1661	622	4092	2532
3508_Non-butter spread type details: Other low or reduced fat spread	3508_Non-butter spread type details: Other low or reduced fat spread	25	623	1	1597	623	3949	739	2863	1004	627	1428	2169	867	1633	1585	1785	3307	1890	4428	2369	4448
2813_BOC - Brother of CDO	2813_BOC - Brother of CDO	25	623	1	2356	2428	1314	1754	623	1839	4686	841	2128	1841	2270	1770	4064	1024	4451	1201	3683	2559
1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1261_Residual from predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	623	1	2252	4424	3530	4457	4472	3643	4674	2465	623	3108	2233	2337	4730	2981	4554	2192	2141	2206
513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	513_Lipid::Ketone bodies::3-hydroxybutyrate (BHBA)	25	623	1	3558	2187	3664	2777	1499	2772	3014	3252	4538	623	3953	2792	4017	3071	4273	3603	2175	4384
313_CD4nv:%TFH (1)	313_CD4nv:%TFH (1)	25	624	1	624	4696	2630	3267	4319	2761	3430	700	4594	650	2340	2420	3370	2057	807	2433	3831	1332
1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	1968_MMSE score (at age 65, FBAT, adjusted for birth-cohort)	25	624	1	1476	624	1699	1843	3537	1634	3556	3679	1747	3254	998	1496	2120	3909	2176	4327	2777	1489
4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	4216_Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)	25	624	1	3456	4291	4633	1027	3450	624	2933	4375	2929	4682	1400	1930	730	1000	2964	772	2570	1798
3761_Depression - Recent trouble concentrating on things	3761_Depression - Recent trouble concentrating on things	25	624	1	2114	3345	3856	1757	4433	3561	4273	1369	1934	2355	724	2789	624	3972	694	4223	3927	2662
3403_Fluid intelligence test - FI5 : family relationship calculation	3403_Fluid intelligence test - FI5 : family relationship calculation	25	625	1	625	3412	2144	1695	2961	3012	4165	2013	2780	3242	1045	2649	4065	4240	2548	1765	4461	2468
2344_VWF - von Willebrand factor	2344_VWF - von Willebrand factor	25	626	1	2347	1291	626	2617	1648	3571	789	2576	2643	3700	1584	3631	3186	1467	842	4723	1097	1618
4280_FEV1/FVC ratio	4280_FEV1/FVC ratio	25	626	1	4138	2458	4067	2867	626	2737	1238	2421	1082	1536	3706	4479	2828	2517	633	2501	2282	2996
2368_DDX19B - ATP-dependent RNA helicase DDX19B	2368_DDX19B - ATP-dependent RNA helicase DDX19B	25	626	1	3539	2711	3798	2023	4501	2620	2896	626	2028	4025	1724	2018	1908	965	3606	2226	771	1975
1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	1232_Usual weekday bedtime (FBAT, adjusted for age, sex and BMI)	25	626	1	2149	860	4271	4160	2379	3892	2525	3051	4193	2417	2930	1189	626	4020	4321	3529	4188	4596
3837_Sum eosinophil basophil count (two-way meta)	3837_Sum eosinophil basophil count (two-way meta)	25	627	1	788	3734	1970	2156	1810	627	1638	3861	4566	3239	1720	2793	1790	4257	1405	2755	4485	2078
2312_JAM2 - Junctional adhesion molecule B	2312_JAM2 - Junctional adhesion molecule B	25	627	1	2995	1799	2059	4538	1381	1930	1116	4086	3960	4239	627	3919	4297	2844	4661	881	1294	4309
4719_Corticospinal tract mode of anisotropy	4719_Corticospinal tract mode of anisotropy	25	627	1	2782	4197	1695	3939	2909	3244	3873	1612	2577	1656	3590	627	3479	4625	2364	4201	3794	4354
2884_GPR114 - Probable G-protein coupled receptor 114	2884_GPR114 - Probable G-protein coupled receptor 114	25	627	1	3970	3757	3691	4554	3777	2697	3837	1607	2589	1814	4084	1961	932	1484	1159	627	3369	2489
386_Amino acid::Histidine metabolism::3-methylhistidine	386_Amino acid::Histidine metabolism::3-methylhistidine	25	628	1	1638	3377	4434	1817	3714	3150	4715	628	3156	4128	3454	2370	4514	1440	1188	4536	4365	4014
3380_Systolic Blood Pressure (automated reading)	3380_Systolic Blood Pressure (automated reading)	25	628	1	4039	4085	4227	4076	2547	2362	3652	1004	3973	3368	1719	2216	2190	628	4348	3206	1607	2073
22_Clozapine-Induced Agranulocytosis/Granulocytopenia	22_Clozapine-Induced Agranulocytosis/Granulocytopenia	25	628	1	1029	4522	2635	1751	4655	3693	2949	2580	1827	1825	1447	1444	4180	2763	3142	4010	628	1379
1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	1614_CD40 Ligand plasma (at exam 7, FBAT, adjusted for age and sex)	25	629	1	2418	3924	629	4474	1036	2644	1813	2369	3842	3684	1350	2752	1863	1575	664	4501	1243	3748
3495_Hair colour (natural, before greying): Blonde	3495_Hair colour (natural, before greying): Blonde	25	629	1	1227	2400	2193	2035	2263	629	2072	2822	2806	3164	2988	1211	990	1612	4441	4146	2252	3646
3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	3711_Diagnoses - secondary ICD10: Z86 Personal history of certain other diseases	25	630	1	2267	2316	1637	2377	4041	630	3662	3283	764	3769	2300	2962	3167	3149	2649	2266	1954	2776
1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	1701_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for multivariable)	25	630	1	2133	2034	3684	4424	1032	1792	2564	4359	2716	666	692	2906	4289	630	4056	707	1932	970
4176_Type 2 Diabetes	4176_Type 2 Diabetes	25	631	1	4046	631	640	2695	2643	1296	2455	1035	812	4195	3443	4300	2593	2154	3332	1502	3372	3752
4540_Right accumbens area	4540_Right accumbens area	25	631	1	852	4735	3931	631	2477	1809	2404	3268	848	4085	2949	1799	1278	3466	2570	3523	3155	2393
3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	3110_CSNK2A2 CSNK2B - Casein kinase II 2-alpha':2-beta heterotetramer	25	631	1	2588	2830	2358	3264	3324	1195	3169	974	780	2646	1831	631	971	3479	3981	2231	3306	3865
343_NKearly:%337+158b+	343_NKearly:%337+158b+	25	631	1	1785	4028	3775	4496	2294	2330	3465	3451	1778	3181	1360	1193	631	4439	2449	3186	3010	3621
2566_CXCL12 - Stromal cell-derived factor 1	2566_CXCL12 - Stromal cell-derived factor 1	25	631	1	3389	1574	1692	2962	1467	2712	1956	3494	1288	4501	880	796	4539	2443	4724	631	3344	930
3296_Risk taking	3296_Risk taking	25	632	1	1910	3613	1564	4261	1255	2815	765	4112	3587	670	632	4150	1810	2718	3795	4085	4191	3922
77_Adiponectin level	77_Adiponectin level	25	633	1	633	2911	3782	3219	1404	3736	4254	1144	3058	3639	2283	2826	2994	3944	1655	2714	4354	3968
4626_Left hippocampus	4626_Left hippocampus	25	634	1	3505	1002	3017	1330	1836	4178	981	4746	984	1680	1588	4158	3493	2231	4707	876	4104	634
3279_Father's age at death	3279_Father's age at death	25	635	1	743	973	3543	2848	4326	3843	2138	3676	635	905	3899	727	826	2835	4623	3072	2559	4415
1991_Age at death (GEE, adjusted for birth-cohort)	1991_Age at death (GEE, adjusted for birth-cohort)	25	635	1	4179	1009	4655	2753	1512	3955	2383	2288	857	635	2239	1073	1905	1713	3402	4042	3591	3351
119_Extreme Waist-hip ratio (adjusted for BMI)	119_Extreme Waist-hip ratio (adjusted for BMI)	25	635	1	748	4165	868	4581	2373	2721	3848	2722	1263	3289	986	635	4174	1305	3383	4613	2518	3323
2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	2114_TYRO3 - Tyrosine-protein kinase receptor TYRO3	25	635	1	4133	3743	892	4635	2204	3413	2635	3312	1970	904	4624	3863	4458	2007	635	4466	952	3255
3620_Treatment/medication code: amlodipine	3620_Treatment/medication code: amlodipine	25	636	1	1223	3320	2431	3079	4177	636	1341	3674	2799	1686	930	4249	2549	4236	1793	2726	1812	1519
1208_FEV1	1208_FEV1	25	636	1	2409	3982	3598	4430	4037	2807	4226	636	841	1539	3796	3756	1713	3590	2772	1797	3297	1428
2867_MMP12 - Macrophage metalloelastase	2867_MMP12 - Macrophage metalloelastase	25	637	1	2557	4313	637	3417	4033	744	4164	4366	2388	1020	3918	3814	3297	3317	2358	1087	1827	1697
4254_Sleep duration (SD)	4254_Sleep duration (SD)	25	637	1	2019	4463	1678	2739	4437	2132	1841	1836	1368	637	2634	4168	1523	4215	3127	2240	1917	3150
1990_Age at death (FBAT, adjusted for birth-cohort)	1990_Age at death (FBAT, adjusted for birth-cohort)	25	637	1	4173	1144	2815	3596	2901	2903	1266	3174	1089	2987	4729	4203	2454	3877	637	1726	2820	3221
1199_Epilepsy	1199_Epilepsy	25	637	1	4562	1707	982	4011	2405	4186	802	3110	3299	4121	1798	4298	3415	3701	2639	637	3216	1732
1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1424_Large high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	638	1	638	3336	853	4532	3437	3371	3363	3781	1473	4175	4133	2475	723	779	1280	3779	4494	2031
3838_Eosinophil count (two-way meta)	3838_Eosinophil count (two-way meta)	25	638	1	654	1743	4264	2089	638	832	1136	3507	2785	4295	3231	4247	1077	4736	1906	2334	4141	1022
3566_Vitamin and mineral supplements: Multivitamins +/- minerals	3566_Vitamin and mineral supplements: Multivitamins +/- minerals	25	638	1	1406	2703	2498	4401	4685	638	4176	3359	4588	4192	4216	1674	1002	4259	680	2645	3935	3491
1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	1367_Total cholesterol (at exam 5, GEE, adjusted for age and sex)	25	638	1	3654	815	3833	2995	2870	2451	3438	3203	945	638	1219	2574	4380	3447	4349	1677	1377	3314
2392_CRISP3 - Cysteine-rich secretory protein 3	2392_CRISP3 - Cysteine-rich secretory protein 3	25	638	1	3193	2240	1032	934	3335	3461	1985	748	3109	1103	638	1658	3793	928	1907	3558	3629	4228
2047_Periodontal complex trait 2	2047_Periodontal complex trait 2	25	639	1	815	639	4113	4052	3484	3126	2179	1488	1224	1688	1705	979	4362	4185	1142	1202	2522	3271
4690_Uncinate fasciculus axial diusivities	4690_Uncinate fasciculus axial diusivities	25	639	1	3932	1251	2767	2259	1433	3897	639	1619	4520	2243	3866	3061	4070	2553	2927	3384	4273	1043
3245_Non-oily fish intake	3245_Non-oily fish intake	25	639	1	3797	2218	4239	2064	720	4251	2112	639	3529	3468	2324	4322	1084	4327	3429	2397	3348	2536
1914_Parietal brain volume (FBAT, adjusted for multivariable)	1914_Parietal brain volume (FBAT, adjusted for multivariable)	25	639	1	842	4244	2175	946	4568	3670	2932	1983	639	3244	2531	2690	2611	3460	1113	4112	2938	3687
2834_CHST2 - Carbohydrate sulfotransferase 2	2834_CHST2 - Carbohydrate sulfotransferase 2	25	640	1	1719	4330	3091	3053	1915	4320	4661	3717	1944	4494	1681	4089	3578	4115	3197	792	640	993
1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	1697_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for multivariable)	25	641	1	641	4738	1935	3083	4403	2481	3102	1132	3554	3473	980	1923	4091	4563	1634	3895	2073	1564
785_::::X-12556	785_::::X-12556	25	641	1	4336	4495	4265	4394	1114	641	1699	4338	1876	3479	3471	1925	3327	1641	4673	3242	3839	3088
3174_CST1 - Cystatin-SN	3174_CST1 - Cystatin-SN	25	642	1	4056	1821	1728	3833	1618	902	1287	4285	1692	3448	1922	2651	4679	3945	642	4236	2477	3682
379_Amino acid::Glycine, serine and threonine metabolism::betaine	379_Amino acid::Glycine, serine and threonine metabolism::betaine	25	643	1	3417	1464	2146	4321	3196	3015	3021	643	2969	1407	1072	2601	2700	2867	2592	3645	3211	4536
380_Amino acid::Glycine, serine and threonine metabolism::glycine	380_Amino acid::Glycine, serine and threonine metabolism::glycine	25	644	1	2665	4745	4637	1996	1968	1109	1729	2611	2066	820	1521	644	4580	3785	3966	3395	1998	3139
14_Posttraumatic stress disorder	14_Posttraumatic stress disorder	25	644	1	4692	3052	3050	1190	1204	4291	1033	1477	4462	1987	4332	649	644	3290	2672	4148	3098	732
4169_Open-angle glaucoma (random-effect model)	4169_Open-angle glaucoma (random-effect model)	25	644	1	799	2314	1621	1971	2435	1437	881	1674	1306	2106	2840	3896	3090	691	905	1370	4185	644
2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	2806_LCORL - Ligand-dependent nuclear receptor corepressor-like protein	25	645	1	645	2638	3887	3176	2026	4413	2908	3423	3791	1635	1538	3841	1627	1178	2583	1231	3142	1592
3257_Hot drink temperature	3257_Hot drink temperature	25	645	1	4114	4131	1402	846	645	791	4543	1255	2348	2468	2741	2207	3115	3866	3767	2215	3724	2693
791_::::X-12704	791_::::X-12704	25	645	1	3192	1826	1693	4009	1898	3128	1713	645	4707	2593	2249	2918	2703	4295	3462	2987	4182	3705
2966_MMP1 - Interstitial collagenase	2966_MMP1 - Interstitial collagenase	25	645	1	2222	1224	3682	4307	2212	780	1365	1031	3627	2062	1926	645	2406	1029	653	3173	4012	4090
1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	1286_Visceral fat by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	645	1	1891	2870	1895	1319	4161	1799	4399	1103	3285	4113	4551	3934	1918	645	1832	4509	3802	3391
4380_Phltrium width	4380_Phltrium width	25	645	1	4265	653	3028	2475	1824	757	4745	2324	2855	3779	2313	2671	3438	4419	4219	645	3706	3192
2418_SFRP1 - Secreted frizzled-related protein 1	2418_SFRP1 - Secreted frizzled-related protein 1	25	645	1	3568	3008	3591	3763	3387	4734	886	1292	4575	2958	1215	4647	4206	3787	4316	3185	645	2899
1003_Macrophage inflammatory protein-1 (CCL3)	1003_Macrophage inflammatory protein-1 (CCL3)	25	646	1	1301	646	4046	1689	1932	2547	717	4013	3097	2298	1093	1883	4682	1719	2748	3187	852	3302
607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	607_Peptide::gamma-glutamyl::gamma-glutamylthreonine*	25	647	1	647	4660	3376	4477	2322	3857	1492	4440	3051	3903	1281	3938	1664	2128	1894	4498	1742	2868
3084_RELT - Tumor necrosis factor receptor superfamily member 19L	3084_RELT - Tumor necrosis factor receptor superfamily member 19L	25	647	1	1529	4273	3695	1584	2541	3069	647	2547	2366	3122	3684	1935	2397	2334	4280	4051	3455	2253
871_Glucose	871_Glucose	25	647	1	3063	3111	3252	3892	4624	2143	2382	1809	1570	1733	2046	2211	647	4698	4604	1987	4500	3179
3026_PPA1 - Inorganic pyrophosphatase	3026_PPA1 - Inorganic pyrophosphatase	25	647	1	4083	4360	4591	674	1692	4228	1654	3890	4425	1189	3406	922	772	647	1351	4416	2496	1298
3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	3117_PPIE - Peptidyl-prolyl cis-trans isomerase E	25	649	1	649	3686	2589	3984	3681	2779	1816	3080	3943	1510	4536	2891	1025	1511	3676	2278	1463	3403
2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	2135_CSF1R - Macrophage colony-stimulating factor 1 receptor	25	650	1	2020	1827	2758	2518	3068	650	4528	808	1227	3135	2885	1471	1519	768	1341	753	2670	4610
1171_Body fat percentage	1171_Body fat percentage	25	650	1	4648	1784	1731	1840	2998	3986	3076	4109	765	3565	650	1209	2556	896	2628	974	4724	4703
2247_NR3C1 - Glucocorticoid receptor	2247_NR3C1 - Glucocorticoid receptor	25	650	1	4526	4365	1462	2697	2344	4485	3201	2130	2921	4316	1223	1171	4420	895	650	4200	2562	3900
3798_Worry subcluster	3798_Worry subcluster	25	650	1	3472	2552	4133	1826	4392	2603	4228	2659	1896	3067	2872	4226	4457	3264	3707	2738	2796	650
836_Peptide::Dipeptide::X-14304--leucylalanine	836_Peptide::Dipeptide::X-14304--leucylalanine	25	651	1	2305	1746	2682	4618	708	1532	4147	702	1903	976	3176	3242	1831	3311	2975	1399	1887	651
2718_MSLN - Mesothelin	2718_MSLN - Mesothelin	25	652	1	652	3154	3215	883	3442	1402	934	3233	2333	1864	3217	4394	777	4423	2056	4589	939	2828
710_::::X-11470	710_::::X-11470	25	652	1	4152	4010	3920	1692	4409	652	4353	2828	1248	2591	4459	2972	769	2826	2638	4513	1641	2769
3258_Water intake	3258_Water intake	25	652	1	4154	4104	1208	3349	4702	2988	1685	804	652	3657	4335	1089	2759	1388	3667	2163	1023	3451
2481_ECM1 - Extracellular matrix protein 1	2481_ECM1 - Extracellular matrix protein 1	25	652	1	1647	3401	3382	1305	2920	3160	3562	966	1932	2680	1363	1647	652	3567	3450	2959	4051	4264
518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	518_Lipid::Long chain fatty acid::dihomo-linoleate (20:2n6)	25	652	1	3862	3777	2613	2229	1387	2907	1333	2522	3019	1720	2135	2364	2030	3536	1730	652	1184	4102
282_CD4:%Eff(127-PD1-)	282_CD4:%Eff(127-PD1-)	25	653	1	1372	3214	653	2911	1284	3270	3152	1627	2784	3675	1784	3650	4233	4745	2994	4222	4395	2429
4726_Posterior limb of internal capsule mode of anisotropy	4726_Posterior limb of internal capsule mode of anisotropy	25	654	1	1087	4455	3945	2981	3483	2639	654	1029	3908	2943	1394	2748	1600	3030	3635	3194	3001	973
3571_Pain type(s) experienced in last month: Neck or shoulder pain	3571_Pain type(s) experienced in last month: Neck or shoulder pain	25	654	1	1099	3974	3403	1774	1071	1994	1982	2596	1968	4123	2285	2255	2839	3486	654	659	2780	2871
2341_PTN - Pleiotrophin	2341_PTN - Pleiotrophin	25	654	1	4113	1550	2741	3708	4332	2108	892	2122	1681	4538	1514	1222	1191	1686	3305	1961	654	3836
4243_Rapid automised naming of objects	4243_Rapid automised naming of objects	25	655	1	655	2858	2576	3257	1328	4368	4539	3181	4456	961	3538	2559	4385	2605	1301	3483	2676	4723
2526_IL18R1 - Interleukin-18 receptor 1	2526_IL18R1 - Interleukin-18 receptor 1	25	655	1	660	3293	2912	655	4034	1626	2442	1626	4329	4034	827	3088	2400	3467	4203	661	4300	684
394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	394_Amino acid::Phenylalanine & tyrosine metabolism::3-phenylpropionate (hydrocinnamate)	25	656	1	2758	3188	2976	4093	4043	656	1423	3570	2914	937	3982	2641	2773	1697	2041	3660	3096	3263
3304_Age first had sexual intercourse	3304_Age first had sexual intercourse	25	656	1	1853	3012	2200	3942	1089	3793	3940	656	4434	1290	2743	2592	3781	1447	3652	863	3894	2107
2074_C8A C8B C8G - Complement component C8	2074_C8A C8B C8G - Complement component C8	25	657	1	772	3652	1991	657	4224	2489	795	3402	2361	4245	1618	4608	2142	3169	913	4186	1587	4083
89_Infant head circumference	89_Infant head circumference	25	657	1	4345	2250	1088	885	3510	657	3552	4180	4200	2674	788	815	2319	2092	1625	2815	4604	2634
1189_Aortic-valve calcification	1189_Aortic-valve calcification	25	658	1	2230	658	1754	3147	783	3290	1305	2643	3757	2948	4074	4185	924	3458	1944	3247	4463	2727
2056_Rheumatoid Arthritis	2056_Rheumatoid Arthritis	25	658	1	3218	2266	658	3633	2175	3297	2853	3189	2324	3641	1511	3989	1082	4363	2274	2165	3597	2827
3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	3719_Ever had known person concerned about, or recommended reduction of alcohol consumption	25	658	1	3711	4091	4580	658	4359	3823	1110	4708	4126	1875	2306	1037	2004	4246	1610	4106	1519	1546
1007_Stem cell factor	1007_Stem cell factor	25	658	1	4246	2887	2945	4702	658	4152	3739	708	924	2000	1428	4508	1584	1336	3471	2035	3425	1202
3864_Red blood cell count (two-way meta)	3864_Red blood cell count (two-way meta)	25	658	1	1622	4334	3470	2331	1963	2096	1631	1687	972	737	4517	1532	2598	658	1418	2643	1192	1151
2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	2512_TNFSF8 - Tumor necrosis factor ligand superfamily member 8	25	658	1	1243	3095	3018	4306	3146	2456	1480	2680	4733	3409	1411	4257	981	2224	1680	658	3760	3462
46_Baldness	46_Baldness	25	658	1	976	3078	1240	729	3639	2810	4445	1680	1178	1055	3983	3539	1673	4697	4527	1335	658	1274
1988_Age at death (FBAT, adjusted for multivariable)	1988_Age at death (FBAT, adjusted for multivariable)	25	659	1	1519	4517	2130	2397	3412	659	3728	3168	4352	3015	4560	4033	1318	3040	3427	2241	2940	3685
1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	1309_Fasting HbA1c (at exam 5, GEE, adjusted for age and sex)	25	659	1	1858	1566	1579	4120	1794	3158	3722	4503	2484	1527	1469	659	4053	4664	1971	2922	3823	3718
2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	2118_ERBB2 - Receptor tyrosine-protein kinase erbB-2	25	660	1	2284	1023	2477	793	660	4007	3713	2932	1809	4230	4581	3221	2898	1532	2515	1242	2006	1808
1083_Hemoglobin A1C level in intensive treatment group	1083_Hemoglobin A1C level in intensive treatment group	25	660	1	3164	2907	2696	3572	1715	2785	1835	847	2177	660	1066	3287	3201	1810	4231	1053	1335	2931
3175_IL17RC - Interleukin-17 receptor C	3175_IL17RC - Interleukin-17 receptor C	25	661	1	1068	2813	782	2872	1617	2866	661	4297	4075	3431	1062	1740	3461	3010	4343	1480	1108	2800
493_Lipid::Fatty acid metabolism::isovalerate	493_Lipid::Fatty acid metabolism::isovalerate	25	661	1	1102	3142	2010	3419	3351	3006	3463	1882	661	3797	4403	2927	3386	3580	2741	2297	4011	3850
4514_3rd ventricle	4514_3rd ventricle	25	661	1	2094	1813	2053	4044	3449	3846	3202	2681	3298	661	2037	1619	4727	758	717	3820	1360	3963
952_Valine	952_Valine	25	662	1	3357	2289	846	3132	1000	1741	1582	4111	4302	2966	1786	4521	3597	662	1232	1249	1076	4297
4477_Right caudal middle frontal	4477_Right caudal middle frontal	25	663	1	3581	1427	2531	2828	3604	1509	4598	4215	3734	4658	1489	3187	4588	663	3865	3689	2891	4728
577_Lipid::Sterol, Steroid::epiandrosterone sulfate	577_Lipid::Sterol, Steroid::epiandrosterone sulfate	25	663	1	2135	3744	1422	3772	2912	3310	3868	2154	834	4544	2007	3293	2106	1319	2728	2699	3223	663
288_CD4:%Treg(39+73+)	288_CD4:%Treg(39+73+)	25	665	1	665	4328	4691	1055	3893	2359	2690	4636	2918	1374	3030	2208	3170	3120	2428	1379	1722	4152
2176_POR - NADPH--cytochrome P450 reductase	2176_POR - NADPH--cytochrome P450 reductase	25	665	1	2002	2807	1275	2547	3770	3178	4637	4622	665	4327	1990	1626	3880	2910	4093	3582	4238	2814
1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	1864_Neck cross-sectional moment of inertia (FBAT, male, adjussted for age)	25	665	1	1360	1501	2864	833	4680	4053	3314	3445	1405	3917	4526	3359	3055	3833	665	1591	3500	3146
2250_KPNA2 - Importin subunit alpha-1	2250_KPNA2 - Importin subunit alpha-1	25	665	1	4161	3675	3207	1085	1688	4293	3988	2435	3039	4548	2290	3596	4465	2238	4250	665	1879	1711
2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	2883_FUT5 - Alpha-(1,3)-fucosyltransferase 5	25	666	1	4570	666	4004	1111	3559	3606	1888	2150	1954	1860	1893	4132	4684	1094	2563	1190	1888	1840
4478_Right cuneus	4478_Right cuneus	25	666	1	916	4430	4329	1379	957	3930	666	1467	2406	3973	3064	3410	2101	3066	2361	4079	4372	2234
4031_Alcohol dependency (discovery)	4031_Alcohol dependency (discovery)	25	666	1	1079	3274	1724	2584	1736	698	4566	1490	1764	1907	1626	994	1174	3435	666	4633	4456	3005
913_Total lipids in medium HDL	913_Total lipids in medium HDL	25	667	1	909	4530	1164	1744	844	3148	667	4632	1521	2226	2580	1124	2309	2778	4431	4086	2210	1311
4156_Epilepsy	4156_Epilepsy	25	667	1	2846	4604	3338	3547	837	4088	3063	3651	4270	667	2954	1250	3113	3942	4455	3853	4728	2724
1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	1262_Residual from predicted FEV1 for latest exam (FBAT, adjusted for multiple covariates)	25	667	1	2419	1640	1801	4741	2100	1763	2017	3684	4684	3465	667	4075	1672	1435	3511	3380	4666	3076
3814_CD8+ T cell level	3814_CD8+ T cell level	25	667	1	4088	1561	4051	2508	4519	900	3608	3931	3676	1165	1412	4293	1136	2255	2073	667	3960	2726
314_CD4nv:%TFH (2)	314_CD4nv:%TFH (2)	25	668	1	668	2148	3518	3421	2283	4200	2757	4321	3459	3933	1703	3577	3123	2901	3552	3973	3293	2595
3627_Treatment/medication code: paracetamol	3627_Treatment/medication code: paracetamol	25	668	1	2883	2522	4136	2442	2737	1268	4367	1567	2710	3469	1988	1144	4224	1940	2335	3458	1741	668
1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	1661_Alkaline phosphatase (at exam 2, GEE, adjusted for multivariable)	25	669	1	4618	4707	2778	669	1491	979	4014	3077	4582	1976	3322	2416	2126	1083	4549	1348	3576	4105
1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	1670_Bilirubin (at exam 2, FBAT, adjusted for age and sex)	25	669	1	4080	2233	1946	1493	904	3722	2662	845	1424	1391	1639	669	1198	2484	1899	1571	3778	4135
2330_CGA FSHB - Follicle stimulating hormone	2330_CGA FSHB - Follicle stimulating hormone	25	669	1	4171	1517	4542	4059	2881	1372	3300	3289	3067	4673	1663	807	4217	4305	669	2227	1708	2093
419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	419_Amino acid::Urea cycle; arginine-, proline-, metabolism::urea	25	669	1	1005	1846	804	2193	2582	3001	2362	4455	2502	2726	1290	2072	4360	1736	1868	669	2115	2014
1047_Trochanter BMD (GEE, adjusted for multivariable)	1047_Trochanter BMD (GEE, adjusted for multivariable)	25	670	1	742	2104	2722	670	3960	3748	1980	1243	1447	3053	4134	995	4078	2261	4311	2412	4673	3268
3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	3130_TYK2 - Non-receptor tyrosine-protein kinase TYK2	25	670	1	3213	1841	1464	1007	670	1331	1866	2994	3242	3459	2846	2761	1243	1861	1766	1108	2048	2767
3206_Number of days/week of moderate physical activity 10+ minutes	3206_Number of days/week of moderate physical activity 10+ minutes	25	670	1	1450	4327	1423	1279	1456	2649	2095	670	1313	2270	1107	2425	3458	1763	3121	3020	3351	3419
2600_LGMN - Legumain	2600_LGMN - Legumain	25	671	1	2528	2192	2939	2118	4719	2247	3217	3309	1194	3856	4139	1508	4698	1145	3689	2081	671	3486
258_CD8mem:%CD31+	258_CD8mem:%CD31+	25	672	1	4376	4214	1549	1192	3273	1800	726	2607	672	1776	1887	2992	3560	3096	3562	2942	2015	4422
3993_Irritability (IRR)	3993_Irritability (IRR)	25	672	1	3033	4487	3601	2971	2071	1722	4697	3978	2291	1715	2139	1419	3837	2146	693	2951	2362	672
1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	1699_Dehydroepiandrosterone sulfate (at exam 3, GEE, adjusted for age and sex)	25	673	1	3866	673	3317	3875	3955	4189	4063	3141	3169	3803	4308	1389	4723	3612	3365	2484	4090	2299
547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	547_Lipid::Lysolipid::1-stearoylglycerophosphoethanolamine	25	673	1	1416	3196	3562	4083	4390	673	3389	3114	1847	2554	698	4285	2216	830	4142	2267	3958	3641
2280_GHR - Growth hormone receptor	2280_GHR - Growth hormone receptor	25	673	1	2635	1413	2850	742	3513	2871	1890	1878	4142	673	3359	3980	2649	4688	3603	3900	2412	1307
2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	2871_ADAMTS15 - A disintegrin and metalloproteinase with thrombospondin motifs 15	25	673	1	3969	4373	2607	2673	864	3143	1395	3497	1638	3139	673	1918	4740	3232	1532	2251	4557	4388
474_Lipid::Bile acid metabolism::ursodeoxycholate	474_Lipid::Bile acid metabolism::ursodeoxycholate	25	673	1	1083	1378	4277	2647	2516	4329	761	2953	3665	4111	3472	2191	4328	804	3217	1842	673	2101
2575_ADIPOQ - Adiponectin	2575_ADIPOQ - Adiponectin	25	676	1	676	1470	2915	4642	971	2943	4138	2791	2001	3721	2073	3051	2088	2147	2656	3724	4566	1124
3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	3073_CD200R1 - Cell surface glycoprotein CD200 receptor 1	25	676	1	981	3341	2724	676	3756	3750	2262	3410	4666	2032	3825	2394	4121	1591	3412	4241	1746	3467
1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	1949_Visuospatial memory and organization (GEE, adjusted for multivariable)	25	676	1	1236	908	3240	2427	1290	4398	4038	3452	1086	676	2563	2869	2943	1111	1070	4366	2440	3790
817_::::X-13429	817_::::X-13429	25	676	1	3378	4637	1685	2130	4196	1338	1283	2235	2690	2168	1465	3080	4343	4016	2064	1777	676	1914
2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	2685_PPIA - Peptidyl-prolyl cis-trans isomerase A	25	677	1	4072	1472	2757	2778	1770	4012	1803	4046	1415	2451	1157	1964	2519	1172	3575	2968	677	4227
1837_Neck width (GEE, male, adjusted for multivariable)	1837_Neck width (GEE, male, adjusted for multivariable)	25	679	1	2138	1133	4259	3402	679	4375	3077	3519	3196	4267	1688	3507	3147	1680	2447	1184	1583	4513
4652_Cingulum (hippocampus) fractional anisotropy	4652_Cingulum (hippocampus) fractional anisotropy	25	679	1	2593	716	901	3462	2182	1444	3239	3228	4025	2692	3641	3680	4671	862	711	3353	1090	679
1112_Visceral sdipose tissue volume (male)	1112_Visceral sdipose tissue volume (male)	25	680	1	4667	4652	4352	1658	4100	1845	3586	680	3735	3433	1008	3685	4710	1568	914	2011	3101	3069
3240_Cooked vegetable intake	3240_Cooked vegetable intake	25	680	1	2168	2585	4286	4224	3281	3080	1300	1381	3246	1025	680	2741	3551	1566	4335	3581	2831	1688
3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	3129_MAP3K7 TAB1 - Mitogen-activated protein kinase kinase kinase 7:TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 fusion	25	680	1	4418	1572	1266	3529	2037	1922	4602	1795	4250	4028	3352	4292	4428	877	2194	2687	680	2976
1174_Extreme chronotype	1174_Extreme chronotype	25	681	1	681	1315	1948	4492	2039	2436	2364	3624	2048	4524	3325	2964	2505	3352	3911	2030	1264	4059
4003_Juvenile idiopathic arthritis with vs without uveitis	4003_Juvenile idiopathic arthritis with vs without uveitis	25	681	1	3429	1946	4500	2818	3957	994	3714	1424	681	4103	1398	4708	758	4624	1422	3673	1623	1851
733_::::X-11818	733_::::X-11818	25	681	1	1788	1985	3842	3145	1424	4698	3138	4044	1081	1012	1239	4725	1721	4021	2736	3866	2150	681
332_NKeff:%Act(335+)	332_NKeff:%Act(335+)	25	682	1	2749	2831	682	1532	2287	3216	3143	2756	2739	3772	3155	863	4577	2168	2791	3223	2860	2934
3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	3528_Never eat eggs, dairy, wheat, sugar: Eggs or foods containing eggs	25	682	1	2444	2683	1327	1756	4459	4118	682	3810	3309	728	4183	1511	1689	2795	1803	3504	1348	1072
1165_Fasting glucose	1165_Fasting glucose	25	682	1	4068	3127	4653	4533	1815	1422	3432	1258	2945	3259	682	804	4407	2411	4504	3640	2225	1239
3782_Depression - Sleeping too much	3782_Depression - Sleeping too much	25	682	1	3007	2294	4487	3959	4358	3765	3081	2526	3723	1790	995	682	4668	3584	1243	3878	1523	3898
3454_Impedance measures - Leg fat-free mass (right)	3454_Impedance measures - Leg fat-free mass (right)	25	682	2	1548	4651	4408	4302	2333	1365	3644	2620	4431	3204	1523	1699	2375	714	1936	682	2456	1694
2314_LSAMP - Limbic system-associated membrane protein	2314_LSAMP - Limbic system-associated membrane protein	25	682	1	2412	2581	3733	4709	2202	1527	3035	3547	4513	2419	982	3745	3586	2770	2230	4617	2913	682
3477_Own or rent accommodation lived in: Own with a mortgage	3477_Own or rent accommodation lived in: Own with a mortgage	25	685	1	1294	1006	3255	3738	3438	2292	4235	3591	685	3894	1792	4735	2984	3874	4029	1395	3036	2169
4297_Extreme obesity (childhood)	4297_Extreme obesity (childhood)	25	686	1	686	3736	1577	4389	1784	2360	3440	1118	4049	2216	2075	3811	3566	2926	1065	2710	4205	3576
709_::::X-11469	709_::::X-11469	25	686	1	3455	3984	4068	3239	2573	1531	2533	686	1714	4145	4060	916	1639	4289	1170	1223	3542	3981
2781_IGF1R - Insulin-like growth factor 1 receptor	2781_IGF1R - Insulin-like growth factor 1 receptor	25	686	1	2598	4666	1528	1349	2398	1748	1425	4264	2457	4255	1491	3607	1146	3488	686	1614	3718	1549
3584_Types of transport used (excluding work): Cycle	3584_Types of transport used (excluding work): Cycle	25	686	1	3848	2891	1486	2461	3369	835	3470	3863	1400	997	4352	3421	4677	1409	2586	1791	1568	686
3570_Pain type(s) experienced in last month: Headache	3570_Pain type(s) experienced in last month: Headache	25	687	1	1064	2220	4507	1662	2254	3202	2653	4674	2536	2666	3500	1147	1032	1881	2498	3480	4446	687
352_NKT:%TM	352_NKT:%TM	25	688	1	688	3868	4042	3429	3704	1078	4130	3636	1172	4212	4132	2151	4693	3838	1233	4421	3033	2561
2089_GFRA3 - GDNF family receptor alpha-3	2089_GFRA3 - GDNF family receptor alpha-3	25	689	1	2306	2219	890	2334	1438	2000	689	4638	2786	2287	3725	871	2127	3685	1080	1938	3167	1967
1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	1130_Ratio of visceral-tosubcutaneous adipose tissue volume (male)	25	689	1	3273	2504	1589	825	3447	1885	3335	1794	2220	689	1079	1176	2183	2891	1641	2128	3421	2144
1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	1567_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for age and sex)	25	690	1	2384	2885	690	3248	4491	4059	3312	2592	784	1919	1614	3796	3641	3364	2856	3230	2434	1321
3391_Ever depressed for a whole week	3391_Ever depressed for a whole week	25	690	1	2181	4221	2916	2098	2123	3653	4730	3786	3881	3884	3620	2650	4361	2104	3248	690	1919	1703
2702_TPO - Thyroid peroxidase	2702_TPO - Thyroid peroxidase	25	691	1	1303	691	4700	2862	3581	4162	1693	1692	2744	1918	2866	2959	2331	2850	3316	3507	2719	2945
2044_Severe gingival inflammation	2044_Severe gingival inflammation	25	691	1	2385	2100	2522	2832	3727	889	691	2967	3225	1451	3828	2381	3495	2782	1395	4438	1592	3293
1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	1525_Triglyceride / High-density lipoprotein cholesterol ratio (at exam 7, GEE, adjusted for age and sex)	25	691	1	1844	2960	1317	1133	3848	1919	3537	1642	3133	3985	3731	993	3056	3586	691	2831	3859	3761
4486_Right lingual	4486_Right lingual	25	692	1	3205	2837	3791	2426	3939	692	2159	2524	3543	2184	2627	3451	3487	4644	2516	2664	2840	1527
1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	1571_Mean abdominal aortic calcification - Agatston score  (at exam 7, GEE, adjusted for age and sex)	25	692	1	3499	3919	3026	1825	1647	3968	2415	4402	3018	2623	1237	4409	692	853	1317	1498	2738	2194
4637_Right putamen	4637_Right putamen	25	692	1	1474	4399	1947	2014	1064	2806	3871	4233	2469	1440	3008	1972	1275	3280	2401	1887	692	4646
3551_Vascular/heart problems diagnosed by doctor: High blood pressure	3551_Vascular/heart problems diagnosed by doctor: High blood pressure	25	693	1	1797	2133	693	2596	1226	2822	3921	1454	940	2391	2661	4486	2626	3851	2337	3101	3896	2211
3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	3664_External causes: Y83 Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or later complication, without mention of misadventure at the time of the procedure	25	693	1	3046	3338	1103	979	3284	693	2803	1056	1321	3493	4154	3046	4151	2847	1326	1391	1695	3234
3229_Getting up in morning	3229_Getting up in morning	25	693	1	1709	2134	4513	1753	2448	2512	2057	4130	2827	2367	747	2903	2686	693	777	4342	2135	4052
831_::::X-14057	831_::::X-14057	25	693	1	1809	970	4366	3180	3334	3471	4572	3260	3386	4170	1999	1512	4037	3067	4074	3320	693	2469
1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	1134_Ratio of visceral-tosubcutaneous adipose tissue volume (adjusted for BMI, female)	25	694	1	1762	3077	4043	1164	694	2271	3126	1274	3666	2262	1934	4109	3237	1030	2483	1181	3668	3587
4125_Fibrinogen	4125_Fibrinogen	25	694	1	2916	695	3589	2479	3150	3598	694	4348	1458	1432	1259	891	3891	3468	3231	1048	2783	3800
1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	1488_Plasma Apolipoprotein E level (at exam 5, FBAT, adjusted for multivariable)	25	694	1	3861	1646	756	2575	1246	4416	2314	4061	4183	694	3299	1051	1258	1248	2928	1237	2097	3507
4581_Right fusiform	4581_Right fusiform	25	695	1	1036	4337	695	3665	1766	2700	4718	4735	1706	4168	1660	4399	3436	825	3735	1843	4017	1825
3681_Diagnoses - main ICD10: R07 Pain in throat and chest	3681_Diagnoses - main ICD10: R07 Pain in throat and chest	25	695	1	3525	3009	2853	2335	3240	695	2079	1652	4371	4573	3463	1141	4371	2293	2025	1094	1806	1243
2789_NSFL1C - NSFL1 cofactor p47	2789_NSFL1C - NSFL1 cofactor p47	25	695	1	4073	984	3565	3838	4237	1106	3692	2379	3274	3502	1406	1299	695	1261	1896	3061	1927	914
2142_ICAM3 - Intercellular adhesion molecule 3	2142_ICAM3 - Intercellular adhesion molecule 3	25	695	1	1611	4580	2451	2455	2713	3760	4187	3441	3232	3335	3387	2341	1959	2567	695	4407	1836	2901
2681_RGMA - Repulsive guidance molecule A	2681_RGMA - Repulsive guidance molecule A	25	696	1	1384	2132	3919	3201	3311	1765	4441	696	1569	2890	1620	786	4538	4157	2192	1923	3230	1902
4369_Thyroid-stimulating hormone	4369_Thyroid-stimulating hormone	25	697	1	1400	1025	1230	1950	2799	697	2659	2801	3407	2068	4554	1666	4010	4329	861	4018	2999	4706
3192_Length of time at current address	3192_Length of time at current address	25	697	1	2073	1297	2105	2735	2755	2042	2310	4456	697	3359	3202	1916	4221	3050	1380	3244	4403	3124
2590_MASP1 - Mannan-binding lectin serine protease 1	2590_MASP1 - Mannan-binding lectin serine protease 1	25	697	1	4661	2452	3861	1474	3987	2329	4396	3332	2823	2475	4246	830	697	2550	3190	3291	2398	1708
3752_Traumatic events - Felt distant from other people in past month	3752_Traumatic events - Felt distant from other people in past month	25	698	1	1469	3459	698	1485	3474	4493	2448	1746	2839	2472	4013	3211	1777	1200	3578	2087	4487	2669
656_::::X-03088	656_::::X-03088	25	698	1	2733	3599	3690	4520	698	701	2513	2966	3085	2117	1850	3083	1852	1899	1915	1621	2791	2836
797_::::X-12729	797_::::X-12729	25	699	1	4543	699	3904	3734	3801	3333	3927	4585	4510	1442	4725	2576	3739	3935	1315	1638	2003	4231
3980_Offspring birthweight (maternal)	3980_Offspring birthweight (maternal)	25	700	1	1257	3621	1840	3002	2040	2485	4501	2517	2340	3458	4055	4595	3906	700	3130	3160	4080	2642
3498_Hair colour (natural, before greying): Dark brown	3498_Hair colour (natural, before greying): Dark brown	25	702	1	1434	4371	848	3510	4560	4670	4272	2252	3035	2031	1861	1405	702	3242	4694	1818	3177	4644
4725_Posterior corona radiata mode of anisotropy	4725_Posterior corona radiata mode of anisotropy	25	704	1	1122	3870	3428	704	987	4570	1066	2217	4150	3262	2834	1906	2013	2505	1721	2478	812	1663
3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	3541_Reason for glasses/contact lenses: For just reading/near work as you are getting older (called 'presbyopia')	25	704	1	1613	1276	4701	2967	3589	704	3629	3539	3195	2193	3498	3314	4500	4051	3327	2357	1096	4091
1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	1314_HOMA-IR (at exam 7, FBAT, adjusted for age and sex)	25	704	1	880	1825	3479	857	3850	1876	1015	3205	1699	704	2928	2899	2131	4524	2461	1595	1834	2471
4189_Fasting glucose	4189_Fasting glucose	25	704	1	2430	2249	4520	2112	2895	3683	4049	3773	3046	3611	704	3337	1815	2746	4225	3604	2598	1833
4398_Menstruation quality of life impact: Bowel movement	4398_Menstruation quality of life impact: Bowel movement	25	704	1	1556	3323	1916	4526	1286	2615	880	949	800	3570	4207	704	1476	1594	3875	2307	813	2610
4553_Left isthmus cingulate	4553_Left isthmus cingulate	25	704	1	3643	3832	773	3184	2602	4011	1958	4548	2642	4282	1622	4002	704	2725	2648	2837	2254	2651
4703_Posterior corona radiata mean diusivities	4703_Posterior corona radiata mean diusivities	25	704	1	4669	3455	3819	3338	3817	1803	3853	3161	2558	3712	2198	2476	2674	3769	3288	3284	3175	704
1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	1951_Visual scanning and motor speed (GEE, adjusted for multivariable)	25	705	1	705	2373	4634	4113	2841	2843	1030	4662	2748	1069	2278	3401	2346	3952	720	4167	819	3589
459_Energy::Krebs cycle::citrate	459_Energy::Krebs cycle::citrate	25	705	1	2524	2012	3282	4333	2458	1210	3037	4296	2646	1899	2756	4027	1626	3743	1761	705	3836	4318
2216_ACE2 - Angiotensin-converting enzyme 2	2216_ACE2 - Angiotensin-converting enzyme 2	25	706	1	4625	706	2534	4470	3497	3381	1318	4226	985	1781	4671	2666	3036	2906	919	1742	3843	1924
2951_FGA FGB FGG - D-dimer	2951_FGA FGB FGG - D-dimer	25	706	1	1154	1965	706	2572	1882	4504	3706	4131	3922	2343	1260	1293	3462	4569	4014	2830	3619	3666
746_::::X-12013	746_::::X-12013	25	706	1	838	4461	2800	706	1333	4374	4378	2059	2817	3058	2726	1117	1762	3090	1376	2229	4459	1679
3994_Sensitivity / hurt feelings (HURT)	3994_Sensitivity / hurt feelings (HURT)	25	707	1	2125	707	1069	3095	2898	2257	1667	4588	3328	3608	3076	2068	2901	4578	2469	4196	4547	1282
653_::::X-02973	653_::::X-02973	25	707	1	2642	4692	953	721	3742	1528	1698	3477	4044	707	1211	3704	4712	3564	4270	3589	3337	3296
1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	1390_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	708	1	4086	3887	2362	708	4398	3552	3186	2847	2201	4077	4143	2852	1766	3741	4403	4624	4581	2817
2877_COL23A1 - Collagen alpha-1(XXIII) chain	2877_COL23A1 - Collagen alpha-1(XXIII) chain	25	708	1	3952	2662	1518	3376	2723	3935	1916	4101	2656	2896	1455	3657	1884	4592	1226	708	924	4427
638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	638_Xenobiotics::Sugar, sugar substitute, starch::erythritol	25	708	1	1071	3589	1863	3604	1691	1345	2830	3475	4260	1466	2586	932	2422	4121	2669	3644	4725	708
3450_Impedance measures - Impedance of arm (right)	3450_Impedance measures - Impedance of arm (right)	25	709	1	1632	4067	2852	3787	709	3810	3174	1575	2751	1419	2712	4570	4108	3155	3344	4311	3200	2417
3892_Myeloid white cell count (three-way meta)	3892_Myeloid white cell count (three-way meta)	25	709	1	1629	4034	806	1677	4607	709	1886	2908	4002	2326	2922	3612	1755	4608	1293	1945	3116	2082
2754_KLKB1 - Plasma kallikrein	2754_KLKB1 - Plasma kallikrein	25	709	1	2875	1862	1600	3279	3405	4400	1213	709	761	2913	1474	771	3203	3713	3608	1167	2205	4123
4253_Sleep duration (mean)	4253_Sleep duration (mean)	25	710	1	954	2540	1469	2926	710	3440	2714	1635	4004	4432	3712	1033	1932	2171	4127	2861	1263	3630
3807_Neutrophil count	3807_Neutrophil count	25	710	1	2286	855	2330	2389	1897	1316	4740	4452	2832	2492	3312	710	2704	1042	4546	3688	2143	2863
248_CD337 on NK early	248_CD337 on NK early	25	711	1	943	4615	786	3889	822	2130	1547	3248	3703	711	3238	2262	4109	4454	4714	733	2866	2390
2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	2523_GSK3A GSK3B - Glycogen synthase kinase-3 alpha/beta	25	712	1	1190	1406	1603	1059	3794	1496	712	4311	3506	4537	3457	4659	3048	4413	4153	3213	2912	4232
1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	1378_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 3, FBAT, adjusted for age and sex)	25	713	1	1066	2913	2102	713	4056	4068	2748	4207	1267	2800	3402	1274	1945	3055	4653	1330	4378	2929
2447_HTRA2 - Serine protease HTRA2, mitochondrial	2447_HTRA2 - Serine protease HTRA2, mitochondrial	25	714	1	3004	3340	714	3537	2394	1377	1760	4457	4418	4583	4115	4447	1866	4160	3834	3077	3182	2858
2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	2537_RPS6KA3 - Ribosomal protein S6 kinase alpha-3	25	714	1	4192	1925	4548	1537	1140	4363	810	3682	3268	3156	3462	3932	2857	1232	1772	1229	4447	714
679_::::X-09706	679_::::X-09706	25	715	1	4033	715	1438	1459	1603	1349	3324	4417	2595	1887	2232	1611	1328	1671	4107	3154	1547	3599
4287_FVC	4287_FVC	25	715	1	1725	1196	4523	2441	2232	3087	1495	2169	715	2447	1671	2494	4132	3168	4741	4265	1499	2141
2259_YES1 - Tyrosine-protein kinase Yes	2259_YES1 - Tyrosine-protein kinase Yes	25	715	1	1314	1700	826	1462	4444	2001	3120	3264	3568	1743	3591	2177	715	2355	2757	1126	4183	3118
3283_Number of full sisters	3283_Number of full sisters	25	716	1	3198	2519	1105	1201	2484	4138	3669	3854	3668	1508	716	2347	4280	4331	3963	1211	2537	1262
2252_KAT6A - Histone acetyltransferase KAT6A	2252_KAT6A - Histone acetyltransferase KAT6A	25	716	1	4496	1798	2100	3160	1712	3667	2854	2947	2584	3635	2047	3977	3339	716	4036	2670	1856	2915
502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	502_Lipid::Fatty acid, dicarboxylate::tetradecanedioate	25	717	1	3972	2068	717	4191	4478	828	2931	4680	4501	3066	3303	3548	4524	3512	2538	2086	3695	2208
2102_MMP9 - Matrix metalloproteinase-9	2102_MMP9 - Matrix metalloproteinase-9	25	717	1	3260	3649	4009	1841	1150	4520	898	789	909	2322	4668	2798	3537	4279	1045	4628	717	4609
1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	1411_High-density lipoprotein cholesterol (at exam 3, GEE, adjusted for age and sex)	25	718	1	2206	1688	1435	2485	2390	4367	1352	718	1554	2678	1606	1269	1111	3456	1103	4440	4127	4689
2091_GFRA2 - GDNF family receptor alpha-2	2091_GFRA2 - GDNF family receptor alpha-2	25	718	1	3072	3716	1507	4670	853	3618	4225	3371	718	2901	2410	3778	936	2490	1524	3692	2200	1198
1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	1534_Ankle-brachial index (at exam 7, FBAT, adjusted for age and sex)	25	720	1	1501	2672	4215	4266	1818	4316	2682	720	1503	1200	4190	1133	4301	1241	2151	3704	1775	739
3268_Alcohol intake versus 10 years previously	3268_Alcohol intake versus 10 years previously	25	720	1	1593	776	3722	1847	3482	2323	3233	2281	2439	3264	1677	3844	2063	4075	1621	720	3089	1010
3569_Why stopped smoking: Financial reasons	3569_Why stopped smoking: Financial reasons	25	721	1	2835	4092	3095	4344	2016	2514	721	1854	3424	1694	1185	1415	3956	2066	3940	1014	3476	2007
3636_Illnesses of father: Severe depression	3636_Illnesses of father: Severe depression	25	721	1	3771	4595	1174	1707	1235	3663	3393	3578	3439	3551	3865	721	794	2220	1497	4100	2157	1993
35_Loneliness (linear)	35_Loneliness (linear)	25	721	1	4354	2771	2958	1866	3232	2793	3225	4388	4362	3758	4491	3363	4130	4541	721	4133	3495	3849
1148_AUC insulin	1148_AUC insulin	25	721	1	3208	4190	1522	3403	4325	4247	3709	2944	2252	872	1693	2319	2813	4490	2785	3710	3424	721
2707_CDC37 - Hsp90 co-chaperone Cdc37	2707_CDC37 - Hsp90 co-chaperone Cdc37	25	722	1	2110	2684	2686	2939	4539	3390	4626	1148	3361	2383	3221	722	4094	1969	2979	2031	4577	2018
3392_Longest period of depression	3392_Longest period of depression	25	722	1	2945	3529	2237	3683	3133	2408	3591	806	2559	2220	4387	1132	2919	3855	1636	2017	722	2540
2930_GPC3 - Glypican-3	2930_GPC3 - Glypican-3	25	723	1	723	915	1404	1686	2080	3109	3253	4368	2988	1262	4736	1927	3409	2834	2323	1127	4105	3203
4593_Right pars orbitalis	4593_Right pars orbitalis	25	723	1	2938	3690	2543	3064	4386	4170	4405	4529	1781	1671	723	3503	3901	1704	3371	2224	3748	968
2076_CXCL16 - C-X-C motif chemokine 16	2076_CXCL16 - C-X-C motif chemokine 16	25	724	1	1553	3837	4493	2496	3912	2911	2238	1182	4385	1071	2455	4384	724	4640	1167	4555	4176	3411
4681_Posterior corona radiata axial diusivities	4681_Posterior corona radiata axial diusivities	25	724	1	3803	4622	2988	3922	3379	1170	2076	2667	1942	2604	1935	4724	1569	4023	3168	3129	2798	724
3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	3040_AMHR2 - Anti-Muellerian hormone type-2 receptor	25	725	1	4025	1507	4343	1456	1569	1664	2954	4006	4098	2859	4733	4480	4007	1780	2526	725	3259	1809
4665_Superior fronto-occipital fasciculus fractional anisotropy	4665_Superior fronto-occipital fasciculus fractional anisotropy	25	726	1	2869	3559	3148	1455	726	2033	3622	4715	3159	1571	4565	1629	1016	4321	4102	2174	2502	3117
3904_White blood cell count (three-way meta)	3904_White blood cell count (three-way meta)	25	727	1	932	4367	2518	3865	2282	3669	4635	3683	4229	932	2466	2245	727	2642	2142	940	4356	1892
4624_Left putamen	4624_Left putamen	25	727	1	1710	2793	1999	1498	2803	2953	1277	4208	3072	3511	3919	1443	1301	2551	727	1383	1921	1639
4049_Achilles tendon injury	4049_Achilles tendon injury	25	728	1	1134	2792	728	4028	1883	2256	3661	3949	3354	2932	4663	2568	3722	2805	1857	3239	3527	4248
1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	1973_Morbidity-free survival (at age 65, GEE, adjusted for multivariable)	25	728	1	3133	1816	3416	728	3811	4134	2534	1523	2571	4146	2646	3718	4346	4193	2117	3693	4120	1030
4283_FVC	4283_FVC	25	728	1	3092	4492	1727	4085	1492	3275	728	3185	785	1378	4432	1150	3987	2546	2018	2337	3366	1713
139_Waist-hip ratio (female)	139_Waist-hip ratio (female)	25	728	1	3963	3433	1399	4198	4144	2253	1214	1214	1090	4500	728	2697	3160	3703	3498	2450	3214	2856
2487_PRKCI - Protein kinase C iota type	2487_PRKCI - Protein kinase C iota type	25	728	1	2781	917	3166	3658	4188	3376	3519	4028	3430	2897	4294	3024	2619	728	1141	2407	844	3901
3615_Treatment/medication code: lansoprazole	3615_Treatment/medication code: lansoprazole	25	728	1	2970	3102	4396	2285	3083	1346	2703	1734	3830	1216	813	2228	1590	4198	728	3889	2815	2514
4134_Lymphocyte count	4134_Lymphocyte count	25	729	1	1170	3518	777	1272	1992	2637	4580	729	1472	4681	3205	2300	3466	1580	3259	1456	1999	3509
2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	2766_YWHAB,YWHAE,YWHAG,YWHAH,YWHAQ,YWHAZ,SFN - 14-3-3 protein family	25	729	1	4742	3276	2781	3905	4508	2558	2633	3482	1603	4489	729	4316	4303	1163	3694	1310	2792	3392
1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	1582_D-dimer (at exam 6, FBAT, adjusted for age and sex)	25	729	1	1142	3642	3901	1705	4449	1189	1942	4655	4256	3130	3461	2279	912	2476	2490	729	4692	3025
266_DPT:%Exhausted	266_DPT:%Exhausted	25	729	1	2773	2578	3037	4107	4453	4225	4448	3819	2885	2784	2475	936	1949	3256	3056	2294	729	1125
2792_PA2G4 - Proliferation-associated protein 2G4	2792_PA2G4 - Proliferation-associated protein 2G4	25	730	1	4379	4303	3712	3165	1468	785	1284	1726	4003	730	1854	4494	2297	842	4736	2751	3741	3022
3929_QT interval	3929_QT interval	25	730	1	2190	3528	3907	2623	3103	782	4373	2926	2011	2077	730	1864	3342	3614	2126	3870	2424	1470
4542_Right vessel	4542_Right vessel	25	730	1	4061	2988	4244	3551	3780	4148	2963	2558	1111	4010	3951	730	2525	2217	4059	1368	1904	3493
1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	1676_Gamma-glutamyl transferase (at exam 2, FBAT, adjusted for multivariable)	25	732	1	3522	1340	2296	4297	1611	1469	2047	4340	4331	732	2457	3250	2761	754	2208	3447	2385	2715
2595_EPHB4 - Ephrin type-B receptor 4	2595_EPHB4 - Ephrin type-B receptor 4	25	733	1	2240	1040	4337	2545	3570	2598	1850	2587	4114	3831	733	4664	4139	3126	2228	4403	2238	4478
1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	1826_Spine Neck BMD (FBAT, female, adjusted for multivariable)	25	733	1	2616	4509	1874	3954	779	4650	3563	3545	2356	1038	4072	733	2623	2028	4017	4470	2391	1192
2817_CRP - C-reactive protein	2817_CRP - C-reactive protein	25	733	1	1620	4687	891	1641	2945	3322	3943	3780	1164	4608	1774	2605	3105	1731	1527	2681	1366	733
3616_Treatment/medication code: omeprazole	3616_Treatment/medication code: omeprazole	25	734	1	3031	4199	3423	2177	4060	1370	2412	3484	2826	2671	734	1609	2892	2654	3855	1227	1616	4360
2785_PKM2 - Pyruvate kinase PKM	2785_PKM2 - Pyruvate kinase PKM	25	734	1	4714	2344	4506	3891	2606	3542	2856	3620	2775	3732	1519	734	4562	2257	3851	1721	4444	1644
2562_LTA LTB - Lymphotoxin alpha2:beta1	2562_LTA LTB - Lymphotoxin alpha2:beta1	25	735	1	3243	2674	1903	735	3528	2958	2648	1851	815	4642	2359	2994	1978	1877	4448	4127	1363	4201
2579_BSG - Basigin	2579_BSG - Basigin	25	735	1	4659	1345	1180	2638	2703	4188	4700	735	1836	1393	3418	2664	2162	2223	2904	3471	2520	4715
23_Major depressive disorder (females)	23_Major depressive disorder (females)	25	735	1	830	2186	3425	820	2907	946	2827	1074	3198	1856	4746	972	4681	2709	1267	735	4427	830
4580_Right entorhinal	4580_Right entorhinal	25	736	1	2981	3272	1949	4368	3011	4541	2806	1730	1354	4265	3003	736	2327	3093	3440	1121	1924	2445
389_Amino acid::Lysine metabolism::lysine	389_Amino acid::Lysine metabolism::lysine	25	736	1	982	2842	2542	2662	2992	1921	3925	3240	3325	3313	4650	3192	3432	3514	736	2260	3296	3499
1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	1677_Gamma-glutamyl transferase (at exam 2, GEE, adjusted for multivariable)	25	737	1	3100	737	4310	2428	2526	3027	2285	1750	3497	2385	867	3290	1331	776	2509	3936	2645	3772
4005_Osteoarthritis (self reported)	4005_Osteoarthritis (self reported)	25	737	1	2774	2884	2434	3615	1557	3772	737	3020	1261	4160	2768	1576	2348	3716	2101	1890	2188	4602
621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	621_Xenobiotics::Drug::2-methoxyacetaminophen sulfate*	25	739	1	3335	3482	4336	4008	2120	1337	739	3316	3781	1052	2915	1888	3206	4621	1310	4038	3362	2940
3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	3666_Diagnoses - main ICD10: D12 Benign neoplasm of colon, rectum, anus and anal canal	25	740	1	1793	740	3736	3304	3971	2106	817	2708	1733	1307	3550	4387	2954	4577	3525	4653	1033	917
2851_SPHK2 - Sphingosine kinase 2	2851_SPHK2 - Sphingosine kinase 2	25	741	1	3469	1348	3336	741	3249	3200	3141	3496	2568	886	4428	1043	2771	2241	1624	3121	2553	3148
2209_MMP3 - Stromelysin-1	2209_MMP3 - Stromelysin-1	25	741	1	3320	792	3380	3276	2971	2012	3604	2260	4315	1072	4458	2652	3098	1479	1408	3305	741	1117
3295_Guilty feelings	3295_Guilty feelings	25	742	1	1039	742	4268	1484	4483	4046	3525	2811	4429	2095	4489	3764	1596	2917	4696	3935	3464	1834
3595_Mineral and other dietary supplements: Zinc	3595_Mineral and other dietary supplements: Zinc	25	742	1	1535	883	742	1205	1773	2633	2376	3183	3496	4515	1980	4056	1285	4531	3246	3986	2659	2260
849_::::X-18601	849_::::X-18601	25	742	1	4537	2546	2233	3746	742	4621	3674	2291	3517	2414	3169	3078	2668	4617	2003	4084	3359	2944
218_T:%NKT	218_T:%NKT	25	742	1	4301	1713	2470	3694	3829	3644	1088	2428	4442	2423	2353	2222	3827	773	1717	742	2370	4578
270_CD4:%Naive	270_CD4:%Naive	25	743	1	1951	1558	1242	3494	743	4587	1240	4615	4249	3959	1305	1247	959	4269	1473	3431	1017	1322
914_Concentration of medium HDL particles	914_Concentration of medium HDL particles	25	743	1	2780	3715	1769	1167	1942	2473	743	2958	4324	4621	2720	2363	2347	2594	3891	4392	950	1201
756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	756_Nucleotide::NAD metabolism::X-12095--N1-methyl-3-pyridone-4-carboxamide	25	743	1	2986	2175	1099	3454	3509	3303	2344	743	3255	2420	1804	1764	2869	1195	2010	4233	3323	1981
1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	1667_Aspartate aminotransferase (at exam 2, GEE, adjusted for age and sex)	25	743	1	1250	4364	4182	1058	2169	1671	1202	2935	1262	2037	743	2180	2886	3867	1216	3068	1280	2215
138_Waist-hip ratio (male)	138_Waist-hip ratio (male)	25	744	1	2272	4693	3469	2899	744	2524	3640	1934	2367	840	2997	2355	3054	2694	2213	4415	1766	2625
3203_Age completed full time education	3203_Age completed full time education	25	744	1	3527	2655	3754	2405	2651	4290	3407	2197	2538	1661	744	3553	3075	3443	1846	828	2739	1978
106_Tanner scale (male)	106_Tanner scale (male)	25	744	1	3313	2169	2824	3420	4303	2677	3490	2981	3891	4599	2809	3714	2789	4119	3783	4388	744	2912
2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	2627_IGHG1 IGHG2 IGHG3 IGHG4 IGK@ IGL@ - Immunoglobulin G	25	744	1	1377	3694	3328	3802	1680	3797	3647	4600	871	1142	3831	2203	4111	3287	3836	4399	2190	744
221_T:%Vg9+Vd2-low	221_T:%Vg9+Vd2-low	25	745	1	2386	1538	3624	3745	3444	3919	1443	2927	2720	919	4727	3910	1235	1287	745	1191	3916	3115
792_::::X-12712	792_::::X-12712	25	746	1	2501	4618	2037	1254	2140	4004	1046	4704	2948	1840	3108	3382	746	765	3668	3083	3690	2239
1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	1413_High-density lipoprotein cholesterol (at exam 4, GEE, adjusted for age and sex)	25	746	1	1251	2502	2659	754	2669	3622	4676	1633	881	1738	1367	1341	4029	3655	746	3489	1286	1558
3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	3049_TNFRSF25 - Tumor necrosis factor receptor superfamily member 25	25	748	1	2415	2548	1901	748	1010	1645	2666	3544	4107	1274	2393	3469	987	1795	2822	2369	1964	2707
3272_Handedness (chirality/laterality)	3272_Handedness (chirality/laterality)	25	749	1	1649	2255	2944	2713	2496	1428	3248	749	2845	3961	1582	4196	2214	4053	1784	2679	1324	2184
24_Attention deficit hyperactivity disorder	24_Attention deficit hyperactivity disorder	25	751	1	1815	2306	1440	4630	890	2293	4706	920	2210	751	1002	3027	2929	3632	1850	2757	3792	1957
734_::::X-11820	734_::::X-11820	25	753	1	753	3414	4229	3017	1100	1577	1501	2437	1490	4158	3533	1408	2392	2130	1031	1009	3773	3093
2588_CLEC7A - C-type lectin domain family 7 member A	2588_CLEC7A - C-type lectin domain family 7 member A	25	753	1	4705	2497	1171	4363	1990	753	1710	2648	3428	4700	2282	1915	1730	1307	3307	2010	4204	3397
2041_Attention function - Hit reaction time - Child	2041_Attention function - Hit reaction time - Child	25	756	1	756	772	2666	2812	1367	1171	2343	1499	1398	1572	3270	965	1045	1069	1685	2939	961	2729
3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	3533_Mental health - Illness, injury, bereavement, stress in last 2 years: Serious illness, injury or assault of a close relative	25	757	1	2640	3929	1658	757	3462	4478	1587	3962	1088	1663	3419	2190	766	4479	4018	2734	4303	4633
3755_Mental distress - Ever sought or received professional help for mental distress	3755_Mental distress - Ever sought or received professional help for mental distress	25	757	1	1162	1814	4128	2037	757	4637	4227	1101	1505	1605	3118	4246	3274	3122	2852	3725	2287	4454
2222_CDH5 - Cadherin-5	2222_CDH5 - Cadherin-5	25	757	1	2771	4380	3512	4364	1335	1533	4698	757	2467	972	4375	2583	3153	3911	3491	1803	3081	3270
1737_Serum phosphorus (at exam 2, GEE, adjusted for multivariable)	1737_Serum phosphorus (at exam 2, GEE, adjusted for multivariable)	25	757	2	4306	1250	902	3674	3710	4551	3213	830	2774	2035	3410	2781	3753	757	2941	945	2474	1333
4599_Right precuneus	4599_Right precuneus	25	758	1	4533	4350	758	1399	1242	4184	3990	4608	818	2717	3349	3234	3968	4103	4086	2353	2439	2831
4085_Type 2 Diabetes	4085_Type 2 Diabetes	25	758	1	4508	1491	962	3651	4344	4344	1309	4621	2790	2614	3518	1808	4399	2451	3496	1006	1649	758
2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	2605_CDC42BPB - Serine/threonine-protein kinase MRCK beta	25	759	1	759	4602	1952	1388	3511	4357	2779	3487	3992	3412	4457	4331	1565	4424	4535	3226	4218	3851
527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	527_Lipid::Long chain fatty acid::pentadecanoate (15:0)	25	760	1	4001	2483	2169	2330	3315	2031	3317	1501	760	3008	3486	1257	2186	2980	4294	3974	3975	889
3593_Mineral and other dietary supplements: Glucosamine	3593_Mineral and other dietary supplements: Glucosamine	25	760	1	2746	1854	3366	839	4068	3304	1389	3789	3639	3353	3496	964	760	3308	1085	3790	3607	822
3427_Fluid intelligence test - FI4 : positional arithmetic	3427_Fluid intelligence test - FI4 : positional arithmetic	25	761	1	2216	3484	2996	4704	4480	2434	3756	4682	3706	3863	3132	1368	761	3140	4706	1467	4549	2957
1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	1995_Survival past average life expectancy (GEE, adjusted for birth-cohort)	25	762	1	4478	762	4428	1081	4688	3123	4156	3778	1906	2910	1790	1816	1536	3534	2729	4724	4032	3995
1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	1304_Fasting insulin (at exam 7, FBAT, adjusted for age and sex)	25	764	1	1408	4005	4123	4567	1638	3831	2267	2393	3154	2482	1313	764	2754	4475	2633	1336	1727	3535
4115_Calcium	4115_Calcium	25	764	1	2211	962	4322	1307	4445	1371	911	2649	1751	2866	4000	3663	1010	3158	764	1702	2888	3434
1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	1368_Total cholesterol (at exam 6, FBAT, adjusted for age and sex)	25	765	1	2096	4442	4725	2288	4209	4063	3047	3035	1109	2711	4107	2103	3828	3267	765	4055	1851	2283
1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	1444_Low-density lipoprotein cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	766	1	4666	3934	2924	3123	2791	1524	3998	766	2345	1401	3183	4050	3847	2187	3769	3942	1726	3374
1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	1247_Mean FEV1/FVC from exam 3 and 5 (GEE, adjusted for multiple covariates)	25	766	1	1214	1527	2176	3830	2815	1601	2316	1059	3834	2868	1276	2720	2260	766	2575	1590	3291	4540
2863_IL5RA - Interleukin-5 receptor subunit alpha	2863_IL5RA - Interleukin-5 receptor subunit alpha	25	766	1	2065	1317	3983	996	4260	3408	1882	2216	4050	2161	2538	2138	1098	2278	2836	766	3595	1740
4743_Fornix (column and body of fornix) radial diusivities	4743_Fornix (column and body of fornix) radial diusivities	25	766	1	1489	2714	2184	3111	1658	1929	1083	3548	795	3849	3172	4051	3085	1420	908	2145	4418	766
2905_LTA - Lymphotoxin-alpha	2905_LTA - Lymphotoxin-alpha	25	767	1	4684	2098	2896	1568	767	4110	2060	4268	3455	2259	926	2238	1254	1690	4238	3969	1973	4364
2567_CPB2 - Carboxypeptidase B2	2567_CPB2 - Carboxypeptidase B2	25	767	1	3914	1865	2212	1780	4436	1887	2517	3813	2267	875	4012	2430	2831	767	4087	2370	3636	4094
2976_CDNF - Cerebral dopamine neurotrophic factor	2976_CDNF - Cerebral dopamine neurotrophic factor	25	769	1	3779	4683	1042	3277	1432	1830	2273	3629	3338	1595	769	3428	2848	1500	936	1112	4106	2757
1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	1824_Inter-trochanteric buckling ratio (FBAT, male, adjussted for age)	25	770	1	2192	1330	770	3741	788	4056	2409	4559	1927	828	1931	4412	2536	4062	1841	4684	4255	2460
2909_IL3 - Interleukin-3	2909_IL3 - Interleukin-3	25	770	1	2437	1280	2785	835	3747	1648	1867	2534	2449	770	2294	2460	1982	3544	4682	3697	3518	3102
2903_FABP3 - Fatty acid-binding protein, heart	2903_FABP3 - Fatty acid-binding protein, heart	25	770	1	833	3074	1606	1606	3853	3059	2812	1413	4390	3240	770	2433	1135	2936	3465	1020	3264	4506
147_Body Mass Index (male > 50 yrs)	147_Body Mass Index (male > 50 yrs)	25	773	1	2160	1580	3117	4143	3089	4249	4251	773	4275	2165	4699	3492	2819	1803	4726	4713	4131	2391
3315_Use of sun/uv protection	3315_Use of sun/uv protection	25	773	1	3620	2918	1234	2825	1324	3989	4486	4347	4001	4053	773	1128	1011	2376	3734	3485	2858	3477
4244_Rapid automised naming and rapid alternating stimulus test performance	4244_Rapid automised naming and rapid alternating stimulus test performance	25	773	1	1104	2554	2641	4586	1934	2309	2811	2678	4350	4271	4692	4623	4555	2378	1995	773	1408	876
1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	1339_HOMA-IR (at exam 7, GEE, adjusted for age, sex and BMI)	25	774	1	4634	2039	2377	4036	774	2270	4102	802	2355	3027	4564	1288	2028	869	1813	2852	1441	2946
1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	1695_Vitamin K percentage of undercarboxylated osteocalcin (at exam 6 or 7, GEE, adjusted for age and sex)	25	774	1	1954	4359	4194	2012	1962	4568	2972	3369	2095	2567	774	1987	2875	4241	3271	1378	1585	2002
4682_Posterior limb of internal capsule axial diusivities	4682_Posterior limb of internal capsule axial diusivities	25	776	1	776	3483	2285	3189	1821	2930	3184	3664	3557	4040	3914	4171	4442	3388	3431	3296	2667	989
1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	1724_Serum calcium (at exam 2, FBAT, adjusted for age, sex and serum creatinine)	25	776	1	3053	4084	808	3808	2355	2260	2122	4540	4404	4131	3416	1901	776	3674	3546	1026	2694	2449
3350_Bilateral oophorectomy (both ovaries removed) (female)	3350_Bilateral oophorectomy (both ovaries removed) (female)	25	778	1	2998	938	2298	1323	3707	1970	3272	2459	3318	2371	3337	1505	1455	778	2924	1663	1352	2991
1288_Waist circumference by CT (FBAT, adjusted for age and sex)	1288_Waist circumference by CT (FBAT, adjusted for age and sex)	25	780	1	1292	4508	2238	2765	3230	1881	2637	780	1392	3064	2029	3947	4560	4046	1646	3583	2711	2535
4390_Dysmenorrhea pain severity	4390_Dysmenorrhea pain severity	25	780	1	3392	3653	4165	3444	2206	3044	956	3481	3017	3630	1222	1356	3197	780	3802	1459	1636	2497
2299_DSG1 - Desmoglein-1	2299_DSG1 - Desmoglein-1	25	783	1	1916	2856	1200	2539	4129	2290	2147	2219	1658	3755	3421	2074	783	851	1116	1714	3357	4006
3721_Frequency of memory loss due to drinking alcohol in last year	3721_Frequency of memory loss due to drinking alcohol in last year	25	783	1	1138	2937	3666	852	1461	1157	1709	2933	1448	2096	1468	3869	1946	4559	4054	4107	2042	783
3984_Heart rate increase	3984_Heart rate increase	25	784	1	948	3489	2553	784	3174	2668	4630	2073	3236	1506	3228	875	2894	1401	2123	3094	1752	1674
589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	589_Nucleotide::Pyrimidine metabolism, uracil containing::pseudouridine	25	784	1	2597	2073	4011	3212	1851	3186	3429	784	2621	3202	2032	3847	3159	906	2800	1906	3014	4165
508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	508_Lipid::Glycerolipid metabolism::glycerol 3-phosphate (G3P)	25	784	1	3756	1287	1056	1910	2932	1588	3008	3071	2590	2251	3784	1848	2225	866	2631	3941	784	2972
103_Late pubertal growth (male)	103_Late pubertal growth (male)	25	785	1	1946	1433	4729	3926	3894	1787	785	4716	2106	4565	1321	2217	1129	1270	1966	2950	2649	4726
4375_Hyperthyroidism	4375_Hyperthyroidism	25	787	1	2503	787	2978	1548	2874	2418	3147	3340	2580	1250	3792	1407	1877	4087	1313	2228	2997	2029
4476_Right caudal anterior cingulate	4476_Right caudal anterior cingulate	25	787	1	2379	3970	1493	2928	4524	4077	1504	2881	2184	3129	1254	1015	3488	787	2518	1323	1859	3133
2557_IL17A - Interleukin-17A	2557_IL17A - Interleukin-17A	25	788	1	2453	2174	1186	3137	1188	4540	872	788	1687	4032	3390	864	4287	1617	4109	1138	858	2498
3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	3124_IMPDH2 - Inosine-5'-monophosphate dehydrogenase 2	25	788	1	4583	1938	4676	3797	2301	4387	2869	3469	3788	788	3785	2286	1727	1125	4599	3035	1319	3488
227_mDC:%CD1c-	227_mDC:%CD1c-	25	788	1	3868	3558	2817	2844	1232	1263	1404	4514	4480	3356	1646	3449	2322	788	1554	4119	2630	4730
4615_3rd ventricle	4615_3rd ventricle	25	788	1	2856	2055	3197	3315	3820	3615	2414	1987	3243	2558	3746	1333	4665	1283	788	2673	1325	4705
3740_Depression - Depression possibly related to stressful or traumatic event	3740_Depression - Depression possibly related to stressful or traumatic event	25	789	1	3800	1597	1602	3342	3941	2295	4192	4335	2858	3599	3524	4564	4687	2966	967	2897	789	4163
4145_Pulse pressure	4145_Pulse pressure	25	791	1	791	2901	1217	2439	3233	3198	3700	3210	1823	1891	2889	3411	3406	2964	2699	2016	3694	3991
2613_CD84 - SLAM family member 5	2613_CD84 - SLAM family member 5	25	792	1	2502	1194	2729	4290	3698	962	4468	2376	961	3907	3540	792	1972	1786	983	3500	2291	2189
3916_Disc area	3916_Disc area	25	792	1	1366	2253	2926	4087	2988	2601	3446	1466	3862	3321	4723	1636	3332	792	821	1652	3933	2437
3888_Mean corpuscular volume (three-way meta)	3888_Mean corpuscular volume (three-way meta)	25	792	1	4326	3028	1877	1101	2402	3686	4383	1161	2248	3756	3293	1038	4450	1842	2397	857	792	1437
3401_Loud music exposure frequency	3401_Loud music exposure frequency	25	795	1	3796	4669	3848	1464	4620	4553	3744	2438	3556	3315	795	1152	3509	4680	4454	2406	3772	3617
2745_CXCL10 - C-X-C motif chemokine 10	2745_CXCL10 - C-X-C motif chemokine 10	25	796	1	3369	3841	3022	881	2650	4241	1578	1143	2938	796	3596	2210	3145	1247	1198	3370	4031	3442
3043_CD226 - CD226 antigen	3043_CD226 - CD226 antigen	25	797	1	938	1512	4576	1004	948	2752	2878	1066	4686	1164	797	3262	1531	1013	4727	3610	2751	1046
2925_SFN - 14-3-3 protein sigma	2925_SFN - 14-3-3 protein sigma	25	798	1	1417	1832	798	1879	1823	4588	1372	2612	3745	4112	4656	3443	4425	2230	2598	4521	4329	4503
3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	3555_Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones: Blood pressure medication	25	798	1	3350	4009	3351	798	4397	1100	3671	2867	3186	4671	3344	3335	1346	2557	2086	2715	3713	1836
348_CD8:%R5+	348_CD8:%R5+	25	798	1	3909	3268	4426	1750	4314	798	2801	2694	3918	3526	3392	4121	1747	3261	2373	1542	2448	2160
4425_Hepatitis B HBc antigen seropositivity	4425_Hepatitis B HBc antigen seropositivity	25	798	1	1332	1371	1080	2689	1748	3132	4593	4014	2151	2426	1556	798	4503	2646	3640	3785	3503	4229
3725_Frequency of drinking alcohol	3725_Frequency of drinking alcohol	25	799	1	4524	2621	1802	3635	1105	1592	3937	2870	4738	2253	799	2804	3125	2297	2810	2453	3050	2509
4494_Right pericalcarine	4494_Right pericalcarine	25	799	1	3055	2295	2656	2781	4602	3305	3226	1871	3685	2079	3847	2685	3482	4294	799	3374	2018	899
45_Self-reported tiredness	45_Self-reported tiredness	25	800	1	2927	3468	1138	2310	1723	1016	2259	800	3941	1873	3946	1456	3599	2764	3699	2946	2726	1810
1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	1671_Bilirubin (at exam 2, GEE, adjusted for age and sex)	25	800	1	1902	4343	4720	1043	2613	2924	4481	3782	4412	3938	2484	3217	800	2866	3339	1644	4638	2453
3397_Shortness of breath walking on level ground	3397_Shortness of breath walking on level ground	25	802	1	3354	2320	4617	3915	4595	1065	2388	3522	4470	2665	2502	2402	4153	1535	802	3181	829	1020
195_Chronic kidney disease	195_Chronic kidney disease	25	803	1	4297	803	1719	3714	925	4055	2974	1212	1616	1513	4521	1417	1659	3837	2251	3711	4128	2241
1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	1498_Triglycerides (at exam 1, FBAT, adjusted for age and sex)	25	806	1	4244	3827	3637	806	3436	2490	2568	3843	3903	1583	1084	4727	4587	1430	3558	4068	4063	2881
463_Energy::Oxidative phosphorylation::phosphate	463_Energy::Oxidative phosphorylation::phosphate	25	810	1	1834	2553	3499	3296	810	2999	1339	2072	4678	2018	2769	1388	3027	1049	4306	2248	1504	2780
1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	1251_Percent predicted FEF25-75/FVC for latest exam (GEE, adjusted for multiple covariates)	25	811	1	2960	4024	3159	3606	2879	3039	4316	1145	811	3968	2084	3983	3928	3782	4205	1345	2333	1397
1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	1122_Pericardial adipose tissue volume (adjusted for height and weight, female)	25	812	1	3944	943	812	860	1641	2306	1472	2677	2783	1096	3332	3409	2233	2711	1796	4535	3800	827
4105_Albumin	4105_Albumin	25	813	1	2257	2470	1150	1747	1440	813	3190	1279	4070	1543	3382	824	3076	1400	3037	4732	3054	1246
4411_Total IgG levels	4411_Total IgG levels	25	813	1	2083	3944	2863	4596	1403	2249	1714	2443	3368	1162	1650	1449	4018	813	1494	1648	4732	4611
3439_Tobacco smoking	3439_Tobacco smoking	25	813	1	3002	2524	3436	2565	3287	3973	3942	2527	3462	4357	2383	3501	1294	3425	4366	2938	4143	813
1857_Neck average buckling ratio (GEE, male, adjussted for age)	1857_Neck average buckling ratio (GEE, male, adjussted for age)	25	814	1	3370	1887	2927	1488	3773	1122	3208	1187	3691	2930	946	3691	4222	2949	833	814	2586	1607
1954_Similarities raw score (FBAT, adjusted for multivariable)	1954_Similarities raw score (FBAT, adjusted for multivariable)	25	815	1	3941	1367	3056	4082	815	3271	1016	1887	3878	1272	917	3987	3591	1464	4141	2883	4705	3017
1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	1653_Tumor necrosis factor alpha (at exam 7, GEE, adjusted for multivariable)	25	816	1	966	4671	4021	2133	816	4227	1032	4673	1258	3172	1833	1621	3544	4195	3041	961	1092	1223
1214_Alcohol consumption (male)	1214_Alcohol consumption (male)	25	816	1	3127	4020	1554	1716	3117	3829	3802	3179	816	4488	4625	2178	3223	4441	4390	2027	2837	4226
2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	2688_GAPDH - Glyceraldehyde-3-phosphate dehydrogenase	25	817	1	3347	2936	4455	3777	2837	4212	2006	817	2582	4107	3125	1292	3635	3712	4721	1739	2041	2802
1140_Type 2 Diabetes (Dominance deviation model)	1140_Type 2 Diabetes (Dominance deviation model)	25	817	1	4630	4555	1160	1088	2396	2801	1203	2424	1352	1609	2577	1854	3311	1338	4232	2851	3720	817
12_Schizophrenia/Bipolar disorder	12_Schizophrenia/Bipolar disorder	25	820	1	4182	2472	4218	3034	820	2955	4341	4036	3316	2021	1654	2146	3385	2103	3738	3048	2876	3080
4331_Postburn scar height	4331_Postburn scar height	25	824	1	4231	1902	1167	1555	2276	4606	2291	1473	1381	3241	2857	1525	824	1939	3499	2575	1331	2955
3607_Non-cancer illness code, self-reported: osteoarthritis	3607_Non-cancer illness code, self-reported: osteoarthritis	25	824	1	2855	1060	3924	2255	4701	1656	3675	4409	4060	3032	2685	1503	4182	2144	2811	824	4586	4677
3085_ROBO2 - Roundabout homolog 2	3085_ROBO2 - Roundabout homolog 2	25	826	1	1185	3087	1929	2126	3165	3537	3618	1358	3216	1994	2975	2327	4566	1741	2257	4410	2381	826
3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	3680_Diagnoses - main ICD10: N39 Other disorders of urinary system	25	827	1	3287	1489	3873	1198	4057	827	1381	2598	1483	2539	1886	2848	4337	3896	4409	1921	2911	4667
2646_IL5 - Interleukin-5	2646_IL5 - Interleukin-5	25	828	1	4062	3861	4085	1082	2697	1191	4371	3787	2677	2151	828	2362	4348	3092	3059	4095	1526	4178
1838_Neck width (FBAT, female, adjusted for age)	1838_Neck width (FBAT, female, adjusted for age)	25	829	1	4257	1963	829	4739	3359	4433	4074	4346	3817	2980	3709	4545	1080	3197	3553	4577	3468	2988
1029_Neck Width (GEE, adjusted for age and sex)	1029_Neck Width (GEE, adjusted for age and sex)	25	830	1	1493	1372	833	1638	3388	1817	3094	1277	4408	830	4328	3233	4476	3531	1104	2383	3452	1831
704_::::X-11441	704_::::X-11441	25	831	1	1355	2353	1284	2165	4704	4050	4386	4136	2380	1426	1716	1328	2606	3335	3909	831	4261	2854
2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	2293_ACVRL1 - Serine/threonine-protein kinase receptor R3	25	832	1	832	2873	2464	4169	892	1152	4589	2297	3658	2696	3144	2419	2596	2561	2905	4281	2767	3815
3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	3683_Diagnoses - main ICD10: R19 Oth symptoms and signs involving the dgstv sys and abdomen	25	832	1	2552	3325	2540	3616	2767	3229	1550	3325	3794	2773	1673	3090	4456	832	4432	2740	3460	3058
739_::::X-11850	739_::::X-11850	25	833	1	2220	2084	4686	2785	2218	1981	1052	1628	2042	833	1113	2935	2727	1614	4223	3702	1203	3866
2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	2675_MATK - Megakaryocyte-associated tyrosine-protein kinase	25	833	1	2770	3977	3274	3631	4158	2917	1876	2113	847	1693	1910	1899	833	1015	3907	3677	4146	3667
433_Amino acid::Valine, leucine and isoleucine metabolism::valine	433_Amino acid::Valine, leucine and isoleucine metabolism::valine	25	833	1	4476	4599	4502	2759	2088	1983	2965	3675	2238	4080	1095	4739	3074	833	3823	1406	4226	4329
4256_Sleep midpoint	4256_Sleep midpoint	25	834	1	2183	834	3077	1786	2261	1518	3423	3659	2946	3243	1457	2368	3485	2657	4296	2499	3445	3651
1222_Mean Hippocampus	1222_Mean Hippocampus	25	834	1	3761	1087	2865	2305	3053	3035	4166	3923	2576	834	1955	3253	2059	1062	3967	3755	4536	4531
2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	2875_CDON - Cell adhesion molecule-related/down-regulated by oncogenes	25	835	1	3489	835	1090	1127	1297	3250	2152	4502	3808	4114	2981	2181	985	2683	3973	3325	3226	2458
735_::::X-11843	735_::::X-11843	25	836	1	979	4124	3495	4021	3323	836	2105	4574	3526	2708	2443	2934	4203	3252	2236	3787	1459	3099
3449_Impedance measures - Impedance of leg (left)	3449_Impedance measures - Impedance of leg (left)	25	836	1	2338	1080	1923	2443	3930	4528	4162	4236	1360	3355	4219	3564	836	1154	3306	4447	2872	992
3775_Traumatic events - Able to pay rent/morgage as an adult	3775_Traumatic events - Able to pay rent/morgage as an adult	25	837	1	2572	2153	2642	837	1653	3776	3263	2338	3134	4708	3704	3167	846	3550	1570	4715	4397	1826
1986_Age at natural menopause (FBAT)	1986_Age at natural menopause (FBAT)	25	837	1	2609	1435	4016	1401	2908	3690	837	2795	4593	1650	4471	2824	3971	2149	1607	3584	3806	3760
2504_BCL2 - Apoptosis regulator Bcl-2	2504_BCL2 - Apoptosis regulator Bcl-2	25	838	1	2203	838	4332	4552	1572	3205	4722	3752	2256	3500	3575	1688	2418	1797	1547	3012	2746	1771
146_Body Mass Index	146_Body Mass Index	25	839	1	991	1543	1867	3669	839	4576	2917	4461	4439	1851	2559	4678	2185	2612	3350	4523	4001	4553
3537_Attendance/disability/mobility allowance: Disability living allowance	3537_Attendance/disability/mobility allowance: Disability living allowance	25	840	1	2369	840	1151	4280	3337	4497	2318	913	1351	3591	1022	3490	2890	4453	4594	4468	4649	4027
3100_UNC5D - Netrin receptor UNC5D	3100_UNC5D - Netrin receptor UNC5D	25	840	1	1845	2193	840	869	4077	3564	1104	1417	1797	1098	3000	1690	1385	3517	3548	3545	1978	2820
4587_Right lingual	4587_Right lingual	25	840	1	4174	2141	3449	4465	3132	3188	3833	3356	4683	3920	3608	3001	3035	2033	2362	4552	2964	840
4544_White matter	4544_White matter	25	841	1	2792	1228	1219	2881	1427	1901	1410	4082	4334	3691	992	1450	3887	841	1924	3450	2066	2650
1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	1446_Low-density lipoprotein cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	841	1	3067	2732	4093	2009	4671	4550	2164	3322	3005	3267	3927	1610	3443	4041	1449	841	2420	2150
3996_Nervous feelings (NERV-FEEL)	3996_Nervous feelings (NERV-FEEL)	25	842	1	3266	1904	1709	2395	1950	4636	2926	4363	1452	4619	4119	3526	4129	4359	3843	3616	4555	842
1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	1862_Neck cross-sectional moment of inertia (FBAT, female, adjussted for age)	25	843	1	3124	3395	3835	2245	1264	2384	3191	3326	843	2273	3409	3481	1836	1769	1700	1314	3158	4168
466_Lipid::Bile acid metabolism::glycochenodeoxycholate	466_Lipid::Bile acid metabolism::glycochenodeoxycholate	25	844	1	3959	4058	4480	1069	4233	4426	1416	4039	3611	2041	1895	2713	2039	1456	844	4307	1567	1136
2437_CST7 - Cystatin-F	2437_CST7 - Cystatin-F	25	847	1	3059	3566	3539	3864	2366	3672	3328	2818	4325	2449	4738	847	1508	4701	2610	3629	2077	1937
1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	1569_Maximum carotid artery stenosis (at exam 6, GEE, adjusted for multivariable)	25	847	1	4563	2977	1290	4351	893	3938	3580	2940	1461	1410	3921	3781	4434	2602	2197	4093	1368	847
3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	3488_Cereal type: Bran cereal (e.g. All Bran, Branflakes)	25	848	1	2871	4568	3549	1626	3583	4452	2391	3144	2667	2850	3887	3769	848	3631	1256	2190	1468	1690
1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	1563_Mean internal carotid artery IMT (at exam 6, GEE, adjusted for age and sex)	25	849	1	1126	3388	2177	4450	1012	4321	1186	1114	1958	3138	1504	849	1775	2802	878	1154	2574	2109
3737_Depression - Ever had prolonged loss of interest in normal activities	3737_Depression - Ever had prolonged loss of interest in normal activities	25	849	1	4176	4212	4070	4634	1067	4584	4111	1557	2079	2325	3272	1735	2816	4457	1383	849	3610	2114
829_::::X-13859	829_::::X-13859	25	849	1	935	1742	973	3688	1667	3798	4668	3193	3914	3097	2016	4290	4568	1937	2392	2918	4478	849
1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	1926_Lateral ventricular volume (FBAT, adjusted for age and sex)	25	856	1	2891	3895	3794	4249	856	2897	4096	3609	2272	3391	3336	3060	1205	3109	3167	3334	2970	964
2993_FABP5 - Fatty acid-binding protein, epidermal	2993_FABP5 - Fatty acid-binding protein, epidermal	25	856	1	2182	2906	2163	2337	2419	2280	3829	856	1552	3191	2714	2439	2492	1274	4499	4424	3556	3012
3510_Reason for reducing amount of alcohol drunk: Health precaution	3510_Reason for reducing amount of alcohol drunk: Health precaution	25	856	1	3903	4437	3614	2315	2527	1416	2529	3865	856	3506	4295	3033	4605	1474	2420	2798	2024	1165
3639_Illnesses of mother: Stroke	3639_Illnesses of mother: Stroke	25	856	1	2111	2257	1736	3625	3274	4069	4482	3677	2619	3859	2558	856	2335	1548	1573	4295	2741	3306
1049_Parkinson disease of sibling pairs (tier 1)	1049_Parkinson disease of sibling pairs (tier 1)	25	856	1	4511	3853	1757	1552	4348	2919	4384	1110	2771	2848	3764	3785	3959	856	1296	4694	4021	3233
39_Memory	39_Memory	25	857	1	857	1805	971	3106	1377	2314	2784	2141	3905	3330	2896	3159	4640	3923	1969	3286	3941	3196
1219_Mean Accumbens	1219_Mean Accumbens	25	858	1	2911	2971	2001	3503	2302	3577	1177	3973	2040	2038	2316	2922	4162	1160	858	2162	3782	1983
1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	1315_HOMA-IR (at exam 7, GEE, adjusted for age and sex)	25	859	1	4202	859	940	956	2962	2351	2725	4652	3967	4162	1585	2342	1602	2498	4095	3034	2954	4471
4239_Latent naming speed	4239_Latent naming speed	25	860	1	1735	2212	4496	4358	3592	3033	3276	4724	3030	2310	3942	860	4564	3497	2609	2442	1930	4598
3750_Traumatic events - Felt irritable or had angry outbursts in past month	3750_Traumatic events - Felt irritable or had angry outbursts in past month	25	861	1	3913	861	4033	1366	3738	3648	3299	1238	3795	2142	2546	1126	3187	2433	1177	2305	3125	2950
206_Serum Urate	206_Serum Urate	25	861	1	4430	3872	4242	2737	1466	1772	2937	861	1339	3354	1751	1757	3122	3555	3657	4502	2515	2699
4612_Right basal forebrain	4612_Right basal forebrain	25	861	1	1561	4697	4287	3940	4617	3589	4530	4204	861	1557	2095	3467	1851	2587	4511	4297	966	1923
885_Isoleucine	885_Isoleucine	25	861	1	2979	2848	3864	4256	1694	3629	1561	3305	2328	2607	2360	1696	3148	2590	2783	2274	2595	861
635_Xenobiotics::Food component, Plant::saccharin	635_Xenobiotics::Food component, Plant::saccharin	25	862	1	4351	1442	865	2601	3038	862	4673	2278	1524	4386	4506	1483	3801	3890	2984	4057	3842	3132
1758_Breast cancer (FBAT, adjusted for age)	1758_Breast cancer (FBAT, adjusted for age)	25	862	1	4553	3701	935	3266	1768	3850	2082	4293	1320	4726	4121	2873	862	991	1156	1916	3703	4637
3335_Light smokers, at least 100 smokes in lifetime	3335_Light smokers, at least 100 smokes in lifetime	25	863	1	1427	4491	1339	4171	3293	863	931	4617	3337	4615	3637	2503	3896	3900	3245	2622	2251	3553
3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	3713_Diagnoses - secondary ICD10: Z88 Allergy status to drug/meds/biol subst	25	864	1	3224	1124	2479	2483	2018	2236	864	3943	3116	3373	3735	2351	2329	3592	1413	2904	4435	3161
478_Lipid::Carnitine metabolism::carnitine	478_Lipid::Carnitine metabolism::carnitine	25	866	1	3912	1156	3725	4423	4207	3886	1222	3921	4417	2735	3553	4455	2964	893	4253	866	2162	1142
2829_MST1 - Hepatocyte growth factor-like protein	2829_MST1 - Hepatocyte growth factor-like protein	25	866	1	1302	4502	4441	2542	2546	3104	3917	2737	2387	1205	3526	4720	3242	2125	3119	1817	866	3284
3188_Pulse rate (automated reading)	3188_Pulse rate (automated reading)	25	867	1	4548	1633	3375	1070	3429	1819	2478	2389	867	3869	4260	2350	3234	3721	2480	2666	2394	2575
4378_High blood pressure	4378_High blood pressure	25	867	1	1950	2812	2289	2026	1903	1187	4585	1993	2135	4631	2877	4695	3097	3363	4237	2497	4600	867
3962_Gestational weight gain (maternal, late)	3962_Gestational weight gain (maternal, late)	25	869	1	3850	869	1615	1748	1209	3753	1746	1244	1005	2931	3634	4715	4308	3212	3559	2208	4364	2661
2453_MATN2 - Matrilin-2	2453_MATN2 - Matrilin-2	25	869	1	4638	3487	3079	3750	1847	3997	1880	2157	3869	2286	2133	3611	4030	3961	869	874	3851	2086
1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	1796_RR interval (female, cohort exam 11 offspring exam 1, FBAT, adjusted for age nad RR)	25	871	1	871	3349	3102	4723	2745	4596	2059	2887	3084	3206	2107	2197	3989	1136	2245	3491	3499	4261
2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	2111_TNFRSF8 - Tumor necrosis factor receptor superfamily member 8	25	871	1	4592	1882	2155	3849	1807	3499	2973	2276	1422	4177	2902	2452	4714	871	3719	1901	2345	3355
1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	1344_Plasma Apolipoprotein A-I level (FBAT, multivariate adjusted)	25	872	1	872	2435	1890	3515	4039	2165	1680	2067	4135	1575	3385	4515	2645	3154	4540	1269	2959	3283
4152_Relative wall thickness	4152_Relative wall thickness	25	872	1	1244	4324	4197	4625	3168	2198	4719	1492	3573	4636	2444	4381	872	2941	2238	1337	3093	2062
4061_Urinary albumin-to-creatinine ratio	4061_Urinary albumin-to-creatinine ratio	25	872	1	1229	2144	4288	3432	3845	2298	1129	2245	2155	1561	1309	3911	4517	1091	1506	1910	3146	872
2088_CDH1 - Cadherin-1	2088_CDH1 - Cadherin-1	25	873	1	1456	1695	4236	2656	3012	3054	2366	988	2932	873	3218	1546	2931	4737	1278	4232	2109	3633
1093_Glioma	1093_Glioma	25	873	1	2718	3539	4482	2415	3995	1846	1784	4356	3928	1905	4032	2640	910	3659	1118	873	1215	2773
3246_Processed meat intake	3246_Processed meat intake	25	874	1	4195	1873	917	1670	874	4345	3949	1951	2130	3875	4075	4551	3910	4465	1882	1142	3391	3904
4147_Posterior wall thickness	4147_Posterior wall thickness	25	875	1	3888	3405	4217	1597	2004	3998	2464	1632	875	2978	1182	1056	3296	1126	4187	3268	2572	2161
1292_Diabetes incidence (FBAT, adjusted for age and sex)	1292_Diabetes incidence (FBAT, adjusted for age and sex)	25	876	1	3836	4205	2962	3705	876	3234	1617	1621	3701	2780	3966	4130	2124	2757	3361	4338	1460	3756
367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	367_Amino acid::Alanine and aspartate metabolism::N-acetylalanine	25	876	1	3401	1860	4387	4410	2811	876	4523	2092	1704	4368	3343	3358	4009	4335	3810	1824	3042	2943
4672_Body of corpus callosum axial diusivities	4672_Body of corpus callosum axial diusivities	25	877	1	3703	3823	4475	3440	3919	877	4137	2108	3235	3233	1243	1393	3224	1651	1254	1068	2643	4284
1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	1687_Vitamin D plasma 25(OH)-D (at exam 6 or 7, GEE, adjusted for age and sex)	25	878	1	2266	4183	878	1202	1508	4136	2576	1902	1402	4303	4693	1259	4394	1878	1259	4207	911	4326
2894_RSPO2 - R-spondin-2	2894_RSPO2 - R-spondin-2	25	878	1	4529	3522	4586	1804	1612	2865	878	1127	3984	4125	3292	2361	3508	1226	2324	3707	1554	4714
2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	2376_ADAMTS5 - A disintegrin and metalloproteinase with thrombospondin motifs 5	25	878	1	3555	3270	1446	4065	2020	3050	3815	4688	1293	1403	3444	3239	4056	878	3956	3031	4553	3172
3265_Average weekly spirits intake	3265_Average weekly spirits intake	25	878	1	3622	4720	1263	4103	3238	2885	1822	4169	4595	3585	4266	1712	2860	1691	4652	4225	878	4355
669_::::X-06267	669_::::X-06267	25	879	1	3209	3146	2532	1287	2387	2780	3056	879	1969	3437	3067	2945	4421	3381	4208	1439	3225	4113
1965_MMSE score (at exam 5, GEE, adjusted for age)	1965_MMSE score (at exam 5, GEE, adjusted for age)	25	879	1	2423	3933	3703	2034	2408	3917	4010	3828	2731	4655	3592	4154	879	2290	3020	4512	4242	1481
3735_Depression - Frequency of depressed days during worst episode of depression	3735_Depression - Frequency of depressed days during worst episode of depression	25	881	1	1209	3490	3667	4233	3363	881	3623	2718	3916	1679	2983	2630	2971	2374	2408	2473	2610	3925
842_::::X-14625	842_::::X-14625	25	882	1	2088	4405	1671	3976	2887	4115	2031	2764	3139	2097	2068	2489	4110	4072	4333	1440	4691	882
3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	3558_Medication for pain relief, constipation, heartburn: Ibuprofen (e.g. Nurofen)	25	884	1	998	884	3157	4091	1238	4354	2024	3881	1696	2045	3527	1537	1598	3417	4211	4642	2795	4277
3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	3753_Traumatic events - Repeated disturbing thoughts of stressful experience in past month	25	884	1	2747	3943	1364	1214	1687	4643	3733	3976	2909	4253	2691	4476	884	2245	3935	1943	3974	1422
2428_CA10 - Carbonic anhydrase-related protein 10	2428_CA10 - Carbonic anhydrase-related protein 10	25	887	1	1840	3310	3156	3292	4614	1737	2584	1532	2299	2529	3672	1572	4104	2720	3082	2114	3574	887
3483_Milk type used: Soya	3483_Milk type used: Soya	25	888	1	1262	1670	3457	1255	1288	888	3023	1739	4094	2594	4373	2264	2247	3357	1802	3434	1865	4124
78_Femoral Neck BMD (males)	78_Femoral Neck BMD (males)	25	888	1	3653	1787	1729	4018	3124	2918	3860	2434	1854	2990	4196	888	3251	4036	1866	3653	4352	2366
2009_Hypertriglyceridemia	2009_Hypertriglyceridemia	25	889	1	3410	889	3672	1625	1774	3051	2741	3238	2353	2144	4016	1885	1411	3348	1196	2745	3848	4437
695_::::X-11334	695_::::X-11334	25	889	1	3203	2467	1690	2594	1879	3355	1898	3197	4654	889	4199	927	3684	2849	3693	4142	1141	3223
560_Lipid::Medium chain fatty acid::pelargonate (9:0)	560_Lipid::Medium chain fatty acid::pelargonate (9:0)	25	891	1	2005	3014	3661	4250	3657	891	4033	2505	2664	4718	2143	4562	1548	3908	2681	4456	3849	1077
832_::::X-14086	832_::::X-14086	25	893	1	3115	1437	893	2532	3301	2337	2693	4661	1357	3771	4365	2092	3082	3781	4537	4640	3973	4691
1016_Femoral BMD (FBAT, adjusted for multivariable)	1016_Femoral BMD (FBAT, adjusted for multivariable)	25	893	1	1359	2392	1102	4193	2627	2760	4712	4045	3736	2846	4710	3900	2366	3689	1172	2839	3891	893
4394_Heavy vaginal discharge	4394_Heavy vaginal discharge	25	894	1	2555	4344	3071	3496	1058	2950	1182	1949	894	2399	2829	1418	1990	2520	2471	4092	3862	2518
703_::::X-11440	703_::::X-11440	25	895	1	2879	4452	4575	3042	895	3783	1973	1928	2005	4652	3105	4159	2922	1481	2715	2430	4609	4739
3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	3113_IMPDH1 - Inosine-5'-monophosphate dehydrogenase 1	25	896	1	1486	896	2788	2616	3553	1125	3046	1645	1192	2510	1670	2031	1527	3539	2733	931	2379	2752
3274_Ease of skin tanning	3274_Ease of skin tanning	25	897	1	2821	2394	897	4089	4597	3311	3377	3812	4246	1482	2525	3748	2449	4585	3411	3234	2275	2123
2196_GDF11 - Growth/differentiation factor 11	2196_GDF11 - Growth/differentiation factor 11	25	899	1	899	3848	2854	1769	4383	1726	4670	3156	1130	4038	3073	1679	1085	2581	3188	3848	1401	2713
3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	3682_Diagnoses - main ICD10: R10 Abdominal and pelvic pain	25	900	1	3885	4236	2215	4500	1009	2536	2140	2929	3853	1651	4243	2833	4403	900	2464	4678	2324	2395
4617_Optic chiasm	4617_Optic chiasm	25	904	1	4203	904	3890	3065	1979	3807	1223	2049	2911	3277	966	1583	3985	4200	2529	3393	2475	2050
1846_Neck Section Modulus (FBAT, female, adjusted for age)	1846_Neck Section Modulus (FBAT, female, adjusted for age)	25	904	1	4079	3629	2653	1801	3341	4521	3041	4300	4112	4099	2585	970	904	3798	3002	3665	1883	2675
3597_Non-cancer illness code, self-reported: hypertension	3597_Non-cancer illness code, self-reported: hypertension	25	907	1	2660	907	1299	2682	1024	2325	3869	1192	2230	2112	3820	3273	2443	2250	3736	1534	2186	3301
558_Lipid::Medium chain fatty acid::heptanoate (7:0)	558_Lipid::Medium chain fatty acid::heptanoate (7:0)	25	907	1	4308	2570	1292	4481	3922	4296	2446	3498	907	1591	3875	1903	2411	1887	4352	4027	3302	4523
2529_SERPINA4 - Kallistatin	2529_SERPINA4 - Kallistatin	25	911	1	1877	4382	3593	1794	1920	2498	3114	1913	3569	1024	1470	4534	4226	2800	966	4284	3231	911
2400_IDE - Insulin-degrading enzyme	2400_IDE - Insulin-degrading enzyme	25	913	1	4011	3874	2935	2773	3264	2404	1628	3404	4125	913	1778	3556	1513	2996	1712	1692	3190	1637
2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	2399_HAPLN1 - Hyaluronan and proteoglycan link protein 1	25	914	1	4658	2475	4362	2670	3305	2460	3783	4705	1551	4340	4498	1821	914	1564	3674	2166	2334	3418
3177_PRKCG - Protein kinase C gamma type	3177_PRKCG - Protein kinase C gamma type	25	914	1	1275	3603	1725	1727	4328	1752	4376	4647	4175	3461	4731	2015	4422	3138	1710	914	3441	4133
18_Former versus current smokers	18_Former versus current smokers	25	915	1	4281	3354	3065	1834	4133	2093	2227	2350	915	1535	4539	2587	2330	3369	3400	1076	4043	3824
3286_Irritability	3286_Irritability	25	915	1	4180	3771	1305	4162	2468	3175	3087	3172	1652	1505	968	1454	4214	2175	915	4150	4341	2147
4402_Menstruation quality of life impact: Joint pina	4402_Menstruation quality of life impact: Joint pina	25	916	1	1965	1235	2895	4312	4036	4169	1602	916	4108	3990	4670	4272	2707	3111	2334	1371	4287	4493
852_Alanine	852_Alanine	25	917	1	2043	4314	2164	4577	1352	4425	2820	4114	3975	917	1870	4686	2663	4543	3330	2926	4059	2705
3732_Depression - Fraction of day affected during worst episode of depression	3732_Depression - Fraction of day affected during worst episode of depression	25	917	1	3931	2315	1702	954	1020	4623	3564	3286	1641	1621	4404	1322	3897	3894	917	2864	2482	2145
2271_SERPINE1 - Plasminogen activator inhibitor 1	2271_SERPINE1 - Plasminogen activator inhibitor 1	25	918	1	3434	918	2062	4292	1858	2886	2454	3489	4283	1673	4722	1765	3864	2575	3458	3045	1730	4257
641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	641_Xenobiotics::Xanthine metabolism::1,7-dimethylurate	25	918	1	4140	1013	2664	3593	1144	1267	2629	3734	3441	3653	4281	3743	3744	918	2053	2367	1010	3412
3182_SPOCK2 - Testican-2	3182_SPOCK2 - Testican-2	25	919	1	2082	3030	4398	1468	2367	2569	1810	4143	1497	2521	1235	2480	1532	919	1566	2015	3702	1122
1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	1648_P-selectin (at exam 7, FBAT, adjusted formultivariable)	25	921	1	1495	1134	2227	3992	3399	1138	3157	2634	3370	1016	921	2353	4002	1325	3871	3074	1759	2335
445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	445_Carbohydrate::Nucleotide sugars, pentose metabolism::arabinose	25	922	1	1020	3708	3027	3329	2709	2821	2731	3017	922	3376	3341	2131	2378	996	1348	3474	2721	1754
3792_Daytime napping	3792_Daytime napping	25	922	1	3749	4597	3941	4222	3746	1663	3665	3694	1716	2540	3366	1569	4423	4213	2597	2743	2983	922
2564_CCL15 - C-C motif chemokine 15	2564_CCL15 - C-C motif chemokine 15	25	923	1	2861	931	3101	923	3049	3429	2765	2948	4230	1728	4024	2850	1195	1306	4233	1226	1588	3531
1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	1438_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for age and sex)	25	925	1	4679	3560	2521	1759	1682	3756	4463	4015	925	2707	3179	2391	1102	3099	4312	3727	1478	4652
257_CD8:%Senescent	257_CD8:%Senescent	25	926	1	3104	2256	926	4318	3312	1820	4282	3411	1607	943	1201	3372	2489	2644	1257	2440	1952	4649
1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1436_Intermediate-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	926	1	2694	3172	2738	3961	1055	2971	1629	3727	926	3111	2568	1694	3730	2003	1889	2992	4388	2598
1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	1860_Neck cross-sectional moment of inertia (FBAT, male, adjussted for multivariable)	25	928	1	928	1383	2917	1477	4628	3914	3029	2096	1866	1157	2934	4520	3102	2781	1523	2675	2114	2867
4207_Blood urea nitrogen	4207_Blood urea nitrogen	25	929	1	929	4080	3414	2311	3459	2575	1858	2792	1033	2752	4616	1493	4156	2534	1619	3062	2045	2493
3982_Schizophrenia	3982_Schizophrenia	25	930	1	1001	2660	930	3712	3998	1286	2891	4146	4033	2271	1346	4036	1415	1847	1077	2695	2556	1778
1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	1402_High-density lipoprotein 3 cholesterol (at exam 4, FBAT, adjusted for multivariable)	25	930	1	962	4139	4606	4684	3267	930	1544	4230	1539	3407	3717	1732	1750	4468	1472	1239	4064	4294
4400_Menstruation quality of life impact: Edema	4400_Menstruation quality of life impact: Edema	25	930	1	1550	2591	3243	3918	4661	3562	4707	3512	930	3778	3548	3819	4149	2573	1545	4506	2637	4502
2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	2322_CTLA4 - Cytotoxic T-lymphocyte protein 4	25	930	1	3024	4617	3810	2257	1258	1612	2103	1380	1010	4398	1369	1615	3403	1534	930	4733	2075	4630
1889_Shaft Width (GEE, female, adjussted for age)	1889_Shaft Width (GEE, female, adjussted for age)	25	934	1	4427	3279	4683	3563	3344	4255	3912	1280	4726	3237	3532	934	4518	3799	3953	3141	4483	3307
3489_Cereal type: Biscuit cereal (e.g. Weetabix)	3489_Cereal type: Biscuit cereal (e.g. Weetabix)	25	934	1	1399	1128	3731	2423	4055	4612	1292	3216	2444	3865	1443	3586	934	3186	1020	2235	1209	1015
4257_Facial attractiveness (male-coder)	4257_Facial attractiveness (male-coder)	25	938	1	4178	1092	2149	3544	3423	938	1933	2568	4632	3821	2196	4670	3150	1884	4277	1400	959	3471
1066_Multiple Sclerosis	1066_Multiple Sclerosis	25	939	1	939	3479	3115	4048	1552	1749	1979	4282	2097	4079	1142	3573	3455	1070	4571	2120	1037	2213
4712_Uncinate fasciculus mean diusivities	4712_Uncinate fasciculus mean diusivities	25	939	1	3627	4346	2197	1203	939	3478	4696	985	3238	1813	2734	2042	3003	1086	3655	4003	1953	1179
1161_Fasting insulin interaction (adjusted for BMI)	1161_Fasting insulin interaction (adjusted for BMI)	25	939	1	4116	1328	1023	4591	1249	2103	2290	1869	939	4436	2781	2868	3268	3401	3537	2862	3566	2279
2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	2357_IGHM IGJ IGK@ IGL@ - Immunoglobulin M	25	941	1	4165	4535	3569	3557	2382	1283	941	2118	2107	2883	1392	1145	1964	2044	3388	3233	3791	4128
1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	1414_High-density lipoprotein cholesterol (at exam 5, FBAT, adjusted for age and sex)	25	941	1	2361	4274	1381	4417	3530	1985	2709	941	4447	3522	2161	3134	2523	2756	2343	3066	3394	2428
1012_TNF-related apoptosis inducing ligand	1012_TNF-related apoptosis inducing ligand	25	943	1	2527	2415	2006	2946	1776	4396	2213	2955	1634	1909	943	2056	3757	4183	4486	4024	3707	2103
1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	1374_Total cholesterol / High-density lipoprotein cholesterol ratio (at exam 1, FBAT, adjusted for age and sex)	25	943	1	3038	2407	1548	4152	3927	3864	3735	3067	3335	3050	4147	3584	3143	943	1835	3078	994	3658
1854_Neck average buckling ratio (FBAT, female, adjussted for age)	1854_Neck average buckling ratio (FBAT, female, adjussted for age)	25	943	1	2662	3231	2016	2838	2827	2683	4680	962	4018	3107	1162	2957	3133	4438	3333	2172	943	3332
2602_PRSS27 - Serine protease 27	2602_PRSS27 - Serine protease 27	25	944	1	1465	1492	1775	2058	2247	3045	3769	944	4639	1458	4538	4507	2238	4196	3426	1836	1475	1554
685_::::X-10506	685_::::X-10506	25	947	1	947	3682	4527	1914	3711	4395	1464	4564	2269	956	2245	2265	1053	4722	2541	1033	2513	2803
3087_RTN4 - Reticulon-4	3087_RTN4 - Reticulon-4	25	947	1	1630	1193	4732	1988	3672	947	4620	2033	3143	1054	1819	2094	1924	1606	3766	3298	3630	2884
4270_Anxiety/tension factors	4270_Anxiety/tension factors	25	947	2	2972	2924	4143	2907	2505	2576	3449	4458	947	1984	2348	4744	3324	3573	3533	4056	3037	1289
4173_Social support - Leisure/social activities: Sports club or gym	4173_Social support - Leisure/social activities: Sports club or gym	25	947	1	2165	3850	4481	3598	2074	3233	1247	3916	2980	947	3434	4550	4495	4159	4733	1080	4543	3957
4374_Free thyroxine (FT4, female)	4374_Free thyroxine (FT4, female)	25	948	1	3296	1206	4169	3500	2558	3147	3428	3088	3591	3993	2881	2069	3677	948	3955	2218	2647	3164
4386_Epithelial ovarian cancer (Borderline serous and mucinous)	4386_Epithelial ovarian cancer (Borderline serous and mucinous)	25	949	1	2715	2989	949	1377	3613	3409	2068	3824	2833	3636	4211	1608	3852	1657	1556	1759	3809	3167
3150_CPNE1 - Copine-1	3150_CPNE1 - Copine-1	25	949	1	2469	2228	2866	2706	4356	1849	2522	2448	4487	2438	1288	3215	2417	949	2775	1979	1444	4574
4047_Medial collateral ligament injury	4047_Medial collateral ligament injury	25	951	1	2873	3466	2997	3840	2804	3708	1170	3422	1859	1308	951	2330	1512	3164	3013	4296	1174	2219
50_Number of children ever born	50_Number of children ever born	25	952	1	2246	952	1113	2181	3243	2692	4437	2762	2170	3492	4144	3530	1334	3107	2696	2530	3978	4621
4165_Juvenile Myoclonic Epilepsy (JME)	4165_Juvenile Myoclonic Epilepsy (JME)	25	952	1	4339	2769	1758	3431	4217	1329	952	4273	3725	3411	3900	1381	4669	1255	1791	4176	4564	4015
1893_Shaft Section Modulus (GEE, adjussted for multivariable)	1893_Shaft Section Modulus (GEE, adjussted for multivariable)	25	953	1	2448	3761	2384	4713	4103	1705	4264	3292	3802	3947	1909	4327	953	2283	2340	3795	1461	3087
1181_Sleep duration	1181_Sleep duration	25	954	1	2939	4620	1001	2865	4092	1271	3195	1829	1707	1223	954	4332	4234	4485	3619	3151	1305	1643
2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	2510_CAMK2D - Calcium/calmodulin-dependent protein kinase type II subunit delta	25	955	1	3571	4060	3120	4380	1487	1536	4642	1347	1284	3823	1647	3662	955	1263	1365	3009	4416	1235
2380_ARSB - Arylsulfatase B	2380_ARSB - Arylsulfatase B	25	957	1	2467	4100	3989	2921	2923	2733	3981	957	3596	3337	2791	1873	3106	1217	2923	3566	1612	2775
1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	1776_Heart failure (censored at interval MI, FBAT, adjusted for age and sex)	25	958	1	4402	1778	958	3081	2640	2888	1167	1268	4610	2409	1381	2277	4441	2907	4556	4077	1791	4317
1221_Mean Caudate	1221_Mean Caudate	25	959	1	4641	2215	1130	4144	3352	3847	959	3821	4526	3739	4481	2776	3836	2473	2297	1996	4639	3015
1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	1815_Femoral Neck BMD (GEE, female, adjusted for multivariable)	25	959	1	1208	3366	4632	1329	3316	2462	1711	1980	2841	4140	4528	1367	3648	2225	4172	1779	2215	959
2601_LY86 - Lymphocyte antigen 86	2601_LY86 - Lymphocyte antigen 86	25	961	1	2942	1631	2026	2119	1031	2186	961	2011	2304	2770	2906	1784	3794	4601	2184	2668	1912	4324
358_earlyB:%27+	358_earlyB:%27+	25	961	1	3151	3440	4180	3592	3184	2976	3966	3590	3132	4292	961	2458	3417	2444	1872	2978	3162	3406
1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	1388_High-density lipoprotein cholesterol (at exam 1, FBAT, adjusted for multivariable)	25	962	1	3426	1459	2314	962	2856	4191	3526	1694	3686	2714	2350	4738	1813	4442	2576	4303	3611	1944
564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	564_Lipid::Monoacylglycerol::1-palmitoylglycerol (1-monopalmitin)	25	962	1	1960	4284	3575	4441	3424	2511	2837	1178	3925	1328	2570	962	3527	1169	2079	3954	3750	1515
3072_MICB - MHC class I polypeptide-related sequence B	3072_MICB - MHC class I polypeptide-related sequence B	25	963	1	1202	4625	4640	1664	1730	1756	1815	3765	3832	3683	3165	4639	963	4570	4685	994	4380	3240
1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	1290_Waist circumference by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	966	1	2313	4029	2216	3117	4552	966	2582	1309	1455	4003	2338	4119	4633	3637	1577	3516	2811	3039
3791_Ease of getting up in the morning	3791_Ease of getting up in the morning	25	967	1	996	1097	3537	2863	2720	4079	3257	3908	4528	967	2924	4135	4038	1721	1203	4393	3463	4281
3499_Hair colour (natural, before greying): Black	3499_Hair colour (natural, before greying): Black	25	967	1	2868	1099	3526	4383	1049	3559	3573	1167	3713	4301	1401	967	1183	4540	2427	2805	2216	4556
3447_Impedance measures - Impedance of whole body	3447_Impedance measures - Impedance of whole body	25	967	1	3470	3619	2350	3588	2446	4451	3534	3370	1703	983	3642	1481	3535	3214	3993	4089	4083	967
3624_Treatment/medication code: glucosamine product	3624_Treatment/medication code: glucosamine product	25	968	1	1350	968	1887	4130	4369	2414	4081	3771	2694	4397	3719	2390	3802	3847	4287	4194	1225	1331
1757_Cancer (GEE, adjusted for multivariable)	1757_Cancer (GEE, adjusted for multivariable)	25	968	1	3496	1364	4621	2178	2622	968	4627	1172	1378	1486	3802	2307	2429	4584	1722	3432	3126	1572
1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	1956_Wide Range Achievement Test (FBAT, adjusted for multivariable)	25	969	1	4185	1710	969	2607	3778	1464	3830	2542	1884	2843	3758	3874	4565	1337	2688	1174	2084	4203
726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	726_Amino acid::Cysteine, methionine, SAM, taurine metabolism::X-11786--methylcysteine	25	971	1	3458	3790	3971	4549	2700	2553	3301	3101	971	1338	3327	3391	3088	1689	999	4348	2536	3357
4013_Major depressive disorder (ICD-coded)	4013_Major depressive disorder (ICD-coded)	25	972	1	3136	1966	2855	4509	972	2349	3491	3004	4720	2051	3101	3927	1378	3083	2727	2116	2656	2738
545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	545_Lipid::Lysolipid::1-palmitoylglycerophosphoinositol*	25	974	1	974	1863	4129	2447	2594	3680	1069	1853	3634	2087	4148	4731	2509	3007	1705	4718	3275	4369
2582_CDH6 - Cadherin-6	2582_CDH6 - Cadherin-6	25	974	1	4520	1361	1782	4535	4377	3481	1351	1283	4424	4666	4632	4330	1628	4374	974	1847	3878	4224
3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	3115_PCSK9 - Proprotein convertase subtilisin/kexin type 9	25	976	1	3860	4725	1701	2020	1801	1127	1121	976	4037	3757	2144	4716	1674	3723	4474	1063	3209	4292
410_Amino acid::Tryptophan metabolism::tryptophan betaine	410_Amino acid::Tryptophan metabolism::tryptophan betaine	25	978	1	2909	2286	3098	1832	3413	3121	4551	3334	978	3417	4092	3500	4292	4118	3224	3971	4156	2318
3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	3120_PRKAA2 PRKAB2 PRKAG1 - AMP Kinase (alpha2beta2gamma1)	25	979	1	3416	1014	3772	3691	1042	4682	2814	2860	3698	979	1948	1557	2421	3545	2898	2134	3402	4618
3086_ROBO3 - Roundabout homolog 3	3086_ROBO3 - Roundabout homolog 3	25	979	1	3291	2538	3439	4186	4139	4037	3844	3211	4558	2534	4180	2499	3151	979	2580	4052	4744	2113
57_Educational attainment	57_Educational attainment	25	979	1	2753	1770	1545	3852	3886	1427	1138	2590	2999	4388	3646	2261	3107	2013	979	4605	4454	2224
4012_Probable major dpressive disorder	4012_Probable major dpressive disorder	25	980	1	988	4616	1021	4615	980	1084	1446	3385	2274	2185	4285	1909	4288	3755	1042	1544	2127	2418
999_Monocyte specific chemokine 3 (CCL7)	999_Monocyte specific chemokine 3 (CCL7)	25	981	1	1909	2031	2306	1728	3638	1818	3162	4515	2825	1604	4634	3585	2279	4744	3994	2956	2489	981
4474_Left transverse temporal	4474_Left transverse temporal	25	983	1	1310	3865	3369	4075	2073	1032	1847	3513	4536	1992	983	4102	4470	3647	4617	3168	1638	2910
40_Reaction time	40_Reaction time	25	985	1	4094	4716	3458	2264	4674	3047	1261	2161	4454	3912	3047	1649	4418	4610	3644	985	3336	3643
2556_IFNA2 - Interferon alpha-2	2556_IFNA2 - Interferon alpha-2	25	986	1	2159	2656	3237	999	986	1972	2071	4197	1822	1701	2699	4326	2484	3049	4575	4256	1846	3036
2079_PLA2G2E - Group IIE secretory phospholipase A2	2079_PLA2G2E - Group IIE secretory phospholipase A2	25	987	1	2164	3538	4255	987	4245	3247	3031	2064	1502	1208	4501	1197	1097	2221	3425	3372	1993	3672
3565_Vitamin and mineral supplements: Vitamin E	3565_Vitamin and mineral supplements: Vitamin E	25	988	1	2967	2560	3293	1530	3019	2711	3951	3298	1912	3643	988	3809	3026	2582	4426	2296	3804	1316
3628_Illnesses of father: Heart disease	3628_Illnesses of father: Heart disease	25	989	1	1177	989	2920	1141	1615	1581	2480	1513	1482	2374	2419	3200	1293	2861	4676	3886	4122	1137
4591_Right paracentral	4591_Right paracentral	25	990	1	1216	3878	2981	2354	4477	4450	3909	1864	4637	3299	2971	1613	4036	2733	990	3674	3149	4622
60_Educational attainment	60_Educational attainment	25	995	1	1612	2716	3358	4460	4609	3963	4744	3936	2853	1507	4023	1151	3497	2674	1074	995	3789	2204
768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	768_Peptide::Dipeptide::X-12244--N-acetylcarnosine	25	1000	1	1000	2210	3307	3944	4064	2778	3600	4304	3118	4043	3512	1404	4069	4371	3678	3810	3246	3689
477_Lipid::Carnitine metabolism::acetylcarnitine	477_Lipid::Carnitine metabolism::acetylcarnitine	25	1000	1	1500	2484	1000	3078	4547	3364	4233	4052	2597	4423	1576	3625	3416	4620	3104	4016	4115	3814
3519_Current employment status: In paid employment or self-employed	3519_Current employment status: In paid employment or self-employed	25	1001	1	3659	2565	3729	3566	3691	4719	2625	1704	2899	2187	1624	3341	3618	1605	3725	2843	1001	3345
2117_EFNA5 - Ephrin-A5	2117_EFNA5 - Ephrin-A5	25	1002	1	1127	1093	2790	2052	1734	4681	4223	3363	3427	2455	3243	1905	4610	1002	3103	1637	4049	4447
3729_Depression - Age at first episode of depression	3729_Depression - Age at first episode of depression	25	1006	1	1623	2340	2953	2312	4518	3055	2458	4437	3471	1503	4229	2755	4047	1006	3225	1780	3227	4497
4138_Mean corpuscular volume	4138_Mean corpuscular volume	25	1008	1	3741	3151	2412	1008	1826	2673	2829	1176	3981	1616	4568	1438	3706	2210	4611	3837	1595	4185
3369_Frequency of other exercises in last 4 weeks	3369_Frequency of other exercises in last 4 weeks	25	1008	1	2334	1471	3136	3241	2899	3352	3477	1008	4583	4455	2417	4592	2382	2933	4475	2299	2468	3532
3851_Mean corpuscular hemoglobin (two-way meta)	3851_Mean corpuscular hemoglobin (two-way meta)	25	1008	1	3691	4302	2152	2096	3114	3762	2618	2227	4619	3936	2848	1008	1795	1997	4245	1835	1176	1994
760_::::X-12189	760_::::X-12189	25	1010	1	3317	4015	2985	1827	3978	3976	2795	2603	4533	1010	1918	2982	2534	2774	4006	1493	3953	1514
1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	1340_28 year time-averaged Fasting plasma glucose (FBAT, adjusted for age, sex and BMI)	25	1010	1	2115	4062	4023	3422	4322	2045	2505	3291	1067	2071	2553	1261	4092	2536	1742	1010	3939	4025
234_Lymph:%NK	234_Lymph:%NK	25	1013	1	2825	1708	2921	2782	1013	3299	1204	3747	2647	3498	2560	1065	2521	2391	1785	2641	4363	3153
2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	2147_TNFRSF17 - Tumor necrosis factor receptor superfamily member 17	25	1016	1	1016	1163	1294	2972	3139	4507	4046	4290	3258	3370	2191	1809	2473	3538	3194	2026	4082	3515
1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	1345_Plasma Apolipoprotein A-I level (GEE, multivariate adjusted)	25	1017	1	3098	1598	3097	1239	2781	1769	3621	1191	2863	3891	3386	2500	3505	3710	3044	3310	4642	1017
3316_Frequency of solarium/sunlamp use	3316_Frequency of solarium/sunlamp use	25	1018	1	3252	2612	1845	3530	1450	2283	3523	1838	3962	2601	4356	2683	2227	1018	1288	4693	3980	4616
1101_Glucose - Birth cohorts	1101_Glucose - Birth cohorts	25	1019	1	1019	3198	1182	4622	4315	4283	4586	4459	2245	2304	2390	1127	1650	4304	4413	3925	4148	2137
3887_Mean corpuscular hemoglobin (three-way meta)	3887_Mean corpuscular hemoglobin (three-way meta)	25	1019	1	4433	4574	3552	2074	3013	3692	2348	2249	2145	4519	3271	1452	1675	1648	3569	1851	1019	2308
1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	1958_MMSE score (at exam 5, FBAT, adjusted for multivariable)	25	1021	1	3566	1021	2418	3133	2116	1172	4664	1896	4363	3372	2536	3231	4589	1295	1574	2696	2257	1258
2833_BCL2L1 - Bcl-2-like protein 1	2833_BCL2L1 - Bcl-2-like protein 1	25	1024	1	2162	2231	4099	1024	4241	3209	3089	3520	2634	1716	3649	3855	2962	4111	2252	1879	1416	4032
4092_Reaction time	4092_Reaction time	25	1025	1	2881	3061	4347	4610	3787	4705	2242	3816	3979	4159	1616	2553	3414	4080	2433	1853	4562	1025
742_::::X-11859	742_::::X-11859	25	1027	1	3281	4023	3915	2884	2565	2746	4603	3013	4476	4287	1027	2183	1480	1473	2281	3463	2426	3854
1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	1348_Plasma Apolipoprotein B level (FBAT, multivariate adjusted)	25	1027	1	3034	3088	4230	4350	2162	2394	2346	2344	1396	3530	1841	1027	4160	3619	1253	3253	2510	4632
1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	1264_Residual from predicted FVC for latest exam (FBAT, adjusted for multiple covariates)	25	1028	1	1118	4216	1350	1028	3169	1086	1159	4495	3182	1469	3023	4366	3278	3843	2501	2349	2794	2235
2061_F11 - Coagulation Factor XI	2061_F11 - Coagulation Factor XI	25	1028	1	2124	2331	3656	3222	3415	3856	1779	4246	1028	4433	1202	3639	2670	3873	2698	1575	1655	2271
4557_Left medial orbitofrontal	4557_Left medial orbitofrontal	25	1030	1	3681	4575	1573	4177	3843	2941	3948	2105	4522	3703	1812	3698	3070	3432	3613	4705	1030	2702
1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	1258_Residual from predicted FEF25-75 for latest exam (FBAT, adjusted for multiple covariates)	25	1044	1	3268	1926	1588	2247	1355	3445	4430	1044	4036	3706	1256	4422	3771	3719	2311	1090	1474	3647
3160_PIM1 - Serine/threonine-protein kinase pim-1	3160_PIM1 - Serine/threonine-protein kinase pim-1	25	1044	1	1654	3155	3596	4180	2770	3056	1899	3892	2138	1366	4519	1689	4454	4217	2895	1044	1427	3528
3955_Ankle injury (random effect)	3955_Ankle injury (random effect)	25	1046	1	1899	1046	4680	2727	2236	3808	4705	1716	3262	2477	4204	3340	3195	3078	3152	3876	4214	3612
1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	1779_Heart failure (censored at interval MI, GEE, adjusted for multivariable)	25	1046	1	3968	3075	1509	2809	4182	3682	2718	2574	1477	3039	3338	4194	1046	3463	1192	1715	2451	3068
3363_Age started hormone-replacement therapy (HRT) (female)	3363_Age started hormone-replacement therapy (HRT) (female)	25	1047	1	4090	4427	3730	4359	2750	4709	4628	3107	3863	1047	4712	2377	4615	3161	3905	1695	4054	2898
1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	1350_Plasma Apolipoprotein B level (FBAT, adjusted for age and sex)	25	1048	1	3651	3436	1098	4213	4502	4378	2524	4318	3748	3999	1277	2900	4686	1897	1048	4290	2505	4005
765_::::X-12230	765_::::X-12230	25	1050	1	3840	3857	1831	1260	1244	1570	1387	3262	4177	2525	3564	4382	4509	3349	3732	1050	2459	2365
2630_GPT - Alanine aminotransferase 1	2630_GPT - Alanine aminotransferase 1	25	1056	1	1296	4118	1536	1056	1185	1180	1797	3142	4000	3615	2697	3370	1239	2615	4562	4226	3543	3747
361_mDCL%274+	361_mDCL%274+	25	1056	1	1510	4240	3701	1809	4537	4364	1250	3407	1470	3077	1659	4712	2303	3937	1739	1056	2998	3970
2226_CX3CL1 - Fractalkine	2226_CX3CL1 - Fractalkine	25	1060	1	2704	1451	2880	2680	1429	2169	4605	3577	3302	1822	2174	1533	2512	3645	1986	1627	1665	1060
43_Social deprivation	43_Social deprivation	25	1061	1	2581	3460	3107	4284	2242	4443	2326	3691	2951	1061	2678	1955	2809	4037	2272	4273	3484	1496
3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	3722_Frequency of feeling guilt or remorse after drinking alcohol in last year	25	1063	1	3780	4254	1406	3711	3432	2974	3381	4469	3963	4234	2094	2080	3617	2606	4254	3827	1063	4729
2094_HMGB1 - High mobility group protein B1	2094_HMGB1 - High mobility group protein B1	25	1065	1	4041	3289	3721	1065	4317	2814	1418	1604	2594	2034	1340	4003	4435	1995	3392	3274	3440	2343
3649_Illnesses of siblings: Stroke	3649_Illnesses of siblings: Stroke	25	1069	1	1069	3983	4615	1923	3446	3633	2197	2089	2707	4715	3371	1138	3052	2162	2829	4598	1212	1094
507_Lipid::Glycerolipid metabolism::glycerol	507_Lipid::Glycerolipid metabolism::glycerol	25	1069	1	1692	2195	2770	3088	3764	1069	2547	4056	4617	3923	2194	3263	3071	4154	4505	3821	1863	4372
255_CD3 on 127+DN T	255_CD3 on 127+DN T	25	1069	1	4365	4050	4597	3731	4254	2083	2324	3607	1367	4057	2321	1069	1925	3270	4720	2633	1133	3670
3008_SCGB2A1 - Mammaglobin-B	3008_SCGB2A1 - Mammaglobin-B	25	1071	1	4078	3504	1316	2140	1606	1909	1254	1071	3629	4574	3393	3802	3312	2157	2963	3457	1073	1891
4117_Total bilirubin	4117_Total bilirubin	25	1071	1	3226	3128	1400	3297	3762	4697	4672	3900	2286	2178	3279	4538	1071	2845	4522	4692	1537	3125
2445_GPC2 - Glypican-2	2445_GPC2 - Glypican-2	25	1073	1	2531	1073	4309	3590	2178	4744	2284	3971	3654	2781	4541	1232	4506	4667	2844	2733	2909	1887
4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	4055_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	1073	1	1453	4673	1718	3933	3075	3895	4293	4450	2652	2195	1172	4669	4694	1073	1160	3722	2016	3490
2489_PAK3 - Serine/threonine-protein kinase PAK 3	2489_PAK3 - Serine/threonine-protein kinase PAK 3	25	1075	1	3199	4250	2959	1320	1075	1108	3396	2070	3383	2476	2950	3173	2097	4471	2027	2653	2690	3777
3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	3478_Own or rent accommodation lived in: Rent - from local authority, local council, housing association	25	1075	1	4187	1579	4081	3480	3618	3894	1486	4479	3055	2461	4633	3880	2108	2462	2319	1075	3883	1207
1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	1825_Inter-trochanteric buckling ratio (GEE, male, adjussted for age)	25	1076	1	3623	1564	4092	1785	4570	2285	2865	1391	2254	1627	4369	4642	1076	1205	1541	1857	2019	4442
2420_ACP5 - Tartrate-resistant acid phosphatase type 5	2420_ACP5 - Tartrate-resistant acid phosphatase type 5	25	1076	1	1790	2019	2746	1227	3218	3943	1419	1086	1529	2571	2665	3168	4319	2339	1076	2789	2737	3909
205_Microalbuminuria	205_Microalbuminuria	25	1078	1	3992	2473	3247	3897	2481	2981	3410	2392	3820	3349	3624	4281	1784	1186	4436	1331	1078	2923
3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	3536_Mental health - Illness, injury, bereavement, stress in last 2 years: Financial difficulties	25	1079	1	4723	4122	4175	3046	2571	2671	2567	1079	3444	4737	1818	4364	3448	2562	3099	1601	3930	2284
4498_Right precuneus	4498_Right precuneus	25	1080	1	2580	2525	1396	4560	3144	3428	1080	2799	1280	3872	3551	2400	4569	4163	1323	2220	3352	2658
4185_Cigarettes per day (excluding nonsmokers)	4185_Cigarettes per day (excluding nonsmokers)	25	1080	1	2559	2149	1306	1900	3205	1165	4655	4211	3789	2997	1080	2436	2772	4339	3860	1556	3671	1751
1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	1842_Neck Section Modulus (FBAT, female, adjusted for multivariable)	25	1084	1	1341	1109	1084	1589	4726	3862	1625	3558	1635	2364	3055	3622	2722	3475	3026	4091	2234	4110
3157_MIF - Macrophage migration inhibitory factor	3157_MIF - Macrophage migration inhibitory factor	25	1085	1	1881	2788	3474	2742	2916	1085	1126	3809	2970	4022	2221	4593	4237	4683	3286	2060	2639	4290
99_Pubertal growth (female)	99_Pubertal growth (female)	25	1087	1	4035	1103	4363	3769	4738	4660	1156	4544	2813	3127	1860	3661	4678	2660	2113	2207	3774	1087
3440_Impedance measures - Weight	3440_Impedance measures - Weight	25	1090	1	4576	2237	4003	1997	3533	1431	1966	4573	1980	1601	1090	2634	3389	2959	4110	2277	3646	4685
3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	3125_PDE11A - Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A	25	1094	1	4491	3813	3371	2993	2308	4397	3315	4157	1791	1094	2327	2388	2002	1250	2590	2157	2941	3946
3326_Number of children fathered (male)	3326_Number of children fathered (male)	25	1095	1	4737	1529	1447	1324	1175	2102	1095	2813	1148	2163	2957	3154	2740	2237	2542	3930	3224	1899
3189_Number of self-reported cancers	3189_Number of self-reported cancers	25	1101	1	4159	1101	2636	1873	1464	2887	2886	1956	3075	2742	1337	2575	1109	1779	4191	4674	3450	3519
2897_SORCS2 - VPS10 domain-containing receptor SorCS2	2897_SORCS2 - VPS10 domain-containing receptor SorCS2	25	1104	1	3806	4329	1931	1104	3856	1185	4714	2654	2630	2014	2490	4616	4284	2825	1515	1572	3007	3366
1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	1852_Neck average buckling ratio (FBAT, male, adjussted for multivariable)	25	1110	1	1962	3807	2471	3258	3858	1643	4080	1141	1572	3358	1761	1863	1137	3421	3204	4007	2021	1110
4001_Loneliness, isolation (LONE)	4001_Loneliness, isolation (LONE)	25	1113	1	1113	3100	1142	4636	4337	2767	2085	1407	1844	3338	3044	4600	2240	3340	2968	4320	2131	3812
4468_Left rostral anterior cingulate	4468_Left rostral anterior cingulate	25	1113	1	3461	3339	2179	3447	3781	2528	1113	1164	4549	2231	3920	2938	4332	1623	2825	4442	3657	3171
3771_Depression - Recent changes in speed/amount of moving or speaking	3771_Depression - Recent changes in speed/amount of moving or speaking	25	1115	1	3379	2038	4281	3587	4035	2909	2183	2820	3141	3486	4182	2820	3539	4675	1115	3170	3071	3939
3368_Chest pain or discomfort walking normally	3368_Chest pain or discomfort walking normally	25	1117	1	3689	3551	2994	3707	4080	2588	1198	2018	1117	3623	2787	4107	4323	4739	1210	2844	2181	1866
1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	1774_Coronary heart disease (MI, CI or CHD death, FBAT, adjusted for multivariable)	25	1120	1	3153	4377	1120	3197	4361	1571	1915	4424	1605	2578	2272	4533	4048	4350	3335	2164	1506	2048
1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	1861_Neck cross-sectional moment of inertia (GEE, male, adjussted for multivariable)	25	1120	1	3826	3167	2113	4456	1573	3484	4244	4441	3223	4334	1120	4250	4536	4042	2338	1504	4111	2643
112_Body Mass Index	112_Body Mass Index	25	1122	1	2003	1122	4560	3020	3852	4078	4167	1689	2939	2872	3841	2967	2515	2294	2755	2762	4684	4260
4259_Facial attractiveness (female-coder, male samples)	4259_Facial attractiveness (female-coder, male samples)	25	1131	1	4160	1131	4214	3071	2922	1551	4129	1893	4232	3021	4678	3591	3512	4486	4465	2718	3560	4546
1154_Insulin at 30 min	1154_Insulin at 30 min	25	1132	1	4143	2632	4348	1721	1229	4343	2759	3888	2122	3664	3699	1430	3469	1132	4015	1676	3138	1613
1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	1664_Alanine transaminase (at exam 2, FBAT, adjusted for multivariable)	25	1133	1	4527	3692	2263	1204	3108	1149	4724	1133	4605	4402	4206	3485	3435	3546	4453	4529	3520	3565
4479_Right entorhinal	4479_Right entorhinal	25	1133	1	3129	2499	1519	3764	3299	4389	3808	3094	2132	4623	2963	1380	2675	1133	2034	3656	2952	1242
3581_Types of transport used (excluding work): Car/motor vehicle	3581_Types of transport used (excluding work): Car/motor vehicle	25	1133	1	3696	1989	3085	1941	4549	1774	4666	3378	3048	2853	4530	4097	4373	4712	1133	4081	4346	2496
4596_Right postcentral	4596_Right postcentral	25	1137	1	4100	3355	4273	2451	3734	1284	1137	2552	2384	3093	2426	4438	3848	3818	2867	2993	4376	4371
4295_Morning person (binary)	4295_Morning person (binary)	25	1142	1	2396	1312	3999	1614	4430	3687	1757	2990	1142	1622	1150	4258	3135	2532	2206	4262	1629	2892
732_::::X-11805	732_::::X-11805	25	1143	1	3902	3787	3813	3459	1484	4217	3983	2513	1361	4551	3066	3107	1577	4720	2690	4325	1143	1837
3420_Pairs matching test - Number of incorrect matches in round	3420_Pairs matching test - Number of incorrect matches in round	25	1150	1	2833	3986	2489	3475	2429	1378	1150	4486	2927	2028	1731	4577	4147	3776	1622	3617	2122	4586
1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	1480_Mean low-density lipoprotein cholesterol fromexam 1-7 (FBAT, adjusted for multivariable)	25	1151	1	2648	2223	2394	4391	1151	3412	1455	4186	3531	4243	3109	2073	4313	4513	4264	2866	1488	4573
2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	2235_TNFSF4 - Tumor necrosis factor ligand superfamily member 4	25	1151	1	1471	3363	4643	2770	3026	3110	4104	3907	1151	2986	4056	2895	4478	1723	2259	4594	3027	3256
438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	438_Carbohydrate::Fructose, mannose, galactose, starch, and sucrose metabolism::mannose	25	1151	1	3407	4443	2437	1258	2244	4054	2278	3530	1363	1151	3420	4254	2035	4478	2865	1247	2620	1651
3214_Frequency of light DIY in last 4 weeks	3214_Frequency of light DIY in last 4 weeks	25	1151	1	4287	2514	2951	4548	3884	2245	3821	3132	4354	4616	4500	2482	2236	4434	1151	3633	1864	3983
2528_INSR - Insulin receptor	2528_INSR - Insulin receptor	25	1152	1	3465	4071	4234	4553	1506	2480	2352	1152	3352	2200	2887	3944	1261	3398	1614	1280	3628	3729
4110_Estimated glomerular filtration rate	4110_Estimated glomerular filtration rate	25	1154	1	3521	3847	3214	2162	3116	1300	3939	1314	1154	1353	2169	2348	1288	2336	4089	3339	2384	3843
7_Anxiety disorder (factor score)	7_Anxiety disorder (factor score)	25	1161	1	3238	3662	1800	2029	2383	2470	3164	2734	4562	4540	1415	1161	2282	1908	4439	1350	2415	2385
4638_Right pallidum	4638_Right pallidum	25	1162	1	4675	1221	2868	2795	3605	3880	4429	1162	3443	3467	2199	2917	2485	3068	4601	4282	2619	2580
3632_Illnesses of father: Chronic bronchitis/emphysema	3632_Illnesses of father: Chronic bronchitis/emphysema	25	1163	1	2659	1557	1163	4040	3275	3580	1747	1295	1851	2939	1456	2931	3990	4406	3356	1468	3547	1512
3405_Fluid intelligence test - FI7 : synonym	3405_Fluid intelligence test - FI7 : synonym	25	1164	1	3763	3387	3954	1620	1852	2440	1804	2029	2109	2407	2051	4040	1164	1539	2009	2176	2650	1735
1293_Diabetes incidence (GEE, adjusted for age and sex)	1293_Diabetes incidence (GEE, adjusted for age and sex)	25	1167	1	4267	2297	3567	4565	3723	3465	3497	3696	2096	1167	3522	1515	3264	3095	3338	3913	1341	2734
1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	1244_Mean FVC from exam 3 and 5 (FBAT, adjusted for multiple covariates)	25	1169	1	2913	3239	4171	3689	4541	3225	3587	4391	2736	1169	3061	2707	4141	2525	3844	3224	2071	4377
3106_PPID - Peptidyl-prolyl cis-trans isomerase D	3106_PPID - Peptidyl-prolyl cis-trans isomerase D	25	1174	1	3502	4045	2654	3051	1174	3533	4202	3972	3680	2036	2909	3476	4099	3461	2145	3038	2893	3094
3436_Weight	3436_Weight	25	1177	1	4369	2171	4027	1177	3296	1676	2167	3687	1556	1234	1496	2874	2679	2464	3768	2268	4220	4483
2391_C2 - Complement C2	2391_C2 - Complement C2	25	1177	1	2701	4550	3921	1819	2399	1526	2717	4603	4238	4344	1228	1177	1486	3992	3820	2865	4667	1315
1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	1698_Dehydroepiandrosterone sulfate (at exam 3, FBAT, adjusted for age and sex)	25	1178	1	4626	1899	4635	3995	2284	2124	1862	3556	3965	2493	1658	2628	3799	4231	3027	1178	1885	2593
412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	412_Amino acid::Urea cycle; arginine-, proline-, metabolism::citrulline	25	1179	1	1653	2404	1625	4447	2842	3516	1993	4404	3346	4476	2802	1179	3919	3663	2534	2760	2462	1861
2459_TFPI - Tissue factor pathway inhibitor	2459_TFPI - Tissue factor pathway inhibitor	25	1182	1	2779	1182	2378	1972	1919	2680	4689	4521	3793	3447	4162	3122	4058	1759	3384	3079	3084	3570
1979_Hand grip (at exam 7, GEE)	1979_Hand grip (at exam 7, GEE)	25	1182	1	1225	4040	4328	4077	3803	2275	2867	1384	1233	1182	3971	1914	3715	1262	4693	4500	3660	1277
1210_FEV1/FCV	1210_FEV1/FCV	25	1182	1	2495	3299	2014	2620	4641	1311	3018	3064	1538	4674	2814	4604	4031	2870	2752	4495	1182	2985
4569_Left rostral anterior cingulate	4569_Left rostral anterior cingulate	25	1185	1	4278	4434	1733	2947	1939	2409	1827	1185	2343	2401	4348	2990	3939	2899	4626	3195	3479	4029
193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	193_Estimated glomerular filtration rate based on serum creatinine (non-diabetic)	25	1185	1	1873	3672	4238	3811	4638	2774	3200	2075	4468	1210	1542	1672	4316	1185	2881	4157	3283	4515
454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	454_Cofactors and vitamins::Pantothenate and CoA metabolism::pantothenate	25	1186	1	1483	4412	3365	4281	2042	2301	1297	2315	4725	1186	2400	4139	3646	2429	2796	1814	2922	2822
4209_Chronic kidney disease	4209_Chronic kidney disease	25	1190	1	2056	1588	1698	2959	3603	4371	3941	3803	3355	1582	1977	3072	2976	3165	4265	4714	1190	4352
2110_CD80 - T-lymphocyte activation antigen CD80	2110_CD80 - T-lymphocyte activation antigen CD80	25	1191	1	1691	4077	4524	3411	4517	4256	3688	1476	4411	1904	1191	1340	4199	2422	4161	4681	3508	1615
4643_Right vessel	4643_Right vessel	25	1198	1	2644	1198	4541	4013	4490	2610	3914	3053	1240	2354	4030	2194	4643	2538	2163	1584	1608	1757
1106_Triglycerides - Birth cohorts	1106_Triglycerides - Birth cohorts	25	1201	1	2678	1907	1201	3601	3984	1515	3118	3770	1385	2847	1448	2689	1618	2578	1754	3289	4264	4316
1211_Type 2 Diabetes	1211_Type 2 Diabetes	25	1204	1	2427	1905	3434	2517	4175	4199	3187	1485	1294	3844	4394	1204	2265	3654	1540	1689	3257	2039
2748_NTF3 - Neurotrophin-3	2748_NTF3 - Neurotrophin-3	25	1207	1	4098	3003	4014	4257	1207	1916	2815	1924	4524	4563	3200	2613	2960	4221	1780	3742	2551	1890
948_Total fatty acids	948_Total fatty acids	25	1210	1	2983	2300	3958	1253	3113	3351	1235	1992	2543	1926	1623	1652	4395	2632	4224	3409	1210	4349
4359_Biliary atresia	4359_Biliary atresia	25	1211	1	3414	1928	1211	2734	1777	2363	3932	1579	3304	3610	4312	2004	2372	3622	3501	4397	1362	3784
2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	2853_TGM3 - Protein-glutamine gamma-glutamyltransferase E	25	1213	1	2991	3920	3824	2431	1213	1858	3946	3571	3297	2746	2126	3742	3377	3117	4126	4350	2989	4107
3429_Fluid intelligence test - FI6 : conditional arithmetic	3429_Fluid intelligence test - FI6 : conditional arithmetic	25	1214	1	3293	3969	1886	2709	1214	3624	4267	2684	1468	3442	2534	4703	3350	3933	2958	1232	3590	4021
4550_Left fusiform	4550_Left fusiform	25	1222	1	3337	1921	4464	1585	4605	3813	1512	4492	2878	4201	2826	3041	1270	3026	4144	3671	1222	1279
3384_Non-accidental death in close genetic family	3384_Non-accidental death in close genetic family	25	1223	1	2044	1223	2056	4214	4157	3183	2723	3372	2154	3661	4227	2867	3374	2420	3647	4611	1814	4409
3297_Frequency of depressed mood in last 2 weeks	3297_Frequency of depressed mood in last 2 weeks	25	1226	1	4019	2269	2079	2280	3526	3510	1226	2196	3237	1967	4664	4459	1434	2090	3686	3162	1771	2479
191_Estimated glomerular filtration rate based on serum creatinine	191_Estimated glomerular filtration rate based on serum creatinine	25	1227	1	1437	1227	4604	3337	2297	2556	2402	2855	2849	1787	4006	2158	4695	1599	1953	2774	2080	4180
429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	429_Amino acid::Valine, leucine and isoleucine metabolism::isoleucine	25	1230	1	3732	4317	4108	3495	4028	2202	1405	1868	1343	1230	2180	3620	2692	1531	1876	3041	1400	2072
2585_CTSE - Cathepsin E	2585_CTSE - Cathepsin E	25	1237	1	3536	4231	2445	1237	2981	3617	2766	3760	2100	2078	2069	2663	3188	2705	3761	4192	4302	4088
4511_Right basal forebrain	4511_Right basal forebrain	25	1238	1	2689	2968	4080	2705	3785	3726	3316	3087	1238	1287	1951	3125	1858	4208	4329	3460	3462	1423
845_::::X-14658	845_::::X-14658	25	1241	1	3025	1616	1989	4556	3246	1241	3725	2891	2708	1570	3737	2880	2636	2955	3478	3338	2134	2631
3542_Reason for glasses/contact lenses: For 'astigmatism'	3542_Reason for glasses/contact lenses: For 'astigmatism'	25	1242	1	2456	2221	2342	3445	1453	2005	2419	3503	3315	3388	3509	4164	2723	1242	1602	3248	2943	2574
3485_Bread type: White	3485_Bread type: White	25	1245	1	1732	1245	3275	2780	1877	2196	2114	3891	3754	2265	2952	4403	2129	3085	4028	2802	3228	4344
4495_Right postcentral	4495_Right postcentral	25	1245	1	2841	3978	3654	2806	3022	1658	4042	2672	1245	4618	2893	3143	3057	2946	3985	3766	3659	3686
3631_Illnesses of father: Bowel cancer	3631_Illnesses of father: Bowel cancer	25	1246	1	4005	3532	2812	2381	4198	1246	2551	2114	1328	2603	3286	3068	3916	1533	3223	1976	3884	1707
2501_TPSB2 - Tryptase beta-2	2501_TPSB2 - Tryptase beta-2	25	1249	1	1249	3795	3496	1956	2353	2444	2431	2555	1727	2767	2481	3208	2581	2786	4157	1390	4625	2904
4242_Rapid automised naming of letters	4242_Rapid automised naming of letters	25	1254	1	2478	1790	2931	2191	3401	1808	2387	3517	3562	1978	3360	3252	1463	3827	3547	1840	4175	1254
2731_C6 - Complement component C6	2731_C6 - Complement component C6	25	1257	1	3026	4607	2973	1257	1624	1639	2559	2121	2335	4033	2931	2226	1696	2164	2164	2905	2067	4722
2941_INS - Insulin	2941_INS - Insulin	25	1259	1	2789	3101	4376	4050	1259	4034	1897	4517	3145	2210	3932	4467	2571	3749	2949	3569	4280	4003
546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	546_Lipid::Lysolipid::1-stearoylglycerophosphocholine	25	1260	1	2033	3220	1960	2268	2451	1260	3813	2402	3615	2504	2156	2435	1824	3452	3906	2663	1310	3173
1141_Chronotype	1141_Chronotype	25	1261	1	1689	4406	2420	2851	2003	3657	2857	3130	1933	2611	2048	3643	3721	3483	3651	2371	3608	1261
2793_PON1 - Serum paraoxonase/arylesterase 1	2793_PON1 - Serum paraoxonase/arylesterase 1	25	1265	1	1558	1265	2987	2674	4313	1704	3967	1416	2402	3056	2976	3838	2698	1556	3311	3932	4178	1706
4210_Chronic kidney disease	4210_Chronic kidney disease	25	1269	1	1851	1419	1776	3069	4461	4099	4649	4644	3379	1765	2234	3166	3032	4146	4739	3857	1269	4340
1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	1672_Bilirubin (at exam 2, FBAT, adjusted for multivariable)	25	1270	1	2699	3303	4468	2211	1270	4614	2593	2056	2987	4549	2291	1358	2969	3777	3666	4528	4424	4678
1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	1358_Total cholesterol (at exam 1, FBAT, adjusted for age and sex)	25	1271	1	3882	3449	4627	3482	1371	2353	2216	3514	1955	2084	1769	1271	2018	3415	2659	1722	2529	3353
2192_FGF18 - Fibroblast growth factor 18	2192_FGF18 - Fibroblast growth factor 18	25	1272	1	3195	2399	3570	1730	2794	4093	1272	4077	1297	1779	3938	2725	4158	1729	2798	4276	3310	1737
405_Amino acid::Tryptophan metabolism::indolelactate	405_Amino acid::Tryptophan metabolism::indolelactate	25	1275	1	1528	4204	1763	4652	2148	2729	3346	2077	4407	2171	3994	1275	3490	2253	3447	4412	4189	3897
1074_Serum levels of soluble E-selectin with T1D	1074_Serum levels of soluble E-selectin with T1D	25	1277	1	3678	2958	3678	3654	3623	3502	3566	4382	2493	3387	4018	2841	4166	3572	1277	3777	1739	3805
561_Lipid::Medium chain fatty acid::undecanoate (11:0)	561_Lipid::Medium chain fatty acid::undecanoate (11:0)	25	1278	1	4153	3139	2578	2686	4493	1943	1278	1643	1807	4629	4642	4191	2022	2838	4226	3426	2297	4613
4431_Toxoplasmosis IgG levels	4431_Toxoplasmosis IgG levels	25	1280	1	3159	3824	1993	1280	1299	3237	2942	2229	4722	2937	4358	3049	4484	2416	4530	3526	1829	2689
1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	1819_Inter-trochanteric buckling ratio (GEE, female, adjussted for multivariable)	25	1282	1	3739	3772	3944	4370	1642	1784	2755	3953	1729	4634	1282	1957	3356	4076	1522	3098	1721	3786
2720_PGAM1 - Phosphoglycerate mutase 1	2720_PGAM1 - Phosphoglycerate mutase 1	25	1284	1	1397	4253	4562	2876	2008	2522	2819	1900	3270	3025	2301	3091	3657	1284	2262	3615	3957	2097
2563_CCL22 - C-C motif chemokine 22	2563_CCL22 - C-C motif chemokine 22	25	1286	1	4406	4011	1419	2712	2010	2011	1347	4489	2512	1286	3583	1348	3031	3951	3662	4620	2211	2654
15_Posttraumatic stress disorder	15_Posttraumatic stress disorder	25	1293	1	4546	4729	3871	4084	3403	1293	3814	3449	3956	2588	2730	2041	4302	1653	4414	2507	2786	4235
1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	1850_Neck average buckling ratio (FBAT, female, adjussted for multivariable)	25	1303	1	3758	1577	3602	1676	3162	3230	3877	1303	3020	2333	4263	4492	4733	3405	1511	1408	2717	1581
4449_Left fusiform	4449_Left fusiform	25	1304	1	2154	1408	4486	3877	2889	2580	1821	3856	1756	3603	3721	2549	1304	3664	3579	4041	1732	2736
2788_NME2 - Nucleoside diphosphate kinase B	2788_NME2 - Nucleoside diphosphate kinase B	25	1312	1	4603	2879	4087	3597	2310	4315	3584	4292	4398	3763	3872	2893	3174	3754	4577	3177	4173	1312
378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	378_Amino acid::Glutathione metabolism::cysteine-glutathione disulfide	25	1313	1	3431	3564	4465	2744	4611	3514	3255	3718	4118	3783	2503	2668	2291	2616	3526	1313	2788	4417
1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1249_Percent predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	1315	1	3557	3928	3127	4668	2726	3922	2211	3596	1315	4593	2608	4684	2930	2754	4731	1907	4018	4661
1207_Longevity (>= 85 yrs vs < 65 yrs)	1207_Longevity (>= 85 yrs vs < 65 yrs)	25	1319	1	2316	1949	2191	3205	1994	3301	3149	1319	2492	3667	1628	3087	3196	3086	4169	4699	3655	3527
3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	3677_Diagnoses - main ICD10: M17 Osteoarthritis of knee	25	1321	1	3542	1808	3640	3640	2127	2094	1860	2945	3263	4407	2038	2196	1682	3604	4547	3898	1321	3523
2055_Remission after 12 weeks of antidepressant treatment in MDD	2055_Remission after 12 weeks of antidepressant treatment in MDD	25	1324	1	3852	4549	3002	2077	4582	3463	3353	1324	2510	1997	3925	4637	4123	2596	3113	2686	1472	3723
3900_Red blood cell count (three-way meta)	3900_Red blood cell count (three-way meta)	25	1329	1	1683	4069	3850	4253	2603	4639	3357	1848	1662	1358	4532	1526	4641	1433	1329	2387	1974	1600
1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	1362_Total cholesterol (at exam 3, FBAT, adjusted for age and sex)	25	1334	1	1485	2657	3780	3387	3874	2665	2206	1394	2635	2863	3245	2125	3124	4407	1667	1334	2399	3936
1069_Diabetic Nephropathy in Type 1 Diabetes	1069_Diabetic Nephropathy in Type 1 Diabetes	25	1339	1	4038	3998	4501	4255	3612	4360	4143	2308	2240	1339	2053	4573	3294	2445	3762	3382	3277	4246
4592_Right pars opercularis	4592_Right pars opercularis	25	1345	1	3564	4569	2270	4027	4178	2116	3985	1925	2695	3926	3544	2369	4074	1345	2091	4294	2601	4636
3365_Back pain for 3+ months	3365_Back pain for 3+ months	25	1354	1	4724	1940	2719	4726	4694	3455	4544	2910	4161	2969	4533	1458	4001	3569	2712	3023	1354	4707
3225_Hands-free device/speakerphone use with mobile phone in last 3 month	3225_Hands-free device/speakerphone use with mobile phone in last 3 month	25	1357	1	2231	4098	3057	1946	1357	2738	3703	3502	1428	1421	2790	2322	2972	2354	1975	2338	2995	4076
4377_Resting heart rate	4377_Resting heart rate	25	1359	1	2078	2071	1359	1724	4700	1482	1924	3527	2585	3723	1928	1807	2783	2455	1491	4706	2848	2605
1095_Diastolic Blood Pressure	1095_Diastolic Blood Pressure	25	1368	1	3929	4263	4280	4519	1368	3630	1607	3220	4099	4721	1775	3997	3216	3295	4473	2506	2058	3377
395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	395_Amino acid::Phenylalanine & tyrosine metabolism::p-cresol sulfate	25	1368	1	3156	4154	3222	2546	4516	3650	4268	1368	3867	3735	1876	2171	4504	1880	4392	3998	4162	2908
1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	1282_Sagittal diameter by CT (FBAT, adjusted for age, sex, smoking and menopause)	25	1369	1	1369	2178	1555	4242	3529	3728	4188	4689	3656	4497	2238	2218	3030	3679	3681	2511	3021	3037
2864_IL11 - Interleukin-11	2864_IL11 - Interleukin-11	25	1371	1	1782	4548	3606	1371	2157	2570	3387	2174	1464	2029	3429	2901	2741	4619	3346	3412	1755	1573
1080_Prostate cancer	1080_Prostate cancer	25	1375	1	4415	4448	2970	2339	1375	2830	1663	2212	2529	3484	1828	3949	2531	4571	1932	4595	2727	3242
124_Body Mass Index (male)	124_Body Mass Index (male)	25	1376	1	4268	4471	2995	4727	4394	3774	2459	3721	1376	2632	3568	3760	3498	3928	2317	3261	4071	3423
2365_ULBP2 - NKG2D ligand 2	2365_ULBP2 - NKG2D ligand 2	25	1383	1	3346	3205	1467	4512	4697	3452	3910	2088	2506	2798	1915	1673	3884	4171	1507	2425	1383	2611
2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	2509_CAMK1D - Calcium/calmodulin-dependent protein kinase type 1D	25	1391	1	4214	2770	2687	2341	4384	1953	2389	1602	4235	1863	1552	3074	3243	4354	3319	2753	1391	2090
1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	1250_Percent predicted FEF25-75/FVC for latest exam (FBAT, adjusted for multiple covariates)	25	1394	1	4120	3062	3936	3067	2179	1975	2398	4330	3709	1612	2654	1394	2156	3848	4519	4120	3398	2233
2423_ACAN - Aggrecan core protein	2423_ACAN - Aggrecan core protein	25	1396	1	3339	2888	3538	1396	4439	1738	2842	4524	3015	2341	2653	4082	2625	3413	3080	1720	1907	1605
3226_Difference in mobile phone use compared to two years previously	3226_Difference in mobile phone use compared to two years previously	25	1401	1	2828	2744	3081	3181	2369	4082	1864	4656	1802	4389	1998	4711	1401	3191	1945	3893	3756	3304
1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	1280_Sagittal diameter by CT (FBAT, adjusted for age and sex)	25	1406	1	1428	3948	1572	4231	4743	2079	1406	2589	2880	4367	4690	1748	3319	1715	4013	2454	4192	3371
1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	1428_Small high-density lipoprotein by NMR (at exam 4, FBAT, adjusted for multivariable)	25	1408	1	2140	2763	2198	1993	4136	4641	3634	3237	2978	1545	2240	2315	3549	4064	2430	1793	3256	1408
3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	3687_Diagnoses - secondary ICD10: E66 Overweight and obesity	25	1414	1	3721	4226	4497	1458	3220	3024	1414	1603	4282	3693	4709	4048	3518	4651	3345	4162	4502	2052
2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	2120_ERBB4 - Receptor tyrosine-protein kinase erbB-4	25	1415	1	1415	3390	3762	3999	2036	4284	2752	3935	3161	3777	4194	3373	4278	4104	1968	2649	1962	4233
1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	1863_Neck cross-sectional moment of inertia (GEE, female, adjussted for age)	25	1418	1	1795	4345	4339	4185	2238	1418	3704	3207	4254	3737	1575	3096	1890	2836	2653	4698	3785	3415
4723_Genu of corpus callosum mode of anisotropy	4723_Genu of corpus callosum mode of anisotropy	25	1421	1	1421	4117	2322	2147	3772	3803	3289	3415	2653	2765	4203	3849	2987	3457	3312	2099	4215	3571
639_Xenobiotics::Tobacco metabolite::cotinine	639_Xenobiotics::Tobacco metabolite::cotinine	25	1422	1	1842	2542	3960	4308	3115	2503	3068	4537	3659	2153	3493	1518	2086	4048	3091	2293	1422	3243
4224_Agents acting on the renin-angiotensin system	4224_Agents acting on the renin-angiotensin system	25	1427	1	3804	3956	3809	4546	4712	3081	4172	3123	3303	2352	3365	3689	3325	1857	3722	3844	2452	1427
2424_ANGPTL3 - Angiopoietin-related protein 3	2424_ANGPTL3 - Angiopoietin-related protein 3	25	1440	1	1440	2713	2511	4469	2740	2925	4509	4438	2883	2556	2993	2367	3315	3426	2024	3124	3887	1952
4317_Drinks per day	4317_Drinks per day	25	1441	1	3292	3026	3940	1441	4525	4021	2606	3631	4531	3871	2256	1523	4673	2286	4046	4122	4709	2552
2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	2728_HSPA1A - Heat shock 70 kDa protein 1A/1B	25	1442	1	1701	1910	2135	4691	2704	4491	2668	4095	4180	4166	1442	2596	4172	2697	3586	3849	2062	3554
500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	500_Lipid::Fatty acid, dicarboxylate::hexadecanedioate	25	1442	1	1490	2198	3019	4235	2134	3634	4050	1790	2178	2777	3184	3378	4208	3390	4478	1442	1605	3018
4448_Left entorhinal	4448_Left entorhinal	25	1458	1	3549	4584	1567	3030	2900	3906	1458	3872	3499	3070	3610	2714	4482	3720	4100	2460	4496	2257
3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	3698_Diagnoses - secondary ICD10: K44 Diaphragmatic hernia	25	1458	1	2085	4627	3687	3317	2787	2530	1859	2709	3230	3098	3803	3750	1458	2862	3179	4562	1678	4544
4420_Influenza A seropositivity	4420_Influenza A seropositivity	25	1459	1	1459	3017	1712	4168	2331	3681	3597	1714	4548	2127	1747	4679	2338	2950	1740	2259	1611	3135
250_CD39 on CD4 T	250_CD39 on CD4 T	25	1467	1	3017	1850	1481	2857	3959	3284	2910	2109	1940	1791	2904	1912	1722	2051	1467	2095	2469	1773
4205_Estimated glomerular filtration rate	4205_Estimated glomerular filtration rate	25	1468	1	3639	1532	3770	1706	3564	3470	2602	4053	3829	1797	1907	1468	2991	2741	3592	3880	2993	4030
2313_JAM3 - Junctional adhesion molecule C	2313_JAM3 - Junctional adhesion molecule C	25	1468	1	2685	3753	3108	2799	2186	3824	2627	3315	3401	2392	2850	3865	1468	2150	3236	2970	4708	1633
3273_Skin colour	3273_Skin colour	25	1471	1	3445	4081	1535	3072	3640	3536	1919	3028	3696	1524	1471	1502	1805	3660	2635	4331	3715	4458
1059_Diabetic Nephropathy in Type 1 Diabetes	1059_Diabetic Nephropathy in Type 1 Diabetes	25	1484	1	4586	3800	1843	3757	2534	1484	4679	3063	4535	2825	2081	4313	3168	3697	4697	2724	2908	1875
1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	1305_Fasting insulin (at exam 7, GEE, adjusted for age and sex)	25	1488	1	2947	1920	3354	3679	1488	1987	3097	2605	2295	3343	2217	3660	2268	3729	2552	4240	2312	2616
2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	2885_HS6ST1 - Heparan-sulfate 6-O-sulfotransferase 1	25	1491	1	3300	2021	1978	1491	1842	4135	4100	4094	2004	3560	4434	3413	3899	3516	2614	1829	4198	2588
1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	1908_Lateral ventricular volume (FBAT, adjusted for multivariable)	25	1497	1	3905	2232	1918	1766	1497	3403	4418	3232	3345	3320	2856	3981	3116	4049	2301	3708	3679	1555
4537_Right pallidum	4537_Right pallidum	25	1498	1	4479	1498	2703	4258	2869	3385	3032	2275	3767	3716	2852	2747	2278	3265	4506	2341	3287	2440
2454_CADM1 - Cell adhesion molecule 1	2454_CADM1 - Cell adhesion molecule 1	25	1499	1	2542	4301	4061	3900	2871	2195	2753	2474	1511	1499	4485	4365	2273	2280	3806	2957	2315	2512
2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	2277_NBL1 - Neuroblastoma suppressor of tumorigenicity 1	25	1506	1	3790	2417	4166	3548	4170	4192	2445	2645	2910	3497	3999	3324	3846	4560	4543	1506	2945	3556
4215_Estimated glomerular filtration rate	4215_Estimated glomerular filtration rate	25	1507	1	3310	3275	2898	3960	3400	3660	2799	3987	3494	4054	2796	2843	3875	4535	1633	1507	3996	4494
718_::::X-11530	718_::::X-11530	25	1530	1	1530	2196	3424	2761	2168	3636	2265	1767	3447	1551	3589	4338	2888	3884	3665	2325	4622	2567
2232_XRCC6 - X-ray repair cross-complementing protein 6	2232_XRCC6 - X-ray repair cross-complementing protein 6	25	1544	1	4622	3422	2136	4240	2222	4566	4294	3265	2680	1855	3384	4280	3390	1972	3404	3585	3429	1544
4063_Estimated glomerular filtration rate based on serum creatinine	4063_Estimated glomerular filtration rate based on serum creatinine	25	1547	1	3374	1694	3410	1764	3033	3378	2354	3398	4291	2318	1897	1547	2993	2788	3102	4243	2902	4273
744_::::X-11905	744_::::X-11905	25	1581	1	2812	4097	3021	2283	4329	1716	3559	4668	3322	2301	3391	1581	3705	4408	4679	3400	4252	4143
1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	1900_Troch Neck BMD (FBAT, male, adjussted for multivariable)	25	1585	1	1585	3901	3566	3238	4623	4301	3499	3038	2147	3131	3465	1592	2542	3499	1665	2945	4448	4367
1097_Mean Arterial Pressure	1097_Mean Arterial Pressure	25	1596	1	3288	2387	3340	3996	3546	3785	4369	4302	3738	4249	1596	4484	3433	4207	4241	3994	4277	4440
563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	563_Lipid::Monoacylglycerol::1-oleoylglycerol (1-monoolein)	25	1615	1	4699	2944	1943	3983	3468	3926	1906	1615	4672	2723	3888	2336	4614	3375	4212	3396	3605	2055
3287_Sensitivity / hurt feelings	3287_Sensitivity / hurt feelings	25	1623	1	3093	4088	1892	3120	4102	1946	1848	4501	2884	2952	2816	1645	3723	3918	2020	4709	3755	1623
4206_Estimated glomerular filtration rate	4206_Estimated glomerular filtration rate	25	1626	1	4122	1626	3811	1768	3086	3515	2649	3981	3871	1874	2078	1733	3051	3031	3457	3909	3030	4159
4491_Right pars opercularis	4491_Right pars opercularis	25	1633	1	3986	4133	4713	4442	1633	4552	2554	4269	4611	3141	3258	3758	2529	4586	4695	3791	2618	1822
2241_WIF1 - Wnt inhibitory factor 1	2241_WIF1 - Wnt inhibitory factor 1	25	1634	1	4081	3520	1634	4486	3099	3638	3022	2537	4638	1949	3068	4472	1688	3594	3435	3214	4696	3502
1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	1259_Residual from predicted FEF25-75 for latest exam (GEE, adjusted for multiple covariates)	25	1634	1	4183	2490	4378	2281	4169	3573	4132	3958	1989	2599	1634	3419	2844	2179	2348	2279	4482	2848
1603_tPA (at exam 5, GEE, adjusted for age and sex)	1603_tPA (at exam 5, GEE, adjusted for age and sex)	25	1644	1	1900	4230	2562	3171	2883	4711	3096	4343	4435	2261	2636	2710	3064	3973	1644	4032	4157	4275
3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	3127_PDE4D - cAMP-specific 3',5'-cyclic phosphodiesterase 4D	25	1645	1	3146	1765	4658	4079	4096	2422	3334	4262	2588	3813	3702	3243	4575	1645	1983	2700	3309	3692
1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	1360_Total cholesterol (at exam 2, FBAT, adjusted for age and sex)	25	1658	1	4359	3838	2265	3681	3563	4593	2307	2562	2682	4247	2817	3374	4377	2352	4677	2953	1658	3492
4130_Neutrophil count	4130_Neutrophil count	25	1664	1	3812	3060	2579	2360	2824	4049	4090	3191	2738	2736	1664	4204	3811	2789	4079	2896	3124	2112
4069_Drinks per week	4069_Drinks per week	25	1686	1	3906	3661	4594	2333	1686	4229	3865	3380	4612	3794	3106	4729	4486	2603	4078	4249	4290	4225
1833_Neck length (GEE, male, adjusted for multivariable)	1833_Neck length (GEE, male, adjusted for multivariable)	25	1725	1	3057	3999	2730	2982	2977	4509	2239	2431	4337	4065	3340	4502	3496	2282	3150	3344	2173	1725
4368_Cannabis use	4368_Cannabis use	25	1741	1	3039	2691	4726	4666	1741	2010	3768	2215	2651	4252	2100	3066	2386	2269	2746	3029	2636	4491
4262_Facial attractiveness (female-coder, female samples)	4262_Facial attractiveness (female-coder, female samples)	25	1746	1	4685	2305	3342	2992	3644	2872	2802	3989	2179	3161	3930	1823	2874	3047	4573	2216	4206	1746
3145_CD86 - T-lymphocyte activation antigen CD86	3145_CD86 - T-lymphocyte activation antigen CD86	25	1756	1	4230	4490	2643	2578	2797	3149	2437	4396	2205	4370	4383	1756	4534	1983	2296	1988	4103	2467
1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	1777_Heart failure (censored at interval MI, GEE, adjusted for age and sex)	25	1872	1	3052	4436	2769	3129	2309	3553	4020	2329	4700	3104	4695	2410	1872	3591	4662	4334	3588	2051
1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	1586_Factor VII (at exam 5, FBAT, adjusted for age and sex)	25	1924	1	1924	2077	2517	4004	4278	2912	4113	3649	4056	3325	4059	2647	3354	2987	2781	3676	2547	2316
2421_CCDC80 - Coiled-coil domain-containing protein 80	2421_CCDC80 - Coiled-coil domain-containing protein 80	25	2082	1	3599	4483	3814	4545	3239	3021	4060	4670	4616	2082	4658	3346	4451	3891	2700	4349	4385	2599
4204_Estimated glomerular filtration rate	4204_Estimated glomerular filtration rate	25	2161	1	3351	4449	4416	3629	4566	4675	3999	3637	3646	4250	3937	4198	2161	3624	3390	2525	2933	4085
1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	1896_Shaft Section Modulus (FBAT, male, adjussted for multivariable)	25	2184	1	3705	2322	3045	4655	2443	2535	4485	4160	4641	3577	4140	2294	3318	2699	2880	2184	4325	3603
3516_Heating type(s) in home: Gas central heating	3516_Heating type(s) in home: Gas central heating	25	2307	1	3727	3803	3210	2307	3599	4131	4249	3737	3947	3957	3142	3097	4653	2441	4336	2611	4662	2880
2689_DNAJB1 - DnaJ homolog subfamily B member 1	2689_DNAJB1 - DnaJ homolog subfamily B member 1	25	2529	1	3983	3361	3076	3335	3374	2707	4420	4430	2742	3121	3928	4187	3727	2529	3902	3354	3665	3074
